Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Health and Human Services Centers for Medicare & Medicaid Services 42 CFR Parts 405, 410, 411, 414, 415, and 424
[CMS-1321-P]
RIN 0938-AO24
 AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.
 ACTION: Proposed rule.
 SUMMARY: This proposed rule would address certain provisions of the Deficit Reduction Act of 2005, as well as make other proposed changes to Medicare Part B payment policy. We are proposing these changes to ensure that our payment systems are updated to reflect changes in medical practice and the relative value of services. This proposed rule also discusses geographic practice cost indices (GPCI) changes; requests for additions to the list of telehealth services; payment for covered outpatient drugs and biologicals; payment for renal dialysis services; policies related to private contracts and opt-out; policies related to bone mass measurement services, independent diagnostic testing facilities, the physician self-referral prohibition; laboratory billing for the technical component (TC) of physician pathology services; the clinical laboratory fee schedule; certification of advanced practice nurses; health information technology, and the health care information transparency initiative.
 DATES: *Comment Date:*
                             Comments will be considered if we receive them at one of the addresses provided below, no later than 5 p.m. on October 10, 2006.
 ADDRESSES: In commenting, please refer to file code CMS-1321-P. Because of staff and resource limitations, we cannot accept comments by facsimile (fax) transmission. You may submit comments in one of three ways (no duplicates, please): 1. 
                            *Electronically.*
                             You may submit electronic comments on specific issues in this regulation to 
                            *http://www.cms.hhs.gov/​eRulemaking*. Click on the link “Submit electronic comments on CMS regulations with an open comment period.” (Attachments should be in Microsoft Word, WordPerfect, or Excel; however, we prefer Microsoft Word.) 2. 
                            *By mail.*
                             You may mail written comments (one original and two copies) to the following address only: Centers for Medicare & Medicaid Services, Department of Health and Human Services, Attention: CMS-1321-P, P.O. Box 8015, Baltimore, MD 21244-8015. Please allow sufficient time for mailed comments to be received before the close of the comment period. 3. 
                            *By express or overnight mail.*
                             You may send written comments (one original and two copies) to the following address only: Centers for Medicare & Medicaid Services, Department of Health and Human Services, Attention: CMS-1321-P, Mail Stop C4-26-05, 7500 Security Boulevard, Baltimore, MD 21244-1850. 4. 
                            *By hand or courier.*
                             If you prefer, you may deliver (by hand or courier) your written comments (one original and two copies) before the close of the comment period to one of the following addresses. If you intend to deliver your comments to the Baltimore address, please call telephone number (410) 786-7197 in advance to schedule your arrival with one of our staff members. Room 445-G, Hubert H. Humphrey Building, 200 Independence Avenue, SW., Washington, DC 20201; or 7500 Security Boulevard, Baltimore, MD 21244-1850. (Because access to the interior of the HHH Building is not readily available to persons without Federal Government identification, commenters are encouraged to leave their comments in the CMS drop slots located in the main lobby of the building. A stamp-in clock is available for persons wishing to retain a proof of filing by stamping in and retaining an extra copy of the comments being filed.) Comments mailed to the addresses indicated as appropriate for hand or courier delivery may be delayed and received after the comment period. *Submission of comments on paperwork requirements.*
                             You may submit comments on this document's paperwork requirements by mailing your comments to the addresses provided at the end of the “Collection of Information Requirements” section in this document. For information on viewing public comments, see the beginning of the 
                            **SUPPLEMENTARY INFORMATION**
                             section.
 FOR FURTHER INFORMATION CONTACT: Pam West, (410) 786-2302 (for issues related to practice expense). Stephanie Monroe, (410) 786-6864 (for issues related to the geographic practice cost index). Craig Dobyski, (410) 786-4584 (for issues related to list of telehealth services). Roberta Epps, (410) 786-4503 (for issues related to diagnostic imaging services). Bill Larson, (410) 786-4639 (for issues related to coverage of bone mass measurement and addition of ultrasound screening for abdominal aortic aneurysm to the “Welcome to Medicare” benefit). Dorothy Shannon, (410) 786-3396 (for issues related to the outpatient therapy cap). Catherine Jansto, (410) 786-7762 (for issues related to payment for covered outpatient drugs and biologicals). Henry Richter, (410) 786-4562 (for issues related to payments for end-stage renal disease facilities). Fred Grabau, (410) 786-0206 (for issues related to private contracts and opt-out provision). Lisa Ohrin, (410) 786-4565 (for issues related to physician self-referral prohibitions). David Walczak (410) 786-4475 (for issues related to reassignment provisions). August Nemec (410) 786-0612 (for issues related to independent diagnostic testing facilities). Anita Greenberg, (410) 786-4601 (for issues related to the clinical laboratory fee schedule). James Menas (410) 786-4507 (for issues related to payment for physician pathology services). Diane Milstead, (410) 786-3355 or Gaysha Brooks (410) 786-9649 (for all other issues).


SUPPLEMENTARY INFORMATION: *Submitting Comments:*
                         We welcome comments from the public on all issues set forth in this rule to assist us in fully considering issues and developing policies. You can assist us by referencing the file code CMS-1321-P and the specific “issue identifier” that precedes the section on which you choose to comment. *Inspection of Public Comments:*
                         All comments received before the close of the comment period are available for viewing by the public, including any personally identifiable or confidential business information that is included in a comment. We post all comments received before the close of the comment period on the following Web site as soon as possible after they have been received: 
                        *http://www.cms.hhs.gov/​eRulemaking*. Click on the link “Electronic Comments on CMS Regulations” on that Web site to view public comments. Comments received timely will also be available for public inspection as 
                        ( print page 48983)
                        they are received, generally beginning approximately 3 weeks after publication of a document, at the headquarters of the Centers for Medicare & Medicaid Services, 7500 Security Boulevard, Baltimore, Maryland 21244, Monday through Friday of each week from 8:30 a.m. to 4 p.m. To schedule an appointment to view public comments, phone 1-800-743-3951. Information on the physician fee schedule can be found on the CMS homepage. You can access this data by using the following directions: 1. Go to the following Web site: 
                        *http://www.cms.hhs.gov/​PhysicianFeeSched/​*. 2. Select “PFS Federal Regulation Notices.” To assist readers in referencing sections contained in this preamble, we are providing the following table of contents. Some of the issues discussed in this preamble affect the payment policies, but do not require changes to the regulations in the 
                        *Code of Federal Regulations*. Information on the regulation's impact appears throughout the preamble and is not exclusively in section VI. Table of Contents I. Background A. Development of the Relative Value System 1. Work RVUs 2. Practice Expense Relative Value Units (PE RVUs) 3. Resource-Based Malpractice RVUs 4. Refinements to the RVUs 5. Adjustments to RVUs Are Budget Neutral B. Components of the Fee Schedule Payment Amounts C. Most Recent Changes to the Fee Schedule II. Provisions of the Proposed Rule A. Resource-Based PE RVUs and Practice Expense Proposals for Calendar Year 2007 B. Geographic Practice Cost Indices C. Medicare Telehealth Services D. Miscellaneous Coding Issues 1. Global Period for Remote Afterloading High Intensity Brachytherapy Procedures 2. Assignment of RVUS to CPT Codes for Proton Beam Treatment Delivery Services E. Deficit Reduction Act (DRA) Related Proposals 1. Section 5102 of the DRA—Proposed Adjustments for Payments to Imaging Services 2. Section 5107 of the DRA—Revisions to Payments for Therapy Services 3. Section 5112 of the DRA—Proposed Addition of Ultrasound Screening for Abdominal Aortic Aneurysm (AAA) 4. Section 5113 of the DRA—Proposed Non-Application of the Part B Deductible for Colorectal Cancer Screening Tests 5. Section 5114—Proposed Addition of Diabetes Outpatient Self-Management Training Services (DSMT) and Medical Nutrition Therapy (MNT) for the FQHC Program F. Proposed Payment for Covered Outpatient Drugs and Biologicals (ASP Issues) G. Proposed Provisions Related to Payment for Renal Dialysis Services Furnished by End Stage Renal Disease (ESRD) Facilities H. Private Contracts and Opt-Out Provision—Practitioner Definition I. Proposed Changes to Reassignment and Physician Self-Referral Rules Relating to Diagnostic Tests J. Supplier Access to Claims Billed on Reassignment K. Coverage of Bone Mass Measurement Tests L. Independent Diagnostic Testing Facility (IDTF) Issues 1. Proposed IDTF Changes in the Physician Fee Schedule Proposed Rule 2. Proposed Performance Standards for IDTFs 3. Supervision 4. Place of Service M. Independent Laboratory Billing for the Technical Component (TC) of Physician Pathology Services to Hospital Patients N. Public Consultation for Medicare Payment for New Outpatient Clinical Diagnostic Laboratory Tests O. Proposal To Establish Criteria for National Certifying Bodies That Certify Advanced Practice Nurses P. Chiropractic Services Demonstration Q. Promoting Effective Use of Health Information Technology R. Health Care Information Transparency Initiative III. Collection of Information Requirements IV. Response to Comments V. Regulatory Impact Analysis Regulation Text Addendum A—Explanation and Use of Addendum B Addendum B—2007 Relative Value Units and Related Information Used in Determining Medicare Payments for 2007 Addendum C—Codes for Which We Received Practice Expense Review Committee (PERC) Recommendations on Practice Expense Direct Cost Inputs Addendum D—2007 Geographic Practice Cost Indices (GPCIs) by Medicare Carrier and Locality Addendum E—2007 Geographic Adjustment Factors (GAF) Addendum F—Proposed CPT/HCPCS Imaging Codes Defined by Section 5102(b) of the DRA In addition, because of the many organizations and terms to which we refer by acronym in this proposed final rule, we are listing these acronyms and their corresponding terms in alphabetical order below: AADA American Academy of Dermatology Association AAH American Association of Homecare AAP Average acquisition price ACC American College of Cardiology ACG American College of Gastroenterology ACHPN Advanced Certified Hospice and Palliative Nurse ACOG American College of Obstetrics and Gynecology ACR American College of Radiology ADA American Dietetic Association AFROC Association of Freestanding Radiation Oncology Centers AGA American Gastroenterological Association AHRQ Agency for Healthcare Research and Quality AMA American Medical Association AMP Average manufacturer price ASA American Society of Anesthesiologists ASGE American Society of Gastrointestinal Endoscopy ASP Average sales price ASTRO American Society for Therapeutic Radiation Oncology ATA American Telemedicine Association AUA American Urological Association AWP Average wholesale price BBA Balanced Budget Act of 1997 BBRA Balanced Budget Refinement Act of 1999 BES (Bureau of the Census) Business Expenditure Survey BIPA Medicare, Medicaid, and SCHIP Benefits Improvement Protection Act of 2000 BLS Bureau of Labor Statistics BMD Bone mineral density BMI Body mass index BMM Bone mass measurement BNF Budget neutrality factor BP Best price BSA Body surface area CAH Critical access hospital CAP College of American Pathologists CBSA Core-Based Statistical Area CCI Correct Coding Initiative CF Conversion factor CFR Code of Federal Regulations CMA California Medical Association CMS Centers for Medicare & Medicaid Services CNS Clinical nurse specialist CPEP Clinical Practice Expert Panel CPI Consumer Price Index CPO Care Plan Oversight CPT (Physicians') Current Procedural Terminology (4th Edition, 2002, copyrighted by the American Medical Association) CRNA Certified Registered Nurse Anesthetist CT Computed tomography CTA Computed tomographic angiography CY Calendar year DHS Designated health services DME Durable medical equipment DMERC Durable Medical Equipment Regional Carrier DRA Deficit Reduction Act DSMT Diabetes outpatient self-management training services DXA Dual energy x-ray absorptiometry E&M Evaluation and management EPO Erythopoeitin ESRD End stage renal disease FAX Facsimile FI Fiscal intermediary FR Federal Register GAF Geographic adjustment factor GAO General Accounting Office GDP Gross domestic product GPO Group purchasing organization
                            ( print page 48984) GPCI Geographic practice cost index HCPAC Health Care Professional Advisory Committee HCPCS Healthcare Common Procedure Coding System HCRIS Healthcare Cost Report Information System HSA Health Savings Account HHA Home health agency HHS (Department of) Health and Human Services HIT Health information technology HOCM High osmolar contrast media HPSA Health Professional Shortage Area HRSA Health Resources Services Administration (HHS) HUD (Department of) Housing and Urban Development IDTF Independent diagnostic testing facility IPF Inpatient psychiatric facility IPPS Inpatient prospective payment system IRF Inpatient rehabilitation facility ISO Insurance Services Office IVIG Intravenous immune globulin JCAAI Joint Council of Allergy, Asthma, and Immunology JUA Joint underwriting association LCD Local coverage determination LTCH Long-term care hospital LOCM Low osmolar contrast media LOINC® Logical Observation Identifiers Names and Codes MA Medicare Advantage MCAC Medicare Coverage Advisory Committee MCG Medical College of Georgia MedPAC Medicare Payment Advisory Commission MEI Medicare Economic Index MMA Medicare Prescription Drug, Improvement, and Modernization Act of 2003 MNT Medical nutrition therapy MRA Magnetic resonance angiography MRI Magnetic resonance imaging MSA Metropolitan statistical area NCD National coverage determination NCQDIS National Coalition of Quality Diagnostic Imaging Services NDC National drug code NECMA New England County Metropolitan Area NECTA New England City and Town Area NP Nurse practitioner NPP Nonphysician practitioners NPWP Nonphysician Work Pool OBRA Omnibus Budget Reconciliation Act OIG Office of Inspector General OMB Office of Management and Budget OPD Outpatient Department OPPS Outpatient prospective payment system OSCAR Online Survey and Certification and Reporting PA Physician assistant PBM Pharmacy benefit managers PC Professional component PE Practice Expense PEAC Practice Expense Advisory Committee PERC Practice Expense Review Committee PET Positron emission tomography PFS Physician Fee Schedule PLI Professional liability insurance PPI Producer price index PPO Preferred provider organization PPS Prospective payment system PRA Paperwork Reduction Act PT Physical therapy QCT Quantitative computerized tomography RFA Regulatory Flexibility Act RIA Regulatory impact analysis RN Registered nurse RUC (AMA's Specialty Society) Relative (Value) Update Committee RVU Relative value unit SXA Single energy x-ray absorptiometry SPA Single photon absorptiometry SGR Sustainable growth rate SMS (AMA's) Socioeconomic Monitoring System SNF Skilled Nursing Facility SNM Society for Nuclear Medicine TA Technology Assessment TC Technical Component UAF Update adjustment factor UPIN Unique Physician Identification Number WAC Wholesale acquisition cost WAMP Widely available market price I. Background [If you choose to comment on issues in this section, please include the caption “BACKGROUND” at the beginning of your comments.] Since January 1, 1992, Medicare has paid for physicians' services under section 1848 of the Social Security Act (the Act), “Payment for Physicians’ Services.” The Act requires that payments under the physician fee schedule (PFS) be based on national uniform relative value units (RVUs) based on the resources used in furnishing a service. Section 1848(c) of the Act requires that national RVUs be established for physician work, practice expense (PE), and malpractice expense. Before the establishment of the resource-based relative value system, Medicare payment for physicians’ services was based on reasonable charges. A. Development of the Relative Value System 1. Work RVUs The concepts and methodology underlying the PFS were enacted as part of the Omnibus Budget Reconciliation Act (OBRA) of 1989, Pub. L. 101-239, and OBRA 1990, (Pub. L. 101-508). The final rule, published November 25, 1991 (56 FR 59502), set forth the fee schedule for payment for physicians’ services beginning January 1, 1992. Initially, only the physician work RVUs were resource-based, and the PE and malpractice RVUs were based on average allowable charges. The physician work RVUs established for the implementation of the fee schedule in January 1992 were developed with extensive input from the physician community. A research team at the Harvard School of Public Health developed the original physician work RVUs for most codes in a cooperative agreement with the Department of Health and Human Services (HHS). In constructing the code-specific vignettes for the original physician work RVUs, Harvard worked with panels of experts, both inside and outside the Federal government, and obtained input from numerous physician specialty groups. Section 1848(b)(2)(A) of the Act specifies that the RVUs for radiology services are based on relative value scale we adopted under section 1834(b)(1)(A) of the Act, (the American College of Radiology (ACR) relative value scale), which we integrated into the overall PFS. Section 1848(b)(2)(B) of the Act specifies that the RVUs for anesthesia services are based on RVUs from a uniform relative value guide. We established a separate conversion factor (CF) for anesthesia services, and we continue to utilize time units as a factor in determining payment for these services. As a result, there is a separate payment methodology for anesthesia services. We establish physician work RVUs for new and revised codes based on recommendations received from the American Medical Association's (AMA) Specialty Society Relative Value Update Committee (RUC). 2. Practice Expense Relative Value Units (PE RVUs) Section 121 of the Social Security Act Amendments of 1994 (Pub. L. 103-432), enacted on October 31, 1994, amended section 1848(c)(2)(C)(ii) of the Act and required us to develop resource-based PE RVUs for each physician's service beginning in 1998. We were to consider general categories of expenses (such as office rent and wages of personnel, but excluding malpractice expenses) comprising practice expenses. Section 4505(a) of the Balanced Budget Act of 1997 (BBA) (Pub. L. 105-33), amended section 1848(c)(2)(C)(ii) of the Act to delay implementation of the resource-based PE RVU system until January 1, 1999. In addition, section 4505(b) of the BBA provided for a 4-year transition period from charge-based PE RVUs to resource-based RVUs. We established the resource-based PE RVUs for each physician's service in a final rule, published November 2, 1998 (63 FR 58814), effective for services furnished in 1999. Based on the requirement to transition to a resource-based system for PE over a 4-year period, resource-based PE RVUs did not become fully effective until 2002.
                        ( print page 48985) This resource-based system was based on two significant sources of actual PE data: The Clinical Practice Expert Panel (CPEP) data and the AMA's Socioeconomic Monitoring System (SMS) data. The CPEP data were collected from panels of physicians, practice administrators, and nonphysicians (for example, registered nurses) nominated by physician specialty societies and other groups. The CPEP panels identified the direct inputs required for each physician's service in both the office setting and out-of-office setting. The AMA's SMS data provided aggregate specialty-specific information on hours worked and practice expenses. Separate PE RVUs are established for procedures that can be performed in both a nonfacility setting, such as a physician's office, and a facility setting, such as a hospital outpatient department. The difference between the facility and nonfacility RVUs reflects the fact that a facility receives separate payment from Medicare for its costs of providing the service, apart from payment under the PFS. The nonfacility RVUs reflect all of the direct and indirect practice expenses of providing a particular service. Section 212 of the Balanced Budget Refinement Act of 1999 (BBRA) (Pub. L. 106-113) directed the Secretary of Health and Human Services (the Secretary) to establish a process under which we accept and use, to the maximum extent practicable and consistent with sound data practices, data collected or developed by entities and organizations to supplement the data we normally collect in determining the PE component. On May 3, 2000, we published the interim final rule (65 FR 25664) that set forth the criteria for the submission of these supplemental PE survey data. The criteria were modified in response to comments received, and published in the 
                        **Federal Register**
                         (65 FR 65376) as part of a November 1, 2000 final rule. The PFS final rules published in 2001 and 2003, respectively, (66 FR 55246 and 68 FR 63196) extended the period during which we would accept these supplemental data. 3. Resource-Based Malpractice RVUs Section 4505(f) of the BBA amended section 1848(c) of the Act to require us to implement resource-based malpractice RVUs for services furnished on or after 2000. The resource-based malpractice RVUs were implemented in the PFS final rule published November 2, 1999 (64 FR 59380). The malpractice RVUs were based on malpractice insurance premium data collected from commercial and physician-owned insurers from all the States, the District of Columbia, and Puerto Rico. 4. Refinements to the RVUs Section 1848(c)(2)(B)(i) of the Act requires that we review all RVUs no less often than every 5 years. The first 5-year review of the physician work RVUs went into effect in 1997, published on November 22, 1996 (61 FR 59489). The second 5-year review went into effect in 2002, published on November 1, 2001 (66 FR 55246). The next scheduled 5-year review is scheduled to go into effect in 2007. In 1999, the AMA's RUC established the Practice Expense Advisory Committee (PEAC) for the purpose of refining the direct PE inputs. Through March of 2004, the PEAC provided recommendations to CMS for over 7,600 codes (all but a few hundred of the codes currently listed in the AMA's Current Procedural Terminology (CPT) codes). In the November 15, 2004, PFS final rule (69 FR 66236), we implemented the first 5-year review of the malpractice RVUs (69 FR 66263). 5. Adjustments to RVUS Are Budget Neutral Section 1848(c)(2)(B)(ii)(II) of the Act provides that adjustments in RVUs for a year may not cause total PFS payments to differ by more than $20 million from what they would have been if the adjustments were not made. In accordance with section 1848(c)(2)(B)(ii)(II) of the Act, if adjustments to RVUs cause expenditures to change by more than $20 million, we make adjustments to ensure that expenditures do not increase or decrease by more than $20 million. B. Components of the Fee Schedule Payment Amounts To calculate the payment for every physician service, the components of the fee schedule (physician work, PE, and malpractice RVUs) are adjusted by a geographic practice cost index (GPCI). The GPCIs reflect the relative costs of physician work, PEs, and malpractice insurance in an area compared to the national average costs for each component. Payments are converted to dollar amounts through the application of a CF, which is calculated by the Office of the Actuary and is updated annually for inflation. The general formula for calculating the Medicare fee schedule amount for a given service and fee schedule area can be expressed as: Payment = [(RVU work × GPCI work) + (RVU PE × GPCI PE) + (RVU malpractice × GPCI malpractice)] × CF. (
                        **Note:**
                         As discussed in the June 29, 2006 proposed notice for the Five-Year Review of Work Relative Value Units Under the Physician Fee Schedule and Proposed Changes to the Practice Expense Methodology (71 FR 37170), we have proposed to establish a separate budget neutrality adjustor that would be applied in the calculation of the work RVUs. Application of this budget neutrality adjustor would enable us to meet the budget neutrality provisions of section 1848(c)(2)(B)(ii) of the Act.) C. Most Recent Changes to the Fee Schedule The final rule with comment period that appeared in the 
                        **Federal Register**
                         on November 21, 2005 (70 FR 70116) addressed Medicare Part B payment policy, including the physician fee schedule, that is applicable for calendar year (CY) 2006; and finalized certain provisions of the interim final rule to implement the Competitive Acquisition Program (CAP) for Part B Drugs. It also revised Medicare Part B payment and related policies regarding: Physician work, practice expense and malpractice RVUs; Medicare telehealth services; multiple diagnostic imaging procedures; covered outpatient drugs and biologicals; supplemental payments to Federally Qualified Health Centers (FQHCs); renal dialysis services; coverage for glaucoma screening services; National Coverage Determination (NCD) timeframes; and physician referrals for nuclear medicine services and supplies to health care entities with which physicians have financial relationships. In addition, the rule finalized the interim RVUs for CY 2005 and issued interim RVUs for new and revised procedure codes for CY 2006. The rule also updated the codes subject to the physician self-referral prohibition and discussed payment policies relating to teaching anesthesia services, therapy caps, private contracts and opt-out, and chiropractic and oncology demonstrations. In accordance with section 1848(d)(1)(E)(i) of the Act, we also announced that the PFS update for CY 2006 would be −4.4 percent; the initial estimate for the sustainable growth rate for CY 2006 would be 1.7; and the CF for CY 2006 would be $36.1770. However, subsequent to publication of the CY 2005 PFS final rule with comment period, section 5104 of the Deficit Reduction Act (DRA) of 2005 (Pub. L. 109-171, February 8, 2006), was enacted which amended section 1848(d) 
                        ( print page 48986)
                        of the statute to provide for a 0 percent update effective January 1, 2006. We also note that the Five-Year Review of Work Relative Value Units Under the Physician Fee Schedule and Proposed Changes to the Practice Expense Methodology proposed notice appeared in the 
                        **Federal Register**
                         on June 29, 2006 (71 FR 37170). In that notice, we proposed revisions to work RVUs affecting payment for physicians’ services. The revisions reflect changes in medical practice, coding changes, and new data on relative value components that affect the relative amount of physician work required to perform each service, as required by the statute. We also proposed revisions to our methodology for calculating PE RVUs, including changes based on supplemental survey data for PE. This revised methodology would be used to establish payment for services beginning January 1, 2007. As indicated in the June 29, 2006 proposed notice, we will respond to the comments received on that notice as part of the final Medicare PFS rule for CY 2007 scheduled for publication this fall. If adopted, the RVU revisions would be fully implemented for services furnished to Medicare beneficiaries on or after January 1, 2007. The PE revisions would be phased-in over a four-year period; although, as we gain experience with the new methodology, we will reexamine this policy beginning next year and propose necessary revisions through future rulemaking. II. Provisions of the Proposed Rule [If you choose to comment on issues in this section, please include the caption “PROVISIONS” at the beginning of your comments.] A. Resource-Based Practice Expense (PE) RVU Proposals for CY 2007 Major changes to the PE methodology for 2007, as well as a detailed discussion of the current PE methodology, are discussed in the June 29, 2006 proposed notice (71 FR 37170 through 37430). This proposed rule contains proposals for direct PE including clinical labor, medical supplies and medical equipment. 1. RUC Recommendations for Direct PE Inputs and Other PE Input Issues The following discussions are proposals concerning direct PE inputs. (a) RUC Recommendations The AMA's Relative Value Update Committee (RUC) established a new committee, the Practice Expense Review Committee (PERC), to assist the RUC in recommending direct PE inputs (clinical staff, supplies, and equipment) for new and existing CPT codes. The PERC reviewed the PE inputs for over 2000 existing codes, some of which were unresolved PE issues from the CY 2006 PFS final rule with comment period, at their meetings held in September 2005, February 2006 and April 2006. (A list of these reviewed codes can be found in Addendum C of this proposed rule.) We have reviewed the PERC-submitted recommendations and propose to adopt all of them. We have worked with the AMA staff to make corrections for any typographical errors and to ensure that previously PEAC-accepted standards are incorporated in the recommendations. The complete PERC recommendations and the revised PE database can be found on our Web site. (See the 
                        **SUPPLEMENTARY INFORMATION**
                         section of this proposed rule for directions on accessing our Web site.) (b) Standard Supplies and Equipment for 90-Day Global Codes We are proposing to revise the CPEP supply and equipment inputs for those 90-day global procedures for which the RUC has only refined the clinical labor inputs. We are proposing to apply the standard supply and equipment inputs for the facility setting for 90-day global services to these remaining unrefined 90-day global procedure codes. As recommended by the RUC, for supplies, we propose to include one minimum supply visit package for each post-operative visit assigned to each code and a post-surgical incision care kit (suture, staples, or both) where appropriate, along with additional items recommended by the RUC for certain procedures. For equipment, we are proposing to include an exam table and light. However, there are several issues on which we need input before we finalize the recommended standards. For example, for many of the 90-day codes in question, the current supply input data contain supplies in far larger quantities than are contained in either the visit package or incision care kit. For other codes, the current data includes items that are not contained in the package or kit. In other cases, the recommendations from the RUC contain additional items in quantities that appear excessive. We plan to work with all the concerned specialties to ensure that the finalized inputs do represent the typical supplies needed to perform each procedure. Because the application of the 90-day global standard supplies and equipment would result in the deletion of some original CPEP inputs, we are requesting that all the medical specialties examine the direct PE inputs on our Web site and let us know whether there are additional items from the original CPEP data that are a necessary part of the post-operative care and if the PE inputs listed are correct. (See the 
                        **SUPPLEMENTARY INFORMATION**
                         section of this proposed rule for directions on accessing our Web site.) 2. Payment for Splint and Cast Supplies In the PFS final rules published November 1999 (64 FR 59380) and November 2000 (65 FR 65376), we removed splint and cast supplies from the PE database for the CPT codes for fracture management and cast/strapping application procedures. Because splint and cast supplies could be separately billed using Healthcare Common Procedure Coding System (HCPCS) codes (Q4001-Q4051) that were established for payment of these supplies under section 1861(s)(5) of the Act, we did not want to make duplicate payment under the PFS for these items. In the CY 2006 PFS proposed rule (70 FR 70116), we proposed to reinstate payment for all splints and cast supplies through the PE component of the PFS because we believed we may have unintentionally prohibited remuneration for these supplies when they are not used for reduction of a fracture or dislocation (covered under section 1861(s)(5) of the Act), but rather are provided (and covered) as “incident to” a physician service under section 1861(s)(2)(A) of the Act. This proposal was not finalized; however, in our final rule we asked the medical specialties and the PERC to determine the typical supplies for splints and casts necessary for each of the fracture management codes and the cast/strapping application codes because we wanted to make certain that the supply inputs were correct before we proceeded with rulemaking for the CY 2007 PFS. At its February 2006 meeting, the PERC reviewed and approved the supply inputs submitted by the AAOS for each CPT code for fracture management and cast/strapping application and these were forwarded to us as PERC recommendations. During this interim period we also reassessed the options for payment of materials for splints and casts. We believe that the majority of the splint and cast supplies that are currently paid through the Q-codes are furnished in relationship to cast/strapping procedures for the management of fractures and dislocations. However, we did not intend for the medically necessary 
                        ( print page 48987)
                        splint and cast supplies used for other reasons (for example, serial casting, wound care, or protection) not to be paid. Because it may be difficult for the contractors to identify the purpose for the cast/strapping application procedure on a claim form, we believe that contractors may have been paying for the splint and cast supply Q-codes when the service is performed for other purposes than treatment of fractures and dislocations. Since these splint and cast supplies can be covered under both sections 1861(s)(5) and 1861(s)(2)(A) of the Act, we are proposing to include payment for both statutory benefits using the separate HCPCS Q-codes. This would allow for payment for these medically necessary supplies whether based on sections 1861(s)(5) or 1861(s)(2)(A) of the Act, while ensuring that no duplicate payments are made. Physicians would continue to bill the HCPCS Q-codes, in addition to the cast/strapping application procedure codes, to be paid for these materials. The following supplies would continue to be paid separately using the HCPCS Q-codes and would not be included in the PE database upon adoption of this proposal: Fiberglass roll.
                    Cast padding.
                    Cast shoe.
                    Stockingnet/stockinette.
                    Plaster bandage.
                    Denver splint.
                    Dome paste bandage.
                    Cast sole.
                    Elastoplast roll.
                    Fiberglass splint.
                    Ace wrap.
                    Kerlix.
                    Webril.
                    Malleable arch bars and elastics. The splint and cast supplies would not be included in the PEs for the following CPT codes: 24500 through 24685
                    25500 through 25695
                    26600 through 26785
                    27500 through 27566
                    27750 through 27848
                    28400 through 28675
                    29000 through 29750. We are requesting input, specifically from medical specialties and contractors on this proposal. 3. Medical Nutrition Therapy Services In 2000, the Health Care Professional Advisory Committee (HCPAC) recommended that we assign work RVUs to three new medical nutrition therapy (MNT) CPT codes—97802 
                        *Medical nutrition therapy; initial assessment and intervention, individual, face-to-face with the patient, each 15 minutes*
                         at 0.45 RVUs, 97803 
                        *Medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes*
                         at 0.37 RVUs, and 97804 
                        *Medical nutrition therapy; group (two or more individuals), each 30 minutes*
                         at 0.25 RVUs. However, during rulemaking for the CY 2001 PFS final rule, we indicated that MNT was not covered because there was yet no statutory benefit category that would allow medical nutritionists to bill these services. We also did not accept the HCPAC recommendations for work RVUs for these MNT services because the codes were designed for use only by nonphysicians. The following year, section 105(c) of the Medicare, Medicaid, and SCHIP Benefits Improvement Protection Act of 2000 (BIPA) provided for the coverage of MNT services when furnished by registered dietitians or nutritional professionals at 85 percent of the amount that a physician would be paid for the same services. As a result, we established values for these MNT services for the 2002 PFS. In keeping with our earlier decision, we did not assign the HCPAC-recommended work values. However, the associated work value for each code was utilized in the conversion of work to clinical labor time for MNTs as part of the PE component. At that time we received several comments, including one from the American Dietetic Association (ADA), urging us to adopt the work values recommended by the HCPAC. More recently, the ADA has requested us to reconsider our decision not to accept the HCPAC recommended work RVUs. The ADA contends that the payment rate established by section 105(c) of BIPA, 85 percent of the PFS amount that would be paid for the same service if furnished by a physician, is based on the premise that work values are inherent to these MNT services. The ADA believes that without work RVUs, the payment for these services does not reflect 85 percent of what a physician would be paid for performing the same service. Because these MNT codes were created specifically for MNT professionals, the ADA compared the work associated with their services to physician E/M services of CPT 99203 and 99213, which have respective work RVUs of 1.34 and 0.67. After reviewing the issues and relevant arguments raised by the ADA, we are persuaded that it would be appropriate to include work RVUs for the MNT services. Consequently, we are proposing to establish work RVUs for each code at the level previously recommended by the HCPAC, as follows: CPT 97802 = 0.45 RVUs.
                    CPT 97803 = 0.37 RVUs.
                    CPT 97804 = 0.25. Because we propose to add the work RVUs to these services, the MNT clinical labor time in the direct input database would be removed with the adoption of this proposal. Additionally, two HCPCS codes, G0270 
                        *MNT subs tx for change dx*
                         and G0271 
                        *Group MNT 2 or more 30 mins*
                         were created to track MNT services following the second referral in the same year. These HCPCS codes correspond to CPT codes 97803 and 97804, respectively. Therefore, we would also propose to add the same work RVUs to these HCPCS codes and to delete the clinical labor inputs from the PE database upon adoption of this policy. We encourage specialty societies and other professional groups to comment on this proposal. 4. Surgical Pathology Codes We heard from the College of American Pathologists (CAP) regarding the equipment times assigned to CPT codes 88304 and 88305 in the basic surgical pathology family of codes. While all six codes in this family have been refined by the PEAC, this refinement occurred at 4 separate PEAC meetings. CPT codes 88304 and 88305 were refined at the first PEAC meeting in April 1999 before time standards were established for the equipment at subsequent PEAC meetings when the other four CPT codes 88300, 88302, 88307, and 88309 were reviewed. Using our proposed bottom-up PE methodology to value these codes, the lack of the equipment time standards for CPT codes 88304 and 88305 create a rank-order anomaly in this family. Consequently, CAP, after reviewing and applying current standards for the equipment times, submitted suggested revised equipment times to us. We are proposing to accept these times and the proposed times will be reflected in the PE database on our Web site (See the 
                        **SUPPLEMENTARY INFORMATION**
                         section of this proposed notice for directions on accessing our Web site.) 5. Other PE Issues In the CY 2006 PFS final rule with comment period (70 FR 70116), we explained that we were not implementing the PERC or other proposed PE changes for CY 2006 due to issues with the PE methodology. In this proposed rule, we are proposing that the PERC and other PE changes originally proposed for CY 2006 would be implemented and effective with the CY 2007 PFS. The following 
                        ( print page 48988)
                        subsections, (a) through (j), summarize the PE proposals from the CY 2006 PFS final rule with comment period that we are including in this proposed rule. Additionally, we are including several other items which concern inputs for PE that are discussed below in subsections (k) through (n). (a) PE Recommendations on CPEP Inputs for CY 2006 We are proposing to use a clinical labor time of 167 minutes for the service period for CPT code 36522, Extracorporeal Photopheresis; maintain the nonfacility setting PE RVUs for CPT code 78350, single photon bone densitometry; and remove the PE inputs for the nonfacility setting for CPT codes 76975, GI endoscopic ultrasound, and 15852, Dressing change not for burn. (70 FR 70136 through 70137) (b) Supply Items for CPT Code 95015 (Which Is Used for Intradermal Allergy Tests With Drugs, Biologicals, or Venoms) We are proposing to implement the allergy and immunology specialty's recommendation to change the test substance in CPT code 95015 to venom, at $10.70 (from single antigen, at $5.18) and the quantity to 0.3 ml (from 0.1 ml). (See 70 FR 70138.) (c) Flow Cytometry Services Based on information from the society representing independent laboratories, we are proposing to implement the following direct PE inputs: Clinical Labor—We are proposing to change the staff type in the service (intra) period in both CPT codes 88184 and 88185 to cytotechnologist, at $0.45 per minute (currently lab technician, at $0.33 per minute).
                    Supplies—We are proposing to change the antibody cost for both CPT codes 88184 and 88185 to $8.50 (from $3.544).
                    Equipment—We are proposing to add the following equipment to CPT code 88184: + Computer. + Printer. + Slide strainer. + Biohazard hood. + Wash assistant. + FAC loader. + We are proposing to add a computer and printer to the equipment for CPT code 88185 (70 FR 70138). (d) Low Osmolar Contrast Media (LOCM) and High Osmolar Contrast Media (HOCM) Because separate payment is available for both types of contrast media, we are proposing to delete LOCM and HOCM from the PE database with the CY 2007 PFS rule. (See 70 FR 70138). (e) Imaging Rooms We are proposing to implement the updates for the contents and prices of 5 “rooms” used in imaging procedures including— Basic radiology room;
                    Radiographic-fluoroscopic room;
                    Mammography room;
                    Computed tomography (CT) room; and
                    Magnetic resonance imaging (MRI) room (See70 FR 70139). (f) Equipment Pricing for Select Services and Procedures We are proposing to accept the following equipment pricing information provided by various specialty societies for select services and procedures as discussed in the CY 2006 PFS final rule with comment period. (See 70 FR 70139): Equipment pricing for certain radiology services received from the ACR as presented in Table 15 of the CY 2006 PFS proposed rule.
                    Equipment pricing on the ultrasound color doppler transducers and vaginal probe received from the American College of Obstetrics and Gynecology (ACOG).
                    For CPT 36522, extracorporeal photopheresis, equipment pricing information specific to this procedure.
                    Pricing of EMG botox machine used in CPT code 92265 as presented by the American Academy of Ophthalmology. (g) Supply Item for In Situ Hybridization Codes (CPT Codes 88365, 88367, and 88368) We are proposing to implement the Society for Clinical Pathologists’ request to change the probe quantity for CPT code 88367 
                        *In situ hybridization, auto*
                         to 1.5, equal to that of the other two codes in the family. (h) Supply Item for Percutaneous Vertebroplasty Procedures (CPT codes 22520 and 22525) Based on documentation provided by the Society for Interventional Radiology, we are proposing to implement a new price of $696.00 for the vertebroplasty kit, to replace a temporary price of $660.50 that was a placeholder price from the CY 2006 PFS final rule with comment period. (See 70 FR 70139.) (i) Clinical Labor for G-Codes Related to Home Health and Hospice Physician Supervision, Certification and Recertification We are proposing to apply the refinements made to the PE inputs to CPT codes 99375 and 99378 for home health and hospice supervision to 4 G-codes that are related to home health and hospice physician supervision, certification and recertification, G0179, GO180, GO181, and GO182. These G-codes are incorrectly valued for clinical labor. These G-codes are cross-walked from CPT codes 99375 and 99378, which underwent PEAC refinement in January 2003 for the CY 2004 PFS. However, at that time we inadvertently did not apply the new refinements to these specific G-codes. (See 70 FR 70139 through 70140.) (j) Programmers for Implantable Neurostimulators and Intrathecal Drug Infusion Pumps Although we had initially proposed, in the CY 2006 PFS proposed rule, to remove two programmers from the PE database (EQ208 for medication pump from two codes (CPT 62367 and 62368) and EQ209 for the neurostimulator from 8 codes (CPT 95970-97979)), based on comments received as discussed in the CY 2006 PFS final rule with comment period (see 70 FR 70140), we determined that we will retain these programmers in the database. In addition, we added “with printer” to the description of EQ208 based on comments received. We are proposing to implement these decisions for CY 2007. (k) Cardiac Monitoring Services We are requesting more specific PE information related to remote cardiac monitoring services because these services do not fit the direct PE model used for typical physician services. These services are overwhelmingly performed by specialized independent diagnostic testing facilities (IDTFs) that are paid under the PFS, but due to the characteristics of cardiac monitoring services, frequently maintain more extensive operating hours than the typical physician office. Specifically, we are looking for data to indicate the typical number and type of transmissions or other encounters per day between the beneficiary and the IDTF for each of the remote monitoring services. We would also like to know the number and type of clinical staff, as well as the corresponding time, that are necessary to ensure appropriate services are available for each patient. Additionally, we are interested in identifying any other direct PE inputs for typical supplies and equipment relating to these services, and any data that would reflect indirect PEs, such as overhead and non-clinical payroll expenses. We believe that the following codes represent atypical PE scenarios 
                        ( print page 48989)
                        and would like to receive PE information regarding these services: Cardiac event monitoring (CPT codes 93271, 93012 and 93270).
                    Pacemaker monitoring (CPT codes 93733 and 93736).
                    Holter monitoring (CPT codes 93232, 93226, 93231 and 93225).
                    INR monitoring (HCPCS codes G0248 and G0249). (l) Clarification With Respect to Non-Facility PE RVUs In the CY 2006 PFS final rule with comment (70 FR 70335) we provided a clarification in Addendum A concerning use of “NA” in the PE RVU columns for Addendum B. Commenters requested that further clarification be made concerning the payment amount for procedures performed in the non-facility setting if there is an “NA” in the non-facility PE RVU column. Our policy is that if the Medicare carrier pays for the service in the non-facility setting, the service will be paid at the facility PE RVU rate. In this proposed rule, we are proposing revisions to Addendum A to include this clarification. (m) Supply for CPT Code 50384, Removal (via Snare/Capture) of Internally Dwelling Ureteral Stent Via Percutaneous Approach, Including Radiological Supervision and Interpretation Upon review of the RUC-recommended direct PE inputs for CPT 50384, a new procedure for CPT 2006, we identified the inappropriate inclusion of a ureteral stent that we are proposing to delete for CY 2007. We believe that the addition of the ureteral stent, valued by the specialty at $162, to CPT code 50384, which is the procedure for the removal of a stent, was an inadvertent error by the specialty during the April 2005 RUC meeting. (n) Supply and Equipment Items Needing Specialty Input We have identified certain supply and equipment items for which we were unable to verify the pricing information (see Table 1: Supply Items Needing Specialty Input for Pricing and Table 2: Equipment Items Needing Specialty Input for Pricing). During the CY 2006 rulemaking process, we listed both supply and equipment items for which pricing documentation was needed from the medical specialty societies and, for many of these items, we received sufficient documentation in the form of catalog listings, vendor Web sites, invoices, and manufacturer quotes. We have accepted the documented prices for many of these items and these prices are reflected in the PE RVUs in Addendum B of this proposed rule. The items listed below in Tables 1 and 2 represent the outstanding items from CY 2006 and new items added from the current RUC recommendations. We are requesting that commenters provide pricing information on items in these tables along with acceptable documentation, as noted in the footnote to each table, to support recommended prices. For supplies or equipment that have previously appeared on this list, and for which we received no or inadequate documentation, we are proposing to delete these items unless we receive adequate information to support current pricing by the conclusion of the comment period for this proposed rule. 
 
  
 
  
 
  B. Geographic Practice Cost Indices (GPCI) [If you choose to comment on issues in this section, please include the caption “GPCI” at the beginning of your comments.] Section 1848(e)(1)(A) of the Act requires us to develop separate GPCIs to measure resource cost differences among localities compared to the national average for each of the three fee schedule components. While requiring that the PE and malpractice GPCIs reflect the full relative cost differences, section 1848(e)(1)(A)(iii) of the Act requires that the physician work GPCIs reflect only one-quarter of the relative cost differences compared to the national average. Section 1848(e)(1)(C) of the Act requires us, in consultation with appropriate physician representatives, to review the GPCIs at least every 3 years and allows us to make adjustments based on our review. This section of the Act also requires us to phase-in the adjustment over 2 years, implementing only one-half of any adjustment in the first year if more than 1 year has elapsed since the last GPCI revision. The GPCIs were first implemented in 1992. The first review and revision was implemented in 1995 and the last GPCI revision was implemented in 2005. The next update is scheduled to be implemented in January 2008. We do not anticipate proposing significant changes to the GPCIs in response to changes in the source data. There have been no new Census data to affect the work GPCI, the PE GPCI will reflect any changes in the Department of Housing and Urban Development (HUD) rental data, and the malpractice GPCI (based on malpractice RVUs) will reflect the national claims-based premium data for 2004 and 2005. Details of the methodology, data sources, and adjustments to the GPCIs will be made available for public comment in the CY 2008 PFS proposed rule. In addition, section 412 of the MMA amended section 1848(e)(1) of the Act to establish a floor of 1.0 for the work GPCI for any locality where the GPCI would otherwise fall below 1.0 for purposes of payment for services furnished on or after January 1, 2004 and before January 1, 2007. Beginning on January 1, 2007, the 1.00 floor will be removed and the work GPCI will revert to the fully implemented value. The values for the work GPCI and subsequent changes to the Geographic Adjustment Factor (GAF) published in this proposed rule reflect the removal of the 1.0 floor. For many payment localities this change had no impact on the GAF; however, the GAFs for a number of payment localities were reduced due to this change. The impact of this change on the GAFs for those payment localities is shown below in Table 3. The proposed GPCIs for 2007 are shown in Addendum D and the proposed GAFs for 2007 are shown in Addendum E. The GPCIs shown in Addendum D are fully implemented and reflect 2007 budget neutrality scaling coefficients provided by the Office of the Actuary. Table 3.—Payment Localities With Negative Percent Change in GAF 1
                             Between 2006 and 2007 Due to Removal of the 1.000 Work Floor
Locality name
2006 GAF
2007 GAF
Percent changeFort Worth, TX
0.998
0.996
−0.17Rest of Michigan
0.986
0.984
−0.20Rest of New York
0.952
0.950
−0.21Rest of Maryland
0.982
0.978
−0.36Metropolitan St. Louis, MO
0.978
0.974
−0.41Rest of Pennsylvania
0.950
0.946
−0.44Ohio
0.970
0.966
−0.44Austin, TX
1.020
1.015
−0.47New Hampshire
1.010
1.005
−0.50Minnesota
0.980
0.975
−0.53Galveston, TX
0.991
0.986
−0.54Metropolitan Kansas City, MO
0.987
0.981
−0.56Fort Lauderdale, FL
1.022
1.016
−0.59Arizona
0.999
0.993
−0.65Wisconsin
0.956
0.950
−0.65Colorado
0.998
0.991
−0.67East St. Louis, IL
1.003
0.996
−0.68New Orleans, LA
0.984
0.977
−0.73Rest of Washington
0.984
0.976
−0.77Indiana
0.937
0.930
−0.79Beaumont, TX
0.951
0.942
−0.96Alabama
0.923
0.914
−0.99Virginia
0.958
0.948
−1.06Southern Maine
0.992
0.981
−1.09Rest of Georgia
0.943
0.932
−1.14Tennessee
0.933
0.921
−1.27Utah
0.960
0.948
−1.30South Carolina
0.930
0.917
−1.41Rest of Illinois
0.952
0.938
−1.43Rest of Florida
0.982
0.968
−1.45West Virginia
0.942
0.928
−1.47North Carolina
0.951
0.936
−1.55New Mexico
0.947
0.932
−1.57Kansas*
0.934
0.919
−1.60Rest of Louisiana
0.936
0.919
−1.78Kentucky
0.932
0.915
−1.80Kansas*
0.936
0.919
−1.81Rest of Oregon
0.946
0.929
−1.81( print page 48994)Vermont
0.968
0.950
−1.82Virgin Islands
1.007
0.989
−1.83Rest of Texas
0.947
0.929
−1.87Idaho
0.922
0.904
−1.91Iowa
0.927
0.909
−1.97Rest of Maine
0.936
0.916
−2.14Oklahoma
0.913
0.893
−2.14Mississippi
0.919
0.898
−2.31Arkansas
0.905
0.884
−2.34Puerto Rico
0.905
0.883
−2.44Nebraska
0.925
0.902
−2.44Wyoming
0.934
0.910
−2.55Montana
0.928
0.902
−2.83Rest of Missouri *
0.910
0.883
−2.97North Dakota
0.924
0.895
−3.16South Dakota
0.922
0.891
−3.351
                             Calculation for the GAF: (.52466*work gpci) + (.03865*mp gpci) + (.52466*pe gpci).
 In the CY 2005 PFS proposed rule, published August 15, 2004, we discussed the issue of changes to the GPCI payment localities (69 FR 47504). In that proposed rule, we noted that we look for the support of a State medical society as the impetus for changes to existing payment localities. Because the GPCIs for each locality are calculated using the average of the county-specific data from all of the counties in the locality, removing high cost counties from a locality will result in lower GPCIs for the remaining counties. Therefore, because of this redistributive impact, we have refrained, in the past, from making changes to payment localities unless the State medical association provides evidence that any proposed change has statewide support. We would be interested in receiving suggestions on alternative ways that we could administratively reconfigure payment localities that could be developed and proposed in future rulemaking. In addition, MEDPAC and the GAO have both expressed interest in studying the physician payment localities. CMS intends to work with both groups to study our current methodology and develop alternative options. C. Medicare Telehealth Services [If you choose to comment on issues in this section, please include the caption “TELEHEALTH” at the beginning of your comments.] 1. Requests for Adding Services to the List of Medicare Telehealth Services Section 1834(m)(4)(F) of the Act defines telehealth services as professional consultations, office visits, and office psychiatry services (identified as of July 1, 2000 by CPT codes 99241 through 99275, 99201 through 99215, 90804 through 90809, and 90862) and any additional service specified by the Secretary. In addition, the statute requires us to establish a process for adding services to or deleting services from the list of telehealth services on an annual basis. In the December 31, 2002 
                        **Federal Register**
                         (67 FR 79988), we established a process for adding services to or deleting services from the list of Medicare telehealth services. This process provides the public an ongoing opportunity to submit requests for adding services. We assign any request to make additions to the list of Medicare telehealth services to one of the following categories: *Category #1:*
                         Services that are similar to office and other outpatient visits, consultation, and office psychiatry services. In reviewing these requests, we look for similarities between the proposed and existing telehealth services for the roles of, and interactions among, the beneficiary, the physician (or other practitioner) at the distant site and, if necessary, the telepresenter. We also look for similarities in the telecommunications system used to deliver the proposed service, for example, the use of interactive audio and video equipment.
                    *Category #2:*
                         Services that are not similar to the current list of telehealth services. Our review of these requests includes an assessment of whether the use of a telecommunications system to deliver the service produces similar diagnostic findings or therapeutic interventions as compared with the faceπtoπface “hands on” delivery of the same service. Requestors should submit evidence showing that the use of a telecommunications system does not affect the diagnosis or treatment plan as compared to a faceπtoπface delivery of the requested service. Since establishing the process, we have added the following to the list of Medicare telehealth services: psychiatric diagnostic interview examination; ESRD services with two to three visits per month and four or more visits per month (although we require at least one visit a month by a physician, CNS, NP, or PA to examine the vascular access site); and individual medical nutritional therapy. Requests to add services to the list of Medicare telehealth services must be submitted and received no later than December 31 of each CY to be considered for the next proposed rule. For example, requests submitted before the end of CY 2005 are considered for the CY 2007 proposed rule. For more information on submitting a request for an addition to the list of Medicare telehealth services, visit our Web site at 
                        *www.cms.hhs.gov/​telehealth.* 2. Submitted Requests for Addition to the List of Telehealth Services We received the following requests for additional approved services in CY 2005: (1) Nursing facility care; (2) speech language pathology; (3) audiology; and (4) physical therapy services. The following is a discussion of the requests submitted in CY 2005. Nursing Facility Care The American Telemedicine Association (ATA) and an individual practitioner submitted a request to add the following services: Initial nursing facility care (as represented by HCPCS 
                        ( print page 48995)
                        codes 99304 through 99306); subsequent nursing facility care (HCPCS codes 99307 through 99310); nursing facility discharge services (HCPCS codes 99315 and 99316); and other nursing facility services as described by HCPCS code 99318. The requestors explained that the primary purpose of using telehealth in the Skilled Nursing Facility (SNF) setting is to provide urgent consultation when the patient has a sudden change in his or her condition, and to provide increased availability to primary and specialty care on days when the physician is not present in the SNF or when traveling is a hardship. The requestors believe that the current list of Medicare telehealth services is not appropriate because the list does not include codes that are specifically intended for nursing facility residents. CMS Review Nursing Facility Care Section 1834(m)(C)(ii) of the Act defines a telehealth originating site as a physician's or practitioner's office; or a hospital, critical access hospital (CAH), rural health clinic, or FQHC. SNFs are not defined in the statute as originating sites. However, section 418 of the MMA required the Health Resources Services Administration (HRSA), a component of HHS, in consultation with CMS, to conduct an evaluation of demonstration projects under which SNFs, as defined in section 1819(a) of the Act, are treated as originating sites for Medicare telehealth services. The MMA also required the Secretary to submit a report to the Congress that includes recommendations on “mechanisms to ensure that permitting a SNF to serve as an originating site for the use of telehealth services or any other service delivered via a telecommunications system does not serve as a substitute for in-person visits furnished by a physician, or for in-person visits furnished by a physician assistant (PA), nurse practitioner (NP), or clinical nurse specialist (CNS), as is otherwise required by the Secretary” and provides the authority to include SNFs as a Medicare telehealth originating site, if the Secretary concludes in the report that it is advisable to do so and that mechanisms could be established to ensure that the use of a telecommunications system does not serve as a substitute for the required in-person physician or practitioner SNF visits. This report is currently under review in DHHS. Given that SNFs are not defined in the statute as a telehealth originating site and the report to the Congress, as discussed above, is currently being reviewed within DHHS, we cannot consider approving nursing facility care for telehealth at this time. We will review and consider the recommendations of the report to the Congress once it is issued. If it is determined that SNFs should be added as an originating site, this change will be considered in future rulemaking. Speech Language Pathology, Audiology and Physical Therapy The ATA and an individual practitioner submitted a request to add various speech therapy, audiology and physical therapy services to the list of Medicare telehealth services. The requestors also asked us to add physical therapists, speech language pathologists and audiologists to the list of approved telehealth practitioners. CMS Review Physical therapists, speech language pathologists and audiologists are not permitted under current law to provide and receive payment for Medicare telehealth services at the distant site. The statute permits only a physician, as defined by section 1861(r) of the Act or a practitioner as described in section 1842(b)(18)(C) of the Act (CNS, NP, PA, nurse midwife, clinical psychologist, clinical social worker, registered dietitian or other nutrition professional), to furnish Medicare telehealth services. Since speech language pathologists, audiologists and physical therapists are not permitted under current law to provide and receive payment for Medicare telehealth services at the distant site, we cannot fully consider the request to add speech therapy, audiology services and physical therapy to the list of Medicare telehealth services. We are exploring this issue as part of a report to the Congress (required by section 223(d) of BIPA) on additional sites and settings, geographic areas, and types of non-physician practitioners that could be reimbursed for the provision of telehealth services. D. Miscellaneous Coding Issues [If you choose to comment on issues in this section, please include the caption “Miscellaneous Coding Issues” at the beginning of your comments.] The following sections address specific coding issues related to payment for services under the PFS. 1. Global Period for Remote Afterloading High Intensity Brachytherapy Procedures CPT Code 77783, Remote afterloading high intensity brachytherapy; 9-12 source positions or catheters, resides in a family of codes with varying numbers of source positions. All of the codes in the family, CPT codes 77781-77784 are currently designated as 90-day global services. CPT codes 77781-77784 are used to treat many clinical conditions, but primarily patients with prostate cancer, breast cancer and sarcoma. Patients with any of these conditions usually receive several treatments (2-10) over a two to ten day period of time. Due to the increasing variability in treatment regimens, it is difficult to assign RVUs for a “typical” patient based on a global period of 90 days. Therefore, we are proposing that this family of codes (CPT codes 77781, 77782, 77783 and 77784) be assigned a global period of “XXX”, which will permit separate payment each time the services are provided and allow payment to be based on the actual service(s) provided. We will request that the RUC revalue the work RVUs and the PE inputs for these services if a change in the global period is finalized. However we are proposing, on an interim basis, to revise the work RVUs and PE inputs to reflect the removal of the postoperative visit, CPT code 99212, that is currently assigned to these services. The proposed interim work RVUs for these services would be as follows: 77781 = 1.21
                    77782 = 2.04
                    77783 = 3.27
                    77784 = 5.15 We are also proposing to delete the registered nurse (RN) time in the post-service period as well as the patient gowns for the post-service visit. We would also note that, to the extent that these services are performed as staged procedures, providers may make use of applicable modifiers. 2. Assignment of RVUs to CPT Codes for Proton Beam Treatment Delivery Services We have received a request to assign PE inputs for the non-facility setting to Proton Beam treatment delivery services represented by CPT codes 77520 through 77525. These services are currently carrier-priced; therefore, payment in the facility or non-facility setting is established by each carrier. To the extent that physicians and suppliers wish to have national RVUs assigned for these services, there is an established process utilizing the AMA-RUC to recommend work RVUs, as well as the direct PE inputs used to compute the PE RVUs, to CMS. We would strongly encourage the physicians and suppliers to use this established process, and would also be 
                        ( print page 48996)
                        interested in receiving comments on this issue. E. Deficit Reduction Act (DRA) Related Proposals [If you choose to comment on issues in this section, please include the caption “DRA PROPOSALS” at the beginning of your comments.] The DRA of 2005 (Pub. L. 109-171), was enacted February 8, 2006 and included provisions that affect the Medicare program. The following section addresses the specific DRA provisions that are being addressed in this proposed rule. 1. Section 5102—Proposed Adjustments for Payments to Imaging Services Section 5102 of the DRA includes two provisions that affect payment of imaging services under the Medicare physician fee schedule. The first provision addresses payment for certain multiple imaging procedures for CY 2007 and application of budget neutrality while the second provision addresses limiting the payment amount under PFS to the outpatient department (OPD) payment amount for the technical component (TC) of certain imaging services. (a) Payment for Multiple Imaging Procedures for 2007 In general, Medicare prices diagnostic imaging procedures in the following three ways: The professional component (PC) represents the physician's interpretation (PC-only services are billed with the 26 modifier).
                    The TC represents PE and includes clinical staff, supplies, and equipment (TC-only services are billed with the TC modifier).
                    The global service represents both PC and TC. As discussed in the CY 2006 PFS final rule with comment period (70 FR 70261), in the CY 2006 PFS proposed rule (70 FR 45764 through 46064), we had proposed to reduce payment for the TC of selected diagnostic imaging procedures belonging to one of eleven imaging families when the procedures are performed on contiguous body areas by 50 percent for CY 2006. However, in the final rule with comment period, we stated that we would phase-in the 50 percent reduction over two years, beginning with a 25 percent reduction in 2006. We also sought additional data and comments on the appropriateness of 50 percent as the final level of reduction. The reduction applies to the TC and the technical portion of the global service, but does not apply to the PC of the service. Currently, we make full payment for the highest priced procedure and reduce payment for each additional procedure by 25 percent, when more than one procedure from the same imaging family is performed during the same session on the same day. As described in the CY 2006 PFS final rule with comment period, at the time, the statute required us to make changes such as this in a budget neutral manner, meaning that the estimated savings generated by the application of the multiple imaging procedure payment reduction were used to increase payment for other physician fee schedule services. We increased the CY 2006 PE RVUs by 0.3 percent to offset the estimated savings generated by the multiple imaging payment reduction policy. Subsequent to the publication of the CY 2006 PFS final rule with comment period, section 5102(a) of the DRA (Multiple Procedure Payment Reduction for Imaging Exempted From Budget Neutrality), required that “effective for fee schedules established beginning with 2007, reduced expenditures attributable to the multiple procedure payment reduction for imaging under the final rule published by the Secretary in the 
                        **Federal Register**
                         on November 21, 2005 (42 CFR 405, 
                        *et al.*) insofar as it relates to the physician fee schedules for 2006 and 2007” are exempted from the budget neutrality provision. As a result, we are proposing to remove the 0.3 percent increase to the CY 2006 PE RVUs from the CY 2007 PE RVUs in accordance with the statute. In addition, in response to our request for data on the appropriateness of the 50 percent reduction in the CY 2006 PFS final rule with comment period (70 FR 70261), the ACR provided information for 25 code combinations supporting a reduction of between 21 and 44 percent. Given the expected interaction between the multiple procedure imaging policy and the further imaging payment reductions mandated by section 5102(b) of the DRA described below, along with the new information we have received from the ACR on the multiple imaging procedure policy as it applies to common combinations of imaging services, we believe it would be prudent to maintain the multiple imaging payment reduction at its current 25 percent level while we continue to examine the appropriate payment levels. Therefore, we are proposing to continue the multiple imaging payment reduction for 2007 at the 25 percent level. We would proceed through future rulemaking in the event we determine that revisions to the policy are warranted. (b) Reduction in TC for Imaging Services Under the PFS to OPD Payment Amount Section 5102(b)(1) of the DRA amended section 1848 of the Act and requires that, with respect to imaging services, if— “(i) The technical component (including the technical component portion of a global fee) of the service established for a year under the fee schedule * * *, without application of the geographic adjustment factor * * *, exceeds, (ii) The Medicare OPD fee schedule amount established under the prospective payment system for hospital outpatient department services * * * for such service for such year, determined without regard to geographic adjustment * * *, the Secretary shall substitute the amount described in clause (ii), adjusted by the geographic adjustment factor [under the PFS]  * * *, for the fee schedule amount for such technical component for such year.” As required by the statute, for imaging services (described below) furnished on or after January 1, 2007, we will cap the PFS payment amount for the year (prior to geographic adjustment) by the CY 2007 outpatient prospective payment system (OPPS) payment amount (prior to geographic adjustment). We will then apply the PFS geographic adjustment to the capped payment amount. Section 5102(b)(2) of the DRA exempts the estimated savings from this provision from the PFS budget neutrality requirement. Section 5102(b)(1) of the DRA defines imaging services as “* * * imaging and computer-assisted imaging services, including X-ray, ultrasound (including echocardiography), nuclear medicine (including positron emission tomography), magnetic resonance imaging, computed tomography, and fluoroscopy, but excluding diagnostic and screening mammography.” In order to apply section 5102(b) of the DRA, we needed to determine the CPT and alpha-numeric HCPCS codes that fall within the scope of “imaging services” defined by the DRA provision. In general, we believe that imaging services provide visual information regarding areas of the body that are not normally visible, thereby assisting in the diagnosis or treatment of illness or injury. We began by considering the CPT 7XXXX series codes for radiology services and then adding in other CPT codes and alpha-numeric HCPCS codes that describe imaging services. We then excluded nuclear medicine services that were either non-imaging diagnostic or treatment services. We also excluded all 
                        ( print page 48997)
                        codes for unlisted procedures, since we would not know in advance of any specific clinical scenario whether or not the unlisted procedure was an imaging service. We excluded all mammography services, consistent with the statute. We excluded radiation oncology services that were not imaging or computer-assisted imaging services. We also excluded all HCPCS codes for imaging services that are not separately paid under the OPPS since there would be no corresponding OPPS payment to serve as a TC cap. We excluded any service where the CPT code describes a procedure for which fluoroscopy, ultrasound, or another imaging modality is either included in the code whether or not it is used or is employed peripherally in the performance of the main procedure, for example, 31622 for bronchoscopy with or without fluoroscopic guidance and 43242 for upper gastrointestinal endoscopy with transendoscopic ultrasound-guided intramural or transmural fine needle aspiration/biopsy(s). In these cases, we are unable to clearly distinguish imaging from non-imaging services because, for example, a specific procedure may or may not utilize an imaging modality, or the use of an imaging technology cannot be segregated from the performance of the main procedure. Note that we included carrier priced services since these services are within the statutory definition of imaging services and are also within the statutory definition of PFS services (that is, carrier-priced TCs of PET scans). Our proposed list of codes that identify imaging services defined by the DRA OPPS cap provision can be found in Addendum F to this proposed rule. Note that this is the list of imaging services for which we propose to make the comparison between the PFS TC payment amount and the OPPS payment amount used to establish OPD payment. Payment for an individual service on this list would only be capped if the PFS TC payment amount exceeds the OPPS payment amount. To the extent changes are made to codes for services already on the list, we propose to update the list through program instructions to our contractors. To the extent that the same imaging service is coded differently under the PFS and the OPPS, we propose to crosswalk the code under the PFS to the appropriate code under the OPPS that could be reported for the same service provided in the hospital outpatient setting. Our proposed list of crosswalks is below: MFS code
Descriptor
OPPS code
Desc74185
Mri angio, abdom w or w/o dye
C8900
MRA w/cont, abd.76093
Magnetic image, breast
C8905
MRI w/o fol w/cont, brst, un.76094
Magnetic image, both breasts
C8908
MRI w/o fol w/cont, breast.71555
Mri angio chest w or w/o dye
C8909
MRA w/cont, chest.73725
Mr ang lwr ext w or w/o dye
C8912
MRA w/cont, lwr ext.72198
Mr angio pelvis w/o & w/dye
C8918
MRA w/cont, pelvis.
 (c) Interaction of the Multiple Imaging Payment Reduction and the OPPS Cap For CY 2007 imaging services potentially subject to both the multiple imaging reduction and the OPPS cap, we propose to first apply the multiple imaging payment reduction and then apply the OPPS cap to the reduced amount as illustrated in the following example. HCPCS
Pre-OPPS cap MPFS rate
25% Multiple imaging reduction
OPPS cap rate
Final MPFS payment7XXX1
$341.89
$256.42
$316.55
$256.427XXX2
552.86
414.65
391.83
391.83
 We considered first applying the OPPS cap and then applying the multiple procedure reduction. However, as indicated in the CY 2006 OPPS final rule, we received public comments suggesting that the OPPS payment rates may implicitly include at least some multiple imaging discount. While we continue to examine this issue, we believe the most appropriate policy is to apply the multiple imaging payment reduction prior to the application of the OPPS cap. 2. Section 5107—Revisions to Payments for Therapy Services Section 1833(g) of the Act applies an annual per beneficiary combined cap beginning January 1, 1999, on outpatient physical therapy and speech-language pathology services and a similar separate cap on outpatient occupational therapy services. These caps apply to expenses incurred for the respective therapy services under Medicare Part B, with the exception of outpatient hospital services. The caps were in effect from January 1, through December 31, 1999, from September 1, 2003 through December 7, 2003, and beginning January 1, 2006. In 2000 through 2002, and from December 8, 2003 through December 31, 2005, the Congress placed moratoria on implementation of the caps. Section 1833(g)(2) of the Act provides that, for 1999 through 2001, the caps were $1500, and for years after 2001, the caps are equal to the preceding year's cap increased by the percentage increase in the Medicare Economic Index (MEI) (except that if an increase for a year is not a multiple of $10, it is rounded to the nearest multiple of $10). We implemented the separate statutory limits of $1740 for outpatient physical therapy and speech-language pathology services and $1740 for occupational therapy on January 1, 2006. The DRA of 2005 was enacted on February 8, 2006. Section 5107(a) of the DRA required the Secretary to develop an exceptions process for the therapy caps effective January 1, 2006. The exceptions process applies only to expenses incurred in 2006. Details of the exceptions process were published in a manual change on February 13, 2006 (CR4364). The change request 
                        ( print page 48998)
                        consists of three transmittals with current numbers of— Transmittal 855, CR 4364, Pub. L. 100-04;
                    Transmittal 47, CR 4365, Pub. L. 100-02; and
                    Transmittal 140, CR 4364, Pub. L. 100-08. The transmittals are available on our Web site at 
                        *http://www.cms.hhs.gov/​Transmittals/​.* In accordance with the statute, the therapy caps will remain in effect, but without the exceptions process, with respect to expenses incurred beginning on January 1, 2007. The dollar amount of the therapy caps in 2007 will be the 2006 rate ($1740) increased by the percentage increase in the MEI. As noted above, under current law, the exceptions process will not apply to therapy services incurred after December 31, 2006, but the therapy caps will remain inapplicable to therapy services provided in the outpatient hospital setting as provided in section 1833(g) of the Act. Section 5107(b) of the DRA requires the Secretary to implement, by July 1, 2006, edits for clinically illogical combinations of procedure codes and other edits in order to limit inappropriate payment for therapy services. In January 2006, we implemented Correct Coding Initiative (CCI) edits for the therapy providers that bill to the fiscal intermediaries, thus, addressing the section 5107 of the DRA requirement with respect to edits for clinically illogical combinations of procedure codes. Adoption of these code edits ensures that these providers of outpatient Part B therapy services, including SNFs, comprehensive outpatient rehabilitation facilities, certain outpatient physical therapy and speech-language therapy providers (rehabilitation agencies) and home health agencies (HHAs) (where beneficiary is not under a Part A plan of care) meet the same CCI edit requirements as those that have been in place for physicians, private practice therapists, and OPPS hospitals. We are considering the implementation of other edits in the future to further address concerns about inappropriate payment for therapy services. 3. Section 5112-Proposed Addition of Ultrasound Screening for Abdominal Aortic Aneurysm (AAA) Section 5112 of the DRA of 2005 amended section 1861 of the Act to provide for coverage under Part B of ultrasound screening for AAAs, effective for services furnished on or after January 1, 2007, subject to certain eligibility and other limitations. This screening test will be available even if the qualifying patient does not present signs or symptoms of disease or illness. To conform the regulations to the statutory requirements of section 5112 of the DRA, we are proposing to include an exception in § 411.15(a)(1) to permit coverage for ultrasound screening for AAAs that meet the conditions for coverage that we are proposing to specify under new § 410.19(b) (Conditions for coverage of an ultrasound screening for abdominal aortic aneurysms). We are also adding a new § 411.15(k)(12). As provided in the DRA, this new coverage allows payment for a one-time only screening examination. We are proposing to add new § 410.19(b) to provide for the coverage of the screening examinations for AAAs as specified in section 5112 of the DRA. We are also proposing to add new § 410.19(c) (Limitation on coverage of ultrasound screening for abdominal aortic aneurysms.) to provide the limitation on coverage for an individual who is not an eligible beneficiary as defined in proposed new § 410.19(a). We are proposing definitions set forth in new § 410.19(a) of this proposed rule that would be included to implement the statutory provisions and to help the reader in understanding the provisions of this regulation. The proposed definitions include the following terms: Eligible beneficiary.
                    Ultrasound screening for abdominal aortic aneurysms. Specifically, section 5112(a)(1) of the DRA amended section 1861 of the Act to provide that coverage of ultrasound screening for AAAs will be available for an individual—(i) who receives a referral for such an ultrasound screening as a result of an initial preventive physical examination (as defined in section 1861(ww)(1) of the Act); (ii) who has not been previously furnished such an ultrasound screening under this title; and (iii) who has a family history of AAA or manifests risk factors included in a beneficiary category recommended for screening by the United States Preventive Services Task Force regarding AAAs. Section 5112(a)(2) of the DRA also adds a definition of the term “ultrasound screening for an Abdominal Aortic Aneurysm” to mean, “(1) a procedure using sound waves (or other procedures using alternative technologies, of commensurate accuracy and cost, that the Secretary may specify) provided for the early detection of abdominal aortic aneurysm; and (2) includes a physician's interpretation of the results of the procedure.” In developing the proposed rule based on this provision, we reviewed the 2005 United States Preventive Services Task Force (USPSTF) recommendations and related material on ultrasound screening for AAAs. This includes— A recommendation for a one-time ultrasound screening for men aged 65 to 75 who have smoked at least 100 cigarettes in their lifetime;
                    No recommendation for or against ultrasound screening for AAAs for men who have not smoked at least 100 cigarettes in their lifetime; and
                    A recommendation against routine screening for AAAs in women. Based on the statutory language and the USPSTF recommendations outlined above, we are proposing to define the term “eligible beneficiary” for coverage of ultrasound screening examinations for AAA to mean an individual who— Has received a referral for an ultrasound screening as a result of an initial preventive physical examination (as defined in section 1861(ww)(1) of the Act);
                    Has not been previously furnished such a covered ultrasound screening examination under the Medicare program; and
                    Is included in at least one of the following risk categories: + Has a family history of an AAA; or + Is a man age 65 to 75 years who smoked at least 100 cigarettes in his lifetime; or + Is an individual who manifests other risk factors that are described in a benefit category recommended by the USPSTF regarding an AAA that has been determined by the Secretary through the NCD process. To facilitate our consideration of possible expansions of coverage in the future for identifying (1) other risk factors in a benefit category recommended for screening for the early detection of AAAs by the USPSTF, and (2) alternative screening technologies to ultrasound screening for AAAs of commensurate accuracy and cost, we are proposing to add language to our regulations that would allow us to make determinations through the NCD process. The NCD process would allow the Secretary to expand coverage more quickly following an assessment of those subjects than is possible under the standard rulemaking process. We intend to use the NCD process, which includes an opportunity for public comments, for evaluating the medical and scientific issues relating to the coverage of alternative screening technologies and the identification of other risk factors for AAAs recommended by the USPSTF that may be brought to our attention in the future. Use of an NCD to establish 
                        ( print page 48999)
                        a change in the scope of benefits is authorized by section 1871(a)(2) of the Act. An aggrieved party can challenge an NCD under the procedures established by section 1869(f) of the Act. These proposed coverage provisions would be set forth in proposed new § 410.19 (a)(1)(i) and § 410.19(a)(2)(iii)(C). Section 5112(b) of DRA also amended section 1861(ww)(2) of the Act (the initial preventive physical examination benefit) by adding the new ultrasound screening benefit to the list of preventive services for which physicians and other qualified nonphysician practitioners must provide “education, counseling and referral” to new beneficiaries who take advantage of the initial preventive physical examination benefit within the first 6 months after the effective date of their first Part B coverage period. Therefore, we are also proposing to amend § 410.16(a)(7) of the regulations so that it reflects the additional responsibilities that physicians and qualified nonphysician practitioners will have under the initial preventive physical examination benefit with respect to the new ultrasound screening benefit. Beginning January 1, 2007, we are proposing to pay for ultrasound screening for AAAs through the use of a new HCPCS code GXXX1, 
                        *Ultrasound, B-scan and/or real time with image documentation; for abdominal aortic aneurysm (AAA) screening.*
                         We are proposing that payment for this service be made at the same level as CPT code 76775 
                        *Ultrasound, retroperitoneal (e.g., renal, aorta, nodes), B-scan and/or real time with image documentation; limited.*
                         CPT code 76775 is used to bill for the service when it is provided as a diagnostic test, and we believe the service associated with the proposed HCPCS code reflects equivalent resources and work intensity to those contained in CPT code 76775. In addition, since the DRA provides that the Medicare Part B deductible will not apply with respect to ultrasound screening for abdominal aortic aneurysm (as defined in section 1861(bbb) of the Act), we are proposing to revise § 410.160 to include an exception from the Medicare Part B deductible for the ultrasound screening for abdominal aortic aneurysm as described in proposed § 410.19. (Conditions for coverage of an ultrasound screening for abdominal aortic aneurysms.) 4. Section 5113—Proposed Non-Application of the Part B Deductible for Colorectal Cancer Screening Tests Current Medicare policy requires that, with limited exceptions, incurred expenses for covered part B services are subject to, and count toward meeting the Part B annual deductible. Section 5113 of the DRA amended section 1833(b) of the Act to provide for an exception to the application of the Part B deductible with respect to colorectal cancer screening tests. Beginning January 1, 2007, colorectal cancer screening services, as described in section 1861(pp)(1) of the Act, are no longer subject to the Part B deductible. The conditions for and limitations on coverage for colorectal cancer screening tests under Medicare part B are described in § 410.37. To conform our regulations to this statutory change, we are proposing to revise § 410.160 to include an exception from the Part B annual deductible for the colorectal cancer screening services described in § 410.37. 5. Section 5114—Proposed Addition of Diabetes Outpatient Self-Management Training Services (DSMT) and Medical Nutrition Therapy (MNT) for the FQHC Program Section 5114 of the DRA amended section 1861(aa)(3) of the Act to add DSMT and MNT services to the list of Medicare covered and reimbursed services under the Medicare FQHC benefit, effective for services provided on or after January 1, 2006. Although this statutory change has already been implemented in administrative instructions, we are proposing to conform the regulations to the new statutory requirement. FQHCs certified as DSMT and MNT providers have been allowed to bundle the cost of those services into their FQHC payment rates. But before the enactment of the DRA, the provision of these services would not generate a separate FQHC visit payment. Effective for services furnished on or after January 1, 2006, FQHCs that are certified providers of DSMT and MNT services can receive per visit payments for covered services furnished by registered dietitians or nutrition professionals. In other words, if all relevant program requirements are met, these services are included under the Medicare FQHC benefit as billable visits. In order to conform the regulations, we are proposing to amend § 405.2446(b) to expand the scope of FQHC services to include certified providers of DSMT and MNT services by adding a new paragraph (10). We are also proposing to revise § 405.2463 by— Revising paragraph (a) to expand the definition of an FQHC visit to include certified providers of DSMT and MNT services under new sub-paragraph (a)(1)(ii)(B). We would also revise the definition of an RHC visit in new subparagraph (a)(1)(i) to include a face-to-face encounter between a patient and a clinical psychologist or clinical social worker to conform to statutory language at section 1861(aa)(1)(B) of the Act. We are also proposing to redesignate and revise paragraphs (b) and (c) as new paragraphs (a)(2) and (a)(3), respectively.
                    We are proposing to incorporate paragraph (a)(2) into (a)(1), and to redesignate and revise current paragraph (a)(3) as new paragraph (b). We would also clarify that it is generally permissible for both FQHCs and Rural Health Clinics to furnish, when necessary, most types of medical and other health visits on the same day to the same patient. We are also proposing to amend this paragraph to permit a separate additional FQHC visit for DSMT and MNT services (which may occur on the same date of service when the beneficiary receives care from their FQHC physician or non-physician practitioner) when reasonable and necessary, consistent with the Congressional mandate under section 5114 of the DRA to provide coverage and adequate access to these services in the FQHC setting.
                    We are proposing to redesignate and revise current paragraph (a)(4) as new paragraph (c). F. Proposed Payment for Covered Outpatient Drugs and Biologicals (ASP Issues) [If you choose to comment on issues in this section, please include the caption “ASP Issues” at the beginning of your comments.] Medicare Part B covers a limited number of prescription drugs and biologicals. For the purposes of this proposed rule, the term “drugs” will hereafter refer to both drugs and biologicals. Medicare Part B covered drugs not paid on a cost or prospective payment basis generally fall into the following three categories: Drugs furnished incident to a physician's service.
                    DME drugs.
                    Drugs specifically covered by statute (certain immunosuppressive drugs, for example). Beginning in CY 2005, the vast majority of Medicare Part B drugs not paid on a cost or prospective payment basis are paid under the ASP 
                        ( print page 49000)
                        methodology. The ASP methodology is based on data submitted to us quarterly by manufacturers. In addition to the payment for the drug, Medicare currently pays a furnishing fee for blood clotting factors, a dispensing fee for inhalation drugs, and a supplying fee to pharmacies for certain Part B drugs. In January 2006, the drug coverage available to Medicare beneficiaries expanded with the implementation of Medicare Part D. The Medicare Part D program does not change Medicare Part B drug coverage. This section of the preamble discusses proposed changes and issues related to the determination of the payment amounts for covered Part B drugs and furnishing blood clotting factor. This section also discusses proposed changes to how manufacturers calculate and report ASP data to us. 1. ASP Issues Section 303(c) of the MMA amended Title XVIII of the Act by adding new section 1847A. This new section revised the payment methodology for the vast majority of drugs and biologicals not paid on a cost or prospective payment basis furnished on or after January 1, 2005. The ASP reporting requirements are set forth in section 1927(b) of the Act. Manufacturers must submit ASP data for each 11-digit National Drug Code (NDC) to us quarterly. The manufacturers' submissions are due to us not later than 30 days after the last day of each calendar quarter. The methodology for developing Medicare drug payment allowances based on the manufacturers' submitted ASP data is specified in the regulations in part 414, subpart K. We update the Part B drug payment amounts quarterly based on the data we receive. In this section of the preamble, we discuss our intent to issue a final rule to implement the provisions in the MMA related to the calculation and submission of manufacturers’ ASP data, and seek further comments on specific issues related to price concessions and certain fees. On April 6, 2004, we published the Manufacturer's Submission of Average Sales Price Data for Medicare Part B Drugs and Biologicals (ASP) interim final rule with comment period (IFC) (69 FR 17935) to implement the ASP calculation and reporting requirements. Manufacturers were required to submit their initial quarterly ASP data to us shortly thereafter, beginning April 30, 2004. We received comments from drug manufacturers, pharmacies, physicians, national associations of the pharmaceutical industry, national associations of physicians, and consultants. These comments addressed a variety of aspects of calculating and reporting ASPs. On September 16, 2004, we published the Manufacturer's Submission of Average Sales Price Data for Medicare Part B Drugs and Biologicals (ASP) final rule (69 FR 55763) addressing only the comments pertaining to the methodology for estimating lagged price concessions. We have also addressed ASP calculation and reporting requirements in other proposed and final rules and information collection notices, including rulemaking to implement the Competitive Acquisition Program for Part B Drugs and Biologicals (CAP). (See 70 FR 39069, 70 FR 45842, 70 FR 70215, and 70 FR 70477.) In addition, we posted official agency guidance, including responses to frequently asked questions, on our Web site to implement the ASP provisions in accordance with section 1847A(c)(5)(C) of the Act. We intend to publish a final rule addressing comments on the April 6, 2004 IFC in the near future. We may publish the final rule as part of this rulemaking, or we may publish a separate final rule, in either case after the close of the comment period for this proposed rule. Because the comments received during the comment period in response to the April 6, 2004 IFC were made during the initial months of manufacturers’ experience with calculating and reporting ASPs and prior to publication of payment amounts based on the ASP methodology, we believe there is good reason to provide the public with the opportunity for additional comments based on what is now more than a year and a half of experience with the ASP reporting requirements. Therefore, we seek comments on the ASP reporting provisions in the April 6, 2004 IFC. In particular, we seek comments on the issues discussed in the sections below. We note that we received many comments in response to the April 6, 2004 interim final rule on the use and potential impacts of the ASP payment methodology. As noted above, we are reopening the comment period on the issue of ASP reporting. Thus, comments about the use or appropriateness of the ASP payment methodology are outside the scope of this rulemaking and the ASP reporting rule (CMS-1380-IFC). Therefore, comments about the appropriateness and use of 106 percent of ASP as the basis for the Medicare Part B drug payment rates will be outside the scope of the comments considered for the final ASP reporting rule we are preparing to publish. a. Fees Not Considered Price Concessions Section 1847A(c)(5)(A) of the Act states that the ASP is to be calculated by the manufacturer on a quarterly basis. As a part of that calculation, manufacturers are to take into account price concessions such as— Volume discounts;
                    Prompt pay discounts;
                    Cash discounts;
                    Free goods that are contingent on any purchase requirement;
                    Chargebacks; and
                    Rebates (other than rebates under the Medicaid drug rebate programs). If the data on these price concessions are lagged, then the manufacturer is required to estimate costs attributable to these price concessions using the required ratio methodology as specified in 42 CFR part 414, subpart J, § 414.804(a)(3). Among the comments from drug manufacturers and national associations representing wholesalers and distributors, we received requests for clarification and detailed guidance on the treatment of administrative fees, service fees and fees paid to pharmacy benefit managers (PBMs) in the ASP calculation. We posted guidance on our Web site (
                        *http://questions.cms.hhs.gov/​cgi-bin/​cmshhs.cfg/​php/​enduser/​std_​adp.php?​p_​faqid=​3323&​p_​created=​1095344721&​p_​sid=​Ghuscgci&​p_​accessibility=​0&​p_​lva=​&​p_​sp=​cF9zcmNoPTEmcF9zb3J0X2J5PSZwX2dyaWRzb3J0PSZwX3Jvd19jbnQ9MzEmcF9wcm9kcz04LDU2LDYwNCZwX2NhdHM9JnBfcHY9My42MDQmcF9jdj0mcF9zZWFyY2hfdHlwZT1hbnN3ZXJzLnNlYXJjaF9ubCZwX3BhZ2U9MQ**&​p_​li=​&​p_​topview=​1*) to clarify that in the absence of specific guidance in the Social Security Act or Federal regulations, the manufacturer may make reasonable assumptions in its calculations of ASP, consistent with the general requirements and intent of the Social Security Act, Federal regulations, and its customary business practices. These assumptions should be submitted along with the ASP data. In December 2004, we posted further guidance on our website addressing service fees and administrative fees paid to buyers (
                        *http://questions.cms.hhs.gov/​cgi-bin/​cmshhs.cfg/​php/​enduser/​std_​adp.php?​p_​faqid=​3318&​p_​created=​1095343992&​p_​sid=​a2qUcgci&​p_​accessibility=​0&​p_​lva=​&​p_​sp=​cF9zcmNoPTEmcF9zb3J0X2J5PSZwX2dyaWRzb3J0PSZwX3Jvd19jbnQ9MzEmcF9wcm9kcz04LDU2LDYwNCZwX2NhdHM9
                            ( print page 49001)
                            JnBfcHY9My42MDQmcF9jdj0mcF9zZWFyY2hfdHlwZT1hbnN3ZXJzLnNlYXJjaF9ubCZwX3BhZ2U9MQ**&​p_​li=​&​p_​topview=​1*
                         and 
                        *http://questions.cms.hhs.gov/​cgi-bin/​cmshhs.cfg/​php/​enduser/​std_​adp.php?​p_​faqid=​4136&​p_​created=​1109786814&​p_​sid=​bxw-cgci&​p_​accessibility=​0&​p_​lva=​&​p_​sp=​cF9zcmNoPTEmcF9zb3J0X2J5PSZwX2dyaWRzb3J0PSZwX3Jvd19jbnQ9MzEmcF9wcm9kcz04LDU2LDYwNCZwX2NhdHM9JnBfcHY9My42MDQmcF9jdj0mcF9zZWFyY2hfdHlwZT1hbnN3ZXJzLnNlYXJjaF9ubCZwX3BhZ2U9MQ**&​p_​li=​&​p_​topview=​1).* On July 6, 2005, we restated our guidance on service fees in the preamble of the Competitive Acquisition of Outpatient Drugs and Biologicals Under Part B (CAP) interim final rule with comment (70 FR 39069). Subsequently, we have received requests for clarification on how fees paid to entities such as group purchasing organizations (GPOs) or PBMs must be treated for purposes of the ASP calculation. We propose to further clarify in the final ASP reporting rule that, beginning with the ASP reporting for sales during the first calendar quarter of 2007, bona fide service fees that are paid by a manufacturer to an entity, whether or not the entity takes title to the drug, are not considered price concessions under § 414.804(a)(2) insofar as, and to the extent that, they satisfy the definition of a bona fide service fee that we are proposing at § 414.802. In § 414.802, we propose to define bona fide service fees as fees paid by a manufacturer to an entity that represent fair market value for a bona fide, itemized service actually performed on behalf of the manufacturer that the manufacturer would otherwise perform (or contract for) in the absence of the service arrangement, and that are not passed on, in whole or in part, to a client or customer of an entity, whether or not the entity takes title to the drug. Our current guidance, which provides that bona fide service fees means expenses that would have generally been paid for by the manufacturer at the same rate had these services been performed by other entities, would continue unless we provide an alternative approach as discussed below. Further, we propose to clarify in the final ASP reporting rule that fees, including service fees, administrative fees and other fees, paid to GPOs or PBMs are not considered price concessions under § 414.804(a)(2) insofar as, and to the extent that, they satisfy the definition of a bona fide service fee that we have proposed at § 414.802. In comments on the April 6, 2004 IFC, groups representing wholesalers, distributors and specialty pharmacies provided some insight into the types of activities that are performed in the distribution of drugs. These commenters suggested that costs for handling, storage, inventory reporting, shipping, receiving, patient education, disease management and data should be borne by manufacturers and be excluded from the ASP calculation as bona fide services. However, these commenters did not provide detailed information about whether and how one would determine the extent to which these activities are bona fide services actually performed on behalf of the manufacturer or otherwise. Because the scope of appropriate services may vary across categories of drugs, we are considering providing guidance on the types of services that may qualify as bona fide services for purposes of the ASP calculation. We are also considering providing further guidance on or revising the approach or methodology manufacturers must use to determine the fair market value of bona fide services performed on their behalf and whether the service fee paid was passed on in whole or in part. In either case, we may implement our policy through rulemaking or through program instruction or other guidance (consistent with our authority under section 1847A(c)(5)(C) of the Act). We seek comments on the specific types of services entities perform on behalf of manufacturers that a manufacturer would otherwise perform (or contract for) and the necessity of those services in the efficient distribution of drugs. We also seek comments on activities that should not be considered bona fide services performed on behalf of manufacturers. To better understand which services may be considered bona fide services performed on behalf of the manufacturer that the manufacturer would otherwise perform (or contract for), we seek to understand the bona fide services that may be appropriate for all or specific types of products, as well as the specific services that may be applicable to unique products or circumstances. We also seek to understand the costs and relative costs of services performed on behalf of manufacturers. To exclude a bona fide service fee from the ASP calculation, a manufacturer must determine whether the fee paid to an entity represents fair market value for a bona fide service actually performed on behalf of the manufacturer that the manufacturer would otherwise perform (or contract for), and that the fee is not passed on, in whole or in part, to a client or customer of the entity.  Our current guidance provides that bona fide service fees means expenses that would have generally been paid for by the manufacturer at the same rate had these services been performed by other entities. We seek comments on appropriate additional guidance or alternative methods for determining fair market value for purposes of identifying bona fide service fees that are excluded from the calculation of ASP, as well as comments on whether, and the extent to which, fees tied to performance of a service, fixed fee, revenue generated by product sales, or other basis may represent fair market prices for purposes of identifying bona fide service fees that are excluded from the calculation of ASP. In addition, we seek comments on the appropriate methods for determining whether a fee is passed on in whole or in part. We also seek comments on how Medicare's guidance on the treatment of service fees for ASP calculation purposes may differ with the treatment of service fees for financial accounting or other purposes, and any implications that this may have for manufacturers. b. Estimation Methodology for Lagged Exempted Sales Section 1847A(c)(2) of the Act requires manufacturers to exclude from the calculation of ASP those sales that are exempt from the Medicaid best price (BP) calculation (for example, Federal sales, sales to State pharmacy assistance programs, sales to a prescription drug plan for use under Medicare Part D). In the comments on the April 6, 2004 IFC, commenters requested more guidance on the method manufacturers should use to exclude exempted sales that are known on a lagged basis. Manufacturers identify exempted sales based on direct sales and through chargeback and rebate data that may not be sufficiently available at the time the ASP is calculated. In the absence of specific guidance on how to account for lagged exempted sales (that is, exempted sales identified through chargeback or rebate processes), manufacturers have relied upon assumptions in accordance with their customary business practices to develop their approach for excluding these sales from the ASP calculation. In our work with manufacturers that submit ASP data, we understand that some manufacturers have used a ratio methodology for estimating exempted sales known on a lagged basis which is similar to the ratio methodology manufacturers must use to estimate 
                        ( print page 49002)
                        price concessions known on a lagged basis. To establish a uniform approach, in § 414.804(a)(4), we propose to require, in the final ASP reporting rule, that all manufacturers use a 12-month (or less, if applicable) rolling average ratio methodology to estimate exempted sales known on a lagged basis (through chargebacks or rebates) in order to more accurately exclude these sales from the ASP calculation. Specifically, for exempted sales known on a lagged basis, the manufacturer sums the lagged exempted sales for the most recent 12-month period available (or the number of months the NDC has been sold for NDCs with less than 12 months of sales, except for redesignated NDCs as described in section d below). The manufacturer then calculates a percentage using this summed amount as the numerator and the sales (the number of units after non-lagged exempted sales have been subtracted from total sales) for the same period (12 months or less, if applicable) as the denominator. The result is a rolling average percentage estimate for lagged exempted sales that is applied to the sales (the number of units after non-lagged exempted sales have been subtracted from total sales) for the quarter being reported. The product that results from multiplying the rolling average percentage estimate of lagged exempted sales and sales (the number of units after non-lagged exempted sales have been subtracted from total sales) determines the number of lagged exempted sales (in units) to be excluded from the denominator of the ASP calculation. Manufacturers must make a corresponding adjustment to the numerator of the ASP calculation to ensure that the total in dollars for the reporting quarter does not include revenue related to lagged exempted sales excluded from the denominator using the proposed estimation methodology. Further, manufacturers must remove the dollar value of lagged exempted sales from their estimates of lagged price concessions by subtracting the dollar value of estimated lagged exempted sales from the denominator as specified in § 414.804(a)(3)(i). Our proposed methodology for excluding lagged exempted sales is similar to the methodology manufacturers are required to use to estimate price concessions known on a lagged basis, and was recommended by manufacturers. We believe requiring similar methods to estimate both lagged exempted sales and lagged price concessions is reasonable and reduces potential errors in the manufacturers’ ASP calculations, while ensuring that exempted sales are appropriately removed from the ASP calculation. In addition, using an estimation methodology to remove lagged exempted sales reduces the likelihood of quarter to quarter variations in the ASP. We seek comments on the proposed methodology for excluding exempted sales known on a lagged basis from the ASP calculation and estimate of lagged price concessions. We also solicit suggestions on appropriate alternative methodologies that may be less complex. c. Nominal Sales Section 1847A(c)(2)(B) of the Act requires manufacturers to exclude from the ASP calculation sales that are merely nominal in amount, as applied for purposes of section 1927(c)(1)(C)(ii)(III) of the Act, except as the Secretary may otherwise provide. Effective January 1, 2007, the DRA (Pub. L. 109-171) modifies section 1927(c)(1)(C)(ii)(III) of the Act. Limitations on nominal sales have been added in new section 1927(c)(1)(D) of the Act. The DRA also modified the average manufacturer price (AMP) calculation and frequency of AMP reporting. Therefore, we are proposing to clarify the method manufacturers must follow, beginning in 2007, to identify nominal sales for ASP reporting purposes and to exclude nominal sales from the calculation of the ASP. We also are seeking comments on whether we should establish an alternative definition of nominal sales for ASP purposes. In the preamble to the ASP reporting interim final rule, we stated sales to an entity that are nominal in amount are defined in the Medicaid drug rebate agreement (see sample agreement at 
                        *http://www.cms.hhs.gov/​MedicaidDrugRebateProgram/​downloads/​rebateagreement.pdf*). That is, for ASP purposes, a nominal sale is a sale at a price less than 10 percent of the AMP in the same quarter for which the AMP is computed. Effective January 1, 2007, the DRA revises the AMP calculation (to omit customary prompt pay discounts extended to wholesalers), added a monthly AMP reporting requirement, and established limitations on nominal sales (only sales to certain entities may qualify as nominal sales). Section 1927(c)(1)(D) of the Act limits the nominal sales exclusion to nominal sales made to the following entities: 340B covered entities as described in section 340B(a)(4) of the Public Health Services Act (PHS Act).
                    Intermediate care facilities for the mentally retarded (ICFs/MR).
                    State-owned or operated nursing facilities.
                    Any other facility or entity that the Secretary determines is a safety net provider to which sales of such drugs at a nominal price would be appropriate based on the factors described in section 1927(c)(1)(D)(ii) of the Act. Because section 1847A(c)(2)(B) of the Act requires manufacturers to exclude from the ASP calculation sales that are merely nominal in amount, as applied for purposes of section 1927(c)(1)(C)(ii)(III) of the Act, except as the Secretary may otherwise provide, the DRA changes will have implications for ASP reporting beginning January 1, 2007 (unless we provide an alternative policy for determining nominal sales as permitted under section 1847A(c)(2)(B) of the Act). One implication is that the limitations set forth in section 1927(c)(1)(D) of the Act will continue the exclusion of nominal sales to certain entities while requiring that sales to entities not identified under section 1927(c)(1)(D) of the Act are included in the ASP calculation, even if such sales are at very low prices. Another implication is the AMP calculation will exclude customary prompt pay discounts extended to wholesalers, yet prompt pay discounts will continue to be a type of price concession that manufacturers must include in their ASP calculations. The change in treatment of customary prompt pay discounts extended to wholesalers in the AMP calculation may result in a higher number of sales that are at less than 10 percent of the AMP than in past ASP reporting periods (notwithstanding the new limitation on what is considered a nominal sale under section 1927(c)(1)(D) of the Act). Still another implication is that the frequency of AMP reporting will include monthly reporting; thus, for ASP purposes, there is further need to clarify how nominal sales are to be identified in 2007. Separate Medicaid rulemaking will address the DRA provisions related to AMP reporting. We believe the DRA modifications to section 1927 of the Act noted above will have minimal effect on reported ASPs. We would expect that the exclusion of customary prompt pay discounts extended to wholesalers from AMP would lead to a modest increase in AMP, and as a result a modest increase in the number of sales that would qualify as nominal under the current ASP reporting regulations. At the same time, we anticipate that the limitation on nominal sales in section 1927(c)(1)(D) of the Act will result in a modest reduction in the number of sales that qualify as nominal sales for 
                        ( print page 49003)
                        purposes of ASP reporting because we believe that the entities outlined in section 1927(c)(1)(D) of the Act generally represent the types of entities to which manufacturers may offer sales at a nominal amount. Consequently, we would expect these two countervailing changes would have a minimal overall impact on nominal sales that would be excluded from the ASP calculation. For 2007 and beyond, we propose to revise § 414.804(a)(4) to clarify that manufacturers must continue to use the Medicaid threshold (less than 10 percent of AMP) to determine nominal sales that are excluded (subject to the limitations in section 1927(c)(1)(D) of the Act) from the ASP calculation. Further, we propose that, in identifying nominal sales, manufacturers must use the AMP for the calendar quarter that is the same calendar quarter for the ASP reporting period. For these reasons, we are proposing to continue the current methodology for identifying and excluding nominal sales (that is, sales that are exempt from the Medicaid best price calculation under section 1927(c)(1)(C)(ii)(III) of the Act) from the manufacturer's calculation of the ASP. We believe this approach helps maintain continuity in the ASP calculation and minimizes manufacturers' reporting burden, as Medicare continues to follow the Medicaid approach for identifying nominal sales and manufacturers can use a single method for identifying nominal sales for both ASP and AMP purposes. We seek comments on our proposal to continue use of the AMP as the basis for identifying nominal sales excluded from the ASP calculation and on whether an alternative threshold for identifying nominal sales for ASP calculation purposes is necessary or desirable to ensure the accuracy of the ASP payment methodology. Specifically, we seek comments on whether sales at less than 10 percent of the ASP (instead of the AMP) should be used to identify nominal sales for ASP purposes (with the new requirement in section 1927(c)(1)(D) of the Act allowing only sales to certain entities to be considered nominal sales still being applicable). We also seek comments on our belief that the new limitations on nominal sales and change to the AMP calculation will have minimal impact on reported ASPs. Subsequent to the April 6, 2004 IFC, we received requests for clarification on a technical aspect related to the identification of nominal sales. Specifically, some manufacturers have asked whether nominal sales are identified by performing a series of calculations once or whether the manufacturer repeats the series of calculations until no remaining ASP eligible sales are below the nominal threshold. Consistent with current Medicaid reporting, for 2005 and 2006, manufacturers must identify nominal sales by performing the following steps once: The manufacturer calculates the AMP for the reporting quarter to identify the dollar amount that represents 10 percent of the AMP for that reporting period.
                    The manufacturer then identifies sales below this amount and excludes these sales from the ASP calculation.
                    Beginning in 2007, the limitations in section 1927(c)(1)(D) of the Act must also be met to exclude the sale. d. Other Price Concession Issues In our ongoing work with manufacturers that submit ASP data, some manufacturers have posed questions or raised concerns about how the estimate of lagged price concessions is done prior to having 12 months of data for a NDC and, when a product is redesignated with a new NDC, whether price concessions from the prior NDC must be included in calculating the ASP for the new NDC. Manufacturers and other stakeholders have also asked us about how Medicare's ASP guidance concerning price concessions is to be applied when drugs are sold under bundling arrangements. In response, we are proposing clarifications and seeking comment on these issues. (1) Price Concessions for NDCs With Less Than 12 Months of Sales To address situations when a NDC with price concessions known on a lagged basis has not been sold for a full 12 months, we propose to revise § 414.804(a)(3) to specify that the period used to estimate lagged price concessions is the total number of months the NDC has been sold. We propose to require that manufacturers use less than 12 months of data in the estimation methodology for lagged price concessions for NDCs with less than 12 months of sales (except when the manufacturer has redesignated the product's NDC, as discussed below). Manufacturers may include the current ASP reporting quarter in the most recent 12 month period (or less for NDCs with less than 12 months of sales) so long as the manufacturer follows this approach in calculating the ASP for all of its reported NDCs. Using less than 12 months in the estimation methodology for lagged price concessions is consistent with our proposal for estimating lagged excluded sales described in section b. above. (2) Redesignated NDCs From time to time, a manufacturer may change the NDC assigned to a specific product and package size while continuing or offering price concessions that span across sales of the product under its prior and redesignated NDCs. For example, an NDC may be changed to reflect a change in the labeler code while lagged price concessions in place under the prior NDC remain in effect and carry over to the redesignated NDC. Another example would be a manufacturer that modifies its package design or other non-drug feature of the NDC and assigns a new NDC to reflect the revised packaging. We propose to clarify in the final ASP reporting rule that, when an NDC is changed (except when a product is repackaged or relabeled by a different manufacturer or relabeler or is privately labeled) and lagged price concessions offered for the prior NDC remain in effect, the manufacturer must use 12 months (or the total number of months of sales of the prior and redesignated NDCs if the total number of months of sales is less than 12 months) of sales and price concession data from the prior and redesignated NDCs to estimate lagged price concessions applicable to the redesignated NDC. In establishing this methodology, we are relying on our authority under section 1847A(c)(5)(A) of the Act. We seek comments on our proposed refinements to the estimation of lagged price concessions for NDCs with less than 12 months of sales and when a manufacturer redesignates the NDC assigned to a product. We also solicit suggestions for potentially clarifying these policies further. (3) Bundled Price Concessions We have heard a few concerns about how Medicare's ASP guidance concerning price concessions is to be applied when drugs are sold under bundling arrangements (for example, when a purchaser's price for one or more drugs is contingent upon the purchase of other drugs or items). We would like to better understand how bundling affects sales of Part B drugs and the ASP calculation, and any concerns stakeholders may have on this issue. Therefore, we are soliciting comments on a number of these issues. We note that we expect manufacturers of drugs reimbursed by Medicare Part B to comply with all applicable laws, regulations, and legal decisions including, but not limited to the Stark law, other relevant anti-kickback laws, 
                        ( print page 49004)
                        antitrust laws, and laws governing fair trade practices. Our discussion of this issue in this proposed rule should not be construed as an endorsement or authorization of any pricing practices that contravene any laws, legal decisions, or regulations. Thus far, we have not provided specific guidance in the ASP context on the issue of apportioning price concessions across drugs that are sold under bundling arrangements. In the absence of specific guidance, the manufacturer may make reasonable assumptions in its calculations of ASP, consistent with the general requirements and the intent of the Social Security Act, Federal regulations, and its customary business practices. Manufacturers must include assumptions in their ASP submissions. We are now considering providing guidance, through rulemaking or through program instruction or other guidance (consistent with our authority under section 1847A(c)(5)(C) of the Act) on the methodology manufacturers must use for apportioning price concessions across Part B drugs sold under bundling arrangements for purposes of the calculation of ASP. As we consider this issue, our goal is to ensure that the ASP is an accurate reflection of market prices for Part B drugs and that the treatment of bundled price concessions in the ASP calculation does not create inappropriate financial incentives. We are soliciting comments on a number of issues, including how frequently Part B drugs are sold under bundling arrangements, the different structures of bundling arrangements that may exist (for example, the number of products included in a bundling arrangement; whether the price concessions are contingent on the purchase of only one product, the purchase of multiple products, or the inclusion of one or more products on a formulary; and the timing of the price concessions), and the extent to which sales of Part B drugs are bundled with sales of non-Part B drugs or non-drug products. We also seek comment on what effect bundling arrangements may have on the ASP calculation, on beneficiary access to high quality, appropriate care (including access to drugs that may not have clinical alternatives), and on costs to the Medicare program and beneficiaries. In addition, we seek comments on whether additional guidance on apportioning bundled price concessions for purposes of the calculation of ASP is needed and potential methodologies that Medicare could consider requiring. Furthermore, we seek comment on how variation in the structure of bundling arrangements may affect the impact of potential apportionment methodologies on the ASP calculation. 2. Clotting Factor Furnishing Fee Section 303(e)(1) of the MMA added section 1842(o)(5) of the Act which requires the Secretary, beginning in CY 2005, to pay a furnishing fee, in an amount the Secretary determines to be appropriate, to hemophilia treatment centers and homecare companies for the items and services associated with the furnishing of blood clotting factor. Section 1842(o)(5)(C) of the Act specifies that the furnishing fee for clotting factor for years after CY 2006 and subsequent years will be equal to the fee for the previous year increased by the percentage increase in the consumer price index (CPI) for medical care for the 12 month period ending with June of the previous year. In the CY 2006 PFS final rule, we announced that, based on the percentage increase in the CPI of 4.2 percent for the 12-month period ending June 2005, the furnishing fee is $0.146 per unit clotting factor for CY 2006. The CPI data for the 12-month period ending in June 2006 is not yet available. In the FY 2007 PFS final rule, we will include the actual figure for the percent change in the CPI for medical care for the 12-month period ending June 2006, and the updated furnishing fee for CY 2007 calculated based on that figure. 3. Widely Available Market Prices (WAMP) and AMP Threshold Section 1847A(d)(1) of the Act states that “the Inspector General of HHS shall conduct studies, which may include surveys to determine the widely available market prices (WAMP) of drugs and biologicals to which this section applies, as the Inspector General, in consultation with the Secretary, determines to be appropriate.” Section 1847A(d)(2) of the Act states that, “Based upon such studies and other data for drugs and biologicals, the Inspector General shall compare the ASP under this section for drugs and biologicals with— The widely available market price (WAMP) for these drugs and biologicals (if any); and
                    The average manufacturer price (AMP) (as determined under section 1927(k)(1) of the Act for such drugs and biologicals.” Section 1847A(d)(3)(A) of the Act states that, “The Secretary may disregard the ASP for a drug or biological that exceeds the WAMP or the AMP for such drug or biological by the applicable threshold percentage (as defined in subparagraph (B)).” The applicable threshold is specified as 5 percent for CY 2005. For CY 2006 and subsequent years, section 1847A(d)(3)(B) of the Act establishes that the applicable threshold is “the percentage applied under this subparagraph subject to such adjustment as the Secretary may specify for the WAMP or the AMP, or both.” In CY 2006, we specified an applicable threshold percentage of 5 percent for both the WAMP and AMP. We based this decision on the limited data available to support a change in the current threshold percentage. For CY 2007, we propose to specify an applicable threshold percentage of 5 percent for the WAMP and the AMP. At present, the OIG is continuing its comparison of both the WAMP and the AMP. Since, at this time we do not have data that suggest another level is more appropriate, we believe that continuing the 5 percent applicable threshold percentage for both the WAMP and AMP is appropriate. There are a number of operational issues associated with Medicare's authority to substitute a lower payment amount for a drug if the OIG finds and informs the Secretary, at such times as the Secretary may specify, that the ASP exceeds the WAMP or AMP by more than the established threshold (currently 5 percent). We would welcome public comment on operational issues such as the timing and frequency of the ASP, AMP, and WAMP comparisons and effective date and duration of the rate substitution. 4. Payment for Drugs Furnished During CY 2006 and Subsequent Years in Connection With the Furnishing of Renal Dialysis Services if Separately Billed by Renal Dialysis Facilities In the November 21, 2005 PFS final rule (70 FR 70116), we stated that payment for a drug furnished during CY 2006 in connection with renal dialysis services and separately billed by freestanding renal dialysis facilities and hospital-based facilities would be based on section 1847A of the Act. We intended this to mean CY 2006 and subsequent years. Therefore, in this proposed rule, we are not proposing a policy change, but rather, we are clarifying that this policy will apply to CY 2006 and subsequent years until otherwise specified. G. Proposed Provisions Related To Payment for Renal Dialysis Services Furnished by End-Stage Renal Disease (ESRD) Facilities [If you choose to comment on issues in this section, please include the 
                        ( print page 49005)
                        caption “ESRD PROVISIONS” at the beginning of your comments.] Since August 1, 1983, payment for dialysis services furnished by ESRD facilities has been based on a composite rate payment system that provides a fixed, prospectively determined amount per dialysis treatment, adjusted for geographic differences in area wage levels. In accordance with section 1881(b)(7) of the Act, separate composite rates have been established for hospital-based and independent ESRD facilities. The composite rate is designed to cover a package of goods and services needed to furnish dialysis treatments that include certain routinely provided drugs, laboratory tests, supplies, and equipment. Unless specifically included in the composite rate, other injectable drugs and laboratory tests medically necessary for the care of the dialysis patient are separately billable. The base composite rates per treatment, effective on August 1, 1983, were $123 for independent ESRD facilities and $127 for hospital-based ESRD facilities. The Congress has enacted a number of adjustments to the composite rate since that time. The current 2006 base composite rates are $130.40 for independent ESRD facilities and $134.53 for hospital-based ESRD facilities. Section 623 of the MMA amended section 1881 of the Act to require changes to the composite rate payment methodology, as well as to the pricing methodology for separately billable drugs and biologicals furnished by ESRD facilities. Section 1881(b)(12) of the Act, as added by MMA, required the establishment of a basic case-mix adjusted prospective payment system (PPS) that would include the services comprising the composite rate and an add-on to the composite rate component for the difference between current payments for separately billed drugs and the revised drug pricing specified in the statute. In addition, section 1881(b)(12) of the Act required that the composite rate be adjusted for a limited number of patient characteristics (case-mix) and section 1881(b)(12)(D) of the Act gave the Secretary discretion to revise the wage indices and the urban and rural definitions used to develop them. Finally, section 1881(b)(12)(E) of the Act imposed a budget neutrality requirement, so that aggregate payments under the basic case-mix adjusted composite payment system for 2005 would equal the aggregate payments that would have been made for the same period if section 1881(b)(12) of the Act did not apply. Before January 1, 2005, payment to both independent and hospital-based facilities for the anti-anemia drug, Erythropoietin (EPO) was established pursuant to section 1881(b)(11) of the Act at $10.00 per 1,000 units. For independent ESRD facilities, payment for all other separately billable drugs and biologicals was based on the lower of actual charges or 95 percent of the average wholesale price (AWP). Hospital-based ESRD facilities were paid based on the reasonable cost methodology for separately billed drugs and biologicals (other than EPO) furnished to dialysis patients. Changes to the payment methodology for separately billed ESRD drugs and biologicals that were established by the MMA and were effective January 1, 2005 are described in sections G.1. and G.2. below. These changes affected payments in both CYs 2005 and 2006. 1. CY 2005 Revisions On November 15, 2004, we published the CY 2005 PFS final rule with comment period (69 FR 66319 through 66334), that revised payments to ESRD facilities based on changes enacted by the MMA. The November 15, 2004 final rule with comment period implemented section 1881(b) of the Act, as amended by section 623 of the MMA. Changes effective January 1, 2005, included implementation of a case-mix adjusted payment system that incorporates services that comprise the composite rate; an update of 1.6 percent to the composite rate component of the payment system; and a drug add-on of 8.7 percent to the composite rate for the difference between current payments for separately billable drugs and payments based on the revised drug pricing for 2005 which used acquisition costs. The final rule also implemented case-mix adjustments to the composite rate for a limited number of patient characteristics (age, low body mass index (BMI), and body surface area (BSA)), effective April 1, 2005. In addition, to implement section 1881(b)(13) of the Act, we revised payments for drugs billed separately by independent ESRD facilities, paying for the top 10 ESRD drugs based on acquisition costs (as determined by the OIG) and for other separately billed drugs at the average sales price +6 percent (hereafter referred to as ASP+6 percent). Hospital-based ESRD facilities continued to receive cost-based payments for all separately billable drugs and biologicals except for EPO which was paid based on average acquisition costs. 2. CY 2006 Revisions In the November 21, 2005 
                        **Federal Register**
                         (70 FR 70161), we published the CY 2006 PFS final rule with comment period (70 FR 70161) implementing additional revisions to payments to ESRD facilities under section 623 of the MMA. For CY 2006, we further revised the drug payment methodology applicable to drugs furnished by ESRD facilities. All separately billed drugs and biologicals furnished by both hospital-based and independent ESRD facilities are now paid based on ASP+6 percent. We recalculated the 2005 drug add-on adjustment to reflect the difference in payments between the pre-MMA AWP pricing and the revised pricing based on ASP+6 percent. The recalculation did not affect the actual add-on adjustment applied to payments in 2005, but provided an estimate of what the adjustment would have been had the 2006 payment methodology been in effect in 2005. The drug add-on adjustment was then updated to reflect the expected growth in expenditures for separately billable drugs in CY 2006. As of January 1, 2006, we also implemented a revised geographic adjustment authorized by section 1881(b)(12) of the Act. As part of that change, we— Revised the labor market areas to incorporate the new CBSA designations established by the Office of Management and Budget (OMB);
                    Eliminated the wage index ceiling and reduced the floor to .8500; and
                    Revised the labor portion of the composite rate to which the geographic adjustment is applied. We also provided a 4-year transition from the previous wage-adjusted composite rates to the current wage-adjusted rates. For CY 2006, only 25 percent of the payment is based on the revised geographic adjustments, and the remaining 75 percent of payment is based on the old Metropolitan Statistical Area-based (MSA-based) payments. In addition, section 5106 of the DRA (Pub. L. 109-171), provided for a 1.6 percent update to the composite rate component of the basic case-mix adjusted payment system, effective January 1, 2006. As a result, the current base composite rate is $130.40 for independent ESRD facilities and $134.53 for hospital-based facilities. The drug add-on adjustment (including the growth update) for 2006 is 14.5 percent. 3. Provisions of the Proposed Rule For CY 2007, we are proposing the following provisions which are described in more detail below: 
                        ( print page 49006) A method to annually calculate the growth update to the drug add-on adjustment required by section 1881(b)(12) of the Act, as well as an estimated growth update adjustment to the add-on amount of 0.6 percent for CY 2007.
                    An update to the wage index adjustments to reflect the latest hospital wage data, including a budget neutrality adjustment of 1.053069 to the wage index for CY 2007. 4. Proposed Growth Update to the Drug Add-On Adjustment to the Composite Rates Section 623(d) of the MMA added section 1881(b)(12)(B)(ii) of the Act which required the establishment of an add-on to the composite rate to account for changes in the drug payment methodology stemming from enactment of the MMA. Section 1881(b)(12)(C) of the Act provides that the drug add-on must reflect the difference in aggregate payments between the revised drug payment methodology for separately billable ESRD drugs (acquisition costs in CY 2005; ASP+6 percent in CY 2006) and the AWP payment methodology in effect in CY 2004. In addition, section 1881(b)(12)(F) of the Act requires that, beginning in CY 2006, we establish an annual update to the drug add-on to reflect estimated growth in expenditures for separately billable drugs and biologicals furnished by ESRD facilities. This growth update applies only to the drug add-on portion of the case-mix adjusted payment system. The CY 2006 drug add-on adjustment to the composite rate is 14.5 percent. The drug add-on adjustment for CY 2006 incorporates an inflation adjustment of 1.4 percent. This computation is explained in detail in the CY 2006 PFS final rule with comment period (70 FR 70162). We note that the drug add-on adjustment of 14.7 percent that was published in November 21, 2005 PFS final rule with comment period did not account for the 1.6 percent update to the composite rate portion of the basic case-mix adjustment payment system that was subsequently enacted by the DRA, effective January 1, 2006. Since we compute the drug add-on adjustment as a percentage of the weighted average base composite rate, the drug add-on percentage was decreased to account for the higher composite payment rate resulting in a 14.5 percent add-on adjustment for CY 2006. This adjustment was necessary to ensure that the total drug add-on dollars remained constant. a. Estimating Growth in Expenditures for Drugs and Biologicals for CY 2007 In developing the growth update to the drug add-on for CY 2006 we conducted a trend analysis of prior years’ ESRD drug expenditure data (2001 through 2004). All 4 years of data used for the trend analysis reflected expenditures associated with payment for separately billed drugs and biologicals under the AWP methodology. We could, therefore, develop growth estimates for CY 2006 using comparable historical expenditure data. To extend the trend analysis for CY 2007, we would need to include drug expenditure data from CY 2005. However, in CY 2005, section 1881(b)(13)(A)(ii) of the Act required that we use a different drug payment methodology, based on average acquisition costs, rather than the AWP methodology used in prior years. Therefore, ESRD drug expenditure data for CY 2005 are not comparable to expenditure data for CY 2001 through CY 2004 for trend analysis purposes. This data issue will extend to subsequent years’ data as well, as we are now paying for separately billable drugs using ASP+6 percent. Because we do not have comparable data on which to base continuing trend analysis, we believe it is necessary to re-evaluate our methodology for updating the drug add-on adjustment. In order to address the issue of data comparability described above, we considered using available drug proxy measures to predict growth in ESRD drug expenditures for CY 2007. We note that section 1881(b)(12)(F) of the Act specifies that the drug update must reflect “the estimated growth in expenditures for drugs and biologicals that are separately billable  * * *.” By referring to “expenditures”, we believe the statute contemplates that the update would account for both increases in drug prices as well as increases in utilization of those drugs. One available proxy measure that reflects both price and utilization is the national health expenditure projection for prescription drugs that is developed by CMS. However, because of uncertainties regarding the impact of the Medicare Part D prescription drug program on expenditures, we are concerned that the current estimates for CY 2007 will likely change, as actual Part D expenditure data become available. Therefore, we do not believe this measure would be an appropriate proxy measure for this purpose. Another widely recognized proxy measure is the producer price index (PPI) for prescription drugs. The PPI is a good measure of drug pricing growth, but does not capture the growth in per patient drug utilization that must also be part of an accurate estimate of growth in ESRD drug expenditures. However, if the PPI is used in conjunction with an estimate of per patient growth in drug utilization, we believe this measure would provide a simple and accurate approach to updating the drug add-on that could be readily used in subsequent years. Moreover, using the PPI would significantly reduce any data bias that is inherent in using historical drug expenditure data that do not reflect current drug payment methodologies. As discussed in detail below, we are proposing to estimate growth in per patient utilization of drugs by using historical data from 2004 and 2005. Another approach to estimating the growth in ESRD drug expenditures is to continue using historical trend analysis by making adjustments to the available data to permit year to year comparisons. This would be accomplished by making an adjustment to the CY 2005 data based on average acquisition price (AAP) using the weighted average difference between AWP prices and AAP prices. We would use trend analysis to project the growth in drug expenditures for CY 2007. While we believe this approach is reasonably accurate for developing the CY 2007 growth estimates, since only one year of data would require adjustment, we are concerned about applying this methodology to future updates. Future year updates would require multiple year to year adjustments in prices. Moreover, historical AWP data does not provide an accurate measure of price changes for EPO under the revised drug payment methodology, since EPO pricing was held constant during that historical period. In addition, our estimate of the weighted average difference between AAP prices and AWP prices (and ASP versus AWP prices in CY 2006) was based on a projection of price levels. It is likely that the weighted average difference would change based on actual pricing data for each of those years. To be consistent with the statute, we expect to update the established adjustment to reflect estimated growth in drug expenditures, but we do not anticipate re-computing the drug add-on adjustment annually. Adjusting our assumptions to estimate projected growth without changing the underlying assumptions in the add-on adjustment would create inconsistencies between the two elements. Therefore, we are proposing to discontinue use of older historical drug spending data to 
                        ( print page 49007)
                        estimate the growth update to the drug add-on adjustment. We will reconsider our methodology when we have sufficient historical data reflecting the revised drug payment methodology using ASP pricing. For the reasons discussed above, we are proposing to develop an estimate of the growth in expenditures for ESRD drugs and biologicals using the PPI for prescription drugs as a measure of price increases in conjunction with two years of historical data from 2004 and 2005 as a basis for estimating utilization growth at the per patient level. We believe that this approach will best reflect the estimated growth in expenditures for ESRD drugs and biologicals. b. Estimating Growth in Per Patient Drug Utilization To isolate and project the growth in per patient utilization of ESRD drugs for CY 2007, we need to remove the enrollment and price growth components from historical drug expenditure data and consider the residual utilization growth. We propose to use total drug expenditure data from CYs 2004 and 2005 to estimate per patient utilization growth for CY 2007. We first needed to estimate total drug expenditures. For this proposed rule, we used the final CY 2004 ESRD claims data and the latest available CY 2005 ESRD facility claims, updated through December 31, 2005, that is, claims with dates of service from January 1 through December 31, 2005, that were received, processed, paid, and passed to the National Claims History File as of December 31, 2005. For the final rule, we will use more updated CY 2005 claims with dates of service for the same time period. This updated CY 2005 data file will include claims that are received, processed, paid, and passed to the National Claims History File as of June 30, 2006. While the December 2005 update of CY 2005 claims used in this proposed rule is the most recently available claims data, we recognize that it is not a fully complete year as claims with dates of service towards the end of the year have not all been processed. To more accurately estimate the update to the drug add-on, we need aggregate drug expenditures. Based on an analysis of the 2004 claims data, we inflated the CY 2005 drug expenditures to estimate the June 30, 2006 update of the 2005 claims file. We used the relationship between the December 2004 and the June 2005 versions of 2004 claims to estimate the more complete 2005 claims that will be available in June 2006. We applied that ratio to the 2005 claims data from the December 2005 claims file. We did this for drug expenditures in aggregate, for each of top ten separately billable drugs, and within each for independent and hospital-based ESRD facilities. All components were then combined to estimate aggregate CY 2005 ESRD drug expenditures. The net adjustment to the CY 2005 claims data was an increase of 13 percent to the 2005 expenditure data. This adjustment allows us to more accurately compare the 2004 and 2005 data, to estimate utilization growth. The next step is to remove the enrollment and price growth components from that total. As discussed earlier in this section, in developing the per patient utilization growth for this proposed rule, we limited our analysis to the latest 2 years of available ESRD drug data, that is, 2004 and 2005. We believe that per patient utilization growth between these years would be a better proxy for future growth, as it best represents current utilization trends. Furthermore, because of the implementation of the new EPO utilization monitoring policy that took effect on April 1, 2006 (Medicare Claims Processing Manual, Chapter 8, section 60-4ff, p. 51-53), we believe that per patient utilization of ESRD drugs will remain relatively stable or decline slightly in future years. We note that EPO accounts for nearly 70 percent of ESRD drug expenditures. To calculate the per patient utilization growth, we removed the enrollment component by using the growth in enrollment data between 2004 and 2005. This was approximately 3 percent. To remove the price effect we used a two-step process. First we calculated a weighted average between EPO and non-EPO price growth factors to account for the growth in pre-MMA pricing between 2004 and 2005. Since EPO was priced at $10 per thousand units prior to the enactment of the MMA, there is no growth for EPO. For the non-EPO drugs, we used the PPI as a proxy for the growth between the 2 years to maintain consistency with the established methodology for calculating the drug add-on adjustment which used the PPI to estimate the price growth in separately billable drugs (November 15, 2004, CY 2005 PFS final rule with comment period, 69 FR 66321). Next, we incorporated the estimated negative 13 percent weighted price difference between 2005 AWP and 2005 AAP pricing as was published in the CY 2005 PFS final rule with comment period (69 FR 66319 through 66334). This two-step process to account for the price effect from 2004 to 2005 led to an overall 12 percent reduction in price between 2004 and 2005. After removing the enrollment and price effects from the expenditure data, we believe the residual growth would reflect the per patient utilization growth. To do this, we divided the product of the enrollment growth of 3 percent (1.03) and the price reduction of 12 percent (1.00 − .12 = .88) into the total drug expenditure decrease between 2004 and 2005 of 9 percent (1.00−.09 = .91). The result is a utilization factor equal to 1.00 (.91/(1.03 * .88) = 1.00). As we observed no growth in per patient utilization of drugs between 2004 and 2005, we are, therefore, projecting no growth in per patient utilization for CY 2007. 1. Applying the Proposed Growth Update to the Drug Add-on Adjustment In CY 2006, we estimated the growth update by trending drug expenditures forward based on four years of AWP payment data (CY 2001 through CY 2004). We then applied the estimated growth update percentage to the total amount of drug add-on dollars established for CY 2005 to come up with a dollar amount for the CY 2006 growth update. In addition, we projected the growth in dialysis treatments for CY 2006 based on the projected growth in ESRD enrollment. We divided the projected total dialysis treatments for CY 2006 into the projected dollar amount of the CY 2006 growth to develop the per treatment growth update amount. This growth update amount, combined with the CY 2005 per treatment drug add-on amount, resulted in an average drug add-on amount per treatment of $18.88 (or a 14.5 percent adjustment to the composite rate) for CY 2006. Beginning in CY 2007, we are proposing to annually update the per treatment drug add-on amount of $18.88 established in CY 2006 and convert the update to an adjustment factor as stipulated in section 1881(b)(12)(F) of the Act. As explained above, we believe this approach is more accurate than recalculating the per treatment add-on adjustment each year using an estimate of growth in treatments. We note that we had received comments that our projections of treatment growth used to calculate the CY 2006 adjustment may have been overstated, however, we believe that the use of enrollment data was and remains the best measure available to predict treatment growth. By proposing to apply the update to the CY 2006 per treatment add-on amount, this estimation component is eliminated for CY 2007 and future years. 
                        ( print page 49008) 2. Proposed Update to the Drug Add-On Adjustment As discussed above, we estimate no growth in per patient utilization of ESRD drugs for CY 2007. Using the projected CY 2007 PPI for prescription drugs of 4.9 percent, we are projecting that the combined growth in per patient utilization and pricing for CY 2007 would result in an update equal to the PPI or 4.9 percent (1.0*1.049 = 1.049). This update factor would be applied to the CY 2006 average per treatment drug add-on amount of $18.88 (reflecting a 14.5 percent adjustment in CY 2006), resulting in a proposed weighted average increase to the composite rate of $.93 for CY 2007 or a 0.6 percent increase in the CY 2006 drug add-on percentage. Thus, the total proposed drug add-on adjustment to the composite rate for CY 2007, including the growth update, would be 15.2 percent (1.145*1.006 = 1.152). In addition, we are proposing to continue to use this method to estimate the growth update to the drug add-on component of the case-mix adjusted payment system until we have at least three years worth of ASP-based historical drug expenditure data that could be used to conduct a trend analysis to estimate the growth in drug expenditures. Given the time lag in the availability of ASP drug expenditure data, we expect that the earliest we could consider using trend analysis to update the drug add-on adjustment would be 2010. We propose to reevaluate our methodology for estimating the growth update at that time. c. OIG Report on New Drug Codes Section 623(c)(1) of the MMA mandated that the OIG conduct two studies to determine the difference between the Medicare payment amount for separately billable ESRD drugs and the facilities” acquisition costs for these drugs, as well as estimating the growth rate of expenditures for these drugs. The initial study, “Medicare Reimbursement for Existing End Stage Renal Disease Drugs” (OEI-03-04-00120) was completed in May 2004, and reported on existing ESRD drugs. This report was used to set the CY 2005 reimbursement rates for ESRD drugs billed by independent dialysis facilities (69 FR 66322). The second study (“Medicare Reimbursement for New ESRD Drugs” (OEI-03-06-00200)) focused on new drugs. New drugs for the purpose of this study were defined as an ESRD drug that did not have a BILLING CODE prior to January 1, 2004. One drug, darbepoetin alfa (Aranesp) accounted for the majority of all payments for new drugs. Therefore, this was the only new ESRD drug studied. The OIG report found that use of this drug was limited to a small number of facilities (only 157 facilities reported using this drug with concentrated use in approximately 55 of these facilities). Because of the recent changes we made to the drug payment methodology and the lack of comparable historical data, the OIG report made no estimate of an expenditure growth rate for this drug. Darbepoetin alfa (Aranesp) is currently paid as a separately billable drug at ASP+6 percent. Because of the recent (CY 2006) implementation of the ASP+6 percent drug reimbursement methodology, the small number of facilities using this drug for ESRD patients, and the lack of historical data for trending purposes, we have no data to indicate that any difference in payment methods for Aranesp (between 2004 and 2006) would affect our calculation of the drug add-on or of the growth update. Moreover, since Aranesp was approved in 2001 for use in ESRD patients, we believe that expenditures for Aranesp were reflected in the historical data used to establish the 2005 drug add-on under a generic drug code. Therefore, we are proposing to make no additional changes to the drug add-on adjustment for CY 2007. 5. Proposed Update to the Geographic Adjustments to the Composite Rates Section 1881(b)(12)(D) of the Act, as amended by section 623(d) of the MMA, gave the Secretary the authority to revise the wage indexes previously applied to the ESRD composite rates. The wage indexes are calculated for each urban and rural area. The purpose of the wage index is to adjust the composite rates for differing wage levels covering the areas in which ESRD facilities are located. a. Updates to CBSA Definitions In the CY 2006 PFS final rule with comment period (70 FR 70167), we announced our adoption of the OMB's CBSA-based geographic area designations to develop revised urban/rural definitions and corresponding wage index values for purposes of calculating ESRD composite rates. OMB's CBSA-based geographic area designations were described in Bulletin 03-04 originally issued June 6, 2003. On February 22, 2005 and December 5, 2005, OMB released Bulletins 05-02 and 06-01, respectively. Those bulletins contained updates to the metropolitan and micropolitan statistical area designations initially announced in Bulletin 03-04. OMB's revisions had no effect on the classification of counties which comprise the urban and rural areas used to develop the ESRD wage index values. However, Bulletins 05-02 and 06-01 changed the titles of several of the MSAs and Metropolitan Divisions used in connection with the ESRD urban wage index. Table 5 below, which contains the proposed wage index values for the ESRD urban areas, includes all of the changes announced by OMB in the February 22, 2005 and December 5, 2005 bulletins. b. Updated Wage Index Values In the CY 2006 PFS final rule with comment period, we stated that we intended to update the wage index values annually (70 FR 70167). Current ESRD wage index values for CY 2006 were developed from FY 2002 wage and employment data obtained from the Medicare hospital cost reports. The values are calculated without regard to geographic reclassifications authorized under sections 1886(d)(8) and (d)(10) of the Act and utilize pre-floor hospital data that is unadjusted for occupational mix. The methodology for calculating the CY 2006 wage index values was described in the CY 2006 PFS final rule with comment period (70 FR 70168). We propose to use the same methodology for CY 2007, with the exception that FY 2003 hospital data will be used to develop the CY 2007 ESRD wage index values. For a detailed description of the development of the proposed CY 2007 ESRD wage index values based on FY 2003 hospital data, see the FY 2007 IPPS proposed rule entitled, “Proposed Changes to the Hospital Inpatient Prospective Payment Systems and Fiscal Year 2007 Rates,” (April 25, 2006, 71 FR 24080). Section III F. (Computation of the Proposed FY 2007 Unadjusted Wage Index) of the preamble to that proposed rule describes the cost report schedules, line items, data elements, adjustments, and wage index computations. The wage index data affecting ESRD composite rates for each urban and rural locale may also be accessed on the CMS website at: 
                        *http://www.cms.hhs.gov/​AcuteInpatientPPS/​WIFN/​list.asp.* The wage data are located in the section entitled, “FY 2007 Proposed Rule Occupational Mix Adjusted and Unadjusted Average Hourly Wage and Pre-reclassified Wage Index by CBSA”. (1) Wage Index Values for Areas With No Hospital Data In CY 2006, while adopting the CBSA designations, we identified a small number of ESRD facilities in both urban and rural geographic areas where there 
                        ( print page 49009)
                        is no hospital wage data on which to base the calculations of the CY 2006 ESRD wage index values. Our CY 2005 policy and CY 2006 proposal for each area are discussed separately below. The first situation was rural Massachusetts. Because there were no reasonable proxies for rural data within Massachusetts, we used the prior year's acute care hospital wage index value for rural Massachusetts. For CY 2007, we propose to continue to use this value and request public input on an alternative methodology. Since there may be additional rural areas in the future similarly impacted by a lack of hospital wage data on which to derive a hospital wage index, we are considering alternative methodologies for imputing a rural wage index for areas in States where no hospital wage data are available. We believe that an evaluation of alternative methodologies for imputing a rural wage index in these areas should adhere to four basic policy criteria. First, an alternative methodology should retain our current longstanding policy to use pre-floor, pre-reclassified hospital wage data to compute wage index values for post acute care facilities, including ESRD facilities. Second, any methodology to impute a rural wage index should use rural wage data to derive the rural wage index value. Third, any methodology to impute a rural wage index should be easy to evaluate. Fourth, any methodology to impute a rural wage index would be able to update wage data from year-to-year. We arrived at one alternative that meets all of the above policy criteria. Under this alternative, we would impute a rural wage index value by using a simple average CBSA-based rural wage index value at the Census Division level. Census Divisions are defined by the U.S. Census Bureau and may be found at (
                        *www.census.gov/​geo/​www/​us_​regdiv.pdf*). As stated above, for CY 2007, hospital wage data are not available to compute a rural wage index for ESRD facilities in rural Massachusetts, and this alternative methodology could be applied in this case. Massachusetts is located in Census Division I (New England). The States in this Census Division, and their respective rural wage index values (using hospital cost report wage data for FY 2003) include— Connecticut (1.1753);
                    Maine (0.8410);
                    New Hampshire (1.0800);
                    Vermont (0.9944)
                    Rhode Island (all five counties classified as urban); and
                    Massachusetts. Under this alternative methodology, the States in Census Division I for which rural wage index values are available, as shown above, would be used; this would result in a simple average rural wage index value of 1.0227 (1.0770 after applying budget neutrality factor (BNF)). Although this methodology would result in a rural Massachusetts wage index that is currently greater than the value under the current proposed policy (1.0216, 1.0758 after applying BNF), we believe this methodology may be able to accurately reflect future increases or decreases of wage data for the States within the applicable Census Division. Rural Puerto Rico is similar to rural Massachusetts in that there are ESRD facilities where there are no acute care hospitals and, therefore, no hospital data. However, the situation for facilities in rural Puerto Rico is different in that the floor would be applied to rural Puerto Rico ESRD facilities. All areas in Puerto Rico that have an index are eligible for the floor because they have wage-index values that are below .8000. For CY 2007, we propose to apply the floor to rural Puerto Rico. The third situation involves an urban area in Hinesville, GA (CBSA 25980). For CY 2006, we used a wage index value based on wage index values in all of the other urban areas within the same State to serve as a reasonable proxy for the urban areas without hospital wage index data. Specifically, we used the average wage index value for all urban areas within the State of Georgia as the urban wage index for purposes of calculating the value for Hinesville for CY 2006. For CY 2007, we are proposing to continue using this method for Hinesville, GA (CBSA 25980). We solicit comments on maintaining our current policy for establishing wage index values for rural and urban areas without hospitals, the alternative approach outlined above in developing wage index values for rural areas without hospitals for CY 2007 and subsequent years, and other methods that meet the policy criteria for imputing wage index values. We will also continue to evaluate existing hospital wage data and, possibly, wage data from other sources, such as the Bureau of Labor Statistics, to determine if other methodologies of imputing a wage index value where hospital wage data are not available may be feasible. (2) Second Year of the Transition In the CY 2006 PFS final rule with comment period, we indicated that we would apply a 4-year transition period to mitigate the impact on composite rates resulting from our adoption of CBSA-based geographic designations (70 FR 70169). Beginning January 1, 2006, during each year of the transition, an ESRD facility's wage-adjusted composite rate (that is, without regard to any case-mix adjustments) will be a blend of its old MSA-based wage-adjusted payment rate and its new CBSA-based wage adjusted payment rate for the transition year involved. For each transition year, the share of the blended wage-adjusted base payment rate that is derived from the MSA-based and CBSA-based wage index values is shown in Table 4 below. In CY 2006, the first year of the transition, we implemented a 75/25 blend. CY 2007 is the second year of the 4-year transition period. Consistent with the transition blends announced in the November 21, 2005 PFS final rule with comment period (70 FR 70170), we are proposing a 50/50 blend between an ESRD facility's MSA-based composite rate, and its CY 2007 CBSA-based rate reflecting its revised wage index values. In CY 2006, we also eliminated the wage index cap of 1.30, and stated that we would implement a gradual reduction in the wage index floor of .90. Prior to January 1, 2006, the wage indexes were restricted to values no less than .90 and no greater than 1.30, meaning that payments to facilities in areas where labor costs fell below 90 percent of the national average, or exceeded 130 percent of that average, were not adjusted beyond the 90 percent or 130 percent level. Although we stated that the ESRD wage index values should not be constrained by the application of floors and ceilings, we also expressed concern that the immediate elimination of the floor could adversely affect ESRD beneficiary access to care. Therefore, we reduced the floor to .85 in CY 2006. For CY 2007, we are proposing to reduce the wage index floor to .80. As we stated in the CY 2006 PFS final rule with comment period, we intend to reassess the continuing need for a wage index floor in CY 2008 and CY 2009 (CY 2006 PFS final rule with comment period, November 21, 2005, 70 FR 70169 through 70170). The proposed wage index floors, caps, and blended shares of the composite rates applicable to all ESRD facilities during CYs 2007 through 2009 are shown in Table 4 below. They are identical to the values shown in Table 20 of the CY 2006 PFS final rule with comment period (70 FR 70170) for the applicable years. 
                        ( print page 49010) Table 4.—Wage Index Transition Blend
CY payment
Floor
Ceiling
Old MSA
                                 (percent)
New CBSA 
                                 (percent)2007
.80 *
None
50
502008
Reassess
None
25
752009
Reassess
None
0
100* Each wage index floor is multiplied by a budget neutrality adjustment factor. For CY 2007 the budget neutrality adjustment is 1.053069 resulting in an actual wage index floor of 0.8425.
 An example of how the wage-adjusted composite rates would be blended during CY 2007 and the two subsequent transition years follows. Example: An ESRD facility has a wage-adjusted composite rate (without regard to any case-mix adjustments) of $135.00 per treatment in CY 2006. Using CBSA-based geographic area designations, the facility's CY 2007 wage-adjusted composite rate, reflecting its wage index value as shown in Table 5 below, would be $145.00. During the remaining 3 years of the four-year transition period to the new CBSA-based wage index values, this facility's blended rate through 2009 would be calculated as follows: CY 2007 .50 × $135.00 + .50 × $145.00 = $140.00 CY 2008 .25 × $135.00 + .75 × $145.00 = $142.50 CY 2009 0 × $135.00 + 1.0 × $145.00 = $145.00 We note that this hypothetical example assumes that the calculated wage-adjusted composite rate of $145.00 for CY 2007 does not change in CYs 2008 and 2009. In actuality, the wage-adjusted composite rate would change because of annual revisions to the wage index. However, the example serves only to demonstrate the effect on the composite rate of the CBSA-based wage index values which will be phased-in during the remaining 3 years of the transition period. c. Budget Neutrality Adjustment Section 1881(b)(12)(E)(i) of the Act, as added by section 623(d) of the MMA, requires that any revisions to the ESRD composite rate payment system as a result of the MMA provision (including the geographic adjustment) be made in a budget neutral manner. This means that aggregate payments to ESRD facilities in CY 2007 should be the same as aggregate payments that would have been made if we had not made any changes to the geographic adjusters. We note that this budget neutrality adjustment only addresses the impact of changes in the geographic adjustments. A separate budget neutrality adjustment was developed for the case-mix adjustments, currently in effect. Since we are not proposing any changes to the case-mix measures for CY 2007, the current case-mix budget neutrality will remain in effect for CY 2007. For CY 2007, we again propose to apply a BNF directly to the ESRD wage index values, as we did in CY 2006. As we explained in the CY 2006 PFS final rule with comment period (70 FR 70170 through 70171), we believe this is the simplest approach because it allows us to maintain our base composite rates during the transition from the current wage adjustments to the revised wage adjustments described earlier in this section. Because the ESRD wage index is only applied to the labor-related portion of the composite rate, we computed the BNF adjustment based on that proportion (53.711 percent). In order to compute the proposed CY 2007 wage index BNF, we used the wage index values in Tables 5 and 6 below, 2005 outpatient claims (paid and processed as of December 31, 2005), and geographic location information for each facility which may be found through Dialysis Facility Compare. Dialysis Facility Compare can be found by going to the following Web site: 
                        *http://www.cms.hhs.gov/​DialysisFacilityCompare/​.* Using treatment counts from the 2005 claims and facility-specific CY 2006 composite rates, we computed the estimated total dollar amount each ESRD provider would have received in CY 2006 (the first year of the 4-year transition). The total of these payments became the target amount of expenditures for all ESRD facilities for CY 2007. Next, we computed the estimated dollar amount that would have been paid to the same ESRD facilities using the proposed ESRD wage index for CY 2007 (the second year of the 4-year transition). The total of these payments became the second year new amount of wage-adjusted composite rate expenditures for all ESRD facilities. After comparing these two dollar amounts (target amount divided by second year new amount), we calculated an adjustment factor that, when multiplied by the applicable CY 2007 ESRD wage index shown in Tables 5 and 6 below, will result in payments to each facility that will remain within the target amount of composite rate expenditures when totaled for all ESRD facilities. The proposed budget neutrality adjustment factor for the CY 2007 wage index is 1.053069. To ensure budget neutrality we also must apply the BNF to the wage index floor of 0.8000 which results in a proposed adjusted wage index floor of 0.8425 for CY 2007. d. ESRD Wage Index Tables The following two tables show the proposed CY 2007 ESRD wage index, including the BNF adjustment, for urban areas (Table 5) and rural areas (Table 6). 
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  
 
  Table 6.—Proposed CY 2007 ESRD Wage Index for Rural Areas Based on CBSA Labor Market Areas
CBSA code
Nonurban area
Wage index1
Alabama
0.84252
Alaska
1.12473
Arizona
0.93984
Arkansas
0.84255
California
1.19026
Colorado
0.98387
Connecticut
1.23778
Delaware
1.023910
Florida
0.905111
Georgia
0.842512
Hawaii
1.102213
Idaho
0.856614
Illinois
0.876915
Indiana
0.892716
Iowa
0.915917
Kansas
0.842518
Kentucky
0.842519
Louisiana
0.842520
Maine
0.885621
Maryland
0.941722
Massachusetts
1.075823
Michigan
0.953224
Minnesota
0.965325
Mississippi
0.842526
Missouri
0.842527
Montana
0.906228
Nebraska
0.915429
Nevada
0.943530
New Hampshire
1.137331
1
                                 New Jersey32
New Mexico
0.879033
New York
0.868834
North Carolina
0.905535
North Dakota
0.842536
Ohio
0.913437
Oklahoma
0.842538
Oregon
1.028839
Pennsylvania
0.877441
1
                                 Rhode Island42
South Carolina
0.842543
South Dakota
0.903844
Tennessee
0.842545
Texas
0.842546
Utah
0.858747
Vermont
1.047248
Virgin Islands
0.842549
Virginia
0.842550
Washington
1.082751
West Virginia
0.842552
Wisconsin
0.997053
Wyoming
0.98051
                             All counties in the States of New Jersey and Rhode Island are urban.
 H. Private Contracts and Opt-Out Provision—Practitioner Definition [If you choose to comment on issues in this section, please include the caption “PRIVATE CONTRACTS AND OPT-OUT” at the beginning of your comments.] Section 4507 of the BBA of 1997 amended section 1802 of the Act to permit certain physicians and practitioners to opt-out of Medicare if certain conditions were met, and to provide through private contracts services that would otherwise be covered by Medicare. Before enactment of BIPA (Pub.L. 106-554), section 1802(b)(5)(C) of the Act, which refers to the definition of “practitioner” at section 1842(b)(18)(C) of the Act, did not include registered dietitians or nutrition professionals among the practitioners who may choose to opt-out of Medicare. Section 105(d) of BIPA amended the definition of practitioner located at section 1842(b)(18)(c) of the Act to include registered dietitians or nutrition professionals. Because section 1802(b)(5)(C) of the Act references section 1842(b)(18)(c) of the Act in order to define the term practitioner for purposes of opting out of Medicare, current law permits registered dietitians or nutrition professionals to opt-out of Medicare. Because the definition of practitioner located in the current regulations at § 405.400 does not include registered dietitians or nutrition professionals, we are proposing to amend that section so that it is consistent with section 1802(b)(5)(C) of the Act. 
                        ( print page 49054) I. Proposed Changes to Reassignment and Physician Self-Referral Rules Relating to Diagnostic Tests [If you choose to comment on issues in this section, please include the caption “REASSIGNMENT AND PHYSICIAN SELF-REFERRAL” at the beginning of your comments.] Historically, Medicare rules have prohibited the markup of the TC of certain diagnostic tests that are performed by outside suppliers and billed to Medicare by a different individual or entity. In addition, Medicare rules restrict who may bill Medicare for the PC (hereafter, also referred to as the “interpretation”) of diagnostic tests. Recent changes to our rules on reassignment of the right to receive Medicare payment may have led to some confusion as to whether the anti-markup and purchased interpretation requirements apply to certain situations where a reassignment has occurred pursuant to a contractual arrangement. Likewise, we are concerned about the existence of certain arrangements that are not within the intended purpose of our physician self-referral rules, which allow physician group practices to bill for services furnished by a contractor physician in a “centralized building.” We are concerned that allowing physician group practices or other suppliers to purchase or otherwise contract for the provision of diagnostic tests and then to realize a profit when billing Medicare may lead to patient and program abuse in the form of overutilization of services and result in higher costs to the Medicare program. Therefore, we are proposing to amend our reassignment regulations to clarify how the purchased test and purchased test interpretation rules apply in the case of a reassignment made under the contractual arrangement exception set forth at § 424.80(d)(2). Specifically, in our reassignment regulations, we propose to incorporate provisions similar to those that currently appear in § 414.50 of our regulations on purchased tests, and we are considering incorporating provisions on purchased test interpretations that currently appear in our manual instructions. In addition, we are proposing to change the definition of “centralized building” at § 411.351 of the physician self-referral regulations to place certain restrictions on what types of space ownership or leasing arrangements will qualify for purposes of the physician self-referral in-office ancillary services exception and physician services exception. Our proposals regarding the reassignment regulations are based on existing requirements for purchased tests and purchased test interpretations. Section 1842(n) of the Act contains certain limitations on billing for the TC of diagnostic tests described in section 1861(s)(3) of the Act (other than clinical diagnostic laboratory tests paid under section 1833(a)(2)(D) of the Act, which are subject to the special rules set forth in section 1833(h)(5)(A) of the Act). Section 1842(n)(1)(A) of the Act provides that if the test was not performed by the billing physician and also was not performed or supervised by a physician with whom the billing physician shares a practice, Medicare payment is the lower of the costs (net of any discount) charged by the performing supplier to the billing physician, or the performing supplier's reasonable charge (or other applicable limit). This is commonly known as the anti-markup provision. Section 1842(n)(2) of the Act further provides that a physician may not bill a beneficiary any amount other than the amount specified in section 1842(n)(1)(A) of the Act and any applicable deductible and coinsurance. Under section 1842(n)(3) of the Act, if a physician knowingly, willfully, and repeatedly bills a Medicare beneficiary for more than the amount allowed under section 1842(n)(2) of the Act, he or she is subject to civil monetary penalties and assessments, and exclusion from Medicare and Medicaid for up to 5 years. Our regulations implementing section 1842(n) of the Act appear at § 414.50 and § 402.1(c)(15). In addition, our Claims Processing Manual (Pub. 100-4) outlines certain conditions regarding who can submit a claim for purchased diagnostic test intepretations. As set forth in Chapter 1, Section 30.2.9.1 of the Claims Processing Manual, the following requirements must be satisfied in order to submit a claim for a purchased diagnostic test interpretation: The test must be ordered by a physician or medical group that is independent of the person or entity performing the TC of the test, and also must be independent of the physician or medical group performing the interpretations.
                    The physician or medical group performing the interpretations does not see the patient.
                    The purchaser (or employee, partner, or owner of the purchaser) performs the TC of the test, and the interpreting physician must be enrolled in the Medicare program. Section 1842(b)(6) of the Act generally prohibits Medicare payment to anyone other than the Medicare beneficiary or the physician or other person who performed the service for the beneficiary. However, section 1842(b)(6) of the Act, also provides exceptions, known as the reassignment exceptions, to this general rule. These exceptions allow us to make payment to an individual or an entity other than the beneficiary or the physician or other person who performed the service for the beneficiary. For example, the reassignment exceptions allow us to make payment to an employer of a physician, such as a group practice or a hospital, to which the physician employee has reassigned his or her right to payment. Prior to the MMA, a physician or other individual supplier could reassign his or her right to bill and receive payment under a contractual arrangement, rather than an employee-employer relationship, only if the services being paid for were performed on the premises of the contracting hospital, critical access hospital, clinic, or other facility. Section 952 of the MMA, however, amended section 1842(b)(6)(A)(ii) of the Act to extend the reassignment exception to contractual arrangements regardless of whether the services are performed on the premises of the billing entity. Section 952 of the MMA permits us to recognize this type of reassignment to the extent that the contractual arrangement between the physician or other individual supplier and the billing entity (excluding a billing agent, which cannot receive reassigned benefits) meets program integrity and other safeguards as the Secretary may determine to be appropriate. A motivating factor behind the passage of section 952 of the MMA appears to have been the desire by the Congress to permit us to allow hospital emergency department staffing companies that employ physicians on a contract basis to bill Medicare (if the staffing companies enroll in Medicare). Our proposed implementation of section 952 of the MMA appeared in the Revisions to Payment Policies Under the Physician Fee Schedule for Calendar Year 2005 proposed rule, 69 FR 47488, 47524 through 47525 (August 5, 2004). We proposed program safeguards, whereby the parties to the contractual arrangement would have joint and several liability for any Medicare overpayments, and the physician or other individual supplier would have unrestricted access to billings submitted on his or her behalf by the entity receiving reassigned payments. In that proposed rule, we stated our awareness that the changes to the reassignment rules authorized by section 952 of the MMA may create new fraud and abuse vulnerabilities, which may not become apparent until the program has 
                        ( print page 49055)
                        experience with new contractual arrangements. We solicited comments on these potential program vulnerabilities and on possible additional safeguards to protect against such vulnerabilities. Comments submitted in response to the CY 2005 PFS proposed rule expressed concern over the recent growth of “pod” or “condo” laboratories (hereinafter “pod labs”). In a typical pod lab arrangement involving pathology services, an entity leases space in a medical building and then subdivides the space into separate areas or cubicles, which are equipped with microscopes and a minimal amount of other laboratory equipment. The entity subleases each space to a physician group practice, even though the space may be located many miles away from any medical office of the group practice and is often located in a different state. The entity hires a histologist who performs the TC of the pathology service, by preparing a microscopic slide of each specimen for review by a pathologist. The entity also makes arrangements with a pathologist, who performs the PC of the pathology service and who also supervises the pod lab. In one type of arrangement, the pathologist and histologist perform their services for the different group practices by moving from cubicle to cubicle. Each group practice pays the pathologist a fee for every slide reviewed and pays the entity a management fee, which covers the rental of the pod lab and the histologist's salary. The group practice then bills Medicare for the entire pathology service, typically at a markup from what the group practice paid the pathologist for the professional service and the entity for its services. In another common arrangement, the histologist performs the TC of the pathology service for the entity and the entity bills Medicare for that service, while the group practice bills for the interpretation that was performed by its independent contractor pathologist, who has reassigned to the group practice his or her right to receive Medicare payment. The commenters stated that pod lab arrangements are subject to fraud, waste and abuse, including, but not limited to the following: Generation of medically unnecessary biopsies.
                    Kickbacks.
                    Fee-splitting.
                    Referrals that would otherwise be prohibited under the physician self-referral statute. The commenters provided several suggestions. One commenter suggested that we prohibit a physician from reassigning benefits to another physician if the physicians do not practice in substantially the same medical specialty. Some commenters also stated that our regulations need to state more clearly that all requirements of the purchased diagnostic test rules and purchased test interpretation rules need to be met. In the CY 2005 PFS final rule, we responded that we shared the commenters concerns, although we declined to incorporate the suggested revisions at that time. We said that we would be paying close attention to this issue, and that we might initiate future rulemaking to address arrangements that are fraudulent or abusive. (See 69 FR 66316, November 15, 2004.) In that final rule, we amended our reassignment regulation at § 424.80(a) to state that nothing in § 424.80 alters an individual's or entity's obligations under other Medicare statutes or rules, including, but not limited to, the physician self-referral law (section 1877 of the Act), the anti-kickback statute (section 1128B(b)(1) of the Act), the regulations regarding purchased diagnostic tests, and the regulations regarding services and supplies provided incident to a physician's service. At about the same time as we published our proposed rule for implementing section 952 of the MMA, we published an IFC concerning exceptions to the physician self-referral law in section 1877 of the Act (69 FR 16054). Section 1877 of the Act prohibits a physician from making referrals for DHS, as defined in section 1877(h)(6) of the Act, payable by Medicare to an entity with which he or she (or an immediate family member) has a financial relationship (ownership or compensation), and it prohibits the entity from billing Medicare, another payor, or the beneficiary for those referred services, unless an exception applies. The statute establishes a number of specific exceptions to these prohibitions and grants the Secretary the authority to create regulatory exceptions for financial relationships that pose no risk of fraud or abuse. One significant exception is at § 411.355(a) for the provision of “physician services” as defined in § 410.20(a). Under this exception, professional physician services that are DHS must be furnished personally by another physician who is a member of the referring physician's group practice, or by a physician in the same group practice as the referring physician, or by someone under the supervision of one of these physicians. A “member” of a group practice is a physician owner, a physician employee, a locum tenens physician, or an on-call physician while the physician is providing on-call services for members of the group practice. “Physician in the group practice” means a member of the group practice, as well as an independent contractor physician during the time the independent contractor is furnishing patient care services for the group practice to the group practice's patients in the group practice's facilities. (See § 411.351.) Another significant exception, at § 411.355(b), is for the provision of in-office ancillary services. This exception allows group practice physicians to refer patients for DHS to other members of their group or to nonphysician staff, provided that certain supervision, location, and billing requirements are satisfied. Specifically, the DHS must be furnished personally by the referring physician, a member of the group practice, or an individual who is supervised by the referring physician or by a physician in the group practice. In addition, the DHS must be furnished in—(1) the “same building” where group physicians perform a certain amount of physician services (as set forth in § 411.355(b)(2)), including physician services unrelated to the provision of DHS; or (2) in a “centralized building.” We define “centralized building,” in pertinent part, as all or part of building that is owned or leased on a full-time basis 24 hours per day, 7 days per week. In the “Phase II” physician self-referral IFC, we reaffirmed our earlier position, set forth in the “Phase I” final rule with comment period that, a group practice may have more than one centralized building (69 FR at 16075). In response to the Phase II IFC, several commenters strongly criticized the centralized building prong of the in-office ancillary services exception. They requested that the rule be changed to require full-time use of the facility and the addition of a commercially reasonable test. According to the commenters, the Phase II IFC encourages numerous abusive arrangements that are designed solely to permit medical groups to bill in circumvention of the prohibition in section 1877 of the Act. Commenters objected to medical groups establishing satellite DHS facilities, sometimes in different States, specifically to capture ancillary income. Several commenters identified pod labs that rent space to urology groups as among the types of abusive arrangements that are proliferating. Several other commenters requested clarification that the in-office ancillary services exception did not 
                        ( print page 49056)
                        override our policies on reassignment and purchased diagnostic tests. According to the comments, some of the arrangements do not satisfy the rules regarding purchased diagnostic tests. On the other hand, a professional association complained that the requirement that the centralized building be occupied exclusively by the medical group is too restrictive. As noted above, we stated, in response to the comments on the proposed rule implementing section 952 of the MMA, that we might address suspect arrangements in a future rulemaking. After additional consideration, including consideration of the comments we received in response to the Phase II IFC, we are now proposing to amend our regulations on reassignment and physician self-referral in this proposed rule. We are proposing to amend § 424.80 of our regulations to clarify that any reassignment pursuant to the contractual arrangement exception is subject to program integrity safeguards that relate to the right to payment for diagnostic tests. First, we would amend § 424.80 of our regulations to provide that if the TC of a diagnostic test (other than clinical diagnostic laboratory tests paid under section 1833(a)(2)(D) of the Act, which are subject to the special rules set forth in section 1833(h)(5)(A) of the Act) is billed by a physician or medical group (the “billing entity”) under a reassignment involving a contractual arrangement with a physician or other supplier who performs the service, the amount billed to Medicare by the billing entity, less the applicable deductibles and coinsurance, may not exceed the lowest of the following amounts: The physician or other supplier's net charge to the billing physician or medical group.
                    The billing physician's or medical group's actual charge.
                    The fee schedule amount for the service that would be allowed if the physician or other supplier billed directly. Second, we would also require that, in order to bill for the TC, the billing entity would be required to perform the interpretation. Third, we are considering further amendments to § 424.80(d) that would impose certain conditions on when a physician or medical group can bill for a reassigned PC of a diagnostic test. We are considering the following conditions: The test must be ordered by a physician that is financially independent of the person or entity performing the test and also of the physician or medical group performing the interpretation.
                    The physician or medical group performing the interpretation does not see the patient.
                    The physician or medical group billing for the interpretation must have performed the TC of the test. We believe that we are comfortably within our authority to place the proposed restrictions on reassignments made before a contractual arrangement, in order to guard against patient and program abuse, and we also believe that we would be within our authority to adopt the conditions on billing for a reassigned PC before a contractual arrangement that we continue to consider. We note that there is no right to effect a reassignment under section 1842(b)(6) of the Act (rather, this section allows, but does not require us to make payment to someone other than the beneficiary or the physician or other person who performed the service), and that section 952 of the MMA permits us to recognize reassignments under the contractual arrangement exception only to the extent that the arrangement meets program integrity and other safeguards as the Secretary may determine to be appropriate. Moreover, we believe that our current rules on purchased diagnostic tests generally should be applicable to both situations in which the billing entity is purchasing the test without a formal reassignment as well as situations in which the physician performing the test has reassigned his or her right to Medicare payment to the billing physician or medical group. Although we welcome comments on all aspects of our proposals, we are particularly interested in soliciting comments on the amendments we have proposed, as well as those we are still considering involving reassigned interpretations, to § 424.80(d). In particular, we are soliciting comments as to whether diagnostic tests in the DHS category of radiology and certain other imaging services should be excepted from any those provisions; whether the proposal in whole or in part should apply only to pathology services; whether any of these provisions should apply to services performed on the premises of the billing entity and if so, how to define the premises appropriately. We are also soliciting suggested regulatory text for the proposal under consideration involving purchased test interpretations, as well as any other comments regarding the appropriate scope of the provisions under consideration. In addition, we are soliciting comments on whether an anti-markup provision should apply to the reassignment of the PC of diagnostic tests performed under a contractual arrangement, and if so, how to determine the correct amount that should be billed to the Medicare program. In addition to our proposed changes to the reassignment rules, we are proposing to change the definition of “centralized building” in § 411.351 for purposes of our physician self-referral regulations. We are persuaded by the commenters who responded to the Phase II IFC that our present definition may encourage the unnecessary ordering of ancillary services. Section 1877(b)(1) of the Act, in conjunction with section 1877(h)(4)(vi) of the Act, states that the Secretary may define by regulation what constitutes a “group practice” for purposes of the physician services exception. Similarly, section 1877(b)(2) of the Act authorizes the Secretary to determine additional terms and conditions relating to the supervision and location requirements of the in-office ancillary services exception as may be necessary to prevent a risk of program or patient abuse. Accordingly, we propose to modify the definition of “centralized building” to include a minimum square footage requirement of 350 square feet. Our modified definition would be relevant to both the physician services exception and the in-office ancillary services exception. That is because, under § 411.351, a “physician in the group practice” includes an independent contractor physician during the time he or she is providing services to the group's patients in the group's facilities. Thus, to the extent that an independent contractor physician would qualify as a “physician in the group” on the basis of furnishing services to a group's patients in a centralized building, the space owned or leased by the group would need to comply with the proposed modification to the definition of “centralized building” in order for the group to rely on the physician services exception or the in-office ancillary services exception when billing Medicare for services furnished by the independent contractor physician. Although we believe that the arrangements we seek to address through our proposed change to the definition of “centralized building” primarily involves independent contractor physicians, the proposed definition would also apply to services performed by physicians who are employees of a group practice. The proposed minimum square footage requirement would not apply to 
                        ( print page 49057)
                        space owned or rented in a building in which no more than three group practices own or lease space in the “same building,” as defined in § 411.351 (that is, in a building with the same street address) and share the same “physician in the group practice” (as defined in § 411.351). The purpose of the square foot minimum and the exception is to prevent abusive arrangements such as pod labs, while not disqualifying legitimate, stand-alone physician offices that are unusually small. The following examples are intended to illustrate how the proposed exception might apply: + Example 1—A space of 200 square feet located in a building in which only two other group practices lease space could qualify as a centralized building, irrespective of whether all three group practices contract with the same individual as a “physician in the group practice.” + Example 2—A space of 200 square feet is located in a building in which seven other group practices lease space. Dr. Jones has a contractual relationship with three group practices as a “physician in the group practice.” Dr. Smith also has a contractual relationship with three group practices. No physician has a contractual relationship as a “physician in the group practice” with four or more group practices that are located in that building. The space could qualify as a “centralized building.” We would also require the space to contain, on a permanent basis, the necessary equipment to perform substantially all of the DHS that are performed in this space, in order to meet the definition of a “centralized building.” That is, we wish to prevent the situation in which an entity would routinely move equipment as needed from one group's space to another group's space (for example, from cubicle to cubicle). We believe these situations are abusive and contrary to the purpose of concept of the “centralized building” concept, but we recognize that there may be an occasional need to bring specialized equipment into the space on a temporary basis. We believe that the proposed clarification to our reassignment rules, in tandem with our proposed changes to the definition of “centralized building” for purposes of our physician self-referral rules would prevent abusive arrangements while preserving legitimate small physician offices. In particular, we anticipate that restrictions on marking up the TC of diagnostic tests as well as the limits we are considering for who can bill for the PC of diagnostic tests, combined with square footage limits and requirements of having necessary equipment on site would make it not financially feasible for pod labs to exist. With respect to our proposed change to the definition of “centralized building,” we seek comments on whether there should be a minimum square foot requirement, and if so, whether the minimum should be 350 square feet or an amount more or less than that. In addition, we seek comments regarding whether there should be an exception to any minimum square foot requirement, and if so, the circumstances under which an exception should apply. With respect to our proposal that the “centralized building” permanently contain the necessary equipment to perform substantially all of the DHS that is furnished in the “centralized building,” we seek comments on whether this test should be imposed, and whether at least 90 percent or some other minimum percentage or measurement is appropriate. We are also considering whether to require that, for space to qualify as a “centralized building,” the group practice must employ, in that space, a nonphysician employee or independent contractor who will perform services exclusively for the group for at least 35 hours per week. We seek comments on whether we should have this requirement or similar requirement, or whether this requirement would be unduly burdensome on a small group practice, and whether this requirement would be likely to reduce the number of existing pod labs and to discourage the development of new pod labs. Finally, we seek comments on whether a group practice should be allowed to maintain a “centralized building” in a State different from the State(s) in which it has an office that meets the criteria of § 411.355(b)(2)(i), and if so, whether space that is located in a different State must be within a certain number of miles from an office of the group practice that meets the criteria of § 411.355(b)(2)(i), in order to qualify as a “centralized building.” J. Supplier Access to Claims Billed on Reassignment Section 1833(e) of the Act provides that, “no payment shall be made to any provider of services or other person under this part unless there has been furnished such information as may be necessary in order to determine the amounts due such provider or other person under this part for the period with respect to which the amounts are being paid or for any prior period.” Section 1842(b)(6) of the Act generally provides that payment may not be made to anyone other than the beneficiary or the physician or other person who provided the service. There are certain exceptions to this prohibition whereby payment may be made to others. These are commonly referred to as the reassignment exceptions and are found at section 1842(b)(6)(A) of the Act. Taking these two statutory provisions together, we are permitted, but not required, to make payment to someone other than the beneficiary, or the physician or other person who furnished the service, but only if we have determined that Medicare has received all necessary information to determine the amounts due the provider. Where Medicare makes payment to an entity rather than to the physician or other person who furnished the service, there is a heightened concern that payment may not be correct. By allowing physicians and other individual suppliers who reassign benefits to an entity such as a group practice to have access to the billing information concerning the services they allegedly furnish, we believe we will reduce the risk of inappropriate billing. Moreover, as noted in section I.2. of this proposed rule, section 952 of the MMA amended section 1842(b)(6)(A)(ii) of the Act to allow a physician or other person who was in a contractual arrangement rather than in an employee-employer relationship to reassign his or her right to bill and receive payment, irrespective of whether the services were performed on the premises of the entity. Section 952 of the MMA permits reassignment to the extent that the contractual arrangement between the physician or other individual supplier and the billing entity meets program integrity and other safeguards that the Secretary may determine to be appropriate. In the FY 2005 Physician Fee Schedule proposed rule, published August 5, 2005 (69 FR 47488, 47524 through 47525), we stated our awareness that changes in the reassignment rules based on section 952 of the MMA may create new fraud and abuse vulnerabilities, which may not become apparent until the program has experience with new contractual arrangements. We proposed program safeguards, whereby the parties to the contractual arrangement would have joint and several liability for any Medicare overpayments, and the physician or other individual supplier would have unrestricted access to billings submitted on their behalf by the entity receiving reassigned payments. In response to the August 5, 2005 proposed 
                        ( print page 49058)
                        rule, we received a comment that questioned the need for the two program integrity safeguards (joint and several liability and unrestricted access to billing records) as a requirement for a reassignment of claims involving a contractual arrangement. The commenter believed that it was premature for CMS to implement these program safeguards, that CMS already imposes joint and several liability through Medicare participation agreements and the signing of the enrollment form for billing reassigned claims (the CMS-855-R form), and questioned why the program safeguards applied only to independent contractors and not to employees. (69 FR 66316 through 66317 (November 15, 2004).) In response to the commenter, we stated that those program integrity safeguards were necessary to monitor the billings of entities with which we have had billing problems (for example, billing for services never furnished and upcoding resulting in Medicare overpayments) in the past, and that the reason the safeguards applied to independent contractors and not to employees, was that the billing problems identified thus far involved certain entities (which, for the most part, contracted with, rather than employed, emergency room (ER) physicians). We also stated that we would study whether the same program integrity safeguards applicable to independent contractors should also apply to employees. Prior to January 1, 2005, the effective date of the program integrity safeguards for the contractual arrangement reassignment exception, we received public inquiries asking why employees do not have unrestricted access to billing records. Since the January 1, 2005 effective date of the program integrity safeguards, we have received an inquiry from an ER physician employee of a medium-sized ER physician staffing company, who was denied access to billing records for services that he claims to have furnished, and who had his employment terminated. We also note that the MMA Conference Report, in its discussion of section 952 of the MMA, states that the Conference Committee supports appropriate program integrity efforts for any entities billing the Medicare program, including entities with independent contractors as well as employees. Having reconsidered the issue, we find no valid reason why an employee should not have access to records on billings for services furnished by that employee. Therefore, we are proposing to change the title of § 424.80(d) and amend § 424.80(d)(2) of our regulations to state that the supplier who reassigns his or her right to bill and receive Medicare payment to an entity has unrestricted access to claims information submitted by that entity for services supposedly furnished by the individual supplier, irrespective of whether the supplier is an employee or independent contractor of the entity. If adopted, our proposal would also mean that if an entity receiving the reassigned benefits were to refuse to provide the billing information to the employee supplier requesting the information, the entity's right to receive reassigned benefits may be revoked under 42 CFR 424.82(c)(3) (which is currently the case with respect to an entity's refusal to provide billing information to an independent contractor supplier). K. Coverage of Bone Mass Measurement (BMM) Tests [If you choose to comment on issues in this section, please include the caption “BONE MASS MEASUREMENT TESTS” at the beginning of your comments.] In an IFC entitled “Medicare Coverage of and Payment for Bone Mass Measurements” published in the 
                        **Federal Register**
                         on June 24, 1998 (63 FR 34320), we implemented section 4106 of the BBA by establishing a new regulatory section, 42 CFR 410.31 (Bone Mass Measurement: Conditions for Coverage and Frequency Standards). Section 4106 of the BBA statutorily defined BMM and individuals that are qualified to receive a BMM. The June 24, 1998 IFC, under the “reasonable and necessary” provisions of 1862(a)(1)(A) of the Act, also established conditions for coverage of the tests that must be ordered by physicians or nonphysician practitioners. Lastly, as directed by section 4106 of the BBA, we established frequency standards governing the time period when qualified individuals would be eligible to receive covered BMMs. 1. Provisions of the June 24, 1998 IFC As stated earlier in this section, the June 24, 1998 IFC implemented section 4106 of the BBA by establishing conditions for coverage and frequency standards for BMMs to ensure that they are paid for uniformly throughout the Medicare program and that they are reasonable and necessary for Medicare beneficiaries who are eligible to receive these measurements. This section summarizes the provisions discussed in the June 24, 1998 IFC. a. Coverage Conditions and Frequency Standards We established conditions for coverage and frequency standards for medically necessary BMMs for five categories of Medicare beneficiaries in § 410.31. In § 410.31(a), we defined “bone mass measurement” based on the statutory definition in section 4106 of the BBA. In accordance with the “reasonable and necessary” provisions of section 1862(a)(1)(A) of the Act, we established the conditions for coverage of BMMs in § 410.31(b) of the regulations. Consistent with § 410.32 (Diagnostic x-ray tests, diagnostic laboratory tests, and diagnostic tests: Conditions), we provided that coverage be available for the BMM only if it is ordered by the physician or a qualified nonphysician practitioner (as defined in § 410.32(a)) treating the beneficiary following an evaluation of the beneficiary's need for the test, including a determination as to the medically appropriate procedure to be used for the beneficiary. We believed that BMMs were not demonstrably reasonable and necessary unless (among other things) they are ordered by the physician treating the beneficiary following a careful evaluation of the beneficiary's medical need, and they are employed to manage the beneficiary's care. To ensure that the BMM is performed as accurately and consistently in accordance with appropriate quality assurance guidelines as possible, we required that it be performed under the appropriate supervision of a physician as defined in § 410.32(b)(3). To ensure that the BMM is medically appropriate for the five categories specified in the law, we provided that it be reasonable and necessary for diagnosing, treating, or monitoring the condition of the beneficiary who meets the coverage requirements specified in § 410.31(d). Furthermore, in § 410.31(c), we set forth limitations on the frequency for covering a BMM. Generally, we cover a BMM for a beneficiary if at least 23 months have passed since the month the last BMM was performed. However, we allow for coverage of follow-up BMMs performed more frequently than once every 23 months when medically necessary. We listed the following examples of situations where more frequent BMMs procedures may be medically necessary to include: Monitoring beneficiaries on long-term glucocorticoid (steroid) therapy of more than 3 months.
                    Allowing for a confirmatory baseline bone mass measurement (either central or peripheral) to permit( print page 49059)
                        monitoring of beneficiaries in the future if the initial test was performed with a technique that is different from the proposed monitoring method. b. Beneficiaries Who May Be Covered In § 410.31(d), we amended our regulations to conform to the statutory requirement that the following categories of beneficiaries may receive Medicare coverage for a medically necessary BMM: A woman who has been determined by the physician or a qualified nonphysician practitioner treating her to be estrogen-deficient and at clinical risk for osteoporosis, based on her medical history and other findings.
                    An individual with vertebral abnormalities as demonstrated by an x-ray to be indicative of osteoporosis, osteopenia, or vertebral fracture.
                    An individual receiving (or expecting to receive) glucocorticoid (steroid) therapy equivalent to 7.5 mg of prednisone, or greater, per day, for more than 3 months.
                    An individual with primary hyperparathyroidism.
                    An individual being monitored to assess the response to or efficacy of an FDA-approved osteoporosis drug therapy. c. Waiver of Liability Section 410.31(e) provides that Medicare payment would be denied for a BMM in accordance with section 1862(a)(1)(A) of the Act if the regulatory standards are not satisfied. Existing regulations concerning limitation on liability are set forth in §§ 411.400 through 411.406 and are applicable to denial of BMMs under § 410.31. d. Payments for BMMs Medicare payments for covered BMMs are paid for under the PFS (42 CFR part 414) as required by statute. In the June 24, 1998 IFC, we revised the definition of “physician services” in § 414.2 to include bone mass measurements. When BMM procedures are furnished to hospital inpatients and outpatients, the TCs of these procedures are payable under existing payment methods for hospital services. These methods include payments under the prospective payment system, on a reasonable cost basis, or under a special provision for determining payment rates for hospital outpatient radiology services. In the June 24, 1998 IFC, we revised § 414.50(a), regarding physician billing for purchased diagnostic tests, to clarify that the section does not apply to payment for BMMs. e. Conforming Changes In the June 24, 1998 IFC, to allow for appropriate placement in the CFR of the BMM coverage requirements, we redesignated § 410.31 (Prescription drugs used in immunosuppressive therapy) as § 410.30. 2. Additional Scientific Evidence In 2004, the Surgeon General issued a report, Bone Health and Osteoporosis (U.S. Department of Health and Human Services, Bone Health and Osteoporosis: A Report of the Surgeon General. Rockville, MD: U.S. Department of Health and Human Services, Office of the Surgeon General, 2004). This report provides scientific evidence related to the prevention, assessment, diagnosis, and treatment of bone disease. The report states that identification of those at risk of bone disease and fracture is important so that appropriate interventions can be implemented. However, as the report states, “Assessing the risk of bone disease and fracture remains a challenge. Not all of the risk factors have been identified, and the relative importance of those that are known remains unclear.” As bone strength is not measured directly, bone mineral density (BMD) remains the single best predictor of fracture risk, with the most widely accepted method for measuring BMD being the dual energy x-ray absorptiometry (DXA) for a bone density study at the axial skeleton (for example, hips and spine). As there are many sources of variability in the measurement of BMD, a quality control system related to both the methodology and reporting of test results is important to ensure the validity of DXA analysis. In addition to DXA of the axial skeleton, bone mass can also be measured using other techniques. These other techniques include DXA bone density study for the appendicular skeleton (for example, radius, wrist, heel); quantitative computerized tomography (QCT), bone mineral density study for the axial skeleton or appendicular skeleton; radiographic absorptiometry (photodensitometry, radiogrammetry); single-photon absorptiometry (SPA); single energy x-ray absorptiometry (SXA) for the appendicular skeleton; and ultrasound bone mineral density study for the appendicular skeleton. With regard to these techniques (except for SPA which was not discussed), the 2004 Surgeon General report states, “While these methods do assess bone density and may provide an indication of fracture risk, it is important to note that the WHO [World Health Organization] recommendations and other guidelines for using BMD and interpreting BMD results for diagnosis are based on DXA measurements of the hip or spine.” The report further states, “Incorporating these techniques for bone assessment into future clinical trials and observational studies will help in better understanding their appropriate use as a means of predicting the risk of bone disease and fracture.” 3. Proposed Changes to the June 24, 1998 IFC We received 18 public comments on the June 24, 1998 IFC. The majority of the comments had specific recommendations for changes to the IFC. In addition to responding to comments that we may receive on our proposed revisions to § 410.31, it is our intent to address all these previous comments in the CY 2007 PFS final rule. Based on the comments received on the IFC, the Surgeon General's report, and other evidence, we are proposing changes to § 410.31. We encourage comments on these proposals. a. Proposed “BMM” Definition (§ 410.31(a)) We are proposing to revise the definition of “bone mass measurement” at § 410.31(a)(2) to remove coverage for the use of SPA, which uses isotope sources to measure BMD. Many medical experts indicate that SPA has largely been replaced by the newer techniques of DXA, which are believed to be superior in accuracy and precision. Medicare claims data in recent years continue to show a steady decline in the use of the SPA procedure by the beneficiary population. Further, there is a lack of evidence to support continued use of SPA, an older procedure where the metrics have not been correlated with fracture rate. We are proposing to revise the definition of a “bone mass measurement” to read, “Is performed with either a bone densitometer (other than a single-photon or dual-photon absorptiometry) or with a bone sonometer system that has been cleared for marketing for this use by the FDA under 21 CFR part 807, or approved for marketing by the FDA for this use under 21 CFR part 814.” We are specifically requesting comments on this proposal regarding the evidence of benefit for SPA, particularly in comparison with other alternatives. b. Conditions for Coverage (§ 410.31(b)) We are proposing to revise the conditions for coverage for BMMs in 
                        ( print page 49060)
                        § 410.31(b) by requiring that for a medically necessary BMM to be covered for an individual being monitored to assess the response to or efficacy of an FDA-approved osteoporosis drug therapy (§ 410.31(d)(5)) the individual would be required to meet the present conditions for coverage under § 410.31(b), and the monitoring would have to be performed by the use of an dual energy x-ray absorptiometry system (axial system). We recognize that in the June 24, 1998 IFC, we allowed the physician or qualified nonphysician practitioner treating the beneficiary more flexibility in ordering those diagnostic measurements, but we are proposing to limit that flexibility with respect to the type of BMM that is used for monitoring individuals receiving osteoporosis drug therapy and other purposes (as discussed later in this section) because of new evidence and other information received since publication of the June 24, 1998 IFC that supports the need for requiring the use of the DXA measurement (axial skeleton) in those circumstances. In addition to the 2004 Surgeon General's Report that recognized the superiority of the DXA (axial skeleton) for measuring bone mass over time, the International Society for Clinical Densitometry currently recommends that if an individual has a low bone mass using a peripheral measurement (appendicular skeleton) he or she should have a DXA (axial skeleton) performed for monitoring or confirmatory diagnostic purposes. Therefore, we are also proposing to revise § 410.31(b) by adding a requirement that in the case of any individual who qualifies for a bone mass measurement as provided for in § 410.31(d) and who receives a confirmatory baseline BMM to permit monitoring in the future, Medicare may cover a medically necessary BMM for that individual, if the present conditions for coverage under § 410.31(b) are met, and the BMM is performed by a dual energy x-ray absorptiometry system (axial skeleton) (if the initial measurement was not performed by this system). As indicated previously, the most widely accepted method for measuring bone mineral density (BMD) is the use of DXA (Surgeons General's Report 2004) at axial skeletal sites. DXA (axial skeleton) measures BMD at the hip and spine (sites likely to fracture in patients who have osteoporosis). DXA is precise, safe, and low in radiation exposure, and permits more accurate and reliable monitoring of individuals over time. DXA of the femoral neck is the best validated test to predict hip fracture and is comparable to forearm measurements for predicting fractures at other sites (Evidence Report/Technology Assessment No 28, Agency for Healthcare Research and Quality (AHRQ), January 2001). c. Bone Mass Measurement: Standards on Frequency of Coverage (§ 410.31(c)) To conform the examples of a BMM exception to the standards on frequency of coverage in § 410.31(c)(2) to the regulation change we are proposing in § 410.31(b)(3), we are proposing to revise the confirmatory baseline test example in § 410.31(c)(2)(ii) to read, “Allowing for a confirmatory baseline measurement to permit monitoring of beneficiaries in the future if the requirements of paragraph (b)(3) of this section are met.” d. Bone Mass Measurement: Beneficiaries Who May Be Covered (§ 410.31(d)) The Congress has recognized that individuals receiving long-term glucocorticoid steroid therapy are qualified individuals for purposes of section 1861(rr)(1) of the Act. Therapy to prevent bone loss in most patients beginning long-term therapy has been recommended at a prednisone equivalent of ≥ 5 mg/day for at least 3 months (McIlwain, 2003). Based on our review of the current evidence, we are proposing to reduce the dosage equivalent in § 410.31(d)(3) from an average of 7.5 mg/day of prednisone for at least 3 months to an average of 5.0 mg/day of prednisone for the same period. e. Use of the NCD Process (§ 410.31(f)) To facilitate future consideration of coverage of additional BMM systems for purposes of proposed paragraphs § 410.31(b)(2) and (b)(3), which would limit coverage of BMMs for monitoring individuals receiving osteoporosis drug therapy and for performing confirmatory baseline measurements, we are proposing to allow CMS, through the NCD process, to identify additional BMM systems for those purposes. By using the NCD process, we could conduct a timely assessment of FDA-approved BMMs. Use of an NCD to add coverage of effective BMM systems for these purposes is authorized by the reasonable and necessary provision of sections 1862(a)(1)(A) and 1871(a)(2) of the Act. In summary, in view of the 18 comments and our review of the post-1998 medical literature, we have decided to propose several revisions to § 410.31 relative to the definition of the term “Bone Mass Measurement” (§ 410.31(a)(2)), the conditions for coverage (§ 410.31(b)), the examples of exceptions to the standards on frequency of coverage (§ 410.31(c)(2)), the category of individuals receiving (or expecting to receive) glucocorticoid (steroid) therapy (§ 410.31(d)(3)), and the addition of a new subparagraph (§ 410.31(f)) on use of the NCD process. L. Independent Diagnostic Testing Facility (IDTF) Issues [If you choose to comment on issues in this section, please include the caption “IDTF ISSUES” at the beginning of your comments.] 1. Proposed IDTF Changes in the Physician Fee Schedule Proposed Rule During the course of a national review in 2003-2004, the Office of Inspector General (OIG) found a potential $71 million in improper payments made to IDTFs (Review of Claims Billed by Independent Diagnostic Testing Facilities for Services Provided to Medicare Beneficiaries During Calendar Year 2001 (A-03-03-00002)). The OIG found that erroneous payments were made as the result of poor or missing documentation or the lack of medical necessity. Moreover, in recent years, CMS and its contractors have determined that a number of IDTFs in California and other States are perpetrating schemes to defraud the Medicare program. Since 2000, the number of IDTFs in California has increased by 40 percent, which is a far greater percentage increase than the Medicare population in that State. The number of IDTFs billing Medicare in California alone increased more than 400 percent from 2000 to 2005. The increased use of IDTF services has not lowered the use of diagnostic testing within other settings. The increased rates of utilization within IDTFs is likely to be unrealistic due to an increase in the need of diagnostic testing within California's Medicare population. Also, these IDTFs are growing at a rate faster than CMS can survey these facilities. The actual growth of IDTFs is not a problem, however, the results of the OIG audit make it clear that we need to closely monitor IDTFs and establish standards to ensure quality care for Medicare beneficiaries. To address the erroneous payments identified by the OIG above, we are proposing to establish IDTF supplier standards similar to those we adopted for Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) Suppliers on October 11, 2000 (see 42 CFR 424.57). We are proposing that each IDTF be required to be in compliance with the 
                        ( print page 49061)
                        proposed fourteen suppler standards discussed in section L.2. below in order to obtain or retain enrollment in the Medicare program. Accordingly, at proposed § 410.33(h), we are proposing that if an IDTF fails to meet one or more of the proposed standards at the time of enrollment or at the time of re-enrollment, then its enrollment application would be denied. Also, if at any time we determine that an enrolled IDTF no longer meets the proposed supplier standards, its billing privileges would be revoked. We believe that these supplier standards are needed to ensure that minimum quality standards are met to protect beneficiaries as well as the Medicare Trust Fund. These standards are merely good business practices which will help to ensure that suppliers are providing a quality care to Medicare beneficiaries. Examples of the kind of standards are a primary business phone number and address. Another example is a posting of standards for review by patients and the public. We are proposing to adopt, for IDTFs, a number of standards we adopted for DMEPOS suppliers, including supplier standard number 6 which requires a supplier to maintain a comprehensive liability insurance policy of $300,000 or 20 percent of its average annual Medicare billings, whichever amount is greater, that covers both the place of business and all customers and employees of the IDTF. Furthermore, we are proposing in the new performance standard number 7 that an IDTF agrees not to directly solicit patients. This provision does not preclude the IDTF from public advertisement or marketing its services to physicians and other suppliers, however it does prohibit recruitment of beneficiaries through direct solicitation. Additionally, the IDTF would be required to grant CMS, or its designated fee-for-service contractors, including our agents, to have access to the IDTF physical location, all equipment, and beneficiary medical records during normal business hours. For portable equipment, an IDTF would be required to maintain a catalog of portable equipment and be able to produce the cataloged equipment within two business days. If the IDTF denies this access, the IDTF's Medicare enrollment would be immediately revoked. To ensure that equipment used by an IDTF is maintained and operates properly, we are seeking public comment regarding IDTF supplier standard number 11, which would require that an IDTF must have its testing equipment calibrated per equipment instructions or in compliance with applicable industry standards. Specifically, we are seeking public comment regarding the organizations or entities that may currently establish testing specifications for diagnostics equipment. Further, if these organizations or entities do not exist, we invite public comment regarding establishment of a supplier standard that relies on the manufacturer's maintenance and calibration standards. While we understand that these proposed additional standards could lead certain IDTFs to withdraw from the Medicare program rather than comply with the new standards, we believe that legitimate businesses would not oppose these changes. Moreover, we emphasize that services provided by an IDTF are also readily available to beneficiaries through other avenues such as physicians' offices, outpatient laboratories, outpatient radiology facilities, and outpatient clinics. We believe that the implementation of these proposed standards would improve the quality of services provided to Medicare beneficiaries by IDTFs without any associated access concerns. 2. Proposed Performance Standards for IDTFs The IDTF would be required to meet the following standards as of January 1, 2007 and any newly or reenrolling IDTF would be required to certify in its enrollment application that it meets and would continue to meet the standards. At § 410.33, we are proposing to revise the regulation to specify that the IDTF would be required to— Operate its business in compliance with all applicable Federal, State, and local licensure and regulatory requirements with regard to the health and safety of patients;
                    Provide complete and accurate information on its enrollment application as stated in the “Requirements for Providers and Suppliers to Establish and Maintain Enrollment final rule” (April 21, 2006 (42 FR 20754)). Any change in enrollment information would be required to be reported to the designated fee-for-service contractor on the Medicare enrollment application within 30 calendar days;
                    Maintain a physical facility on an appropriate site. For the purposes of this proposed standard, a post office box or commercial mailbox would not be considered a physical facility. The physical facility would be required to contain space for equipment appropriate to the services designated on the enrollment application, facilities for hand washing, adequate patient privacy accommodations, and the storage of both business records and current medical records;
                    Have all applicable testing equipment available at the physical site, excluding portable equipment. A catalog of portable equipment, including equipment serial numbers, would be maintained at the physical site. In addition, portable equipment would be made available for inspection within two business days of our inspection request. The IDTF would be required to maintain a current inventory of the equipment (including serial/registration numbers), provide this information to the designated fee-for-service contractor and notify the contractor of any changes in equipment;
                    Maintain a primary business phone under the name of the business. The business phone would be located at the designated site of the business. The telephone number or toll free numbers would be available in a local directory and through directory assistance;
                    Have a comprehensive liability insurance policy of at least $300,000 or 20 percent of its average annual Medicare billings, whichever amount is greater, that covers both the place of business and all customers and employees of the IDTF. The insurance policy would be carried by a non-relative owned company. The policy would be required to list the serial numbers of any and all equipment used by the IDTF;
                    Agree not to directly solicit patients, which includes, but is not limited to, a prohibition on telephone, computer, or in-person contracts. The IDTF would accept only those patients referred for diagnostic testing by an attending physician, who is furnishing a consultation or treating a beneficiary for a specific medical problem and who uses the results in the management of the beneficiary's specific medical problem. Nonphysician practictioners may order tests as set forth in § 410.32(a)(3);
                    Answer beneficiaries' questions and respond to their complaints. Documentation of those contacts would be maintained at the physical site;
                    Openly post these standards for review by patients and the public;
                    Disclose to the government, any person having ownership, financial or control interest, or any other legal interest in the supplier at the time of enrollment or within 30 days of a change;
                    Have its testing equipment calibrated per equipment instructions and in compliance with applicable national standards;( print page 49062)
                    Have technical staff on duty with the appropriate credentials to perform tests. The IDTF would be required to produce the applicable Federal or State licenses and/or certifications of the individuals performing these services;
                    Have proper medical record storage and be able to retrieve medical records upon request from CMS or its designated fee-for-service contractor within 2 business days; and
                    Permit CMS, including its agents or its designated fee-for-service contractors, to conduct unannounced, on-site inspections to confirm the IDTF's compliance with these proposed standards. The IDTF would be required to provide access, during regular business hours, to CMS and beneficiaries, as well as maintain a visible sign posting the normal business hours of the IDTF. 3. Supervision To ensure quality care is provided to Medicare beneficiaries, we are proposing to revise § 410.33(b)(1) to read that physicians will be limited to providing supervision to “no more than three (3) IDTF sites.” 4. Place of Service In addition to proposing the establishment of specific supplier standards for IDTFs, at proposed § 410.33(i), we are proposing to define the “point of the actual delivery of service” as the correct “Place of Service” for the claim form in the case of diagnostic testing performed outside the IDTF's physical location. For example, when an IDTF performs a diagnostic test at a beneficiary's residence, we believe that it is reasonable to establish the beneficiary's residence as the “Place of Service.” Previously, there has been no set procedure, so therefore, we believe that the information is gathered at the collection point from the beneficiary, and this is the point service. While most diagnostic tests are performed in an office setting, we are seeking public comment regarding the types of services that can be safely and appropriately used in a residential setting. M. Independent Laboratory Billing for the TC of Physician Pathology Services to Hospital Patients [If you choose to comment on issues in this section, please include the caption “INDEPENDENT LAB BILLING” at the beginning of your comments.] The TC of physician pathology services refers to the preparation of the slide involving tissue or cells that a pathologist will interpret. (In contrast, the pathologist's interpretation of the slide is the PC service. If this service is furnished by the hospital pathologist for a hospital patient, it is separately billable. If the independent laboratory's pathologist furnishes the PC service, it is usually billed with the TC service as a combined service.) In the “Revisions to Payment Policies Under the Physician Fee Schedule for Calendar Year 2000” final rule published in the 
                        **Federal Register**
                         on November 2, 1999 (64 FR 59380 and 59408 through 59409), we stated that we would implement a policy to pay only the hospital for the TC of physician pathology services furnished to hospital patients. Before that proposal, any independent laboratory could bill the carrier under the PFS for the TC of physician pathology services for hospital patients. As pointed out in the November 2, 1999 final rule, this policy has contributed to the Medicare program paying twice for the TC service, first through the inpatient prospective payment rate to the hospital where the patient is an inpatient and again to the independent laboratory that bills the carrier, instead of the hospital, for the TC service. Therefore, in that final rule at § 415.130, we provided that, for services furnished on or after January 11, 2001, the carriers would no longer pay claims to the independent laboratory under the physician fee schedule for the TC of physician pathology services for hospital patients. Ordinarily, the provisions in the final PFS are implemented in the following year. However, in this case, the change to § 415.130 was delayed one year (until January 1, 2001), at the request of the industry, to allow independent laboratories and hospitals sufficient time to negotiate arrangements. Moreover, our full implementation of § 415.130 was further delayed through CY 2006. We continue to believe, however, that hospital prospective payment amounts already compensate hospitals for the TC of physician pathology tests and that additional payment under the PFS is inappropriate. Therefore, we are proposing to amend § 415.130 to provide that, for services furnished after December 31, 2006, an independent laboratory may not bill the carrier for physician pathology services furnished to a hospital inpatient or outpatient. Under proposed § 415.130(d), we would pay under the PFS for the TC of a physician pathology service furnished by an independent laboratory for services provided to an inpatient or outpatient of a “covered hospital” on or before December 31, 2006. A “covered hospital” is defined in § 415.130(a)(1). N. Public Consultation for Medicare Payment for New Outpatient Clinical Diagnostic Laboratory Tests [If you choose to comment on issues in this section, please include the caption “CLINICAL DIAGNOSTIC LAB TESTS” at the beginning of your comments.] Section 1833(h) of the Act requires the Secretary to establish fee schedules for clinical laboratory tests under Medicare Part B. In this section of the preamble, we are proposing to implement section 942(b) of the MMA which specifies annual procedures for consulting the public on how to establish payment for new clinical laboratory test codes to be included in the annual update of the clinical laboratory fee schedule. 1. BIPA (Pub. L. 106-554) Section 531(b) of BIPA mandated that we establish, no later than 1 year after the date of enactment, procedures that permit public consultation for payment determinations for new clinical diagnostic laboratory tests under Medicare Part B in a manner consistent with the procedures established for implementing ICD-9-CM coding modifications. In the November 23, 2001 
                        **Federal Register**
                         (66 FR 58743), we specified the procedures to implement section 531(b) of BIPA. These procedures were most recently used to determine the payments for new 2006 clinical laboratory fee schedule codes. First, we convened a public meeting to solicit expert input on the nature of the new tests before rate determinations were made. We have held these meetings each year since 2002 to receive this expert input on the next year's codes. Our most recent meeting was announced in the 
                        **Federal Register**
                         on May 27, 2005 (70 FR 30734) and occurred on July 18, 2005. In that meeting, we requested that presenters address the new test codes, each test's purpose, method, cost, and a recommendation for one of two methods (crosswalking or gapfilling) for determining payment for the new clinical laboratory codes. Crosswalking and gapfilling are discussed below in section N.2.d. Following the public meeting, we posted, on our Website, a summary of the new codes and the payment recommendations that were presented during the public meeting. The summary also displayed our tentative payment determinations and indicated a comment period for interested parties to submit written comments. After reviewing the comments received, we issued Medicare Transmittal 750, 2006 Annual Update for Clinical Laboratory 
                        ( print page 49063)
                        Fee Schedule, which provided all instructions and final rate determinations for the 2006 clinical laboratory fee schedule including the new codes and fees, on November 18, 2005. 2. Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA) (Pub. L. 108-173) Further legislation affecting public consultation for new clinical laboratory tests was enacted at section 942(b) of the MMA (Pub. L. 108-173), which added section 1833(h)(8) to the Act. Section 1833(h)(8)(A) of the Act requires the Secretary to establish by regulation procedures for determining the basis for and amount of payment for a clinical diagnostic laboratory test that is assigned a new or substantially revised Healthcare Common Procedure Coding System (HCPCS) code on or after January 1, 2005. We refer to these tests as “new tests.” Section 1833(h)(8)(B) of the Act provides that determinations of payment amounts for new tests shall be made only after the Secretary— Makes available to the public (through an Internet Web site and other appropriate mechanisms) a list that includes codes for which establishment of a payment amount is being considered for the next calendar year;
                    On the same day the list of codes is made available, publishes a**Federal Register**
                         notice of a meeting to receive public comments and recommendations (and data on which recommendations are based) on the appropriate basis for establishing payment amounts for the list of codes made available to the public;
                    Not less than 30 days after publication of the notice in the**Federal Register**
                        , convenes a meeting that includes representatives of CMS officials involved in determining payment amounts, to receive public comments and recommendations (and data on which the recommendations are based); and
                    Taking into account the comments and recommendations (and accompanying data) received at the public meeting, develops and makes available to the public (through an Internet Web site and other appropriate mechanisms)— + A list of proposed determinations with respect to the appropriate basis for establishing a payment amount for each code, together with an explanation of the reasons for each determination, the data on which the determinations are based, and a request for public written comments on the proposed determination; and + A list of final determinations of the payment amounts for tests, together with the rationale for each determination, the data on which the determinations are based, and responses to comments and suggestions from the public. We believe that our current process for providing for public consultation on the establishment of payment amounts for new clinical laboratory tests is consistent with the requirements of section 1833(h)(8)(B) of the Act. We currently make available to the public through a posting on the CMS Web site a list of new laboratory test codes for the next calendar year. We publish a 
                        **Federal Register**
                         notice of a meeting to receive public comments and recommendations and convene the meeting with appropriate CMS officials in attendance. We take into account the input received at the public meeting and we make available to the public on the CMS Web site a list of the proposed determinations and seek comment. We then make available to the public our final determinations in the instructions that we provide to our claims processing contractors to implement the Medicare Part B clinical laboratory fee schedule each year. The most significant change required by section 1886(h)(8)(A) of the Act with respect to our procedures for public consultation is that we codify this process in regulations. Therefore, in this proposed rule, we are proposing to codify our current process for public consultation for new clinical diagnostic laboratory tests paid under the Medicare Part B clinical laboratory fee schedule at proposed new Subpart F—Payment for New Clinical Diagnostic Laboratory Tests (§ 414.402 through § 414.406). a. Proposed Basis and Scope (§ 414.400) This proposed new subpart would implement provisions of section 1833(h)(8) of the Act—procedures for determining the basis for, and amount of, payment for a new clinical diagnostic laboratory test with respect to which a new or substantially revised Healthcare Common Procedure Coding System code is assigned on or after January 1, 2005. b. Proposed Definition (§ 414.402) As specified in section 942(b) of the MMA, we propose to define the term “Substantially Revised Healthcare Common Procedure Coding System Code” to mean a code for which there has been a substantive change to the definition of the test or procedure to which the code applies (such as a new analyte or a new methodology for measuring an existing analyte specific test). c. Proposed Procedures for Public Consultation for Payment for a New Clinical Diagnostic Laboratory Test (§ 414.406) For a clinical laboratory test that is assigned a new or substantially revised code on or after January 1, 2005, we would establish a local fee schedule amount only after the following: We make available to the public (through an Internet Web site and other appropriate mechanisms) a list that includes codes for which establishment of a payment amount is being considered for the next calendar year.
                    We publish a**Federal Register**
                         notice of a meeting to receive public comments and recommendations (and data on which recommendations are based) on the appropriate basis, as specified in proposed new § 414.408, for establishing payment amounts for the list of codes made available to the public.
                    Not less than 30 days after publication of the notice in the**Federal Register**
                        , we convene a meeting, that includes representatives of CMS officials involved in determining payment amounts, to receive public comments and recommendations (and data on which the recommendations are based).
                    Taking into account the comments and recommendations (and accompanying data) received at the public meeting, we develop and make available to the public (through an Internet Web site and other appropriate mechanisms)— + A list of proposed determinations with respect to the appropriate basis for establishing a payment amount for each code, together with an explanation of the reasons for each determination, the data on which the determinations are based, and a request for public written comments on the proposed determination within a specified time period; and + A list of final determinations of the payment amounts for tests, together with the rationale for each determination, the data on which the determinations are based, and responses to comments and suggestions from the public. d. Proposed Payment for a New Clinical Diagnostic Laboratory Test—Crosswalking and Gapfilling (§ 414.408) We are proposing to add a new § 414.408 to indicate when, in establishing the payment amount for a new clinical laboratory test, one of two payment methods can be utilized. The 
                        ( print page 49064)
                        first payment method, called “crosswalking,” is used if a new test is determined to be comparable to an existing test, multiple existing test codes, or a portion of an existing test code. We propose that a new test code would be assigned the related existing local fee schedule amounts and national limitation amount. In new § 414.408, we propose to use the second method, called “gapfilling,” when no comparable, existing test is available. Currently when using this method, manual instructions are provided to each Medicare carrier to determine a payment amount for its geographic area(s) for use in the first year, and the carrier-specific amounts are used to establish a national limitation amount for following years. Consistent with our current process, the sources of information carriers examine in determining gapfill amounts, if available, include— Charges for the test and routine discounts to charges;
                    Resources required to perform the test;
                    Payment amounts determined by other payers; and
                    Charges, payment amounts, and resources required for other tests that may be comparable or otherwise relevant. Currently, our manual instructions allow carriers to consider other sources of information as appropriate, including clinical studies and information provided by clinicians practicing in the area, manufacturers, or other interested parties. Carriers are also instructed to establish carrier specific amounts on or before March 31 of the year and to revise their carrier specific amount, if necessary, on or before September 1 of the year. In this manner, a carrier may revise its carrier specific amount based on additional information, but there is also a specific time frame to perform this revision so that we have adequate time to receive and use the carrier specific amounts for the calculation of the next year's clinical laboratory fee schedule. Currently for new gapfilled laboratory tests, the payment amount beginning in the second year is based on the lower of the carrier specific amount determined in the first year or the national limitation amount. In accordance with section 1833(h) of the Act, the national limitation amount is set at the median of the carrier-specific amounts. In light of new MMA provisions, however, we are proposing, in new § 414.408, to prospectively eliminate payment of new gapfilled tests at a carrier specific amount after the first year. Section 1833(h)(8)(A) of the Act gives the Secretary authority to establish procedures for determining the payment amount for laboratory tests for which new or substantially revised HCPCS codes were established on or after January 1, 2005. Under this authority, we propose, in new § 414.408(b), to pay for a new gapfilled laboratory test under our existing methodology for the first year (the carrier would establish a gapfill amount.) Beginning in the second year, the test would be paid at the national limitation amount. This would result in consistent payment in geographic areas for a new test using the median of the carrier gapfill amounts. 3. Other Laboratory Issues This section discusses other laboratory issues related to quality and glucose monitoring in SNFs. a. Quality In addition to providing payments, Medicare's clinical laboratory fee schedule for both new and existing tests should foster the provision of quality care and the prevention of avoidable health care costs. We are exploring the development of measures related to the quality and efficiency of care, including those involving clinical laboratory fee schedule services. Physicians' decisions are central to the health care their patients receive and are informed by appropriate clinical laboratory testing. We want to work with physicians, providers and the clinical laboratory community to identify ways to promote utilization decisions that clearly increase the quality of care while avoiding unnecessary costs for beneficiaries and the Medicare program. As part of its strategies to improve quality of care, CMS could require those who perform laboratory tests to submit laboratory values using common vocabulary standards, such as those found in the Logical Observation Identifiers Names and Codes (LOINC®) database. The LOINC® database currently contains about 41,000 observational terms, of which nearly 31,000 are observational terms related to laboratory testing. The laboratory subset of the LOINC® database provides universal names and codes for identifying the results of clinical laboratory tests and it facilitates the exchange and pooling of clinical laboratory results for clinical care, outcomes management and research. Note that LOINC® describes the test result, but does not provide it. It is, therefore, only one possible component of a comprehensive system of collecting clinical laboratory fee test results. Each LOINC® record corresponds to a single test result or panel. The following are some examples of LOINC records: LOINC code LOINC name (component: property: timing: specimen: scale) 2951-2 SODIUM:SCNC:PT:SER/PLAS:QN 2955-2 SODIUM:SCNC:PT:UR:QN 2956-1 SODIUM:SRAT:24H:UR:QN 2164-2 CREATININE RENAL CLEARANCE:VRAT:24H:UR:QN 1514-9 GLUCOSE‸
                        2H POST 100 G GLUCOSE PO:MCNC:PT:SER/PLAS:QN 3665-7 GENTAMICIN‸
                        TROUGH:MCNC:PT:SER/PLAS:QN 17863-2 CALCIUM.IONIZED:MCNC:PT:SER/PLAS:QN 2863-9 ALBUMIN:MCNC:PT:SNV:QN:ELECTROPHORESIS The parts of the LOINC® name refer to different aspects of the test result. The component is the analyte (for example, sodium). The property is the characteristic of the analyte that is measured, evaluated or observed (for example SCNC = substance concentration). Timing indicates whether the measurement is an observation at a moment of time, or an observation integrated over an extended duration of time (for example, PT = point in time). The specimen is the type of sample (for example, SER/PLAS = serum or plasma). The scale is the type of scale (for example QN = quantitative). For further detail, please see the LOINC® Web site at 
                        *http://www.loinc.org.* On September 23, 2005 (70 FR 55900-56025), we published the proposed rule “HIPAA Administrative Simplification: Standards for Electronic Health Care Claims Attachments.” This rule proposed standards for electronically requesting and supplying particular types of additional health care information in the form of an electronic attachment to support submitted health care claims data. The proposed rule specified a standard attachment form for reporting laboratory results (among other standards) and proposed adoption of LOINC® as the standard code set for reporting such results. While the laboratory claims attachment standard and use of LOINC® could provide a means for reporting test result data, we recognize that there are significant operational and other challenges that would need to be addressed before Medicare could begin to collect laboratory values in a comprehensive fashion using common vocabulary standards and that these challenges need to be met in partnership with the clinical laboratory community. We look forward to working 
                        ( print page 49065)
                        collaboratively with the clinical laboratory community on these issues. b. Blood Glucose Monitoring in SNFs In response to inquiries regarding our policy on blood glucose monitoring in SNFs, we are taking this opportunity to restate our long-standing policy on coverage of blood glucose monitoring services and to propose to codify physician certification requirements for blood glucose monitoring in SNFs. Generally, section 1862(a)(1)(A) of the Act requires that a service be reasonable and necessary for diagnosis and treatment in order to be eligible for coverage by Medicare. Our regulations at § 410.32(a) already require that, for any diagnostic test, including a clinical diagnostic laboratory test, to be considered reasonable and necessary, it must be both ordered by the physician and the ordering physician must use the result in the management of the beneficiary's specific medical problem. Tests not ordered by the physician who is treating the beneficiary are not reasonable and necessary. In the context of blood glucose monitoring, we most recently stated this policy in Transmittal AB-00-108, “Glucose Monitoring”, which is available on our Web site at 
                        *http://www.cms.hhs.gov/​transmittals/​downloads/​ab00108.pdf.*
                         This interpretation of § 410.32 is also the basis for our policy in Chapter 7 of the Medicare Claims Processing Manual (“Skilled Nursing Facility Part B Billing” available on our Web site at 
                        *http://www.cms.hhs.gov/​manuals/​downloads/​clm104c07.pdf.*) In addition, section 1835(a)(2)(B) of the Act provides that, in the case of certain “medical and other health services” (including clinical diagnostic laboratory services), payment may be made for Part B services that are furnished by a provider of services only if a physician certifies—and recertifies where those services are furnished over a period of time, with such frequency, and accompanied by such supporting material, as may be provided by regulation—that those services were medically necessary.  The regulations currently implementing this provision at § 424.24 do not specifically address the issue of blood glucose monitoring in SNFs. Therefore, we are proposing to amend § 424.24 to provide that, for each blood glucose test furnished to a resident of a SNF, the physician must certify that the test is medically necessary. We are also proposing to amend § 424.24 to clarify that a physician's standing order is not sufficient to order routine blood glucose monitoring. c. Other Lab Issues—Proposed Clinical Diagnostic Laboratory Date of Service (DOS) for Stored Specimens We are proposing to add a new § 414.410 to address concerns that have been raised regarding the date of service of a clinical diagnostic laboratory test that use a stored (or “archived”) specimen. In the final rule of coverage and administrative policies for clinical diagnostic laboratory services that we published on November 23, 2001 (66 FR 58792), we adopted a policy under which the date of service for clinical diagnostic laboratory services generally is the date the specimen is collected. For laboratory tests that use an archived specimen, however, the date of service is the date the specimen was obtained from the storage. In 2002, we issued Program Memorandum AB-02-134 which permitted contractors discretion in making determinations regarding the length of time a specimen must be stored to be considered archived. In response to comments requesting that we issue a national standard to clarify when a stored specimen can be considered “archived,” in the Procedures for Maintaining Code Lists in the Negotiated National Coverage Determinations for Clinical Diagnostic Laboratory Services final notice, published in the 
                        **Federal Register**
                         on February 25, 2005 (70 FR 9355), we defined an “archived” specimen as a specimen that is stored for more than 30 calendar days before testing. The date of service for these archived specimens is the date the specimen was obtained from storage. Specimens stored 30 days or less have a date of service of the date the specimen was collected. The February 25, 2005 final notice also clarified that the date of service for tests when the collection spanned more than two calendar days is the date the collection ended. Instructions that implemented these policies were added to Chapter 16, section 40.8 of the Medicare Claims Processing Manual (Pub. 100-04) with the issuance of Transmittal 800 (CR 4156), on December 30, 2005. Recently, we have received correspondence that expressed concern that our policies have created some unintended consequences, especially in situations in which a specimen is taken in a hospital setting, but then later used for a test after the patient has left the hospital. Under the current manual instructions, if the specimen used for a test ordered subsequent to the beneficiary's discharge is obtained less than 31 calendar days following the date the specimen was collected, the date of service of the test is the date of collection. The date of service of a test may affect payment because, if the date of service falls during an inpatient stay or on a day on which the beneficiary had an outpatient procedure, payment for the laboratory test usually is bundled with the hospital service. To address these concerns, we are proposing to change our current policy so that the date of service would be the date the specimen is obtained from storage, even if the specimen is obtained less than 31 days from the date it was collected, without violating the unbundling rules as long as the following conditions are met: The test is ordered by the patient's physician at least 14 days following the date of the patient's discharge from the hospital.
                    The test could not reasonably have been ordered while the patient was hospitalized.
                    The procedure performed while the beneficiary is a patient of the hospital is for purposes other than collection of the specimen needed for the test.
                    The test is reasonable and medically necessary. These conditions are consistent with the guidance in Chapter 16, sec 40.3 of the Claims Processing Manual, which states that “When the hospital obtains laboratory tests for outpatients under arrangements with clinical laboratories or other hospital laboratories, only the hospital can bill for the arranged services.” In addition, Chapter 3 of the Program Integrity Manual contains instructions for additional documentation if further development of laboratory claims for pre-or postpay are required. Although we believe these changes will help to maintain beneficiary access to care, we are concerned about the potential for these policy changes creating inappropriate incentives in the development of technology and the implications for the unbundling of services. We solicit comment on the proposed changes and these concerns. O. Proposal to Establish Criteria for National Certifying Bodies That Certify Advanced Practice Nurses [If you choose to comment on issues in this section, please include the caption “Criteria for National Certifying Bodies-Advanced Practice Nurses” at the beginning of your comments.] Federal regulatory qualifications for nurse practitioners (NPs) at 42 CFR 410.75 require that an individual be certified as an NP by a recognized national certifying body that has established standards for NPs. Similarly, Federal regulatory qualifications for clinical nurse specialists (CNSs) at 42 
                        ( print page 49066)
                        CFR 410.76 require that an individual be certified as a CNS by a national certifying body that has established standards for CNSs and that is approved by the Secretary. Currently, there is not a list of recognized or approved national certifying bodies for NPs and CNSs in regulations. However, Chapter 15, section 200 of the Benefit Policy Manual, Pub. 100-02 contains a list of national certifying bodies that are recognized by Medicare as being appropriate for certification of NPs. Although the manual provision regarding CNS services at Chapter 15, section 210 of the Benefit Policy Manual lists only the American Nurses Credentialing Center as an approved national certifying body for CNSs, we indicated that the list of recognized certifying bodies in the manual provision for NP services would also apply for CNSs in the “Revisions to Payment Policies Under the CY 2003 Physician Fee Schedule and Inclusion of Registered Nurses in the Personnel Provision of the Critical Access Hospital Emergency Services Requirement for Frontier Areas and Remote Locations; Payment Policies final rule (December 31, 2002, 67 FR 79987). The national certifying bodies that are listed under the manual instruction at section 200, and that currently apply for both NPs and CNSs (collectively, advanced practice nurses) are as follows: American Academy of Nurse Practitioners;
                    American Nurses Credentialing Center;
                    National Certification Corporation for Obstetric, Gynecologic and Neonatal Nursing Specialties;
                    National Certification Board of Pediatric Nurse Practitioners and Nurses;
                    Oncology Nurses Certification Corporation;
                    Critical Care Certification Corporation. In the December 31, 2002 final rule, in response to a public comment, we stated, “it is not the agency's intention to be overly restrictive in our program requirements and consequently prevent qualified CNSs who specialize in areas of medicine other than those certified by the American Nurses Credentialing Center (ANCC) from participating under the CNS benefit and from rendering care to patients in need of specialized services. Furthermore, the intent of the revision to the certification requirement for CNSs is to recognize all appropriate national certifying bodies for CNSs as the program does for NPs.” Accordingly, in an effort to recognize all appropriate national certifying bodies for CNSs and NPs, we added, at that time, the Oncology Nurses Certification Corporation (ONCC) and the Critical Care Certification Corporation (CCCC) to the list of recognized national certifying bodies for advanced practice nurses. The National Board on Certification of Hospice and Palliative Care Nurses (NBCHPN) has requested that we now follow the same course of action as we did for the ONCC and the CCCC by adding its name to the list of recognized national certifying bodies. That is, NBCHPN believes that it is an appropriate national certifying body based on its certification experience, principles, services, and the certification exam that it administers to advanced practice nurses who specialize in palliative care for hospice patients. The NBCHPN stated in information it sent to the agency that its organization is a well-established certification body with more than 12-years history of certification and that it has been certifying advanced practice hospice and palliative nurses since 2003 in partnership with the ANCC. Starting in 2005, the NBCHPN became sole proprietor of the Advanced Certified Hospice and Palliative Nurse (ACHPN) examination. Master's level nurse practitioners and clinical nurse specialists sit for this ACHPN examination that is based on a role delineation study for the advanced practice level of hospice and palliative nursing. Additionally, the NBCHPN stated that it has met the requirements of the American Board of Nursing Specialties and is an active member of the Board of Specialties, as is the ANCC. The Executive Director of the NBCHPN stated that she believes that the absence of the NBCHPN from the current list of recognized national certifying bodies presents a barrier for advanced practice nurses in the hospice palliative care specialty because they are denied enrollment on the basis that they do not meet the certification qualification requirement. The Web site for the NBCHPN can be found at 
                        *www.nbchpn.com.* We are soliciting public comments on whether it would be appropriate to include the NBCHPN under the list of recognized and approved national certifying bodies for NPs and CNSs under manual instructions for both NPs and CNSs. We are also soliciting public comments on criteria or standards that we could use to determine whether an organization is an appropriate national certifying body for advanced practice nurses. CMS realizes that the agency may receive other requests in the future from organizations that wish to be to be added to the list of recognized or approved national certifying bodies. In anticipation of those requests, the agency is interested in developing certification standards that would facilitate the process for making these decisions. P. Chiropractic Services Demonstration [If you choose to comment on issues in this section, please include the caption “Chiropractic Services Demonstration” at the beginning of your comments.] In the FY 2006 PFS final rule (November 21, 2005), we included a discussion of the 2-year demonstration authorized by section 651 of the MMA to evaluate the feasibility and advisability of covering chiropractic services under Medicare. These services extend beyond the current coverage for manipulation to care for neuromusculoskeletal conditions typical among eligible beneficiaries, and cover diagnostic and other services that a chiropractor is legally authorized to perform by the State or jurisdiction in which the treatment is provided. The demonstration is being conducted in four sites, two rural and two urban. The demonstration must be budget neutral as the statute requires the Secretary to ensure that the aggregate payment made under the Medicare program does not exceed the amount which would be paid in the absence of the demonstration. Ensuring budget neutrality requires that the Secretary develop a strategy for recouping funds should the demonstration result in costs higher than those that would occur in the absence of the demonstration. As we stated in the FY 2006 PFS, we would make adjustments in the national chiropractor fee schedule to recover the costs of the demonstration in excess of the amount estimated to yield budget neutrality. We will assess budget neutrality by determining the change in costs based on a pre/post comparison of costs and the rate of change for specific diagnoses that are treated by chiropractors and physicians in the demonstration sites and control sites. We will not limit our analysis to reviewing only chiropractor claims, because the costs of the expanded chiropractor services may have an impact on other Medicare costs. Any needed reduction would be made in the 2010 and 2011 physician fee schedules as it will take approximately 2 years to complete the claims analysis. If we determine that the adjustment for budget neutrality is greater than 2 percent of spending for the chiropractor fee schedule codes (comprised of the 3 
                        ( print page 49067)
                        currently covered CPT codes 98940, 98941, and 98942), we would implement the adjustment over a 2-year period. However, if the adjustment is less than 2 percent of spending under the chiropractor fee schedule codes, we would implement the adjustment over a 1-year period. We will include the detailed analysis of budget neutrality and the proposed offset during the 2009 rulemaking process. PT services performed by chiropractors under the demonstration are subject to the PT therapy cap. These services are included under the cap because chiropractors are subject to the same rules as medical doctors for therapy services under the demonstration. Q. Promoting Effective Use of Health Information Technology (HIT) (If you choose to comment on issues in this section, please include the caption “Promoting Effective Use of HIT” at the beginning of your comment.) We recognize the potential for health information technology (HIT) to facilitate improvements in the quality and efficiency of health care services. One recent RAND study found that broad adoption of electronic health records could save more than $81 billion annually and, at the same time, improve quality of care.[1]
                        
                         The largest potential savings that the study identified was in the hospital setting because of shorter hospital stays promoted by better coordinated care; less nursing time spent on administrative tasks; better use of medications in hospitals; and better utilization of drugs, laboratory services, and radiology services in hospital outpatient settings. The study also identified potential quality gains through enhanced patient safety, decision support tools for evidence-based medicine, and reminder mechanisms for screening and preventive care. Despite these large potential benefits, the study found that only about 20 to 25 percent of hospitals have adopted HIT systems. It is important to note the caveats to the RAND study. The projected savings are across the health care sector, and any Federal savings would be a reduced percentage. In addition, there are significant assumptions made in the RAND study. National savings are projected in some cases based on one or two small studies. Also, the study assumes patient compliance, in the form of participation in disease management programs and following medical advice. For these reasons, extreme caution should be used in interpreting these results. In summary, there are mixed signals about the potential of HIT to reduce costs. Some studies have indicated that HIT adoption does not necessarily lead to lower costs and improved quality. In addition, some industry experts have stated that factors such as an aging population, medical advances, and increasing provider expenses would make any projected savings impossible. In his 2004 State of the Union Address, the President announced a plan to ensure that most Americans have electronic health records within 10 years.[2]
                        
                         One part of this plan involves developing voluntary standards and promoting the adoption of interoperable HIT systems that use these standards. The 2007 Budget states that “The Administration supports the adoption of health information technology (IT) as a normal cost of doing business to ensure patients receive high quality care.” Over the past several years, we have undertaken several activities to promote the adoption and effective use of HIT in coordination with other Federal agencies and with the Office of the National Coordinator for Health Information Technology. One of those activities is promotion of data standards for clinical information, as well as for claims and administrative data. As noted above, the Administration supports the adoption of HIT as a normal cost of doing business. The adoption and use of HIT may contribute to improved processes and outcomes of care, including shortened illnesses and the avoidance of adverse drug reactions. R. Health Care Information Transparency Initiative (If you choose to comment on issues in this section, please include the caption “Health Care Information Transparency Initiative” at the beginning of your comment.) The United States (U.S.) faces a dilemma in health care. Although the rate of increase in health care spending slowed last year, costs are still growing at an unsustainable rate. The U.S. spends $1.9 trillion on health care, or 16 percent of the gross domestic product (GDP). By 2015, projections are that health care will consume 20 percent of GDP. As indicated in the 2006 Annual Report of the Boards of Trustees, the Medicare program alone consumes 3.2 percent of the GDP and by 2040, it will consume 8.0 percent of the GDP. Part of the reason health care costs are rising so quickly is that most consumers of health care—the patients—are frequently not aware of the actual cost of their care. Health insurance shields them from the full cost of services, and they have only limited information about the quality and costs of their care. Consequently, consumers do not have the incentive or means to carefully shop for providers offering the best value. Thus, providers of care are not subject to the competitive pressures that exist in other markets for offering quality services at the best possible price. Reducing the rate of increase in health care prices and avoiding health services of little value could help to stem the growth in health care spending, and potentially reduce the number of individuals who are unable to afford health insurance. Part of the President's health care agenda is to expand Health Savings Accounts (HSAs), which would provide consumers with greater financial incentives to compare providers in terms of price and quality, and choose those that offer the best value. In order to exercise those choices, consumers must have accessible and useful information on the price and quality of health care items and services. Typically, health care providers do not publicly quote or publish their prices. Moreover, list prices, or charges, generally differ from the actual prices negotiated and paid by different health plans. Thus, even if consumers were financially motivated to shop for the best price, it would be very difficult at the current time for them to access usable information. For these reasons, DHHS is launching a major health care information transparency initiative in 2006. This effort builds on steps taken by CMS to make quality and price information available. For example, Medicare has provided unprecedented information about drug prices in the Medicare drug benefit, and is now adding to these efforts in other areas. Medicare payment information for common elective procedures and other common admissions for all hospitals by county has been posted on our Web site at: 
                        *http://www.cms.hhs.gov/​HealthCareConInit/​01 Overview.asp#TopOfP.* We will post geographically-based Medicare payment information for common elective procedures for ambulatory surgery centers this summer and for common hospital outpatient and physician services this fall. 
                        ( print page 49068) In addition, a number of tools providing usable healthcare information are already available to Medicare beneficiaries. Supported by the public-private quality alliances, consumers can access “Compare” Web sites through 
                        *www.medicare.gov*
                         where they can evaluate important aspects of their health care options for care at a hospital, nursing home, home health agency, and dialysis facility, as well as compare their costs and coverage when choosing a prescription drug plan. We are developing a project with the goals of providing more comprehensive information on quality and costs, including more complete measures of health outcomes, satisfaction, and volume of services that matter to consumers, and more comprehensive measures of costs for entire episodes of care, not just payments for particular services and admissions. We intend for the project to combine public and private health care data to measure cost and quality of care information at the physician and hospital levels. Quality, cost, pricing, and patient information will be reported to consumers and purchasers of health care in a meaningful and transparent way. III. Collection of Information Requirements Under the Paperwork Reduction Act of 1995, we are required to provide 60-day notice in the 
                        **Federal Register**
                         and solicit public comment before a collection of information requirement is submitted to the Office of Management and Budget (OMB) for review and approval. In order to fairly evaluate whether an information collection should be approved by OMB, section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 requires that we solicit comment on the following issues: The need for the information collection and its usefulness in carrying out the proper functions of our agency.
                    The accuracy of our estimate of the information collection burden.
                    The quality, utility, and clarity of the information to be collected.
                    Recommendations to minimize the information collection burden on the affected public, including automated collection techniques. We are soliciting public comment on each of these issues for the following sections of this document that contain information collection requirements: Section 410.33 Independent Diagnostic Testing Facility Section 410.33(e)(1) imposes a recordkeeping requirement on multi-state entities. Specifically, an independent diagnostic testing facility (IDTF) that operates across State boundaries must maintain documentation that its supervising physicians and technicians are licensed and certified in each of the States in which it operates. The burden associated with this requirement is the time and effort it takes the IDTF to collect and maintain the aforementioned information. While subject to the PRA, we believe this information collection requirement is exempt as defined in 5 CFR 1320.3(b)(2), because the time, effort, and financial resources necessary to comply with the requirement would be incurred by persons in the normal course of their activities (for example, in compiling and maintaining business records) and is considered to be usual and customary. Section 410.33(g) discusses the application certification standards that an IDTF must meet. An IDTF must complete an enrollment application and certify the information contained in the application. The certification is part of an application that is subject to the PRA. The burden associated with this requirement is the time and effort necessary to complete the application. This requirement is currently approved in OMB No. 0938-0685, with a current expiration date of April 30, 2009. If you comment on these information collection and recordkeeping requirements, please mail copies directly to the following: Centers for Medicare & Medicaid Services, Office of Strategic Operations and Regulatory Affairs, Regulations Development Group, Attn: William N. Parham, III, [CMS-1321-P], Room C4-26-05, 7500 Security Boulevard, Baltimore, MD 21244-1850; and Office of Information and Regulatory Affairs, Office of Management and Budget, Room 10235, New Executive Office Building, Washington, DC 20503, Attn: Carolyn Lovett, CMS Desk Officer, [CMS-1321-P], carolyn_lovett@omb.eop.gov. Fax (202) 395-6974. IV. Response to Comments Because of the large number of public comments we normally receive on 
                        **Federal Register**
                         documents, we are not able to acknowledge or respond to them individually. We will consider all comments we receive by the date and time specified in the 
                        **DATES**
                         section of this preamble, and, when we proceed with a subsequent document, we will respond to the comments in the preamble to that document. V. Regulatory Impact Analysis [If you choose to comment on issues in this section, please include the caption “IMPACT” at the beginning of your comments.] We have examined the impact of this rule as required by Executive Order 12866 (September 1993, Regulatory Planning and Review), the Regulatory Flexibility Act (RFA) (September 19, 1980 Pub. L. 96-354), section 1102(b) of the Social Security Act, the Unfunded Mandates Reform Act of 1995 (Pub. L. 104-4), and Executive Order 13132. Executive Order 12866 (as amended by Executive Order 13258, which merely reassigns responsibilities of duties) directs agencies to assess all costs and benefits of available regulatory alternatives and, when regulation is necessary, to select regulatory approaches that maximize net benefits (including potential economic, environmental, public health and safety effects, distributive impacts, and equity). A regulatory impact analysis must be prepared for proposed rules with economically significant effects (that is, a proposed rule that would have an annual effect on the economy of $100 million or more in any one year, or would adversely affect in a material way the economy, a sector of the economy, productivity, competition, jobs, the environment, public health or safety, or State, local, or tribal governments or communities). As indicated in more detail below, we estimate that the PFS provisions included in this proposed rule will redistribute more than $100 million in one year. We are considering this proposed rule to be economically significant because its provisions are estimated to result in an increase, decrease or aggregate redistribution of Medicare spending that will exceed $100 million. Therefore, this proposed rule is a major rule and we have prepared a regulatory impact analysis. The RFA requires that we analyze regulatory options for small businesses and other entities. We prepare a regulatory flexibility analysis unless we certify that a rule would not have a significant economic impact on a substantial number of small entities. The analysis must include a justification concerning the reason action is being taken, the kinds and number of small entities the rule affects, and an explanation of any meaningful options that achieve the objectives with less significant adverse economic impact on the small entities. Section 1102(b) of the Act requires us to prepare a regulatory impact analysis for any proposed rule that may have a significant impact on the operations of 
                        ( print page 49069)
                        a substantial number of small rural hospitals. This analysis must conform to the provisions of section 603 of the RFA. For purposes of section 1102(b) of the Act, we define a small rural hospital as a hospital that is located outside a Metropolitan Statistical Area and has fewer than 100 beds. We have determined that this proposed rule would have minimal impact on small hospitals located in rural areas. Of the 222 hospital-based ESRD facilities located in rural areas, only 40 are affiliated with hospitals with fewer than 100 beds. For purposes of the RFA, physicians, nonphysician practitioners, and suppliers are considered small businesses if they generate revenues of $6 million or less. Approximately 95 percent of physicians are considered to be small entities. There are about 980,000 physicians, other practitioners and medical suppliers that receive Medicare payment under the PFS. For purposes of the RFA, approximately 80 percent of clinical diagnostic laboratories are considered small businesses according to the Small Business Administration's size standards. In addition, most ESRD facilities are considered small entities, either based on nonprofit status or by having revenues of $29 million or less in any year. We consider a substantial number of entities to be affected if the proposed rule is estimated to impact more than 5 percent of the total number of small entities. Based on our analysis of the 927 nonprofit ESRD facilities considered small entities in accordance with the above definitions, we estimate that the combined impact of the proposed changes to payment for renal dialysis services included in this proposed rule would have a 0.9 percent increase in overall payments relative to current overall payments. IDTFs are suppliers under the Medicare program. For purposes of the RFA, suppliers with annual sales of $6 million or less are considered to be small entities. (Individuals and States are not included in the definition of a small entity.) We believe that our proposed standards for IDTFs will help bar fraudulent suppliers from participating in the Medicare program and provide an added level of protection to Medicare beneficiaries. Therefore, we expect to have an impact on an unknown number of persons and entities who will effectively be prevented from practicing their aberrant billing activities. The vast majority of suppliers would not be significantly affected by this proposed rule. The reduction in program overpayments and the added level of protection to beneficiaries that we expect to achieve as a result of this proposed rule justifies the relatively small burden this proposed rule would impose on all small entities. The analysis and discussion provided in this section, as well as elsewhere in this proposed rule, complies with the RFA requirements. Section 202 of the Unfunded Mandates Reform Act of 1995 also requires that agencies assess anticipated costs and benefits before issuing any rule that may result in expenditures in any year by State, local, or tribal governments, in the aggregate, or by the private sector, of $120 million. Medicare beneficiaries are considered to be part of the private sector for this purpose. We have examined this proposed rule in accordance with Executive Order 13132 and have determined that this regulation would not have any significant impact on the rights, roles, or responsibilities of State, local, or tribal governments. A discussion concerning the impact of this rule on beneficiaries is found later in this section. We have prepared the following analysis, which, together with the information provided in the rest of this preamble, meets all assessment requirements. The analysis explains the rationale for and purposes of this proposed rule; details the costs and benefits of the rule; analyzes alternatives; and presents the measures we propose to use to minimize the burden on small entities. As indicated elsewhere in this proposed rule, we propose to change our methodology for calculating resource-based PE RVUs and make a variety of other changes to our regulations, payments, or payment policies to ensure that our payment systems reflect changes in medical practice and the relative value of services. We provide information for each of the policy changes in the relevant sections of this proposed rule. We are unaware of any relevant Federal rules that duplicate, overlap or conflict with this proposed rule. The relevant sections of this proposed rule contain a description of significant alternatives if applicable. A. Resource Based PE RVU Proposals for CY 2007 and Section 5102 of the DRA-Proposed Adjustments for Payments for Imaging Services As required by section 5102(a) of the DRA and described earlier in section II.E.1. of this proposed rule, we are removing, from the PE RVUs under the PFS the 0.3 percent increase made to the PE RVUs in the CY 2006 PFS final rule with comment period to ensure the budget neutrality of the impact of the multiple imaging policy adopted for CY 2006. Section 5102(a) of the DRA exempts the CY 2006 and 2007 impact of the multiple imaging policy from budget neutrality. Because we are proposing to maintain the current 25 percent payment reduction for multiple imaging procedures in CY 2007, there is no additional impact resulting from our proposals for CY 2007. Section 5102 of the DRA also exempts the estimated savings from the application of the OPPS-based payment limitation on PFS imaging services from the PFS budget neutrality requirement. We estimate that the combined impact of the budget neutrality exemptions in section 5102 of the DRA would reduce PFS expenditures by approximately 1.3 percent in CY 2007. Table 7 below shows the specialty-level impact of section 5102 of the DRA and our most recent estimate (−5.1 percent) of the CY 2007 Medicare PFS update. For reference purposes, we have also included the specialty-level impacts using the methodology from the separate June 29, 2006 proposed notice (71 FR 37170), which solicited comments on proposed changes to the PE methodology as well as changes to work RVUs for certain services based on the agency's completion of a five-year review of work RVUs. The CY 2007 impact of the PE input changes described in section II.A. of this proposed rule that were not included in the June 29, 2006 proposed notice are minimal at the specialty level. Additionally, the impacts in this proposed rule reflect the use of updated physician time data from the AMA-RUC. Our estimates of changes in Medicare revenues for PFS services compare payment rates for CY 2006 with proposed payment rates for CY 2007 using CY 2005 Medicare utilization for all years. We are using CY 2005 Medicare claims processed and paid through March 30, 2005, that we estimate are 98 percent complete. To the extent that there are year-to-year changes in the volume and mix of services provided by physicians, the actual impact on total Medicare revenues will be different than those shown here. The payment impacts reflect averages for each specialty based on Medicare utilization. The payment impact for an individual physician would be different from the average, based on the mix of services the physician provides. The average change in total revenues would be less than the impact displayed here because physicians furnish services to both Medicare and non-Medicare patients 
                        ( print page 49070)
                        and specialties may receive substantial Medicare revenues for services that are not paid under the PFS. For instance, independent laboratories receive approximately 80 percent of their Medicare revenues from clinical laboratory services that are not paid under the PFS. Table 7 shows only the payment impact on PFS services. The following is an explanation of the information represented in Table 7: Specialty—The physician specialty or type of practitioner/supplier.
                    Allowed Charges—Allowed charges are the Medicare Fee Schedule amounts for covered services and include copayments and deductibles (which are the financial responsibility of the beneficiary.) These amounts have been summed across all services provided by physicians, practitioners, or suppliers with a specialty to arrive at the total allowed charges for the specialty.
                    Impact of Work and PE RVU Changes using the June 29, 2006 proposed notice methodology—For references purposes, the combined CY 2007 percentage increase or decrease in allowed charges attributed to changes in the work and PE RVUs described in and republished from the June 29, 2006 proposed notice methodology.
                    Impact of section 5102 of the DRA—The CY 2007 percentage decrease in allowed charges attributed to section 5102 of the DRA.
                    Combined impact of the June 29, 2006 proposed notice methodology and section 5102 of the DRA.
                    CY 2007 Update—The percentage decrease in allowed charges attributed to the most recent estimate of the CY 2007 PFS conversion factor update (−5.1 percent).
                    Combined impact with CY 2007 update—The CY 2007 percentage decrease in allowed charges attributed to the June 29, 2006 proposed notice methodology, section 5102 of the DRA, and the CY 2007 update.  
 
  Table 8 below shows the impact on total payments for selected high-volume procedures of all of the changes previously discussed. We selected these procedures because they are the most commonly provided by a broad 
                        ( print page 49072)
                        spectrum of physician specialties. There are separate columns that show the change in the facility rates and the nonfacility rates. For an explanation of facility and nonfacility PE refer to Addendum A of this proposed rule. If we change any of the proposed provisions following the consideration of public comments, these figures may change.  
 
  B. Geographic Practice Cost Indices (GPCI)—Payment Localities As discussed in section II.B. of the preamble to this proposed rule, we are proposing new GPCIs for 2007. In the November 15, 2004 PFS final rule, we published 2005 and 2006 GPCI and GAF values reflecting the 2 year phase-in of updated GPCI data. In 2007, the proposed GPCI and GAF values will reflect new budget neutrality scalers (developed by the Office of the Actuary) and the removal of the 1.000 MMA floor from the physician work GPCI. The negative impact of these changes on a number of payment localities is shown in 4 of section II.B. in this proposed rule. C. Global Period for Remote Afterloading High Intensity Brachytherapy Procedures As discussed in section II.D.1. of this proposed rule, we are proposing changes to the global period for these 
                        ( print page 49074)
                        services. We do not anticipate this proposed change will have a significant impact on Medicare expenditures. D. DRA 5112—Proposed Addition of the Ultrasound Screening for Abdominal Aortic Aneurysm to Welcome to Medicare Benefit As discussed earlier in section II.E.3. of this preamble, section 5112 of the DRA authorizes coverage of an ultrasound screening for abdominal aortic aneurysms effective January 1, 2007, subject to certain eligibility and other limitations. We estimate that this new benefit would result in an increase in Medicare expenditures to physicians and other practitioners and suppliers of ultrasound services and related follow-up tests and treatment that may be required as a result of the coverage of these screening examinations. However, this is not expected to have a significant cost impact on the Medicare program. E. DRA 5113—Proposed Colorectal Screening Exemption From Part B Deductible As discussed earlier in section II.E.4. of this preamble, beginning January 1, 2007, colorectal cancer screening services as described in section 1861(pp)(1) of the Act are no longer subject to the Part B deductible. While waiver of this deductible will be beneficial to Medicare beneficiaries, we do not anticipate that this change will have a significant cost impact on the Medicare program. F. Section 5114—Proposed Addition of Diabetes Outpatient Self-Management Training Services (DSMT) and Medical Nutrition Therapy (MNT) for the FQHC Program As discussed earlier in section E.4. of this preamble, section 5114 of the DRA amended section 1861(aa)(3) the Act to add DSMT and MNT to the list of Medicare covered and reimbursed services under the Medicare FQHC benefit, effective for services provided on or after January 1, 2006. Although this statutory change has already been implemented in administrative instructions, we are proposing to conform the regulations to meet the new statutory requirement. FQHCs certified as DSMT and MNT providers have been allowed to bundle the cost of those services into their FQHC payment rates. But before the enactment of the DRA, the provision of these services would not generate a separate FQHC visit payment. Effective for services furnished on or after January 1, 2006, FQHCs that are certified providers of DSMT and MNT services can receive per visit payments for covered services furnished by registered dietitians or nutrition professionals. In light of the fact there are a limited number of qualified centers for DSMT and MNT services, the increase in Medicare expenditures should be negligible. G. Proposed Payment for Covered Outpatient Drugs and Biologicals (ASP Issues) The proposed changes discussed in section II.F. of this proposed rule, with respect to payment for covered outpatient drugs and biologicals, are estimated to have no impact on Medicare expenditures. However, we believe the changes will assist in clarifying existing policy with respect to ASP payment. H. Proposed Provisions Related to Payment for Renal Dialysis Services Furnished by End State Renal Disease (ESRD) Facilities The ESRD related provisions in this proposed rule are discussed in section II.G. of this preamble. In order to understand the impact of the proposed changes affecting payments to different categories of ESRD facilities, it is necessary to compare estimated payments under the current year (current 2006 payments) to estimated payments under the proposed revisions to the composite rate payment system as discussed in II.G. of this proposed rule (proposed 2007 payments). To estimate the impact among various classes of ESRD facilities, it is imperative that the estimates of current payments and proposed payments contain similar inputs. Therefore, we simulated payments only for those ESRD facilities that we are able to calculate both current 2006 payments and proposed 2007 payments. Due to data limitations, we are unable to estimate current and proposed payments for 226 facilities that bill for ESRD dialysis treatments. ESRD providers were grouped into the categories based on characteristics provided in the Online Survey and Certification and Reporting (OSCAR) file and the most recent cost report data from the Healthcare Cost Report Information System (HCRIS). We also used the December 2005 update of CY 2005 National Claims History file as a basis for Medicare dialysis treatments and separately billable drugs and biologicals. While the December 2005 update of the 2005 claims file is not complete, we wanted to use the most recent data available, and plan to use an updated version of the 2005 claims file for the final rule. 
 
  Table 9 above shows the impact of this year's proposed changes to CY 2007 payments to hospital-based and independent ESRD facilities. The first column of Table 9 identifies the type of ESRD provider, the second column 
                        ( print page 49076)
                        indicates the number of ESRD facilities for each type, and the third column indicates the number of dialysis treatments. The fourth column shows the effect of CY 2007 proposed changes to the ESRD wage index as it affects the composite rate payments to ESRD facilities. The fourth column compares aggregate ESRD wage adjusted composite rate payments in the second year of the transition (CY 2007) to aggregate ESRD wage adjusted composite rate payments in first year of the transition (CY 2006). In the second year of the transition (CY 2007), ESRD facilities receive 50 percent of the CBSA wage adjusted composite rate and 50 percent of the MSA adjusted composite rate. In the first year of the transition, ESRD facilities receive 25 percent of the CBSA wage adjusted composite rate and 75 percent of the MSA adjusted composite rate. The overall effect to all ESRD providers in aggregate is zero because the proposed CY 2007 ESRD wage index has been multiplied by a budget neutrality factor to comply with the statutory requirement that any wage index revisions be done in a manner that results in the same aggregate amount of expenditures as would have been made without any changes in the wage index. The decreases shown among census regions is primarily due to reducing the wage index floor, as there were areas in these areas with wage index values below the proposed floor. The fifth column shows the overall effect of the proposed changes in composite rate payments to ESRD providers. The overall effect is measured as the difference between CY 2007 proposed payment with all changes as proposed in this rule and CY 2006 current payment. This amount is computed by multiplying the wage adjusted composite rate with the drug add-on for each provider times dialysis treatments from 2005 claims. The CY 2007 proposed payment is transition year two wage adjusted composite rate for each provider (with the proposed 15.2 percent drug add-on) times dialysis treatments from 2005 claims. The CY 2006 current payment is transition year one wage adjusted composite rate for each provider (with the current 14.5 percent drug add on) times dialysis treatments from 2005 claims. The overall impact to ESRD providers in aggregate is 0.6 percent. This increase corresponds to the proposed 0.6 percent increase to the drug add-on. The variation seen in column 5 is due to variation in change in the wage index (column 4). All provider types receive the same 0.6 percent increase to the drug add on. I. Private Contracts and Opt-Out Provision The changes discussed in this proposed rule, with respect to private contracts and the opt-out provision, are currently estimated to have no significant impact on Medicare expenditures. J. Proposals Related to Physician Self Referral Prohibitions As discussed in section II.I of this proposed rule, we would clarify in regulations at § 424.80(d) under the contractual arrangement reassignment exception that, if a physician or other individual supplier reassigns his or her right to bill for the TC of a diagnostic test, the entity to which the reassignment is made may not be paid more than the physician or other individual supplier would have been paid for the TC. In addition, in order to bill for the TC of the diagnostic test, the entity to which the reassignment is made must perform the PC. We also propose that, in order to bill for the PC of a diagnostic test following a reassignment, the billing entity must meet current requirements in our manual instructions. In addition, as discussed in section II.I., we also propose to revise §§ 424.80(b) and (d) to provide that a physician or other individual supplier who reassigns his or her right to benefits has a right to review the bills for his or her services, irrespective of whether the individual is an employee or an independent contractor of the entity to which the reassignment is made. We also propose the following changes to the physician self-referral provisions: A “centralized building” for purposes of the physician services exception and the in-office ancillary services exception at §§ 411.355(a) and (b), respectively, would have to measure at least 350 square feet and include permanent placement of the equipment used in the provision of substantially all of the designated health services. We believe that these changes would have little effect on Medicare expenditures. K. Supplier Access to Claims Billed on Reassignment The reassignment provisions discussed in section II.J.2. of this preamble are currently estimated to have no significant impact on Medicare expenditures. L. Proposed Coverage of Bone Mass Measurement As discussed in section II.K. of this preamble, we have decided to propose several revisions to § 410.31 relative to the definition of the term “Bone Mass Measurement” (§ 410.31(a)(2)), the conditions for coverage (§ 410.31(b)), the examples of exceptions to the standards on frequency of coverage (§ 410.31(c)(2)), and the category of individuals receiving glucocorticoid (steroid) therapy (§ 410.31(d)(3)). We are also proposing the addition of a new paragraph (f) that would allow CMS, through the NCD process, to identify additional BMM systems for monitoring individuals receiving osteoporosis drug therapy and for performing confirmatory baseline measurements. We do not expect that this addition would have a significant cost impact on the Medicare program in the next several years. Based on the projected impact of the first three changes that would place greater reliance on the use of the more expensive DXA (axial skeleton) devices, we estimate that this revised benefit would result in an increase in Medicare payments for providers who use the DXA (axial skeleton) devices and a somewhat smaller decrease in payments to providers who use QCT (axial skeleton) and peripheral devices. However, we do not expect that these changes would have a significant cost impact on the Medicare program due to the fact that at present a very small percentage of our total Medicare payments for bone mass measurements are being made to providers who use QCT or peripheral devices. In addition, we estimate that lowering the eligibility standard for coverage of individuals on steroid therapy from 7.5 mg/day to 5.0 mg/day of prednisone (the fourth change) would result in an increase in Medicare payment for testing of additional patients, but this modest lowering of the steroid standard is not expected to have a significant cost impact on the program. M. Proposed IDTF Changes The costs associated with these proposed changes would be as follows: 1. Liability Insurance Requirement (§ 424.57(c)(10)) We estimate that only 10 percent of IDTFs do not already have liability insurance that meets this requirement. Based on Medicare data as of June 2005, 10 percent of the total number of IDTFs is approximately 559 suppliers. Using the previously highest estimate received ($1,800 annually), results in an approximate additional liability insurance cost of $1 million annually (559 times $1,800) to the IDTF industry due to this proposed rule. 
                        ( print page 49077) 2. Primary Business Telephone Listed Under the Name of the Business Locally or Toll-free for Beneficiaries Proposed Requirement (§ 424.57(c)(9)) We estimate that only 1 percent of IDTFs do not already meet this requirement. Based on Medicare data as of June 2005, we determined that 1 percent of IDTFs is approximately 56 suppliers. Therefore, 56 times the approximate $600 annual cost of telephone service results in an additional cost of $33,600 annually. Total Cost = $1 Million + $33,600 = approximately $1.04 million annually. N. Independent Lab Billing for TC Component of Physician Pathology Services for Hospital Patients The most current information on the number of affected hospitals and the impact on laboratories and hospitals comes from a report issued by the General Accounting Office (GAO) in September 2003. The GAO estimated that approximately 95 percent of the total of all Medicare hospitals on the prospective payment system, as well as CAHs sent the TC of physician pathology services to independent laboratories and the independent laboratories billed the carrier under the PFS. The GAO estimated that the median number of services sent by each hospital to outside independent laboratories was small, approximately 81 services. The GAO was unable to identify the number of laboratories billing for the TC service because a single laboratory may submit claims under multiple provider numbers. In general, the impact on the individual hospital is small; however, we do not know the impact on the individual independent laboratory If the independent laboratories had not received payments from the carriers for these TC services for hospital patients, the GAO estimates that Medicare spending would have been $42 million less in 2001 and beneficiary cost sharing obligations for inpatient and outpatient services would have been reduced by $2 million. Based on what they learned from the hospital industry, the GAO thought that Medicare beneficiaries' access to pathology services would not likely be affected if independent laboratories could not longer bill the carrier for these services. Hospital representatives indicated that they would likely continue to use independent laboratories to provide TC pathology services. In is unclear if the hospitals contracting with independent laboratories would pay the laboratories at the same rates that the laboratories received by billing the Medicare carriers under the physician fee schedule. O. Public Consultation for Medicare Payment for New Outpatient Clinical Diagnostic Laboratory Tests This codification of our process for public consultation for new clinical diagnostic laboratory tests paid under the Medicare Part B clinical laboratory fee schedule, if adopted, would not increase or decrease payment amounts for existing clinical diagnostic laboratory tests because it would not alter our current methodology for calculating payment amounts for existing clinical diagnostic laboratory tests. For new tests, this proposal would primarily codify an existing process for the determination of payment amounts. Because any new laboratory tests to be gapfilled are unknown to us at the current time, we do not have any data to estimate the impact of our proposal to pay for new gapfilled lab tests at the median of the local carrier amounts for all carriers rather than the lower of that amount and the local carrier amount. P. Alternatives Considered This proposed rule contains a range of policies, including some proposals related to specific MMA provisions. The preamble provides descriptions of the statutory provisions that are addressed, identifies those policies when discretion has been exercised, presents rationale for our decisions and, where relevant, alternatives that were considered. Q. Impact on Beneficiaries There are a number of changes made in this proposed rule that would have an effect on beneficiaries. In general, we believe these proposed changes, particularly the DRA provisions that provide for an exception to the application of the Part B deductible with respect to colorectal cancer screening tests and coverage of an ultrasound screening for the early detection of AAAs, as part of the Initial Preventive Physical Examination benefit (referred to as the Welcome to Medicare benefit) would improve beneficiary access to services that are currently covered or expand the Medicare benefit package to include new services. As explained in more detail below, the regulatory provisions may affect beneficiary liability in some cases. Any changes in aggregate beneficiary liability from a particular provision would be a function of the coinsurance (20 percent if applicable for the particular provision after the beneficiary has met the deductible) and the effect of the aggregate cost (savings) of the provision on the calculation of the Medicare Part B premium rate (generally 25 percent of the provision's cost or savings). To illustrate this point, as shown in Table 8, the 2006 national payment amount in the nonfacility setting for CPT code 99203 (Office/outpatient visit, new), is $97.02 which means that currently a beneficiary is responsible for 20 percent of this amount, or $19.40. Based on the June 29, 2006 proposed notice (71 FR 37170) and this proposed rule, the 2007 national payment amount in the nonfacility setting for CPT code 99203, as shown in Table 8, is $91.71 which means that, in 2007, the beneficiary coinsurance for this service would be $18.34. Very few of the changes we are proposing impact overall payments and, therefore, would affect Medicare beneficiaries' coinsurance liability. Proposals discussed above that do affect overall spending, such as DRA 5102 imaging provisions, would similarly impact beneficiaries' coinsurance. R. Accounting Statement As required by OMB Circular A-4 (available at 
                        *http://www.whitehouse.gov/​omb/​circulars/​a004/​a-4.pdf*), in Table 10 below, we have prepared an accounting statement showing the classification of the expenditures associated with the provisions of this proposed rule. This table includes the impact of the proposed changes in this rule on providers and suppliers. Expenditures are classified as transfers to Medicare providers/or suppliers (that is, ESRD facilities and physicians, other practitioners, clinical laboratories and medical suppliers that receive payment under the physician fee schedule or Medicare Part B). Based on the proposals contained in this proposed rule, there would be an estimated decrease in expenditures from CY 2006 to 2007. This is a result of the CY 2007 increased payment to ESRD facilities the reduction to the payments for imaging services under the PFS required by section 5102 of the DRA and the −5.1 percent Medicare PFS conversion factor update required by the statutory update formula. Table 10.—Accounting Statement: Classification of Estimated Expenditures, From CY 2006 to the CY 2007 (in Millions)
Category
TransfersAnnualized Monetized Transfers
Estimated decrease in expenditures of $3,600( print page 49078)From Whom To Whom?
Federal Government To ESRD Medicare Providers; physicians, other practitioners and suppliers who receive payment under the Medicare Physician Fee Schedule; and Medicare Suppliers billing for Part B drugs.
 In accordance with the provisions of Executive Order 12866, this final rule was reviewed by the Office of Management and Budget. List of Subjects 42 CFR Part 405 Administrative practice and procedure
Health facilities
Health professions
Kidney diseases
Medical devices
Medicare
Reporting and recordkeeping requirements
Rural areas
X-rays 42 CFR Part 410 Health facilities
Health professions
Kidney diseases
Laboratories
Medicare
Reporting and recordkeeping requirements
Rural areas
X-rays 42 CFR Part 411 Kidney diseases
Medicare
Physician Referral
Reporting and recordkeeping requirements 42 CFR Part 414 Administrative practice and procedure
Health facilities
Health professions
Kidney diseases
Medicare
Reporting and recordkeeping 42 CFR Part 415 Health facilities
Health professions
Medicare
Reporting and recordkeeping requirements 42 CFR Part 424 Emergency medical services
Health facilities
Health professions
Medicare
Reporting and recordkeeping requirements
 For the reasons set forth in the preamble, the Centers for Medicare & Medicaid Services proposes to amend 42 CFR chapter IV as set forth below: PART 405—FEDERAL HEALTH INSURANCE FOR THE AGED AND DISABLED 1. The authority citation for part 405 continues to read as follows: Authority:
                            Secs. 1102, 1861, 1862(a), 1871, 1874, 1881, and 1886(k) of the Social Security Act (42 U.S.C. 1302, 1395x, 1395y(a), 1395hh, 1395kk, 1395rr, and 1395ww(k)), and sec. 353 of the Public Health Service Act (42 U.S.C. 263a). Subpart D—Private Contracts
 2. Section 405.400 is amended by revising the definition of “Practitioner” to read as follows: § 405.400
  
 *Practitioner*
                                 means a physician assistant, nurse practitioner, clinical nurse specialist, certified registered nurse anesthetist, certified nurse midwife, clinical psychologist, clinical social worker, registered dietitian or nutrition professional, who is currently legally authorized to practice in that capacity by each State in which he or she furnishes services to patients or clients.
 Subpart X—Rural Health Clinic and Federally Qualified Health Center Services Payment for Rural Health Clinic and Federally Qualified Health Center Services
 3. Section 405.2446 is amended by adding paragraph (b)(10) to read as follows: § 405.2446
  
 (b) * * * (10) Medical nutrition therapy services as specified in part 410, subpart G of this chapter, and diabetes outpatient self-management training services as specified in part 410, subpart H of this chapter. 
 4. Section 405.2463 is revised to read as follows:
 § 405.2463
  (a) 
                                *Visit*
                                —(1) 
                                *General*. (i) For RHCs, a visit is a face-to-face encounter between a clinic or center patient and a physician, physician assistant, nurse practitioner, nurse midwife, visiting nurse, clinical psychologist, or clinical social worker. (ii) For FQHCs, a visit means— (A) A face-to-face encounter, as described in paragraph (a)(1)(i) of this section; or (B) A face-to-face encounter between a patient and a qualified provider of medical nutrition therapy services as defined in part 410, subpart G of this chapter; or a qualified provider of outpatient diabetes self-management training services as defined in part 410, subpart H of this chapter. (2) 
                                *Medical visit.*
                                 For purposes of this section, a medical visit is a face-to-face encounter between a clinic or center patient and a physician, physician assistant, nurse practitioner, nurse midwife, or a visiting nurse; and for FQHCs only, a medical visit also includes a separately billable medical nutrition therapy visit or a diabetes outpatient self-management training visit. (3) 
                                *Other health visit.*
                                 For purposes of this section, a other health visit is a face-to-face encounter between a clinic or center patient and a clinical psychologist, clinical social worker, or other health professional for mental health services. (b) 
                                *Encounters.*
                                 Encounters with more than one health professional and multiple encounters with the same health professional that take place on the same day and at a single location constitute a single visit, except when one of the following conditions exist: (1) After the first encounter, the patient suffers illness or injury requiring additional diagnosis or treatment. (2) The patient has a medical visit and other health visit(s), as defined in paragraph (a) of this section. (c) 
                                *Payment.*
                                 Medicare pays for more than one visit per day when the conditions in paragraph (b) of this section are met or a separate visit under paragraph (a)(1)(ii)(B) of this section is made.
 PART 410—SUPPLEMENTARY MEDICAL INSURANCE (SMI) BENEFITS 5. The authority citation for part 410 continues to read as follows: Authority:
                            Secs. 1102, 1834, and 1871 of the Social Security Act (42 U.S.C. 1302, 1395m, and 1395hh). Subpart B—Medical and Other Health Services
 6. Section 410.16 is amended in paragraph (a) by revising paragraph (7) of the definition of “Initial preventive physical examination” to read as follows: § 410.16
  (a) * * * 
 
 
 *Initial preventive physical examination*
                                 * * * 
 (7) Education, counseling, and referral, including a written plan such as a checklist provided to the beneficiary for obtaining the appropriate screening and other preventive services that are covered as separate Medicare Part B benefits as described in section 1861(s)(10), section 1861(jj), section 1861(nn), section 1861(oo), section 1861(pp), section 1861(qq)(1), section 1861(rr), section 1861(uu), section 1861(vv), section 1861(xx)(1), section 1861(yy), and section 1861(bbb) of the Act. 
 7. A new § 410.19 is added to read as follows:
 § 410.19
  (a) 
                                *Definitions:*
                                 As used in this section, the following definitions apply: *Eligible beneficiary*
                                 means an individual who— (1) Has received a referral for an ultrasound screening for an abdominal aortic aneurysm as a result of an initial preventive physical examination (as defined in section 1861(ww)(1) of the Act); (2) Has not been previously furnished an ultrasound screening for an abdominal aortic aneurysm under the Medicare program; and (3) Is included in at least one of the following risk categories: (i) Has a family history of an abdominal aortic aneurysm. (ii) Is a man age 65 to 75 who has smoked at least 100 cigarettes in his lifetime. (iii) Is an individual who manifests other risk factors in a beneficiary category recommended for screening by the United States Preventive Services Task Force regarding abdominal aortic aneurysms, as specified by the Secretary through a national coverage determination process. *Ultrasound screening for abdominal aortic aneurysms*
                                 means the following services furnished to an asymptomatic individual for the early detection of an abdominal aortic aneurysm: (1) A procedure using soundwaves (or other procedures using alternative technologies of commensurate accuracy and cost, as specified by the Secretary through a national coverage determination process) provided for the early detection of abdominal aortic aneurysms. (2) Includes a physician's interpretation of the results of the procedure. (b) 
                                *Conditions for coverage of an ultrasound screening for abdominal aortic aneurysms.*
                                 Medicare Part B pays for one ultrasound screening for an abdominal aortic aneurysm provided to eligible beneficiaries, as described in this section, after a referral from a physician or a qualified nonphysician practitioner as defined in § 410.16(a). (c) 
                                *Limitation on coverage of ultrasound screening for abdominal aortic aneurysms.*
                                 Payment may not be made for an ultrasound screening for an abdominal aortic aneurysm that is performed for an individual who is not an eligible beneficiary, as described in the definition of “Eligible beneficiary” in this section. 8. Section 410.31 is revised to read as follows:
 § 410.31
  (a) 
                                *Definition.*
                                 As used in this section unless specified otherwise, the following definition applies: *Bone mass measurement*
                                 means a radiologic, radioisotopic, or other procedure that meets the following conditions: (1) Is performed for the purpose of identifying bone mass, detecting bone loss, or determining bone quality. (2) Is performed with either a bone densitometer (other than single-photon or dual-photon absorptiometry) or with a bone sonometer system that has been cleared for marketing for this use by the FDA under 21 CFR part 807, or approved for marketing by the FDA for this use under 21 CFR part 814. (3) Includes a physician's interpretation of the results of the procedure. (b) 
                                *Conditions for coverage.*
                                 (1) Medicare covers a medically necessary bone mass measurement if the following conditions are met: (i) Following an evaluation of the beneficiary's need for the measurement, including a determination as to the medically appropriate procedure to be used for the beneficiary, it is ordered by the physician or a qualified nonphysician practitioner (as these terms are defined in § 410.32(a)) treating the beneficiary. (ii) It is performed under the appropriate level of supervision of a physician (as set forth in § 410.32(b)). (iii) It is reasonable and necessary for diagnosing and treating the condition of a beneficiary who meets the conditions described in paragraph (d) of this section. (2) Medicare covers a medically necessary bone mass measurement for an individual defined under paragraph (d)(5) of this section if the conditions under paragraph (b)(1) of this section are met and the monitoring is performed by the use of a dual energy x-ray absorptiometry system (axial skeleton). (3) Medicare covers a medically necessary confirmatory baseline bone mass measurement for an individual defined under paragraph (d) of this section, if the conditions under paragraph (b)(1) of this section are met and the confirmatory baseline bone mass measurement is performed by a dual energy x-ray absorptiometry system (axial skeleton) and the initial measurement was not performed by a dual energy x-ray absorptiometry system (axial skeleton). (c) 
                                *Standards on frequency of coverage*
                                 —(1) 
                                *General rule.*
                                 Except as allowed under paragraph (c)(2) of this section, Medicare may cover a bone mass measurement for a beneficiary if at least 23 months have passed since the month the last bone mass measurement was performed. (2) 
                                *Exception.*
                                 If medically necessary, Medicare may cover a bone mass measurement for a beneficiary more frequently than allowed under paragraph (c)(1) of this section. Examples of situations where more frequent bone mass measurement procedures may be medically necessary include, but are not limited to the following medical circumstances. (i) Monitoring beneficiaries on long-term glucocorticoid (steroid) therapy of more than 3 months. (ii) Allowing for a confirmatory baseline measurement to permit monitoring of beneficiaries in the future if the requirements of paragraph (b)(3) of this section are met. (d) 
                                *Beneficiaries who may be covered.*
                                 The following categories of beneficiaries may receive Medicare coverage for a medically necessary bone mass measurement: (1) A woman who has been determined by the physician (or a qualified nonphysician practitioner) treating her to be estrogen-deficient and at clinical risk for osteoporosis, based on her medical history and other findings. (2) An individual with vertebral abnormalities as demonstrated by an x-ray to be indicative of osteoporosis, osteopenia, or vertebral fracture. (3) An individual receiving (or expecting to receive) glucocorticoid (steroid) therapy equivalent to an average of 5.0 mg of prednisone, or greater, per day for more than 3 months. (4) An individual with primary hyperparathyroidism. (5) An individual being monitored to assess the response to or efficacy of an 
                                ( print page 49080)
                                FDA-approved osteoporosis drug therapy. (e) 
                                *Denial as not reasonable and necessary.*
                                 If CMS determines that a bone mass measurement does not meet the conditions for coverage in paragraphs (b) or (d) of this section, or the standards on frequency of coverage in paragraph (c) of this section, it is excluded from Medicare coverage as not “reasonable” and “necessary” under section 1862(a)(1)(A) of the Act and § 411.15(k) of this chapter. (f) 
                                *Use of the National Coverage Determination Process.*
                                 For the purposes of paragraphs (b)(2) and (b)(3) of this section, CMS may determine through the National Coverage Determination process that additional bone mass measurement systems are reasonable and necessary under section 1862(a)(1) of the Act for monitoring and confirming baseline bone mass measurements. 
 9. Section 410.33 is amended by— A. Revising paragraph (b)(1). B. Revising paragraph (e). C. Adding paragraphs (g), (h), and (i). The revision and additions read as follows:
 § 410.33
  
 (b) 
                                *Supervising physician.*
                                 (1) Each supervising physician must be limited to providing supervision to no more than three (3) IDTF sites. The IDTF supervising physician is responsible for the overall operation and administration of the IDTFs, including the employment of personnel who are competent to perform test procedures, record and report test results promptly, accurately and proficiently, and for assuring compliance with the applicable regulations. 
 (e) 
                                *Multi-State entities.*
                                 (1) An IDTF that operates across State boundaries must— (i) Maintain documentation that its supervising physicians and technicians are licensed and certified in each of the States in which it operates; and (ii) Operate in compliance with all applicable Federal, State, and local licensure and regulatory requirements with regard to the health and safety of patients. (2) The point of the actual delivery of services is the Place of Service on the claim form. When an IDTF performs a diagnostic test at the beneficiary's residence, the beneficiary's residence is the Place of Service. 
 (g) 
                                *Application certification standards.*
                                 The IDTF must certify in its enrollment application that it meets the following standards: (1) Operate its business in compliance with all applicable Federal and State licensure and regulatory requirements. (2) Provide complete and accurate information on their enrollment application. Any change in enrollment information must be reported to the designated fee-for-service contractor on the Medicare enrollment application within 30 calendar days of the change. (3) Maintain a physical facility on an appropriate site. For the purposes of this standard, a post office box or commercial mail box is not considered a physical facility. The physical facility must contain space for equipment appropriate to the services designated on the enrollment application, facilities for hand washing, adequate patient privacy accommodations, and the storage of both business records and current medical records. (4) Have all applicable testing equipment available at the physical site excluding portable equipment. A catalog of portable equipment, including equipment serial numbers, must be maintained at the physical site. In addition, portable equipment must be available for inspection within two business days of a CMS inspection request. The IDTF must maintain a current inventory of the equipment, including serial and registration numbers, provide this information to the designated fee-for-service contractor upon request, and notify the contractor of any changes in equipment within 90 days. (5) Maintain a primary business phone under the name of the designated business. The business phone must be located at the designated site of the business. The telephone number or toll free numbers must be available in a local directory and through directory assistance. (6) Have a comprehensive liability insurance policy of at least $300,000 or 20 percent of its average annual Medicare billings, whichever amount is greater, that covers both the place of business and all customers and employees of the IDTF. The policy must be carried by a non-relative owned company and list the serial numbers of any and all equipment used by the IDTF. (7) Agree not to directly solicit patients through any means including, but not limited to, a prohibition on telephone, computer, or in-person contacts. The IDTF must accept only those patients referred for diagnostic testing by an attending physician, who is furnishing a consultation or treating a beneficiary for a specific medical problem and who uses the results in the management of the beneficiary's specific medical problem. Nonphysician practictioners may order tests as set forth in § 410.32(a)(3). (8) Answer beneficiaries’ questions and respond to their complaints. Documentation of those contacts must be maintained at the physical site. (9) Openly post these standards for review by patients and the public. (10) Disclose to the government any person having ownership, financial, or control interest or any other legal interest in the supplier. (11) Have its testing equipment calibrated per equipment instructions and in compliance with applicable national standards. (12) Have technical staff on duty with the appropriate credentials to perform tests. The IDTF must be able to produce the applicable Federal or State licenses or certifications of the individuals performing these services. (13) Have proper medical record storage and be able to retrieve medical records upon request from CMS or its fee-for-service contractor within 2 business days. (14) Permit CMS, including its agents, or its designated fee-for-service contractors, to conduct unannounced, on-site inspections to confirm the IDTF's compliance with these standards. The IDTF must be accessible during regular business hours to CMS and beneficiaries and must maintain a visible sign posting the normal business hours of the IDTF. (h) 
                                *Failure to meet standards.*
                                 If an IDTF fails to meet one or more of the standards in paragraph (g) of this section at the time of enrollment, its enrollment will be denied. CMS will revoke a supplier's billing privileges if and IDTF is found not to meet the standards in paragraph (g) or (b)(1) of this section. (i) 
                                *Definition.*
                                 For purposes of this section, the following definition applies: *Point of actual delivery of service.*
                                 The point of the actual delivery of service means the Place of Service on the claim form. When an IDTF performs a diagnostic test at the beneficiary's residence, the beneficiary's residence is the Place of Service.
 Subpart I—Payment of SMI Benefits
 10. Section 410.160 is amended by adding paragraphs (b)(7) and (b)(8) to read as follows: § 410.160
  
 
 
 (b) * * * (7) Beginning January 1, 2007, colorectal cancer screening tests as described in § 410.37. (8) Beginning January 1, 2007, ultrasound screening for abdominal aortic aneurysms described in § 410.19.
 PART 411—EXCLUSIONS FROM MEDICARE AND LIMITATIONS ON MEDICARE PAYMENT 11. The authority citation for part 411 is amended to read as follows: Authority:
                            Secs. 1102, 1860D-1 through 1860D-42, 1871, and 1877 of the Social Security Act (42 U.S.C. 1302, 1395w-101 through 1395w-152, 1395hh, and 1395nn). Subpart A—General Exclusions and Exclusion of Particular Services
 12. Section 411.15 is amended by— A. Revising paragraph (a)(1). B. Adding a new paragraph (k)(12). C. Revising paragraph (o). The revisions and addition read as follows: § 411.15
  
 (a) * * * (1) Examinations performed for a purpose other than treatment or diagnosis of a specific illness, symptoms, complaint, or injury, except for screening mammography, colorectal cancer screening tests, screening pelvic exams, prostate cancer screening tests, glaucoma screening exams, initial preventive physical examinations, or ultrasound screening for abdominal aortic aneurysms that meet the criteria specified in paragraphs (k)(6) through (k)(12) of this section. 
 (k) * * * (12) In the case of ultrasound screening for abdominal aortic aneurysms, with the goal of early detection of abdominal aortic aneurysms, subject to the conditions and limitation specified in § 410.19 of this chapter. 
 (o) Experimental or investigational devices, except for certain devices— (1) Categorized by the FDA as a Category A or B device defined in § 405.201(b) of this chapter; and (2) Furnished in accordance with the CMS clinical research policy.
 Subpart J—Financial Relationships Between Physicians and Entities Furnishing Designated Health Services
 13. Section 411.351 is amended by— A. Revising the definition “Centralized building”. B. Revising the definition “Physician in the group practice”. The revisions read as follows: § 411.351
  
 *Centralized building*
                                 means all or part of a building, including, for purposes of this subpart only, a mobile vehicle, van, or trailer that is owned or leased on a full-time basis (that is, 24 hours per day, 7 days per week, for a term of not less than 6 months) by a group practice and that is used exclusively by the group practice. Space in a building or a mobile vehicle, van, or trailer that is shared by more than one group practice, by a group practice and one or more solo practitioners, or by a group practice and another provider or supplier (for example, a diagnostic imaging facility) is not a centralized building for purposes of this subpart. This definition does not preclude a group practice from providing services to other providers or suppliers (for example, purchased diagnostic tests) in the group practice's centralized building. A group practice may have more than one centralized building. A centralized building does not include space that is owned or leased by a group practice if that space is less than 350 square feet. This limitation does not apply to space owned or rented in a building where no more than three group practices own or lease space in the “same building” (as defined in this section) and share the same “physician in the group practice” (as defined in this section). A centralized building does not include space owned or leased by a group practice if equipment needed to perform substantially all (at least 90 percent) of the designated health services furnished in that space in any given calendar year is not permanently located in that space. That is, equipment needed to perform more than 10 percent of the designated health services furnished in that space in a calendar year cannot be temporarily moved into that space from another space in the “same building” or from outside the “same building” (as defined in this section). 
 *Physician in the group practice*
                                 means a member of the group practice, as well as an independent contractor physician during the time the independent contractor is furnishing patient care services (as defined in this section) for the group practice under a contractual arrangement with the group practice to provide services to the group practice's patients in the group practice's facilities. The contract must contain the same restrictions on compensation that apply to members of the group practice under § 411.352(g) (or the contract must fit in the personal services exception in § 411.357(d)), and the independent contractor's arrangement with the group practice and must comply with the reassignment rules at § 424.80(d)(3) of this chapter or section 30.2.9.1 of the CMS Internet-only manual, publication 100-04, Claims Processing Manual, chapter 1 on general billing requirements (as amended or replaced from time to time). Referrals from an independent contractor who is a physician in the group practice are subject to the prohibition on referrals in § 411.353(a), and the group practice is subject to the limitation on billing for those referrals in § 411.353(b).
 PART 414—PAYMENT FOR PART B MEDICAL AND OTHER HEALTH SERVICES 14. The authority citation for part 414 continues to read as follows: Authority:
                            Secs. 1102, 1871, and 1881(b)(1) of the Social Security Act (42 U.S.C. 1302, 1395hh, and 1395rr(b)(1). 15. A new subpart F is added as follows: Subpart F—Payment for New Clinical Diagnostic Laboratory Tests
 414.400
                            Basis and scope.
                            414.402
                            Definitions.
                            414.404
                            [Reserved]
                            414.406
                            Procedures for public consultation for payment for a new clinical diagnostic laboratory test.
                            414.408
                            Payment for a new clinical diagnostic laboratory test.
                            414.410
                            Clinical Diagnostic Laboratory Date of Service for Specimens
 Subpart F—Payment for New Clinical Diagnostic Laboratory Tests § 414.400
  This subpart implements provisions of 1833(h)(8) of the Act procedures for determining the basis for, and amount of, payment for a new clinical diagnostic laboratory test with respect to which a new or substantially revised Healthcare Common Procedure Coding System code is assigned on or after January 1, 2005.
 § 414.402
  For purposes of this subpart— *Substantially Revised Healthcare Common Procedure Coding System Code*
                                     means a code for which there has been a substantive change to the definition of the test or procedure to which the code applies (such as a new 
                                    ( print page 49082)
                                    analyte or a new methodology for measuring an existing analyte specific test).
 § 414.404
 § 414.406
  For a new clinical diagnostic laboratory test that is assigned a new or substantially revised code on or after January 1, 2005, CMS determines the payment after the performance of the following: (a) CMS makes available to the public (through an Internet Web site and other appropriate mechanisms) a list that includes codes for which establishment of a payment amount is being considered for the next calendar year. (b) CMS publishes a 
                                    **Federal Register**
                                     notice of a meeting to receive public comments and recommendations (and data on which recommendations are based) on the appropriate basis, as specified in § 414.408, for establishing payment amounts for the list of codes made available to the public. (c) Not fewer than 30 days after publication of the notice in the 
                                    **Federal Register**
                                    , CMS convenes a meeting that includes representatives of CMS officials involved in determining payment amounts, to receive public comments and recommendations (and data on which the recommendations are based). (d) Taking into account the comments and recommendations (and accompanying data) received at the public meeting, CMS develops and makes available to the public (through an Internet Web site and other appropriate mechanisms)— (1) A list of proposed determinations with respect to the appropriate basis for establishing a payment amount for each code, with an explanation of the reasons for each determination, the data on which the determinations are based, and a request for public written comments within a specified time period on the proposed determination; and (2) A list of final determinations of the payment amounts for tests, with the rationale for each determination, the data on which the determinations are based, and responses to comments and suggestions from the public.
 § 414.408
  For a new clinical diagnostic laboratory test that is assigned a new or substantially revised code on or after January 1, 2005, CMS determines the payment amount based on either of the following: (a) 
                                    *Crosswalking.*
                                     Crosswalking is used if it is determined that a new test is comparable to an existing test, multiple existing test codes, or a portion of an existing test code. (1) CMS assigns to the new test code, the local fee schedule amounts and national limitation amount of the existing test. (2) Payment for the new test code is made at the lesser of the local fee schedule amount or the national limitation amount. (b) 
                                    *Gapfilling.*
                                     Gapfilling is used when no comparable existing test is available. (1) Carrier-specific amounts are established for the new test code for the first year using the following sources of information to determine gapfill amounts, if available: (i) Charges for the test and routine discounts to charges; (ii) Resources required to perform the test; (iii) Payment amounts determined by other payers; and (iv) Charges, payment amounts, and resources required for other tests that may be comparable or otherwise relevant. (2) In the second year, the test code is paid at the national limitation amount, which is the median of the carrier-specific amounts.
 § 414.410
  The date of service for a laboratory test is as follows: (a) Except as provided under paragraph (b) of this section, the date of service of the test shall be the date the specimen was collected. (b)(1) If a specimen is collected over a period that spans two calendar days, then the date of service shall be the date the collection ended. (2) If a specimen was stored for more than 30 calendar days before testing (otherwise known as “an archived specimen”), the date of service of the test shall be the date the specimen was obtained from storage. (3) If a specimen was stored for less than or equal to 30 calendar days from the date it was collected, the date of service of the test must be the date the specimen was obtained from storage if— (i) The test is ordered by the patient's physician at least 14 days following the date of the patient's discharge from the hospital. (ii) The test could not reasonably have been ordered while the patient was hospitalized. (iii) The procedure performed while the beneficiary is a patient of the hospital is for purposes other than collection of the specimen needed for the test. (iv) The test is reasonable and medically necessary.
 Subpart J—Submission of Manufacturer's Average Sales Price Data
 16. Section 414.802 is amended by adding the definition of “Bona fide service fees” in alphabetical order to read as follows: § 414.802
  
 *Bona fide service fees*
                                 means fees paid by a manufacturer to an entity, that represent fair market value for a bona fide, itemized service actually performed on behalf of the manufacturer that the manufacturer would otherwise perform (or contract for) in the absence of the service arrangement, and that are not passed on in whole or in part to a client or customer of an entity, whether or not the entity takes title to the drug. 
 17. Section 414.804 is amended by revising paragraphs (a)(1), (a)(2), (a)(3), and (a)(4). The revisions read as follows:
 § 414.804
  (a) * * * (1) The manufacturer's average sales price for a quarter for a drug represented by a particular 11-digit National Drug Code must be calculated as the manufacturer's sales to all purchasers in the United States for that particular 11-digit National Drug Code (after excluding sales as specified in paragraph (a)(4) of this section and then deducting price concessions as specified in paragraphs (a)(2) and (a)(3) of this section) divided by the total number of units sold by the manufacturer in that quarter (after excluding units associated with sales as specified in paragraph (a)(4) of this section). (2) 
                                *Price concessions.*
                                 (i) In calculating the manufacturer's average sales price, a manufacturer must deduct price concessions. Price concessions include the following types of transactions and items: (A) Volume discounts. (B) Prompt pay discounts. (C) Cash discounts. (D) Free goods that are contingent on any purchase requirement. (E) Chargebacks and rebates (other than rebates under the Medicaid program). (ii) For the purposes of paragraph (a)(2)(i), bona fide services fees are not considered price concessions. (3) To the extent that data on price concessions, as described in paragraph (a)(2) of this section, are available on a 
                                ( print page 49083)
                                lagged basis, the manufacturer must estimate this amount in accordance with the methodology described in this paragraph. (i)(A) For each National Drug Code with at least 12 months of sales (including products for which the manufacturer has redesignated the National Drug Code for the specific product and package size and has 12 months of sales across the prior and current National Drug Codes), after adjusting for exempted sales, the manufacturer calculates a percentage equal to the sum of the price concessions for the most recent 12-month period available associated with sales subject to the average sales price reporting requirement divided by the total in dollars for the sales subject to the average sales price reporting requirement for the same 12-month period. (B) For each National Drug Code with less than 12 months of sales, the calculation described in paragraph (i)(A) of this section is performed for the time period equaling the total number of months of sales. (ii) The manufacturer multiplies the applicable percentage described in paragraph (a)(3)(i)(A) or (a)(3)(i)(B) of this section by the total in dollars for the sales subject to the average sales price reporting requirement (after adjusting for exempted sales) for the quarter being submitted. (The manufacturer must carry a sufficient number of decimal places in the calculation of the price concessions percentage in order to round accurately the net total sales amount for the quarter to the nearest whole dollar.) The result of this multiplication is then subtracted from the total in dollars for the sales subject to the average sales price reporting requirement (after adjusting for exempted sales) for the quarter being submitted. (iii) The manufacturer uses the result of the calculation described in paragraph (a)(3)(ii) of this section as the numerator and the number of units sold in the quarter (after adjusting for exempted sales) as the denominator to calculate the manufacturer's average sales price for the National Drug Code for the quarter being submitted. (iv) 
                                *Example.*
                                 After adjusting for exempted sales, the total lagged price concessions (discounts, rebates, etc.) over the most recent 12-month period available associated with sales for National Drug Code 12345-6789-01 subject to the ASP reporting requirement equal $200,000, and the total in dollars for the sales subject to the average sales price reporting requirement for the same period equals $600,000. The lagged price concessions percentage for this period equals 200,000/600,000 = .33333. The total in dollars for the sales subject to the average sales price reporting requirement for the quarter being reported, after accounting for non-lagged price concessions, equals $50,000 for 10,000 units sold. The manufacturer's average sales price calculation for this National Drug Code for this quarter is: $50,000 − (0.33333 × 50,000) = $33,334 (net total sales amount); $33,334/10,000 = $3.33 (average sales price). (4) 
                                *Exempted sales.*
                                 (i) In calculating the manufacturer's average sales price, a manufacturer must exclude sales that are exempt from the Medicaid best price calculation under sections 1927(c)(1)(C)(i) and 1927(c)(1)(C)(ii)(III) of the Act as limited by section 1927(c)(1)(D) of the Act. (ii) In determining nominal sales exempted under section 1927(c)(1)(C)(ii)(III) of the Act, the manufacturer calculates the average manufacturer price as defined in section 1927(k) of the Act and then identifies sales that are eligible to be considered a nominal sale under section 1927(c)(1)(D) of the Act and are at less than 10 percent of the average manufacturer price. To identify nominal sales, the manufacturer must use the average manufacturer price for the calendar quarter that is the same calendar quarter as the average sales price reporting period. (iii) For exempted sales under section 1927(c)(1)(C)(i) of the Act known on a lagged basis because of chargebacks or rebates, manufacturers must estimate such lagged exempted sales using the ratio methodology specified in this paragraph to exclude lagged exempted sales before accounting for price concessions as specified in paragraphs (a)(2) and (a)(3) of this section. (A) For each National Drug Code with at least 12 months of sales (including products for which the manufacturer has redesignated the Nation Drug Code and has 12 months of sales across the prior and current National Drug Codes), the manufacturer calculates a percentage using the sum of lagged exempted sales (in units) for the most recent 12 month period available as the numerator and the sales (the number of units after non-lagged exempted sales have been subtracted from total sales) for the same 12 month period as the denominator. The result is a rolling average percentage estimate of lagged exempted sales that is applied to the sales (the number of units after non-lagged exempted sales have been subtracted from total sales) for the quarter being submitted. The product that results from the multiplication of the rolling average percentage estimate of lagged exempted sales and the sales for the quarter determines the estimated lagged exempted sales in units to subtract from the denominator of the average sales price calculation. Manufacturers must make a corresponding adjustment to the numerator of the average sales price calculation to ensure that the total in dollars for the reporting quarter does not include revenue related to lagged exempted sales removed from the denominator using the estimation methodology. (B) For National Drug Codes with less than 12 months of sales, the calculation described in paragraph (4)(iii)(A) of this section is calculated based on the sales and exempted sales (lagged and non-lagged) for the period equaling the total number of months of sales. (C) Manufacturers must exclude lagged exempted sales (as calculated using the ratio methodology in paragraph (a)(4)(iii)(A) of this section) from their estimates of lagged price concessions described in paragraph (a)(3) of this section.
 Subpart K—Payment for Drugs and Biologicals Under Part B
 18. Section 414.904 is amended by revising paragraphs (d)(2)(iii) and (d)(3) to read as follows: § 414.904
  
 (d) * * * (2) * * * (iii) Effective for drugs and biologicals furnished in CY 2006 and subsequent calendar years, the payment for such drugs and biologicals furnished in connection with renal dialysis services and separately billed by freestanding and hospital-based renal dialysis facilities not paid on a cost basis is 106 percent of the average sales price. (3) 
                                *Widely available market price and average manufacturer price.*
                                 If the Inspector General finds that the average sales price exceeds the widely available market price or the average manufacturer price by 5 percent or more in CY 2007, the payment limit in the quarter following the transmittal of this information to the Secretary is the lesser of the widely available market price or 103 percent of the average manufacturer price.
 PART 415—SERVICES FURNISHED BY PHYSICIANS IN PROVIDERS, SUPERVISING PHYSICIANS IN TEACHING SETTINGS, AND RESIDENTS IN CERTAIN SETTINGS 19. The authority citation for part 415 continues to read as follows: Authority:
                            Secs. 1102 and 1871 of the Social Security Act (42 U.S.C. 1302 and 1395hh). Subpart C—Part B Carrier Payments for Physician Services to Beneficiaries in Providers
 20. Section 415.130 is amended by revising paragraph (d) to read as follows: § 415.130
  
 (d) 
                                *Physician pathology services furnished by an independent laboratory.*
                                 The technical component of physician pathology services furnished by an independent laboratory to a hospital inpatient or outpatient on or before December 31, 2006 may be paid to the laboratory by the carrier under the physician fee schedule if the Medicare beneficiary is a patient of a covered hospital as defined in paragraph (a)(1) of this section. For services furnished after December 31, 2006, an independent laboratory may not bill the carrier for physician pathology services furnished to a hospital inpatient or outpatient.
 PART 424—CONDITIONS FOR MEDICARE PAYMENT 21. The authority citation for part 424 continues to read as follows: Authority:
                            Secs. 1102 and 1871 of the Social Security Act (42 U.S.C. 1302 and 1395hh). Subpart B—Certification and Plan of Treatment Requirements
 22. Section 424.24 is amended by— A. Redesignating paragraph (f) as paragraph (g). B. Adding a new paragraph (f). The addition reads as follows: § 424.24
  
 (f) 
                                *Blood glucose monitoring in skilled nursing facilities.*
                                 For each blood glucose test furnished to a resident of a skilled nursing facility, the physician must certify that the test is medically necessary. A physician's standing order is not sufficient to order a series of blood glucose tests.
 Subpart F—Limitations on Assignment and Reassignment of Claims
 23. Section 424.80 is amended by— A. Revising the heading of paragraph (d). B. Revising paragraph (d)(2) C. Adding a new paragraph (d)(3). The revisions and addition read as follows: § 424.80
  
 (d) 
                                *Reassignment to an entity under an employer-employee relationship or under a contractual arrangement: Conditions and limitations.*
                                 (1) * * * (2) 
                                *Access to records*. The supplier who furnishes the service has unrestricted access to claims submitted by an entity for services provided by that supplier. This paragraph applies irrespective of whether the supplier is an employee or whether the service is provided under a contractual arrangement. If an entity refuses to provide, upon request, the billing information to the supplier performing the service, the entity's right to receive reassigned benefits may be revoked under § 424.82(c)(3). (3) 
                                *Contractual arrangements for provision of diagnostic test services.*
                                 If a physician or medical group bills for the technical component of a diagnostic test covered under section 1861(s)(3) of the Act and paid for under part 414 of this chapter (other than clinical diagnostic laboratory tests paid under section 1833(a)(2)(D) of the Act, which are subject to the special rules set forth in section 1833(h)(5)(A) of the Act), following a reassignment involving a contractual arrangement with the physician or other supplier who performed the technical component, each of the following conditions must be met: (i) The payment to the billing physician, or medical group, less the applicable deductibles and coinsurance, may not exceed the lowest of the following amounts: (A) The physician or other supplier's net charge to the billing physician or medical group. (B) The billing physician's or medical group's actual charge. (C) The fee schedule amount for the service that would be allowed if the physician or other supplier billed directly. (ii) The physician or medical group billing for the test must identify the physician or other supplier that performed the test and indicate the supplier's net charge for the test. If the physician or medical group billing for the test fails to provide this information, CMS will not make any payment to the physician or medical group billing for the test and the billing physician or medical group can not bill the beneficiary. (iii) In order to bill for the technical component of the service, the physician or medical group must directly perform the professional component of the service. (Catalog of Federal Domestic Assistance Program No. 93.774, Medicare—Supplementary Medical Insurance Program)
 Dated: June 29, 2006. Mark B. McClellan, Administrator,  Centers for Medicare & Medicaid Services.
 Michael O. Leavitt, Secretary.
 Note: These addenda will not appear in the Code of Federal Regulations. Addendum A: Explanation and Use of Addenda B The addenda on the following pages provide various data pertaining to the Medicare fee schedule for physicians' services furnished in 2007. Addendum B contains the RVUs for work, non-facility PE, facility PE, and malpractice expense, and other information for all services included in the PFS. In previous years, we have listed many services in Addendum B that are not paid under the PFS. To avoid publishing as many pages of codes for these services, we are not including clinical laboratory codes or the alphanumeric codes (Healthcare Common Procedure Coding System (HCPCS) codes not included in CPT) not paid under the PFS in Addendum B. Addendum B—2007 Relative Value Units and Related Information Used in Determining Medicare Payments for 2007 This addendum contains the following information for each CPT code and alphanumeric HCPCS code, except for: alphanumeric codes beginning with B (enteral and parenteral therapy), E (durable medical equipment), K (temporary stcodes for nonphysicians' services or items), or L (orthotics); and codes for anesthesiology. Please also note the following: An “NA” in the “Non-facility PE RVUs” column of Addendum B means that CMS has not developed a PE RVU( print page 49085)
                            in the non-facility setting for the service because it is typically performed in the hospital (for example, an open heart surgery is generally performed in the hospital setting and not a physician's office). If there is an “NA” in the non-facility PE RVU column, and the contractor determines that this service can be performed in the non-facility setting, the service will be paid at the facility PE RVU rate.
                        Services that have an “NA” in the “Facility PE RVUs” column of Addendum B are typically not paid using the PFS when provided in a facility setting. These services (which include “incident to” services and the technical portion of diagnostic tests) are generally paid under either the outpatient hospital prospective payment system or bundled into the hospital inpatient prospective payment system payment. 1. 
                            *CPT/HCPCS code.*
                             This is the CPT or alphanumeric HCPCS number for the service. Alphanumeric HCPCS codes are included at the end of this addendum. 2. 
                            *Modifier.*
                             A modifier is shown if there is a technical component (modifier TC) and a professional component (PC) (modifier -26) for the service. If there is a PC and a TC for the service, Addendum B contains three entries for the code. A code for: the global values (both professional and technical); modifier -26 (PC); and, modifier TC. The global service is not designated by a modifier, and physicians must bill using the code without a modifier if the physician furnishes both the PC and the TC of the service. Modifier-53 is shown for a discontinued procedure, for example, a colonoscopy that is not completed. There will be RVUs for a code with this modifier. 3. 
                            *Status indicator.*
                             This indicator shows whether the CPT/HCPCS code is in the PFS and whether it is separately payable if the service is covered. A = Active code. These codes are separately payable under the PFS if covered. There will be RVUs for codes with this status. The presence of an “A” indicator does not mean that Medicare has made a national coverage determination regarding the service. Carriers remain responsible for coverage decisions in the absence of a national Medicare policy. B = Bundled code. Payments for covered services are always bundled into payment for other services not specified. If RVUs are shown, they are not used for Medicare payment. If these services are covered, payment for them is subsumed by the payment for the services to which they are incident (an example is a telephone call from a hospital nurse regarding care of a patient). C = Carriers price the code. Carriers will establish RVUs and payment amounts for these services, generally on an individual case basis following review of documentation, such as an operative report. D* = Deleted/discontinued code. E = Excluded from the PFS by regulation. These codes are for items and services that CMS chose to exclude from the fee schedule payment by regulation. No RVUs are shown, and no payment may be made under the PFS for these codes. Payment for them, when covered, continues under reasonable charge procedures. F = Deleted/discontinued codes. (Code not subject to a 90-day grace period.) These codes are deleted effective with the beginning of the year and are never subject to a grace period. This indicator is no longer effective beginning with the 2005 fee schedule as of January 1, 2005. G = Code not valid for Medicare purposes. Medicare uses another code for reporting of, and payment for, these services. (Codes subject to a 90-day grace period.) This indicator is no longer effective with the 2005 PFS as of January 1, 2005. H* = Deleted modifier. For 2000 and later years, either the TC or PC component shown for the code has been deleted and the deleted component is shown in the database with the H status indicator. I = Not valid for Medicare purposes. Medicare uses another code for the reporting of, and the payment for these services. (Codes not subject to a 90-day grace period.) L = Local codes. Carriers will apply this status to all local codes in effect on January 1, 1998 or subsequently approved by central office for use. Carriers will complete the RVUs and payment amounts for these codes. M = Measurement codes, used for reporting purposes only. There are no RVUs and no payment amounts for these codes. Medicare uses them to aid with performance measurement. No separate payment is made. These codes should be billed with a zero (($0.00) charge and are denied) on the MPFSDB. N = Non-covered service. These codes are noncovered services. Medicare payment may not be made for these codes. If RVUs are shown, they are not used for Medicare payment. R = Restricted coverage. Special coverage instructions apply. If the service is covered and no RVUs are shown, it is carrier-priced. T = There are RVUs for these services, but they are only paid if there are no other services payable under the PFS billed on the same date by the same provider. If any other services payable under the PFS are billed on the same date by the same provider, these services are bundled into the service(s) for which payment is made. X = Statutory exclusion. These codes represent an item or service that is not within the statutory definition of “physicians' services” for PFS payment purposes. No RVUs are shown for these codes, and no payment may be made under the PFS. (Examples are ambulance services and clinical diagnostic laboratory services.) 4. 
                            *Description of code.*
                             This is an abbreviated version of the narrative description of the code. 5. 
                            *Physician work RVUs.*
                             These are the RVUs for the physician work for this service in 2007. As stated in the June 29, 2006 proposed notice, the RVUs for codes with a 10- or 90-day global period reflect the application of the RUC-recommended values for the E/M services that are included as part of the global period for the service. Note: The separate budget neutrality adjustor is 
                            *not*
                             reflected in these physician work RVUs. 6. 
                            *Fully implemented non-facility practice expense RVUs.*
                             These are the fully implemented resource-based PE RVUs for non-facility settings. 7. 
                            *Transitional Non-facility practice expense RVUs.*
                             These are the 2007 resource-based PE RVUs for non-facility settings. 8. 
                            *Fully implemented facility practice expense RVUs.*
                             These are the fully implemented resource-based PE RVUs for facility settings. 9. 
                            *Transitional facility practice expense RVUs.*
                             These are the 2007 resource-based PE RVUs for facility settings. 10. 
                            *Malpractice expense RVUs.*
                             These are the RVUs for the malpractice expense for the service for 2006. 11. 
                            *Non-facility total.*
                             This is the sum of the work, fully implemented non-facility PE, and malpractice expense RVUs. 12. 
                            *Transitional non-facility total.*
                             This is the sum of the work, 2007 transitional non-facility PE, and malpractice expense RVUs. 13. 
                            *Facility total.*
                             This is the sum of the work, fully implemented facility PE, and malpractice expense RVUs. 14. 
                            *Transitional facility total.*
                             This is the sum of the work, 2007 transitional facility PE, and malpractice expense RVUs. 15. 
                            *Global period.*
                             This indicator shows the number of days in the global period for the code (0, 10, or 90 days). 
                            ( print page 49086)
                            An explanation of the alpha codes follows: MMM = Code describes a service furnished in uncomplicated maternity cases including antepartum care, delivery, and postpartum care. The usual global surgical concept does not apply. See the 1999 Physicians' Current Procedural Terminology for specific definitions. XXX = The global concept does not apply. YYY = The global period is to be set by the carrier (for example, unlisted surgery codes). ZZZ = Code related to another service that is always included in the global period of the other service. (Note: Physician work and PE are associated with intra service time and in some instances in the post service time. *Codes with these indicators had a 90-day grace period before January 1, 2005. 
                            ( print page 49087) Addendum B.—Relative Value Units (RVUs) and Related Information Used In Determining Medicare Payments For 2007
CPT1
                                    /HCPCS2
Mod
Status
Description
Physician Work RVUs
Fully Implemented Non-Facility PE RVUs
Year 2007 Transitional Non-Facility PE RVUs
Fully Implemented Facility PE RVUs
Year 2007 Transitional Facility PE RVUs
Mal-Practice RVUs
Fully Implemented Non-Facility Total
Year  2007 Transitional Non-Facility Total
Fully Implemented Facility Total
Year 2007 Transitional Facility Total
Global0003T

C
Cervicography
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0008T

C
Upper gi endoscopy w/suture
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0016T

C
Thermotx choroid vasc lesion
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0017T

C
Photocoagulat macular drusen
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0018T

C
Transcranial magnetic stimul
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0019T

C
Extracorp shock wv tx,ms nos
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0021T

C
Fetal oximetry, trnsvag/cerv
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0024T

C
Transcath cardiac reduction
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0026T

C
Measure remnant lipoproteins
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0027T

C
Endoscopic epidural lysis
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0028T

C
Dexa body composition study
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0029T

C
Magnetic tx for incontinence
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0030T

C
Antiprothrombin antibody
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0031T

C
Speculoscopy
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0032T

C
Speculoscopy w/direct sample
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0041T

C
Detect ur infect agnt w/cpas
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0042T

C
Ct perfusion w/contrast, cbf
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0043T

C
Co expired gas analysis
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0044T

C
Whole body photography
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0045T

C
Whole body photography
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0046T

C
Cath lavage, mammary duct(s
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0047T

C
Cath lavage, mammary duct(s)
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0048T

C
Implant ventricular device
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0049T

C
External circulation assist
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0050T

C
Removal circulation assist
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0051T

C
Implant total heart system
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0052T

C
Replace component heart syst
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0053T

C
Replace component heart syst
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0054T

C
Bone surgery using computer
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0055T

C
Bone surgery using computer
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0056T

C
Bone surgery using computer
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0058T

C
Cryopreservation, ovary tiss
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0059T

C
Cryopreservation, oocyte
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0060T

C
Electrical impedance scan
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0061T

C
Destruction of tumor, breast
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0062T

C
Rep intradisc annulus;1 lev
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0063T

C
Rep intradisc annulus;>1lev
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0064T

C
Spectroscop eval expired gas
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0065T

C
Ocular photoscreen bilat
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0067T

C
Ct colonography;dx
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0067T
26
C
Ct colonography;dx
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0067T
TC
C
Ct colonography;dx
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0068T

C
Interp/rept heart sound
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0069T

C
Analysis only heart sound
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0070T

C
Interp only heart sound
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0071T

C
U/s leiomyomata ablate <200
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0072T

C
U/s leiomyomata ablate >200
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0073T

A
Delivery, comp imrt
0.00
13.02
16.77
NA
NA
0.13
13.15
16.90
NA
NA
XXX0075T

C
Perq stent/chest vert art
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0075T
26
C
Perq stent/chest vert art
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0075T
TC
C
Perq stent/chest vert art
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0076T

C
S&i stent/chest vert art
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0076T
26
C
S&i stent/chest vert art
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0076T
TC
C
S&i stent/chest vert art
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0077T

C
Cereb therm perfusion probe
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0078T

C
Endovasc aort repr w/device
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX( print page 49088)0079T

C
Endovasc visc extnsn repr
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0080T

C
Endovasc aort repr rad s&i
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0081T

C
Endovasc visc extnsn s&i
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0082T

C
Stereotactic rad delivery
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0083T

C
Stereotactic rad tx mngmt
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0084T

C
Temp prostate urethral stent
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0085T

C
Breath test heart reject
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0086T

C
L ventricle fill pressure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0087T

C
Sperm eval hyaluronan
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0088T

C
Rf tongue base vol reduxn
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0089T

C
Actigraphy testing, 3-day
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0090T

C
Cervical artific disc
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0091T

C
Lumbar artific disc
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0092T

C
Artific disc addl
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0093T

C
Cervical artific diskectomy
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0094T

C
Lumbar artific diskectomy
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0095T

C
Artific diskectomy addl
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0096T

C
Rev cervical artific disc
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0097T

C
Rev lumbar artific disc
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0098T

C
Rev artific disc addl
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0099T

C
Implant corneal ring
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0100T

C
Prosth retina receive&gen
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0101T

C
Extracorp shockwv tx,hi enrg
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0102T

C
Extracorp shockwv tx,anesth
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0103T

C
Holotranscobalamin
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0104T

C
At rest cardio gas rebreathe
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0105T

C
Exerc cardio gas rebreathe
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0106T

C
Touch quant sensory test
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0107T

C
Vibrate quant sensory test
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0108T

C
Cool quant sensory test
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0109T

C
Heat quant sensory test
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0110T

C
Nos quant sensory test
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0111T

C
Rbc membranes fatty acids
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0115T

C
Med tx mngmt 15 min
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0116T

C
Med tx mngmt subsqt
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0117T

C
Med tx mngmt addl 15 min
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0120T

C
Fibroadenoma cryoablate, ea
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0123T

C
Scleral fistulization
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0124T

C
Conjunctival drug placement
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0126T

C
Chd risk imt study
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0130T

C
Chron care drug investigatn
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0133T

C
Esophageal implant injexn
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0135T

C
Perq cryoablate renal tumor
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0137T

C
Prostate saturation sampling
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0140T

C
Exhaled breath condensate ph
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0144T

C
CT heart wo dye; qual calc
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0144T
26
C
CT heart wo dye; qual calc
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0144T
TC
C
CT heart wo dye; qual calc
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0145T

C
CT heart w/wo dye funct
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0145T
26
C
CT heart w/wo dye funct
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0145T
TC
C
CT heart w/wo dye funct
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0146T

C
CCTA w/wo dye
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0146T
26
C
CCTA w/wo dye
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0146T
TC
C
CCTA w/wo dye
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0147T

C
CCTA w/wo, quan calcium
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0147T
26
C
CCTA w/wo, quan calcium
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX( print page 49089)0147T
TC
C
CCTA w/wo, quan calcium
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0148T

C
CCTA w/wo, strxr
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0148T
26
C
CCTA w/wo, strxr
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0148T
TC
C
CCTA w/wo, strxr
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0149T

C
CCTA w/wo, strxr quan calc
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0149T
26
C
CCTA w/wo, strxr quan calc
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0149T
TC
C
CCTA w/wo, strxr quan calc
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0150T

C
CCTA w/wo, disease strxr
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0150T
26
C
CCTA w/wo, disease strxr
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0150T
TC
C
CCTA w/wo, disease strxr
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0151T

C
CT heart funct add-on
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0151T
26
C
CT heart funct add-on
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0151T
TC
C
CT heart funct add-on
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0152T

C
Computer chest add-on
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0153T

C
Implant aneur sensor add-on
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0154T

C
Implant aneur sensor study
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0155T

C
Lap ins gastr eltrd for mo
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0156T

C
Lap redo gastr eltrd for mo
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0157T

C
Opn ins gastr eltrd for mo
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0158T

C
Opn redo gastr eltrd for mo
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0159T

C
Computer breast MRI add-on
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
ZZZ0159T
26
C
Computer breast MRI add-on
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
ZZZ0159T
TC
C
Computer breast MRI add-on
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
ZZZ0160T

C
Transcran mag stim planning
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX0161T

C
Transcran mag stim delivery
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX10021

A
Fna w/o image
1.27
2.13
2.15
0.36
0.50
0.10
3.50
3.52
1.73
1.87
XXX10022

A
Fna w/image
1.27
2.13
2.44
0.38
0.41
0.08
3.48
3.79
1.73
1.76
XXX10040

A
Acne surgery
1.18
1.26
1.07
0.93
0.83
0.05
2.49
2.30
2.16
2.06
01010060

A
Drainage of skin abscess
1.17
1.50
1.28
1.08
0.97
0.12
2.79
2.57
2.37
2.26
01010061

A
Drainage of skin abscess
2.40
2.07
1.88
1.51
1.50
0.26
4.73
4.54
4.17
4.16
01010080

A
Drainage of pilonidal cyst
1.17
2.65
2.99
1.09
1.11
0.11
3.93
4.27
2.37
2.39
01010081

A
Drainage of pilonidal cyst
2.45
3.49
3.93
1.44
1.49
0.24
6.18
6.62
4.13
4.18
01010120

A
Remove foreign body
1.22
2.10
2.15
0.94
0.96
0.12
3.44
3.49
2.28
2.30
01010121

A
Remove foreign body
2.69
3.52
3.51
1.65
1.75
0.33
6.54
6.53
4.67
4.77
01010140

A
Drainage of hematoma/fluid
1.53
2.27
1.90
1.29
1.29
0.19
3.99
3.62
3.01
3.01
01010160

A
Puncture drainage of lesion
1.20
1.85
1.66
1.07
1.08
0.14
3.19
3.00
2.41
2.42
01010180

A
Complex drainage, wound
2.25
3.30
3.06
1.83
1.94
0.35
5.90
5.66
4.43
4.54
01011000

A
Debride infected skin
0.60
0.73
0.62
0.16
0.21
0.07
1.40
1.29
0.83
0.88
00011001

A
Debride infected skin add-on
0.30
0.23
0.23
0.08
0.10
0.04
0.57
0.57
0.42
0.44
ZZZ11004

A
Debride genitalia & perineum
10.31
NA
NA
3.04
3.69
0.67
NA
NA
14.02
14.67
00011005

A
Debride abdom wall
13.75
NA
NA
4.06
5.19
0.96
NA
NA
18.77
19.90
00011006

A
Debride genit/per/abdom wall
12.61
NA
NA
3.61
4.54
1.28
NA
NA
17.50
18.43
00011008

A
Remove mesh from abd wall
5.00
NA
NA
1.36
1.86
0.61
NA
NA
6.97
7.47
ZZZ11010

A
Debride skin, fx
4.19
6.77
6.85
2.33
2.55
0.66
11.62
11.70
7.18
7.40
01011011

A
Debride skin/muscle, fx
4.94
7.09
7.89
2.04
2.27
0.74
12.77
13.57
7.72
7.95
00011012

A
Debride skin/muscle/bone, fx
6.87
9.03
11.33
3.12
3.66
1.16
17.06
19.36
11.15
11.69
00011040

A
Debride skin, partial
0.48
0.68
0.56
0.16
0.20
0.06
1.22
1.10
0.70
0.74
00011041

A
Debride skin, full
0.60
0.73
0.68
0.19
0.30
0.10
1.43
1.38
0.89
1.00
00011042

A
Debride skin/tissue
0.80
0.96
0.97
0.25
0.39
0.13
1.89
1.90
1.18
1.32
00011043

A
Debride tissue/muscle
3.00
3.64
3.45
2.71
2.62
0.32
6.96
6.77
6.03
5.94
01011044

A
Debride tissue/muscle/bone
4.05
4.96
4.58
3.67
3.73
0.43
9.44
9.06
8.15
8.21
01011055

R
Trim skin lesion
0.43
0.82
0.63
0.11
0.16
0.05
1.30
1.11
0.59
0.64
00011056

R
Trim skin lesions, 2 to 4
0.61
0.89
0.70
0.16
0.21
0.07
1.57
1.38
0.84
0.89
00011057

R
Trim skin lesions, over 4
0.79
1.00
0.81
0.21
0.28
0.10
1.89
1.70
1.10
1.17
00011100

A
Biopsy, skin lesion
0.81
1.83
1.40
0.37
0.37
0.03
2.67
2.24
1.21
1.21
00011101

A
Biopsy, skin add-on
0.41
0.40
0.35
0.19
0.19
0.02
0.83
0.78
0.62
0.62
ZZZ11200

A
Removal of skin tags
0.77
1.20
1.08
0.88
0.79
0.04
2.01
1.89
1.69
1.60
01011201

A
Remove skin tags add-on
0.29
0.16
0.16
0.11
0.12
0.02
0.47
0.47
0.42
0.43
ZZZ11300

A
Shave skin lesion
0.51
1.17
1.04
0.20
0.21
0.03
1.71
1.58
0.74
0.75
00011301

A
Shave skin lesion
0.85
1.47
1.20
0.37
0.38
0.04
2.36
2.09
1.26
1.27
00011302

A
Shave skin lesion
1.05
1.73
1.41
0.47
0.46
0.05
2.83
2.51
1.57
1.56
00011303

A
Shave skin lesion
1.24
1.97
1.68
0.53
0.52
0.07
3.28
2.99
1.84
1.83
00011305

A
Shave skin lesion
0.67
1.06
0.90
0.20
0.25
0.07
1.80
1.64
0.94
0.99
00011306

A
Shave skin lesion
0.99
1.39
1.17
0.37
0.41
0.07
2.45
2.23
1.43
1.47
00011307

A
Shave skin lesion
1.14
1.66
1.38
0.46
0.48
0.07
2.87
2.59
1.67
1.69
00011308

A
Shave skin lesion
1.41
1.71
1.52
0.50
0.57
0.13
3.25
3.06
2.04
2.11
000( print page 49090)11310

A
Shave skin lesion
0.73
1.35
1.17
0.30
0.32
0.04
2.12
1.94
1.07
1.09
00011311

A
Shave skin lesion
1.05
1.60
1.32
0.46
0.48
0.05
2.70
2.42
1.56
1.58
00011312

A
Shave skin lesion
1.20
1.87
1.53
0.54
0.55
0.06
3.13
2.79
1.80
1.81
00011313

A
Shave skin lesion
1.62
2.13
1.88
0.71
0.72
0.10
3.85
3.60
2.43
2.44
00011400

A
Exc tr-ext b9+marg 0.5 < cm
0.85
1.86
1.96
0.92
0.89
0.06
2.77
2.87
1.83
1.80
01011401

A
Exc tr-ext b9+marg 0.6-1 cm
1.23
2.14
2.07
1.12
1.05
0.10
3.47
3.40
2.45
2.38
01011402

A
Exc tr-ext b9+marg 1.1-2 cm
1.40
2.35
2.25
1.18
1.11
0.13
3.88
3.78
2.71
2.64
01011403

A
Exc tr-ext b9+marg 2.1-3 cm
1.79
2.52
2.42
1.54
1.38
0.17
4.48
4.38
3.50
3.34
01011404

A
Exc tr-ext b9+marg 3.1-4 cm
2.06
2.84
2.74
1.61
1.45
0.21
5.11
5.01
3.88
3.72
01011406

A
Exc tr-ext b9+marg > 4.0 cm
3.45
3.50
3.17
2.07
1.76
0.32
7.27
6.94
5.84
5.53
01011420

A
Exc h-f-nk-sp b9+marg 0.5 <
0.98
1.82
1.78
0.92
0.93
0.09
2.89
2.85
1.99
2.00
01011421

A
Exc h-f-nk-sp b9+marg 0.6-1
1.42
2.18
2.09
1.14
1.12
0.13
3.73
3.64
2.69
2.67
01011422

A
Exc h-f-nk-sp b9+marg 1.1-2
1.63
2.39
2.29
1.50
1.37
0.16
4.18
4.08
3.29
3.16
01011423

A
Exc h-f-nk-sp b9+marg 2.1-3
2.01
2.62
2.59
1.62
1.49
0.20
4.83
4.80
3.83
3.70
01011424

A
Exc h-f-nk-sp b9+marg 3.1-4
2.43
2.94
2.84
1.75
1.64
0.25
5.62
5.52
4.43
4.32
01011426

A
Exc h-f-nk-sp b9+marg > 4 cm
4.02
3.58
3.51
2.29
2.15
0.44
8.04
7.97
6.75
6.61
01011440

A
Exc face-mm b9+marg 0.5 < cm
1.00
1.99
2.15
1.30
1.31
0.08
3.07
3.23
2.38
2.39
01011441

A
Exc face-mm b9+marg 0.6-1 cm
1.48
2.34
2.33
1.52
1.50
0.13
3.95
3.94
3.13
3.11
01011442

A
Exc face-mm b9+marg 1.1-2 cm
1.72
2.59
2.55
1.62
1.58
0.16
4.47
4.43
3.50
3.46
01011443

A
Exc face-mm b9+marg 2.1-3 cm
2.29
2.82
2.89
1.79
1.81
0.22
5.33
5.40
4.30
4.32
01011444

A
Exc face-mm b9+marg 3.1-4 cm
3.14
3.23
3.41
2.04
2.15
0.30
6.67
6.85
5.48
5.59
01011446

A
Exc face-mm b9+marg > 4 cm
4.73
4.01
4.03
2.62
2.73
0.43
9.17
9.19
7.78
7.89
01011450

A
Removal, sweat gland lesion
3.11
5.19
5.07
2.44
2.13
0.34
8.64
8.52
5.89
5.58
09011451

A
Removal, sweat gland lesion
4.32
6.17
6.49
2.79
2.60
0.53
11.02
11.34
7.64
7.45
09011462

A
Removal, sweat gland lesion
2.89
5.33
5.17
2.47
2.13
0.32
8.54
8.38
5.68
5.34
09011463

A
Removal, sweat gland lesion
4.32
6.64
6.78
2.98
2.76
0.54
11.50
11.64
7.84
7.62
09011470

A
Removal, sweat gland lesion
3.63
5.61
5.20
2.70
2.37
0.40
9.64
9.23
6.73
6.40
09011471

A
Removal, sweat gland lesion
4.78
6.48
6.65
2.99
2.82
0.58
11.84
12.01
8.35
8.18
09011600

A
Exc tr-ext mlg+marg 0.5 < cm
1.56
2.71
2.65
1.12
1.01
0.10
4.37
4.31
2.78
2.67
01011601

A
Exc tr-ext mlg+marg 0.6-1 cm
2.00
3.37
2.87
1.47
1.28
0.12
5.49
4.99
3.59
3.40
01011602

A
Exc tr-ext mlg+marg 1.1-2 cm
2.20
3.74
3.05
1.63
1.35
0.12
6.06
5.37
3.95
3.67
01011603

A
Exc tr-ext mlg+marg 2.1-3 cm
2.75
3.95
3.29
1.81
1.45
0.16
6.86
6.20
4.72
4.36
01011604

A
Exc tr-ext mlg+marg 3.1-4 cm
3.10
4.26
3.59
1.88
1.51
0.20
7.56
6.89
5.18
4.81
01011606

A
Exc tr-ext mlg+marg > 4 cm
4.95
5.41
4.40
2.41
1.90
0.36
10.72
9.71
7.72
7.21
01011620

A
Exc h-f-nk-sp mlg+marg 0.5 <
1.57
2.81
2.65
1.17
1.01
0.09
4.47
4.31
2.83
2.67
01011621

A
Exc h-f-nk-sp mlg+marg 0.6-1
2.01
3.42
2.88
1.49
1.30
0.12
5.55
5.01
3.62
3.43
01011622

A
Exc h-f-nk-sp mlg+marg 1.1-2
2.34
3.80
3.17
1.69
1.47
0.14
6.28
5.65
4.17
3.95
01011623

A
Exc h-f-nk-sp mlg+marg 2.1-3
3.04
4.03
3.51
1.90
1.66
0.20
7.27
6.75
5.14
4.90
01011624

A
Exc h-f-nk-sp mlg+marg 3.1-4
3.55
4.35
3.89
2.03
1.84
0.27
8.17
7.71
5.85
5.66
01011626

A
Exc h-f-nk-sp mlg+mar > 4 cm
4.54
4.90
4.70
2.28
2.36
0.45
9.89
9.69
7.27
7.35
01011640

A
Exc face-mm malig+marg 0.5 <
1.60
3.00
2.74
1.26
1.15
0.11
4.71
4.45
2.97
2.86
01011641

A
Exc face-mm malig+marg 0.6-1
2.10
3.55
3.15
1.56
1.54
0.16
5.81
5.41
3.82
3.80
01011642

A
Exc face-mm malig+marg 1.1-2
2.55
3.93
3.53
1.78
1.73
0.19
6.67
6.27
4.52
4.47
01011643

A
Exc face-mm malig+marg 2.1-3
3.35
4.18
3.90
2.04
1.98
0.26
7.79
7.51
5.65
5.59
01011644

A
Exc face-mm malig+marg 3.1-4
4.27
4.95
4.75
2.38
2.43
0.37
9.59
9.39
7.02
7.07
01011646

A
Exc face-mm mlg+marg > 4 cm
6.19
5.76
5.75
3.03
3.36
0.61
12.56
12.55
9.83
10.16
01011719

R
Trim nail(s)
0.17
0.38
0.28
0.04
0.06
0.02
0.57
0.47
0.23
0.25
00011720

A
Debride nail, 1-5
0.32
0.47
0.37
0.08
0.11
0.04
0.83
0.73
0.44
0.47
00011721

A
Debride nail, 6 or more
0.54
0.55
0.47
0.14
0.19
0.07
1.16
1.08
0.75
0.80
00011730

A
Removal of nail plate
1.10
1.35
1.11
0.29
0.40
0.14
2.59
2.35
1.53
1.64
00011732

A
Remove nail plate, add-on
0.57
0.55
0.47
0.15
0.20
0.07
1.19
1.11
0.79
0.84
ZZZ11740

A
Drain blood from under nail
0.37
0.80
0.61
0.44
0.37
0.04
1.21
1.02
0.85
0.78
00011750

A
Removal of nail bed
2.36
2.98
2.37
1.89
1.79
0.22
5.56
4.95
4.47
4.37
01011752

A
Remove nail bed/finger tip
3.42
4.12
3.27
2.82
2.95
0.35
7.89
7.04
6.59
6.72
01011755

A
Biopsy, nail unit
1.31
2.02
1.68
0.76
0.77
0.14
3.47
3.13
2.21
2.22
00011760

A
Repair of nail bed
1.58
3.45
2.83
1.44
1.70
0.21
5.24
4.62
3.23
3.49
010( print page 49091)11762

A
Reconstruction of nail bed
2.89
3.72
3.09
1.69
2.18
0.36
6.97
6.34
4.94
5.43
01011765

A
Excision of nail fold, toe
0.69
2.69
2.01
1.01
0.82
0.08
3.46
2.78
1.78
1.59
01011770

A
Removal of pilonidal lesion
2.61
3.49
3.48
1.53
1.51
0.33
6.43
6.42
4.47
4.45
01011771

A
Removal of pilonidal lesion
5.91
6.72
5.91
3.74
3.42
0.74
13.37
12.56
10.39
10.07
09011772

A
Removal of pilonidal lesion
7.15
8.06
7.64
5.56
5.19
0.89
16.10
15.68
13.60
13.23
09011900

A
Injection into skin lesions
0.52
0.89
0.71
0.24
0.22
0.02
1.43
1.25
0.78
0.76
00011901

A
Added skin lesions injection
0.80
0.98
0.74
0.38
0.36
0.03
1.81
1.57
1.21
1.19
00011920

R
Correct skin color defects
1.61
2.40
3.38
1.12
1.10
0.24
4.25
5.23
2.97
2.95
00011921

R
Correct skin color defects
1.93
2.67
3.64
1.26
1.27
0.29
4.89
5.86
3.48
3.49
00011922

R
Correct skin color defects
0.49
0.93
1.09
0.22
0.24
0.07
1.49
1.65
0.78
0.80
ZZZ11950

R
Therapy for contour defects
0.84
0.86
1.07
0.35
0.38
0.06
1.76
1.97
1.25
1.28
00011951

R
Therapy for contour defects
1.19
1.18
1.41
0.53
0.52
0.11
2.48
2.71
1.83
1.82
00011952

R
Therapy for contour defects
1.69
1.71
1.82
0.81
0.71
0.16
3.56
3.67
2.66
2.56
00011954

R
Therapy for contour defects
1.85
1.76
2.27
0.76
0.87
0.25
3.86
4.37
2.86
2.97
00011960

A
Insert tissue expander(s)
10.85
NA
NA
10.58
10.44
1.31
NA
NA
22.74
22.60
09011970

A
Replace tissue expander
7.80
NA
NA
6.20
6.15
1.05
NA
NA
15.05
15.00
09011971

A
Remove tissue expander(s)
3.13
7.42
8.69
4.01
3.85
0.32
10.87
12.14
7.46
7.30
09011975

N
Insert contraceptive cap
1.48
1.55
1.45
0.34
0.51
0.17
3.20
3.10
1.99
2.16
XXX11976

R
Removal of contraceptive cap
1.78
1.71
1.72
0.47
0.63
0.21
3.70
3.71
2.46
2.62
00011977

N
Removal/reinsert contra cap
3.30
2.00
2.20
0.77
1.14
0.37
5.67
5.87
4.44
4.81
XXX11980

A
Implant hormone pellet(s)
1.48
1.17
1.10
0.55
0.54
0.13
2.78
2.71
2.16
2.15
00011981

A
Insert drug implant device
1.48
1.92
1.76
0.59
0.66
0.12
3.52
3.36
2.19
2.26
XXX11982

A
Remove drug implant device
1.78
2.05
1.97
0.71
0.80
0.17
4.00
3.92
2.66
2.75
XXX11983

A
Remove/insert drug implant
3.30
2.67
2.38
1.34
1.44
0.23
6.20
5.91
4.87
4.97
XXX12001

A
Repair superficial wound(s)
1.70
1.73
1.92
0.72
0.76
0.15
3.58
3.77
2.57
2.61
01012002

A
Repair superficial wound(s)
1.86
1.79
1.98
0.83
0.88
0.17
3.82
4.01
2.86
2.91
01012004

A
Repair superficial wound(s)
2.24
2.07
2.26
0.92
0.99
0.21
4.52
4.71
3.37
3.44
01012005

A
Repair superficial wound(s)
2.86
2.52
2.75
1.06
1.17
0.27
5.65
5.88
4.19
4.30
01012006

A
Repair superficial wound(s)
3.66
3.03
3.30
1.30
1.46
0.35
7.04
7.31
5.31
5.47
01012007

A
Repair superficial wound(s)
4.11
3.40
3.72
1.49
1.73
0.45
7.96
8.28
6.05
6.29
01012011

A
Repair superficial wound(s)
1.76
1.89
2.07
0.75
0.77
0.16
3.81
3.99
2.67
2.69
01012013

A
Repair superficial wound(s)
1.99
2.05
2.22
0.88
0.92
0.18
4.22
4.39
3.05
3.09
01012014

A
Repair superficial wound(s)
2.46
2.28
2.50
0.97
1.04
0.23
4.97
5.19
3.66
3.73
01012015

A
Repair superficial wound(s)
3.19
2.76
3.04
1.11
1.22
0.29
6.24
6.52
4.59
4.70
01012016

A
Repair superficial wound(s)
3.92
3.16
3.45
1.29
1.46
0.37
7.45
7.74
5.58
5.75
01012017

A
Repair superficial wound(s)
4.70
NA
NA
1.48
1.79
0.47
NA
NA
6.65
6.96
01012018

A
Repair superficial wound(s)
5.52
NA
NA
1.96
2.18
0.64
NA
NA
8.12
8.34
01012020

A
Closure of split wound
2.62
3.75
3.80
1.77
1.88
0.30
6.67
6.72
4.69
4.80
01012021

A
Closure of split wound
1.84
1.86
1.83
1.33
1.39
0.24
3.94
3.91
3.41
3.47
01012031

A
Layer closure of wound(s)
2.15
3.82
2.67
1.73
1.15
0.17
6.14
4.99
4.05
3.47
01012032

A
Layer closure of wound(s)
2.47
5.08
4.15
2.21
1.90
0.16
7.71
6.78
4.84
4.53
01012034

A
Layer closure of wound(s)
2.92
4.50
3.52
1.93
1.57
0.25
7.67
6.69
5.10
4.74
01012035

A
Layer closure of wound(s)
3.42
5.25
5.21
2.08
2.13
0.39
9.06
9.02
5.89
5.94
01012036

A
Layer closure of wound(s)
4.04
5.38
5.51
2.22
2.46
0.55
9.97
10.10
6.81
7.05
01012037

A
Layer closure of wound(s)
4.66
5.94
6.05
2.59
2.87
0.66
11.26
11.37
7.91
8.19
01012041

A
Layer closure of wound(s)
2.37
3.77
2.85
1.72
1.28
0.19
6.33
5.41
4.28
3.84
01012042

A
Layer closure of wound(s)
2.74
4.36
3.54
2.04
1.61
0.17
7.27
6.45
4.95
4.52
01012044

A
Layer closure of wound(s)
3.14
5.27
3.73
1.89
1.67
0.27
8.68
7.14
5.30
5.08
01012045

A
Layer closure of wound(s)
3.63
5.07
5.21
2.06
2.23
0.41
9.11
9.25
6.10
6.27
01012046

A
Layer closure of wound(s)
4.24
5.64
6.29
2.27
2.63
0.54
10.42
11.07
7.05
7.41
01012047

A
Layer closure of wound(s)
4.64
6.16
6.30
2.51
2.94
0.58
11.38
11.52
7.73
8.16
01012051

A
Layer closure of wound(s)
2.47
4.01
3.46
1.86
1.55
0.20
6.68
6.13
4.53
4.22
01012052

A
Layer closure of wound(s)
2.77
4.69
3.59
2.44
1.68
0.17
7.63
6.53
5.38
4.62
01012053

A
Layer closure of wound(s)
3.12
5.23
3.74
2.05
1.66
0.23
8.58
7.09
5.40
5.01
01012054

A
Layer closure of wound(s)
3.45
5.30
4.00
2.01
1.73
0.30
9.05
7.75
5.76
5.48
01012055

A
Layer closure of wound(s)
4.42
6.00
4.86
2.10
2.12
0.45
10.87
9.73
6.97
6.99
01012056

A
Layer closure of wound(s)
5.23
6.21
6.62
2.38
2.88
0.59
12.03
12.44
8.20
8.70
01012057

A
Layer closure of wound(s)
5.95
7.45
6.46
2.79
3.51
0.56
13.96
12.97
9.30
10.02
01013100

A
Repair of wound or lesion
3.12
4.32
4.12
2.39
2.32
0.26
7.70
7.50
5.77
5.70
01013101

A
Repair of wound or lesion
3.91
5.79
4.94
2.88
2.73
0.26
9.96
9.11
7.05
6.90
01013102

A
Repair wound/lesion add-on
1.24
1.34
1.21
0.52
0.56
0.13
2.71
2.58
1.89
1.93
ZZZ13120

A
Repair of wound or lesion
3.30
4.46
4.22
2.50
2.38
0.26
8.02
7.78
6.06
5.94
01013121

A
Repair of wound or lesion
4.32
6.47
5.26
3.46
2.96
0.25
11.04
9.83
8.03
7.53
01013122

A
Repair wound/lesion add-on
1.44
1.37
1.48
0.58
0.62
0.15
2.96
3.07
2.17
2.21
ZZZ13131

A
Repair of wound or lesion
3.78
4.86
4.49
2.78
2.71
0.26
8.90
8.53
6.82
6.75
01013132

A
Repair of wound or lesion
6.44
7.64
6.34
4.77
4.31
0.32
14.40
13.10
11.53
11.07
010( print page 49092)13133

A
Repair wound/lesion add-on
2.19
1.82
1.70
0.94
1.01
0.18
4.19
4.07
3.31
3.38
ZZZ13150

A
Repair of wound or lesion
3.80
4.59
4.80
2.64
2.73
0.34
8.73
8.94
6.78
6.87
01013151

A
Repair of wound or lesion
4.44
5.35
4.94
3.11
3.13
0.31
10.10
9.69
7.86
7.88
01013152

A
Repair of wound or lesion
6.32
7.31
6.35
3.77
3.97
0.40
14.03
13.07
10.49
10.69
01013153

A
Repair wound/lesion add-on
2.38
1.98
1.94
0.98
1.10
0.24
4.60
4.56
3.60
3.72
ZZZ13160

A
Late closure of wound
11.76
NA
NA
7.07
7.14
1.54
NA
NA
20.37
20.44
09014000

A
Skin tissue rearrangement
6.76
8.78
8.08
5.92
5.58
0.59
16.13
15.43
13.27
12.93
09014001

A
Skin tissue rearrangement
9.52
10.90
9.78
7.40
7.15
0.82
21.24
20.12
17.74
17.49
09014020

A
Skin tissue rearrangement
7.58
9.79
8.91
6.70
6.57
0.64
18.01
17.13
14.92
14.79
09014021

A
Skin tissue rearrangement
11.10
12.13
10.52
8.40
8.31
0.81
24.04
22.43
20.31
20.22
09014040

A
Skin tissue rearrangement
8.36
9.92
9.08
6.77
7.09
0.62
18.90
18.06
15.75
16.07
09014041

A
Skin tissue rearrangement
12.59
13.17
11.24
9.03
8.76
0.73
26.49
24.56
22.35
22.08
09014060

A
Skin tissue rearrangement
8.99
9.40
8.94
6.94
7.31
0.68
19.07
18.61
16.61
16.98
09014061

A
Skin tissue rearrangement
13.58
14.41
12.30
9.84
9.59
0.76
28.75
26.64
24.18
23.93
09014300

A
Skin tissue rearrangement
13.17
13.26
11.66
9.24
9.19
1.16
27.59
25.99
23.57
23.52
09014350

A
Skin tissue rearrangement
10.73
NA
NA
6.92
7.09
1.34
NA
NA
18.99
19.16
09015000

A
Wound prep, 1st 100 sq cm
3.99
4.24
3.90
1.73
2.07
0.54
8.77
8.43
6.26
6.60
00015001

A
Wound prep, addl 100 sq cm
1.00
0.56
1.15
0.35
0.40
0.14
1.70
2.29
1.49
1.54
ZZZ15040

A
Harvest cultured skin graft
2.00
3.86
4.39
1.03
1.11
0.24
6.10
6.63
3.27
3.35
00015050

A
Skin pinch graft
5.29
7.65
7.10
5.02
5.09
0.57
13.51
12.96
10.88
10.95
09015100

A
Skin splt grft, trnk/arm/leg
9.66
9.84
11.90
6.73
7.55
1.28
20.78
22.84
17.67
18.49
09015101

A
Skin splt grft t/a/l, add-on
1.72
2.51
3.43
0.87
1.10
0.24
4.47
5.39
2.83
3.06
ZZZ15110

A
Epidrm autogrft trnk/arm/leg
10.82
8.92
10.23
6.50
6.88
1.31
21.05
22.36
18.63
19.01
09015111

A
Epidrm autogrft t/a/l add-on
1.85
0.89
1.19
0.64
0.75
0.26
3.00
3.30
2.75
2.86
ZZZ15115

A
Epidrm a-grft face/nck/hf/g
11.13
9.16
9.21
6.68
7.18
1.15
21.44
21.49
18.96
19.46
09015116

A
Epidrm a-grft f/n/hf/g addl
2.50
1.22
1.49
0.89
1.06
0.33
4.05
4.32
3.72
3.89
ZZZ15120

A
Skn splt a-grft fac/nck/hf/g
10.88
11.18
10.84
7.32
7.67
1.16
23.22
22.88
19.36
19.71
09015121

A
Skn splt a-grft f/n/hf/g add
2.67
3.47
4.24
1.33
1.71
0.36
6.50
7.27
4.36
4.74
ZZZ15130

A
Derm autograft, trnk/arm/leg
7.33
8.03
9.40
5.64
6.17
0.97
16.33
17.70
13.94
14.47
09015131

A
Derm autograft t/a/l add-on
1.50
0.70
0.98
0.52
0.61
0.21
2.41
2.69
2.23
2.32
ZZZ15135

A
Derm autograft face/nck/hf/g
10.83
9.41
9.76
6.98
7.84
1.23
21.47
21.82
19.04
19.90
09015136

A
Derm autograft, f/n/hf/g add
1.50
0.68
0.84
0.53
0.64
0.20
2.38
2.54
2.23
2.34
ZZZ15150

A
Cult epiderm grft t/arm/leg
9.24
7.22
8.15
5.92
6.31
1.14
17.60
18.53
16.30
16.69
09015151

A
Cult epiderm grft t/a/l addl
2.00
0.90
1.21
0.70
0.81
0.28
3.18
3.49
2.98
3.09
ZZZ15152

A
Cult epiderm graft t/a/l +%
2.50
1.08
1.44
0.87
1.01
0.35
3.93
4.29
3.72
3.86
ZZZ15155

A
Cult epiderm graft, f/n/hf/g
9.99
7.60
7.77
6.25
6.78
1.05
18.64
18.81
17.29
17.82
09015156

A
Cult epidrm grft f/n/hfg add
2.75
1.18
1.47
0.98
1.18
0.36
4.29
4.58
4.09
4.29
ZZZ15157

A
Cult epiderm grft f/n/hfg +%
3.00
1.37
1.67
1.07
1.28
0.39
4.76
5.06
4.46
4.67
ZZZ15170

A
Acell graft trunk/arms/legs
5.99
3.65
3.79
2.36
2.36
0.55
10.19
10.33
8.90
8.90
09015171

A
Acell graft t/arm/leg add-on
1.55
0.65
0.67
0.51
0.59
0.19
2.39
2.41
2.25
2.33
ZZZ15175

A
Acellular graft, f/n/hf/g
7.99
5.24
5.38
3.75
3.94
0.82
14.05
14.19
12.56
12.75
09015176

A
Acell graft, f/n/hf/g add-on
2.45
1.07
1.10
0.81
0.95
0.29
3.81
3.84
3.55
3.69
ZZZ15200

A
Skin full graft, trunk
8.90
9.85
9.51
6.29
6.22
0.98
19.73
19.39
16.17
16.10
09015201

A
Skin full graft trunk add-on
1.32
2.11
2.45
0.56
0.61
0.19
3.62
3.96
2.07
2.12
ZZZ15220

A
Skin full graft sclp/arm/leg
7.86
10.21
9.44
6.51
6.64
0.84
18.91
18.14
15.21
15.34
09015221

A
Skin full graft add-on
1.19
2.01
2.24
0.50
0.55
0.16
3.36
3.59
1.85
1.90
ZZZ15240

A
Skin full grft face/genit/hf
10.03
11.73
10.58
8.64
8.12
0.92
22.68
21.53
19.59
19.07
09015241

A
Skin full graft add-on
1.86
2.51
2.46
0.79
0.88
0.23
4.60
4.55
2.88
2.97
ZZZ15260

A
Skin full graft een & lips
11.29
12.63
10.82
9.02
8.69
0.69
24.61
22.80
21.00
20.67
09015261

A
Skin full graft add-on
2.23
2.91
2.75
1.12
1.33
0.21
5.35
5.19
3.56
3.77
ZZZ15300

A
Apply skinallogrft, t/arm/lg
4.65
3.36
3.24
2.10
2.20
0.49
8.50
8.38
7.24
7.34
09015301

A
Apply sknallogrft t/a/l addl
1.00
0.47
0.47
0.34
0.39
0.14
1.61
1.61
1.48
1.53
ZZZ15320

A
Apply skin allogrft f/n/hf/g
5.36
3.75
3.65
2.32
2.48
0.58
9.69
9.59
8.26
8.42
09015321

A
Aply sknallogrft f/n/hfg add
1.50
0.68
0.69
0.50
0.57
0.21
2.39
2.40
2.21
2.28
ZZZ15330

A
Aply acell alogrft t/arm/leg
3.99
3.14
3.18
1.90
2.14
0.49
7.62
7.66
6.38
6.62
09015331

A
Aply acell grft t/a/l add-on
1.00
0.46
0.46
0.34
0.39
0.14
1.60
1.60
1.48
1.53
ZZZ( print page 49093)15335

A
Apply acell graft, f/n/hf/g
4.50
3.40
3.45
2.06
2.35
0.55
8.45
8.50
7.11
7.40
09015336

A
Aply acell grft f/n/hf/g add
1.43
0.72
0.70
0.48
0.55
0.20
2.35
2.33
2.11
2.18
ZZZ15340

A
Apply cult skin substitute
3.72
3.79
3.95
2.72
2.74
0.41
7.92
8.08
6.85
6.87
01015341

A
Apply cult skin sub add-on
0.50
0.72
0.64
0.17
0.19
0.06
1.28
1.20
0.73
0.75
ZZZ15360

A
Apply cult derm sub, t/a/l
3.87
4.31
4.43
3.11
3.09
0.43
8.61
8.73
7.41
7.39
09015361

A
Aply cult derm sub t/a/l add
1.15
0.57
0.58
0.38
0.44
0.14
1.86
1.87
1.67
1.73
ZZZ15365

A
Apply cult derm sub f/n/hf/g
4.15
4.35
4.50
3.19
3.19
0.46
8.96
9.11
7.80
7.80
09015366

A
Apply cult derm f/hf/g add
1.45
0.69
0.70
0.48
0.56
0.17
2.31
2.32
2.10
2.18
ZZZ15400

A
Apply skin xenograft, t/a/l
4.32
4.91
4.24
3.69
3.93
0.47
9.70
9.03
8.48
8.72
09015401

A
Apply skn xenogrft t/a/l add
1.00
1.02
1.67
0.35
0.42
0.14
2.16
2.81
1.49
1.56
ZZZ15420

A
Apply skin xgraft, f/n/hf/g
4.83
5.04
4.85
3.86
3.81
0.52
10.39
10.20
9.21
9.16
09015421

A
Apply skn xgrft f/n/hf/g add
1.50
1.20
1.29
0.52
0.60
0.21
2.91
3.00
2.23
2.31
ZZZ15430

A
Apply acellular xenograft
5.75
7.01
6.93
6.44
6.57
0.66
13.42
13.34
12.85
12.98
09015431

C
Apply acellular xgraft add
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
ZZZ15570

A
Form skin pedicle flap
9.94
10.36
11.07
6.46
6.69
1.34
21.64
22.35
17.74
17.97
09015572

A
Form skin pedicle flap
9.88
9.74
9.55
6.62
6.49
1.20
20.82
20.63
17.70
17.57
09015574

A
Form skin pedicle flap
10.48
10.36
10.60
6.89
7.57
1.20
22.04
22.28
18.57
19.25
09015576

A
Form skin pedicle flap
9.18
9.50
9.69
6.39
6.76
0.87
19.55
19.74
16.44
16.81
09015600

A
Skin graft
1.91
5.28
7.02
2.71
2.97
0.27
7.46
9.20
4.89
5.15
09015610

A
Skin graft
2.42
5.55
4.91
3.03
3.32
0.35
8.32
7.68
5.80
6.09
09015620

A
Skin graft
3.57
6.33
7.42
3.80
3.86
0.35
10.25
11.34
7.72
7.78
09015630

A
Skin graft
3.90
6.89
7.00
4.18
4.16
0.34
11.13
11.24
8.42
8.40
09015650

A
Transfer skin pedicle flap
4.59
7.02
7.11
4.20
4.21
0.42
12.03
12.12
9.21
9.22
09015732

A
Muscle-skin graft, head/neck
19.62
14.71
17.21
11.13
11.94
1.99
36.32
38.82
32.74
33.55
09015734

A
Muscle-skin graft, trunk
19.52
15.75
17.52
11.89
12.25
2.61
37.88
39.65
34.02
34.38
09015736

A
Muscle-skin graft, arm
16.86
13.77
17.12
9.95
10.90
2.45
33.08
36.43
29.26
30.21
09015738

A
Muscle-skin graft, leg
18.86
14.03
16.99
10.41
11.39
2.65
35.54
38.50
31.92
32.90
09015740

A
Island pedicle flap graft
11.48
13.10
10.87
9.05
8.46
0.63
25.21
22.98
21.16
20.57
09015750

A
Neurovascular pedicle graft
12.64
NA
NA
8.80
8.98
1.42
NA
NA
22.86
23.04
09015756

A
Free myo/skin flap microvasc
36.64
NA
NA
18.38
20.02
4.61
NA
NA
59.63
61.27
09015757

A
Free skin flap, microvasc
36.85
NA
NA
16.63
20.35
3.89
NA
NA
57.37
61.09
09015758

A
Free fascial flap, microvasc
36.60
NA
NA
16.47
20.30
4.23
NA
NA
57.30
61.13
09015760

A
Composite skin graft
9.61
10.14
10.05
6.84
7.16
0.85
20.60
20.51
17.30
17.62
09015770

A
Derma-fat-fascia graft
8.64
NA
NA
6.56
6.65
1.05
NA
NA
16.25
16.34
09015775

R
Hair transplant punch grafts
3.95
3.50
4.05
1.70
1.40
0.52
7.97
8.52
6.17
5.87
00015776

R
Hair transplant punch grafts
5.53
3.98
5.01
1.61
2.50
0.72
10.23
11.26
7.86
8.75
00015780

A
Abrasion treatment of skin
8.41
11.65
11.55
6.74
7.87
0.67
20.73
20.63
15.82
16.95
09015781

A
Abrasion treatment of skin
4.84
8.43
7.29
5.47
5.39
0.34
13.61
12.47
10.65
10.57
09015782

A
Abrasion treatment of skin
4.31
9.44
9.75
5.43
6.27
0.34
14.09
14.40
10.08
10.92
09015783

A
Abrasion treatment of skin
4.28
7.83
7.11
4.89
4.36
0.28
12.39
11.67
9.45
8.92
09015786

A
Abrasion, lesion, single
2.03
3.76
3.45
1.22
1.30
0.11
5.90
5.59
3.36
3.44
01015787

A
Abrasion, lesions, add-on
0.33
0.83
1.03
0.10
0.15
0.04
1.20
1.40
0.47
0.52
ZZZ15788

R
Chemical peel, face, epiderm
2.09
8.43
7.14
3.66
3.23
0.11
10.63
9.34
5.86
5.43
09015789

R
Chemical peel, face, dermal
4.91
9.00
8.32
5.56
4.99
0.20
14.11
13.43
10.67
10.10
09015792

R
Chemical peel, nonfacial
1.86
6.85
7.03
3.46
4.20
0.13
8.84
9.02
5.45
6.19
09015793

A
Chemical peel, nonfacial
3.73
5.54
6.10
3.27
4.10
0.19
9.46
10.02
7.19
8.02
09015819

A
Plastic surgery, neck
10.37
NA
NA
6.67
7.05
0.97
NA
NA
18.01
18.39
09015820

A
Revision of lower eyelid
6.02
6.47
6.85
5.25
5.48
0.40
12.89
13.27
11.67
11.90
09015821

A
Revision of lower eyelid
6.59
6.73
7.20
5.41
5.64
0.45
13.77
14.24
12.45
12.68
09015822

A
Revision of upper eyelid
4.44
5.34
5.71
4.18
4.41
0.37
10.15
10.52
8.99
9.22
09015823

A
Revision of upper eyelid
8.04
7.59
7.79
6.29
6.40
0.50
16.13
16.33
14.83
14.94
09015831

A
Excise excessive skin tissue
13.57
NA
NA
8.73
8.30
1.75
NA
NA
24.05
23.62
09015832

A
Excise excessive skin tissue
12.57
NA
NA
8.30
8.33
1.66
NA
NA
22.53
22.56
09015833

A
Excise excessive skin tissue
11.62
NA
NA
7.09
7.93
1.49
NA
NA
20.20
21.04
09015834

A
Excise excessive skin tissue
11.89
NA
NA
7.73
7.70
1.61
NA
NA
21.23
21.20
09015835

A
Excise excessive skin tissue
12.71
NA
NA
7.81
7.61
1.60
NA
NA
22.12
21.92
09015836

A
Excise excessive skin tissue
10.33
NA
NA
7.02
6.84
1.34
NA
NA
18.69
18.51
09015837

A
Excise excessive skin tissue
9.30
8.79
8.61
5.78
6.97
1.18
19.27
19.09
16.26
17.45
09015838

A
Excise excessive skin tissue
8.00
NA
NA
4.88
5.77
0.58
NA
NA
13.46
14.35
09015839

A
Excise excessive skin tissue
10.25
9.40
8.97
6.19
6.34
1.22
20.87
20.44
17.66
17.81
09015840

A
Graft for face nerve palsy
14.67
NA
NA
8.55
9.62
1.32
NA
NA
24.54
25.61
09015841

A
Graft for face nerve palsy
25.57
NA
NA
13.05
14.51
2.54
NA
NA
41.16
42.62
09015842

A
Flap for face nerve palsy
40.55
NA
NA
21.01
22.44
4.93
NA
NA
66.49
67.92
09015845

A
Skin and muscle repair, face
13.93
NA
NA
8.77
9.17
0.81
NA
NA
23.51
23.91
09015850

B
Removal of sutures
0.78
1.21
1.47
0.18
0.27
0.05
2.04
2.30
1.01
1.10
XXX15851

A
Removal of sutures
0.86
1.33
1.59
0.24
0.29
0.06
2.25
2.51
1.16
1.21
000( print page 49094)15852

A
Dressing change not for burn
0.86
1.62
1.79
0.25
0.31
0.09
2.57
2.74
1.20
1.26
00015860

A
Test for blood flow in graft
1.95
NA
NA
0.70
0.76
0.27
NA
NA
2.92
2.98
00015920

A
Removal of tail bone ulcer
8.06
NA
NA
5.83
5.62
1.04
NA
NA
14.93
14.72
09015922

A
Removal of tail bone ulcer
10.13
NA
NA
7.01
7.16
1.42
NA
NA
18.56
18.71
09015931

A
Remove sacrum pressure sore
9.89
NA
NA
5.55
5.65
1.25
NA
NA
16.69
16.79
09015933

A
Remove sacrum pressure sore
11.49
NA
NA
7.34
7.72
1.52
NA
NA
20.35
20.73
09015934

A
Remove sacrum pressure sore
13.45
NA
NA
7.61
7.93
1.78
NA
NA
22.84
23.16
09015935

A
Remove sacrum pressure sore
15.45
NA
NA
10.14
10.28
2.09
NA
NA
27.68
27.82
09015936

A
Remove sacrum pressure sore
12.96
NA
NA
7.49
8.04
1.76
NA
NA
22.21
22.76
09015937

A
Remove sacrum pressure sore
14.91
NA
NA
8.96
9.61
2.06
NA
NA
25.93
26.58
09015940

A
Remove hip pressure sore
10.05
NA
NA
5.84
6.09
1.31
NA
NA
17.20
17.45
09015941

A
Remove hip pressure sore
12.13
NA
NA
8.51
9.22
1.66
NA
NA
22.30
23.01
09015944

A
Remove hip pressure sore
12.16
NA
NA
8.24
8.51
1.65
NA
NA
22.05
22.32
09015945

A
Remove hip pressure sore
13.45
NA
NA
9.15
9.52
1.84
NA
NA
24.44
24.81
09015946

A
Remove hip pressure sore
23.72
NA
NA
13.95
14.27
3.16
NA
NA
40.83
41.15
09015950

A
Remove thigh pressure sore
7.83
NA
NA
5.40
5.41
1.04
NA
NA
14.27
14.28
09015951

A
Remove thigh pressure sore
11.30
NA
NA
8.00
7.90
1.49
NA
NA
20.79
20.69
09015952

A
Remove thigh pressure sore
12.03
NA
NA
7.77
7.76
1.60
NA
NA
21.40
21.39
09015953

A
Remove thigh pressure sore
13.27
NA
NA
9.10
9.02
1.79
NA
NA
24.16
24.08
09015956

A
Remove thigh pressure sore
16.46
NA
NA
9.66
10.49
2.21
NA
NA
28.33
29.16
09015958

A
Remove thigh pressure sore
16.42
NA
NA
10.28
10.85
2.25
NA
NA
28.95
29.52
09015999

C
Removal of pressure sore
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY16000

A
Initial treatment of burn(s)
0.89
0.73
0.83
0.24
0.26
0.08
1.70
1.80
1.21
1.23
00016020

A
Dress/debrid p-thick burn, s
0.80
1.11
1.25
0.56
0.58
0.08
1.99
2.13
1.44
1.46
00016025

A
Dress/debrid p-thick burn, m
1.85
1.61
1.72
0.88
0.94
0.19
3.65
3.76
2.92
2.98
00016030

A
Dress/debrid p-thick burn, l
2.08
1.98
2.12
0.96
1.08
0.24
4.30
4.44
3.28
3.40
00016035

A
Incision of burn scab, initi
3.74
NA
NA
1.27
1.50
0.46
NA
NA
5.47
5.70
09016036

A
Escharotomy; addIl incision
1.50
NA
NA
0.49
0.57
0.20
NA
NA
2.19
2.27
ZZZ17000

A
Destroy benign/premlg lesion
0.60
1.36
1.07
0.71
0.58
0.03
1.99
1.70
1.34
1.21
01017003

A
Destroy lesions, 2-14
0.07
0.10
0.11
0.03
0.06
0.01
0.18
0.19
0.11
0.14
ZZZ17004

A
Destroy lesions, 15 or more
1.58
2.23
2.28
1.20
1.49
0.11
3.92
3.97
2.89
3.18
01017106

A
Destruction of skin lesions
4.58
4.56
4.59
3.18
3.29
0.35
9.49
9.52
8.11
8.22
09017107

A
Destruction of skin lesions
9.15
7.08
7.17
5.01
5.34
0.63
16.86
16.95
14.79
15.12
09017108

A
Destruction of skin lesions
13.18
9.19
9.24
6.64
7.41
0.54
22.91
22.96
20.36
21.13
09017110

A
Destruct lesion, 1-14
0.65
1.74
1.65
0.85
0.74
0.05
2.44
2.35
1.55
1.44
01017111

A
Destruct lesion, 15 or more
0.92
2.23
1.81
1.09
0.88
0.05
3.20
2.78
2.06
1.85
01017250

A
Chemical cautery, tissue
0.50
1.32
1.25
0.38
0.35
0.06
1.88
1.81
0.94
0.91
00017260

A
Destruction of skin lesions
0.91
1.37
1.30
0.68
0.67
0.04
2.32
2.25
1.63
1.62
01017261

A
Destruction of skin lesions
1.17
2.42
1.81
1.02
0.88
0.05
3.64
3.03
2.24
2.10
01017262

A
Destruction of skin lesions
1.58
2.74
2.10
1.22
1.07
0.06
4.38
3.74
2.86
2.71
01017263

A
Destruction of skin lesions
1.79
2.97
2.28
1.31
1.15
0.07
4.83
4.14
3.17
3.01
01017264

A
Destruction of skin lesions
1.94
3.17
2.46
1.38
1.19
0.08
5.19
4.48
3.40
3.21
01017266

A
Destruction of skin lesions
2.34
3.42
2.73
1.54
1.30
0.09
5.85
5.16
3.97
3.73
01017270

A
Destruction of skin lesions
1.32
2.36
1.87
1.05
0.92
0.05
3.73
3.24
2.42
2.29
01017271

A
Destruction of skin lesions
1.49
2.58
1.97
1.17
1.03
0.06
4.13
3.52
2.72
2.58
01017272

A
Destruction of skin lesions
1.77
2.88
2.21
1.31
1.16
0.07
4.72
4.05
3.15
3.00
01017273

A
Destruction of skin lesions
2.05
3.12
2.43
1.43
1.27
0.08
5.25
4.56
3.56
3.40
01017274

A
Destruction of skin lesions
2.59
3.50
2.80
1.68
1.50
0.10
6.19
5.49
4.37
4.19
01017276

A
Destruction of skin lesions
3.20
3.78
3.15
1.91
1.74
0.16
7.14
6.51
5.27
5.10
01017280

A
Destruction of skin lesions
1.17
2.29
1.78
0.99
0.86
0.05
3.51
3.00
2.21
2.08
01017281

A
Destruction of skin lesions
1.72
2.65
2.09
1.28
1.14
0.07
4.44
3.88
3.07
2.93
01017282

A
Destruction of skin lesions
2.04
3.04
2.37
1.43
1.29
0.08
5.16
4.49
3.55
3.41
01017283

A
Destruction of skin lesions
2.64
3.45
2.77
1.70
1.54
0.11
6.20
5.52
4.45
4.29
01017284

A
Destruction of skin lesions
3.21
3.86
3.16
1.95
1.80
0.13
7.20
6.50
5.29
5.14
01017286

A
Destruction of skin lesions
4.43
4.28
3.82
2.38
2.43
0.23
8.94
8.48
7.04
7.09
01017304

A
1 stage mohs, up to 5 spec
7.59
11.63
9.09
3.58
3.57
0.30
19.52
16.98
11.47
11.46
000( print page 49095)17305

A
2 stage mohs, up to 5 spec
2.85
6.74
4.60
1.34
1.34
0.11
9.70
7.56
4.30
4.30
00017306

A
3 stage mohs, up to 5 spec
2.85
6.99
4.68
1.33
1.35
0.11
9.95
7.64
4.29
4.31
00017307

A
Mohs addl stage up to 5 spec
2.85
6.74
4.36
1.34
1.36
0.11
9.70
7.32
4.30
4.32
00017310

A
Mohs any stage > 5 spec each
0.95
1.94
1.70
0.45
0.46
0.03
2.92
2.68
1.43
1.44
ZZZ17340

A
Cryotherapy of skin
0.76
0.33
0.36
0.36
0.36
0.05
1.14
1.17
1.17
1.17
01017360

A
Skin peel therapy
1.43
1.38
1.43
0.95
0.89
0.06
2.87
2.92
2.44
2.38
01017999

C
Skin tissue procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY19000

A
Drainage of breast lesion
0.84
1.90
1.96
0.24
0.29
0.08
2.82
2.88
1.16
1.21
00019001

A
Drain breast lesion add-on
0.42
0.24
0.25
0.12
0.14
0.04
0.70
0.71
0.58
0.60
ZZZ19020

A
Incision of breast lesion
3.68
6.67
6.42
3.05
2.77
0.45
10.80
10.55
7.18
6.90
09019030

A
Injection for breast x-ray
1.53
2.62
2.80
0.48
0.50
0.09
4.24
4.42
2.10
2.12
00019100

A
Bx breast percut w/o image
1.27
2.09
2.08
0.33
0.40
0.16
3.52
3.51
1.76
1.83
00019101

A
Biopsy of breast, open
3.18
4.35
4.46
1.77
1.88
0.39
7.92
8.03
5.34
5.45
01019102

A
Bx breast percut w/image
2.00
3.41
3.73
0.61
0.65
0.14
5.55
5.87
2.75
2.79
00019103

A
Bx breast percut w/device
3.69
10.05
11.13
1.09
1.20
0.30
14.04
15.12
5.08
5.19
00019110

A
Nipple exploration
4.29
6.45
5.96
3.28
2.97
0.57
11.31
10.82
8.14
7.83
09019112

A
Excise breast duct fistula
3.66
6.31
6.12
3.17
2.80
0.48
10.45
10.26
7.31
6.94
09019120

A
Removal of breast lesion
5.80
5.12
4.69
3.39
3.14
0.73
11.65
11.22
9.92
9.67
09019125

A
Excision, breast lesion
6.55
5.60
4.99
3.68
3.38
0.80
12.95
12.34
11.03
10.73
09019126

A
Excision, addl breast lesion
2.93
NA
NA
0.76
0.94
0.38
NA
NA
4.07
4.25
ZZZ19140

A
Removal of breast tissue
5.13
8.06
7.37
3.85
3.51
0.69
13.88
13.19
9.67
9.33
09019160

A
Partial mastectomy
5.98
NA
NA
3.64
3.48
0.79
NA
NA
10.41
10.25
09019162

A
P-mastectomy w/ln removal
13.81
NA
NA
6.16
6.29
1.79
NA
NA
21.76
21.89
09019180

A
Removal of breast
15.61
NA
NA
7.07
5.53
1.18
NA
NA
23.86
22.32
09019182

A
Removal of breast
7.72
NA
NA
5.01
4.82
1.04
NA
NA
13.77
13.58
09019200

A
Removal of breast
17.14
NA
NA
8.22
8.03
1.92
NA
NA
27.28
27.09
09019220

A
Removal of breast
17.74
NA
NA
8.69
8.35
2.07
NA
NA
28.50
28.16
09019240

A
Removal of breast
17.84
NA
NA
8.85
8.36
2.12
NA
NA
28.81
28.32
09019260

A
Removal of chest wall lesion
17.53
NA
NA
10.33
10.95
2.13
NA
NA
29.99
30.61
09019271

A
Revision of chest wall
21.73
NA
NA
16.03
17.47
2.62
NA
NA
40.38
41.82
09019272

A
Extensive chest wall surgery
24.68
NA
NA
17.13
18.48
2.99
NA
NA
44.80
46.15
09019290

A
Place needle wire, breast
1.27
2.85
2.85
0.39
0.41
0.07
4.19
4.19
1.73
1.75
00019291

A
Place needle wire, breast
0.63
1.12
1.19
0.20
0.21
0.04
1.79
1.86
0.87
0.88
ZZZ19295

A
Place breast clip, percut
0.00
2.30
2.59
0.00
2.02
0.01
2.31
2.60
0.01
2.03
ZZZ19296

A
Place po breast cath for rad
3.63
85.32
115.4
1.21
1.45
0.36
89.31
119.4
5.20
5.44
00019297

A
Place breast cath for rad
1.72
NA
NA
0.47
0.60
0.17
NA
NA
2.36
2.49
ZZZ19298

A
Place breast rad tube/caths
6.00
22.79
37.32
1.92
2.29
0.43
29.22
43.75
8.35
8.72
00019316

A
Suspension of breast
10.92
NA
NA
7.10
7.41
1.64
NA
NA
19.66
19.97
09019318

A
Reduction of large breast
15.85
NA
NA
9.99
10.88
2.92
NA
NA
28.76
29.65
09019324

A
Enlarge breast
6.59
NA
NA
4.67
4.84
0.84
NA
NA
12.10
12.27
09019325

A
Enlarge breast with implant
8.44
NA
NA
6.46
6.51
1.33
NA
NA
16.23
16.28
09019328

A
Removal of breast implant
6.30
NA
NA
5.03
5.02
0.91
NA
NA
12.24
12.23
09019330

A
Removal of implant material
8.33
NA
NA
6.21
6.08
1.26
NA
NA
15.80
15.67
09019340

A
Immediate breast prosthesis
6.32
NA
NA
2.86
3.05
1.06
NA
NA
10.24
10.43
ZZZ19342

A
Delayed breast prosthesis
12.31
NA
NA
9.01
8.94
1.83
NA
NA
23.15
23.08
09019350

A
Breast reconstruction
8.91
9.93
12.86
6.61
7.03
1.41
20.25
23.18
16.93
17.35
09019355

A
Correct inverted nipple(s)
8.31
7.78
9.63
4.93
4.76
0.92
17.01
18.86
14.16
13.99
09019357

A
Breast reconstruction
20.33
NA
NA
15.50
15.58
2.93
NA
NA
38.76
38.84
09019361

A
Breast reconstruction
20.63
NA
NA
12.36
12.41
2.92
NA
NA
35.91
35.96
09019364

A
Breast reconstruction
42.30
NA
NA
22.88
23.38
6.22
NA
NA
71.40
71.90
09019366

A
Breast reconstruction
21.62
NA
NA
10.10
11.21
3.24
NA
NA
34.96
36.07
09019367

A
Breast reconstruction
26.51
NA
NA
15.33
16.35
4.03
NA
NA
45.87
46.89
09019368

A
Breast reconstruction
33.51
NA
NA
18.23
18.75
5.52
NA
NA
57.26
57.78
09019369

A
Breast reconstruction
30.92
NA
NA
15.98
17.80
4.50
NA
NA
51.40
53.22
09019370

A
Surgery of breast capsule
8.92
NA
NA
6.86
6.89
1.29
NA
NA
17.07
17.10
09019371

A
Removal of breast capsule
10.34
NA
NA
7.74
7.80
1.62
NA
NA
19.70
19.76
09019380

A
Revise breast reconstruction
10.13
NA
NA
7.67
7.69
1.44
NA
NA
19.24
19.26
09019396

A
Design custom breast implant
2.17
4.52
1.94
1.24
1.05
0.30
6.99
4.41
3.71
3.52
00019499

C
Breast surgery procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY20000

A
Incision of abscess
2.12
2.79
2.72
1.53
1.68
0.25
5.16
5.09
3.90
4.05
01020005

A
Incision of deep abscess
3.53
3.72
3.55
2.04
2.20
0.46
7.71
7.54
6.03
6.19
01020100

A
Explore wound, neck
10.31
NA
NA
3.63
4.25
1.21
NA
NA
15.15
15.77
01020101

A
Explore wound, chest
3.22
6.46
6.06
1.52
1.60
0.44
10.12
9.72
5.18
5.26
01020102

A
Explore wound, abdomen
3.93
6.99
7.34
1.85
1.89
0.49
11.41
11.76
6.27
6.31
01020103

A
Explore wound, extremity
5.29
7.72
8.37
2.73
3.23
0.75
13.76
14.41
8.77
9.27
01020150

A
Excise epiphyseal bar
14.54
NA
NA
7.73
7.21
2.03
NA
NA
24.30
23.78
090( print page 49096)20200

A
Muscle biopsy
1.46
3.17
3.07
0.70
0.74
0.23
4.86
4.76
2.39
2.43
00020205

A
Deep muscle biopsy
2.35
3.86
3.88
1.11
1.17
0.33
6.54
6.56
3.79
3.85
00020206

A
Needle biopsy, muscle
0.99
5.25
6.19
0.54
0.61
0.07
6.31
7.25
1.60
1.67
00020220

A
Bone biopsy, trocar/needle
1.27
2.71
4.10
0.65
0.76
0.08
4.06
5.45
2.00
2.11
00020225

A
Bone biopsy, trocar/needle
1.87
13.16
21.63
1.03
1.11
0.22
15.25
23.72
3.12
3.20
00020240

A
Bone biopsy, excisional
3.23
NA
NA
2.07
2.43
0.44
NA
NA
5.74
6.10
01020245

A
Bone biopsy, excisional
8.71
NA
NA
5.79
6.38
1.31
NA
NA
15.81
16.40
01020250

A
Open bone biopsy
5.14
NA
NA
3.74
3.56
1.02
NA
NA
9.90
9.72
01020251

A
Open bone biopsy
5.67
NA
NA
3.91
4.10
1.15
NA
NA
10.73
10.92
01020500

A
Injection of sinus tract
1.23
1.30
2.02
0.85
1.36
0.12
2.65
3.37
2.20
2.71
01020501

A
Inject sinus tract for x-ray
0.76
2.35
2.77
0.24
0.25
0.04
3.15
3.57
1.04
1.05
00020520

A
Removal of foreign body
1.85
2.59
2.83
1.44
1.68
0.21
4.65
4.89
3.50
3.74
01020525

A
Removal of foreign body
3.49
7.09
8.63
2.20
2.52
0.51
11.09
12.63
6.20
6.52
01020526

A
Ther injection, carp tunnel
0.94
0.82
0.93
0.41
0.49
0.13
1.89
2.00
1.48
1.56
00020550

A
Inj tendon sheath/ligament
0.75
0.63
0.69
0.28
0.24
0.09
1.47
1.53
1.12
1.08
00020551

A
Inj tendon origin/insertion
0.75
0.64
0.67
0.29
0.32
0.08
1.47
1.50
1.12
1.15
00020552

A
Inj trigger point, 1/2 muscl
0.66
0.58
0.69
0.25
0.21
0.05
1.29
1.40
0.96
0.92
00020553

A
Inject trigger points, =/> 3
0.75
0.65
0.78
0.27
0.23
0.04
1.44
1.57
1.06
1.02
00020600

A
Drain/inject, joint/bursa
0.66
0.67
0.66
0.31
0.34
0.08
1.41
1.40
1.05
1.08
00020605

A
Drain/inject, joint/bursa
0.68
0.74
0.76
0.33
0.35
0.08
1.50
1.52
1.09
1.11
00020610

A
Drain/inject, joint/bursa
0.79
1.07
0.98
0.40
0.42
0.11
1.97
1.88
1.30
1.32
00020612

A
Aspirate/inj ganglion cyst
0.70
0.70
0.71
0.32
0.35
0.10
1.50
1.51
1.12
1.15
00020615

A
Treatment of bone cyst
2.28
2.72
3.31
1.41
1.73
0.20
5.20
5.79
3.89
4.21
01020650

A
Insert and remove bone pin
2.23
2.51
2.40
1.48
1.53
0.31
5.05
4.94
4.02
4.07
01020660

A
Apply, rem fixation device
2.51
3.39
3.14
1.50
1.58
0.59
6.49
6.24
4.60
4.68
00020661

A
Application of head brace
5.06
NA
NA
6.00
5.18
1.14
NA
NA
12.20
11.38
09020662

A
Application of pelvis brace
6.18
NA
NA
4.85
5.35
0.56
NA
NA
11.59
12.09
09020663

A
Application of thigh brace
5.54
NA
NA
5.14
4.91
0.94
NA
NA
11.62
11.39
09020664

A
Halo brace application
9.78
NA
NA
8.13
7.31
1.74
NA
NA
19.65
18.83
09020665

A
Removal of fixation device
1.31
1.38
1.96
0.97
1.26
0.19
2.88
3.46
2.47
2.76
01020670

A
Removal of support implant
1.74
6.70
10.33
1.68
2.00
0.28
8.72
12.35
3.70
4.02
01020680

A
Removal of support implant
5.86
8.20
8.64
4.10
3.82
0.56
14.62
15.06
10.52
10.24
09020690

A
Apply bone fixation device
3.63
NA
NA
2.27
2.45
0.59
NA
NA
6.49
6.67
09020692

A
Apply bone fixation device
6.40
NA
NA
3.29
3.65
1.05
NA
NA
10.74
11.10
09020693

A
Adjust bone fixation device
5.91
NA
NA
4.54
5.22
0.98
NA
NA
11.43
12.11
09020694

A
Remove bone fixation device
4.15
5.37
6.70
3.56
3.92
0.71
10.23
11.56
8.42
8.78
09020802

A
Replantation, arm, complete
42.16
NA
NA
24.05
21.73
3.81
NA
NA
70.02
67.70
09020805

A
Replant forearm, complete
51.00
NA
NA
25.95
32.22
4.84
NA
NA
81.79
88.06
09020808

A
Replantation hand, complete
62.63
NA
NA
38.79
41.36
6.86
NA
NA
108.28
110.85
09020816

A
Replantation digit, complete
31.64
NA
NA
24.53
34.48
4.52
NA
NA
60.69
70.64
09020822

A
Replantation digit, complete
26.30
NA
NA
22.24
31.50
4.18
NA
NA
52.72
61.98
09020824

A
Replantation thumb, complete
31.64
NA
NA
25.77
33.85
4.61
NA
NA
62.02
70.10
09020827

A
Replantation thumb, complete
27.12
NA
NA
23.90
33.33
3.66
NA
NA
54.68
64.11
09020838

A
Replantation foot, complete
42.42
NA
NA
13.65
20.12
1.12
NA
NA
57.19
63.66
09020900

A
Removal of bone for graft
5.69
9.33
8.66
4.95
5.49
0.94
15.96
15.29
11.58
12.12
09020902

A
Removal of bone for graft
7.90
NA
NA
5.84
6.62
1.30
NA
NA
15.04
15.82
09020910

A
Remove cartilage for graft
5.33
NA
NA
4.62
5.04
0.71
NA
NA
10.66
11.08
09020912

A
Remove cartilage for graft
6.34
NA
NA
4.67
5.51
0.69
NA
NA
11.70
12.54
09020920

A
Removal of fascia for graft
5.36
NA
NA
4.36
4.26
0.66
NA
NA
10.38
10.28
09020922

A
Removal of fascia for graft
6.78
7.52
7.54
4.96
4.89
0.70
15.00
15.02
12.44
12.37
09020924

A
Removal of tendon for graft
6.53
NA
NA
5.00
5.66
1.04
NA
NA
12.57
13.23
09020926

A
Removal of tissue for graft
5.64
NA
NA
4.41
4.67
0.87
NA
NA
10.92
11.18
09020931

A
Spinal bone allograft
1.81
NA
NA
0.69
0.87
0.43
NA
NA
2.93
3.11
ZZZ20937

A
Spinal bone autograft
2.79
NA
NA
1.09
1.36
0.54
NA
NA
4.42
4.69
ZZZ20938

A
Spinal bone autograft
3.02
NA
NA
1.16
1.46
0.64
NA
NA
4.82
5.12
ZZZ20950

A
Fluid pressure, muscle
1.26
4.19
6.18
0.88
0.96
0.20
5.65
7.64
2.34
2.42
000( print page 49097)20955

A
Fibula bone graft, microvasc
39.90
NA
NA
18.08
22.72
4.89
NA
NA
62.87
67.51
09020956

A
Iliac bone graft, microvasc
40.79
NA
NA
20.77
23.75
7.01
NA
NA
68.57
71.55
09020957

A
Mt bone graft, microvasc
42.17
NA
NA
19.43
19.06
7.05
NA
NA
68.65
68.28
09020962

A
Other bone graft, microvasc
39.21
NA
NA
21.28
25.21
6.55
NA
NA
67.04
70.97
09020969

A
Bone/skin graft, microvasc
44.99
NA
NA
20.27
25.04
4.79
NA
NA
70.05
74.82
09020970

A
Bone/skin graft, iliac crest
44.14
NA
NA
20.21
24.09
6.60
NA
NA
70.95
74.83
09020972

A
Bone/skin graft, metatarsal
44.07
NA
NA
17.61
19.84
5.30
NA
NA
66.98
69.21
09020973

A
Bone/skin graft, great toe
46.83
NA
NA
15.05
22.63
5.54
NA
NA
67.42
75.00
09020974

A
Electrical bone stimulation
0.62
0.99
0.77
0.49
0.53
0.11
1.72
1.50
1.22
1.26
00020975

A
Electrical bone stimulation
2.60
NA
NA
1.48
1.65
0.51
NA
NA
4.59
4.76
00020979

A
Us bone stimulation
0.62
0.58
0.75
0.19
0.30
0.09
1.29
1.46
0.90
1.01
00020982

A
Ablate, bone tumor(s) perq
7.27
83.20
103.0
2.62
2.88
0.69
91.16
110.9
10.58
10.84
00020999

C
Musculoskeletal surgery
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY21010

A
Incision of jaw joint
10.82
NA
NA
5.85
6.78
1.11
NA
NA
17.78
18.71
09021015

A
Resection of facial tumor
5.53
NA
NA
4.30
4.83
0.70
NA
NA
10.53
11.06
09021025

A
Excision of bone, lower jaw
10.99
12.48
12.30
8.68
9.18
1.32
24.79
24.61
20.99
21.49
09021026

A
Excision of facial bone(s)
5.46
8.70
8.07
5.84
6.20
0.60
14.76
14.13
11.90
12.26
09021029

A
Contour of face bone lesion
8.20
9.26
9.34
6.27
6.83
0.94
18.40
18.48
15.41
15.97
09021030

A
Excise max/zygoma b9 tumor
4.74
7.18
6.54
4.67
4.94
0.54
12.46
11.82
9.95
10.22
09021031

A
Remove exostosis, mandible
3.24
5.99
5.38
3.51
3.59
0.48
9.71
9.10
7.23
7.31
09021032

A
Remove exostosis, maxilla
3.24
6.07
5.52
3.37
3.48
0.47
9.78
9.23
7.08
7.19
09021034

A
Excise max/zygoma mlg tumor
17.09
13.17
15.23
9.51
11.87
1.71
31.97
34.03
28.31
30.67
09021040

A
Excise mandible lesion
4.74
7.25
6.61
4.67
4.71
0.54
12.53
11.89
9.95
9.99
09021044

A
Removal of jaw bone lesion
12.53
NA
NA
7.48
8.90
1.12
NA
NA
21.13
22.55
09021045

A
Extensive jaw surgery
18.03
NA
NA
10.01
11.77
1.52
NA
NA
29.56
31.32
09021046

A
Remove mandible cyst complex
13.85
NA
NA
11.62
11.83
1.85
NA
NA
27.32
27.53
09021047

A
Excise lwr jaw cyst w/repair
19.71
NA
NA
9.74
12.52
2.12
NA
NA
31.57
34.35
09021048

A
Remove maxilla cyst complex
14.35
NA
NA
11.37
11.94
1.76
NA
NA
27.48
28.05
09021049

A
Excis uppr jaw cyst w/repair
18.96
NA
NA
9.09
12.04
1.59
NA
NA
29.64
32.59
09021050

A
Removal of jaw joint
11.44
NA
NA
8.18
9.13
1.47
NA
NA
21.09
22.04
09021060

A
Remove jaw joint cartilage
10.83
NA
NA
7.52
8.34
1.38
NA
NA
19.73
20.55
09021070

A
Remove coronoid process
8.44
NA
NA
6.15
6.86
1.27
NA
NA
15.86
16.57
09021076

A
Prepare face/oral prosthesis
13.40
7.85
11.23
4.80
8.70
1.99
23.24
26.62
20.19
24.09
01021077

A
Prepare face/oral prosthesis
33.70
18.26
28.06
12.31
22.58
4.55
56.51
66.31
50.56
60.83
09021079

A
Prepare face/oral prosthesis
22.31
13.35
19.46
8.28
14.93
3.15
38.81
44.92
33.74
40.39
09021080

A
Prepare face/oral prosthesis
25.06
15.43
22.23
9.22
16.83
3.74
44.23
51.03
38.02
45.63
09021081

A
Prepare face/oral prosthesis
22.85
14.17
20.27
8.48
15.24
3.20
40.22
46.32
34.53
41.29
09021082

A
Prepare face/oral prosthesis
20.84
14.12
18.04
8.42
13.90
3.11
38.07
41.99
32.37
37.85
09021083

A
Prepare face/oral prosthesis
19.27
14.06
17.61
7.91
12.80
2.88
36.21
39.76
30.06
34.95
09021084

A
Prepare face/oral prosthesis
22.48
15.56
20.71
8.82
15.48
2.18
40.22
45.37
33.48
40.14
09021085

A
Prepare face/oral prosthesis
8.99
6.54
7.85
3.57
5.98
1.27
16.80
18.11
13.83
16.24
01021086

A
Prepare face/oral prosthesis
24.88
12.62
20.96
8.63
16.73
3.71
41.21
49.55
37.22
45.32
09021087

A
Prepare face/oral prosthesis
24.88
12.85
20.67
8.82
16.60
3.44
41.17
48.99
37.14
44.92
09021088

C
Prepare face/oral prosthesis
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
09021089

C
Prepare face/oral prosthesis
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
09021100

A
Maxillofacial fixation
4.46
13.75
12.09
5.05
4.82
0.34
18.55
16.89
9.85
9.62
09021110

A
Interdental fixation
5.70
13.26
10.49
9.89
8.74
0.72
19.68
16.91
16.31
15.16
09021116

A
Injection, jaw joint x-ray
0.81
2.44
3.86
0.22
0.30
0.06
3.31
4.73
1.09
1.17
00021120

A
Reconstruction of chin
4.92
10.02
10.44
6.88
7.34
0.60
15.54
15.96
12.40
12.86
09021121

A
Reconstruction of chin
7.63
10.59
9.95
7.50
7.74
0.90
19.12
18.48
16.03
16.27
09021122

A
Reconstruction of chin
8.51
NA
NA
7.64
8.38
1.07
NA
NA
17.22
17.96
09021123

A
Reconstruction of chin
11.14
NA
NA
10.06
10.62
1.40
NA
NA
22.60
23.16
09021125

A
Augmentation, lower jaw bone
10.60
68.89
58.64
7.04
8.00
0.79
80.28
70.03
18.43
19.39
09021127

A
Augmentation, lower jaw bone
12.16
86.74
53.79
7.70
9.01
1.52
100.4
67.47
21.38
22.69
09021137

A
Reduction of forehead
10.06
NA
NA
6.30
7.37
1.32
NA
NA
17.68
18.75
09021138

A
Reduction of forehead
12.67
NA
NA
8.50
9.27
1.74
NA
NA
22.91
23.68
09021139

A
Reduction of forehead
14.84
NA
NA
8.49
10.42
1.18
NA
NA
24.51
26.44
09021141

A
Reconstruct midface, lefort
19.13
NA
NA
11.47
13.11
2.35
NA
NA
32.95
34.59
09021142

A
Reconstruct midface, lefort
19.84
NA
NA
10.53
12.25
2.38
NA
NA
32.75
34.47
09021143

A
Reconstruct midface, lefort
20.61
NA
NA
8.90
12.96
1.66
NA
NA
31.17
35.23
09021145

A
Reconstruct midface, lefort
23.52
NA
NA
12.75
13.61
2.84
NA
NA
39.11
39.97
09021146

A
Reconstruct midface, lefort
24.42
NA
NA
9.45
13.86
3.09
NA
NA
36.96
41.37
09021147

A
Reconstruct midface, lefort
26.01
NA
NA
13.58
14.68
1.84
NA
NA
41.43
42.53
09021150

A
Reconstruct midface, lefort
25.70
NA
NA
13.25
15.88
2.55
NA
NA
41.50
44.13
09021151

A
Reconstruct midface, lefort
28.76
NA
NA
11.72
20.14
2.30
NA
NA
42.78
51.20
09021154

A
Reconstruct midface, lefort
30.95
NA
NA
21.25
22.65
2.48
NA
NA
54.68
56.08
090( print page 49098)21155

A
Reconstruct midface, lefort
34.88
NA
NA
13.43
21.28
6.64
NA
NA
54.95
62.80
09021159

A
Reconstruct midface, lefort
42.80
NA
NA
15.27
25.63
8.18
NA
NA
66.25
76.61
09021160

A
Reconstruct midface, lefort
46.85
NA
NA
23.11
26.38
4.13
NA
NA
74.09
77.36
09021172

A
Reconstruct orbit/forehead
28.01
NA
NA
13.59
13.71
3.55
NA
NA
45.15
45.27
09021175

A
Reconstruct orbit/forehead
33.37
NA
NA
12.92
16.57
4.83
NA
NA
51.12
54.77
09021179

A
Reconstruct entire forehead
22.47
NA
NA
10.96
13.34
2.80
NA
NA
36.23
38.61
09021180

A
Reconstruct entire forehead
25.40
NA
NA
13.01
14.79
3.48
NA
NA
41.89
43.67
09021181

A
Contour cranial bone lesion
10.14
NA
NA
7.05
7.36
1.32
NA
NA
18.51
18.82
09021182

A
Reconstruct cranial bone
32.39
NA
NA
14.29
17.91
2.80
NA
NA
49.48
53.10
09021183

A
Reconstruct cranial bone
35.51
NA
NA
15.48
19.49
4.47
NA
NA
55.46
59.47
09021184

A
Reconstruct cranial bone
38.43
NA
NA
21.02
21.71
5.70
NA
NA
65.15
65.84
09021188

A
Reconstruction of midface
22.91
NA
NA
14.82
17.86
1.69
NA
NA
39.42
42.46
09021193

A
Reconst lwr jaw w/o graft
18.55
NA
NA
10.06
12.00
2.23
NA
NA
30.84
32.78
09021194

A
Reconst lwr jaw w/graft
21.43
NA
NA
11.45
13.18
2.02
NA
NA
34.90
36.63
09021195

A
Reconst lwr jaw w/o fixation
18.77
NA
NA
13.26
14.43
1.64
NA
NA
33.67
34.84
09021196

A
Reconst lwr jaw w/fixation
20.44
NA
NA
13.20
15.07
2.07
NA
NA
35.71
37.58
09021198

A
Reconstr lwr jaw segment
15.39
NA
NA
11.05
12.29
1.44
NA
NA
27.88
29.12
09021199

A
Reconstr lwr jaw w/advance
16.56
NA
NA
6.79
8.53
1.39
NA
NA
24.74
26.48
09021206

A
Reconstruct upper jaw bone
15.27
NA
NA
11.15
12.26
1.33
NA
NA
27.75
28.86
09021208

A
Augmentation of facial bones
11.03
32.43
24.86
7.71
9.11
1.09
44.55
36.98
19.83
21.23
09021209

A
Reduction of facial bones
7.46
12.33
11.18
7.42
7.91
0.90
20.69
19.54
15.78
16.27
09021210

A
Face bone graft
11.28
43.84
29.61
7.70
8.94
1.30
56.42
42.19
20.28
21.52
09021215

A
Lower jaw bone graft
11.82
86.57
53.05
7.99
9.02
1.53
99.92
66.40
21.34
22.37
09021230

A
Rib cartilage graft
11.00
NA
NA
6.94
7.77
1.29
NA
NA
19.23
20.06
09021235

A
Ear cartilage graft
7.21
9.70
9.81
5.89
6.28
0.61
17.52
17.63
13.71
14.10
09021240

A
Reconstruction of jaw joint
15.65
NA
NA
11.31
11.87
2.24
NA
NA
29.20
29.76
09021242

A
Reconstruction of jaw joint
14.20
NA
NA
10.64
11.29
1.78
NA
NA
26.62
27.27
09021243

A
Reconstruction of jaw joint
23.83
NA
NA
15.77
17.02
3.25
NA
NA
42.85
44.10
09021244

A
Reconstruction of lower jaw
13.23
NA
NA
10.93
11.80
1.25
NA
NA
25.41
26.28
09021245

A
Reconstruction of jaw
12.78
13.37
14.14
7.99
9.39
1.19
27.34
28.11
21.96
23.36
09021246

A
Reconstruction of jaw
12.70
NA
NA
6.67
8.45
1.35
NA
NA
20.72
22.50
09021247

A
Reconstruct lower jaw bone
23.91
NA
NA
13.59
16.41
2.83
NA
NA
40.33
43.15
09021248

A
Reconstruction of jaw
12.46
12.60
12.25
7.51
8.93
1.55
26.61
26.26
21.52
22.94
09021249

A
Reconstruction of jaw
18.49
16.13
16.57
9.94
12.00
2.48
37.10
37.54
30.91
32.97
09021255

A
Reconstruct lower jaw bone
18.00
NA
NA
13.33
15.43
2.38
NA
NA
33.71
35.81
09021256

A
Reconstruction of orbit
17.32
NA
NA
9.98
11.36
1.50
NA
NA
28.80
30.18
09021260

A
Revise eye sockets
17.66
NA
NA
9.51
11.95
0.97
NA
NA
28.14
30.58
09021261

A
Revise eye sockets
33.66
NA
NA
14.88
21.89
3.42
NA
NA
51.96
58.97
09021263

A
Revise eye sockets
30.60
NA
NA
14.17
17.85
2.62
NA
NA
47.39
51.07
09021267

A
Revise eye sockets
20.35
NA
NA
16.14
18.86
1.70
NA
NA
38.19
40.91
09021268

A
Revise eye sockets
26.66
NA
NA
15.74
19.09
3.65
NA
NA
46.05
49.40
09021270

A
Augmentation, cheek bone
10.46
11.17
11.53
5.89
6.91
0.72
22.35
22.71
17.07
18.09
09021275

A
Revision, orbitofacial bones
11.59
NA
NA
7.41
7.97
1.29
NA
NA
20.29
20.85
09021280

A
Revision of eyelid
6.84
NA
NA
5.84
5.90
0.42
NA
NA
13.10
13.16
09021282

A
Revision of eyelid
4.05
NA
NA
4.26
4.43
0.26
NA
NA
8.57
8.74
09021295

A
Revision of jaw muscle/bone
1.78
NA
NA
2.61
2.55
0.16
NA
NA
4.55
4.49
09021296

A
Revision of jaw muscle/bone
4.61
NA
NA
5.46
5.05
0.34
NA
NA
10.41
10.00
09021299

C
Cranio/maxillofacial surgery
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY21300

A
Treatment of skull fracture
0.72
0.28
1.84
0.28
0.27
0.13
1.13
2.69
1.13
1.12
00021310

A
Treatment of nose fracture
0.58
1.97
2.20
0.11
0.14
0.05
2.60
2.83
0.74
0.77
00021315

A
Treatment of nose fracture
1.76
4.46
4.29
1.65
1.82
0.14
6.36
6.19
3.55
3.72
01021320

A
Treatment of nose fracture
1.85
4.05
3.95
1.25
1.53
0.18
6.08
5.98
3.28
3.56
01021325

A
Treatment of nose fracture
4.01
NA
NA
6.72
8.15
0.31
NA
NA
11.04
12.47
09021330

A
Treatment of nose fracture
5.62
NA
NA
7.44
9.14
0.56
NA
NA
13.62
15.32
09021335

A
Treatment of nose fracture
8.85
NA
NA
7.74
9.15
0.74
NA
NA
17.33
18.74
09021336

A
Treat nasal septal fracture
6.46
NA
NA
8.16
9.25
0.55
NA
NA
15.17
16.26
090( print page 49099)21337

A
Treat nasal septal fracture
3.20
5.87
6.06
3.36
3.52
0.28
9.35
9.54
6.84
7.00
09021338

A
Treat nasoethmoid fracture
6.70
NA
NA
9.66
12.93
0.82
NA
NA
17.18
20.45
09021339

A
Treat nasoethmoid fracture
8.33
NA
NA
10.63
13.08
0.96
NA
NA
19.92
22.37
09021340

A
Treatment of nose fracture
11.25
NA
NA
7.36
8.14
1.15
NA
NA
19.76
20.54
09021343

A
Treatment of sinus fracture
14.01
NA
NA
12.51
14.73
1.47
NA
NA
27.99
30.21
09021344

A
Treatment of sinus fracture
21.26
NA
NA
13.04
15.64
2.43
NA
NA
36.73
39.33
09021345

A
Treat nose/jaw fracture
8.77
9.69
9.80
5.98
6.87
0.92
19.38
19.49
15.67
16.56
09021346

A
Treat nose/jaw fracture
11.21
NA
NA
10.76
11.84
1.21
NA
NA
23.18
24.26
09021347

A
Treat nose/jaw fracture
13.29
NA
NA
11.56
15.03
1.47
NA
NA
26.32
29.79
09021348

A
Treat nose/jaw fracture
17.28
NA
NA
6.42
9.94
2.48
NA
NA
26.18
29.70
09021355

A
Treat cheek bone fracture
4.26
5.61
6.08
3.00
3.36
0.34
10.21
10.68
7.60
7.96
01021356

A
Treat cheek bone fracture
4.64
6.78
7.04
3.92
4.39
0.46
11.88
12.14
9.02
9.49
01021360

A
Treat cheek bone fracture
6.95
NA
NA
5.25
5.76
0.74
NA
NA
12.94
13.45
09021365

A
Treat cheek bone fracture
16.42
NA
NA
8.90
10.35
1.69
NA
NA
27.01
28.46
09021366

A
Treat cheek bone fracture
18.36
NA
NA
10.35
11.09
2.49
NA
NA
31.20
31.94
09021385

A
Treat eye socket fracture
9.40
NA
NA
6.90
7.94
0.97
NA
NA
17.27
18.31
09021386

A
Treat eye socket fracture
9.40
NA
NA
5.69
6.73
0.97
NA
NA
16.06
17.10
09021387

A
Treat eye socket fracture
9.94
NA
NA
7.25
8.53
1.08
NA
NA
18.27
19.55
09021390

A
Treat eye socket fracture
11.01
NA
NA
7.05
7.61
0.90
NA
NA
18.96
19.52
09021395

A
Treat eye socket fracture
14.58
NA
NA
7.78
8.71
1.44
NA
NA
23.80
24.73
09021400

A
Treat eye socket fracture
1.40
2.74
2.64
1.98
1.90
0.15
4.29
4.19
3.53
3.45
09021401

A
Treat eye socket fracture
3.51
7.21
7.80
3.10
3.39
0.38
11.10
11.69
6.99
7.28
09021406

A
Treat eye socket fracture
7.25
NA
NA
5.08
5.83
0.73
NA
NA
13.06
13.81
09021407

A
Treat eye socket fracture
8.85
NA
NA
5.89
6.62
0.94
NA
NA
15.68
16.41
09021408

A
Treat eye socket fracture
12.61
NA
NA
7.91
8.64
1.44
NA
NA
21.96
22.69
09021421

A
Treat mouth roof fracture
5.70
12.09
10.02
8.96
8.47
0.73
18.52
16.45
15.39
14.90
09021422

A
Treat mouth roof fracture
8.56
NA
NA
6.79
7.76
0.99
NA
NA
16.34
17.31
09021423

A
Treat mouth roof fracture
10.63
NA
NA
7.28
8.81
1.27
NA
NA
19.18
20.71
09021431

A
Treat craniofacial fracture
7.66
NA
NA
9.34
9.48
0.70
NA
NA
17.70
17.84
09021432

A
Treat craniofacial fracture
8.72
NA
NA
7.18
7.84
0.81
NA
NA
16.71
17.37
09021433

A
Treat craniofacial fracture
26.05
NA
NA
12.51
15.43
2.78
NA
NA
41.34
44.26
09021435

A
Treat craniofacial fracture
19.92
NA
NA
10.77
12.22
1.98
NA
NA
32.67
34.12
09021436

A
Treat craniofacial fracture
29.89
NA
NA
14.38
17.26
3.09
NA
NA
47.36
50.24
09021440

A
Treat dental ridge fracture
3.20
10.31
7.90
7.63
6.53
0.38
13.89
11.48
11.21
10.11
09021445

A
Treat dental ridge fracture
5.94
12.48
10.43
8.61
8.43
0.78
19.20
17.15
15.33
15.15
09021450

A
Treat lower jaw fracture
3.47
10.41
8.14
7.64
7.06
0.33
14.21
11.94
11.44
10.86
09021451

A
Treat lower jaw fracture
5.36
12.93
10.25
9.63
8.71
0.63
18.92
16.24
15.62
14.70
09021452

A
Treat lower jaw fracture
2.23
11.77
12.71
5.89
4.93
0.27
14.27
15.21
8.39
7.43
09021453

A
Treat lower jaw fracture
6.28
14.74
11.74
11.59
10.95
0.74
21.76
18.76
18.61
17.97
09021454

A
Treat lower jaw fracture
7.07
NA
NA
5.64
6.11
0.82
NA
NA
13.53
14.00
09021461

A
Treat lower jaw fracture
8.95
41.23
28.65
12.59
12.64
0.98
51.16
38.58
22.52
22.57
09021462

A
Treat lower jaw fracture
10.65
42.46
31.32
13.17
12.83
1.27
54.38
43.24
25.09
24.75
09021465

A
Treat lower jaw fracture
12.76
NA
NA
8.26
9.42
1.50
NA
NA
22.52
23.68
09021470

A
Treat lower jaw fracture
17.12
NA
NA
10.05
11.53
1.96
NA
NA
29.13
30.61
09021480

A
Reset dislocated jaw
0.61
1.51
1.71
0.18
0.19
0.06
2.18
2.38
0.85
0.86
00021485

A
Reset dislocated jaw
4.48
12.20
9.22
9.18
8.04
0.51
17.19
14.21
14.17
13.03
09021490

A
Repair dislocated jaw
12.59
NA
NA
7.86
9.23
1.96
NA
NA
22.41
23.78
09021495

A
Treat hyoid bone fracture
6.43
NA
NA
9.57
8.71
0.46
NA
NA
16.46
15.60
09021497

A
Interdental wiring
4.35
11.96
9.33
9.14
8.02
0.50
16.81
14.18
13.99
12.87
09021499

C
Head surgery procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY21501

A
Drain neck/chest lesion
3.80
6.42
6.42
3.43
3.72
0.43
10.65
10.65
7.66
7.95
09021502

A
Drain chest lesion
7.35
NA
NA
4.77
5.42
0.97
NA
NA
13.09
13.74
09021510

A
Drainage of bone lesion
5.97
NA
NA
4.71
5.42
0.80
NA
NA
11.48
12.19
09021550

A
Biopsy of neck/chest
2.06
4.28
3.76
1.73
1.72
0.16
6.50
5.98
3.95
3.94
01021555

A
Remove lesion, neck/chest
4.34
5.76
5.57
3.41
3.25
0.56
10.66
10.47
8.31
8.15
09021556

A
Remove lesion, neck/chest
5.56
NA
NA
4.01
4.08
0.65
NA
NA
10.22
10.29
09021557

A
Remove tumor, neck/chest
8.87
NA
NA
4.42
5.12
1.08
NA
NA
14.37
15.07
09021600

A
Partial removal of rib
7.06
NA
NA
5.79
5.75
0.99
NA
NA
13.84
13.80
09021610

A
Partial removal of rib
15.70
NA
NA
8.13
8.68
3.07
NA
NA
26.90
27.45
09021615

A
Removal of rib
10.22
NA
NA
5.46
6.38
1.45
NA
NA
17.13
18.05
09021616

A
Removal of rib and nerves
12.44
NA
NA
7.15
7.80
1.86
NA
NA
21.45
22.10
09021620

A
Partial removal of sternum
7.08
NA
NA
4.88
5.70
0.98
NA
NA
12.94
13.76
09021627

A
Sternal debridement
7.10
NA
NA
5.62
6.13
1.02
NA
NA
13.74
14.25
09021630

A
Extensive sternum surgery
18.90
NA
NA
10.55
11.52
2.58
NA
NA
32.03
33.00
09021632

A
Extensive sternum surgery
19.40
NA
NA
9.62
10.74
2.65
NA
NA
31.67
32.79
09021685

A
Hyoid myotomy & suspension
14.77
NA
NA
7.81
9.43
1.06
NA
NA
23.64
25.26
090( print page 49100)21700

A
Revision of neck muscle
6.18
NA
NA
3.93
4.31
0.32
NA
NA
10.43
10.81
09021705

A
Revision of neck muscle/rib
9.77
NA
NA
4.71
5.36
1.43
NA
NA
15.91
16.56
09021720

A
Revision of neck muscle
5.67
NA
NA
4.32
2.93
0.91
NA
NA
10.90
9.51
09021725

A
Revision of neck muscle
7.04
NA
NA
4.60
5.23
1.21
NA
NA
12.85
13.48
09021740

A
Reconstruction of sternum
17.43
NA
NA
8.77
8.58
2.36
NA
NA
28.56
28.37
09021742

C
Repair stern/nuss w/o scope
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
09021743

C
Repair sternum/nuss w/scope
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
09021750

A
Repair of sternum separation
11.33
NA
NA
5.45
5.95
1.63
NA
NA
18.41
18.91
09021800

A
Treatment of rib fracture
0.96
1.35
1.34
1.42
1.36
0.09
2.40
2.39
2.47
2.41
09021805

A
Treatment of rib fracture
2.75
NA
NA
3.56
3.29
0.38
NA
NA
6.69
6.42
09021810

A
Treatment of rib fracture(s)
6.85
NA
NA
5.27
5.05
0.94
NA
NA
13.06
12.84
09021820

A
Treat sternum fracture
1.28
1.80
1.82
1.87
1.79
0.16
3.24
3.26
3.31
3.23
09021825

A
Treat sternum fracture
7.58
NA
NA
5.46
6.16
1.11
NA
NA
14.15
14.85
09021899

C
Neck/chest surgery procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY21920

A
Biopsy soft tissue of back
2.06
4.32
3.54
1.82
1.56
0.14
6.52
5.74
4.02
3.76
01021925

A
Biopsy soft tissue of back
4.48
5.50
5.25
3.45
3.29
0.60
10.58
10.33
8.53
8.37
09021930

A
Remove lesion, back or flank
4.99
6.05
5.80
3.77
3.49
0.66
11.70
11.45
9.42
9.14
09021935

A
Remove tumor, back
18.29
NA
NA
8.56
9.36
2.47
NA
NA
29.32
30.12
09022010

A
I&d, p-spine, c/t/cerv-thor
12.49
NA
NA
8.06
8.68
1.73
NA
NA
22.28
22.90
09022015

A
I&d, p-spine, l/s/ls
12.38
NA
NA
8.02
8.62
1.71
NA
NA
22.11
22.71
09022100

A
Remove part of neck vertebra
10.72
NA
NA
8.01
7.65
2.13
NA
NA
20.86
20.50
09022101

A
Remove part, thorax vertebra
10.80
NA
NA
7.94
7.80
1.90
NA
NA
20.64
20.50
09022102

A
Remove part, lumbar vertebra
10.80
NA
NA
7.24
7.89
1.87
NA
NA
19.91
20.56
09022103

A
Remove extra spine segment
2.34
NA
NA
0.89
1.13
0.44
NA
NA
3.67
3.91
ZZZ22110

A
Remove part of neck vertebra
13.72
NA
NA
9.09
9.14
2.76
NA
NA
25.57
25.62
09022112

A
Remove part, thorax vertebra
13.79
NA
NA
8.97
9.20
2.52
NA
NA
25.28
25.51
09022114

A
Remove part, lumbar vertebra
13.79
NA
NA
9.08
9.21
2.63
NA
NA
25.50
25.63
09022116

A
Remove extra spine segment
2.32
NA
NA
0.87
1.10
0.50
NA
NA
3.69
3.92
ZZZ22210

A
Revision of neck spine
25.03
NA
NA
14.74
15.24
5.44
NA
NA
45.21
45.71
09022212

A
Revision of thorax spine
20.64
NA
NA
12.49
13.08
3.90
NA
NA
37.03
37.62
09022214

A
Revision of lumbar spine
20.67
NA
NA
12.59
13.51
3.91
NA
NA
37.17
38.09
09022216

A
Revise, extra spine segment
6.03
NA
NA
2.37
2.94
1.29
NA
NA
9.69
10.26
ZZZ22220

A
Revision of neck spine
22.59
NA
NA
13.42
13.57
5.06
NA
NA
41.07
41.22
09022222

A
Revision of thorax spine
22.74
NA
NA
12.19
11.40
4.12
NA
NA
39.05
38.26
09022224

A
Revision of lumbar spine
22.74
NA
NA
13.17
13.96
4.18
NA
NA
40.09
40.88
09022226

A
Revise, extra spine segment
6.03
NA
NA
2.15
2.86
1.29
NA
NA
9.47
10.18
ZZZ22305

A
Treat spine process fracture
2.05
2.16
2.27
1.81
1.89
0.39
4.60
4.71
4.25
4.33
09022310

A
Treat spine fracture
3.61
2.99
2.85
2.50
2.39
0.50
7.10
6.96
6.61
6.50
09022315

A
Treat spine fracture
9.83
9.81
9.71
7.39
7.35
1.85
21.49
21.39
19.07
19.03
09022318

A
Treat odontoid fx w/o graft
22.46
NA
NA
13.25
13.35
5.28
NA
NA
40.99
41.09
09022319

A
Treat odontoid fx w/graft
25.07
NA
NA
14.00
14.53
6.03
NA
NA
45.10
45.63
09022325

A
Treat spine fracture
19.52
NA
NA
12.03
12.06
3.87
NA
NA
35.42
35.45
09022326

A
Treat neck spine fracture
20.56
NA
NA
12.13
12.56
4.42
NA
NA
37.11
37.54
09022327

A
Treat thorax spine fracture
20.42
NA
NA
12.07
12.29
3.98
NA
NA
36.47
36.69
09022328

A
Treat each add spine fx
4.60
NA
NA
1.80
2.15
0.94
NA
NA
7.34
7.69
ZZZ22505

A
Manipulation of spine
1.87
NA
NA
1.06
0.97
0.36
NA
NA
3.29
3.20
01022520

A
Percut vertebroplasty thor
9.15
44.71
57.42
4.39
4.92
1.71
55.57
68.28
15.25
15.78
01022521

A
Percut vertebroplasty lumb
8.58
45.98
53.47
4.20
4.76
1.60
56.16
63.65
14.38
14.94
01022522

A
Percut vertebroplasty addIl
4.30
NA
NA
1.41
1.61
0.82
NA
NA
6.53
6.73
ZZZ22523

A
Percut kyphoplasty, thor
9.19
NA
NA
4.75
5.61
1.71
NA
NA
15.65
16.51
01022524

A
Percut kyphoplasty, lumbar
8.79
NA
NA
4.60
5.42
1.60
NA
NA
14.99
15.81
01022525

A
Percut kyphoplasty, add-on
4.47
NA
NA
1.68
2.12
0.82
NA
NA
6.97
7.41
ZZZ22532

A
Lat thorax spine fusion
25.73
NA
NA
13.79
14.56
4.34
NA
NA
43.86
44.63
09022533

A
Lat lumbar spine fusion
24.53
NA
NA
13.43
13.55
3.15
NA
NA
41.11
41.23
09022534

A
Lat thor/lumb, addIl seg
5.99
NA
NA
2.31
2.85
1.25
NA
NA
9.55
10.09
ZZZ22548

A
Neck spine fusion
26.78
NA
NA
15.08
15.62
5.59
NA
NA
47.45
47.99
090( print page 49101)22554

A
Neck spine fusion
17.48
NA
NA
10.74
11.94
4.45
NA
NA
32.67
33.87
09022556

A
Thorax spine fusion
24.42
NA
NA
13.07
14.32
4.34
NA
NA
41.83
43.08
09022558

A
Lumbar spine fusion
23.25
NA
NA
11.53
12.85
3.15
NA
NA
37.93
39.25
09022585

A
Additional spinal fusion
5.52
NA
NA
2.09
2.62
1.25
NA
NA
8.86
9.39
ZZZ22590

A
Spine & skull spinal fusion
21.48
NA
NA
13.10
13.27
4.78
NA
NA
39.36
39.53
09022595

A
Neck spinal fusion
20.36
NA
NA
12.61
12.78
4.40
NA
NA
37.37
37.54
09022600

A
Neck spine fusion
17.12
NA
NA
11.28
11.21
3.72
NA
NA
32.12
32.05
09022610

A
Thorax spine fusion
17.00
NA
NA
10.88
11.28
3.52
NA
NA
31.40
31.80
09022612

A
Lumbar spine fusion
22.50
NA
NA
12.92
13.88
4.46
NA
NA
39.88
40.84
09022614

A
Spine fusion, extra segment
6.43
NA
NA
2.49
3.14
1.38
NA
NA
10.30
10.95
ZZZ22630

A
Lumbar spine fusion
21.81
NA
NA
12.64
13.36
4.72
NA
NA
39.17
39.89
09022632

A
Spine fusion, extra segment
5.22
NA
NA
2.01
2.50
1.16
NA
NA
8.39
8.88
ZZZ22800

A
Fusion of spine
19.22
NA
NA
11.15
12.37
3.75
NA
NA
34.12
35.34
09022802

A
Fusion of spine
31.83
NA
NA
16.17
18.74
6.15
NA
NA
54.15
56.72
09022804

A
Fusion of spine
37.22
NA
NA
18.20
21.57
6.98
NA
NA
62.40
65.77
09022808

A
Fusion of spine
27.23
NA
NA
13.85
15.69
4.92
NA
NA
46.00
47.84
09022810

A
Fusion of spine
31.22
NA
NA
14.93
17.50
5.13
NA
NA
51.28
53.85
09022812

A
Fusion of spine
33.90
NA
NA
16.75
19.23
5.28
NA
NA
55.93
58.41
09022818

A
Kyphectomy, 1-2 segments
34.12
NA
NA
16.65
18.32
6.45
NA
NA
57.22
58.89
09022819

A
Kyphectomy, 3 or more
39.10
NA
NA
19.45
19.90
7.65
NA
NA
66.20
66.65
09022830

A
Exploration of spinal fusion
11.07
NA
NA
7.11
7.75
2.29
NA
NA
20.47
21.11
09022840

A
Insert spine fixation device
12.52
NA
NA
4.84
6.08
2.78
NA
NA
20.14
21.38
ZZZ22842

A
Insert spine fixation device
12.56
NA
NA
4.86
6.09
2.74
NA
NA
20.16
21.39
ZZZ22843

A
Insert spine fixation device
13.44
NA
NA
5.26
6.27
2.85
NA
NA
21.55
22.56
ZZZ22844

A
Insert spine fixation device
16.42
NA
NA
6.47
8.18
3.18
NA
NA
26.07
27.78
ZZZ22845

A
Insert spine fixation device
11.94
NA
NA
4.55
5.69
2.85
NA
NA
19.34
20.48
ZZZ22846

A
Insert spine fixation device
12.40
NA
NA
4.72
5.93
2.95
NA
NA
20.07
21.28
ZZZ22847

A
Insert spine fixation device
13.78
NA
NA
5.34
6.60
2.99
NA
NA
22.11
23.37
ZZZ22848

A
Insert pelv fixation device
5.99
NA
NA
2.37
2.98
1.15
NA
NA
9.51
10.12
ZZZ22849

A
Reinsert spinal fixation
19.02
NA
NA
10.28
11.37
3.89
NA
NA
33.19
34.28
09022850

A
Remove spine fixation device
9.69
NA
NA
6.51
6.87
2.04
NA
NA
18.24
18.60
09022851

A
Apply spine prosth device
6.70
NA
NA
2.58
3.17
1.49
NA
NA
10.77
11.36
ZZZ22852

A
Remove spine fixation device
9.24
NA
NA
6.23
6.65
1.89
NA
NA
17.36
17.78
09022855

A
Remove spine fixation device
15.71
NA
NA
9.28
9.57
3.51
NA
NA
28.50
28.79
09022899

C
Spine surgery procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY22900

A
Remove abdominal wall lesion
6.09
NA
NA
3.56
3.31
0.76
NA
NA
10.41
10.16
09022999

C
Abdomen surgery procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY23000

A
Removal of calcium deposits
4.35
7.83
8.36
3.68
4.24
0.68
12.86
13.39
8.71
9.27
09023020

A
Release shoulder joint
9.16
NA
NA
6.51
7.30
1.54
NA
NA
17.21
18.00
09023030

A
Drain shoulder lesion
3.42
6.32
7.12
2.41
2.78
0.57
10.31
11.11
6.40
6.77
01023031

A
Drain shoulder bursa
2.74
6.53
7.53
2.23
2.60
0.46
9.73
10.73
5.43
5.80
01023035

A
Drain shoulder bone lesion
8.96
NA
NA
7.02
7.96
1.47
NA
NA
17.45
18.39
09023040

A
Exploratory shoulder surgery
9.55
NA
NA
6.80
7.60
1.60
NA
NA
17.95
18.75
09023044

A
Exploratory shoulder surgery
7.41
NA
NA
5.59
6.22
1.24
NA
NA
14.24
14.87
09023065

A
Biopsy shoulder tissues
2.27
2.91
2.59
1.70
1.64
0.20
5.38
5.06
4.17
4.11
01023066

A
Biopsy shoulder tissues
4.15
7.72
7.68
3.60
3.89
0.63
12.50
12.46
8.38
8.67
09023075

A
Removal of shoulder lesion
2.39
3.74
3.68
1.74
1.77
0.34
6.47
6.41
4.47
4.50
01023076

A
Removal of shoulder lesion
7.68
NA
NA
5.33
5.50
1.13
NA
NA
14.14
14.31
09023077

A
Remove tumor of shoulder
17.98
NA
NA
9.81
10.11
2.33
NA
NA
30.12
30.42
09023100

A
Biopsy of shoulder joint
6.02
NA
NA
5.15
5.53
1.04
NA
NA
12.21
12.59
09023101

A
Shoulder joint surgery
5.57
NA
NA
4.58
5.14
0.96
NA
NA
11.11
11.67
09023105

A
Remove shoulder joint lining
8.28
NA
NA
6.12
6.87
1.42
NA
NA
15.82
16.57
09023106

A
Incision of collarbone joint
5.95
NA
NA
4.62
5.43
0.99
NA
NA
11.56
12.37
09023107

A
Explore treat shoulder joint
8.67
NA
NA
6.27
7.11
1.49
NA
NA
16.43
17.27
09023120

A
Partial removal, collar bone
7.16
NA
NA
5.50
6.22
1.23
NA
NA
13.89
14.61
09023125

A
Removal of collar bone
9.44
NA
NA
6.38
7.27
1.62
NA
NA
17.44
18.33
09023130

A
Remove shoulder bone, part
7.54
NA
NA
6.10
6.87
1.30
NA
NA
14.94
15.71
09023140

A
Removal of bone lesion
6.94
NA
NA
4.82
5.12
1.08
NA
NA
12.84
13.14
09023145

A
Removal of bone lesion
9.20
NA
NA
5.83
7.04
1.49
NA
NA
16.52
17.73
09023146

A
Removal of bone lesion
7.88
NA
NA
5.99
6.83
1.35
NA
NA
15.22
16.06
09023150

A
Removal of humerus lesion
8.71
NA
NA
6.06
6.71
1.32
NA
NA
16.09
16.74
09023155

A
Removal of humerus lesion
10.63
NA
NA
7.36
8.09
1.80
NA
NA
19.79
20.52
09023156

A
Removal of humerus lesion
8.91
NA
NA
6.42
7.14
1.50
NA
NA
16.83
17.55
09023170

A
Remove collar bone lesion
7.03
NA
NA
5.08
5.79
1.12
NA
NA
13.23
13.94
09023172

A
Remove shoulder blade lesion
7.13
NA
NA
4.98
5.96
1.01
NA
NA
13.12
14.10
09023174

A
Remove humerus lesion
9.80
NA
NA
7.30
8.10
1.65
NA
NA
18.75
19.55
090( print page 49102)23180

A
Remove collar bone lesion
8.76
NA
NA
7.08
8.51
1.47
NA
NA
17.31
18.74
09023182

A
Remove shoulder blade lesion
8.38
NA
NA
6.91
8.14
1.37
NA
NA
16.66
17.89
09023184

A
Remove humerus lesion
9.67
NA
NA
7.55
8.87
1.63
NA
NA
18.85
20.17
09023190

A
Partial removal of scapula
7.29
NA
NA
5.43
5.99
1.17
NA
NA
13.89
14.45
09023195

A
Removal of head of humerus
10.16
NA
NA
6.80
7.50
1.70
NA
NA
18.66
19.36
09023200

A
Removal of collar bone
12.60
NA
NA
7.51
8.42
1.93
NA
NA
22.04
22.95
09023210

A
Removal of shoulder blade
13.07
NA
NA
8.24
8.80
2.02
NA
NA
23.33
23.89
09023220

A
Partial removal of humerus
15.26
NA
NA
9.09
10.39
2.48
NA
NA
26.83
28.13
09023221

A
Partial removal of humerus
18.31
NA
NA
6.67
10.46
3.05
NA
NA
28.03
31.82
09023222

A
Partial removal of humerus
25.36
NA
NA
13.58
15.23
3.94
NA
NA
42.88
44.53
09023330

A
Remove shoulder foreign body
1.85
3.37
3.60
1.53
1.79
0.24
5.46
5.69
3.62
3.88
01023331

A
Remove shoulder foreign body
7.43
NA
NA
5.89
6.57
1.27
NA
NA
14.59
15.27
09023332

A
Remove shoulder foreign body
12.14
NA
NA
8.03
9.00
2.02
NA
NA
22.19
23.16
09023350

A
Injection for shoulder x-ray
1.00
2.72
3.28
0.32
0.33
0.06
3.78
4.34
1.38
1.39
00023395

A
Muscle transfer,shoulder/arm
18.19
NA
NA
11.26
12.46
2.93
NA
NA
32.38
33.58
09023397

A
Muscle transfers
16.53
NA
NA
9.70
10.95
2.73
NA
NA
28.96
30.21
09023400

A
Fixation of shoulder blade
13.64
NA
NA
8.57
9.70
2.29
NA
NA
24.50
25.63
09023405

A
Incision of tendon & muscle
8.36
NA
NA
5.97
6.68
1.45
NA
NA
15.78
16.49
09023406

A
Incise tendon(s) & muscle(s)
10.83
NA
NA
6.95
7.99
1.87
NA
NA
19.65
20.69
09023410

A
Repair rotator cuff, acute
12.55
NA
NA
7.84
9.01
2.16
NA
NA
22.55
23.72
09023412

A
Repair rotator cuff, chronic
13.47
NA
NA
8.23
9.48
2.31
NA
NA
24.01
25.26
09023415

A
Release of shoulder ligament
10.02
NA
NA
6.62
7.65
1.73
NA
NA
18.37
19.40
09023420

A
Repair of shoulder
14.65
NA
NA
9.78
10.58
2.31
NA
NA
26.74
27.54
09023430

A
Repair biceps tendon
9.97
NA
NA
6.81
7.78
1.73
NA
NA
18.51
19.48
09023440

A
Remove/transplant tendon
10.46
NA
NA
6.82
7.90
1.82
NA
NA
19.10
20.18
09023450

A
Repair shoulder capsule
13.50
NA
NA
8.21
9.43
2.32
NA
NA
24.03
25.25
09023455

A
Repair shoulder capsule
14.47
NA
NA
8.60
9.98
2.49
NA
NA
25.56
26.94
09023460

A
Repair shoulder capsule
15.59
NA
NA
9.36
10.87
2.66
NA
NA
27.61
29.12
09023462

A
Repair shoulder capsule
15.52
NA
NA
9.11
10.34
2.59
NA
NA
27.22
28.45
09023465

A
Repair shoulder capsule
16.07
NA
NA
9.61
10.79
2.76
NA
NA
28.44
29.62
09023466

A
Repair shoulder capsule
15.45
NA
NA
10.11
11.06
2.46
NA
NA
28.02
28.97
09023470

A
Reconstruct shoulder joint
17.66
NA
NA
10.20
11.74
2.98
NA
NA
30.84
32.38
09023472

A
Reconstruct shoulder joint
22.39
NA
NA
12.25
13.87
3.66
NA
NA
38.30
39.92
09023480

A
Revision of collar bone
11.34
NA
NA
7.37
8.42
1.94
NA
NA
20.65
21.70
09023485

A
Revision of collar bone
13.71
NA
NA
8.33
9.50
2.33
NA
NA
24.37
25.54
09023490

A
Reinforce clavicle
11.96
NA
NA
6.69
8.19
1.47
NA
NA
20.12
21.62
09023491

A
Reinforce shoulder bones
14.31
NA
NA
8.89
10.26
2.46
NA
NA
25.66
27.03
09023500

A
Treat clavicle fracture
2.08
2.64
2.81
2.71
2.57
0.30
5.02
5.19
5.09
4.95
09023505

A
Treat clavicle fracture
3.68
4.03
4.32
3.63
3.79
0.61
8.32
8.61
7.92
8.08
09023515

A
Treat clavicle fracture
7.40
NA
NA
5.59
6.31
1.28
NA
NA
14.27
14.99
09023520

A
Treat clavicle dislocation
2.16
2.65
2.80
2.72
2.74
0.34
5.15
5.30
5.22
5.24
09023525

A
Treat clavicle dislocation
3.59
4.51
4.53
3.92
3.94
0.46
8.56
8.58
7.97
7.99
09023530

A
Treat clavicle dislocation
7.30
NA
NA
5.28
5.77
1.20
NA
NA
13.78
14.27
09023532

A
Treat clavicle dislocation
8.00
NA
NA
6.08
6.75
1.38
NA
NA
15.46
16.13
09023540

A
Treat clavicle dislocation
2.23
2.62
2.80
2.70
2.45
0.29
5.14
5.32
5.22
4.97
09023545

A
Treat clavicle dislocation
3.25
3.75
4.08
3.27
3.34
0.35
7.35
7.68
6.87
6.94
09023550

A
Treat clavicle dislocation
7.41
NA
NA
5.54
6.16
1.25
NA
NA
14.20
14.82
09023552

A
Treat clavicle dislocation
8.62
NA
NA
6.28
7.06
1.46
NA
NA
16.36
17.14
09023570

A
Treat shoulder blade fx
2.23
2.80
2.96
2.94
2.90
0.36
5.39
5.55
5.53
5.49
09023575

A
Treat shoulder blade fx
4.05
4.36
4.75
3.86
4.20
0.59
9.00
9.39
8.50
8.84
09023585

A
Treat scapula fracture
9.07
NA
NA
6.52
7.36
1.54
NA
NA
17.13
17.97
09023600

A
Treat humerus fracture
2.93
4.08
4.43
3.66
3.58
0.48
7.49
7.84
7.07
6.99
09023605

A
Treat humerus fracture
4.86
5.42
5.97
4.63
4.99
0.84
11.12
11.67
10.33
10.69
09023615

A
Treat humerus fracture
10.83
NA
NA
8.33
8.71
1.62
NA
NA
20.78
21.16
09023616

A
Treat humerus fracture
21.60
NA
NA
11.56
13.50
3.69
NA
NA
36.85
38.79
09023620

A
Treat humerus fracture
2.40
3.42
3.56
3.16
3.03
0.40
6.22
6.36
5.96
5.83
090( print page 49103)23625

A
Treat humerus fracture
3.92
4.44
4.82
3.91
4.19
0.67
9.03
9.41
8.50
8.78
09023630

A
Treat humerus fracture
7.40
NA
NA
5.69
6.40
1.27
NA
NA
14.36
15.07
09023650

A
Treat shoulder dislocation
3.38
3.27
3.65
2.80
2.77
0.30
6.95
7.33
6.48
6.45
09023655

A
Treat shoulder dislocation
4.56
NA
NA
4.17
4.17
0.69
NA
NA
9.42
9.42
09023660

A
Treat shoulder dislocation
7.48
NA
NA
5.63
6.19
1.29
NA
NA
14.40
14.96
09023665

A
Treat dislocation/fracture
4.46
4.85
5.21
4.26
4.61
0.71
10.02
10.38
9.43
9.78
09023670

A
Treat dislocation/fracture
7.95
NA
NA
5.89
6.60
1.36
NA
NA
15.20
15.91
09023675

A
Treat dislocation/fracture
6.04
6.16
6.66
5.16
5.66
1.01
13.21
13.71
12.21
12.71
09023680

A
Treat dislocation/fracture
10.22
NA
NA
7.02
7.84
1.75
NA
NA
18.99
19.81
09023700

A
Fixation of shoulder
2.52
NA
NA
1.92
2.11
0.44
NA
NA
4.88
5.07
01023800

A
Fusion of shoulder joint
14.50
NA
NA
7.55
9.70
2.35
NA
NA
24.40
26.55
09023802

A
Fusion of shoulder joint
18.07
NA
NA
10.99
10.38
2.70
NA
NA
31.76
31.15
09023900

A
Amputation of arm & girdle
20.47
NA
NA
10.72
11.46
3.18
NA
NA
34.37
35.11
09023920

A
Amputation at shoulder joint
15.95
NA
NA
9.56
9.83
2.46
NA
NA
27.97
28.24
09023921

A
Amputation follow-up surgery
5.54
NA
NA
4.88
5.03
0.78
NA
NA
11.20
11.35
09023929

C
Shoulder surgery procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY23930

A
Drainage of arm lesion
2.94
5.00
5.99
1.99
2.23
0.43
8.37
9.36
5.36
5.60
01023931

A
Drainage of arm bursa
1.79
4.34
5.52
1.75
2.07
0.28
6.41
7.59
3.82
4.14
01023935

A
Drain arm/elbow bone lesion
6.20
NA
NA
5.14
5.72
1.05
NA
NA
12.39
12.97
09024000

A
Exploratory elbow surgery
5.93
NA
NA
4.78
5.25
0.97
NA
NA
11.68
12.15
09024006

A
Release elbow joint
9.54
NA
NA
6.67
7.48
1.50
NA
NA
17.71
18.52
09024065

A
Biopsy arm/elbow soft tissue
2.08
4.08
3.43
1.87
1.77
0.17
6.33
5.68
4.12
4.02
01024066

A
Biopsy arm/elbow soft tissue
5.20
8.33
8.78
3.94
4.08
0.80
14.33
14.78
9.94
10.08
09024075

A
Remove arm/elbow lesion
3.91
7.22
7.32
3.27
3.37
0.56
11.69
11.79
7.74
7.84
09024076

A
Remove arm/elbow lesion
6.29
NA
NA
4.59
4.79
0.95
NA
NA
11.83
12.03
09024077

A
Remove tumor of arm/elbow
11.86
NA
NA
6.96
7.55
1.72
NA
NA
20.54
21.13
09024100

A
Biopsy elbow joint lining
4.92
NA
NA
4.28
4.46
0.85
NA
NA
10.05
10.23
09024101

A
Explore/treat elbow joint
6.12
NA
NA
5.08
5.72
1.03
NA
NA
12.23
12.87
09024102

A
Remove elbow joint lining
8.08
NA
NA
5.82
6.60
1.33
NA
NA
15.23
16.01
09024105

A
Removal of elbow bursa
3.60
NA
NA
4.04
4.30
0.61
NA
NA
8.25
8.51
09024110

A
Remove humerus lesion
7.38
NA
NA
5.66
6.41
1.28
NA
NA
14.32
15.07
09024115

A
Remove/graft bone lesion
9.92
NA
NA
6.83
7.12
1.67
NA
NA
18.42
18.71
09024116

A
Remove/graft bone lesion
12.03
NA
NA
7.67
8.72
2.05
NA
NA
21.75
22.80
09024120

A
Remove elbow lesion
6.64
NA
NA
5.22
5.75
1.10
NA
NA
12.96
13.49
09024125

A
Remove/graft bone lesion
7.94
NA
NA
6.03
6.13
1.06
NA
NA
15.03
15.13
09024126

A
Remove/graft bone lesion
8.42
NA
NA
6.22
6.82
1.16
NA
NA
15.80
16.40
09024130

A
Removal of head of radius
6.24
NA
NA
5.13
5.80
1.04
NA
NA
12.41
13.08
09024134

A
Removal of arm bone lesion
10.02
NA
NA
7.49
8.51
1.64
NA
NA
19.15
20.17
09024136

A
Remove radius bone lesion
8.22
NA
NA
5.67
6.83
1.38
NA
NA
15.27
16.43
09024138

A
Remove elbow bone lesion
8.22
NA
NA
6.71
7.51
1.34
NA
NA
16.27
17.07
09024140

A
Partial removal of arm bone
9.35
NA
NA
7.20
8.63
1.51
NA
NA
18.06
19.49
09024145

A
Partial removal of radius
7.63
NA
NA
6.30
7.62
1.25
NA
NA
15.18
16.50
09024147

A
Partial removal of elbow
7.59
NA
NA
6.90
8.18
1.30
NA
NA
15.79
17.07
09024149

A
Radical resection of elbow
15.80
NA
NA
10.86
11.43
2.34
NA
NA
29.00
29.57
09024150

A
Extensive humerus surgery
13.61
NA
NA
8.54
9.63
2.32
NA
NA
24.47
25.56
09024151

A
Extensive humerus surgery
15.98
NA
NA
9.77
11.08
2.59
NA
NA
28.34
29.65
09024152

A
Extensive radius surgery
10.16
NA
NA
6.29
7.37
1.48
NA
NA
17.93
19.01
09024153

A
Extensive radius surgery
11.64
NA
NA
4.92
5.41
0.74
NA
NA
17.30
17.79
09024155

A
Removal of elbow joint
11.89
NA
NA
7.61
8.20
1.92
NA
NA
21.42
22.01
09024160

A
Remove elbow joint implant
7.82
NA
NA
5.82
6.62
1.30
NA
NA
14.94
15.74
09024164

A
Remove radius head implant
6.28
NA
NA
4.92
5.56
1.03
NA
NA
12.23
12.87
09024200

A
Removal of arm foreign body
1.76
2.78
3.25
1.38
1.57
0.20
4.74
5.21
3.34
3.53
01024201

A
Removal of arm foreign body
4.55
7.92
9.34
3.71
4.10
0.72
13.19
14.61
8.98
9.37
09024220

A
Injection for elbow x-ray
1.31
2.64
3.38
0.43
0.44
0.08
4.03
4.77
1.82
1.83
00024300

A
Manipulate elbow w/anesth
3.74
NA
NA
5.18
5.58
0.65
NA
NA
9.57
9.97
09024301

A
Muscle/tendon transfer
10.18
NA
NA
6.85
7.85
1.66
NA
NA
18.69
19.69
09024305

A
Arm tendon lengthening
7.44
NA
NA
5.66
6.45
1.15
NA
NA
14.25
15.04
09024310

A
Revision of arm tendon
5.97
NA
NA
4.78
5.38
0.96
NA
NA
11.71
12.31
09024320

A
Repair of arm tendon
10.66
NA
NA
7.11
7.43
1.73
NA
NA
19.50
19.82
09024330

A
Revision of arm muscles
9.59
NA
NA
6.64
7.57
1.60
NA
NA
17.83
18.76
09024331

A
Revision of arm muscles
10.75
NA
NA
6.52
8.13
1.77
NA
NA
19.04
20.65
09024332

A
Tenolysis, triceps
7.69
NA
NA
5.75
6.52
1.23
NA
NA
14.67
15.44
09024340

A
Repair of biceps tendon
7.88
NA
NA
6.00
6.74
1.36
NA
NA
15.24
15.98
09024341

A
Repair arm tendon/muscle
9.14
NA
NA
7.52
7.82
1.36
NA
NA
18.02
18.32
09024342

A
Repair of ruptured tendon
10.66
NA
NA
7.11
8.17
1.85
NA
NA
19.62
20.68
09024343

A
Repr elbow lat ligmnt w/tiss
8.89
NA
NA
7.02
7.87
1.43
NA
NA
17.34
18.19
090( print page 49104)24344

A
Reconstruct elbow lat ligmnt
14.85
NA
NA
10.06
11.16
2.36
NA
NA
27.27
28.37
09024345

A
Repr elbw med ligmnt w/tissu
8.89
NA
NA
6.98
7.76
1.44
NA
NA
17.31
18.09
09024346

A
Reconstruct elbow med ligmnt
14.85
NA
NA
10.06
11.02
2.33
NA
NA
27.24
28.20
09024350

A
Repair of tennis elbow
5.24
NA
NA
4.89
5.41
0.87
NA
NA
11.00
11.52
09024351

A
Repair of tennis elbow
5.90
NA
NA
5.01
5.69
1.02
NA
NA
11.93
12.61
09024352

A
Repair of tennis elbow
6.42
NA
NA
5.23
5.94
1.10
NA
NA
12.75
13.46
09024354

A
Repair of tennis elbow
6.47
NA
NA
5.25
5.93
1.07
NA
NA
12.79
13.47
09024356

A
Revision of tennis elbow
6.67
NA
NA
5.32
6.06
1.11
NA
NA
13.10
13.84
09024360

A
Reconstruct elbow joint
12.44
NA
NA
7.97
9.10
2.05
NA
NA
22.46
23.59
09024361

A
Reconstruct elbow joint
14.18
NA
NA
8.78
10.13
2.18
NA
NA
25.14
26.49
09024362

A
Reconstruct elbow joint
15.09
NA
NA
9.30
9.86
2.60
NA
NA
26.99
27.55
09024363

A
Replace elbow joint
22.39
NA
NA
12.26
13.35
3.01
NA
NA
37.66
38.75
09024365

A
Reconstruct head of radius
8.44
NA
NA
5.94
6.89
1.41
NA
NA
15.79
16.74
09024366

A
Reconstruct head of radius
9.18
NA
NA
6.31
7.23
1.52
NA
NA
17.01
17.93
09024400

A
Revision of humerus
11.10
NA
NA
7.62
8.54
1.92
NA
NA
20.64
21.56
09024410

A
Revision of humerus
14.86
NA
NA
9.32
10.06
2.57
NA
NA
26.75
27.49
09024420

A
Revision of humerus
13.48
NA
NA
8.88
10.13
2.17
NA
NA
24.53
25.78
09024430

A
Repair of humerus
14.99
NA
NA
9.30
9.63
2.21
NA
NA
26.50
26.83
09024435

A
Repair humerus with graft
14.64
NA
NA
9.86
10.63
2.27
NA
NA
26.77
27.54
09024470

A
Revision of elbow joint
8.73
NA
NA
6.43
7.40
1.48
NA
NA
16.64
17.61
09024495

A
Decompression of forearm
8.23
NA
NA
6.68
8.23
1.18
NA
NA
16.09
17.64
09024498

A
Reinforce humerus
12.08
NA
NA
7.75
8.88
2.06
NA
NA
21.89
23.02
09024500

A
Treat humerus fracture
3.21
4.45
4.75
3.80
3.71
0.50
8.16
8.46
7.51
7.42
09024505

A
Treat humerus fracture
5.16
5.87
6.42
4.90
5.27
0.89
11.92
12.47
10.95
11.32
09024515

A
Treat humerus fracture
11.87
NA
NA
8.09
9.06
2.02
NA
NA
21.98
22.95
09024516

A
Treat humerus fracture
11.99
NA
NA
7.71
8.76
2.02
NA
NA
21.72
22.77
09024530

A
Treat humerus fracture
3.49
4.74
5.09
4.00
4.03
0.57
8.80
9.15
8.06
8.09
09024535

A
Treat humerus fracture
6.86
6.82
7.59
5.86
6.43
1.18
14.86
15.63
13.90
14.47
09024538

A
Treat humerus fracture
9.54
NA
NA
7.22
8.33
1.64
NA
NA
18.40
19.51
09024545

A
Treat humerus fracture
10.80
NA
NA
7.24
8.15
1.82
NA
NA
19.86
20.77
09024546

A
Treat humerus fracture
15.91
NA
NA
9.50
10.87
2.73
NA
NA
28.14
29.51
09024560

A
Treat humerus fracture
2.80
4.05
4.37
3.38
3.24
0.44
7.29
7.61
6.62
6.48
09024565

A
Treat humerus fracture
5.55
5.86
6.42
4.97
5.38
0.93
12.34
12.90
11.45
11.86
09024566

A
Treat humerus fracture
8.78
NA
NA
6.97
7.86
1.30
NA
NA
17.05
17.94
09024575

A
Treat humerus fracture
10.94
NA
NA
7.27
8.12
1.86
NA
NA
20.07
20.92
09024576

A
Treat humerus fracture
2.86
4.45
4.68
3.74
3.72
0.46
7.77
8.00
7.06
7.04
09024577

A
Treat humerus fracture
5.78
6.01
6.70
5.08
5.65
0.95
12.74
13.43
11.81
12.38
09024579

A
Treat humerus fracture
11.88
NA
NA
7.87
8.59
2.02
NA
NA
21.77
22.49
09024582

A
Treat humerus fracture
9.79
NA
NA
8.21
8.89
1.48
NA
NA
19.48
20.16
09024586

A
Treat elbow fracture
15.55
NA
NA
9.36
10.76
2.64
NA
NA
27.55
28.95
09024587

A
Treat elbow fracture
15.56
NA
NA
9.37
10.61
2.52
NA
NA
27.45
28.69
09024600

A
Treat elbow dislocation
4.22
3.87
4.61
3.29
3.45
0.50
8.59
9.33
8.01
8.17
09024605

A
Treat elbow dislocation
5.41
NA
NA
4.96
5.26
0.89
NA
NA
11.26
11.56
09024615

A
Treat elbow dislocation
9.65
NA
NA
6.59
7.51
1.60
NA
NA
17.84
18.76
09024620

A
Treat elbow fracture
6.97
NA
NA
5.48
6.06
1.07
NA
NA
13.52
14.10
09024635

A
Treat elbow fracture
13.47
NA
NA
10.23
13.10
2.28
NA
NA
25.98
28.85
09024640

A
Treat elbow dislocation
1.20
1.48
1.75
0.80
0.80
0.12
2.80
3.07
2.12
2.12
01024650

A
Treat radius fracture
2.16
3.44
3.70
3.00
2.81
0.35
5.95
6.21
5.51
5.32
09024655

A
Treat radius fracture
4.39
5.20
5.76
4.41
4.70
0.70
10.29
10.85
9.50
9.79
09024665

A
Treat radius fracture
8.13
NA
NA
6.53
7.27
1.41
NA
NA
16.07
16.81
09024666

A
Treat radius fracture
9.66
NA
NA
7.00
7.80
1.62
NA
NA
18.28
19.08
09024670

A
Treat ulnar fracture
2.54
3.74
4.02
3.16
3.09
0.41
6.69
6.97
6.11
6.04
09024675

A
Treat ulnar fracture
4.71
5.30
5.83
4.50
4.85
0.81
10.82
11.35
10.02
10.37
09024685

A
Treat ulnar fracture
8.85
NA
NA
6.48
7.26
1.52
NA
NA
16.85
17.63
09024800

A
Fusion of elbow joint
11.18
NA
NA
7.66
8.47
1.63
NA
NA
20.47
21.28
09024802

A
Fusion/graft of elbow joint
14.09
NA
NA
8.56
9.93
2.37
NA
NA
25.02
26.39
090( print page 49105)24900

A
Amputation of upper arm
9.95
NA
NA
6.47
6.91
1.53
NA
NA
17.95
18.39
09024920

A
Amputation of upper arm
9.95
NA
NA
6.45
6.82
1.61
NA
NA
18.01
18.38
09024925

A
Amputation follow-up surgery
7.12
NA
NA
4.95
5.80
1.14
NA
NA
13.21
14.06
09024930

A
Amputation follow-up surgery
10.65
NA
NA
5.90
6.91
1.67
NA
NA
18.22
19.23
09024931

A
Amputate upper arm & implant
13.24
NA
NA
8.23
6.35
1.89
NA
NA
23.36
21.48
09024935

A
Revision of amputation
16.20
NA
NA
8.90
8.24
2.13
NA
NA
27.23
26.57
09024940

C
Revision of upper arm
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
09024999

C
Upper arm/elbow surgery
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY25000

A
Incision of tendon sheath
3.37
NA
NA
5.06
6.42
0.55
NA
NA
8.98
10.34
09025001

A
Incise flexor carpi radialis
3.62
NA
NA
3.85
4.14
0.55
NA
NA
8.02
8.31
09025020

A
Decompress forearm 1 space
5.91
NA
NA
6.90
8.90
0.93
NA
NA
13.74
15.74
09025023

A
Decompress forearm 1 space
13.60
NA
NA
11.48
14.08
2.03
NA
NA
27.11
29.71
09025024

A
Decompress forearm 2 spaces
10.52
NA
NA
7.20
7.40
1.36
NA
NA
19.08
19.28
09025025

A
Decompress forearm 2 spaces
17.67
NA
NA
9.03
9.74
1.82
NA
NA
28.52
29.23
09025028

A
Drainage of forearm lesion
5.24
NA
NA
6.25
7.68
0.81
NA
NA
12.30
13.73
09025031

A
Drainage of forearm bursa
4.13
NA
NA
5.47
7.31
0.63
NA
NA
10.23
12.07
09025035

A
Treat forearm bone lesion
7.47
NA
NA
8.88
12.41
1.24
NA
NA
17.59
21.12
09025040

A
Explore/treat wrist joint
7.35
NA
NA
5.90
6.95
1.15
NA
NA
14.40
15.45
09025065

A
Biopsy forearm soft tissues
1.99
4.19
3.46
1.90
1.90
0.15
6.33
5.60
4.04
4.04
01025066

A
Biopsy forearm soft tissues
4.12
NA
NA
5.46
6.66
0.64
NA
NA
10.22
11.42
09025075

A
Removal forearm lesion subcu
3.73
NA
NA
4.90
5.64
0.55
NA
NA
9.18
9.92
09025076

A
Removal forearm lesion deep
4.91
NA
NA
6.92
8.89
0.74
NA
NA
12.57
14.54
09025077

A
Remove tumor, forearm/wrist
9.81
NA
NA
8.95
11.30
1.42
NA
NA
20.18
22.53
09025085

A
Incision of wrist capsule
5.49
NA
NA
5.44
6.70
0.85
NA
NA
11.78
13.04
09025100

A
Biopsy of wrist joint
3.89
NA
NA
4.28
5.02
0.59
NA
NA
8.76
9.50
09025101

A
Explore/treat wrist joint
4.68
NA
NA
4.83
5.63
0.75
NA
NA
10.26
11.06
09025105

A
Remove wrist joint lining
5.84
NA
NA
5.82
6.93
0.92
NA
NA
12.58
13.69
09025107

A
Remove wrist joint cartilage
7.42
NA
NA
7.16
8.05
0.99
NA
NA
15.57
16.46
09025110

A
Remove wrist tendon lesion
3.91
NA
NA
5.29
6.61
0.62
NA
NA
9.82
11.14
09025111

A
Remove wrist tendon lesion
3.38
NA
NA
4.10
4.55
0.53
NA
NA
8.01
8.46
09025112

A
Reremove wrist tendon lesion
4.52
NA
NA
4.54
5.07
0.70
NA
NA
9.76
10.29
09025115

A
Remove wrist/forearm lesion
9.81
NA
NA
10.21
13.08
1.31
NA
NA
21.33
24.20
09025116

A
Remove wrist/forearm lesion
7.28
NA
NA
9.08
12.13
1.11
NA
NA
17.47
20.52
09025118

A
Excise wrist tendon sheath
4.36
NA
NA
4.63
5.46
0.68
NA
NA
9.67
10.50
09025119

A
Partial removal of ulna
6.03
NA
NA
5.86
7.17
0.96
NA
NA
12.85
14.16
09025120

A
Removal of forearm lesion
6.09
NA
NA
7.93
11.04
1.00
NA
NA
15.02
18.13
09025125

A
Remove/graft forearm lesion
7.47
NA
NA
8.75
11.82
1.06
NA
NA
17.28
20.35
09025126

A
Remove/graft forearm lesion
7.54
NA
NA
8.78
11.95
1.27
NA
NA
17.59
20.76
09025130

A
Removal of wrist lesion
5.25
NA
NA
5.21
6.12
0.80
NA
NA
11.26
12.17
09025135

A
Remove & graft wrist lesion
6.88
NA
NA
6.12
7.16
1.02
NA
NA
14.02
15.06
09025136

A
Remove & graft wrist lesion
5.96
NA
NA
5.53
6.33
1.03
NA
NA
12.52
13.32
09025145

A
Remove forearm bone lesion
6.36
NA
NA
8.12
11.08
1.01
NA
NA
15.49
18.45
09025150

A
Partial removal of ulna
7.20
NA
NA
6.38
7.75
1.14
NA
NA
14.72
16.09
09025151

A
Partial removal of radius
7.50
NA
NA
8.52
11.67
1.18
NA
NA
17.20
20.35
09025170

A
Extensive forearm surgery
11.25
NA
NA
10.52
13.99
1.77
NA
NA
23.54
27.01
09025210

A
Removal of wrist bone
5.94
NA
NA
5.53
6.48
0.88
NA
NA
12.35
13.30
09025215

A
Removal of wrist bones
7.94
NA
NA
6.83
8.27
1.19
NA
NA
15.96
17.40
09025230

A
Partial removal of radius
5.22
NA
NA
4.96
5.85
0.79
NA
NA
10.97
11.86
09025240

A
Partial removal of ulna
5.16
NA
NA
5.27
6.53
0.81
NA
NA
11.24
12.50
09025246

A
Injection for wrist x-ray
1.45
2.70
3.26
0.48
0.48
0.09
4.24
4.80
2.02
2.02
00025248

A
Remove forearm foreign body
5.13
NA
NA
6.57
8.03
0.72
NA
NA
12.42
13.88
09025250

A
Removal of wrist prosthesis
6.59
NA
NA
5.32
5.91
1.01
NA
NA
12.92
13.51
09025251

A
Removal of wrist prosthesis
9.62
NA
NA
6.71
7.62
1.26
NA
NA
17.59
18.50
09025259

A
Manipulate wrist w/anesthes
3.74
NA
NA
5.14
5.58
0.62
NA
NA
9.50
9.94
09025260

A
Repair forearm tendon/muscle
7.79
NA
NA
9.22
12.29
1.19
NA
NA
18.20
21.27
09025263

A
Repair forearm tendon/muscle
7.81
NA
NA
8.96
12.19
1.18
NA
NA
17.95
21.18
09025265

A
Repair forearm tendon/muscle
9.87
NA
NA
10.00
13.23
1.47
NA
NA
21.34
24.57
09025270

A
Repair forearm tendon/muscle
5.99
NA
NA
7.90
11.00
0.95
NA
NA
14.84
17.94
09025272

A
Repair forearm tendon/muscle
7.03
NA
NA
8.37
11.69
1.11
NA
NA
16.51
19.83
09025274

A
Repair forearm tendon/muscle
8.74
NA
NA
9.20
12.52
1.36
NA
NA
19.30
22.62
09025275

A
Repair forearm tendon sheath
8.74
NA
NA
6.50
7.31
1.31
NA
NA
16.55
17.36
09025280

A
Revise wrist/forearm tendon
7.21
NA
NA
8.47
11.59
1.08
NA
NA
16.76
19.88
09025290

A
Incise wrist/forearm tendon
5.28
NA
NA
9.17
13.54
0.82
NA
NA
15.27
19.64
09025295

A
Release wrist/forearm tendon
6.54
NA
NA
8.14
11.15
1.00
NA
NA
15.68
18.69
09025300

A
Fusion of tendons at wrist
8.79
NA
NA
7.19
8.14
1.26
NA
NA
17.24
18.19
09025301

A
Fusion of tendons at wrist
8.39
NA
NA
6.73
7.73
1.29
NA
NA
16.41
17.41
090( print page 49106)25310

A
Transplant forearm tendon
8.19
NA
NA
8.82
11.98
1.21
NA
NA
18.22
21.38
09025312

A
Transplant forearm tendon
9.62
NA
NA
9.60
12.86
1.41
NA
NA
20.63
23.89
09025315

A
Revise palsy hand tendon(s)
10.48
NA
NA
10.00
13.30
1.58
NA
NA
22.06
25.36
09025316

A
Revise palsy hand tendon(s)
12.67
NA
NA
11.08
14.94
1.74
NA
NA
25.49
29.35
09025320

A
Repair/revise wrist joint
12.28
NA
NA
10.38
11.14
1.61
NA
NA
24.27
25.03
09025332

A
Revise wrist joint
11.51
NA
NA
7.74
8.81
1.83
NA
NA
21.08
22.15
09025335

A
Realignment of hand
13.16
NA
NA
7.01
10.45
1.92
NA
NA
22.09
25.53
09025337

A
Reconstruct ulna/radioulnar
11.36
NA
NA
9.39
10.66
1.61
NA
NA
22.36
23.63
09025350

A
Revision of radius
8.89
NA
NA
9.27
12.80
1.46
NA
NA
19.62
23.15
09025355

A
Revision of radius
10.33
NA
NA
10.03
13.47
1.73
NA
NA
22.09
25.53
09025360

A
Revision of ulna
8.54
NA
NA
9.13
12.69
1.41
NA
NA
19.08
22.64
09025365

A
Revise radius & ulna
12.68
NA
NA
11.06
14.50
2.15
NA
NA
25.89
29.33
09025370

A
Revise radius or ulna
13.82
NA
NA
11.97
15.05
2.28
NA
NA
28.07
31.15
09025375

A
Revise radius & ulna
13.32
NA
NA
11.33
15.15
2.26
NA
NA
26.91
30.73
09025390

A
Shorten radius or ulna
10.50
NA
NA
9.94
13.42
1.65
NA
NA
22.09
25.57
09025391

A
Lengthen radius or ulna
14.05
NA
NA
11.65
15.33
2.21
NA
NA
27.91
31.59
09025392

A
Shorten radius & ulna
14.35
NA
NA
11.78
14.92
2.10
NA
NA
28.23
31.37
09025393

A
Lengthen radius & ulna
16.33
NA
NA
13.18
16.48
2.76
NA
NA
32.27
35.57
09025394

A
Repair carpal bone, shorten
10.63
NA
NA
6.80
7.75
1.59
NA
NA
19.02
19.97
09025400

A
Repair radius or ulna
11.08
NA
NA
10.18
13.94
1.82
NA
NA
23.08
26.84
09025405

A
Repair/graft radius or ulna
14.78
NA
NA
11.92
15.93
2.32
NA
NA
29.02
33.03
09025415

A
Repair radius & ulna
13.57
NA
NA
11.02
15.14
2.17
NA
NA
26.76
30.88
09025420

A
Repair/graft radius & ulna
16.79
NA
NA
12.79
16.90
2.61
NA
NA
32.19
36.30
09025425

A
Repair/graft radius or ulna
13.49
NA
NA
14.14
19.58
2.08
NA
NA
29.71
35.15
09025426

A
Repair/graft radius & ulna
16.22
NA
NA
12.50
15.54
2.54
NA
NA
31.26
34.30
09025430

A
Vasc graft into carpal bone
9.49
NA
NA
7.04
7.27
1.27
NA
NA
17.80
18.03
09025431

A
Repair nonunion carpal bone
10.67
NA
NA
7.26
8.12
1.90
NA
NA
19.83
20.69
09025440

A
Repair/graft wrist bone
10.48
NA
NA
7.53
8.93
1.63
NA
NA
19.64
21.04
09025441

A
Reconstruct wrist joint
13.06
NA
NA
8.50
9.63
2.07
NA
NA
23.63
24.76
09025442

A
Reconstruct wrist joint
10.89
NA
NA
7.32
8.49
1.53
NA
NA
19.74
20.91
09025443

A
Reconstruct wrist joint
10.43
NA
NA
6.61
8.23
1.37
NA
NA
18.41
20.03
09025444

A
Reconstruct wrist joint
11.19
NA
NA
7.65
8.69
1.71
NA
NA
20.55
21.59
09025445

A
Reconstruct wrist joint
9.68
NA
NA
6.72
7.67
1.55
NA
NA
17.95
18.90
09025446

A
Wrist replacement
17.07
NA
NA
9.88
11.41
2.47
NA
NA
29.42
30.95
09025447

A
Repair wrist joint(s)
10.85
NA
NA
7.88
8.46
1.61
NA
NA
20.34
20.92
09025449

A
Remove wrist joint implant
14.71
NA
NA
9.05
10.27
2.21
NA
NA
25.97
27.19
09025450

A
Revision of wrist joint
7.86
NA
NA
7.34
9.48
1.36
NA
NA
16.56
18.70
09025455

A
Revision of wrist joint
9.48
NA
NA
6.50
9.77
0.96
NA
NA
16.94
20.21
09025490

A
Reinforce radius
9.53
NA
NA
9.47
12.67
1.43
NA
NA
20.43
23.63
09025491

A
Reinforce ulna
9.95
NA
NA
9.73
13.28
1.60
NA
NA
21.28
24.83
09025492

A
Reinforce radius and ulna
12.43
NA
NA
10.59
14.12
2.14
NA
NA
25.16
28.69
09025500

A
Treat fracture of radius
2.45
3.33
3.51
2.89
2.76
0.35
6.13
6.31
5.69
5.56
09025505

A
Treat fracture of radius
5.20
5.87
6.37
5.01
5.32
0.90
11.97
12.47
11.11
11.42
09025515

A
Treat fracture of radius
9.29
NA
NA
6.75
7.28
1.59
NA
NA
17.63
18.16
09025520

A
Treat fracture of radius
6.25
6.02
6.65
5.43
5.90
1.08
13.35
13.98
12.76
13.23
09025525

A
Treat fracture of radius
12.59
NA
NA
8.74
9.68
2.12
NA
NA
23.45
24.39
09025526

A
Treat fracture of radius
13.33
NA
NA
10.23
12.68
2.19
NA
NA
25.75
28.20
09025530

A
Treat fracture of ulna
2.09
3.48
3.69
2.97
2.89
0.34
5.91
6.12
5.40
5.32
09025535

A
Treat fracture of ulna
5.13
5.68
5.93
4.93
5.20
0.89
11.70
11.95
10.95
11.22
09025545

A
Treat fracture of ulna
9.01
NA
NA
6.64
7.41
1.53
NA
NA
17.18
17.95
09025560

A
Treat fracture radius & ulna
2.44
3.40
3.62
2.87
2.67
0.35
6.19
6.41
5.66
5.46
09025565

A
Treat fracture radius & ulna
5.62
5.97
6.52
4.99
5.31
0.93
12.52
13.07
11.54
11.86
09025574

A
Treat fracture radius & ulna
7.37
NA
NA
6.64
7.06
1.21
NA
NA
15.22
15.64
09025575

A
Treat fracture radius/ulna
11.92
NA
NA
9.00
9.38
1.81
NA
NA
22.73
23.11
09025600

A
Treat fracture radius/ulna
2.63
3.69
3.99
3.18
3.02
0.42
6.74
7.04
6.23
6.07
09025605

A
Treat fracture radius/ulna
6.93
6.91
7.15
6.18
6.21
1.00
14.84
15.08
14.11
14.14
090( print page 49107)25611

A
Treat fracture radius/ulna
9.14
NA
NA
8.34
8.81
1.34
NA
NA
18.82
19.29
09025620

A
Treat fracture radius/ulna
8.54
NA
NA
6.27
7.01
1.42
NA
NA
16.23
16.97
09025622

A
Treat wrist bone fracture
2.61
3.91
4.18
3.36
3.17
0.41
6.93
7.20
6.38
6.19
09025624

A
Treat wrist bone fracture
4.52
5.58
6.12
4.73
4.99
0.76
10.86
11.40
10.01
10.27
09025628

A
Treat wrist bone fracture
9.42
NA
NA
7.34
7.70
1.37
NA
NA
18.13
18.49
09025630

A
Treat wrist bone fracture
2.88
3.76
4.08
3.25
3.02
0.45
7.09
7.41
6.58
6.35
09025635

A
Treat wrist bone fracture
4.38
5.38
5.80
4.56
4.07
0.74
10.50
10.92
9.68
9.19
09025645

A
Treat wrist bone fracture
7.24
NA
NA
5.80
6.42
1.20
NA
NA
14.24
14.86
09025650

A
Treat wrist bone fracture
3.05
3.86
4.20
3.46
3.24
0.45
7.36
7.70
6.96
6.74
09025651

A
Pin ulnar styloid fracture
5.60
NA
NA
5.13
5.39
0.86
NA
NA
11.59
11.85
09025652

A
Treat fracture ulnar styloid
7.84
NA
NA
6.21
6.80
1.21
NA
NA
15.26
15.85
09025660

A
Treat wrist dislocation
4.75
NA
NA
4.48
4.65
0.58
NA
NA
9.81
9.98
09025670

A
Treat wrist dislocation
7.91
NA
NA
5.99
6.74
1.28
NA
NA
15.18
15.93
09025671

A
Pin radioulnar dislocation
6.24
NA
NA
5.53
6.00
1.00
NA
NA
12.77
13.24
09025675

A
Treat wrist dislocation
4.66
4.88
5.46
4.14
4.52
0.62
10.16
10.74
9.42
9.80
09025676

A
Treat wrist dislocation
8.09
NA
NA
6.28
7.05
1.34
NA
NA
15.71
16.48
09025680

A
Treat wrist fracture
5.98
NA
NA
4.37
4.65
0.78
NA
NA
11.13
11.41
09025685

A
Treat wrist fracture
9.89
NA
NA
6.70
7.53
1.60
NA
NA
18.19
19.02
09025690

A
Treat wrist dislocation
5.49
NA
NA
4.82
5.33
0.88
NA
NA
11.19
11.70
09025695

A
Treat wrist dislocation
8.33
NA
NA
6.19
6.87
1.32
NA
NA
15.84
16.52
09025800

A
Fusion of wrist joint
9.87
NA
NA
7.28
8.64
1.57
NA
NA
18.72
20.08
09025805

A
Fusion/graft of wrist joint
11.50
NA
NA
8.17
9.73
1.80
NA
NA
21.47
23.03
09025810

A
Fusion/graft of wrist joint
11.67
NA
NA
8.56
9.57
1.67
NA
NA
21.90
22.91
09025820

A
Fusion of hand bones
7.44
NA
NA
6.28
7.46
1.22
NA
NA
14.94
16.12
09025825

A
Fuse hand bones with graft
9.44
NA
NA
7.56
8.81
1.41
NA
NA
18.41
19.66
09025830

A
Fusion, radioulnar jnt/ulna
10.61
NA
NA
10.46
13.42
1.55
NA
NA
22.62
25.58
09025900

A
Amputation of forearm
9.36
NA
NA
9.27
11.74
1.30
NA
NA
19.93
22.40
09025905

A
Amputation of forearm
9.41
NA
NA
8.44
11.33
1.40
NA
NA
19.25
22.14
09025907

A
Amputation follow-up surgery
7.91
NA
NA
7.81
10.77
1.10
NA
NA
16.82
19.78
09025909

A
Amputation follow-up surgery
9.13
NA
NA
9.04
11.46
1.44
NA
NA
19.61
22.03
09025915

A
Amputation of forearm
17.30
NA
NA
8.23
16.22
2.93
NA
NA
28.46
36.45
09025920

A
Amputate hand at wrist
8.85
NA
NA
6.72
7.57
1.35
NA
NA
16.92
17.77
09025922

A
Amputate hand at wrist
7.47
NA
NA
6.40
6.89
1.12
NA
NA
14.99
15.48
09025924

A
Amputation follow-up surgery
8.63
NA
NA
6.71
7.75
1.32
NA
NA
16.66
17.70
09025927

A
Amputation of hand
8.91
NA
NA
8.62
10.92
1.27
NA
NA
18.80
21.10
09025929

A
Amputation follow-up surgery
7.64
NA
NA
5.42
5.76
1.14
NA
NA
14.20
14.54
09025931

A
Amputation follow-up surgery
7.86
NA
NA
8.53
10.73
1.15
NA
NA
17.54
19.74
09025999

C
Forearm or wrist surgery
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY26010

A
Drainage of finger abscess
1.54
4.02
5.18
1.51
1.60
0.18
5.74
6.90
3.23
3.32
01026011

A
Drainage of finger abscess
2.19
6.29
8.18
1.98
2.24
0.33
8.81
10.70
4.50
4.76
01026020

A
Drain hand tendon sheath
4.90
NA
NA
4.75
5.20
0.73
NA
NA
10.38
10.83
09026025

A
Drainage of palm bursa
4.93
NA
NA
4.46
4.96
0.76
NA
NA
10.15
10.65
09026030

A
Drainage of palm bursa(s)
6.10
NA
NA
4.99
5.54
0.92
NA
NA
12.01
12.56
09026034

A
Treat hand bone lesion
6.40
NA
NA
5.55
6.15
1.01
NA
NA
12.96
13.56
09026035

A
Decompress fingers/hand
11.05
NA
NA
8.01
7.91
1.47
NA
NA
20.53
20.43
09026037

A
Decompress fingers/hand
7.42
NA
NA
5.51
6.12
1.13
NA
NA
14.06
14.67
09026040

A
Release palm contracture
3.33
NA
NA
3.60
3.94
0.53
NA
NA
7.46
7.80
09026045

A
Release palm contracture
5.55
NA
NA
4.88
5.45
0.93
NA
NA
11.36
11.93
09026055

A
Incise finger tendon sheath
2.94
9.07
13.03
3.83
3.91
0.43
12.44
16.40
7.20
7.28
09026060

A
Incision of finger tendon
2.81
NA
NA
3.06
3.40
0.45
NA
NA
6.32
6.66
09026070

A
Explore/treat hand joint
3.68
NA
NA
3.04
3.28
0.48
NA
NA
7.20
7.44
09026075

A
Explore/treat finger joint
3.78
NA
NA
3.41
3.69
0.53
NA
NA
7.72
8.00
09026080

A
Explore/treat finger joint
4.29
NA
NA
4.34
4.72
0.66
NA
NA
9.29
9.67
09026100

A
Biopsy hand joint lining
3.66
NA
NA
3.56
3.99
0.54
NA
NA
7.76
8.19
09026105

A
Biopsy finger joint lining
3.70
NA
NA
3.74
4.11
0.59
NA
NA
8.03
8.40
09026110

A
Biopsy finger joint lining
3.52
NA
NA
3.60
3.93
0.53
NA
NA
7.65
7.98
09026115

A
Removal hand lesion subcut
3.85
9.84
12.28
4.21
4.63
0.59
14.28
16.72
8.65
9.07
09026116

A
Removal hand lesion, deep
5.52
NA
NA
5.29
5.82
0.84
NA
NA
11.65
12.18
09026117

A
Remove tumor, hand/finger
8.54
NA
NA
6.21
6.85
1.26
NA
NA
16.01
16.65
09026121

A
Release palm contracture
7.53
NA
NA
5.94
6.71
1.17
NA
NA
14.64
15.41
09026123

A
Release palm contracture
10.53
NA
NA
8.23
8.70
1.43
NA
NA
20.19
20.66
09026125

A
Release palm contracture
4.60
NA
NA
1.89
2.30
0.70
NA
NA
7.19
7.60
ZZZ26130

A
Remove wrist joint lining
5.41
NA
NA
4.85
5.22
0.94
NA
NA
11.20
11.57
09026135

A
Revise finger joint, each
6.95
NA
NA
5.49
6.22
1.07
NA
NA
13.51
14.24
09026140

A
Revise finger joint, each
6.16
NA
NA
5.17
5.82
0.92
NA
NA
12.25
12.90
09026145

A
Tendon excision, palm/finger
6.31
NA
NA
5.19
5.84
0.97
NA
NA
12.47
13.12
090( print page 49108)26160

A
Remove tendon sheath lesion
3.40
9.02
11.53
3.92
4.07
0.49
12.91
15.42
7.81
7.96
09026170

A
Removal of palm tendon, each
4.76
NA
NA
4.36
4.80
0.69
NA
NA
9.81
10.25
09026180

A
Removal of finger tendon
5.17
NA
NA
4.77
5.25
0.78
NA
NA
10.72
11.20
09026185

A
Remove finger bone
6.24
NA
NA
5.81
5.98
0.81
NA
NA
12.86
13.03
09026200

A
Remove hand bone lesion
5.50
NA
NA
4.58
5.16
0.88
NA
NA
10.96
11.54
09026205

A
Remove/graft bone lesion
7.75
NA
NA
5.85
6.63
1.20
NA
NA
14.80
15.58
09026210

A
Removal of finger lesion
5.14
NA
NA
4.74
5.25
0.79
NA
NA
10.67
11.18
09026215

A
Remove/graft finger lesion
7.09
NA
NA
5.53
6.12
0.98
NA
NA
13.60
14.19
09026230

A
Partial removal of hand bone
6.32
NA
NA
5.01
5.69
1.01
NA
NA
12.34
13.02
09026235

A
Partial removal, finger bone
6.18
NA
NA
4.96
5.60
0.95
NA
NA
12.09
12.73
09026236

A
Partial removal, finger bone
5.31
NA
NA
4.55
5.13
0.81
NA
NA
10.67
11.25
09026250

A
Extensive hand surgery
7.54
NA
NA
5.21
6.13
1.07
NA
NA
13.82
14.74
09026255

A
Extensive hand surgery
12.71
NA
NA
8.39
9.13
1.68
NA
NA
22.78
23.52
09026260

A
Extensive finger surgery
7.02
NA
NA
5.36
5.98
1.01
NA
NA
13.39
14.01
09026261

A
Extensive finger surgery
9.20
NA
NA
6.88
6.35
1.14
NA
NA
17.22
16.69
09026262

A
Partial removal of finger
5.66
NA
NA
4.66
5.16
0.88
NA
NA
11.20
11.70
09026320

A
Removal of implant from hand
3.97
NA
NA
3.78
4.18
0.59
NA
NA
8.34
8.74
09026340

A
Manipulate finger w/anesth
2.50
NA
NA
4.60
4.81
0.39
NA
NA
7.49
7.70
09026350

A
Repair finger/hand tendon
5.98
NA
NA
9.45
13.32
0.93
NA
NA
16.36
20.23
09026352

A
Repair/graft hand tendon
7.67
NA
NA
10.04
14.03
1.13
NA
NA
18.84
22.83
09026356

A
Repair finger/hand tendon
10.06
NA
NA
13.68
17.20
1.21
NA
NA
24.95
28.47
09026357

A
Repair finger/hand tendon
8.57
NA
NA
10.26
14.29
1.33
NA
NA
20.16
24.19
09026358

A
Repair/graft hand tendon
9.13
NA
NA
10.81
15.18
1.38
NA
NA
21.32
25.69
09026370

A
Repair finger/hand tendon
7.10
NA
NA
9.50
13.71
1.12
NA
NA
17.72
21.93
09026372

A
Repair/graft hand tendon
8.81
NA
NA
10.48
15.02
1.40
NA
NA
20.69
25.23
09026373

A
Repair finger/hand tendon
8.21
NA
NA
10.16
14.57
1.23
NA
NA
19.60
24.01
09026390

A
Revise hand/finger tendon
9.24
NA
NA
9.08
12.23
1.40
NA
NA
19.72
22.87
09026392

A
Repair/graft hand tendon
10.30
NA
NA
11.02
15.30
1.57
NA
NA
22.89
27.17
09026410

A
Repair hand tendon
4.62
NA
NA
7.56
10.85
0.73
NA
NA
12.91
16.20
09026412

A
Repair/graft hand tendon
6.30
NA
NA
8.57
12.10
0.97
NA
NA
15.84
19.37
09026415

A
Excision, hand/finger tendon
8.33
NA
NA
6.71
10.51
0.98
NA
NA
16.02
19.82
09026416

A
Graft hand or finger tendon
9.36
NA
NA
8.70
13.12
0.79
NA
NA
18.85
23.27
09026418

A
Repair finger tendon
4.24
NA
NA
8.07
11.26
0.67
NA
NA
12.98
16.17
09026420

A
Repair/graft finger tendon
6.76
NA
NA
8.75
12.41
1.07
NA
NA
16.58
20.24
09026426

A
Repair finger/hand tendon
6.14
NA
NA
8.52
12.00
0.95
NA
NA
15.61
19.09
09026428

A
Repair/graft finger tendon
7.20
NA
NA
9.19
12.69
1.09
NA
NA
17.48
20.98
09026432

A
Repair finger tendon
4.01
NA
NA
6.71
9.37
0.64
NA
NA
11.36
14.02
09026433

A
Repair finger tendon
4.55
NA
NA
6.93
9.83
0.72
NA
NA
12.20
15.10
09026434

A
Repair/graft finger tendon
6.08
NA
NA
7.87
10.62
0.93
NA
NA
14.88
17.63
09026437

A
Realignment of tendons
5.81
NA
NA
7.71
10.61
0.89
NA
NA
14.41
17.31
09026440

A
Release palm/finger tendon
5.01
NA
NA
8.43
12.18
0.75
NA
NA
14.19
17.94
09026442

A
Release palm & finger tendon
9.40
NA
NA
11.61
14.86
1.20
NA
NA
22.21
25.46
09026445

A
Release hand/finger tendon
4.30
NA
NA
8.10
11.88
0.65
NA
NA
13.05
16.83
09026449

A
Release forearm/hand tendon
8.24
NA
NA
11.30
14.65
1.06
NA
NA
20.60
23.95
09026450

A
Incision of palm tendon
3.66
NA
NA
5.11
6.78
0.59
NA
NA
9.36
11.03
09026455

A
Incision of finger tendon
3.63
NA
NA
5.07
6.73
0.58
NA
NA
9.28
10.94
09026460

A
Incise hand/finger tendon
3.45
NA
NA
5.01
6.61
0.55
NA
NA
9.01
10.61
09026471

A
Fusion of finger tendons
5.72
NA
NA
7.66
10.35
0.88
NA
NA
14.26
16.95
09026474

A
Fusion of finger tendons
5.31
NA
NA
7.48
10.41
0.76
NA
NA
13.55
16.48
09026476

A
Tendon lengthening
5.17
NA
NA
7.39
10.05
0.79
NA
NA
13.35
16.01
09026477

A
Tendon shortening
5.14
NA
NA
7.47
10.16
0.81
NA
NA
13.42
16.11
09026478

A
Lengthening of hand tendon
5.79
NA
NA
7.67
10.80
0.90
NA
NA
14.36
17.49
09026479

A
Shortening of hand tendon
5.73
NA
NA
7.66
10.59
0.92
NA
NA
14.31
17.24
09026480

A
Transplant hand tendon
6.68
NA
NA
9.57
13.67
1.02
NA
NA
17.27
21.37
09026483

A
Transplant/graft hand tendon
8.28
NA
NA
10.22
14.18
1.26
NA
NA
19.76
23.72
09026485

A
Transplant palm tendon
7.69
NA
NA
9.94
14.01
1.15
NA
NA
18.78
22.85
090( print page 49109)26489

A
Transplant/graft palm tendon
9.66
NA
NA
10.29
11.62
1.26
NA
NA
21.21
22.54
09026490

A
Revise thumb tendon
8.40
NA
NA
8.89
11.84
1.21
NA
NA
18.50
21.45
09026492

A
Tendon transfer with graft
9.61
NA
NA
9.77
12.64
1.40
NA
NA
20.78
23.65
09026494

A
Hand tendon/muscle transfer
8.46
NA
NA
9.01
11.98
1.28
NA
NA
18.75
21.72
09026496

A
Revise thumb tendon
9.58
NA
NA
9.46
12.29
1.45
NA
NA
20.49
23.32
09026497

A
Finger tendon transfer
9.56
NA
NA
9.42
12.53
1.41
NA
NA
20.39
23.50
09026498

A
Finger tendon transfer
13.98
NA
NA
11.48
14.99
2.10
NA
NA
27.56
31.07
09026499

A
Revision of finger
8.97
NA
NA
8.72
11.96
1.35
NA
NA
19.04
22.28
09026500

A
Hand tendon reconstruction
5.95
NA
NA
7.75
10.52
0.90
NA
NA
14.60
17.37
09026502

A
Hand tendon reconstruction
7.13
NA
NA
8.34
11.10
1.13
NA
NA
16.60
19.36
09026504

A
Hand tendon reconstruction
7.46
NA
NA
8.59
11.58
1.24
NA
NA
17.29
20.28
09026508

A
Release thumb contracture
6.00
NA
NA
7.75
10.70
0.98
NA
NA
14.73
17.68
09026510

A
Thumb tendon transfer
5.42
NA
NA
7.56
10.40
0.79
NA
NA
13.77
16.61
09026516

A
Fusion of knuckle joint
7.14
NA
NA
8.22
11.23
1.10
NA
NA
16.46
19.47
09026517

A
Fusion of knuckle joints
8.88
NA
NA
9.21
12.43
1.41
NA
NA
19.50
22.72
09026518

A
Fusion of knuckle joints
9.07
NA
NA
9.24
12.35
1.35
NA
NA
19.66
22.77
09026520

A
Release knuckle contracture
5.29
NA
NA
8.81
12.62
0.80
NA
NA
14.90
18.71
09026525

A
Release finger contracture
5.32
NA
NA
8.82
12.68
0.81
NA
NA
14.95
18.81
09026530

A
Revise knuckle joint
6.68
NA
NA
5.43
5.96
1.04
NA
NA
13.15
13.68
09026531

A
Revise knuckle with implant
7.90
NA
NA
6.15
6.88
1.17
NA
NA
15.22
15.95
09026535

A
Revise finger joint
5.23
NA
NA
4.04
3.82
0.71
NA
NA
9.98
9.76
09026536

A
Revise/implant finger joint
6.36
NA
NA
9.14
9.52
0.96
NA
NA
16.46
16.84
09026540

A
Repair hand joint
6.42
NA
NA
7.98
10.90
0.99
NA
NA
15.39
18.31
09026541

A
Repair hand joint with graft
8.61
NA
NA
9.04
12.30
1.28
NA
NA
18.93
22.19
09026542

A
Repair hand joint with graft
6.77
NA
NA
8.13
11.06
1.02
NA
NA
15.92
18.85
09026545

A
Reconstruct finger joint
6.91
NA
NA
8.32
11.18
1.05
NA
NA
16.28
19.14
09026546

A
Repair nonunion hand
10.41
NA
NA
11.42
14.13
1.44
NA
NA
23.27
25.98
09026548

A
Reconstruct finger joint
8.02
NA
NA
8.78
11.83
1.20
NA
NA
18.00
21.05
09026550

A
Construct thumb replacement
21.46
NA
NA
15.40
17.04
2.45
NA
NA
39.31
40.95
09026551

A
Great toe-hand transfer
48.09
NA
NA
21.71
29.76
7.96
NA
NA
77.76
85.81
09026553

A
Single transfer, toe-hand
47.78
NA
NA
20.29
22.08
2.41
NA
NA
70.48
72.27
09026554

A
Double transfer, toe-hand
56.57
NA
NA
19.56
33.04
9.41
NA
NA
85.54
99.02
09026555

A
Positional change of finger
16.86
NA
NA
13.88
17.11
2.48
NA
NA
33.22
36.45
09026556

A
Toe joint transfer
49.27
NA
NA
17.86
29.46
2.57
NA
NA
69.70
81.30
09026560

A
Repair of web finger
5.37
NA
NA
7.09
9.12
0.85
NA
NA
13.31
15.34
09026561

A
Repair of web finger
10.90
NA
NA
9.41
11.61
1.45
NA
NA
21.76
23.96
09026562

A
Repair of web finger
16.30
NA
NA
13.88
16.33
2.23
NA
NA
32.41
34.86
09026565

A
Correct metacarpal flaw
6.73
NA
NA
7.90
10.98
1.00
NA
NA
15.63
18.71
09026567

A
Correct finger deformity
6.81
NA
NA
8.15
11.00
1.04
NA
NA
16.00
18.85
09026568

A
Lengthen metacarpal/finger
9.07
NA
NA
10.13
14.11
1.49
NA
NA
20.69
24.67
09026580

A
Repair hand deformity
19.40
NA
NA
11.01
12.98
2.28
NA
NA
32.69
34.66
09026587

A
Reconstruct extra finger
14.28
NA
NA
8.43
9.02
1.53
NA
NA
24.24
24.83
09026590

A
Repair finger deformity
18.43
NA
NA
10.52
13.09
2.77
NA
NA
31.72
34.29
09026591

A
Repair muscles of hand
3.25
NA
NA
6.26
8.78
0.48
NA
NA
9.99
12.51
09026593

A
Release muscles of hand
5.30
NA
NA
7.73
10.28
0.78
NA
NA
13.81
16.36
09026596

A
Excision constricting tissue
8.94
NA
NA
7.48
8.49
1.43
NA
NA
17.85
18.86
09026600

A
Treat metacarpal fracture
2.40
3.83
3.67
3.48
2.86
0.30
6.53
6.37
6.18
5.56
09026605

A
Treat metacarpal fracture
2.85
4.09
4.44
3.50
3.61
0.49
7.43
7.78
6.84
6.95
09026607

A
Treat metacarpal fracture
5.35
NA
NA
4.88
5.92
0.87
NA
NA
11.10
12.14
09026608

A
Treat metacarpal fracture
5.35
NA
NA
5.25
6.00
0.88
NA
NA
11.48
12.23
09026615

A
Treat metacarpal fracture
5.32
NA
NA
4.75
5.16
0.86
NA
NA
10.93
11.34
09026641

A
Treat thumb dislocation
3.93
4.17
4.47
3.52
3.53
0.39
8.49
8.79
7.84
7.85
09026645

A
Treat thumb fracture
4.40
4.62
5.03
3.93
4.13
0.67
9.69
10.10
9.00
9.20
09026650

A
Treat thumb fracture
5.71
NA
NA
5.62
6.42
0.94
NA
NA
12.27
13.07
09026665

A
Treat thumb fracture
7.65
NA
NA
5.87
6.43
0.90
NA
NA
14.42
14.98
09026670

A
Treat hand dislocation
3.68
3.55
4.08
2.96
2.95
0.39
7.62
8.15
7.03
7.02
09026675

A
Treat hand dislocation
4.63
4.85
5.32
4.15
4.39
0.77
10.25
10.72
9.55
9.79
09026676

A
Pin hand dislocation
5.51
NA
NA
5.57
6.41
0.91
NA
NA
11.99
12.83
09026685

A
Treat hand dislocation
7.03
NA
NA
5.44
5.97
1.09
NA
NA
13.56
14.09
09026686

A
Treat hand dislocation
7.99
NA
NA
6.12
6.71
1.24
NA
NA
15.35
15.94
09026700

A
Treat knuckle dislocation
3.68
3.32
3.65
2.95
2.88
0.35
7.35
7.68
6.98
6.91
09026705

A
Treat knuckle dislocation
4.18
4.82
5.20
4.10
4.25
0.66
9.66
10.04
8.94
9.09
09026706

A
Pin knuckle dislocation
5.11
NA
NA
4.69
4.99
0.81
NA
NA
10.61
10.91
09026715

A
Treat knuckle dislocation
5.73
NA
NA
4.92
5.36
0.91
NA
NA
11.56
12.00
09026720

A
Treat finger fracture, each
1.66
2.59
2.73
2.31
2.12
0.24
4.49
4.63
4.21
4.02
09026725

A
Treat finger fracture, each
3.33
4.10
4.60
3.42
3.48
0.53
7.96
8.46
7.28
7.34
090( print page 49110)26727

A
Treat finger fracture, each
5.22
NA
NA
5.21
5.98
0.84
NA
NA
11.27
12.04
09026735

A
Treat finger fracture, each
5.97
NA
NA
5.00
5.41
0.95
NA
NA
11.92
12.33
09026740

A
Treat finger fracture, each
1.94
2.95
3.09
2.66
2.69
0.31
5.20
5.34
4.91
4.94
09026742

A
Treat finger fracture, each
3.84
4.33
4.83
3.62
3.82
0.58
8.75
9.25
8.04
8.24
09026746

A
Treat finger fracture, each
5.80
NA
NA
4.96
5.41
0.91
NA
NA
11.67
12.12
09026750

A
Treat finger fracture, each
1.70
2.25
2.42
2.26
2.07
0.22
4.17
4.34
4.18
3.99
09026755

A
Treat finger fracture, each
3.10
3.79
4.26
2.98
3.00
0.42
7.31
7.78
6.50
6.52
09026756

A
Pin finger fracture, each
4.38
NA
NA
4.86
5.51
0.71
NA
NA
9.95
10.60
09026765

A
Treat finger fracture, each
4.16
NA
NA
4.02
4.30
0.66
NA
NA
8.84
9.12
09026770

A
Treat finger dislocation
3.02
2.91
3.30
2.53
2.44
0.27
6.20
6.59
5.82
5.73
09026775

A
Treat finger dislocation
3.70
4.54
5.03
3.81
3.81
0.54
8.78
9.27
8.05
8.05
09026776

A
Pin finger dislocation
4.79
NA
NA
5.01
5.75
0.77
NA
NA
10.57
11.31
09026785

A
Treat finger dislocation
4.20
NA
NA
4.08
4.42
0.68
NA
NA
8.96
9.30
09026820

A
Thumb fusion with graft
8.25
NA
NA
8.71
12.12
1.30
NA
NA
18.26
21.67
09026841

A
Fusion of thumb
7.12
NA
NA
8.69
12.10
1.18
NA
NA
16.99
20.40
09026842

A
Thumb fusion with graft
8.29
NA
NA
8.95
12.27
1.32
NA
NA
18.56
21.88
09026843

A
Fusion of hand joint
7.60
NA
NA
8.17
11.31
1.15
NA
NA
16.92
20.06
09026844

A
Fusion/graft of hand joint
8.78
NA
NA
9.14
12.31
1.33
NA
NA
19.25
22.42
09026850

A
Fusion of knuckle
6.96
NA
NA
8.29
11.22
1.06
NA
NA
16.31
19.24
09026852

A
Fusion of knuckle with graft
8.51
NA
NA
9.12
11.95
1.22
NA
NA
18.85
21.68
09026860

A
Fusion of finger joint
4.68
NA
NA
7.54
10.28
0.73
NA
NA
12.95
15.69
09026861

A
Fusion of finger jnt, add-on
1.74
NA
NA
0.71
0.88
0.27
NA
NA
2.72
2.89
ZZZ26862

A
Fusion/graft of finger joint
7.36
NA
NA
8.68
11.43
1.10
NA
NA
17.14
19.89
09026863

A
Fuse/graft added joint
3.89
NA
NA
1.58
1.98
0.56
NA
NA
6.03
6.43
ZZZ26910

A
Amputate metacarpal bone
7.59
NA
NA
8.30
10.49
1.16
NA
NA
17.05
19.24
09026951

A
Amputation of finger/thumb
5.75
NA
NA
8.39
9.71
0.71
NA
NA
14.85
16.17
09026952

A
Amputation of finger/thumb
6.30
NA
NA
7.94
10.73
0.95
NA
NA
15.19
17.98
09026989

C
Hand/finger surgery
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY26990

A
Drainage of pelvis lesion
7.77
NA
NA
6.29
6.98
1.22
NA
NA
15.28
15.97
09026991

A
Drainage of pelvis bursa
6.91
8.60
10.52
4.85
5.29
1.11
16.62
18.54
12.87
13.31
09026992

A
Drainage of bone lesion
13.30
NA
NA
8.64
9.95
2.16
NA
NA
24.10
25.41
09027000

A
Incision of hip tendon
5.61
NA
NA
4.55
5.10
0.98
NA
NA
11.14
11.69
09027001

A
Incision of hip tendon
6.99
NA
NA
5.23
5.88
1.24
NA
NA
13.46
14.11
09027003

A
Incision of hip tendon
7.63
NA
NA
5.82
6.32
1.12
NA
NA
14.57
15.07
09027005

A
Incision of hip tendon
9.89
NA
NA
6.79
7.56
1.72
NA
NA
18.40
19.17
09027006

A
Incision of hip tendons
9.91
NA
NA
6.84
7.70
1.69
NA
NA
18.44
19.30
09027025

A
Incision of hip/thigh fascia
12.57
NA
NA
8.10
8.44
1.84
NA
NA
22.51
22.85
09027030

A
Drainage of hip joint
13.47
NA
NA
8.10
9.26
2.26
NA
NA
23.83
24.99
09027033

A
Exploration of hip joint
13.91
NA
NA
8.45
9.55
2.32
NA
NA
24.68
25.78
09027035

A
Denervation of hip joint
17.14
NA
NA
9.53
10.81
2.15
NA
NA
28.82
30.10
09027036

A
Excision of hip joint/muscle
14.10
NA
NA
8.98
9.75
2.26
NA
NA
25.34
26.11
09027040

A
Biopsy of soft tissues
2.87
5.14
5.21
1.81
1.96
0.27
8.28
8.35
4.95
5.10
01027041

A
Biopsy of soft tissues
10.00
NA
NA
5.79
6.43
1.35
NA
NA
17.14
17.78
09027047

A
Remove hip/pelvis lesion
7.44
7.12
7.11
4.57
4.72
1.03
15.59
15.58
13.04
13.19
09027048

A
Remove hip/pelvis lesion
6.36
NA
NA
4.65
4.76
0.92
NA
NA
11.93
12.04
09027049

A
Remove tumor, hip/pelvis
15.12
NA
NA
8.24
8.36
2.06
NA
NA
25.42
25.54
09027050

A
Biopsy of sacroiliac joint
4.59
NA
NA
3.79
4.26
0.60
NA
NA
8.98
9.45
09027052

A
Biopsy of hip joint
7.21
NA
NA
5.68
5.83
1.08
NA
NA
13.97
14.12
09027054

A
Removal of hip joint lining
9.01
NA
NA
6.49
7.13
1.47
NA
NA
16.97
17.61
09027060

A
Removal of ischial bursa
5.72
NA
NA
4.38
4.37
0.80
NA
NA
10.90
10.89
09027062

A
Remove femur lesion/bursa
5.60
NA
NA
4.63
5.05
0.93
NA
NA
11.16
11.58
09027065

A
Removal of hip bone lesion
6.37
NA
NA
5.12
5.36
1.01
NA
NA
12.50
12.74
09027066

A
Removal of hip bone lesion
10.97
NA
NA
7.46
8.20
1.79
NA
NA
20.22
20.96
09027067

A
Remove/graft hip bone lesion
14.47
NA
NA
8.80
10.20
1.84
NA
NA
25.11
26.51
09027070

A
Partial removal of hip bone
11.36
NA
NA
7.94
8.83
1.74
NA
NA
21.04
21.93
09027071

A
Partial removal of hip bone
12.16
NA
NA
8.54
9.73
1.92
NA
NA
22.62
23.81
090( print page 49111)27075

A
Extensive hip surgery
36.71
NA
NA
16.62
18.56
5.64
NA
NA
58.97
60.91
09027076

A
Extensive hip surgery
24.17
NA
NA
12.75
14.07
3.70
NA
NA
40.62
41.94
09027077

A
Extensive hip surgery
42.48
NA
NA
19.99
21.99
6.12
NA
NA
68.59
70.59
09027078

A
Extensive hip surgery
14.44
NA
NA
8.79
9.65
2.22
NA
NA
25.45
26.31
09027079

A
Extensive hip surgery
14.81
NA
NA
7.52
9.04
1.94
NA
NA
24.27
25.79
09027080

A
Removal of tail bone
6.74
NA
NA
4.72
4.80
0.93
NA
NA
12.39
12.47
09027086

A
Remove hip foreign body
1.87
3.78
4.36
1.54
1.75
0.25
5.90
6.48
3.66
3.87
01027087

A
Remove hip foreign body
8.65
NA
NA
5.66
6.41
1.35
NA
NA
15.66
16.41
09027090

A
Removal of hip prosthesis
11.49
NA
NA
7.44
8.45
1.94
NA
NA
20.87
21.88
09027091

A
Removal of hip prosthesis
24.07
NA
NA
13.05
13.76
3.84
NA
NA
40.96
41.67
09027093

A
Injection for hip x-ray
1.30
3.09
4.12
0.44
0.47
0.13
4.52
5.55
1.87
1.90
00027095

A
Injection for hip x-ray
1.50
3.73
5.22
0.50
0.52
0.14
5.37
6.86
2.14
2.16
00027096

A
Inject sacroiliac joint
1.40
2.54
3.90
0.33
0.33
0.08
4.02
5.38
1.81
1.81
00027097

A
Revision of hip tendon
9.09
NA
NA
6.35
6.40
1.57
NA
NA
17.01
17.06
09027098

A
Transfer tendon to pelvis
9.12
NA
NA
4.96
6.51
0.95
NA
NA
15.03
16.58
09027100

A
Transfer of abdominal muscle
11.12
NA
NA
7.39
8.34
1.85
NA
NA
20.36
21.31
09027105

A
Transfer of spinal muscle
11.81
NA
NA
7.93
8.85
1.72
NA
NA
21.46
22.38
09027110

A
Transfer of iliopsoas muscle
13.54
NA
NA
8.61
8.99
2.18
NA
NA
24.33
24.71
09027111

A
Transfer of iliopsoas muscle
12.37
NA
NA
8.13
8.88
1.94
NA
NA
22.44
23.19
09027120

A
Reconstruction of hip socket
19.00
NA
NA
10.79
11.58
3.08
NA
NA
32.87
33.66
09027122

A
Reconstruction of hip socket
15.86
NA
NA
9.49
10.65
2.61
NA
NA
27.96
29.12
09027125

A
Partial hip replacement
16.39
NA
NA
9.69
10.39
2.54
NA
NA
28.62
29.32
09027130

A
Total hip arthroplasty
17.40
NA
NA
10.24
12.54
3.50
NA
NA
31.14
33.44
09027132

A
Total hip arthroplasty
25.41
NA
NA
13.57
15.12
4.04
NA
NA
43.02
44.57
09027134

A
Revise hip joint replacement
30.07
NA
NA
14.86
17.06
4.94
NA
NA
49.87
52.07
09027137

A
Revise hip joint replacement
22.49
NA
NA
11.85
13.41
3.67
NA
NA
38.01
39.57
09027138

A
Revise hip joint replacement
23.49
NA
NA
12.24
13.85
3.84
NA
NA
39.57
41.18
09027140

A
Transplant femur ridge
12.58
NA
NA
7.81
9.01
2.11
NA
NA
22.50
23.70
09027146

A
Incision of hip bone
18.64
NA
NA
10.74
11.78
2.96
NA
NA
32.34
33.38
09027147

A
Revision of hip bone
21.79
NA
NA
11.94
12.92
3.57
NA
NA
37.30
38.28
09027151

A
Incision of hip bones
23.84
NA
NA
12.44
9.07
3.91
NA
NA
40.19
36.82
09027156

A
Revision of hip bones
25.95
NA
NA
13.54
15.43
4.21
NA
NA
43.70
45.59
09027158

A
Revision of pelvis
20.79
NA
NA
7.19
10.03
3.16
NA
NA
31.14
33.98
09027161

A
Incision of neck of femur
17.64
NA
NA
10.42
11.68
2.94
NA
NA
31.00
32.26
09027165

A
Incision/fixation of femur
19.97
NA
NA
11.73
12.62
3.10
NA
NA
34.80
35.69
09027170

A
Repair/graft femur head/neck
17.40
NA
NA
9.82
10.93
2.81
NA
NA
30.03
31.14
09027175

A
Treat slipped epiphysis
9.23
NA
NA
5.80
6.45
1.46
NA
NA
16.49
17.14
09027176

A
Treat slipped epiphysis
12.69
NA
NA
8.26
8.82
2.22
NA
NA
23.17
23.73
09027177

A
Treat slipped epiphysis
15.84
NA
NA
9.69
10.59
2.61
NA
NA
28.14
29.04
09027178

A
Treat slipped epiphysis
12.69
NA
NA
8.26
8.38
2.08
NA
NA
23.03
23.15
09027179

A
Revise head/neck of femur
13.74
NA
NA
8.56
9.63
2.25
NA
NA
24.55
25.62
09027181

A
Treat slipped epiphysis
15.90
NA
NA
9.83
10.11
1.57
NA
NA
27.30
27.58
09027185

A
Revision of femur epiphysis
9.59
NA
NA
6.69
7.31
2.39
NA
NA
18.67
19.29
09027187

A
Reinforce hip bones
14.00
NA
NA
8.72
9.92
2.37
NA
NA
25.09
26.29
09027193

A
Treat pelvic ring fracture
5.92
4.65
4.98
4.78
5.01
0.96
11.53
11.86
11.66
11.89
09027194

A
Treat pelvic ring fracture
10.00
NA
NA
6.62
7.39
1.65
NA
NA
18.27
19.04
09027200

A
Treat tail bone fracture
1.84
2.09
2.19
2.24
2.17
0.28
4.21
4.31
4.36
4.29
09027202

A
Treat tail bone fracture
7.21
NA
NA
11.28
15.47
1.06
NA
NA
19.55
23.74
09027215

A
Treat pelvic fracture(s)
10.39
NA
NA
6.53
6.94
1.97
NA
NA
18.89
19.30
09027216

A
Treat pelvic ring fracture
15.65
NA
NA
9.25
9.51
2.63
NA
NA
27.53
27.79
09027217

A
Treat pelvic ring fracture
14.57
NA
NA
8.70
9.78
2.41
NA
NA
25.68
26.76
09027218

A
Treat pelvic ring fracture
20.85
NA
NA
11.41
11.40
3.48
NA
NA
35.74
35.73
09027220

A
Treat hip socket fracture
6.65
5.28
5.61
5.18
5.52
1.07
13.00
13.33
12.90
13.24
09027222

A
Treat hip socket fracture
13.88
NA
NA
8.50
9.60
2.19
NA
NA
24.57
25.67
09027226

A
Treat hip wall fracture
15.37
NA
NA
9.00
8.11
2.48
NA
NA
26.85
25.96
09027227

A
Treat hip fracture(s)
25.13
NA
NA
13.44
14.91
4.05
NA
NA
42.62
44.09
09027228

A
Treat hip fracture(s)
29.05
NA
NA
15.03
16.97
4.66
NA
NA
48.74
50.68
09027230

A
Treat thigh fracture
5.61
4.98
5.38
4.91
5.05
0.95
11.54
11.94
11.47
11.61
09027232

A
Treat thigh fracture
11.62
NA
NA
6.00
6.88
1.85
NA
NA
19.47
20.35
09027235

A
Treat thigh fracture
12.80
NA
NA
8.05
9.10
2.11
NA
NA
22.96
24.01
09027236

A
Treat thigh fracture
14.54
NA
NA
9.10
10.56
2.71
NA
NA
26.35
27.81
09027238

A
Treat thigh fracture
5.57
NA
NA
4.69
5.03
0.89
NA
NA
11.15
11.49
09027240

A
Treat thigh fracture
13.56
NA
NA
8.10
9.13
2.16
NA
NA
23.82
24.85
09027244

A
Treat thigh fracture
17.00
NA
NA
9.71
10.90
2.77
NA
NA
29.48
30.67
09027245

A
Treat thigh fracture
21.01
NA
NA
11.46
13.17
3.52
NA
NA
35.99
37.70
09027246

A
Treat thigh fracture
4.70
3.93
4.33
3.97
4.31
0.81
9.44
9.84
9.48
9.82
090( print page 49112)27248

A
Treat thigh fracture
10.73
NA
NA
7.01
7.91
1.81
NA
NA
19.55
20.45
09027250

A
Treat hip dislocation
7.12
NA
NA
4.27
4.53
0.62
NA
NA
12.01
12.27
09027252

A
Treat hip dislocation
10.85
NA
NA
6.52
7.20
1.66
NA
NA
19.03
19.71
09027253

A
Treat hip dislocation
13.38
NA
NA
8.26
9.40
2.24
NA
NA
23.88
25.02
09027254

A
Treat hip dislocation
18.71
NA
NA
10.56
11.66
3.17
NA
NA
32.44
33.54
09027256

A
Treat hip dislocation
4.23
2.39
3.24
1.39
1.91
0.46
7.08
7.93
6.08
6.60
01027257

A
Treat hip dislocation
5.33
NA
NA
2.57
2.75
0.69
NA
NA
8.59
8.77
01027258

A
Treat hip dislocation
15.95
NA
NA
9.45
10.52
2.64
NA
NA
28.04
29.11
09027259

A
Treat hip dislocation
22.95
NA
NA
12.91
13.82
3.74
NA
NA
39.60
40.51
09027265

A
Treat hip dislocation
5.04
NA
NA
3.98
4.59
0.63
NA
NA
9.65
10.26
09027266

A
Treat hip dislocation
7.60
NA
NA
5.55
6.14
1.29
NA
NA
14.44
15.03
09027275

A
Manipulation of hip joint
2.27
NA
NA
1.89
2.05
0.39
NA
NA
4.55
4.71
01027280

A
Fusion of sacroiliac joint
14.39
NA
NA
9.05
9.96
2.53
NA
NA
25.97
26.88
09027282

A
Fusion of pubic bones
11.62
NA
NA
7.83
7.96
1.86
NA
NA
21.31
21.44
09027284

A
Fusion of hip joint
24.85
NA
NA
12.86
14.29
3.92
NA
NA
41.63
43.06
09027286

A
Fusion of hip joint
24.89
NA
NA
13.47
15.21
3.12
NA
NA
41.48
43.22
09027290

A
Amputation of leg at hip
24.27
NA
NA
12.53
13.68
3.43
NA
NA
40.23
41.38
09027295

A
Amputation of leg at hip
19.46
NA
NA
9.79
10.93
2.95
NA
NA
32.20
33.34
09027299

C
Pelvis/hip joint surgery
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY27301

A
Drain thigh/knee lesion
6.60
8.23
9.61
4.66
5.02
1.04
15.87
17.25
12.30
12.66
09027303

A
Drainage of bone lesion
8.45
NA
NA
6.07
6.75
1.43
NA
NA
15.95
16.63
09027305

A
Incise thigh tendon & fascia
6.03
NA
NA
4.63
5.04
1.01
NA
NA
11.67
12.08
09027306

A
Incision of thigh tendon
4.61
NA
NA
4.07
4.56
0.85
NA
NA
9.53
10.02
09027307

A
Incision of thigh tendons
5.91
NA
NA
4.81
5.24
1.04
NA
NA
11.76
12.19
09027310

A
Exploration of knee joint
9.80
NA
NA
6.83
7.39
1.61
NA
NA
18.24
18.80
09027315

A
Partial removal, thigh nerve
7.02
NA
NA
5.44
5.07
1.09
NA
NA
13.55
13.18
09027320

A
Partial removal, thigh nerve
6.29
NA
NA
4.75
5.11
1.06
NA
NA
12.10
12.46
09027323

A
Biopsy, thigh soft tissues
2.28
4.09
3.66
1.87
1.88
0.24
6.61
6.18
4.39
4.40
01027324

A
Biopsy, thigh soft tissues
4.89
NA
NA
3.85
4.10
0.75
NA
NA
9.49
9.74
09027327

A
Removal of thigh lesion
4.46
6.08
6.01
3.61
3.69
0.64
11.18
11.11
8.71
8.79
09027328

A
Removal of thigh lesion
5.56
NA
NA
4.07
4.30
0.84
NA
NA
10.47
10.70
09027329

A
Remove tumor, thigh/knee
15.60
NA
NA
8.58
8.91
2.14
NA
NA
26.32
26.65
09027330

A
Biopsy, knee joint lining
4.96
NA
NA
4.12
4.46
0.86
NA
NA
9.94
10.28
09027331

A
Explore/treat knee joint
5.87
NA
NA
4.84
5.35
1.02
NA
NA
11.73
12.24
09027332

A
Removal of knee cartilage
8.26
NA
NA
6.15
6.88
1.43
NA
NA
15.84
16.57
09027333

A
Removal of knee cartilage
7.35
NA
NA
5.73
6.44
1.26
NA
NA
14.34
15.05
09027334

A
Remove knee joint lining
8.99
NA
NA
6.49
7.18
1.51
NA
NA
16.99
17.68
09027335

A
Remove knee joint lining
10.35
NA
NA
7.06
7.93
1.74
NA
NA
19.15
20.02
09027340

A
Removal of kneecap bursa
4.17
NA
NA
4.05
4.43
0.72
NA
NA
8.94
9.32
09027345

A
Removal of knee cyst
5.91
NA
NA
4.89
5.44
1.00
NA
NA
11.80
12.35
09027347

A
Remove knee cyst
6.52
NA
NA
5.26
5.38
0.98
NA
NA
12.76
12.88
09027350

A
Removal of kneecap
8.46
NA
NA
6.29
7.00
1.41
NA
NA
16.16
16.87
09027355

A
Remove femur lesion
7.82
NA
NA
5.87
6.55
1.32
NA
NA
15.01
15.69
09027356

A
Remove femur lesion/graft
9.89
NA
NA
6.86
7.60
1.65
NA
NA
18.40
19.14
09027357

A
Remove femur lesion/graft
10.93
NA
NA
7.54
8.41
1.95
NA
NA
20.42
21.29
09027358

A
Remove femur lesion/fixation
4.73
NA
NA
1.90
2.37
0.82
NA
NA
7.45
7.92
ZZZ27360

A
Partial removal, leg bone(s)
11.26
NA
NA
8.13
9.20
1.83
NA
NA
21.22
22.29
09027365

A
Extensive leg surgery
17.85
NA
NA
10.52
11.39
2.79
NA
NA
31.16
32.03
09027370

A
Injection for knee x-ray
0.96
2.82
3.50
0.33
0.32
0.08
3.86
4.54
1.37
1.36
00027372

A
Removal of foreign body
5.06
8.34
9.62
4.05
4.53
0.84
14.24
15.52
9.95
10.43
09027380

A
Repair of kneecap tendon
7.27
NA
NA
6.08
6.98
1.24
NA
NA
14.59
15.49
09027381

A
Repair/graft kneecap tendon
10.56
NA
NA
7.56
8.71
1.79
NA
NA
19.91
21.06
09027385

A
Repair of thigh muscle
7.93
NA
NA
6.36
7.31
1.36
NA
NA
15.65
16.60
09027386

A
Repair/graft of thigh muscle
10.90
NA
NA
7.98
9.13
1.85
NA
NA
20.73
21.88
09027390

A
Incision of thigh tendon
5.38
NA
NA
4.57
4.98
0.92
NA
NA
10.87
11.28
09027391

A
Incision of thigh tendons
7.31
NA
NA
5.52
6.30
1.23
NA
NA
14.06
14.84
090( print page 49113)27392

A
Incision of thigh tendons
9.43
NA
NA
6.72
7.37
1.57
NA
NA
17.72
18.37
09027393

A
Lengthening of thigh tendon
6.44
NA
NA
5.01
5.63
1.10
NA
NA
12.55
13.17
09027394

A
Lengthening of thigh tendons
8.61
NA
NA
6.19
6.96
1.47
NA
NA
16.27
17.04
09027395

A
Lengthening of thigh tendons
12.01
NA
NA
7.99
8.99
2.04
NA
NA
22.04
23.04
09027396

A
Transplant of thigh tendon
7.97
NA
NA
5.93
6.73
1.34
NA
NA
15.24
16.04
09027397

A
Transplants of thigh tendons
12.38
NA
NA
8.42
8.89
1.82
NA
NA
22.62
23.09
09027400

A
Revise thigh muscles/tendons
9.13
NA
NA
6.17
6.98
1.31
NA
NA
16.61
17.42
09027403

A
Repair of knee cartilage
8.44
NA
NA
6.09
6.91
1.44
NA
NA
15.97
16.79
09027405

A
Repair of knee ligament
8.88
NA
NA
6.44
7.23
1.51
NA
NA
16.83
17.62
09027407

A
Repair of knee ligament
10.62
NA
NA
6.67
7.91
1.78
NA
NA
19.07
20.31
09027409

A
Repair of knee ligaments
13.48
NA
NA
8.44
9.57
2.24
NA
NA
24.16
25.29
09027412

A
Autochondrocyte implant knee
24.43
NA
NA
13.66
14.52
4.35
NA
NA
42.44
43.30
09027415

A
Osteochondral knee allograft
19.69
NA
NA
11.86
12.38
4.35
NA
NA
35.90
36.42
09027418

A
Repair degenerated kneecap
11.37
NA
NA
7.61
8.58
1.88
NA
NA
20.86
21.83
09027420

A
Revision of unstable kneecap
10.06
NA
NA
6.96
7.82
1.71
NA
NA
18.73
19.59
09027422

A
Revision of unstable kneecap
10.01
NA
NA
6.91
7.82
1.70
NA
NA
18.62
19.53
09027424

A
Revision/removal of kneecap
10.04
NA
NA
6.92
7.80
1.70
NA
NA
18.66
19.54
09027425

A
Lat retinacular release open
5.21
NA
NA
4.71
5.32
0.90
NA
NA
10.82
11.43
09027427

A
Reconstruction, knee
9.59
NA
NA
6.70
7.53
1.63
NA
NA
17.92
18.75
09027428

A
Reconstruction, knee
15.23
NA
NA
10.13
10.96
2.42
NA
NA
27.78
28.61
09027429

A
Reconstruction, knee
17.12
NA
NA
11.33
12.14
2.70
NA
NA
31.15
31.96
09027430

A
Revision of thigh muscles
9.96
NA
NA
6.89
7.72
1.69
NA
NA
18.54
19.37
09027435

A
Incision of knee joint
10.60
NA
NA
7.69
8.28
1.69
NA
NA
19.98
20.57
09027437

A
Revise kneecap
8.75
NA
NA
6.24
6.99
1.49
NA
NA
16.48
17.23
09027438

A
Revise kneecap with implant
11.69
NA
NA
7.57
8.30
1.95
NA
NA
21.21
21.94
09027440

A
Revision of knee joint
10.89
NA
NA
7.16
6.28
1.81
NA
NA
19.86
18.98
09027441

A
Revision of knee joint
11.34
NA
NA
7.50
6.91
1.88
NA
NA
20.72
20.13
09027442

A
Revision of knee joint
12.17
NA
NA
7.78
8.63
2.09
NA
NA
22.04
22.89
09027443

A
Revision of knee joint
11.21
NA
NA
7.40
8.39
1.90
NA
NA
20.51
21.50
09027445

A
Revision of knee joint
18.43
NA
NA
10.53
11.90
3.08
NA
NA
32.04
33.41
09027446

A
Revision of knee joint
16.18
NA
NA
9.37
10.80
2.80
NA
NA
28.35
29.78
09027447

A
Total knee arthroplasty
20.81
NA
NA
11.84
13.91
3.79
NA
NA
36.44
38.51
09027448

A
Incision of thigh
11.40
NA
NA
7.43
8.31
1.94
NA
NA
20.77
21.65
09027450

A
Incision of thigh
14.38
NA
NA
8.85
10.15
2.42
NA
NA
25.65
26.95
09027454

A
Realignment of thigh bone
18.89
NA
NA
10.74
12.06
3.12
NA
NA
32.75
34.07
09027455

A
Realignment of knee
13.16
NA
NA
8.40
9.51
2.24
NA
NA
23.80
24.91
09027457

A
Realignment of knee
13.85
NA
NA
8.26
9.51
2.34
NA
NA
24.45
25.70
09027465

A
Shortening of thigh bone
18.36
NA
NA
10.30
10.24
2.47
NA
NA
31.13
31.07
09027466

A
Lengthening of thigh bone
17.03
NA
NA
10.15
11.41
2.77
NA
NA
29.95
31.21
09027468

A
Shorten/lengthen thighs
19.72
NA
NA
11.28
12.08
3.30
NA
NA
34.30
35.10
09027470

A
Repair of thigh
16.87
NA
NA
10.22
11.40
2.79
NA
NA
29.88
31.06
09027472

A
Repair/graft of thigh
18.47
NA
NA
10.72
12.19
3.07
NA
NA
32.26
33.73
09027475

A
Surgery to stop leg growth
8.75
NA
NA
6.65
7.07
1.36
NA
NA
16.76
17.18
09027477

A
Surgery to stop leg growth
9.96
NA
NA
6.65
7.46
1.73
NA
NA
18.34
19.15
09027479

A
Surgery to stop leg growth
12.96
NA
NA
5.11
8.51
2.78
NA
NA
20.85
24.25
09027485

A
Surgery to stop leg growth
8.95
NA
NA
6.24
7.11
1.53
NA
NA
16.72
17.59
09027486

A
Revise/replace knee joint
20.84
NA
NA
11.74
13.05
3.36
NA
NA
35.94
37.25
09027487

A
Revise/replace knee joint
26.83
NA
NA
14.14
15.95
4.39
NA
NA
45.36
47.17
09027488

A
Removal of knee prosthesis
17.32
NA
NA
10.34
11.36
2.74
NA
NA
30.40
31.42
09027495

A
Reinforce thigh
16.31
NA
NA
9.70
10.98
2.71
NA
NA
28.72
30.00
09027496

A
Decompression of thigh/knee
6.58
NA
NA
5.02
5.46
0.99
NA
NA
12.59
13.03
09027497

A
Decompression of thigh/knee
7.64
NA
NA
4.68
5.24
1.15
NA
NA
13.47
14.03
09027498

A
Decompression of thigh/knee
8.46
NA
NA
5.37
5.81
1.24
NA
NA
15.07
15.51
09027499

A
Decompression of thigh/knee
9.23
NA
NA
5.83
6.57
1.47
NA
NA
16.53
17.27
09027500

A
Treatment of thigh fracture
6.15
5.44
5.95
4.65
4.91
1.02
12.61
13.12
11.82
12.08
09027501

A
Treatment of thigh fracture
6.28
5.04
5.60
4.95
5.27
1.03
12.35
12.91
12.26
12.58
09027502

A
Treatment of thigh fracture
11.16
NA
NA
6.92
7.81
1.78
NA
NA
19.86
20.75
09027503

A
Treatment of thigh fracture
11.05
NA
NA
7.26
8.03
1.84
NA
NA
20.15
20.92
09027506

A
Treatment of thigh fracture
19.33
NA
NA
11.21
12.39
3.03
NA
NA
33.57
34.75
09027507

A
Treatment of thigh fracture
14.33
NA
NA
8.20
9.43
2.42
NA
NA
24.95
26.18
09027508

A
Treatment of thigh fracture
6.00
5.71
6.27
5.07
5.38
0.97
12.68
13.24
12.04
12.35
09027509

A
Treatment of thigh fracture
7.94
NA
NA
6.57
7.61
1.34
NA
NA
15.85
16.89
09027510

A
Treatment of thigh fracture
9.60
NA
NA
6.34
7.08
1.53
NA
NA
17.47
18.21
09027511

A
Treatment of thigh fracture
13.86
NA
NA
9.11
10.68
2.37
NA
NA
25.34
26.91
09027513

A
Treatment of thigh fracture
19.37
NA
NA
11.85
13.37
3.12
NA
NA
34.34
35.86
09027514

A
Treatment of thigh fracture
19.00
NA
NA
11.98
13.01
3.00
NA
NA
33.98
35.01
090( print page 49114)27516

A
Treat thigh fx growth plate
5.36
5.69
6.19
5.05
5.40
0.81
11.86
12.36
11.22
11.57
09027517

A
Treat thigh fx growth plate
8.89
NA
NA
6.04
7.10
1.22
NA
NA
16.15
17.21
09027519

A
Treat thigh fx growth plate
15.72
NA
NA
9.88
11.16
2.55
NA
NA
28.15
29.43
09027520

A
Treat kneecap fracture
2.86
4.11
4.43
3.53
3.46
0.47
7.44
7.76
6.86
6.79
09027524

A
Treat kneecap fracture
10.17
NA
NA
6.98
7.92
1.74
NA
NA
18.89
19.83
09027530

A
Treat knee fracture
3.89
4.83
5.19
4.27
4.38
0.65
9.37
9.73
8.81
8.92
09027532

A
Treat knee fracture
7.35
6.45
7.13
5.67
6.26
1.26
15.06
15.74
14.28
14.87
09027535

A
Treat knee fracture
11.72
NA
NA
8.26
9.65
2.00
NA
NA
21.98
23.37
09027536

A
Treat knee fracture
17.11
NA
NA
10.29
11.28
2.73
NA
NA
30.13
31.12
09027538

A
Treat knee fracture(s)
4.86
5.54
5.98
4.92
5.12
0.84
11.24
11.68
10.62
10.82
09027540

A
Treat knee fracture
13.38
NA
NA
8.02
9.14
2.27
NA
NA
23.67
24.79
09027550

A
Treat knee dislocation
5.75
5.31
5.84
4.59
4.85
0.76
11.82
12.35
11.10
11.36
09027552

A
Treat knee dislocation
7.95
NA
NA
6.12
6.74
1.36
NA
NA
15.43
16.05
09027556

A
Treat knee dislocation
14.87
NA
NA
9.31
11.07
2.50
NA
NA
26.68
28.44
09027557

A
Treat knee dislocation
17.22
NA
NA
10.58
12.49
2.97
NA
NA
30.77
32.68
09027558

A
Treat knee dislocation
17.93
NA
NA
10.62
12.44
3.08
NA
NA
31.63
33.45
09027560

A
Treat kneecap dislocation
3.81
3.93
4.61
3.41
3.24
0.40
8.14
8.82
7.62
7.45
09027562

A
Treat kneecap dislocation
5.78
NA
NA
4.45
4.69
0.94
NA
NA
11.17
11.41
09027566

A
Treat kneecap dislocation
12.51
NA
NA
7.85
8.95
2.12
NA
NA
22.48
23.58
09027570

A
Fixation of knee joint
1.74
NA
NA
1.62
1.73
0.30
NA
NA
3.66
3.77
01027580

A
Fusion of knee
20.82
NA
NA
12.34
14.19
3.37
NA
NA
36.53
38.38
09027590

A
Amputate leg at thigh
13.27
NA
NA
6.14
6.54
1.74
NA
NA
21.15
21.55
09027591

A
Amputate leg at thigh
13.74
NA
NA
7.43
8.34
2.02
NA
NA
23.19
24.10
09027592

A
Amputate leg at thigh
10.78
NA
NA
5.50
6.00
1.45
NA
NA
17.73
18.23
09027594

A
Amputation follow-up surgery
7.09
NA
NA
4.76
5.07
1.02
NA
NA
12.87
13.18
09027596

A
Amputation follow-up surgery
11.06
NA
NA
6.06
6.62
1.57
NA
NA
18.69
19.25
09027598

A
Amputate lower leg at knee
10.99
NA
NA
6.34
6.85
1.65
NA
NA
18.98
19.49
09027599

C
Leg surgery procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY27600

A
Decompression of lower leg
5.88
NA
NA
3.85
4.36
0.86
NA
NA
10.59
11.10
09027601

A
Decompression of lower leg
5.87
NA
NA
4.26
4.70
0.80
NA
NA
10.93
11.37
09027602

A
Decompression of lower leg
7.64
NA
NA
4.39
4.95
1.10
NA
NA
13.13
13.69
09027603

A
Drain lower leg lesion
5.05
7.05
7.38
3.90
4.10
0.74
12.84
13.17
9.69
9.89
09027604

A
Drain lower leg bursa
4.46
6.47
6.18
3.42
3.83
0.69
11.62
11.33
8.57
8.98
09027605

A
Incision of achilles tendon
2.87
5.28
7.08
1.78
2.19
0.41
8.56
10.36
5.06
5.47
01027606

A
Incision of achilles tendon
4.13
NA
NA
2.67
3.19
0.69
NA
NA
7.49
8.01
01027607

A
Treat lower leg bone lesion
8.44
NA
NA
5.76
6.07
1.31
NA
NA
15.51
15.82
09027610

A
Explore/treat ankle joint
8.93
NA
NA
6.17
6.79
1.40
NA
NA
16.50
17.12
09027612

A
Exploration of ankle joint
7.92
NA
NA
5.35
5.91
1.13
NA
NA
14.40
14.96
09027613

A
Biopsy lower leg soft tissue
2.17
3.81
3.38
1.72
1.78
0.20
6.18
5.75
4.09
4.15
01027614

A
Biopsy lower leg soft tissue
5.65
7.88
7.32
4.00
4.33
0.78
14.31
13.75
10.43
10.76
09027615

A
Remove tumor, lower leg
12.84
NA
NA
8.04
9.05
1.83
NA
NA
22.71
23.72
09027618

A
Remove lower leg lesion
5.08
6.40
6.11
3.77
3.94
0.72
12.20
11.91
9.57
9.74
09027619

A
Remove lower leg lesion
8.39
10.08
9.65
5.29
5.79
1.25
19.72
19.29
14.93
15.43
09027620

A
Explore/treat ankle joint
5.97
NA
NA
4.61
5.25
0.97
NA
NA
11.55
12.19
09027625

A
Remove ankle joint lining
8.29
NA
NA
5.59
6.24
1.28
NA
NA
15.16
15.81
09027626

A
Remove ankle joint lining
8.90
NA
NA
5.95
6.68
1.48
NA
NA
16.33
17.06
09027630

A
Removal of tendon lesion
4.79
7.98
7.67
3.80
4.24
0.74
13.51
13.20
9.33
9.77
09027635

A
Remove lower leg bone lesion
7.83
NA
NA
5.67
6.47
1.31
NA
NA
14.81
15.61
09027637

A
Remove/graft leg bone lesion
10.08
NA
NA
7.16
8.01
1.66
NA
NA
18.90
19.75
09027638

A
Remove/graft leg bone lesion
10.79
NA
NA
6.98
7.96
1.84
NA
NA
19.61
20.59
09027640

A
Partial removal of tibia
12.01
NA
NA
8.19
9.78
1.88
NA
NA
22.08
23.67
09027641

A
Partial removal of fibula
9.65
NA
NA
6.78
7.95
1.46
NA
NA
17.89
19.06
09027645

A
Extensive lower leg surgery
14.69
NA
NA
9.51
11.42
2.41
NA
NA
26.61
28.52
09027646

A
Extensive lower leg surgery
13.12
NA
NA
8.41
10.38
2.05
NA
NA
23.58
25.55
09027647

A
Extensive ankle/heel surgery
12.76
NA
NA
6.61
7.36
1.75
NA
NA
21.12
21.87
09027648

A
Injection for ankle x-ray
0.96
2.71
3.32
0.31
0.33
0.08
3.75
4.36
1.35
1.37
000( print page 49115)27650

A
Repair achilles tendon
9.86
NA
NA
6.30
7.21
1.59
NA
NA
17.75
18.66
09027652

A
Repair/graft achilles tendon
10.55
NA
NA
6.45
7.64
1.71
NA
NA
18.71
19.90
09027654

A
Repair of achilles tendon
10.24
NA
NA
5.96
6.85
1.58
NA
NA
17.78
18.67
09027656

A
Repair leg fascia defect
4.56
8.06
8.41
3.65
3.74
0.69
13.31
13.66
8.90
8.99
09027658

A
Repair of leg tendon, each
4.97
NA
NA
3.91
4.40
0.79
NA
NA
9.67
10.16
09027659

A
Repair of leg tendon, each
6.92
NA
NA
4.87
5.45
1.09
NA
NA
12.88
13.46
09027664

A
Repair of leg tendon, each
4.58
NA
NA
3.95
4.40
0.76
NA
NA
9.29
9.74
09027665

A
Repair of leg tendon, each
5.39
NA
NA
4.50
4.85
0.89
NA
NA
10.78
11.13
09027675

A
Repair lower leg tendons
7.17
NA
NA
4.75
5.49
1.11
NA
NA
13.03
13.77
09027676

A
Repair lower leg tendons
8.53
NA
NA
5.79
6.51
1.37
NA
NA
15.69
16.41
09027680

A
Release of lower leg tendon
5.73
NA
NA
4.37
4.93
0.93
NA
NA
11.03
11.59
09027681

A
Release of lower leg tendons
6.87
NA
NA
4.77
5.63
1.15
NA
NA
12.79
13.65
09027685

A
Revision of lower leg tendon
6.49
8.82
7.67
4.59
5.24
0.97
16.28
15.13
12.05
12.70
09027686

A
Revise lower leg tendons
7.57
NA
NA
5.38
6.21
1.24
NA
NA
14.19
15.02
09027687

A
Revision of calf tendon
6.23
NA
NA
4.54
5.12
1.00
NA
NA
11.77
12.35
09027690

A
Revise lower leg tendon
8.88
NA
NA
5.47
6.13
1.33
NA
NA
15.68
16.34
09027691

A
Revise lower leg tendon
10.19
NA
NA
6.72
7.50
1.64
NA
NA
18.55
19.33
09027692

A
Revise additional leg tendon
1.87
NA
NA
0.73
0.88
0.32
NA
NA
2.92
3.07
ZZZ27695

A
Repair of ankle ligament
6.50
NA
NA
5.00
5.65
1.05
NA
NA
12.55
13.20
09027696

A
Repair of ankle ligaments
8.38
NA
NA
5.39
6.17
1.28
NA
NA
15.05
15.83
09027698

A
Repair of ankle ligament
9.41
NA
NA
5.93
6.69
1.47
NA
NA
16.81
17.57
09027700

A
Revision of ankle joint
9.46
NA
NA
5.14
5.55
1.30
NA
NA
15.90
16.31
09027702

A
Reconstruct ankle joint
14.19
NA
NA
8.73
10.03
2.37
NA
NA
25.29
26.59
09027703

A
Reconstruction, ankle joint
16.69
NA
NA
9.89
10.90
2.76
NA
NA
29.34
30.35
09027704

A
Removal of ankle implant
7.61
NA
NA
5.70
5.62
1.27
NA
NA
14.58
14.50
09027705

A
Incision of tibia
10.66
NA
NA
6.91
7.86
1.80
NA
NA
19.37
20.32
09027707

A
Incision of fibula
4.60
NA
NA
4.50
4.83
0.76
NA
NA
9.86
10.19
09027709

A
Incision of tibia & fibula
17.24
NA
NA
9.94
8.58
1.73
NA
NA
28.91
27.55
09027712

A
Realignment of lower leg
15.59
NA
NA
9.18
10.35
2.47
NA
NA
27.24
28.41
09027715

A
Revision of lower leg
15.27
NA
NA
9.07
10.35
2.49
NA
NA
26.83
28.11
09027720

A
Repair of tibia
12.13
NA
NA
7.97
9.04
2.04
NA
NA
22.14
23.21
09027722

A
Repair/graft of tibia
12.22
NA
NA
8.07
8.87
2.05
NA
NA
22.34
23.14
09027724

A
Repair/graft of tibia
19.12
NA
NA
10.34
11.86
3.16
NA
NA
32.62
34.14
09027725

A
Repair of lower leg
17.07
NA
NA
10.61
11.59
2.71
NA
NA
30.39
31.37
09027727

A
Repair of lower leg
14.59
NA
NA
8.59
9.90
2.43
NA
NA
25.61
26.92
09027730

A
Repair of tibia epiphysis
7.52
NA
NA
5.30
6.14
1.72
NA
NA
14.54
15.38
09027732

A
Repair of fibula epiphysis
5.31
NA
NA
4.68
4.87
0.77
NA
NA
10.76
10.95
09027734

A
Repair lower leg epiphyses
8.65
NA
NA
6.20
6.26
1.35
NA
NA
16.20
16.26
09027740

A
Repair of leg epiphyses
9.41
NA
NA
6.65
7.66
1.62
NA
NA
17.68
18.69
09027742

A
Repair of leg epiphyses
10.40
NA
NA
5.20
5.47
1.79
NA
NA
17.39
17.66
09027745

A
Reinforce tibia
10.29
NA
NA
7.01
7.88
1.75
NA
NA
19.05
19.92
09027750

A
Treatment of tibia fracture
3.19
4.33
4.65
3.74
3.82
0.55
8.07
8.39
7.48
7.56
09027752

A
Treatment of tibia fracture
6.07
5.98
6.48
5.14
5.54
1.01
13.06
13.56
12.22
12.62
09027756

A
Treatment of tibia fracture
7.25
NA
NA
5.77
6.29
1.17
NA
NA
14.19
14.71
09027758

A
Treatment of tibia fracture
12.31
NA
NA
8.07
8.90
2.03
NA
NA
22.41
23.24
09027759

A
Treatment of tibia fracture
14.23
NA
NA
8.73
9.92
2.38
NA
NA
25.34
26.53
09027760

A
Treatment of ankle fracture
3.01
4.29
4.58
3.68
3.61
0.48
7.78
8.07
7.17
7.10
09027762

A
Treatment of ankle fracture
5.24
5.58
6.14
4.75
5.14
0.85
11.67
12.23
10.84
11.23
09027766

A
Treatment of ankle fracture
8.65
NA
NA
6.29
6.99
1.44
NA
NA
16.38
17.08
09027780

A
Treatment of fibula fracture
2.65
3.89
4.11
3.33
3.24
0.41
6.95
7.17
6.39
6.30
09027781

A
Treatment of fibula fracture
4.39
4.97
5.36
4.34
4.57
0.73
10.09
10.48
9.46
9.69
09027784

A
Treatment of fibula fracture
7.34
NA
NA
5.62
6.26
1.23
NA
NA
14.19
14.83
09027786

A
Treatment of ankle fracture
2.84
4.07
4.36
3.44
3.36
0.46
7.37
7.66
6.74
6.66
09027788

A
Treatment of ankle fracture
4.44
5.00
5.48
4.26
4.55
0.74
10.18
10.66
9.44
9.73
09027792

A
Treatment of ankle fracture
7.83
NA
NA
5.95
6.71
1.32
NA
NA
15.10
15.86
09027808

A
Treatment of ankle fracture
2.83
4.40
4.70
3.70
3.70
0.46
7.69
7.99
6.99
6.99
09027810

A
Treatment of ankle fracture
5.12
5.46
6.05
4.60
5.01
0.82
11.40
11.99
10.54
10.95
09027814

A
Treatment of ankle fracture
11.02
NA
NA
7.28
8.24
1.85
NA
NA
20.15
21.11
09027816

A
Treatment of ankle fracture
2.89
4.03
4.29
3.36
3.40
0.43
7.35
7.61
6.68
6.72
09027818

A
Treatment of ankle fracture
5.49
5.44
6.14
4.47
5.00
0.82
11.75
12.45
10.78
11.31
09027822

A
Treatment of ankle fracture
12.04
NA
NA
8.87
10.21
1.91
NA
NA
22.82
24.16
09027823

A
Treatment of ankle fracture
14.18
NA
NA
9.51
10.98
2.25
NA
NA
25.94
27.41
09027824

A
Treat lower leg fracture
3.14
3.74
3.98
3.55
3.56
0.45
7.33
7.57
7.14
7.15
09027825

A
Treat lower leg fracture
6.54
5.88
6.42
4.84
5.25
1.02
13.44
13.98
12.40
12.81
09027826

A
Treat lower leg fracture
8.89
NA
NA
7.01
8.37
1.47
NA
NA
17.37
18.73
09027827

A
Treat lower leg fracture
15.65
NA
NA
10.82
12.28
2.43
NA
NA
28.90
30.36
090( print page 49116)27828

A
Treat lower leg fracture
18.07
NA
NA
12.36
13.54
2.81
NA
NA
33.24
34.42
09027829

A
Treat lower leg joint
5.60
NA
NA
5.53
6.47
0.95
NA
NA
12.08
13.02
09027830

A
Treat lower leg dislocation
3.78
4.32
4.37
3.76
3.83
0.54
8.64
8.69
8.08
8.15
09027831

A
Treat lower leg dislocation
4.55
NA
NA
3.99
4.34
0.73
NA
NA
9.27
9.62
09027832

A
Treat lower leg dislocation
6.60
NA
NA
4.75
5.82
1.03
NA
NA
12.38
13.45
09027840

A
Treat ankle dislocation
4.57
NA
NA
3.62
3.73
0.46
NA
NA
8.65
8.76
09027842

A
Treat ankle dislocation
6.26
NA
NA
4.90
5.07
1.00
NA
NA
12.16
12.33
09027846

A
Treat ankle dislocation
10.08
NA
NA
6.87
7.67
1.70
NA
NA
18.65
19.45
09027848

A
Treat ankle dislocation
11.48
NA
NA
7.72
9.21
1.94
NA
NA
21.14
22.63
09027860

A
Fixation of ankle joint
2.34
NA
NA
1.70
1.91
0.39
NA
NA
4.43
4.64
01027870

A
Fusion of ankle joint, open
15.13
NA
NA
9.19
10.19
2.36
NA
NA
26.68
27.68
09027871

A
Fusion of tibiofibular joint
9.34
NA
NA
6.54
7.32
1.59
NA
NA
17.47
18.25
09027880

A
Amputation of lower leg
15.18
NA
NA
6.78
7.04
1.75
NA
NA
23.71
23.97
09027881

A
Amputation of lower leg
13.22
NA
NA
7.45
8.49
1.98
NA
NA
22.65
23.69
09027882

A
Amputation of lower leg
9.59
NA
NA
5.55
6.25
1.29
NA
NA
16.43
17.13
09027884

A
Amputation follow-up surgery
8.56
NA
NA
5.11
5.59
1.22
NA
NA
14.89
15.37
09027886

A
Amputation follow-up surgery
9.79
NA
NA
5.75
6.32
1.40
NA
NA
16.94
17.51
09027888

A
Amputation of foot at ankle
10.14
NA
NA
6.25
7.19
1.51
NA
NA
17.90
18.84
09027889

A
Amputation of foot at ankle
10.63
NA
NA
5.35
6.19
1.46
NA
NA
17.44
18.28
09027892

A
Decompression of leg
7.74
NA
NA
4.88
5.41
1.10
NA
NA
13.72
14.25
09027893

A
Decompression of leg
7.70
NA
NA
5.14
5.38
1.10
NA
NA
13.94
14.18
09027894

A
Decompression of leg
12.32
NA
NA
7.36
7.67
1.65
NA
NA
21.33
21.64
09027899

C
Leg/ankle surgery procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY28001

A
Drainage of bursa of foot
2.73
4.04
3.25
1.63
1.87
0.33
7.10
6.31
4.69
4.93
01028002

A
Treatment of foot infection
5.72
6.77
5.44
3.62
3.73
0.61
13.10
11.77
9.95
10.06
01028003

A
Treatment of foot infection
8.88
7.86
6.64
4.61
5.07
1.12
17.86
16.64
14.61
15.07
09028005

A
Treat foot bone lesion
9.21
NA
NA
5.48
5.90
1.16
NA
NA
15.85
16.27
09028008

A
Incision of foot fascia
4.44
6.22
4.97
3.02
3.16
0.57
11.23
9.98
8.03
8.17
09028010

A
Incision of toe tendon
2.84
2.87
2.50
2.35
2.37
0.36
6.07
5.70
5.55
5.57
09028011

A
Incision of toe tendons
4.13
3.83
3.43
3.05
3.24
0.59
8.55
8.15
7.77
7.96
09028020

A
Exploration of foot joint
5.00
7.57
6.40
3.68
4.02
0.72
13.29
12.12
9.40
9.74
09028022

A
Exploration of foot joint
4.66
6.94
5.63
3.33
3.72
0.62
12.22
10.91
8.61
9.00
09028024

A
Exploration of toe joint
4.37
6.71
5.59
3.19
3.74
0.58
11.66
10.54
8.14
8.69
09028030

A
Removal of foot nerve
6.14
NA
NA
3.47
3.61
0.74
NA
NA
10.35
10.49
09028035

A
Decompression of tibia nerve
5.08
7.52
6.27
3.68
3.99
0.70
13.30
12.05
9.46
9.77
09028043

A
Excision of foot lesion
3.53
4.84
4.07
2.76
3.07
0.46
8.83
8.06
6.75
7.06
09028045

A
Excision of foot lesion
4.71
7.12
5.81
3.29
3.52
0.63
12.46
11.15
8.63
8.86
09028046

A
Resection of tumor, foot
10.46
10.49
9.19
5.84
6.31
1.36
22.31
21.01
17.66
18.13
09028050

A
Biopsy of foot joint lining
4.24
6.93
5.40
3.28
3.51
0.60
11.77
10.24
8.12
8.35
09028052

A
Biopsy of foot joint lining
3.93
6.49
5.31
2.96
3.31
0.53
10.95
9.77
7.42
7.77
09028054

A
Biopsy of toe joint lining
3.44
6.25
5.10
2.78
3.12
0.46
10.15
9.00
6.68
7.02
09028060

A
Partial removal, foot fascia
5.22
7.19
5.90
3.60
3.80
0.70
13.11
11.82
9.52
9.72
09028062

A
Removal of foot fascia
6.51
7.91
6.86
3.86
3.97
0.83
15.25
14.20
11.20
11.31
09028070

A
Removal of foot joint lining
5.09
7.27
5.73
3.48
3.73
0.73
13.09
11.55
9.30
9.55
09028072

A
Removal of foot joint lining
4.57
7.66
6.06
3.65
4.14
0.68
12.91
11.31
8.90
9.39
09028080

A
Removal of foot lesion
4.57
7.73
5.77
4.22
3.82
0.47
12.77
10.81
9.26
8.86
09028086

A
Excise foot tendon sheath
4.77
7.85
7.95
3.80
4.46
0.76
13.38
13.48
9.33
9.99
09028088

A
Excise foot tendon sheath
3.85
7.00
6.06
3.18
3.71
0.61
11.46
10.52
7.64
8.17
09028090

A
Removal of foot lesion
4.40
6.84
5.57
3.21
3.39
0.59
11.83
10.56
8.20
8.38
09028092

A
Removal of toe lesions
3.63
6.55
5.55
3.02
3.40
0.49
10.67
9.67
7.14
7.52
09028100

A
Removal of ankle/heel lesion
5.65
8.29
8.04
4.10
4.54
0.82
14.76
14.51
10.57
11.01
09028102

A
Remove/graft foot lesion
7.72
NA
NA
4.97
5.70
1.14
NA
NA
13.83
14.56
09028103

A
Remove/graft foot lesion
6.49
NA
NA
4.17
4.50
0.91
NA
NA
11.57
11.90
09028104

A
Removal of foot lesion
5.11
7.31
5.94
3.50
3.82
0.70
13.12
11.75
9.31
9.63
09028106

A
Remove/graft foot lesion
7.15
NA
NA
4.46
4.44
0.97
NA
NA
12.58
12.56
09028107

A
Remove/graft foot lesion
5.55
7.90
6.87
3.76
4.09
0.74
14.19
13.16
10.05
10.38
090( print page 49117)28108

A
Removal of toe lesions
4.15
6.42
5.05
3.01
3.19
0.53
11.10
9.73
7.69
7.87
09028110

A
Part removal of metatarsal
4.07
7.02
5.66
3.10
3.19
0.54
11.63
10.27
7.71
7.80
09028111

A
Part removal of metatarsal
5.00
7.37
6.55
3.33
3.57
0.67
13.04
12.22
9.00
9.24
09028112

A
Part removal of metatarsal
4.48
7.31
6.18
3.30
3.50
0.61
12.40
11.27
8.39
8.59
09028113

A
Part removal of metatarsal
5.78
8.48
6.66
4.67
4.40
0.63
14.89
13.07
11.08
10.81
09028114

A
Removal of metatarsal heads
11.49
13.43
12.07
8.31
8.36
1.42
26.34
24.98
21.22
21.27
09028116

A
Revision of foot
8.86
9.58
7.49
5.41
5.23
1.03
19.47
17.38
15.30
15.12
09028118

A
Removal of heel bone
5.95
8.00
6.68
4.05
4.27
0.84
14.79
13.47
10.84
11.06
09028119

A
Removal of heel spur
5.38
7.28
5.89
3.60
3.69
0.70
13.36
11.97
9.68
9.77
09028120

A
Part removal of ankle/heel
5.57
8.14
7.50
3.98
4.30
0.77
14.48
13.84
10.32
10.64
09028122

A
Partial removal of foot bone
7.46
8.57
7.27
4.83
5.15
0.98
17.01
15.71
13.27
13.59
09028124

A
Partial removal of toe
4.80
6.82
5.45
3.47
3.61
0.60
12.22
10.85
8.87
9.01
09028126

A
Partial removal of toe
3.51
6.00
4.66
2.67
2.91
0.45
9.96
8.62
6.63
6.87
09028130

A
Removal of ankle bone
9.22
NA
NA
5.91
6.51
1.26
NA
NA
16.39
16.99
09028140

A
Removal of metatarsal
6.96
7.91
7.39
4.16
4.61
0.92
15.79
15.27
12.04
12.49
09028150

A
Removal of toe
4.08
6.46
5.24
3.03
3.22
0.53
11.07
9.85
7.64
7.83
09028153

A
Partial removal of toe
3.65
6.23
4.79
2.89
2.73
0.47
10.35
8.91
7.01
6.85
09028160

A
Partial removal of toe
3.73
6.41
5.02
2.97
3.24
0.49
10.63
9.24
7.19
7.46
09028171

A
Extensive foot surgery
9.77
NA
NA
5.34
5.40
1.33
NA
NA
16.44
16.50
09028173

A
Extensive foot surgery
8.97
8.85
7.91
4.68
5.06
1.12
18.94
18.00
14.77
15.15
09028175

A
Extensive foot surgery
6.10
7.18
6.07
3.64
3.69
0.73
14.01
12.90
10.47
10.52
09028190

A
Removal of foot foreign body
1.96
4.04
3.55
1.34
1.45
0.22
6.22
5.73
3.52
3.63
01028192

A
Removal of foot foreign body
4.63
6.79
5.80
3.22
3.54
0.61
12.03
11.04
8.46
8.78
09028193

A
Removal of foot foreign body
5.72
7.38
6.05
3.64
3.85
0.73
13.83
12.50
10.09
10.30
09028200

A
Repair of foot tendon
4.59
6.95
5.56
3.26
3.48
0.61
12.15
10.76
8.46
8.68
09028202

A
Repair/graft of foot tendon
6.89
8.03
7.42
4.09
4.39
0.91
15.83
15.22
11.89
12.19
09028208

A
Repair of foot tendon
4.36
6.73
5.29
3.19
3.27
0.58
11.67
10.23
8.13
8.21
09028210

A
Repair/graft of foot tendon
6.34
7.59
6.56
3.91
3.99
0.81
14.74
13.71
11.06
11.14
09028220

A
Release of foot tendon
4.52
6.45
5.12
3.09
3.34
0.57
11.54
10.21
8.18
8.43
09028222

A
Release of foot tendons
5.61
6.93
5.66
3.34
3.93
0.69
13.23
11.96
9.64
10.23
09028225

A
Release of foot tendon
3.65
6.09
4.73
2.75
2.86
0.46
10.20
8.84
6.86
6.97
09028226

A
Release of foot tendons
4.52
7.01
5.35
3.32
3.64
0.58
12.11
10.45
8.42
8.74
09028230

A
Incision of foot tendon(s)
4.23
6.34
5.09
2.91
3.48
0.55
11.12
9.87
7.69
8.26
09028232

A
Incision of toe tendon
3.38
5.99
4.89
2.70
3.16
0.44
9.81
8.71
6.52
6.98
09028234

A
Incision of foot tendon
3.36
6.32
5.08
3.06
3.28
0.44
10.12
8.88
6.86
7.08
09028238

A
Revision of foot tendon
7.78
8.40
7.53
4.37
4.79
1.06
17.24
16.37
13.21
13.63
09028240

A
Release of big toe
4.35
6.47
5.09
3.00
3.36
0.58
11.40
10.02
7.93
8.29
09028250

A
Revision of foot fascia
5.91
7.49
6.09
3.78
4.04
0.82
14.22
12.82
10.51
10.77
09028260

A
Release of midfoot joint
8.01
8.65
6.90
4.73
4.93
1.14
17.80
16.05
13.88
14.08
09028261

A
Revision of foot tendon
12.83
10.79
9.16
6.40
7.08
1.57
25.19
23.56
20.80
21.48
09028262

A
Revision of foot and ankle
16.93
15.68
14.08
9.83
10.64
2.59
35.20
33.60
29.35
30.16
09028264

A
Release of midfoot joint
10.45
10.45
8.41
6.03
6.97
1.54
22.44
20.40
18.02
18.96
09028270

A
Release of foot contracture
4.75
6.97
5.41
3.46
3.66
0.62
12.34
10.78
8.83
9.03
09028272

A
Release of toe joint, each
3.79
5.87
4.60
2.66
2.80
0.46
10.12
8.85
6.91
7.05
09028280

A
Fusion of toes
5.18
7.41
6.53
3.60
4.26
0.73
13.32
12.44
9.51
10.17
09028285

A
Repair of hammertoe
4.58
6.77
5.34
3.37
3.41
0.59
11.94
10.51
8.54
8.58
09028286

A
Repair of hammertoe
4.55
6.54
5.23
3.05
3.20
0.57
11.66
10.35
8.17
8.32
09028288

A
Partial removal of foot bone
5.73
8.69
6.62
4.74
4.85
0.65
15.07
13.00
11.12
11.23
09028289

A
Repair hallux rigidus
8.03
9.52
8.37
5.39
5.67
1.02
18.57
17.42
14.44
14.72
09028290

A
Correction of bunion
5.65
8.24
6.75
3.98
4.54
0.82
14.71
13.22
10.45
11.01
09028292

A
Correction of bunion
8.60
10.42
8.20
6.19
5.70
0.91
19.93
17.71
15.70
15.21
09028293

A
Correction of bunion
10.96
14.60
11.71
6.97
6.32
1.13
26.69
23.80
19.06
18.41
09028294

A
Correction of bunion
8.55
9.19
7.87
4.61
4.69
1.09
18.83
17.51
14.25
14.33
09028296

A
Correction of bunion
9.23
9.66
8.53
4.83
5.27
1.19
20.08
18.95
15.25
15.69
09028297

A
Correction of bunion
9.23
10.54
9.34
5.36
6.03
1.32
21.09
19.89
15.91
16.58
09028298

A
Correction of bunion
7.93
9.30
7.73
4.58
4.90
1.05
18.28
16.71
13.56
13.88
09028299

A
Correction of bunion
11.31
10.63
9.23
5.77
5.99
1.37
23.31
21.91
18.45
18.67
09028300

A
Incision of heel bone
9.53
NA
NA
6.11
6.80
1.54
NA
NA
17.18
17.87
09028302

A
Incision of ankle bone
9.54
NA
NA
5.72
6.59
1.42
NA
NA
16.68
17.55
09028304

A
Incision of midfoot bones
9.21
9.57
8.35
5.09
5.57
1.27
20.05
18.83
15.57
16.05
09028305

A
Incise/graft midfoot bones
10.54
NA
NA
5.61
6.44
1.27
NA
NA
17.42
18.25
09028306

A
Incision of metatarsal
5.85
8.39
7.22
3.87
4.10
0.84
15.08
13.91
10.56
10.79
09028307

A
Incision of metatarsal
6.32
9.57
10.66
4.48
5.08
0.90
16.79
17.88
11.70
12.30
09028308

A
Incision of metatarsal
5.28
7.95
6.29
3.83
3.72
0.70
13.93
12.27
9.81
9.70
09028309

A
Incision of metatarsals
13.88
NA
NA
7.79
7.91
2.04
NA
NA
23.71
23.83
09028310

A
Revision of big toe
5.42
7.56
6.20
3.42
3.52
0.70
13.68
12.32
9.54
9.64
090( print page 49118)28312

A
Revision of toe
4.54
7.41
5.93
3.24
3.53
0.63
12.58
11.10
8.41
8.70
09028313

A
Repair deformity of toe
5.00
7.39
5.80
3.67
4.54
0.73
13.12
11.53
9.40
10.27
09028315

A
Removal of sesamoid bone
4.85
6.74
5.35
3.25
3.31
0.63
12.22
10.83
8.73
8.79
09028320

A
Repair of foot bones
9.17
NA
NA
5.78
6.48
1.43
NA
NA
16.38
17.08
09028322

A
Repair of metatarsals
8.33
10.03
9.39
5.48
6.12
1.27
19.63
18.99
15.08
15.72
09028340

A
Resect enlarged toe tissue
6.97
8.08
6.85
4.07
4.20
0.84
15.89
14.66
11.88
12.01
09028341

A
Resect enlarged toe
8.52
8.70
7.37
4.47
4.73
1.01
18.23
16.90
14.00
14.26
09028344

A
Repair extra toe(s)
4.25
6.83
6.01
3.19
3.52
0.51
11.59
10.77
7.95
8.28
09028345

A
Repair webbed toe(s)
5.91
7.82
6.60
3.89
4.48
0.80
14.53
13.31
10.60
11.19
09028360

A
Reconstruct cleft foot
14.57
NA
NA
6.39
9.47
2.28
NA
NA
23.24
26.32
09028400

A
Treatment of heel fracture
2.16
3.39
3.57
2.93
3.02
0.35
5.90
6.08
5.44
5.53
09028405

A
Treatment of heel fracture
4.56
4.53
4.76
3.76
4.41
0.73
9.82
10.05
9.05
9.70
09028406

A
Treatment of heel fracture
6.36
NA
NA
5.69
6.52
1.11
NA
NA
13.16
13.99
09028415

A
Treat heel fracture
17.44
NA
NA
10.92
12.69
2.66
NA
NA
31.02
32.79
09028420

A
Treat/graft heel fracture
16.98
NA
NA
10.21
12.24
2.80
NA
NA
29.99
32.02
09028430

A
Treatment of ankle fracture
2.09
3.15
3.33
2.59
2.57
0.31
5.55
5.73
4.99
4.97
09028435

A
Treatment of ankle fracture
3.39
3.76
3.85
3.07
3.57
0.55
7.70
7.79
7.01
7.51
09028436

A
Treatment of ankle fracture
4.70
NA
NA
5.00
5.68
0.81
NA
NA
10.51
11.19
09028445

A
Treat ankle fracture
16.99
NA
NA
9.79
10.72
2.58
NA
NA
29.36
30.29
09028450

A
Treat midfoot fracture, each
1.90
2.95
3.07
2.44
2.46
0.28
5.13
5.25
4.62
4.64
09028455

A
Treat midfoot fracture, each
3.09
3.68
3.49
3.05
3.33
0.44
7.21
7.02
6.58
6.86
09028456

A
Treat midfoot fracture
2.68
NA
NA
3.63
4.02
0.44
NA
NA
6.75
7.14
09028465

A
Treat midfoot fracture, each
7.06
NA
NA
5.09
6.01
1.10
NA
NA
13.25
14.17
09028470

A
Treat metatarsal fracture
1.99
2.84
3.05
2.40
2.43
0.30
5.13
5.34
4.69
4.72
09028475

A
Treat metatarsal fracture
2.97
3.18
3.29
2.56
3.05
0.44
6.59
6.70
5.97
6.46
09028476

A
Treat metatarsal fracture
3.37
NA
NA
4.35
4.82
0.54
NA
NA
8.26
8.73
09028485

A
Treat metatarsal fracture
5.70
NA
NA
4.57
5.22
0.83
NA
NA
11.10
11.75
09028490

A
Treat big toe fracture
1.09
2.11
2.04
1.69
1.65
0.14
3.34
3.27
2.92
2.88
09028495

A
Treat big toe fracture
1.58
2.48
2.25
1.88
2.02
0.20
4.26
4.03
3.66
3.80
09028496

A
Treat big toe fracture
2.33
7.22
7.99
2.90
3.12
0.36
9.91
10.68
5.59
5.81
09028505

A
Treat big toe fracture
3.80
7.53
7.96
3.28
3.75
0.56
11.89
12.32
7.64
8.11
09028510

A
Treatment of toe fracture
1.09
1.68
1.57
1.61
1.55
0.14
2.91
2.80
2.84
2.78
09028515

A
Treatment of toe fracture
1.46
2.25
1.98
1.84
1.88
0.18
3.89
3.62
3.48
3.52
09028525

A
Treat toe fracture
3.32
6.93
7.37
2.92
3.30
0.49
10.74
11.18
6.73
7.11
09028530

A
Treat sesamoid bone fracture
1.06
1.65
1.49
1.36
1.42
0.14
2.85
2.69
2.56
2.62
09028531

A
Treat sesamoid bone fracture
2.47
5.84
6.91
2.13
2.08
0.34
8.65
9.72
4.94
4.89
09028540

A
Treat foot dislocation
2.04
2.78
2.50
2.33
2.38
0.26
5.08
4.80
4.63
4.68
09028545

A
Treat foot dislocation
2.45
3.25
2.57
2.66
2.42
0.37
6.07
5.39
5.48
5.24
09028546

A
Treat foot dislocation
3.20
7.69
7.11
3.45
4.15
0.52
11.41
10.83
7.17
7.87
09028555

A
Repair foot dislocation
6.35
9.82
9.88
4.96
5.49
1.04
17.21
17.27
12.35
12.88
09028570

A
Treat foot dislocation
1.66
2.59
2.46
2.00
2.25
0.23
4.48
4.35
3.89
4.14
09028575

A
Treat foot dislocation
3.31
4.38
3.89
3.68
3.71
0.56
8.25
7.76
7.55
7.58
09028576

A
Treat foot dislocation
4.40
NA
NA
4.01
4.13
0.69
NA
NA
9.10
9.22
09028585

A
Repair foot dislocation
8.10
9.98
7.99
5.29
5.70
1.25
19.33
17.34
14.64
15.05
09028600

A
Treat foot dislocation
1.89
3.06
2.87
2.40
2.61
0.27
5.22
5.03
4.56
4.77
09028605

A
Treat foot dislocation
2.71
3.76
3.28
3.16
3.13
0.40
6.87
6.39
6.27
6.24
09028606

A
Treat foot dislocation
4.89
NA
NA
4.31
4.60
0.82
NA
NA
10.02
10.31
09028615

A
Repair foot dislocation
8.88
NA
NA
7.00
7.78
1.30
NA
NA
17.18
17.96
09028630

A
Treat toe dislocation
1.70
1.96
1.67
0.95
0.99
0.20
3.86
3.57
2.85
2.89
01028635

A
Treat toe dislocation
1.91
2.27
2.08
1.33
1.48
0.26
4.44
4.25
3.50
3.65
01028636

A
Treat toe dislocation
2.77
4.38
4.00
2.05
2.48
0.43
7.58
7.20
5.25
5.68
01028645

A
Repair toe dislocation
4.21
6.90
5.44
3.20
3.25
0.57
11.68
10.22
7.98
8.03
09028660

A
Treat toe dislocation
1.23
1.31
1.27
0.79
0.79
0.13
2.67
2.63
2.15
2.15
01028665

A
Treat toe dislocation
1.92
1.85
1.54
1.34
1.41
0.26
4.03
3.72
3.52
3.59
01028666

A
Treat toe dislocation
2.66
NA
NA
1.92
2.42
0.43
NA
NA
5.01
5.51
01028675

A
Repair of toe dislocation
2.92
6.72
7.04
2.87
3.23
0.45
10.09
10.41
6.24
6.60
090( print page 49119)28705

A
Fusion of foot bones
20.04
NA
NA
10.77
12.02
3.08
NA
NA
33.89
35.14
09028715

A
Fusion of foot bones
14.32
NA
NA
8.54
9.45
2.16
NA
NA
25.02
25.93
09028725

A
Fusion of foot bones
11.89
NA
NA
6.95
7.92
1.86
NA
NA
20.70
21.67
09028730

A
Fusion of foot bones
12.11
NA
NA
7.79
8.31
1.70
NA
NA
21.60
22.12
09028735

A
Fusion of foot bones
11.95
NA
NA
6.99
7.61
1.68
NA
NA
20.62
21.24
09028737

A
Revision of foot bones
10.75
NA
NA
6.13
6.63
1.47
NA
NA
18.35
18.85
09028740

A
Fusion of foot bones
9.01
10.96
10.89
6.04
6.36
1.22
21.19
21.12
16.27
16.59
09028750

A
Fusion of big toe joint
8.29
10.90
11.66
5.95
6.48
1.13
20.32
21.08
15.37
15.90
09028755

A
Fusion of big toe joint
4.73
7.30
6.40
3.37
3.66
0.65
12.68
11.78
8.75
9.04
09028760

A
Fusion of big toe joint
8.86
10.01
8.48
5.34
5.47
1.05
19.92
18.39
15.25
15.38
09028800

A
Amputation of midfoot
8.56
NA
NA
5.08
5.61
1.15
NA
NA
14.79
15.32
09028805

A
Amputation thru metatarsal
12.47
NA
NA
6.02
5.74
1.18
NA
NA
19.67
19.39
09028810

A
Amputation toe & metatarsal
6.44
NA
NA
4.13
4.39
0.86
NA
NA
11.43
11.69
09028820

A
Amputation of toe
4.82
7.78
7.61
3.60
3.74
0.61
13.21
13.04
9.03
9.17
09028825

A
Partial amputation of toe
3.64
7.23
7.05
3.16
3.40
0.50
11.37
11.19
7.30
7.54
09028890

A
High energy eswt, plantar f
3.30
4.65
5.45
2.31
2.14
0.41
8.36
9.16
6.02
5.85
09028899

C
Foot/toes surgery procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY29000

A
Application of body cast
2.25
4.76
3.41
1.85
1.76
0.41
7.42
6.07
4.51
4.42
00029010

A
Application of body cast
2.06
3.37
3.30
1.33
1.66
0.45
5.88
5.81
3.84
4.17
00029015

A
Application of body cast
2.41
3.37
3.07
1.48
1.57
0.28
6.06
5.76
4.17
4.26
00029020

A
Application of body cast
2.11
3.79
3.33
1.48
1.43
0.28
6.18
5.72
3.87
3.82
00029025

A
Application of body cast
2.40
3.62
3.26
1.59
1.79
0.44
6.46
6.10
4.43
4.63
00029035

A
Application of body cast
1.77
3.71
3.64
1.48
1.56
0.28
5.76
5.69
3.53
3.61
00029040

A
Application of body cast
2.22
3.63
2.75
1.50
1.51
0.36
6.21
5.33
4.08
4.09
00029044

A
Application of body cast
2.12
3.98
3.97
1.66
1.84
0.35
6.45
6.44
4.13
4.31
00029046

A
Application of body cast
2.41
4.21
3.48
1.80
2.02
0.42
7.04
6.31
4.63
4.85
00029049

A
Application of figure eight
0.89
1.13
1.26
0.60
0.55
0.13
2.15
2.28
1.62
1.57
00029055

A
Application of shoulder cast
1.78
2.92
2.97
1.31
1.43
0.30
5.00
5.05
3.39
3.51
00029058

A
Application of shoulder cast
1.31
1.25
1.48
0.68
0.71
0.17
2.73
2.96
2.16
2.19
00029065

A
Application of long arm cast
0.87
1.28
1.32
0.71
0.74
0.15
2.30
2.34
1.73
1.76
00029075

A
Application of forearm cast
0.77
1.24
1.26
0.67
0.68
0.13
2.14
2.16
1.57
1.58
00029085

A
Apply hand/wrist cast
0.87
1.26
1.28
0.69
0.65
0.14
2.27
2.29
1.70
1.66
00029086

A
Apply finger cast
0.62
1.03
0.98
0.53
0.50
0.07
1.72
1.67
1.22
1.19
00029105

A
Apply long arm splint
0.87
1.10
1.20
0.53
0.52
0.12
2.09
2.19
1.52
1.51
00029125

A
Apply forearm splint
0.59
0.97
1.01
0.43
0.40
0.07
1.63
1.67
1.09
1.06
00029126

A
Apply forearm splint
0.77
1.02
1.16
0.48
0.47
0.07
1.86
2.00
1.32
1.31
00029130

A
Application of finger splint
0.50
0.43
0.46
0.18
0.17
0.06
0.99
1.02
0.74
0.73
00029131

A
Application of finger splint
0.55
0.63
0.71
0.26
0.25
0.03
1.21
1.29
0.84
0.83
00029200

A
Strapping of chest
0.65
0.62
0.70
0.35
0.34
0.04
1.31
1.39
1.04
1.03
00029220

A
Strapping of low back
0.64
0.62
0.70
0.35
0.38
0.04
1.30
1.38
1.03
1.06
00029240

A
Strapping of shoulder
0.71
0.67
0.81
0.39
0.37
0.06
1.44
1.58
1.16
1.14
00029260

A
Strapping of elbow or wrist
0.55
0.65
0.72
0.36
0.33
0.05
1.25
1.32
0.96
0.93
00029280

A
Strapping of hand or finger
0.51
0.66
0.77
0.37
0.33
0.03
1.20
1.31
0.91
0.87
00029305

A
Application of hip cast
2.03
3.40
3.36
1.61
1.72
0.35
5.78
5.74
3.99
4.10
00029325

A
Application of hip casts
2.32
3.70
3.57
1.75
1.90
0.40
6.42
6.29
4.47
4.62
00029345

A
Application of long leg cast
1.40
1.67
1.74
0.95
1.03
0.24
3.31
3.38
2.59
2.67
00029355

A
Application of long leg cast
1.53
1.64
1.69
0.95
1.08
0.26
3.43
3.48
2.74
2.87
00029358

A
Apply long leg cast brace
1.43
2.06
2.06
0.94
1.05
0.25
3.74
3.74
2.62
2.73
00029365

A
Application of long leg cast
1.18
1.58
1.64
0.86
0.93
0.20
2.96
3.02
2.24
2.31
00029405

A
Apply short leg cast
0.86
1.21
1.22
0.66
0.70
0.14
2.21
2.22
1.66
1.70
00029425

A
Apply short leg cast
1.01
1.24
1.23
0.67
0.72
0.15
2.40
2.39
1.83
1.88
00029435

A
Apply short leg cast
1.18
1.54
1.56
0.82
0.90
0.20
2.92
2.94
2.20
2.28
00029440

A
Addition of walker to cast
0.57
0.62
0.67
0.25
0.27
0.08
1.27
1.32
0.90
0.92
00029445

A
Apply rigid leg cast
1.78
1.62
1.76
0.93
0.95
0.27
3.67
3.81
2.98
3.00
00029450

A
Application of leg cast
2.08
1.53
1.49
0.86
1.03
0.27
3.88
3.84
3.21
3.38
00029505

A
Application, long leg splint
0.69
1.06
1.15
0.45
0.45
0.08
1.83
1.92
1.22
1.22
00029515

A
Application lower leg splint
0.73
0.96
0.89
0.46
0.46
0.09
1.78
1.71
1.28
1.28
00029520

A
Strapping of hip
0.54
0.68
0.81
0.38
0.45
0.03
1.25
1.38
0.95
1.02
00029530

A
Strapping of knee
0.57
0.65
0.76
0.36
0.34
0.05
1.27
1.38
0.98
0.96
00029540

A
Strapping of ankle and/or ft
0.51
0.55
0.45
0.31
0.31
0.06
1.12
1.02
0.88
0.88
00029550

A
Strapping of toes
0.47
0.57
0.46
0.30
0.29
0.06
1.10
0.99
0.83
0.82
00029580

A
Application of paste boot
0.55
0.73
0.67
0.34
0.35
0.07
1.35
1.29
0.96
0.97
00029590

A
Application of foot splint
0.76
0.60
0.53
0.26
0.28
0.09
1.45
1.38
1.11
1.13
00029700

A
Removal/revision of cast
0.57
0.97
0.91
0.26
0.28
0.08
1.62
1.56
0.91
0.93
00029705

A
Removal/revision of cast
0.76
0.77
0.81
0.37
0.38
0.13
1.66
1.70
1.26
1.27
00029710

A
Removal/revision of cast
1.34
1.45
1.51
0.63
0.68
0.20
2.99
3.05
2.17
2.22
000( print page 49120)29715

A
Removal/revision of cast
0.94
1.14
1.16
0.41
0.40
0.09
2.17
2.19
1.44
1.43
00029720

A
Repair of body cast
0.68
1.15
1.16
0.34
0.38
0.12
1.95
1.96
1.14
1.18
00029730

A
Windowing of cast
0.75
0.76
0.80
0.35
0.35
0.12
1.63
1.67
1.22
1.22
00029740

A
Wedging of cast
1.12
1.05
1.13
0.49
0.49
0.18
2.35
2.43
1.79
1.79
00029750

A
Wedging of clubfoot cast
1.26
0.91
1.02
0.44
0.55
0.21
2.38
2.49
1.91
2.02
00029799

C
Casting/strapping procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY29800

A
Jaw arthroscopy/surgery
6.67
NA
NA
5.72
6.66
0.99
NA
NA
13.38
14.32
09029804

A
Jaw arthroscopy/surgery
8.63
NA
NA
7.34
7.55
1.38
NA
NA
17.35
17.56
09029805

A
Shoulder arthroscopy, dx
5.88
NA
NA
4.74
5.44
1.02
NA
NA
11.64
12.34
09029806

A
Shoulder arthroscopy/surgery
14.85
NA
NA
9.41
10.72
2.49
NA
NA
26.75
28.06
09029807

A
Shoulder arthroscopy/surgery
14.38
NA
NA
9.28
10.56
2.41
NA
NA
26.07
27.35
09029819

A
Shoulder arthroscopy/surgery
7.61
NA
NA
5.66
6.51
1.32
NA
NA
14.59
15.44
09029820

A
Shoulder arthroscopy/surgery
7.06
NA
NA
5.21
5.97
1.22
NA
NA
13.49
14.25
09029821

A
Shoulder arthroscopy/surgery
7.71
NA
NA
5.68
6.52
1.33
NA
NA
14.72
15.56
09029822

A
Shoulder arthroscopy/surgery
7.42
NA
NA
5.61
6.42
1.28
NA
NA
14.31
15.12
09029823

A
Shoulder arthroscopy/surgery
8.16
NA
NA
6.07
6.93
1.41
NA
NA
15.64
16.50
09029824

A
Shoulder arthroscopy/surgery
8.74
NA
NA
6.57
7.29
1.42
NA
NA
16.73
17.45
09029825

A
Shoulder arthroscopy/surgery
7.61
NA
NA
5.67
6.49
1.32
NA
NA
14.60
15.42
09029826

A
Shoulder arthroscopy/surgery
8.98
NA
NA
6.22
7.20
1.55
NA
NA
16.75
17.73
09029827

A
Arthroscop rotator cuff repr
15.34
NA
NA
9.38
10.99
2.66
NA
NA
27.38
28.99
09029830

A
Elbow arthroscopy
5.75
NA
NA
4.52
5.14
0.99
NA
NA
11.26
11.88
09029834

A
Elbow arthroscopy/surgery
6.27
NA
NA
4.87
5.59
1.08
NA
NA
12.22
12.94
09029835

A
Elbow arthroscopy/surgery
6.47
NA
NA
4.99
5.66
1.13
NA
NA
12.59
13.26
09029836

A
Elbow arthroscopy/surgery
7.54
NA
NA
5.59
6.49
1.22
NA
NA
14.35
15.25
09029837

A
Elbow arthroscopy/surgery
6.86
NA
NA
5.15
5.89
1.19
NA
NA
13.20
13.94
09029838

A
Elbow arthroscopy/surgery
7.70
NA
NA
5.70
6.59
1.30
NA
NA
14.70
15.59
09029840

A
Wrist arthroscopy
5.53
NA
NA
4.62
5.15
0.84
NA
NA
10.99
11.52
09029843

A
Wrist arthroscopy/surgery
6.00
NA
NA
4.92
5.45
0.92
NA
NA
11.84
12.37
09029844

A
Wrist arthroscopy/surgery
6.36
NA
NA
4.96
5.61
1.04
NA
NA
12.36
13.01
09029845

A
Wrist arthroscopy/surgery
7.51
NA
NA
5.51
6.23
0.99
NA
NA
14.01
14.73
09029846

A
Wrist arthroscopy/surgery
6.74
NA
NA
5.10
5.81
1.07
NA
NA
12.91
13.62
09029847

A
Wrist arthroscopy/surgery
7.07
NA
NA
5.17
5.94
1.08
NA
NA
13.32
14.09
09029848

A
Wrist endoscopy/surgery
6.18
NA
NA
5.29
5.52
0.86
NA
NA
12.33
12.56
09029850

A
Knee arthroscopy/surgery
8.18
NA
NA
5.13
5.07
1.25
NA
NA
14.56
14.50
09029851

A
Knee arthroscopy/surgery
13.08
NA
NA
8.32
9.42
2.34
NA
NA
23.74
24.84
09029855

A
Tibial arthroscopy/surgery
10.60
NA
NA
7.39
8.42
1.84
NA
NA
19.83
20.86
09029856

A
Tibial arthroscopy/surgery
14.12
NA
NA
8.76
10.19
2.39
NA
NA
25.27
26.70
09029860

A
Hip arthroscopy, dx
8.79
NA
NA
6.23
6.77
1.36
NA
NA
16.38
16.92
09029861

A
Hip arthroscopy/surgery
9.89
NA
NA
6.64
7.17
1.59
NA
NA
18.12
18.65
09029862

A
Hip arthroscopy/surgery
10.89
NA
NA
7.62
8.33
1.62
NA
NA
20.13
20.84
09029863

A
Hip arthroscopy/surgery
10.89
NA
NA
7.53
8.27
1.42
NA
NA
19.84
20.58
09029866

A
Autgrft implnt, knee w/scope
14.38
NA
NA
9.54
10.90
2.39
NA
NA
26.31
27.67
09029867

A
Allgrft implnt, knee w/scope
18.08
NA
NA
11.24
12.73
2.78
NA
NA
32.10
33.59
09029868

A
Meniscal trnspl, knee w/scpe
24.79
NA
NA
13.94
16.08
4.35
NA
NA
43.08
45.22
09029870

A
Knee arthroscopy, dx
5.06
NA
NA
4.18
4.71
0.85
NA
NA
10.09
10.62
09029871

A
Knee arthroscopy/drainage
6.54
NA
NA
5.03
5.66
1.14
NA
NA
12.71
13.34
09029873

A
Knee arthroscopy/surgery
5.99
NA
NA
5.61
6.33
1.04
NA
NA
12.64
13.36
09029874

A
Knee arthroscopy/surgery
7.04
NA
NA
5.18
5.85
1.11
NA
NA
13.33
14.00
09029875

A
Knee arthroscopy/surgery
6.30
NA
NA
4.92
5.62
1.09
NA
NA
12.31
13.01
09029876

A
Knee arthroscopy/surgery
8.66
NA
NA
6.23
6.82
1.37
NA
NA
16.26
16.85
09029877

A
Knee arthroscopy/surgery
8.09
NA
NA
5.99
6.55
1.28
NA
NA
15.36
15.92
09029879

A
Knee arthroscopy/surgery
8.78
NA
NA
6.28
6.91
1.39
NA
NA
16.45
17.08
09029880

A
Knee arthroscopy/surgery
9.24
NA
NA
6.48
7.14
1.47
NA
NA
17.19
17.85
09029881

A
Knee arthroscopy/surgery
8.50
NA
NA
6.18
6.77
1.34
NA
NA
16.02
16.61
09029882

A
Knee arthroscopy/surgery
9.39
NA
NA
6.52
7.06
1.50
NA
NA
17.41
17.95
09029883

A
Knee arthroscopy/surgery
11.53
NA
NA
7.65
8.71
1.92
NA
NA
21.10
22.16
090( print page 49121)29884

A
Knee arthroscopy/surgery
8.07
NA
NA
6.01
6.53
1.27
NA
NA
15.35
15.87
09029885

A
Knee arthroscopy/surgery
9.96
NA
NA
7.05
7.74
1.58
NA
NA
18.58
19.28
09029886

A
Knee arthroscopy/surgery
8.28
NA
NA
6.08
6.66
1.30
NA
NA
15.66
16.24
09029887

A
Knee arthroscopy/surgery
9.91
NA
NA
7.04
7.71
1.57
NA
NA
18.52
19.19
09029888

A
Knee arthroscopy/surgery
14.06
NA
NA
8.34
9.74
2.41
NA
NA
24.81
26.21
09029889

A
Knee arthroscopy/surgery
17.05
NA
NA
10.75
12.01
2.78
NA
NA
30.58
31.84
09029891

A
Ankle arthroscopy/surgery
9.39
NA
NA
6.69
7.31
1.39
NA
NA
17.47
18.09
09029892

A
Ankle arthroscopy/surgery
9.99
NA
NA
6.58
7.45
1.41
NA
NA
17.98
18.85
09029893

A
Scope, plantar fasciotomy
5.96
8.86
6.93
4.67
4.16
0.63
15.45
13.52
11.26
10.75
09029894

A
Ankle arthroscopy/surgery
7.20
NA
NA
4.72
5.28
1.15
NA
NA
13.07
13.63
09029895

A
Ankle arthroscopy/surgery
6.98
NA
NA
4.54
5.24
1.11
NA
NA
12.63
13.33
09029897

A
Ankle arthroscopy/surgery
7.17
NA
NA
4.96
5.65
1.17
NA
NA
13.30
13.99
09029898

A
Ankle arthroscopy/surgery
8.31
NA
NA
5.29
5.97
1.28
NA
NA
14.88
15.56
09029899

A
Ankle arthroscopy/surgery
15.13
NA
NA
9.30
10.23
2.40
NA
NA
26.83
27.76
09029900

A
Mcp joint arthroscopy, dx
5.66
NA
NA
4.74
5.58
0.94
NA
NA
11.34
12.18
09029901

A
Mcp joint arthroscopy, surg
6.37
NA
NA
5.50
6.07
1.06
NA
NA
12.93
13.50
09029902

A
Mcp joint arthroscopy, surg
6.94
NA
NA
3.68
5.83
1.12
NA
NA
11.74
13.89
09029999

C
Arthroscopy of joint
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY30000

A
Drainage of nose lesion
1.43
3.73
3.99
1.23
1.35
0.12
5.28
5.54
2.78
2.90
01030020

A
Drainage of nose lesion
1.43
3.86
3.42
1.26
1.42
0.12
5.41
4.97
2.81
2.97
01030100

A
Intranasal biopsy
0.94
2.40
2.08
0.68
0.79
0.07
3.41
3.09
1.69
1.80
00030110

A
Removal of nose polyp(s)
1.63
3.62
3.34
1.32
1.51
0.14
5.39
5.11
3.09
3.28
01030115

A
Removal of nose polyp(s)
4.34
NA
NA
5.47
5.69
0.41
NA
NA
10.22
10.44
09030117

A
Removal of intranasal lesion
3.16
16.90
14.08
4.51
4.60
0.26
20.32
17.50
7.93
8.02
09030118

A
Removal of intranasal lesion
9.74
NA
NA
7.73
8.83
0.78
NA
NA
18.25
19.35
09030120

A
Revision of nose
5.26
6.78
6.56
4.84
5.71
0.52
12.56
12.34
10.62
11.49
09030124

A
Removal of nose lesion
3.10
NA
NA
3.59
3.61
0.25
NA
NA
6.94
6.96
09030125

A
Removal of nose lesion
7.15
NA
NA
7.00
7.99
0.63
NA
NA
14.78
15.77
09030130

A
Excise inferior turbinate
3.37
NA
NA
5.28
5.51
0.31
NA
NA
8.96
9.19
09030140

A
Resect inferior turbinate
3.42
NA
NA
6.54
6.28
0.35
NA
NA
10.31
10.05
09030150

A
Partial removal of nose
9.37
NA
NA
8.50
10.38
0.93
NA
NA
18.80
20.68
09030160

A
Removal of nose
9.81
NA
NA
8.12
9.69
0.88
NA
NA
18.81
20.38
09030200

A
Injection treatment of nose
0.78
1.87
1.68
0.61
0.71
0.06
2.71
2.52
1.45
1.55
00030210

A
Nasal sinus therapy
1.08
2.31
2.15
1.15
1.27
0.09
3.48
3.32
2.32
2.44
01030220

A
Insert nasal septal button
1.54
5.41
4.53
1.29
1.47
0.12
7.07
6.19
2.95
3.13
01030300

A
Remove nasal foreign body
1.04
4.14
4.51
1.79
1.88
0.08
5.26
5.63
2.91
3.00
01030310

A
Remove nasal foreign body
1.96
NA
NA
2.71
3.00
0.16
NA
NA
4.83
5.12
01030320

A
Remove nasal foreign body
4.51
NA
NA
5.93
6.76
0.39
NA
NA
10.83
11.66
09030400

R
Reconstruction of nose
10.46
NA
NA
13.64
15.03
1.04
NA
NA
25.14
26.53
09030410

R
Reconstruction of nose
13.60
NA
NA
14.27
17.35
1.42
NA
NA
29.29
32.37
09030420

R
Reconstruction of nose
16.50
NA
NA
14.69
17.11
1.46
NA
NA
32.65
35.07
09030430

R
Revision of nose
7.84
NA
NA
12.76
15.20
0.77
NA
NA
21.37
23.81
09030435

R
Revision of nose
12.33
NA
NA
14.67
18.18
1.22
NA
NA
28.22
31.73
09030450

R
Revision of nose
19.26
NA
NA
16.12
20.45
1.96
NA
NA
37.34
41.67
09030460

A
Revision of nose
10.20
NA
NA
7.13
9.24
1.03
NA
NA
18.36
20.47
09030462

A
Revision of nose
20.04
NA
NA
14.29
18.75
2.53
NA
NA
36.86
41.32
09030465

A
Repair nasal stenosis
12.12
NA
NA
10.25
11.54
1.06
NA
NA
23.43
24.72
09030520

A
Repair of nasal septum
7.63
NA
NA
7.58
6.89
0.46
NA
NA
15.67
14.98
09030540

A
Repair nasal defect
7.74
NA
NA
7.01
8.71
0.67
NA
NA
15.42
17.12
09030545

A
Repair nasal defect
11.42
NA
NA
10.02
11.43
1.70
NA
NA
23.14
24.55
09030560

A
Release of nasal adhesions
1.26
4.93
4.81
1.87
2.07
0.10
6.29
6.17
3.23
3.43
01030580

A
Repair upper jaw fistula
6.68
8.15
7.87
4.69
5.52
0.89
15.72
15.44
12.26
13.09
09030600

A
Repair mouth/nose fistula
6.01
7.47
7.51
4.04
4.78
0.70
14.18
14.22
10.75
11.49
09030620

A
Intranasal reconstruction
5.96
NA
NA
8.08
8.64
0.57
NA
NA
14.61
15.17
09030630

A
Repair nasal septum defect
7.11
NA
NA
7.05
7.73
0.61
NA
NA
14.77
15.45
09030801

A
Ablate inf turbinate, superf
1.09
4.03
4.11
1.97
1.93
0.09
5.21
5.29
3.15
3.11
01030802

A
Cauterization, inner nose
2.03
4.60
4.61
2.30
2.35
0.16
6.79
6.80
4.49
4.54
01030901

A
Control of nosebleed
1.21
1.20
1.32
0.28
0.31
0.11
2.52
2.64
1.60
1.63
00030903

A
Control of nosebleed
1.54
3.07
2.80
0.38
0.47
0.13
4.74
4.47
2.05
2.14
00030905

A
Control of nosebleed
1.97
3.73
3.57
0.46
0.69
0.17
5.87
5.71
2.60
2.83
00030906

A
Repeat control of nosebleed
2.45
3.96
3.91
0.66
1.07
0.20
6.61
6.56
3.31
3.72
00030915

A
Ligation, nasal sinus artery
7.31
NA
NA
5.80
6.47
0.58
NA
NA
13.69
14.36
09030920

A
Ligation, upper jaw artery
10.97
NA
NA
8.11
8.76
0.80
NA
NA
19.88
20.53
09030930

A
Ther fx, nasal inf turbinate
1.26
NA
NA
1.52
1.60
0.12
NA
NA
2.90
2.98
01030999

C
Nasal surgery procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY31000

A
Irrigation, maxillary sinus
1.15
3.00
2.88
1.23
1.36
0.09
4.24
4.12
2.47
2.60
010( print page 49122)31002

A
Irrigation, sphenoid sinus
1.91
NA
NA
2.51
3.06
0.15
NA
NA
4.57
5.12
01031020

A
Exploration, maxillary sinus
2.94
8.06
8.41
5.16
5.18
0.29
11.29
11.64
8.39
8.41
09031030

A
Exploration, maxillary sinus
5.91
9.77
11.07
6.01
6.50
0.60
16.28
17.58
12.52
13.01
09031032

A
Explore sinus, remove polyps
6.56
NA
NA
6.46
7.04
0.59
NA
NA
13.61
14.19
09031040

A
Exploration behind upper jaw
9.59
NA
NA
7.26
9.18
0.87
NA
NA
17.72
19.64
09031050

A
Exploration, sphenoid sinus
5.27
NA
NA
6.12
6.29
0.49
NA
NA
11.88
12.05
09031051

A
Sphenoid sinus surgery
7.10
NA
NA
7.68
8.10
0.62
NA
NA
15.40
15.82
09031070

A
Exploration of frontal sinus
4.27
NA
NA
5.68
5.87
0.38
NA
NA
10.33
10.52
09031075

A
Exploration of frontal sinus
9.33
NA
NA
8.49
9.42
0.75
NA
NA
18.57
19.50
09031080

A
Removal of frontal sinus
12.46
NA
NA
10.39
12.75
1.23
NA
NA
24.08
26.44
09031081

A
Removal of frontal sinus
13.91
NA
NA
14.59
14.15
2.46
NA
NA
30.96
30.52
09031084

A
Removal of frontal sinus
14.67
NA
NA
11.82
13.08
1.19
NA
NA
27.68
28.94
09031085

A
Removal of frontal sinus
15.36
NA
NA
12.90
13.70
1.72
NA
NA
29.98
30.78
09031086

A
Removal of frontal sinus
14.08
NA
NA
11.66
12.88
1.07
NA
NA
26.81
28.03
09031087

A
Removal of frontal sinus
14.32
NA
NA
10.69
12.07
1.44
NA
NA
26.45
27.83
09031090

A
Exploration of sinuses
10.78
NA
NA
12.26
12.48
0.94
NA
NA
23.98
24.20
09031200

A
Removal of ethmoid sinus
4.96
NA
NA
7.42
8.76
0.29
NA
NA
12.67
14.01
09031201

A
Removal of ethmoid sinus
8.42
NA
NA
8.22
8.93
0.82
NA
NA
17.46
18.17
09031205

A
Removal of ethmoid sinus
10.40
NA
NA
9.52
11.29
0.67
NA
NA
20.59
22.36
09031225

A
Removal of upper jaw
26.34
NA
NA
16.28
17.44
1.59
NA
NA
44.21
45.37
09031230

A
Removal of upper jaw
30.46
NA
NA
16.95
18.76
1.77
NA
NA
49.18
50.99
09031231

A
Nasal endoscopy, dx
1.10
3.34
3.37
0.69
0.83
0.09
4.53
4.56
1.88
2.02
00031233

A
Nasal/sinus endoscopy, dx
2.18
3.94
4.21
0.99
1.36
0.20
6.32
6.59
3.37
3.74
00031235

A
Nasal/sinus endoscopy, dx
2.64
4.28
4.75
1.12
1.57
0.26
7.18
7.65
4.02
4.47
00031237

A
Nasal/sinus endoscopy, surg
2.98
4.51
5.02
1.22
1.72
0.28
7.77
8.28
4.48
4.98
00031238

A
Nasal/sinus endoscopy, surg
3.26
4.43
5.03
1.30
1.89
0.27
7.96
8.56
4.83
5.42
00031239

A
Nasal/sinus endoscopy, surg
9.19
NA
NA
6.27
7.57
0.62
NA
NA
16.08
17.38
01031240

A
Nasal/sinus endoscopy, surg
2.61
NA
NA
1.12
1.58
0.24
NA
NA
3.97
4.43
00031254

A
Revision of ethmoid sinus
4.64
NA
NA
1.70
2.56
0.45
NA
NA
6.79
7.65
00031255

A
Removal of ethmoid sinus
6.95
NA
NA
2.34
3.67
0.73
NA
NA
10.02
11.35
00031256

A
Exploration maxillary sinus
3.29
NA
NA
1.31
1.91
0.33
NA
NA
4.93
5.53
00031267

A
Endoscopy, maxillary sinus
5.45
NA
NA
1.92
2.95
0.55
NA
NA
7.92
8.95
00031276

A
Sinus endoscopy, surgical
8.84
NA
NA
2.87
4.56
0.92
NA
NA
12.63
14.32
00031287

A
Nasal/sinus endoscopy, surg
3.91
NA
NA
1.48
2.21
0.39
NA
NA
5.78
6.51
00031288

A
Nasal/sinus endoscopy, surg
4.57
NA
NA
1.67
2.53
0.46
NA
NA
6.70
7.56
00031290

A
Nasal/sinus endoscopy, surg
18.46
NA
NA
7.99
11.04
1.40
NA
NA
27.85
30.90
01031291

A
Nasal/sinus endoscopy, surg
19.41
NA
NA
8.60
11.50
1.68
NA
NA
29.69
32.59
01031292

A
Nasal/sinus endoscopy, surg
15.75
NA
NA
7.20
9.76
1.21
NA
NA
24.16
26.72
01031293

A
Nasal/sinus endoscopy, surg
17.32
NA
NA
7.82
10.49
1.28
NA
NA
26.42
29.09
01031294

A
Nasal/sinus endoscopy, surg
20.16
NA
NA
8.72
11.83
1.53
NA
NA
30.41
33.52
01031299

C
Sinus surgery procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY31300

A
Removal of larynx lesion
15.63
NA
NA
13.43
14.59
1.17
NA
NA
30.23
31.39
09031320

A
Diagnostic incision, larynx
5.55
NA
NA
9.17
10.02
0.46
NA
NA
15.18
16.03
09031360

A
Removal of larynx
27.23
NA
NA
17.39
16.89
1.38
NA
NA
46.00
45.50
09031365

A
Removal of larynx
34.85
NA
NA
19.55
20.16
1.97
NA
NA
56.37
56.98
09031367

A
Partial removal of larynx
27.11
NA
NA
19.32
21.25
1.78
NA
NA
48.21
50.14
09031368

A
Partial removal of larynx
33.73
NA
NA
22.12
24.65
2.20
NA
NA
58.05
60.58
09031370

A
Partial removal of larynx
27.11
NA
NA
20.11
21.72
1.74
NA
NA
48.96
50.57
09031375

A
Partial removal of larynx
25.61
NA
NA
19.22
20.09
1.63
NA
NA
46.46
47.33
09031380

A
Partial removal of larynx
25.11
NA
NA
18.90
20.18
1.70
NA
NA
45.71
46.99
09031382

A
Partial removal of larynx
28.11
NA
NA
20.41
21.31
1.67
NA
NA
50.19
51.09
09031390

A
Removal of larynx & pharynx
38.72
NA
NA
22.29
23.86
2.23
NA
NA
63.24
64.81
09031395

A
Reconstruct larynx & pharynx
43.34
NA
NA
25.53
27.61
2.48
NA
NA
71.35
73.43
09031400

A
Revision of larynx
11.40
NA
NA
11.42
13.18
0.83
NA
NA
23.65
25.41
09031420

A
Removal of epiglottis
11.25
NA
NA
7.82
9.11
0.83
NA
NA
19.90
21.19
09031500

A
Insert emergency airway
2.33
NA
NA
0.43
0.52
0.17
NA
NA
2.93
3.02
000( print page 49123)31502

A
Change of windpipe airway
0.65
NA
NA
0.20
0.26
0.05
NA
NA
0.90
0.96
00031505

A
Diagnostic laryngoscopy
0.61
1.33
1.42
0.54
0.59
0.05
1.99
2.08
1.20
1.25
00031510

A
Laryngoscopy with biopsy
1.92
2.98
3.22
0.91
1.17
0.16
5.06
5.30
2.99
3.25
00031511

A
Remove foreign body, larynx
2.16
2.75
3.03
0.93
1.03
0.19
5.10
5.38
3.28
3.38
00031512

A
Removal of larynx lesion
2.07
2.73
3.08
0.95
1.26
0.18
4.98
5.33
3.20
3.51
00031513

A
Injection into vocal cord
2.10
NA
NA
0.97
1.34
0.17
NA
NA
3.24
3.61
00031515

A
Laryngoscopy for aspiration
1.80
3.06
3.42
0.83
1.00
0.14
5.00
5.36
2.77
2.94
00031520

A
Dx laryngoscopy, newborn
2.56
NA
NA
1.09
1.44
0.20
NA
NA
3.85
4.20
00031525

A
Dx laryngoscopy excl nb
2.63
3.22
3.54
1.10
1.52
0.21
6.06
6.38
3.94
4.36
00031526

A
Dx laryngoscopy w/oper scope
2.57
NA
NA
1.10
1.57
0.21
NA
NA
3.88
4.35
00031527

A
Laryngoscopy for treatment
3.27
NA
NA
1.29
1.73
0.26
NA
NA
4.82
5.26
00031528

A
Laryngoscopy and dilation
2.37
NA
NA
0.97
1.34
0.19
NA
NA
3.53
3.90
00031529

A
Laryngoscopy and dilation
2.68
NA
NA
1.09
1.56
0.22
NA
NA
3.99
4.46
00031530

A
Laryngoscopy w/fb removal
3.38
NA
NA
1.29
1.79
0.29
NA
NA
4.96
5.46
00031531

A
Laryngoscopy w/fb & op scope
3.58
NA
NA
1.39
2.05
0.29
NA
NA
5.26
5.92
00031535

A
Laryngoscopy w/biopsy
3.16
NA
NA
1.27
1.81
0.26
NA
NA
4.69
5.23
00031536

A
Laryngoscopy w/bx & op scope
3.55
NA
NA
1.38
2.03
0.29
NA
NA
5.22
5.87
00031540

A
Laryngoscopy w/exc of tumor
4.12
NA
NA
1.54
2.29
0.33
NA
NA
5.99
6.74
00031541

A
Larynscop w/tumr exc + scope
4.52
NA
NA
1.66
2.50
0.37
NA
NA
6.55
7.39
00031545

A
Remove vc lesion w/scope
6.30
NA
NA
2.19
3.15
0.37
NA
NA
8.86
9.82
00031546

A
Remove vc lesion scope/graft
9.73
NA
NA
3.71
4.66
0.78
NA
NA
14.22
15.17
00031560

A
Laryngoscop w/arytenoidectom
5.45
NA
NA
1.87
2.83
0.43
NA
NA
7.75
8.71
00031561

A
Larynscop, remve cart + scop
5.99
NA
NA
2.02
3.03
0.49
NA
NA
8.50
9.51
00031570

A
Laryngoscope w/vc inj
3.86
3.93
5.24
1.46
2.15
0.31
8.10
9.41
5.63
6.32
00031571

A
Laryngoscop w/vc inj + scope
4.26
NA
NA
1.58
2.35
0.35
NA
NA
6.19
6.96
00031575

A
Diagnostic laryngoscopy
1.10
1.56
1.82
0.69
0.84
0.09
2.75
3.01
1.88
2.03
00031576

A
Laryngoscopy with biopsy
1.97
3.26
3.56
0.94
1.20
0.14
5.37
5.67
3.05
3.31
00031577

A
Remove foreign body, larynx
2.47
3.22
3.63
1.09
1.42
0.21
5.90
6.31
3.77
4.10
00031578

A
Removal of larynx lesion
2.84
3.66
4.13
1.18
1.44
0.23
6.73
7.20
4.25
4.51
00031579

A
Diagnostic laryngoscopy
2.26
2.63
3.49
1.02
1.37
0.18
5.07
5.93
3.46
3.81
00031580

A
Revision of larynx
14.38
NA
NA
13.35
15.27
1.00
NA
NA
28.73
30.65
09031582

A
Revision of larynx
22.73
NA
NA
20.27
24.42
1.75
NA
NA
44.75
48.90
09031584

A
Treat larynx fracture
20.27
NA
NA
14.11
17.14
1.71
NA
NA
36.09
39.12
09031587

A
Revision of larynx
15.06
NA
NA
7.88
8.92
0.97
NA
NA
23.91
24.95
09031588

A
Revision of larynx
14.48
NA
NA
11.28
13.03
1.06
NA
NA
26.82
28.57
09031590

A
Reinnervate larynx
7.53
NA
NA
11.98
14.64
0.84
NA
NA
20.35
23.01
09031595

A
Larynx nerve surgery
8.69
NA
NA
8.86
10.13
0.68
NA
NA
18.23
19.50
09031599

C
Larynx surgery procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY31600

A
Incision of windpipe
7.17
NA
NA
2.19
2.94
0.80
NA
NA
10.16
10.91
00031601

A
Incision of windpipe
4.44
NA
NA
1.61
2.20
0.40
NA
NA
6.45
7.04
00031603

A
Incision of windpipe
4.14
NA
NA
1.11
1.56
0.44
NA
NA
5.69
6.14
00031605

A
Incision of windpipe
3.57
NA
NA
0.82
1.10
0.40
NA
NA
4.79
5.07
00031610

A
Incision of windpipe
9.23
NA
NA
7.12
7.98
0.79
NA
NA
17.14
18.00
09031611

A
Surgery/speech prosthesis
5.87
NA
NA
6.44
6.91
0.46
NA
NA
12.77
13.24
09031612

A
Puncture/clear windpipe
0.91
1.07
1.09
0.24
0.32
0.08
2.06
2.08
1.23
1.31
00031613

A
Repair windpipe opening
4.58
NA
NA
5.79
5.94
0.42
NA
NA
10.79
10.94
09031614

A
Repair windpipe opening
8.39
NA
NA
8.81
8.74
0.58
NA
NA
17.78
17.71
09031615

A
Visualization of windpipe
2.09
2.21
2.50
0.95
1.14
0.16
4.46
4.75
3.20
3.39
00031620

A
Endobronchial us add-on
1.40
6.04
5.74
0.34
0.50
0.11
7.55
7.25
1.85
2.01
ZZZ31622

A
Dx bronchoscope/wash
2.78
5.26
5.55
0.90
1.02
0.18
8.22
8.51
3.86
3.98
00031623

A
Dx bronchoscope/brush
2.88
6.03
6.32
0.90
1.01
0.13
9.04
9.33
3.91
4.02
00031624

A
Dx bronchoscope/lavage
2.88
5.38
5.67
0.90
1.01
0.13
8.39
8.68
3.91
4.02
00031625

A
Bronchoscopy w/biopsy(s)
3.36
5.52
5.74
1.02
1.16
0.18
9.06
9.28
4.56
4.70
00031628

A
Bronchoscopy/lung bx, each
3.80
7.02
7.02
1.11
1.25
0.18
11.00
11.00
5.09
5.23
00031629

A
Bronchoscopy/needle bx, each
4.09
12.10
13.71
1.19
1.35
0.16
16.35
17.96
5.44
5.60
00031630

A
Bronchoscopy dilate/fx repr
3.81
NA
NA
1.25
1.60
0.32
NA
NA
5.38
5.73
00031631

A
Bronchoscopy, dilate w/stent
4.36
NA
NA
1.39
1.67
0.34
NA
NA
6.09
6.37
00031632

A
Bronchoscopy/lung bx, addIl
1.03
0.86
0.82
0.24
0.29
0.18
2.07
2.03
1.45
1.50
ZZZ31633

A
Bronchoscopy/needle bx addIl
1.32
0.99
0.94
0.31
0.38
0.16
2.47
2.42
1.79
1.86
ZZZ31635

A
Bronchoscopy w/fb removal
3.67
5.20
5.88
1.13
1.36
0.24
9.11
9.79
5.04
5.27
00031636

A
Bronchoscopy, bronch stents
4.30
NA
NA
1.37
1.66
0.31
NA
NA
5.98
6.27
00031637

A
Bronchoscopy, stent add-on
1.58
NA
NA
0.42
0.53
0.13
NA
NA
2.13
2.24
ZZZ31638

A
Bronchoscopy, revise stent
4.88
NA
NA
1.55
1.87
0.22
NA
NA
6.65
6.97
00031640

A
Bronchoscopy w/tumor excise
4.93
NA
NA
1.52
1.93
0.46
NA
NA
6.91
7.32
00031641

A
Bronchoscopy, treat blockage
5.02
NA
NA
1.49
1.78
0.35
NA
NA
6.86
7.15
00031643

A
Diag bronchoscope/catheter
3.49
NA
NA
1.05
1.19
0.20
NA
NA
4.74
4.88
000( print page 49124)31645

A
Bronchoscopy, clear airways
3.16
4.77
5.05
0.97
1.08
0.16
8.09
8.37
4.29
4.40
00031646

A
Bronchoscopy, reclear airway
2.72
4.48
4.77
0.86
0.97
0.14
7.34
7.63
3.72
3.83
00031656

A
Bronchoscopy, inj for x-ray
2.17
5.31
6.80
0.65
0.79
0.15
7.63
9.12
2.97
3.11
00031700

A
Insertion of airway catheter
1.34
2.30
2.19
0.68
0.68
0.08
3.72
3.61
2.10
2.10
00031708

A
Instill airway contrast dye
1.41
NA
NA
0.40
0.45
0.07
NA
NA
1.88
1.93
00031710

A
Insertion of airway catheter
1.30
NA
NA
0.42
0.41
0.12
NA
NA
1.84
1.83
00031715

A
Injection for bronchus x-ray
1.11
NA
NA
0.29
0.33
0.07
NA
NA
1.47
1.51
00031717

A
Bronchial brush biopsy
2.12
5.86
7.65
0.76
0.78
0.14
8.12
9.91
3.02
3.04
00031720

A
Clearance of airways
1.06
NA
NA
0.25
0.31
0.07
NA
NA
1.38
1.44
00031725

A
Clearance of airways
1.96
NA
NA
0.45
0.55
0.14
NA
NA
2.55
2.65
00031730

A
Intro, windpipe wire/tube
2.85
25.67
8.06
0.72
0.93
0.21
28.73
11.12
3.78
3.99
00031750

A
Repair of windpipe
15.11
NA
NA
16.11
17.19
1.05
NA
NA
32.27
33.35
09031755

A
Repair of windpipe
17.05
NA
NA
22.15
23.93
1.29
NA
NA
40.49
42.27
09031760

A
Repair of windpipe
23.28
NA
NA
9.76
10.47
2.94
NA
NA
35.98
36.69
09031766

A
Reconstruction of windpipe
31.52
NA
NA
11.44
13.10
4.52
NA
NA
47.48
49.14
09031770

A
Repair/graft of bronchus
23.44
NA
NA
8.83
9.89
2.83
NA
NA
35.10
36.16
09031775

A
Reconstruct bronchus
24.46
NA
NA
9.07
11.11
3.01
NA
NA
36.54
38.58
09031780

A
Reconstruct windpipe
19.62
NA
NA
7.98
10.28
1.65
NA
NA
29.25
31.55
09031781

A
Reconstruct windpipe
24.72
NA
NA
9.17
11.38
2.24
NA
NA
36.13
38.34
09031785

A
Remove windpipe lesion
18.25
NA
NA
5.49
9.01
1.59
NA
NA
25.33
28.85
09031786

A
Remove windpipe lesion
25.29
NA
NA
9.74
12.25
3.29
NA
NA
38.32
40.83
09031800

A
Repair of windpipe injury
8.05
NA
NA
8.35
9.02
0.79
NA
NA
17.19
17.86
09031805

A
Repair of windpipe injury
13.29
NA
NA
6.24
6.97
1.82
NA
NA
21.35
22.08
09031820

A
Closure of windpipe lesion
4.54
5.43
5.60
2.98
3.48
0.38
10.35
10.52
7.90
8.40
09031825

A
Repair of windpipe defect
6.92
6.78
7.44
4.00
5.03
0.53
14.23
14.89
11.45
12.48
09031830

A
Revise windpipe scar
4.49
5.60
5.72
3.33
3.82
0.44
10.53
10.65
8.26
8.75
09031899

C
Airways surgical procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY32000

A
Drainage of chest
1.54
2.39
2.89
0.43
0.47
0.08
4.01
4.51
2.05
2.09
00032002

A
Treatment of collapsed lung
2.19
2.85
3.12
0.99
1.04
0.12
5.16
5.43
3.30
3.35
00032005

A
Treat lung lining chemically
2.19
5.11
6.12
0.59
0.67
0.23
7.53
8.54
3.01
3.09
00032019

A
Insert pleural catheter
4.17
15.54
18.86
1.45
1.60
0.42
20.13
23.45
6.04
6.19
00032020

A
Insertion of chest tube
3.97
NA
NA
1.14
1.30
0.43
NA
NA
5.54
5.70
00032035

A
Exploration of chest
11.14
NA
NA
6.11
5.92
1.26
NA
NA
18.50
18.32
09032036

A
Exploration of chest
12.15
NA
NA
6.43
6.43
1.43
NA
NA
20.01
20.01
09032095

A
Biopsy through chest wall
10.03
NA
NA
5.22
5.33
1.22
NA
NA
16.47
16.58
09032100

A
Exploration/biopsy of chest
16.04
NA
NA
7.09
7.64
2.23
NA
NA
25.36
25.91
09032110

A
Explore/repair chest
25.11
NA
NA
10.03
10.56
3.21
NA
NA
38.35
38.88
09032120

A
Re-exploration of chest
14.24
NA
NA
6.91
7.03
1.63
NA
NA
22.78
22.90
09032124

A
Explore chest free adhesions
15.30
NA
NA
7.09
7.18
1.89
NA
NA
24.28
24.37
09032140

A
Removal of lung lesion(s)
16.51
NA
NA
7.48
7.63
1.96
NA
NA
25.95
26.10
09032141

A
Remove/treat lung lesions
17.14
NA
NA
7.69
7.59
2.00
NA
NA
26.83
26.73
09032150

A
Removal of lung lesion(s)
16.67
NA
NA
7.54
7.59
2.00
NA
NA
26.21
26.26
09032151

A
Remove lung foreign body
16.79
NA
NA
8.73
8.18
2.03
NA
NA
27.55
27.00
09032160

A
Open chest heart massage
13.00
NA
NA
5.89
5.42
1.31
NA
NA
20.20
19.73
09032200

A
Drain, open, lung lesion
18.43
NA
NA
8.91
8.69
2.13
NA
NA
29.47
29.25
09032201

A
Drain, percut, lung lesion
3.99
19.87
20.49
1.26
1.29
0.24
24.10
24.72
5.49
5.52
00032215

A
Treat chest lining
12.90
NA
NA
6.43
6.78
1.68
NA
NA
21.01
21.36
09032220

A
Release of lung
26.31
NA
NA
12.11
12.74
3.56
NA
NA
41.98
42.61
09032225

A
Partial release of lung
16.60
NA
NA
7.54
7.62
2.06
NA
NA
26.20
26.28
09032310

A
Removal of chest lining
15.13
NA
NA
6.98
7.29
1.99
NA
NA
24.10
24.41
09032320

A
Free/remove chest lining
26.96
NA
NA
11.63
12.02
3.51
NA
NA
42.10
42.49
09032400

A
Needle biopsy chest lining
1.76
2.12
2.12
0.52
0.54
0.10
3.98
3.98
2.38
2.40
00032402

A
Open biopsy chest lining
8.86
NA
NA
4.81
5.04
1.07
NA
NA
14.74
14.97
09032405

A
Biopsy, lung or mediastinum
1.93
0.61
0.66
0.61
0.63
0.11
2.65
2.70
2.65
2.67
00032420

A
Puncture/clear lung
2.18
NA
NA
0.68
0.68
0.12
NA
NA
2.98
2.98
00032440

A
Removal of lung
27.11
NA
NA
11.11
12.45
3.68
NA
NA
41.90
43.24
090( print page 49125)32442

A
Sleeve pneumonectomy
37.74
NA
NA
13.28
14.39
3.84
NA
NA
54.86
55.97
09032445

A
Removal of lung
40.73
NA
NA
16.31
14.62
3.71
NA
NA
60.75
59.06
09032480

A
Partial removal of lung
25.65
NA
NA
10.37
11.64
3.49
NA
NA
39.51
40.78
09032482

A
Bilobectomy
27.22
NA
NA
11.22
12.49
3.66
NA
NA
42.10
43.37
09032484

A
Segmentectomy
22.67
NA
NA
8.92
10.77
3.03
NA
NA
34.62
36.47
09032486

A
Sleeve lobectomy
31.72
NA
NA
11.89
12.90
3.51
NA
NA
47.12
48.13
09032488

A
Completion pneumonectomy
32.69
NA
NA
12.78
13.53
3.80
NA
NA
49.27
50.02
09032491

R
Lung volume reduction
25.03
NA
NA
10.69
12.14
2.98
NA
NA
38.70
40.15
09032500

A
Partial removal of lung
24.42
NA
NA
10.43
11.87
3.25
NA
NA
38.10
39.54
09032501

A
Repair bronchus add-on
4.68
NA
NA
1.37
1.50
0.65
NA
NA
6.70
6.83
ZZZ32503

A
Resect apical lung tumor
31.55
NA
NA
12.31
14.38
4.37
NA
NA
48.23
50.30
09032504

A
Resect apical lung tum/chest
36.35
NA
NA
13.73
15.94
5.07
NA
NA
55.15
57.36
09032540

A
Removal of lung lesion
23.68
NA
NA
10.25
9.79
2.07
NA
NA
36.00
35.54
09032601

A
Thoracoscopy, diagnostic
5.45
NA
NA
2.11
2.29
0.80
NA
NA
8.36
8.54
00032602

A
Thoracoscopy, diagnostic
5.95
NA
NA
2.25
2.45
0.87
NA
NA
9.07
9.27
00032603

A
Thoracoscopy, diagnostic
7.80
NA
NA
2.99
3.02
1.14
NA
NA
11.93
11.96
00032604

A
Thoracoscopy, diagnostic
8.77
NA
NA
3.08
3.36
1.25
NA
NA
13.10
13.38
00032605

A
Thoracoscopy, diagnostic
6.92
NA
NA
2.56
2.82
1.00
NA
NA
10.48
10.74
00032606

A
Thoracoscopy, diagnostic
8.39
NA
NA
3.02
3.25
1.22
NA
NA
12.63
12.86
00032650

A
Thoracoscopy, surgical
10.73
NA
NA
5.32
6.40
1.58
NA
NA
17.63
18.71
09032651

A
Thoracoscopy, surgical
16.28
NA
NA
7.09
7.20
1.86
NA
NA
25.23
25.34
09032652

A
Thoracoscopy, surgical
23.34
NA
NA
9.65
10.02
2.72
NA
NA
35.71
36.08
09032653

A
Thoracoscopy, surgical
19.86
NA
NA
8.01
7.23
1.88
NA
NA
29.75
28.97
09032654

A
Thoracoscopy, surgical
18.49
NA
NA
7.47
7.52
1.63
NA
NA
27.59
27.64
09032655

A
Thoracoscopy, surgical
14.95
NA
NA
6.74
7.12
1.89
NA
NA
23.58
23.96
09032656

A
Thoracoscopy, surgical
13.14
NA
NA
6.04
7.47
1.89
NA
NA
21.07
22.50
09032657

A
Thoracoscopy, surgical
14.54
NA
NA
6.47
7.38
1.99
NA
NA
23.00
23.91
09032658

A
Thoracoscopy, surgical
11.61
NA
NA
5.64
6.92
1.69
NA
NA
18.94
20.22
09032659

A
Thoracoscopy, surgical
11.82
NA
NA
5.95
7.08
1.62
NA
NA
19.39
20.52
09032660

A
Thoracoscopy, surgical
17.65
NA
NA
7.52
8.99
2.08
NA
NA
27.25
28.72
09032661

A
Thoracoscopy, surgical
13.23
NA
NA
6.22
7.40
1.92
NA
NA
21.37
22.55
09032662

A
Thoracoscopy, surgical
17.00
NA
NA
7.23
8.42
2.17
NA
NA
26.40
27.59
09032663

A
Thoracoscopy, surgical
19.96
NA
NA
8.91
10.30
2.72
NA
NA
31.59
32.98
09032664

A
Thoracoscopy, surgical
14.18
NA
NA
6.42
7.33
2.32
NA
NA
22.92
23.83
09032665

A
Thoracoscopy, surgical
17.37
NA
NA
7.66
8.01
2.15
NA
NA
27.18
27.53
09032800

A
Repair lung hernia
15.56
NA
NA
7.13
7.34
1.98
NA
NA
24.67
24.88
09032810

A
Close chest after drainage
14.80
NA
NA
7.12
7.42
1.93
NA
NA
23.85
24.15
09032815

A
Close bronchial fistula
37.94
NA
NA
15.43
12.09
3.27
NA
NA
56.64
53.30
09032820

A
Reconstruct injured chest
22.27
NA
NA
11.75
12.06
2.52
NA
NA
36.54
36.85
09032851

A
Lung transplant, single
40.72
NA
NA
20.99
25.99
5.56
NA
NA
67.27
72.27
09032852

A
Lung transplant with bypass
44.37
NA
NA
23.82
30.83
6.00
NA
NA
74.19
81.20
09032853

A
Lung transplant, double
49.89
NA
NA
23.39
29.66
7.05
NA
NA
80.33
86.60
09032854

A
Lung transplant with bypass
53.60
NA
NA
26.62
32.70
7.20
NA
NA
87.42
93.50
09032855

C
Prepare donor lung, single
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX32856

C
Prepare donor lung, double
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX32900

A
Removal of rib(s)
23.66
NA
NA
9.81
9.86
2.93
NA
NA
36.40
36.45
09032905

A
Revise & repair chest wall
23.14
NA
NA
9.64
10.01
3.15
NA
NA
35.93
36.30
09032906

A
Revise & repair chest wall
29.15
NA
NA
11.34
11.88
3.97
NA
NA
44.46
45.00
09032940

A
Revision of lung
21.19
NA
NA
8.66
9.27
2.88
NA
NA
32.73
33.34
09032960

A
Therapeutic pneumothorax
1.84
1.59
1.70
0.67
0.59
0.16
3.59
3.70
2.67
2.59
00032997

A
Total lung lavage
5.99
NA
NA
1.51
1.81
0.55
NA
NA
8.05
8.35
00032999

C
Chest surgery procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY33010

A
Drainage of heart sac
2.24
NA
NA
1.02
0.84
0.14
NA
NA
3.40
3.22
00033011

A
Repeat drainage of heart sac
2.24
NA
NA
1.10
0.88
0.15
NA
NA
3.49
3.27
00033015

A
Incision of heart sac
8.41
NA
NA
5.08
4.98
0.65
NA
NA
14.14
14.04
09033020

A
Incision of heart sac
14.85
NA
NA
6.54
6.72
1.79
NA
NA
23.18
23.36
09033025

A
Incision of heart sac
13.63
NA
NA
5.98
6.26
1.80
NA
NA
21.41
21.69
09033030

A
Partial removal of heart sac
22.24
NA
NA
9.26
9.46
2.83
NA
NA
34.33
34.53
09033031

A
Partial removal of heart sac
25.28
NA
NA
9.96
10.01
3.13
NA
NA
38.37
38.42
09033050

A
Removal of heart sac lesion
16.82
NA
NA
7.63
7.79
2.14
NA
NA
26.59
26.75
09033120

A
Removal of heart lesion
27.30
NA
NA
10.79
11.38
3.69
NA
NA
41.78
42.37
09033130

A
Removal of heart lesion
24.02
NA
NA
9.48
9.95
3.00
NA
NA
36.50
36.97
09033140

A
Heart revascularize (tmr)
22.72
NA
NA
10.09
10.68
2.85
NA
NA
35.66
36.25
09033141

A
Heart tmr w/other procedure
4.83
NA
NA
1.52
1.57
0.69
NA
NA
7.04
7.09
ZZZ33200

A
Insertion of heart pacemaker
14.70
NA
NA
7.45
6.99
1.70
NA
NA
23.85
23.39
09033201

A
Insertion of heart pacemaker
12.08
NA
NA
6.40
6.54
1.36
NA
NA
19.84
19.98
090( print page 49126)33206

A
Insertion of heart pacemaker
7.28
NA
NA
5.13
4.63
0.52
NA
NA
12.92
12.42
09033207

A
Insertion of heart pacemaker
9.03
NA
NA
5.78
4.94
0.59
NA
NA
15.40
14.56
09033208

A
Insertion of heart pacemaker
8.12
NA
NA
5.43
4.94
0.56
NA
NA
14.11
13.62
09033210

A
Insertion of heart electrode
3.30
NA
NA
1.70
1.36
0.18
NA
NA
5.18
4.84
00033211

A
Insertion of heart electrode
3.39
NA
NA
1.67
1.40
0.21
NA
NA
5.27
5.00
00033212

A
Insertion of pulse generator
5.51
NA
NA
3.75
3.46
0.43
NA
NA
9.69
9.40
09033213

A
Insertion of pulse generator
6.36
NA
NA
4.17
3.83
0.45
NA
NA
10.98
10.64
09033214

A
Upgrade of pacemaker system
7.74
NA
NA
5.38
5.01
0.58
NA
NA
13.70
13.33
09033215

A
Reposition pacing-defib lead
4.87
NA
NA
3.52
3.27
0.37
NA
NA
8.76
8.51
09033216

A
Insert lead pace-defib, one
5.77
NA
NA
4.58
4.30
0.36
NA
NA
10.71
10.43
09033217

A
Insert lead pace-defib, dual
5.74
NA
NA
4.50
4.30
0.39
NA
NA
10.63
10.43
09033218

A
Repair lead pace-defib, one
5.93
NA
NA
4.83
4.43
0.37
NA
NA
11.13
10.73
09033220

A
Repair lead pace-defib, dual
6.01
NA
NA
4.89
4.43
0.37
NA
NA
11.27
10.81
09033222

A
Revise pocket, pacemaker
4.95
NA
NA
4.33
4.30
0.42
NA
NA
9.70
9.67
09033223

A
Revise pocket, pacing-defib
6.45
NA
NA
4.97
4.69
0.45
NA
NA
11.87
11.59
09033224

A
Insert pacing lead & connect
9.04
NA
NA
5.03
4.26
0.54
NA
NA
14.61
13.84
00033225

A
L ventric pacing lead add-on
8.33
NA
NA
4.45
3.55
0.45
NA
NA
13.23
12.33
ZZZ33226

A
Reposition l ventric lead
8.68
NA
NA
4.87
4.08
0.59
NA
NA
14.14
13.35
00033233

A
Removal of pacemaker system
3.29
NA
NA
3.29
3.28
0.22
NA
NA
6.80
6.79
09033234

A
Removal of pacemaker system
7.81
NA
NA
5.52
5.06
0.56
NA
NA
13.89
13.43
09033235

A
Removal pacemaker electrode
9.85
NA
NA
7.32
6.94
0.73
NA
NA
17.90
17.52
09033236

A
Remove electrode/thoracotomy
12.58
NA
NA
6.70
7.25
1.68
NA
NA
20.96
21.51
09033237

A
Remove electrode/thoracotomy
13.69
NA
NA
7.68
7.76
1.59
NA
NA
22.96
23.04
09033238

A
Remove electrode/thoracotomy
15.20
NA
NA
8.35
8.24
2.02
NA
NA
25.57
25.46
09033240

A
Insert pulse generator
7.59
NA
NA
5.34
4.77
0.41
NA
NA
13.34
12.77
09033241

A
Remove pulse generator
3.24
NA
NA
3.04
2.98
0.18
NA
NA
6.46
6.40
09033243

A
Remove eltrd/thoracotomy
23.36
NA
NA
11.00
11.35
2.09
NA
NA
36.45
36.80
09033244

A
Remove eltrd, transven
13.74
NA
NA
9.53
9.05
0.99
NA
NA
24.26
23.78
09033245

A
Insert epic eltrd pace-defib
16.82
NA
NA
7.96
7.92
2.01
NA
NA
26.79
26.75
09033246

A
Insert epic eltrd/generator
23.11
NA
NA
10.73
10.39
2.63
NA
NA
36.47
36.13
09033249

A
Eltrd/insert pace-defib
14.96
NA
NA
10.33
8.85
0.77
NA
NA
26.06
24.58
09033250

A
Ablate heart dysrhythm focus
25.75
NA
NA
10.16
10.81
3.18
NA
NA
39.09
39.74
09033251

A
Ablate heart dysrhythm focus
28.77
NA
NA
11.15
11.53
3.59
NA
NA
43.51
43.89
09033253

A
Reconstruct atria
31.33
NA
NA
12.15
13.40
4.52
NA
NA
48.00
49.25
09033261

A
Ablate heart dysrhythm focus
28.77
NA
NA
11.33
11.66
3.45
NA
NA
43.55
43.88
09033282

A
Implant pat-active ht record
4.66
NA
NA
4.29
4.09
0.23
NA
NA
9.18
8.98
09033284

A
Remove pat-active ht record
3.00
NA
NA
3.40
3.50
0.14
NA
NA
6.54
6.64
09033300

A
Repair of heart wound
29.93
NA
NA
11.14
9.71
2.65
NA
NA
43.72
42.29
09033305

A
Repair of heart wound
33.67
NA
NA
12.24
11.02
3.12
NA
NA
49.03
47.81
09033310

A
Exploratory heart surgery
20.19
NA
NA
8.83
9.39
2.58
NA
NA
31.60
32.16
09033315

A
Exploratory heart surgery
26.02
NA
NA
10.46
10.78
3.27
NA
NA
39.75
40.07
09033320

A
Repair major blood vessel(s)
18.43
NA
NA
8.69
8.34
2.07
NA
NA
29.19
28.84
09033321

A
Repair major vessel
20.67
NA
NA
10.28
9.91
2.90
NA
NA
33.85
33.48
09033322

A
Repair major blood vessel(s)
24.27
NA
NA
9.83
10.23
2.85
NA
NA
36.95
37.35
09033330

A
Insert major vessel graft
25.14
NA
NA
9.80
10.15
2.81
NA
NA
37.75
38.10
09033332

A
Insert major vessel graft
24.42
NA
NA
9.65
10.30
3.02
NA
NA
37.09
37.74
09033335

A
Insert major vessel graft
33.76
NA
NA
12.97
13.24
4.27
NA
NA
51.00
51.27
09033400

A
Repair of aortic valve
39.23
NA
NA
14.57
15.39
4.10
NA
NA
57.90
58.72
09033401

A
Valvuloplasty, open
24.33
NA
NA
9.83
12.58
3.56
NA
NA
37.72
40.47
09033403

A
Valvuloplasty, w/cp bypass
25.31
NA
NA
10.53
13.36
3.54
NA
NA
39.38
42.21
09033404

A
Prepare heart-aorta conduit
31.22
NA
NA
12.26
13.97
4.32
NA
NA
47.80
49.51
09033405

A
Replacement of aortic valve
39.97
NA
NA
15.12
17.50
5.31
NA
NA
60.40
62.78
09033406

A
Replacement of aortic valve
48.87
NA
NA
17.72
18.77
5.43
NA
NA
72.02
73.07
09033410

A
Replacement of aortic valve
38.69
NA
NA
14.63
16.09
4.68
NA
NA
58.00
59.46
09033411

A
Replacement of aortic valve
57.11
NA
NA
20.12
19.09
5.46
NA
NA
82.69
81.66
09033412

A
Replacement of aortic valve
43.71
NA
NA
16.57
19.44
6.37
NA
NA
66.65
69.52
090( print page 49127)33413

A
Replacement of aortic valve
55.27
NA
NA
19.33
20.44
6.51
NA
NA
81.11
82.22
09033414

A
Repair of aortic valve
39.27
NA
NA
15.20
14.40
4.56
NA
NA
59.03
58.23
09033415

A
Revision, subvalvular tissue
29.70
NA
NA
11.14
11.80
4.13
NA
NA
44.97
45.63
09033416

A
Revise ventricle muscle
36.39
NA
NA
13.63
13.53
4.56
NA
NA
54.58
54.48
09033417

A
Repair of aortic valve
29.13
NA
NA
12.14
13.24
4.09
NA
NA
45.36
46.46
09033420

A
Revision of mitral valve
25.64
NA
NA
8.85
9.38
1.81
NA
NA
36.30
36.83
09033422

A
Revision of mitral valve
29.58
NA
NA
12.50
13.36
3.93
NA
NA
46.01
46.87
09033425

A
Repair of mitral valve
38.37
NA
NA
14.50
13.41
4.06
NA
NA
56.93
55.84
09033426

A
Repair of mitral valve
41.28
NA
NA
15.51
16.73
5.01
NA
NA
61.80
63.02
09033427

A
Repair of mitral valve
42.78
NA
NA
16.33
18.60
6.07
NA
NA
65.18
67.45
09033430

A
Replacement of mitral valve
49.81
NA
NA
18.75
17.66
5.08
NA
NA
73.64
72.55
09033460

A
Revision of tricuspid valve
27.97
NA
NA
10.98
11.22
3.44
NA
NA
42.39
42.63
09033463

A
Valvuloplasty, tricuspid
42.57
NA
NA
15.50
13.56
3.86
NA
NA
61.93
59.99
09033464

A
Valvuloplasty, tricuspid
30.93
NA
NA
12.13
13.17
4.14
NA
NA
47.20
48.24
09033465

A
Replace tricuspid valve
33.58
NA
NA
12.60
12.87
4.38
NA
NA
50.56
50.83
09033468

A
Revision of tricuspid valve
32.79
NA
NA
15.30
14.06
4.06
NA
NA
52.15
50.91
09033470

A
Revision of pulmonary valve
21.24
NA
NA
8.74
10.20
1.03
NA
NA
31.01
32.47
09033471

A
Valvotomy, pulmonary valve
22.79
NA
NA
7.77
9.26
3.38
NA
NA
33.94
35.43
09033472

A
Revision of pulmonary valve
22.86
NA
NA
7.28
10.72
3.54
NA
NA
33.68
37.12
09033474

A
Revision of pulmonary valve
25.85
NA
NA
12.10
11.19
3.21
NA
NA
41.16
40.25
09033475

A
Replacement, pulmonary valve
44.81
NA
NA
16.54
15.66
4.92
NA
NA
66.27
65.39
09033476

A
Revision of heart chamber
26.37
NA
NA
11.78
11.92
2.41
NA
NA
40.56
40.70
09033478

A
Revision of heart chamber
27.34
NA
NA
11.04
12.55
3.88
NA
NA
42.26
43.77
09033496

A
Repair, prosth valve clot
29.67
NA
NA
11.51
12.43
4.12
NA
NA
45.30
46.22
09033500

A
Repair heart vessel fistula
27.79
NA
NA
11.08
11.37
3.86
NA
NA
42.73
43.02
09033501

A
Repair heart vessel fistula
19.39
NA
NA
8.25
8.27
1.90
NA
NA
29.54
29.56
09033502

A
Coronary artery correction
21.65
NA
NA
9.32
10.63
2.99
NA
NA
33.96
35.27
09033503

A
Coronary artery graft
22.21
NA
NA
10.61
9.95
1.77
NA
NA
34.59
33.93
09033504

A
Coronary artery graft
25.26
NA
NA
10.18
11.40
3.35
NA
NA
38.79
40.01
09033505

A
Repair artery w/tunnel
38.33
NA
NA
12.33
12.76
2.18
NA
NA
52.84
53.27
09033506

A
Repair artery, translocation
37.78
NA
NA
15.51
14.80
4.65
NA
NA
57.94
57.23
09033507

A
Repair art, intramural
31.33
NA
NA
11.78
13.18
4.05
NA
NA
47.16
48.56
09033508

A
Endoscopic vein harvest
0.31
NA
NA
0.10
0.10
0.04
NA
NA
0.45
0.45
ZZZ33510

A
CABG, vein, single
33.45
NA
NA
12.81
15.45
4.40
NA
NA
50.66
53.30
09033511

A
CABG, vein, two
34.59
NA
NA
13.37
16.15
4.55
NA
NA
52.51
55.29
09033512

A
CABG, vein, three
38.73
NA
NA
14.72
16.88
4.66
NA
NA
58.11
60.27
09033513

A
CABG, vein, four
39.69
NA
NA
15.13
17.12
4.87
NA
NA
59.69
61.68
09033514

A
CABG, vein, five
40.50
NA
NA
15.38
17.38
4.76
NA
NA
60.64
62.64
09033516

A
Cabg, vein, six or more
41.96
NA
NA
16.16
18.14
5.11
NA
NA
63.23
65.21
09033517

A
CABG, artery-vein, single
2.57
NA
NA
0.79
0.83
0.39
NA
NA
3.75
3.79
ZZZ33518

A
CABG, artery-vein, two
4.84
NA
NA
1.48
1.56
0.73
NA
NA
7.05
7.13
ZZZ33519

A
CABG, artery-vein, three
7.11
NA
NA
2.18
2.29
1.04
NA
NA
10.33
10.44
ZZZ33521

A
CABG, artery-vein, four
9.39
NA
NA
2.89
3.03
1.37
NA
NA
13.65
13.79
ZZZ33522

A
CABG, artery-vein, five
11.65
NA
NA
3.56
3.75
1.77
NA
NA
16.98
17.17
ZZZ33523

A
Cabg, art-vein, six or more
13.93
NA
NA
4.29
4.47
2.12
NA
NA
20.34
20.52
ZZZ33530

A
Coronary artery, bypass/reop
5.85
NA
NA
1.79
1.88
0.88
NA
NA
8.52
8.61
ZZZ33533

A
CABG, arterial, single
37.38
NA
NA
14.00
15.85
4.55
NA
NA
55.93
57.78
09033534

A
CABG, arterial, two
38.81
NA
NA
14.74
16.97
4.69
NA
NA
58.24
60.47
09033535

A
CABG, arterial, three
41.48
NA
NA
15.68
17.52
5.01
NA
NA
62.17
64.01
09033536

A
Cabg, arterial, four or more
40.79
NA
NA
15.30
17.54
5.42
NA
NA
61.51
63.75
09033542

A
Removal of heart lesion
32.65
NA
NA
12.64
12.90
4.37
NA
NA
49.66
49.92
09033545

A
Repair of heart damage
41.12
NA
NA
15.46
15.58
5.19
NA
NA
61.77
61.89
09033548

A
Restore/remodel, ventricle
42.46
NA
NA
16.52
18.60
5.51
NA
NA
64.49
66.57
09033572

A
Open coronary endarterectomy
4.44
NA
NA
1.34
1.42
0.65
NA
NA
6.43
6.51
ZZZ33600

A
Closure of valve
30.11
NA
NA
12.44
12.49
4.41
NA
NA
46.96
47.01
09033602

A
Closure of valve
29.14
NA
NA
13.30
12.66
3.81
NA
NA
46.25
45.61
09033606

A
Anastomosis/artery-aorta
31.33
NA
NA
12.17
13.30
4.40
NA
NA
47.90
49.03
09033608

A
Repair anomaly w/conduit
31.68
NA
NA
13.41
13.93
4.73
NA
NA
49.82
50.34
09033610

A
Repair by enlargement
31.20
NA
NA
11.20
13.00
4.55
NA
NA
46.95
48.75
09033611

A
Repair double ventricle
35.47
NA
NA
12.37
13.69
4.36
NA
NA
52.20
53.52
09033612

A
Repair double ventricle
36.47
NA
NA
12.97
14.61
5.28
NA
NA
54.72
56.36
09033615

A
Repair, modified fontan
35.72
NA
NA
12.49
12.98
4.31
NA
NA
52.52
53.01
09033617

A
Repair single ventricle
38.92
NA
NA
16.37
16.09
5.64
NA
NA
60.93
60.65
09033619

A
Repair single ventricle
48.56
NA
NA
18.36
20.19
6.44
NA
NA
73.36
75.19
09033641

A
Repair heart septum defect
28.47
NA
NA
10.73
9.86
3.22
NA
NA
42.42
41.55
09033645

A
Revision of heart veins
27.95
NA
NA
11.02
11.58
3.78
NA
NA
42.75
43.31
090( print page 49128)33647

A
Repair heart septum defects
29.33
NA
NA
12.34
13.41
3.31
NA
NA
44.98
46.05
09033660

A
Repair of heart defects
31.73
NA
NA
11.49
12.98
4.48
NA
NA
47.70
49.19
09033665

A
Repair of heart defects
34.75
NA
NA
12.45
13.49
3.99
NA
NA
51.19
52.23
09033670

A
Repair of heart chambers
36.56
NA
NA
12.28
12.95
4.64
NA
NA
53.48
54.15
09033681

A
Repair heart septum defect
32.10
NA
NA
13.28
14.33
4.44
NA
NA
49.82
50.87
09033684

A
Repair heart septum defect
34.27
NA
NA
19.40
15.07
3.38
NA
NA
57.05
52.72
09033688

A
Repair heart septum defect
34.65
NA
NA
9.50
10.23
4.72
NA
NA
48.87
49.60
09033690

A
Reinforce pulmonary artery
20.16
NA
NA
8.63
9.78
1.96
NA
NA
30.75
31.90
09033692

A
Repair of heart defects
31.34
NA
NA
9.29
12.76
4.57
NA
NA
45.20
48.67
09033694

A
Repair of heart defects
35.47
NA
NA
10.16
13.21
5.26
NA
NA
50.89
53.94
09033697

A
Repair of heart defects
37.47
NA
NA
21.66
16.57
4.08
NA
NA
63.21
58.12
09033702

A
Repair of heart defects
27.07
NA
NA
11.48
12.29
3.67
NA
NA
42.22
43.03
09033710

A
Repair of heart defects
30.24
NA
NA
11.69
13.39
4.42
NA
NA
46.35
48.05
09033720

A
Repair of heart defect
27.09
NA
NA
11.17
12.00
3.83
NA
NA
42.09
42.92
09033722

A
Repair of heart defect
29.01
NA
NA
8.75
12.58
1.30
NA
NA
39.06
42.89
09033730

A
Repair heart-vein defect(s)
35.97
NA
NA
13.35
13.93
5.01
NA
NA
54.33
54.91
09033732

A
Repair heart-vein defect
28.76
NA
NA
14.75
13.72
3.67
NA
NA
47.18
46.15
09033735

A
Revision of heart chamber
22.00
NA
NA
9.50
9.09
1.91
NA
NA
33.41
33.00
09033736

A
Revision of heart chamber
24.12
NA
NA
10.80
11.59
3.08
NA
NA
38.00
38.79
09033737

A
Revision of heart chamber
22.30
NA
NA
7.62
10.10
3.24
NA
NA
33.16
35.64
09033750

A
Major vessel shunt
22.02
NA
NA
11.30
10.48
1.16
NA
NA
34.48
33.66
09033755

A
Major vessel shunt
22.40
NA
NA
7.87
8.57
3.25
NA
NA
33.52
34.22
09033762

A
Major vessel shunt
22.40
NA
NA
7.21
9.42
3.13
NA
NA
32.74
34.95
09033764

A
Major vessel shunt & graft
22.40
NA
NA
9.29
9.99
3.00
NA
NA
34.69
35.39
09033766

A
Major vessel shunt
23.37
NA
NA
8.58
10.90
3.69
NA
NA
35.64
37.96
09033767

A
Major vessel shunt
25.10
NA
NA
9.47
11.16
3.81
NA
NA
38.38
40.07
09033768

A
Cavopulmonary shunting
8.00
NA
NA
2.22
2.55
1.19
NA
NA
11.41
11.74
ZZZ33770

A
Repair great vessels defect
39.00
NA
NA
10.67
13.68
5.72
NA
NA
55.39
58.40
09033771

A
Repair great vessels defect
40.56
NA
NA
10.65
11.95
5.66
NA
NA
56.87
58.17
09033774

A
Repair great vessels defect
31.48
NA
NA
12.45
14.11
4.80
NA
NA
48.73
50.39
09033775

A
Repair great vessels defect
32.79
NA
NA
10.21
13.80
4.98
NA
NA
47.98
51.57
09033776

A
Repair great vessels defect
34.45
NA
NA
13.39
15.20
5.07
NA
NA
52.91
54.72
09033777

A
Repair great vessels defect
33.87
NA
NA
10.02
14.21
5.47
NA
NA
49.36
53.55
09033778

A
Repair great vessels defect
42.58
NA
NA
15.26
16.48
6.18
NA
NA
64.02
65.24
09033779

A
Repair great vessels defect
43.13
NA
NA
11.48
14.40
2.91
NA
NA
57.52
60.44
09033780

A
Repair great vessels defect
43.83
NA
NA
11.79
17.26
3.67
NA
NA
59.29
64.76
09033781

A
Repair great vessels defect
43.14
NA
NA
14.18
13.54
5.95
NA
NA
63.27
62.63
09033786

A
Repair arterial trunk
41.70
NA
NA
11.53
15.42
5.69
NA
NA
58.92
62.81
09033788

A
Revision of pulmonary artery
27.22
NA
NA
9.69
11.39
4.02
NA
NA
40.93
42.63
09033800

A
Aortic suspension
17.21
NA
NA
7.32
7.91
2.45
NA
NA
26.98
27.57
09033802

A
Repair vessel defect
18.20
NA
NA
7.50
8.79
2.26
NA
NA
27.96
29.25
09033803

A
Repair vessel defect
20.14
NA
NA
7.95
9.31
3.19
NA
NA
31.28
32.64
09033813

A
Repair septal defect
21.19
NA
NA
9.00
10.43
3.12
NA
NA
33.31
34.74
09033814

A
Repair septal defect
26.37
NA
NA
10.48
12.10
3.84
NA
NA
40.69
42.31
09033820

A
Revise major vessel
16.59
NA
NA
8.39
8.37
2.34
NA
NA
27.32
27.30
09033822

A
Revise major vessel
17.61
NA
NA
6.00
8.21
2.67
NA
NA
26.28
28.49
09033824

A
Revise major vessel
20.06
NA
NA
8.62
9.64
2.88
NA
NA
31.56
32.58
09033840

A
Remove aorta constriction
21.17
NA
NA
8.99
9.97
2.15
NA
NA
32.31
33.29
09033845

A
Remove aorta constriction
22.73
NA
NA
9.64
10.92
3.21
NA
NA
35.58
36.86
09033851

A
Remove aorta constriction
21.81
NA
NA
9.17
10.30
3.17
NA
NA
34.15
35.28
09033852

A
Repair septal defect
24.24
NA
NA
9.90
11.00
2.15
NA
NA
36.29
37.39
09033853

A
Repair septal defect
32.31
NA
NA
13.03
14.37
4.47
NA
NA
49.81
51.15
09033860

A
Ascending aortic graft
43.13
NA
NA
15.73
16.27
5.74
NA
NA
64.60
65.14
09033861

A
Ascending aortic graft
43.88
NA
NA
16.12
17.31
6.35
NA
NA
66.35
67.54
09033863

A
Ascending aortic graft
48.52
NA
NA
17.69
18.44
6.57
NA
NA
72.78
73.53
09033870

A
Transverse aortic arch graft
45.87
NA
NA
16.67
17.95
6.60
NA
NA
69.14
70.42
090( print page 49129)33875

A
Thoracic aortic graft
35.64
NA
NA
13.16
13.86
4.88
NA
NA
53.68
54.38
09033877

A
Thoracoabdominal graft
57.75
NA
NA
18.83
16.94
5.92
NA
NA
82.50
80.61
09033880

A
Endovasc taa repr incl subcl
34.44
NA
NA
10.59
12.75
2.74
NA
NA
47.77
49.93
09033881

A
Endovasc taa repr w/o subcl
29.44
NA
NA
9.35
11.31
2.32
NA
NA
41.11
43.07
09033883

A
Insert endovasc prosth, taa
20.95
NA
NA
7.01
8.64
2.10
NA
NA
30.06
31.69
09033884

A
Endovasc prosth, taa, add-on
8.20
NA
NA
2.01
2.43
0.86
NA
NA
11.07
11.49
ZZZ33886

A
Endovasc prosth, delayed
17.95
NA
NA
6.25
7.74
1.79
NA
NA
25.99
27.48
09033889

A
Artery transpose/endovas taa
15.92
NA
NA
4.17
4.92
2.17
NA
NA
22.26
23.01
00033891

A
Car-car bp grft/endovas taa
20.00
NA
NA
6.45
6.83
2.72
NA
NA
29.17
29.55
00033910

A
Remove lung artery emboli
29.56
NA
NA
11.34
11.41
3.69
NA
NA
44.59
44.66
09033915

A
Remove lung artery emboli
24.80
NA
NA
10.04
9.73
1.44
NA
NA
36.28
35.97
09033916

A
Surgery of great vessel
28.27
NA
NA
10.92
11.24
3.66
NA
NA
42.85
43.17
09033917

A
Repair pulmonary artery
25.10
NA
NA
10.43
11.74
3.69
NA
NA
39.22
40.53
09033920

A
Repair pulmonary atresia
32.54
NA
NA
11.39
13.21
4.37
NA
NA
48.30
50.12
09033922

A
Transect pulmonary artery
24.05
NA
NA
11.44
11.04
3.09
NA
NA
38.58
38.18
09033924

A
Remove pulmonary shunt
5.49
NA
NA
2.12
1.91
0.82
NA
NA
8.43
8.22
ZZZ33925

A
Rpr pul art unifocal w/o cpb
31.23
NA
NA
10.21
13.55
4.60
NA
NA
46.04
49.38
09033926

A
Repr pul art, unifocal w/cpb
44.66
NA
NA
14.38
16.86
6.20
NA
NA
65.24
67.72
09033933

C
Prepare donor heart/lung
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX33935

R
Transplantation, heart/lung
61.56
NA
NA
23.37
27.42
9.03
NA
NA
93.96
98.01
09033944

C
Prepare donor heart
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX33945

R
Transplantation of heart
50.14
NA
NA
19.01
20.80
6.24
NA
NA
75.39
77.18
09033960

A
External circulation assist
19.33
NA
NA
5.60
5.08
2.66
NA
NA
27.59
27.07
00033961

A
External circulation assist
10.91
NA
NA
2.91
3.44
0.88
NA
NA
14.70
15.23
ZZZ33967

A
Insert ia percut device
4.84
NA
NA
2.44
1.99
0.35
NA
NA
7.63
7.18
00033968

A
Remove aortic assist device
0.64
NA
NA
0.27
0.24
0.07
NA
NA
0.98
0.95
00033970

A
Aortic circulation assist
6.74
NA
NA
2.54
2.35
0.82
NA
NA
10.10
9.91
00033971

A
Aortic circulation assist
11.89
NA
NA
6.09
6.02
1.25
NA
NA
19.23
19.16
09033973

A
Insert balloon device
9.75
NA
NA
3.88
3.45
1.26
NA
NA
14.89
14.46
00033974

A
Remove intra-aortic balloon
14.89
NA
NA
7.79
7.86
1.73
NA
NA
24.41
24.48
09033975

A
Implant ventricular device
20.97
NA
NA
6.63
6.37
3.06
NA
NA
30.66
30.40
XXX33976

A
Implant ventricular device
22.97
NA
NA
7.92
7.64
3.25
NA
NA
34.14
33.86
XXX33977

A
Remove ventricular device
19.99
NA
NA
9.37
10.65
2.80
NA
NA
32.16
33.44
09033978

A
Remove ventricular device
22.43
NA
NA
10.52
11.44
3.30
NA
NA
36.25
37.17
09033979

A
Insert intracorporeal device
45.93
NA
NA
14.38
14.79
6.95
NA
NA
67.26
67.67
XXX33980

A
Remove intracorporeal device
64.76
NA
NA
25.09
25.20
8.56
NA
NA
98.41
98.52
09033999

C
Cardiac surgery procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY34001

A
Removal of artery clot
17.74
NA
NA
6.68
6.70
1.84
NA
NA
26.26
26.28
09034051

A
Removal of artery clot
16.86
NA
NA
6.93
7.57
2.20
NA
NA
25.99
26.63
09034101

A
Removal of artery clot
10.81
NA
NA
4.44
5.12
1.41
NA
NA
16.66
17.34
09034111

A
Removal of arm artery clot
10.81
NA
NA
4.50
5.14
1.40
NA
NA
16.71
17.35
09034151

A
Removal of artery clot
26.35
NA
NA
8.87
10.02
3.55
NA
NA
38.77
39.92
09034201

A
Removal of artery clot
18.40
NA
NA
6.57
5.70
1.45
NA
NA
26.42
25.55
09034203

A
Removal of leg artery clot
17.67
NA
NA
6.57
7.69
2.35
NA
NA
26.59
27.71
09034401

A
Removal of vein clot
26.35
NA
NA
9.64
10.41
3.09
NA
NA
39.08
39.85
09034421

A
Removal of vein clot
13.25
NA
NA
5.36
6.06
1.55
NA
NA
20.16
20.86
09034451

A
Removal of vein clot
28.35
NA
NA
9.71
11.01
3.83
NA
NA
41.89
43.19
09034471

A
Removal of vein clot
20.94
NA
NA
7.73
5.91
1.18
NA
NA
29.85
28.03
09034490

A
Removal of vein clot
10.79
NA
NA
4.54
5.20
1.41
NA
NA
16.74
17.40
09034501

A
Repair valve, femoral vein
16.68
NA
NA
6.96
8.11
2.34
NA
NA
25.98
27.13
09034502

A
Reconstruct vena cava
27.80
NA
NA
10.78
11.91
3.62
NA
NA
42.20
43.33
09034510

A
Transposition of vein valve
19.74
NA
NA
7.25
8.87
2.32
NA
NA
29.31
30.93
09034520

A
Cross-over vein graft
18.99
NA
NA
9.19
8.64
2.28
NA
NA
30.46
29.91
09034530

A
Leg vein fusion
17.69
NA
NA
7.88
8.43
1.73
NA
NA
27.30
27.85
09034800

A
Endovas aaa repr w/sm tube
21.42
NA
NA
7.49
8.74
2.45
NA
NA
31.36
32.61
09034802

A
Endovas aaa repr w/2-p part
23.67
NA
NA
8.32
9.42
2.32
NA
NA
34.31
35.41
09034803

A
Endovas aaa repr w/3-p part
24.70
NA
NA
8.25
9.72
2.00
NA
NA
34.95
36.42
09034804

A
Endovas aaa repr w/1-p part
23.67
NA
NA
8.18
9.40
2.29
NA
NA
34.14
35.36
09034805

A
Endovas aaa repr w/long tube
22.55
NA
NA
7.34
9.07
2.00
NA
NA
31.89
33.62
09034808

A
Endovas iliac a device addon
4.12
NA
NA
1.11
1.31
0.59
NA
NA
5.82
6.02
ZZZ34812

A
Xpose for endoprosth, femorl
6.74
NA
NA
1.73
2.11
1.18
NA
NA
9.65
10.03
00034813

A
Femoral endovas graft add-on
4.79
NA
NA
1.21
1.48
0.67
NA
NA
6.67
6.94
ZZZ34820

A
Xpose for endoprosth, iliac
9.74
NA
NA
2.47
3.04
1.50
NA
NA
13.71
14.28
00034825

A
Endovasc extend prosth, init
12.68
NA
NA
5.23
5.91
1.28
NA
NA
19.19
19.87
09034826

A
Endovasc exten prosth, addIl
4.12
NA
NA
1.16
1.32
0.44
NA
NA
5.72
5.88
ZZZ34830

A
Open aortic tube prosth repr
35.04
NA
NA
10.82
12.97
4.54
NA
NA
50.40
52.55
090( print page 49130)34831

A
Open aortoiliac prosth repr
37.79
NA
NA
12.15
11.84
4.88
NA
NA
54.82
54.51
09034832

A
Open aortofemor prosth repr
37.79
NA
NA
11.68
13.89
4.84
NA
NA
54.31
56.52
09034833

A
Xpose for endoprosth, iliac
11.98
NA
NA
3.32
4.15
1.69
NA
NA
16.99
17.82
00034834

A
Xpose, endoprosth, brachial
5.34
NA
NA
1.62
2.05
0.76
NA
NA
7.72
8.15
00034900

A
Endovasc iliac repr w/graft
16.73
NA
NA
6.34
7.27
1.99
NA
NA
25.06
25.99
09035001

A
Repair defect of artery
20.63
NA
NA
7.64
9.07
2.80
NA
NA
31.07
32.50
09035002

A
Repair artery rupture, neck
22.05
NA
NA
7.82
9.22
2.99
NA
NA
32.86
34.26
09035005

A
Repair defect of artery
19.11
NA
NA
8.14
8.67
1.76
NA
NA
29.01
29.54
09035011

A
Repair defect of artery
18.46
NA
NA
6.43
7.59
2.54
NA
NA
27.43
28.59
09035013

A
Repair artery rupture, arm
23.04
NA
NA
7.96
9.24
3.09
NA
NA
34.09
35.37
09035021

A
Repair defect of artery
22.04
NA
NA
8.70
9.23
2.86
NA
NA
33.60
34.13
09035022

A
Repair artery rupture, chest
25.57
NA
NA
9.50
9.76
3.16
NA
NA
38.23
38.49
09035045

A
Repair defect of arm artery
17.91
NA
NA
6.42
7.23
2.44
NA
NA
26.77
27.58
09035081

A
Repair defect of artery
33.31
NA
NA
11.10
11.37
4.00
NA
NA
48.41
48.68
09035082

A
Repair artery rupture, aorta
41.87
NA
NA
13.19
14.77
5.42
NA
NA
60.48
62.06
09035091

A
Repair defect of artery
35.35
NA
NA
10.46
12.79
5.12
NA
NA
50.93
53.26
09035092

A
Repair artery rupture, aorta
50.75
NA
NA
15.09
17.00
6.38
NA
NA
72.22
74.13
09035102

A
Repair defect of artery
36.31
NA
NA
11.68
12.18
4.47
NA
NA
52.46
52.96
09035103

A
Repair artery rupture, groin
43.43
NA
NA
13.31
15.21
5.74
NA
NA
62.48
64.38
09035111

A
Repair defect of artery
26.11
NA
NA
8.62
10.00
3.46
NA
NA
38.19
39.57
09035112

A
Repair artery rupture,spleen
32.38
NA
NA
10.53
11.60
4.07
NA
NA
46.98
48.05
09035121

A
Repair defect of artery
31.35
NA
NA
10.51
11.90
4.29
NA
NA
46.15
47.54
09035122

A
Repair artery rupture, belly
37.70
NA
NA
12.17
13.39
4.74
NA
NA
54.61
55.83
09035131

A
Repair defect of artery
26.23
NA
NA
8.92
10.29
3.79
NA
NA
38.94
40.31
09035132

A
Repair artery rupture, groin
32.38
NA
NA
10.33
11.86
4.29
NA
NA
47.00
48.53
09035141

A
Repair defect of artery
20.79
NA
NA
7.15
8.47
2.89
NA
NA
30.83
32.15
09035142

A
Repair artery rupture, thigh
24.97
NA
NA
8.46
9.89
3.35
NA
NA
36.78
38.21
09035151

A
Repair defect of artery
23.55
NA
NA
7.96
9.48
3.23
NA
NA
34.74
36.26
09035152

A
Repair artery rupture, knee
27.47
NA
NA
9.15
10.82
3.60
NA
NA
40.22
41.89
09035180

A
Repair blood vessel lesion
14.95
NA
NA
6.15
6.74
1.00
NA
NA
22.10
22.69
09035182

A
Repair blood vessel lesion
31.52
NA
NA
11.82
12.55
4.35
NA
NA
47.69
48.42
09035184

A
Repair blood vessel lesion
18.67
NA
NA
6.96
7.96
2.52
NA
NA
28.15
29.15
09035188

A
Repair blood vessel lesion
14.98
NA
NA
6.23
7.28
2.15
NA
NA
23.36
24.41
09035189

A
Repair blood vessel lesion
29.79
NA
NA
10.15
11.50
4.00
NA
NA
43.94
45.29
09035190

A
Repair blood vessel lesion
13.27
NA
NA
5.34
6.19
1.79
NA
NA
20.40
21.25
09035201

A
Repair blood vessel lesion
16.78
NA
NA
6.45
7.61
2.33
NA
NA
25.56
26.72
09035206

A
Repair blood vessel lesion
13.72
NA
NA
5.42
6.27
1.86
NA
NA
21.00
21.85
09035207

A
Repair blood vessel lesion
10.79
NA
NA
6.60
7.16
1.48
NA
NA
18.87
19.43
09035211

A
Repair blood vessel lesion
24.45
NA
NA
10.11
10.49
3.19
NA
NA
37.75
38.13
09035216

A
Repair blood vessel lesion
36.43
NA
NA
13.90
10.20
2.64
NA
NA
52.97
49.27
09035221

A
Repair blood vessel lesion
26.50
NA
NA
8.59
9.60
3.36
NA
NA
38.45
39.46
09035226

A
Repair blood vessel lesion
15.18
NA
NA
5.91
7.05
2.01
NA
NA
23.10
24.24
09035231

A
Repair blood vessel lesion
21.04
NA
NA
7.70
9.25
2.88
NA
NA
31.62
33.17
09035236

A
Repair blood vessel lesion
17.90
NA
NA
6.50
7.54
2.42
NA
NA
26.82
27.86
09035241

A
Repair blood vessel lesion
25.45
NA
NA
9.97
10.83
3.52
NA
NA
38.94
39.80
09035246

A
Repair blood vessel lesion
28.11
NA
NA
11.95
11.55
3.85
NA
NA
43.91
43.51
09035251

A
Repair blood vessel lesion
31.79
NA
NA
9.83
11.30
4.12
NA
NA
45.74
47.21
09035256

A
Repair blood vessel lesion
18.94
NA
NA
6.65
7.93
2.62
NA
NA
28.21
29.49
09035261

A
Repair blood vessel lesion
18.84
NA
NA
7.26
7.82
2.60
NA
NA
28.70
29.26
09035266

A
Repair blood vessel lesion
15.71
NA
NA
5.72
6.68
2.09
NA
NA
23.52
24.48
09035271

A
Repair blood vessel lesion
24.45
NA
NA
9.69
10.31
3.15
NA
NA
37.29
37.91
09035276

A
Repair blood vessel lesion
25.67
NA
NA
9.66
10.82
3.48
NA
NA
38.81
39.97
09035281

A
Repair blood vessel lesion
29.87
NA
NA
9.81
11.23
3.96
NA
NA
43.64
45.06
09035286

A
Repair blood vessel lesion
17.00
NA
NA
6.47
7.66
2.34
NA
NA
25.81
27.00
09035301

A
Rechanneling of artery
19.49
NA
NA
6.90
8.05
2.67
NA
NA
29.06
30.21
09035311

A
Rechanneling of artery
28.48
NA
NA
9.69
11.23
3.41
NA
NA
41.58
43.12
090( print page 49131)35321

A
Rechanneling of artery
16.47
NA
NA
6.00
7.04
2.24
NA
NA
24.71
25.75
09035331

A
Rechanneling of artery
27.55
NA
NA
9.04
10.68
3.82
NA
NA
40.41
42.05
09035341

A
Rechanneling of artery
26.03
NA
NA
8.58
10.29
3.77
NA
NA
38.38
40.09
09035351

A
Rechanneling of artery
24.49
NA
NA
7.98
9.19
3.34
NA
NA
35.81
37.02
09035355

A
Rechanneling of artery
19.74
NA
NA
6.57
7.70
2.66
NA
NA
28.97
30.10
09035361

A
Rechanneling of artery
30.05
NA
NA
9.75
11.21
4.14
NA
NA
43.94
45.40
09035363

A
Rechanneling of artery
32.16
NA
NA
10.60
12.09
4.32
NA
NA
47.08
48.57
09035371

A
Rechanneling of artery
15.19
NA
NA
5.51
6.59
2.13
NA
NA
22.83
23.91
09035372

A
Rechanneling of artery
18.46
NA
NA
6.33
7.61
2.62
NA
NA
27.41
28.69
09035381

A
Rechanneling of artery
16.63
NA
NA
6.33
7.44
2.25
NA
NA
25.21
26.32
09035390

A
Reoperation, carotid add-on
3.19
NA
NA
0.85
1.01
0.46
NA
NA
4.50
4.66
ZZZ35400

A
Angioscopy
3.00
NA
NA
0.75
1.02
0.43
NA
NA
4.18
4.45
ZZZ35450

A
Repair arterial blockage
10.05
NA
NA
3.22
3.48
1.25
NA
NA
14.52
14.78
00035452

A
Repair arterial blockage
6.90
NA
NA
2.12
2.48
0.94
NA
NA
9.96
10.32
00035454

A
Repair arterial blockage
6.03
NA
NA
1.83
2.19
0.87
NA
NA
8.73
9.09
00035456

A
Repair arterial blockage
7.34
NA
NA
2.30
2.65
1.04
NA
NA
10.68
11.03
00035458

A
Repair arterial blockage
9.48
NA
NA
2.91
3.33
1.26
NA
NA
13.65
14.07
00035459

A
Repair arterial blockage
8.62
NA
NA
2.53
3.01
1.21
NA
NA
12.36
12.84
00035460

A
Repair venous blockage
6.03
NA
NA
1.79
2.15
0.83
NA
NA
8.65
9.01
00035470

A
Repair arterial blockage
8.62
62.11
82.17
3.47
3.38
0.69
71.42
91.48
12.78
12.69
00035471

A
Repair arterial blockage
10.05
66.97
91.94
4.70
4.14
0.67
77.69
102.7
15.42
14.86
00035472

A
Repair arterial blockage
6.90
48.34
60.35
2.81
2.76
0.58
55.82
67.83
10.29
10.24
00035473

A
Repair arterial blockage
6.03
47.23
56.69
2.51
2.44
0.51
53.77
63.23
9.05
8.98
00035474

A
Repair arterial blockage
7.35
61.24
81.11
3.00
2.92
0.57
69.16
89.03
10.92
10.84
00035475

R
Repair arterial blockage
9.48
49.26
54.39
3.40
3.52
0.62
59.36
64.49
13.50
13.62
00035476

A
Repair venous blockage
6.03
37.43
42.91
2.13
2.30
0.34
43.80
49.28
8.50
8.67
00035480

A
Atherectomy, open
11.06
NA
NA
3.96
4.02
1.28
NA
NA
16.30
16.36
00035481

A
Atherectomy, open
7.60
NA
NA
2.50
2.78
1.13
NA
NA
11.23
11.51
00035482

A
Atherectomy, open
6.64
NA
NA
2.13
2.45
0.89
NA
NA
9.66
9.98
00035483

A
Atherectomy, open
8.09
NA
NA
2.79
2.96
1.15
NA
NA
12.03
12.20
00035484

A
Atherectomy, open
10.42
NA
NA
3.08
3.60
1.27
NA
NA
14.77
15.29
00035485

A
Atherectomy, open
9.48
NA
NA
3.00
3.40
1.35
NA
NA
13.83
14.23
00035490

A
Atherectomy, percutaneous
11.06
NA
NA
6.27
5.09
0.71
NA
NA
18.04
16.86
00035491

A
Atherectomy, percutaneous
7.60
NA
NA
3.97
3.46
0.74
NA
NA
12.31
11.80
00035492

A
Atherectomy, percutaneous
6.64
NA
NA
3.63
3.30
0.43
NA
NA
10.70
10.37
00035493

A
Atherectomy, percutaneous
8.09
NA
NA
4.15
3.89
0.56
NA
NA
12.80
12.54
00035494

A
Atherectomy, percutaneous
10.42
NA
NA
5.23
4.65
0.59
NA
NA
16.24
15.66
00035495

A
Atherectomy, percutaneous
9.48
NA
NA
4.64
4.45
0.69
NA
NA
14.81
14.62
00035500

A
Harvest vein for bypass
6.44
NA
NA
1.69
1.94
0.93
NA
NA
9.06
9.31
ZZZ35501

A
Artery bypass graft
19.70
NA
NA
7.29
8.17
2.80
NA
NA
29.79
30.67
09035506

A
Artery bypass graft
25.19
NA
NA
8.48
9.22
2.86
NA
NA
36.53
37.27
09035507

A
Artery bypass graft
20.60
NA
NA
7.54
8.95
2.84
NA
NA
30.98
32.39
09035508

A
Artery bypass graft
25.95
NA
NA
9.15
9.37
2.77
NA
NA
37.87
38.09
09035509

A
Artery bypass graft
18.94
NA
NA
6.78
8.27
2.61
NA
NA
28.33
29.82
09035510

A
Artery bypass graft
24.25
NA
NA
7.80
9.58
2.11
NA
NA
34.16
35.94
09035511

A
Artery bypass graft
22.08
NA
NA
7.33
8.85
2.90
NA
NA
32.31
33.83
09035512

A
Artery bypass graft
23.75
NA
NA
7.53
9.38
2.11
NA
NA
33.39
35.24
09035515

A
Artery bypass graft
25.95
NA
NA
8.45
9.07
2.77
NA
NA
37.17
37.79
09035516

A
Artery bypass graft
24.07
NA
NA
7.80
7.05
2.33
NA
NA
34.20
33.45
09035518

A
Artery bypass graft
22.53
NA
NA
7.54
8.61
3.02
NA
NA
33.09
34.16
09035521

A
Artery bypass graft
23.94
NA
NA
8.15
9.41
3.12
NA
NA
35.21
36.47
09035522

A
Artery bypass graft
23.01
NA
NA
7.51
9.19
2.11
NA
NA
32.63
34.31
09035525

A
Artery bypass graft
21.55
NA
NA
7.19
8.83
2.11
NA
NA
30.85
32.49
09035526

A
Artery bypass graft
31.43
NA
NA
18.22
13.93
3.62
NA
NA
53.27
48.98
09035531

A
Artery bypass graft
38.92
NA
NA
11.95
13.84
5.16
NA
NA
56.03
57.92
09035533

A
Artery bypass graft
29.73
NA
NA
9.99
11.29
3.84
NA
NA
43.56
44.86
09035536

A
Artery bypass graft
33.54
NA
NA
10.69
12.38
4.61
NA
NA
48.84
50.53
09035541

A
Artery bypass graft
26.90
NA
NA
9.26
10.72
3.70
NA
NA
39.86
41.32
09035546

A
Artery bypass graft
26.40
NA
NA
9.07
10.41
3.69
NA
NA
39.16
40.50
09035548

A
Artery bypass graft
22.50
NA
NA
7.97
9.06
2.97
NA
NA
33.44
34.53
09035549

A
Artery bypass graft
24.27
NA
NA
9.18
10.07
3.29
NA
NA
36.74
37.63
09035551

A
Artery bypass graft
27.65
NA
NA
9.90
11.09
3.74
NA
NA
41.29
42.48
09035556

A
Artery bypass graft
26.56
NA
NA
8.93
9.52
3.09
NA
NA
38.58
39.17
09035558

A
Artery bypass graft
22.94
NA
NA
8.09
9.18
2.99
NA
NA
34.02
35.11
09035560

A
Artery bypass graft
33.84
NA
NA
10.79
12.68
4.74
NA
NA
49.37
51.26
09035563

A
Artery bypass graft
25.93
NA
NA
8.62
10.05
3.51
NA
NA
38.06
39.49
090( print page 49132)35565

A
Artery bypass graft
24.94
NA
NA
8.51
9.73
3.29
NA
NA
36.74
37.96
09035566

A
Artery bypass graft
32.16
NA
NA
10.20
11.09
3.82
NA
NA
46.18
47.07
09035571

A
Artery bypass graft
25.33
NA
NA
8.45
10.24
3.42
NA
NA
37.20
38.99
09035572

A
Harvest femoropopliteal vein
6.81
NA
NA
1.88
2.15
0.99
NA
NA
9.68
9.95
ZZZ35583

A
Vein bypass graft
27.56
NA
NA
9.01
9.87
3.16
NA
NA
39.73
40.59
09035585

A
Vein bypass graft
32.16
NA
NA
10.15
11.70
4.01
NA
NA
46.32
47.87
09035587

A
Vein bypass graft
26.02
NA
NA
8.69
10.76
3.51
NA
NA
38.22
40.29
09035600

A
Harvest artery for cabg
4.94
NA
NA
1.54
1.60
0.73
NA
NA
7.21
7.27
ZZZ35601

A
Artery bypass graft
18.31
NA
NA
6.63
8.12
2.49
NA
NA
27.43
28.92
09035606

A
Artery bypass graft
22.32
NA
NA
7.68
8.68
2.69
NA
NA
32.69
33.69
09035612

A
Artery bypass graft
16.64
NA
NA
6.40
7.51
2.08
NA
NA
25.12
26.23
09035616

A
Artery bypass graft
21.70
NA
NA
7.14
7.86
2.19
NA
NA
31.03
31.75
09035621

A
Artery bypass graft
20.91
NA
NA
7.04
8.26
2.91
NA
NA
30.86
32.08
09035623

A
Bypass graft, not vein
25.73
NA
NA
8.65
10.03
3.45
NA
NA
37.83
39.21
09035626

A
Artery bypass graft
29.02
NA
NA
10.25
11.54
4.07
NA
NA
43.34
44.63
09035631

A
Artery bypass graft
35.84
NA
NA
11.04
13.13
4.95
NA
NA
51.83
53.92
09035636

A
Artery bypass graft
31.56
NA
NA
9.94
11.70
4.09
NA
NA
45.59
47.35
09035641

A
Artery bypass graft
26.24
NA
NA
9.23
10.60
3.53
NA
NA
39.00
40.37
09035642

A
Artery bypass graft
18.79
NA
NA
7.70
8.44
2.27
NA
NA
28.76
29.50
09035645

A
Artery bypass graft
18.28
NA
NA
7.32
8.03
2.49
NA
NA
28.09
28.80
09035646

A
Artery bypass graft
32.78
NA
NA
10.78
12.52
4.43
NA
NA
47.99
49.73
09035647

A
Artery bypass graft
29.56
NA
NA
9.79
11.28
3.98
NA
NA
43.33
44.82
09035650

A
Artery bypass graft
20.04
NA
NA
6.80
7.97
2.71
NA
NA
29.55
30.72
09035651

A
Artery bypass graft
25.90
NA
NA
8.84
10.25
3.35
NA
NA
38.09
39.50
09035654

A
Artery bypass graft
26.11
NA
NA
8.59
10.14
3.52
NA
NA
38.22
39.77
09035656

A
Artery bypass graft
20.35
NA
NA
7.05
8.21
2.79
NA
NA
30.19
31.35
09035661

A
Artery bypass graft
20.16
NA
NA
7.30
8.52
2.71
NA
NA
30.17
31.39
09035663

A
Artery bypass graft
23.74
NA
NA
8.13
9.51
3.10
NA
NA
34.97
36.35
09035665

A
Artery bypass graft
22.16
NA
NA
7.65
8.99
3.00
NA
NA
32.81
34.15
09035666

A
Artery bypass graft
23.47
NA
NA
8.78
10.18
3.15
NA
NA
35.40
36.80
09035671

A
Artery bypass graft
20.58
NA
NA
7.98
9.02
2.77
NA
NA
31.33
32.37
09035681

A
Composite bypass graft
1.60
NA
NA
0.42
0.50
0.23
NA
NA
2.25
2.33
ZZZ35682

A
Composite bypass graft
7.19
NA
NA
1.78
2.23
1.03
NA
NA
10.00
10.45
ZZZ35683

A
Composite bypass graft
8.49
NA
NA
2.12
2.65
1.20
NA
NA
11.81
12.34
ZZZ35685

A
Bypass graft patency/patch
4.04
NA
NA
1.01
1.27
0.58
NA
NA
5.63
5.89
ZZZ35686

A
Bypass graft/av fist patency
3.34
NA
NA
0.85
1.06
0.47
NA
NA
4.66
4.87
ZZZ35691

A
Arterial transposition
18.26
NA
NA
6.33
7.88
2.58
NA
NA
27.17
28.72
09035693

A
Arterial transposition
15.58
NA
NA
6.09
7.31
2.21
NA
NA
23.88
25.10
09035694

A
Arterial transposition
19.13
NA
NA
6.59
8.10
2.69
NA
NA
28.41
29.92
09035695

A
Arterial transposition
19.91
NA
NA
6.64
8.07
2.73
NA
NA
29.28
30.71
09035697

A
Reimplant artery each
3.00
NA
NA
0.77
0.96
0.41
NA
NA
4.18
4.37
ZZZ35700

A
Reoperation, bypass graft
3.08
NA
NA
0.80
0.97
0.44
NA
NA
4.32
4.49
ZZZ35701

A
Exploration, carotid artery
9.07
NA
NA
4.26
4.93
1.12
NA
NA
14.45
15.12
09035721

A
Exploration, femoral artery
7.62
NA
NA
3.76
4.26
1.03
NA
NA
12.41
12.91
09035741

A
Exploration popliteal artery
8.57
NA
NA
3.98
4.49
1.12
NA
NA
13.67
14.18
09035761

A
Exploration of artery/vein
5.78
NA
NA
3.49
3.88
0.75
NA
NA
10.02
10.41
09035800

A
Explore neck vessels
7.94
NA
NA
3.96
4.48
0.95
NA
NA
12.85
13.37
09035820

A
Explore chest vessels
30.08
NA
NA
11.17
8.19
1.94
NA
NA
43.19
40.21
09035840

A
Explore abdominal vessels
10.81
NA
NA
4.89
5.18
1.34
NA
NA
17.04
17.33
09035860

A
Explore limb vessels
6.67
NA
NA
3.49
3.90
0.78
NA
NA
10.94
11.35
09035870

A
Repair vessel graft defect
24.32
NA
NA
8.25
9.38
3.00
NA
NA
35.57
36.70
09035875

A
Removal of clot in graft
10.60
NA
NA
4.43
4.99
1.41
NA
NA
16.44
17.00
09035876

A
Removal of clot in graft
17.70
NA
NA
6.16
7.17
2.39
NA
NA
26.25
27.26
09035879

A
Revise graft w/vein
17.24
NA
NA
6.17
7.31
2.27
NA
NA
25.68
26.82
09035881

A
Revise graft w/vein
19.16
NA
NA
6.72
8.18
2.55
NA
NA
28.43
29.89
09035901

A
Excision, graft, neck
8.18
NA
NA
4.32
5.06
1.15
NA
NA
13.65
14.39
090( print page 49133)35903

A
Excision, graft, extremity
9.38
NA
NA
4.72
5.79
1.30
NA
NA
15.40
16.47
09035905

A
Excision, graft, thorax
33.33
NA
NA
10.76
12.58
4.43
NA
NA
48.52
50.34
09035907

A
Excision, graft, abdomen
37.08
NA
NA
11.35
13.46
4.91
NA
NA
53.34
55.45
09036000

A
Place needle in vein
0.18
0.46
0.54
0.06
0.05
0.01
0.65
0.73
0.25
0.24
XXX36002

A
Pseudoaneurysm injection trt
1.96
2.23
2.70
0.82
0.93
0.17
4.36
4.83
2.95
3.06
00036005

A
Injection ext venography
0.95
8.54
7.87
0.37
0.33
0.05
9.54
8.87
1.37
1.33
00036010

A
Place catheter in vein
2.43
11.23
17.28
0.75
0.78
0.20
13.86
19.91
3.38
3.41
XXX36011

A
Place catheter in vein
3.14
19.70
25.79
0.97
1.04
0.27
23.11
29.20
4.38
4.45
XXX36012

A
Place catheter in vein
3.51
20.46
19.33
1.20
1.19
0.23
24.20
23.07
4.94
4.93
XXX36013

A
Place catheter in artery
2.52
19.36
20.86
0.96
0.76
0.25
22.13
23.63
3.73
3.53
XXX36014

A
Place catheter in artery
3.02
19.16
19.88
1.03
1.03
0.19
22.37
23.09
4.24
4.24
XXX36015

A
Place catheter in artery
3.51
18.23
22.30
0.94
1.13
0.21
21.95
26.02
4.66
4.85
XXX36100

A
Establish access to artery
3.02
11.30
11.88
1.20
1.13
0.26
14.58
15.16
4.48
4.41
XXX36120

A
Establish access to artery
2.01
9.35
10.36
0.58
0.63
0.14
11.50
12.51
2.73
2.78
XXX36140

A
Establish access to artery
2.01
10.55
12.22
0.70
0.66
0.16
12.72
14.39
2.87
2.83
XXX36145

A
Artery to vein shunt
2.01
10.36
12.00
0.62
0.65
0.11
12.48
14.12
2.74
2.77
XXX36160

A
Establish access to aorta
2.52
11.88
13.08
0.76
0.82
0.26
14.66
15.86
3.54
3.60
XXX36200

A
Place catheter in aorta
3.02
13.76
15.82
1.00
1.01
0.24
17.02
19.08
4.26
4.27
XXX36215

A
Place catheter in artery
4.67
26.10
26.80
1.83
1.67
0.27
31.04
31.74
6.77
6.61
XXX36216

A
Place catheter in artery
5.27
28.11
28.84
1.99
1.84
0.31
33.69
34.42
7.57
7.42
XXX36217

A
Place catheter in artery
6.29
46.29
53.15
2.30
2.20
0.44
53.02
59.88
9.03
8.93
XXX36218

A
Place catheter in artery
1.01
3.78
4.76
0.36
0.35
0.07
4.86
5.84
1.44
1.43
ZZZ36245

A
Place catheter in artery
4.67
29.09
31.34
2.09
1.78
0.31
34.07
36.32
7.07
6.76
XXX36246

A
Place catheter in artery
5.27
27.75
29.41
1.96
1.86
0.38
33.40
35.06
7.61
7.51
XXX36247

A
Place catheter in artery
6.29
45.77
48.58
2.34
2.19
0.47
52.53
55.34
9.10
8.95
XXX36248

A
Place catheter in artery
1.01
3.21
3.83
0.37
0.35
0.07
4.29
4.91
1.45
1.43
ZZZ36260

A
Insertion of infusion pump
9.76
NA
NA
4.86
4.88
1.29
NA
NA
15.91
15.93
09036261

A
Revision of infusion pump
5.50
NA
NA
3.25
3.56
0.70
NA
NA
9.45
9.76
09036262

A
Removal of infusion pump
4.01
NA
NA
2.69
2.74
0.54
NA
NA
7.24
7.29
09036299

C
Vessel injection procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY36400

A
Bl draw < 3 yrs fem/jugular
0.38
0.33
0.29
0.11
0.10
0.03
0.74
0.70
0.52
0.51
XXX36405

A
Bl draw < 3 yrs scalp vein
0.31
0.29
0.27
0.08
0.08
0.03
0.63
0.61
0.42
0.42
XXX36406

A
Bl draw < 3 yrs other vein
0.18
0.30
0.29
0.08
0.06
0.01
0.49
0.48
0.27
0.25
XXX36410

A
Non-routine bl draw > 3 yrs
0.18
0.32
0.30
0.05
0.05
0.01
0.51
0.49
0.24
0.24
XXX36420

A
Vein access cutdown < 1 yr
1.01
NA
NA
0.21
0.26
0.07
NA
NA
1.29
1.34
XXX36425

A
Vein access cutdown > 1 yr
0.76
NA
NA
0.22
0.22
0.06
NA
NA
1.04
1.04
XXX36430

A
Blood transfusion service
0.00
0.93
0.99
0.00
0.76
0.06
0.99
1.05
0.06
0.82
XXX36440

A
Bl push transfuse, 2 yr or <
1.03
NA
NA
0.43
0.33
0.10
NA
NA
1.56
1.46
XXX36450

A
Bl exchange/transfuse, nb
2.23
NA
NA
0.78
0.73
0.21
NA
NA
3.22
3.17
XXX36455

A
Bl exchange/transfuse non-nb
2.43
NA
NA
0.74
0.94
0.15
NA
NA
3.32
3.52
XXX36460

A
Transfusion service, fetal
6.58
NA
NA
1.70
2.11
0.79
NA
NA
9.07
9.48
XXX36470

A
Injection therapy of vein
1.09
2.46
2.63
0.66
0.71
0.12
3.67
3.84
1.87
1.92
01036471

A
Injection therapy of veins
1.57
2.58
2.95
0.80
0.92
0.19
4.34
4.71
2.56
2.68
01036475

A
Endovenous rf, 1st vein
6.72
36.90
47.77
1.97
2.39
0.37
43.99
54.86
9.06
9.48
00036476

A
Endovenous rf, vein add-on
3.38
6.04
7.42
0.89
1.08
0.18
9.60
10.98
4.45
4.64
ZZZ36478

A
Endovenous laser, 1st vein
6.72
33.79
43.53
2.08
2.42
0.37
40.88
50.62
9.17
9.51
00036479

A
Endovenous laser vein addon
3.38
6.55
7.63
1.01
1.11
0.18
10.11
11.19
4.57
4.67
ZZZ36481

A
Insertion of catheter, vein
6.98
NA
NA
2.14
2.48
0.55
NA
NA
9.67
10.01
00036500

A
Insertion of catheter, vein
3.51
NA
NA
1.25
1.34
0.20
NA
NA
4.96
5.05
00036510

A
Insertion of catheter, vein
1.09
1.09
3.19
0.31
0.54
0.10
2.28
4.38
1.50
1.73
00036511

A
Apheresis wbc
1.74
NA
NA
0.58
0.69
0.08
NA
NA
2.40
2.51
00036512

A
Apheresis rbc
1.74
NA
NA
0.61
0.71
0.08
NA
NA
2.43
2.53
00036513

A
Apheresis platelets
1.74
NA
NA
0.52
0.68
0.17
NA
NA
2.43
2.59
00036514

A
Apheresis plasma
1.74
10.54
15.36
0.53
0.67
0.08
12.36
17.18
2.35
2.49
00036515

A
Apheresis, adsorp/reinfuse
1.74
45.31
61.05
0.51
0.62
0.08
47.13
62.87
2.33
2.44
00036516

A
Apheresis, selective
1.22
49.90
75.51
0.38
0.46
0.08
51.20
76.81
1.68
1.76
00036522

A
Photopheresis
1.67
35.02
33.03
0.85
0.93
0.13
36.82
34.83
2.65
2.73
00036550

A
Declot vascular device
0.00
0.33
0.38
0.06
0.31
0.37
0.70
0.75
0.43
0.68
XXX36555

A
Insert non-tunnel cv cath
2.68
4.16
5.35
0.62
0.76
0.11
6.95
8.14
3.41
3.55
00036556

A
Insert non-tunnel cv cath
2.50
2.91
4.94
0.57
0.70
0.19
5.60
7.63
3.26
3.39
00036557

A
Insert tunneled cv cath
5.09
14.96
19.60
2.37
2.58
0.57
20.62
25.26
8.03
8.24
01036558

A
Insert tunneled cv cath
4.79
15.00
19.53
2.30
2.49
0.57
20.36
24.89
7.66
7.85
01036560

A
Insert tunneled cv cath
6.24
21.22
27.56
2.55
2.91
0.57
28.03
34.37
9.36
9.72
01036561

A
Insert tunneled cv cath
5.99
22.48
27.81
2.61
2.87
0.57
29.04
34.37
9.17
9.43
01036563

A
Insert tunneled cv cath
6.19
23.25
25.87
2.62
2.89
0.84
30.28
32.90
9.65
9.92
01036565

A
Insert tunneled cv cath
5.99
17.83
22.98
2.51
2.84
0.57
24.39
29.54
9.07
9.40
010( print page 49134)36566

A
Insert tunneled cv cath
6.49
114.71
47.80
2.67
3.00
0.57
121.77
54.86
9.73
10.06
01036568

A
Insert picc cath
1.92
5.73
7.08
0.57
0.58
0.11
7.76
9.11
2.60
2.61
00036569

A
Insert picc cath
1.82
4.46
6.62
0.61
0.58
0.19
6.47
8.63
2.62
2.59
00036570

A
Insert picvad cath
5.31
23.19
30.68
2.34
2.63
0.57
29.07
36.56
8.22
8.51
01036571

A
Insert picvad cath
5.29
25.04
31.19
2.42
2.64
0.57
30.90
37.05
8.28
8.50
01036575

A
Repair tunneled cv cath
0.67
3.33
3.87
0.23
0.25
0.20
4.20
4.74
1.10
1.12
00036576

A
Repair tunneled cv cath
3.19
5.88
6.68
1.55
1.77
0.19
9.26
10.06
4.93
5.15
01036578

A
Replace tunneled cv cath
3.49
9.11
10.63
1.91
2.20
0.19
12.79
14.31
5.59
5.88
01036580

A
Replace cvad cath
1.31
3.99
6.20
0.41
0.41
0.19
5.49
7.70
1.91
1.91
00036581

A
Replace tunneled cv cath
3.43
15.64
18.53
1.66
1.86
0.19
19.26
22.15
5.28
5.48
01036582

A
Replace tunneled cv cath
5.19
20.79
24.71
2.29
2.72
0.19
26.17
30.09
7.67
8.10
01036583

A
Replace tunneled cv cath
5.24
21.00
24.77
2.41
2.76
0.19
26.43
30.20
7.84
8.19
01036584

A
Replace picc cath
1.20
3.97
6.22
0.57
0.56
0.19
5.36
7.61
1.96
1.95
00036585

A
Replace picvad cath
4.79
22.75
26.55
2.30
2.62
0.19
27.73
31.53
7.28
7.60
01036589

A
Removal tunneled cv cath
2.27
1.86
2.15
1.22
1.35
0.24
4.37
4.66
3.73
3.86
01036590

A
Removal tunneled cv cath
3.30
3.64
3.44
1.59
1.69
0.44
7.38
7.18
5.33
5.43
01036595

A
Mech remov tunneled cv cath
3.59
10.85
15.65
1.31
1.42
0.21
14.65
19.45
5.11
5.22
00036596

A
Mech remov tunneled cv cath
0.75
2.59
3.42
0.42
0.48
0.05
3.39
4.22
1.22
1.28
00036597

A
Reposition venous catheter
1.21
2.02
2.31
0.42
0.44
0.07
3.30
3.59
1.70
1.72
00036598

T
Inj w/fluor, eval cv device
0.74
2.25
2.54
0.26
2.05
0.05
3.04
3.33
1.05
2.84
00036600

A
Withdrawal of arterial blood
0.32
0.50
0.49
0.08
0.09
0.02
0.84
0.83
0.42
0.43
XXX36620

A
Insertion catheter, artery
1.15
NA
NA
0.17
0.22
0.07
NA
NA
1.39
1.44
00036625

A
Insertion catheter, artery
2.11
NA
NA
0.49
0.52
0.26
NA
NA
2.86
2.89
00036640

A
Insertion catheter, artery
2.10
NA
NA
0.91
1.01
0.21
NA
NA
3.22
3.32
00036660

A
Insertion catheter, artery
1.40
NA
NA
0.20
0.38
0.14
NA
NA
1.74
1.92
00036680

A
Insert needle, bone cavity
1.20
NA
NA
0.33
0.45
0.11
NA
NA
1.64
1.76
00036800

A
Insertion of cannula
2.43
NA
NA
1.55
1.74
0.25
NA
NA
4.23
4.42
00036810

A
Insertion of cannula
3.96
NA
NA
1.36
1.60
0.45
NA
NA
5.77
6.01
00036815

A
Insertion of cannula
2.62
NA
NA
1.04
1.14
0.35
NA
NA
4.01
4.11
00036818

A
Av fuse, uppr arm, cephalic
11.77
NA
NA
4.88
5.74
1.89
NA
NA
18.54
19.40
09036819

A
Av fuse, uppr arm, basilic
14.35
NA
NA
5.26
6.09
1.95
NA
NA
21.56
22.39
09036820

A
Av fusion/forearm vein
14.35
NA
NA
5.34
6.12
1.94
NA
NA
21.63
22.41
09036821

A
Av fusion direct any site
9.10
NA
NA
4.04
4.50
1.23
NA
NA
14.37
14.83
09036822

A
Insertion of cannula(s)
5.47
NA
NA
3.82
4.24
0.79
NA
NA
10.08
10.50
09036823

A
Insertion of cannula(s)
22.74
NA
NA
8.91
9.26
2.88
NA
NA
34.53
34.88
09036825

A
Artery-vein autograft
9.95
NA
NA
4.34
4.87
1.35
NA
NA
15.64
16.17
09036830

A
Artery-vein nonautograft
11.98
NA
NA
4.25
4.99
1.66
NA
NA
17.89
18.63
09036831

A
Open thrombect av fistula
7.99
NA
NA
3.28
3.78
1.09
NA
NA
12.36
12.86
09036832

A
Av fistula revision, open
10.48
NA
NA
3.87
4.51
1.44
NA
NA
15.79
16.43
09036833

A
Av fistula revision
11.93
NA
NA
4.25
4.96
1.65
NA
NA
17.83
18.54
09036834

A
Repair A-V aneurysm
11.07
NA
NA
4.35
4.68
1.37
NA
NA
16.79
17.12
09036835

A
Artery to vein shunt
7.38
NA
NA
3.90
4.22
0.98
NA
NA
12.26
12.58
09036838

A
Dist revas ligation, hemo
21.55
NA
NA
7.14
8.82
3.01
NA
NA
31.70
33.38
09036860

A
External cannula declotting
2.01
3.35
2.17
0.62
0.67
0.11
5.47
4.29
2.74
2.79
00036861

A
Cannula declotting
2.52
NA
NA
1.25
1.43
0.27
NA
NA
4.04
4.22
00036870

A
Percut thrombect av fistula
5.15
41.10
50.05
2.67
3.03
0.29
46.54
55.49
8.11
8.47
09037140

A
Revision of circulation
25.05
NA
NA
9.04
10.12
2.01
NA
NA
36.10
37.18
09037145

A
Revision of circulation
26.06
NA
NA
9.10
10.42
3.25
NA
NA
38.41
39.73
09037160

A
Revision of circulation
23.06
NA
NA
8.16
8.98
2.81
NA
NA
34.03
34.85
09037180

A
Revision of circulation
26.06
NA
NA
9.00
9.97
3.34
NA
NA
38.40
39.37
09037181

A
Splice spleen/kidney veins
28.19
NA
NA
9.34
10.59
3.40
NA
NA
40.92
42.17
09037182

A
Insert hepatic shunt (tips)
16.97
NA
NA
5.73
5.98
1.00
NA
NA
23.70
23.95
00037183

A
Remove hepatic shunt (tips)
7.99
NA
NA
2.80
2.96
0.47
NA
NA
11.26
11.42
00037184

A
Prim art mech thrombectomy
8.66
49.86
66.23
3.00
3.26
0.55
59.07
75.44
12.21
12.47
00037185

A
Prim art m-thrombect add-on
3.28
16.20
21.21
1.02
1.09
0.21
19.69
24.70
4.51
4.58
ZZZ37186

A
Sec art m-thrombect add-on
4.92
34.21
45.60
1.53
1.63
0.32
39.45
50.84
6.77
6.87
ZZZ( print page 49135)37187

A
Venous mech thrombectomy
8.03
48.71
64.81
2.81
3.06
0.51
57.25
73.35
11.35
11.60
00037188

A
Venous m-thrombectomy add-on
5.71
42.51
57.11
2.09
2.29
0.37
48.59
63.19
8.17
8.37
00037195

C
Thrombolytic therapy, stroke
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX37200

A
Transcatheter biopsy
4.55
NA
NA
1.49
1.50
0.27
NA
NA
6.31
6.32
00037201

A
Transcatheter therapy infuse
4.99
NA
NA
2.25
2.47
0.33
NA
NA
7.57
7.79
00037202

A
Transcatheter therapy infuse
5.67
NA
NA
3.40
3.12
0.43
NA
NA
9.50
9.22
00037203

A
Transcatheter retrieval
5.02
30.34
32.24
1.95
2.01
0.29
35.65
37.55
7.26
7.32
00037204

A
Transcatheter occlusion
18.11
NA
NA
5.79
5.87
1.48
NA
NA
25.38
25.46
00037205

A
Transcath iv stent, percut
8.27
NA
NA
3.90
3.79
0.60
NA
NA
12.77
12.66
00037206

A
Transcath iv stent/perc addl
4.12
NA
NA
1.59
1.47
0.31
NA
NA
6.02
5.90
ZZZ37207

A
Transcath iv stent, open
8.27
NA
NA
2.45
2.98
1.17
NA
NA
11.89
12.42
00037208

A
Transcath iv stent/open addl
4.12
NA
NA
1.05
1.30
0.59
NA
NA
5.76
6.01
ZZZ37209

A
Change iv cath at thromb tx
2.27
NA
NA
0.73
0.74
0.15
NA
NA
3.15
3.16
00037215

R
Transcath stent, cca w/eps
19.54
NA
NA
10.12
9.35
1.09
NA
NA
30.75
29.98
09037216

N
Transcath stent, cca w/o eps
18.81
NA
NA
8.74
8.79
1.04
NA
NA
28.59
28.64
09037250

A
Iv us first vessel add-on
2.10
NA
NA
0.81
0.77
0.21
NA
NA
3.12
3.08
ZZZ37251

A
Iv us each add vessel add-on
1.60
NA
NA
0.52
0.54
0.19
NA
NA
2.31
2.33
ZZZ37500

A
Endoscopy ligate perf veins
11.48
NA
NA
5.46
6.50
1.54
NA
NA
18.48
19.52
09037501

C
Vascular endoscopy procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY37565

A
Ligation of neck vein
11.93
NA
NA
5.10
5.49
1.33
NA
NA
18.36
18.75
09037600

A
Ligation of neck artery
12.30
NA
NA
4.80
6.17
1.41
NA
NA
18.51
19.88
09037605

A
Ligation of neck artery
14.16
NA
NA
5.57
6.57
1.98
NA
NA
21.71
22.71
09037606

A
Ligation of neck artery
8.66
NA
NA
4.87
4.64
1.23
NA
NA
14.76
14.53
09037607

A
Ligation of a-v fistula
6.15
NA
NA
3.11
3.45
0.85
NA
NA
10.11
10.45
09037609

A
Temporal artery procedure
3.00
4.24
4.44
1.84
1.93
0.36
7.60
7.80
5.20
5.29
01037615

A
Ligation of neck artery
7.67
NA
NA
3.98
4.08
0.68
NA
NA
12.33
12.43
09037616

A
Ligation of chest artery
18.84
NA
NA
7.94
8.05
2.32
NA
NA
29.10
29.21
09037617

A
Ligation of abdomen artery
23.67
NA
NA
7.92
8.86
2.97
NA
NA
34.56
35.50
09037618

A
Ligation of extremity artery
5.90
NA
NA
3.40
3.56
0.67
NA
NA
9.97
10.13
09037620

A
Revision of major vein
11.44
NA
NA
5.24
5.59
0.91
NA
NA
17.59
17.94
09037650

A
Revision of major vein
8.37
NA
NA
4.22
4.57
1.01
NA
NA
13.60
13.95
09037660

A
Revision of major vein
22.16
NA
NA
8.13
8.82
2.48
NA
NA
32.77
33.46
09037700

A
Revise leg vein
3.72
NA
NA
2.45
2.71
0.53
NA
NA
6.70
6.96
09037718

A
Ligate/strip short leg vein
7.01
NA
NA
3.53
3.93
0.14
NA
NA
10.68
11.08
09037722

A
Ligate/strip long leg vein
8.04
NA
NA
3.80
4.26
0.86
NA
NA
12.70
13.16
09037735

A
Removal of leg veins/lesion
10.75
NA
NA
4.67
5.29
1.48
NA
NA
16.90
17.52
09037760

A
Ligation, leg veins, open
10.63
NA
NA
4.55
5.14
1.44
NA
NA
16.62
17.21
09037765

A
Phleb veins—extrem—to 20
7.59
NA
NA
3.60
4.37
0.48
NA
NA
11.67
12.44
09037766

A
Phleb veins—extrem 20+
9.54
NA
NA
4.15
5.03
0.48
NA
NA
14.17
15.05
09037780

A
Revision of leg vein
3.83
NA
NA
2.50
2.76
0.53
NA
NA
6.86
7.12
09037785

A
Ligate/divide/excise vein
3.83
4.96
5.13
2.59
2.69
0.54
9.33
9.50
6.96
7.06
09037788

A
Revascularization, penis
23.13
NA
NA
11.95
9.80
2.25
NA
NA
37.33
35.18
09037790

A
Penile venous occlusion
8.33
NA
NA
5.09
4.55
0.59
NA
NA
14.01
13.47
09037799

C
Vascular surgery procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY38100

A
Removal of spleen, total
19.43
NA
NA
6.94
6.36
1.91
NA
NA
28.28
27.70
09038101

A
Removal of spleen, partial
19.43
NA
NA
7.36
6.73
2.04
NA
NA
28.83
28.20
09038102

A
Removal of spleen, total
4.79
NA
NA
1.27
1.55
0.63
NA
NA
6.69
6.97
ZZZ38115

A
Repair of ruptured spleen
21.76
NA
NA
7.59
6.88
2.08
NA
NA
31.43
30.72
09038120

A
Laparoscopy, splenectomy
16.97
NA
NA
7.00
7.29
2.24
NA
NA
26.21
26.50
09038129

C
Laparoscope proc, spleen
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY38200

A
Injection for spleen x-ray
2.64
NA
NA
1.00
0.92
0.14
NA
NA
3.78
3.70
00038205

R
Harvest allogenic stem cells
1.50
NA
NA
0.54
0.64
0.07
NA
NA
2.11
2.21
00038206

R
Harvest auto stem cells
1.50
NA
NA
0.54
0.64
0.07
NA
NA
2.11
2.21
00038220

A
Bone marrow aspiration
1.08
2.67
3.46
0.44
0.50
0.05
3.80
4.59
1.57
1.63
XXX38221

A
Bone marrow biopsy
1.37
2.79
3.65
0.57
0.63
0.07
4.23
5.09
2.01
2.07
XXX38230

R
Bone marrow collection
4.78
NA
NA
2.76
3.11
0.48
NA
NA
8.02
8.37
01038240

R
Bone marrow/stem transplant
2.24
NA
NA
0.93
1.01
0.11
NA
NA
3.28
3.36
XXX38241

R
Bone marrow/stem transplant
2.24
NA
NA
0.93
1.01
0.11
NA
NA
3.28
3.36
XXX38242

A
Lymphocyte infuse transplant
1.71
NA
NA
0.69
0.76
0.08
NA
NA
2.48
2.55
00038300

A
Drainage, lymph node lesion
2.24
3.63
4.13
1.75
1.98
0.25
6.12
6.62
4.24
4.47
01038305

A
Drainage, lymph node lesion
6.49
NA
NA
3.42
4.19
0.88
NA
NA
10.79
11.56
09038308

A
Incision of lymph channels
6.69
NA
NA
3.59
3.70
0.85
NA
NA
11.13
11.24
09038380

A
Thoracic duct procedure
8.26
NA
NA
4.64
5.42
0.74
NA
NA
13.64
14.42
09038381

A
Thoracic duct procedure
13.28
NA
NA
6.11
6.69
1.84
NA
NA
21.23
21.81
09038382

A
Thoracic duct procedure
10.42
NA
NA
5.47
5.68
1.37
NA
NA
17.26
17.47
09038500

A
Biopsy/removal, lymph nodes
3.74
3.78
3.71
2.04
2.07
0.49
8.01
7.94
6.27
6.30
010( print page 49136)38505

A
Needle biopsy, lymph nodes
1.14
2.08
2.06
0.70
0.76
0.09
3.31
3.29
1.93
1.99
00038510

A
Biopsy/removal, lymph nodes
6.67
5.21
5.46
2.96
3.35
0.72
12.60
12.85
10.35
10.74
01038520

A
Biopsy/removal, lymph nodes
6.91
NA
NA
3.71
3.97
0.84
NA
NA
11.46
11.72
09038525

A
Biopsy/removal, lymph nodes
6.31
NA
NA
3.50
3.34
0.80
NA
NA
10.61
10.45
09038530

A
Biopsy/removal, lymph nodes
8.22
NA
NA
4.12
4.32
1.12
NA
NA
13.46
13.66
09038542

A
Explore deep node(s), neck
6.02
NA
NA
3.73
4.29
0.60
NA
NA
10.35
10.91
09038550

A
Removal, neck/armpit lesion
6.91
NA
NA
4.24
3.99
0.88
NA
NA
12.03
11.78
09038555

A
Removal, neck/armpit lesion
15.31
NA
NA
7.25
8.21
1.75
NA
NA
24.31
25.27
09038562

A
Removal, pelvic lymph nodes
10.83
NA
NA
5.77
5.77
1.20
NA
NA
17.80
17.80
09038564

A
Removal, abdomen lymph nodes
11.23
NA
NA
5.25
5.24
1.32
NA
NA
17.80
17.79
09038570

A
Laparoscopy, lymph node biop
9.24
NA
NA
3.98
3.97
1.13
NA
NA
14.35
14.34
01038571

A
Laparoscopy, lymphadenectomy
14.66
NA
NA
6.86
5.95
1.15
NA
NA
22.67
21.76
01038572

A
Laparoscopy, lymphadenectomy
16.82
NA
NA
6.16
6.84
1.90
NA
NA
24.88
25.56
01038589

C
Laparoscope proc, lymphatic
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY38700

A
Removal of lymph nodes, neck
12.62
NA
NA
5.91
6.15
0.72
NA
NA
19.25
19.49
09038720

A
Removal of lymph nodes, neck
21.64
NA
NA
9.21
9.32
1.20
NA
NA
32.05
32.16
09038724

A
Removal of lymph nodes, neck
23.64
NA
NA
9.79
9.82
1.28
NA
NA
34.71
34.74
09038740

A
Remove armpit lymph nodes
10.51
NA
NA
5.07
4.97
1.32
NA
NA
16.90
16.80
09038745

A
Remove armpit lymph nodes
13.65
NA
NA
6.12
6.08
1.73
NA
NA
21.50
21.46
09038746

A
Remove thoracic lymph nodes
4.88
NA
NA
1.45
1.57
0.72
NA
NA
7.05
7.17
ZZZ38747

A
Remove abdominal lymph nodes
4.88
NA
NA
1.28
1.57
0.64
NA
NA
6.80
7.09
ZZZ38760

A
Remove groin lymph nodes
13.43
NA
NA
6.01
6.09
1.71
NA
NA
21.15
21.23
09038765

A
Remove groin lymph nodes
21.72
NA
NA
8.72
8.78
2.47
NA
NA
32.91
32.97
09038770

A
Remove pelvis lymph nodes
13.93
NA
NA
6.91
6.03
1.40
NA
NA
22.24
21.36
09038780

A
Remove abdomen lymph nodes
17.47
NA
NA
8.00
8.15
1.88
NA
NA
27.35
27.50
09038790

A
Inject for lymphatic x-ray
1.29
NA
NA
0.73
0.75
0.13
NA
NA
2.15
2.17
00038792

A
Identify sentinel node
0.52
NA
NA
0.48
0.45
0.06
NA
NA
1.06
1.03
00038794

A
Access thoracic lymph duct
4.44
NA
NA
3.04
3.35
0.32
NA
NA
7.80
8.11
09038999

C
Blood/lymph system procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY39000

A
Exploration of chest
7.46
NA
NA
4.36
4.58
0.89
NA
NA
12.71
12.93
09039010

A
Exploration of chest
13.08
NA
NA
6.17
7.20
1.75
NA
NA
21.00
22.03
09039200

A
Removal chest lesion
15.02
NA
NA
6.29
7.22
2.02
NA
NA
23.33
24.26
09039220

A
Removal chest lesion
18.42
NA
NA
7.64
8.93
2.45
NA
NA
28.51
29.80
09039400

A
Visualization of chest
5.97
NA
NA
3.62
4.54
0.82
NA
NA
10.41
11.33
01039499

C
Chest procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY39501

A
Repair diaphragm laceration
13.83
NA
NA
5.93
6.32
1.77
NA
NA
21.53
21.92
09039502

A
Repair paraesophageal hernia
17.03
NA
NA
6.66
7.02
2.16
NA
NA
25.85
26.21
09039503

A
Repair of diaphragm hernia
108.57
NA
NA
30.95
32.77
10.95
NA
NA
150.47
152.29
09039520

A
Repair of diaphragm hernia
16.56
NA
NA
6.93
7.76
2.23
NA
NA
25.72
26.55
09039530

A
Repair of diaphragm hernia
16.17
NA
NA
6.43
6.96
2.10
NA
NA
24.70
25.23
09039531

A
Repair of diaphragm hernia
17.18
NA
NA
6.63
7.19
2.21
NA
NA
26.02
26.58
09039540

A
Repair of diaphragm hernia
14.47
NA
NA
5.65
6.08
1.79
NA
NA
21.91
22.34
09039541

A
Repair of diaphragm hernia
15.62
NA
NA
6.21
6.49
1.92
NA
NA
23.75
24.03
09039545

A
Revision of diaphragm
14.52
NA
NA
7.23
7.46
1.83
NA
NA
23.58
23.81
09039560

A
Resect diaphragm, simple
12.91
NA
NA
5.58
6.11
1.59
NA
NA
20.08
20.61
09039561

A
Resect diaphragm, complex
19.69
NA
NA
9.42
9.35
2.44
NA
NA
31.55
31.48
09039599

C
Diaphragm surgery procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY40490

A
Biopsy of lip
1.22
2.02
1.73
0.55
0.60
0.05
3.29
3.00
1.82
1.87
00040500

A
Partial excision of lip
4.27
7.65
7.08
4.18
4.29
0.38
12.30
11.73
8.83
8.94
09040510

A
Partial excision of lip
4.69
6.52
6.59
3.48
3.88
0.49
11.70
11.77
8.66
9.06
09040520

A
Partial excision of lip
4.66
6.79
7.35
3.68
4.00
0.52
11.97
12.53
8.86
9.18
09040525

A
Reconstruct lip with flap
7.54
NA
NA
5.23
6.03
0.85
NA
NA
13.62
14.42
09040527

A
Reconstruct lip with flap
9.12
NA
NA
5.84
6.97
0.97
NA
NA
15.93
17.06
09040530

A
Partial removal of lip
5.39
7.28
7.68
4.07
4.45
0.55
13.22
13.62
10.01
10.39
09040650

A
Repair lip
3.63
5.91
6.57
3.12
3.25
0.38
9.92
10.58
7.13
7.26
09040652

A
Repair lip
4.25
6.97
7.55
3.94
4.18
0.52
11.74
12.32
8.71
8.95
090( print page 49137)40654

A
Repair lip
5.30
7.98
8.45
4.60
4.85
0.60
13.88
14.35
10.50
10.75
09040700

A
Repair cleft lip/nasal
13.89
NA
NA
9.13
9.09
0.95
NA
NA
23.97
23.93
09040701

A
Repair cleft lip/nasal
16.95
NA
NA
11.13
11.28
1.65
NA
NA
29.73
29.88
09040702

A
Repair cleft lip/nasal
14.02
NA
NA
7.21
7.99
1.23
NA
NA
22.46
23.24
09040720

A
Repair cleft lip/nasal
14.47
NA
NA
9.01
9.67
1.79
NA
NA
25.27
25.93
09040761

A
Repair cleft lip/nasal
15.63
NA
NA
8.82
9.91
1.93
NA
NA
26.38
27.47
09040799

C
Lip surgery procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY40800

A
Drainage of mouth lesion
1.17
3.84
3.18
1.88
1.80
0.13
5.14
4.48
3.18
3.10
01040801

A
Drainage of mouth lesion
2.53
4.85
4.23
2.55
2.69
0.31
7.69
7.07
5.39
5.53
01040804

A
Removal, foreign body, mouth
1.24
3.63
3.45
1.75
1.83
0.11
4.98
4.80
3.10
3.18
01040805

A
Removal, foreign body, mouth
2.69
5.04
4.62
2.56
2.75
0.32
8.05
7.63
5.57
5.76
01040806

A
Incision of lip fold
0.31
2.38
1.97
0.50
0.50
0.04
2.73
2.32
0.85
0.85
00040808

A
Biopsy of mouth lesion
0.96
3.51
2.87
1.57
1.50
0.10
4.57
3.93
2.63
2.56
01040810

A
Excision of mouth lesion
1.31
3.57
3.05
1.66
1.66
0.13
5.01
4.49
3.10
3.10
01040812

A
Excise/repair mouth lesion
2.31
4.51
3.92
2.26
2.37
0.28
7.10
6.51
4.85
4.96
01040814

A
Excise/repair mouth lesion
3.41
5.62
5.11
3.64
3.83
0.41
9.44
8.93
7.46
7.65
09040816

A
Excision of mouth lesion
3.66
5.79
5.33
3.68
3.92
0.40
9.85
9.39
7.74
7.98
09040818

A
Excise oral mucosa for graft
2.66
5.77
5.32
3.70
3.90
0.21
8.64
8.19
6.57
6.77
09040819

A
Excise lip or cheek fold
2.41
4.87
4.28
3.06
3.08
0.29
7.57
6.98
5.76
5.78
09040820

A
Treatment of mouth lesion
1.28
5.11
4.23
2.82
2.54
0.11
6.50
5.62
4.21
3.93
01040830

A
Repair mouth laceration
1.76
4.11
3.82
2.02
2.07
0.19
6.06
5.77
3.97
4.02
01040831

A
Repair mouth laceration
2.46
5.33
4.83
2.73
2.97
0.30
8.09
7.59
5.49
5.73
01040840

R
Reconstruction of mouth
8.97
9.99
9.83
5.53
6.61
1.08
20.04
19.88
15.58
16.66
09040842

R
Reconstruction of mouth
8.97
9.71
9.97
5.32
6.42
1.08
19.76
20.02
15.37
16.47
09040843

R
Reconstruction of mouth
12.56
11.76
11.90
6.01
7.36
1.39
25.71
25.85
19.96
21.31
09040844

R
Reconstruction of mouth
16.47
14.78
15.52
8.75
10.86
1.99
33.24
33.98
27.21
29.32
09040845

R
Reconstruction of mouth
19.03
15.15
16.58
9.55
12.30
2.00
36.18
37.61
30.58
33.33
09040899

C
Mouth surgery procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY41000

A
Drainage of mouth lesion
1.30
2.49
2.36
1.29
1.38
0.12
3.91
3.78
2.71
2.80
01041005

A
Drainage of mouth lesion
1.26
4.23
3.56
1.71
1.72
0.12
5.61
4.94
3.09
3.10
01041006

A
Drainage of mouth lesion
3.24
5.29
4.92
2.73
3.06
0.35
8.88
8.51
6.32
6.65
09041007

A
Drainage of mouth lesion
3.10
5.33
5.19
2.71
2.94
0.31
8.74
8.60
6.12
6.35
09041008

A
Drainage of mouth lesion
3.36
5.41
4.86
2.78
3.10
0.42
9.19
8.64
6.56
6.88
09041009

A
Drainage of mouth lesion
3.58
5.80
5.18
3.11
3.46
0.47
9.85
9.23
7.16
7.51
09041010

A
Incision of tongue fold
1.06
3.44
3.43
1.37
1.54
0.07
4.57
4.56
2.50
2.67
01041015

A
Drainage of mouth lesion
3.95
6.21
5.60
3.93
4.09
0.46
10.62
10.01
8.34
8.50
09041016

A
Drainage of mouth lesion
4.06
6.16
5.75
4.02
4.17
0.53
10.75
10.34
8.61
8.76
09041017

A
Drainage of mouth lesion
4.06
6.31
5.80
4.08
4.25
0.53
10.90
10.39
8.67
8.84
09041018

A
Drainage of mouth lesion
5.09
6.54
6.23
4.32
4.51
0.68
12.31
12.00
10.09
10.28
09041100

A
Biopsy of tongue
1.37
2.57
2.46
1.11
1.34
0.15
4.09
3.98
2.63
2.86
01041105

A
Biopsy of tongue
1.42
2.56
2.37
1.13
1.27
0.13
4.11
3.92
2.68
2.82
01041108

A
Biopsy of floor of mouth
1.05
2.40
2.15
1.02
1.10
0.10
3.55
3.30
2.17
2.25
01041110

A
Excision of tongue lesion
1.51
3.46
3.10
1.54
1.62
0.13
5.10
4.74
3.18
3.26
01041112

A
Excision of tongue lesion
2.73
5.11
4.63
3.14
3.20
0.28
8.12
7.64
6.15
6.21
09041113

A
Excision of tongue lesion
3.19
5.38
4.90
3.29
3.43
0.34
8.91
8.43
6.82
6.96
09041114

A
Excision of tongue lesion
8.64
NA
NA
5.94
6.88
0.83
NA
NA
15.41
16.35
09041115

A
Excision of tongue fold
1.74
4.27
3.54
1.75
1.83
0.18
6.19
5.46
3.67
3.75
01041116

A
Excision of mouth lesion
2.44
5.31
4.59
2.65
2.76
0.23
7.98
7.26
5.32
5.43
09041120

A
Partial removal of tongue
10.83
NA
NA
13.22
14.79
0.79
NA
NA
24.84
26.41
09041130

A
Partial removal of tongue
15.43
NA
NA
14.55
15.78
0.93
NA
NA
30.91
32.14
09041135

A
Tongue and neck surgery
29.71
NA
NA
19.86
22.38
1.88
NA
NA
51.45
53.97
09041140

A
Removal of tongue
28.69
NA
NA
21.36
25.34
2.26
NA
NA
52.31
56.29
09041145

A
Tongue removal, neck surgery
37.47
NA
NA
26.29
29.48
2.54
NA
NA
66.30
69.49
09041150

A
Tongue, mouth, jaw surgery
29.40
NA
NA
21.09
23.81
1.94
NA
NA
52.43
55.15
09041153

A
Tongue, mouth, neck surgery
33.16
NA
NA
21.82
24.22
2.00
NA
NA
56.98
59.38
09041155

A
Tongue, jaw, & neck surgery
39.84
NA
NA
23.98
26.10
2.33
NA
NA
66.15
68.27
09041250

A
Repair tongue laceration
1.91
3.79
3.00
1.58
1.28
0.18
5.88
5.09
3.67
3.37
01041251

A
Repair tongue laceration
2.27
3.15
3.24
1.63
1.57
0.22
5.64
5.73
4.12
4.06
01041252

A
Repair tongue laceration
2.97
4.34
4.00
1.96
2.18
0.29
7.60
7.26
5.22
5.44
01041500

A
Fixation of tongue
3.70
NA
NA
6.54
7.22
0.30
NA
NA
10.54
11.22
09041510

A
Tongue to lip surgery
3.41
NA
NA
7.02
7.70
0.20
NA
NA
10.63
11.31
09041520

A
Reconstruction, tongue fold
2.73
5.71
4.89
3.20
3.52
0.27
8.71
7.89
6.20
6.52
09041599

C
Tongue and mouth surgery
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY41800

A
Drainage of gum lesion
1.17
4.76
3.13
2.09
1.48
0.12
6.05
4.42
3.38
2.77
01041805

A
Removal foreign body, gum
1.24
4.73
3.19
2.75
2.35
0.13
6.10
4.56
4.12
3.72
01041806

A
Removal foreign body,jawbone
2.69
5.91
4.16
3.39
3.12
0.37
8.97
7.22
6.45
6.18
010( print page 49138)41822

R
Excision of gum lesion
2.31
4.65
4.08
1.77
1.85
0.31
7.27
6.70
4.39
4.47
01041823

R
Excision of gum lesion
3.55
6.48
5.79
3.74
3.94
0.47
10.50
9.81
7.76
7.96
09041825

A
Excision of gum lesion
1.31
3.62
3.20
1.43
2.04
0.15
5.08
4.66
2.89
3.50
01041826

A
Excision of gum lesion
2.31
5.12
3.10
2.59
2.22
0.30
7.73
5.71
5.20
4.83
01041827

A
Excision of gum lesion
3.66
6.60
5.78
3.35
3.58
0.35
10.61
9.79
7.36
7.59
09041828

R
Excision of gum lesion
3.09
4.12
3.88
1.65
2.63
0.44
7.65
7.41
5.18
6.16
01041830

R
Removal of gum tissue
3.34
6.03
5.23
3.13
3.50
0.44
9.81
9.01
6.91
7.28
01041872

R
Repair gum
2.84
5.87
5.23
3.25
3.41
0.30
9.01
8.37
6.39
6.55
09041874

R
Repair tooth socket
3.09
5.76
5.07
2.76
3.07
0.45
9.30
8.61
6.30
6.61
09041899

C
Dental surgery procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY42000

A
Drainage mouth roof lesion
1.23
2.34
2.51
1.14
1.22
0.12
3.69
3.86
2.49
2.57
01042100

A
Biopsy roof of mouth
1.31
2.18
2.11
1.20
1.32
0.13
3.62
3.55
2.64
2.76
01042104

A
Excision lesion, mouth roof
1.64
3.43
2.76
1.58
1.56
0.16
5.23
4.56
3.38
3.36
01042106

A
Excision lesion, mouth roof
2.10
4.41
3.52
2.04
2.34
0.25
6.76
5.87
4.39
4.69
01042107

A
Excision lesion, mouth roof
4.43
6.31
5.86
3.53
3.85
0.44
11.18
10.73
8.40
8.72
09042120

A
Remove palate/lesion
11.62
NA
NA
11.41
11.68
0.52
NA
NA
23.55
23.82
09042140

A
Excision of uvula
1.62
4.22
3.85
1.93
2.05
0.13
5.97
5.60
3.68
3.80
09042145

A
Repair palate, pharynx/uvula
9.57
NA
NA
6.75
7.31
0.65
NA
NA
16.97
17.53
09042160

A
Treatment mouth roof lesion
1.80
3.61
4.09
1.60
2.12
0.17
5.58
6.06
3.57
4.09
01042180

A
Repair palate
2.50
3.21
3.11
1.76
2.02
0.21
5.92
5.82
4.47
4.73
01042182

A
Repair palate
3.82
4.01
3.91
2.36
2.86
0.40
8.23
8.13
6.58
7.08
01042200

A
Reconstruct cleft palate
12.35
NA
NA
8.11
9.69
1.27
NA
NA
21.73
23.31
09042205

A
Reconstruct cleft palate
13.51
NA
NA
7.46
9.42
1.58
NA
NA
22.55
24.51
09042210

A
Reconstruct cleft palate
14.85
NA
NA
9.72
11.03
2.16
NA
NA
26.73
28.04
09042215

A
Reconstruct cleft palate
8.81
NA
NA
7.21
8.61
1.31
NA
NA
17.33
18.73
09042220

A
Reconstruct cleft palate
7.01
NA
NA
6.71
6.76
0.73
NA
NA
14.45
14.50
09042225

A
Reconstruct cleft palate
9.59
NA
NA
12.00
15.80
0.86
NA
NA
22.45
26.25
09042226

A
Lengthening of palate
10.17
NA
NA
11.33
13.86
1.01
NA
NA
22.51
25.04
09042227

A
Lengthening of palate
9.75
NA
NA
9.68
14.08
0.98
NA
NA
20.41
24.81
09042235

A
Repair palate
7.86
NA
NA
10.27
11.46
0.72
NA
NA
18.85
20.04
09042260

A
Repair nose to lip fistula
10.04
9.54
10.03
5.81
6.75
1.26
20.84
21.33
17.11
18.05
09042280

A
Preparation, palate mold
1.54
2.25
2.03
0.84
1.07
0.19
3.98
3.76
2.57
2.80
01042281

A
Insertion, palate prosthesis
1.93
2.82
2.68
1.56
1.79
0.17
4.92
4.78
3.66
3.89
01042299

C
Palate/uvula surgery
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY42300

A
Drainage of salivary gland
1.93
2.92
2.85
1.59
1.76
0.16
5.01
4.94
3.68
3.85
01042305

A
Drainage of salivary gland
6.18
NA
NA
3.65
4.45
0.51
NA
NA
10.34
11.14
09042310

A
Drainage of salivary gland
1.56
2.18
2.24
1.31
1.48
0.13
3.87
3.93
3.00
3.17
01042320

A
Drainage of salivary gland
2.35
3.54
3.34
1.76
2.01
0.21
6.10
5.90
4.32
4.57
01042330

A
Removal of salivary stone
2.21
3.19
3.15
1.59
1.78
0.19
5.59
5.55
3.99
4.18
01042335

A
Removal of salivary stone
3.31
5.43
5.03
2.65
3.02
0.29
9.03
8.63
6.25
6.62
09042340

A
Removal of salivary stone
4.59
6.27
6.10
3.21
3.75
0.42
11.28
11.11
8.22
8.76
09042400

A
Biopsy of salivary gland
0.78
1.90
1.71
0.60
0.69
0.06
2.74
2.55
1.44
1.53
00042405

A
Biopsy of salivary gland
3.29
3.71
3.93
1.99
2.34
0.28
7.28
7.50
5.56
5.91
01042408

A
Excision of salivary cyst
4.53
6.07
5.95
3.05
3.47
0.45
11.05
10.93
8.03
8.45
09042409

A
Drainage of salivary cyst
2.81
5.05
4.65
2.37
2.66
0.27
8.13
7.73
5.45
5.74
09042410

A
Excise parotid gland/lesion
9.39
NA
NA
4.90
5.89
0.91
NA
NA
15.20
16.19
09042415

A
Excise parotid gland/lesion
17.92
NA
NA
7.69
10.07
1.43
NA
NA
27.04
29.42
09042420

A
Excise parotid gland/lesion
20.80
NA
NA
8.50
11.40
1.65
NA
NA
30.95
33.85
09042425

A
Excise parotid gland/lesion
13.24
NA
NA
6.03
7.97
1.05
NA
NA
20.32
22.26
09042426

A
Excise parotid gland/lesion
22.46
NA
NA
8.77
11.95
1.80
NA
NA
33.03
36.21
09042440

A
Excise submaxillary gland
7.02
NA
NA
3.46
4.46
0.59
NA
NA
11.07
12.07
09042450

A
Excise sublingual gland
4.61
5.87
5.89
3.66
4.10
0.42
10.90
10.92
8.69
9.13
09042500

A
Repair salivary duct
4.29
5.79
5.71
3.62
4.04
0.41
10.49
10.41
8.32
8.74
09042505

A
Repair salivary duct
6.17
6.73
7.02
4.32
5.10
0.55
13.45
13.74
11.04
11.82
09042507

A
Parotid duct diversion
6.10
NA
NA
5.90
6.37
0.49
NA
NA
12.49
12.96
09042508

A
Parotid duct diversion
9.15
NA
NA
7.50
8.13
1.04
NA
NA
17.69
18.32
090( print page 49139)42509

A
Parotid duct diversion
11.58
NA
NA
8.70
9.82
0.93
NA
NA
21.21
22.33
09042510

A
Parotid duct diversion
8.20
NA
NA
6.33
7.43
0.66
NA
NA
15.19
16.29
09042550

A
Injection for salivary x-ray
1.25
2.24
2.97
0.39
0.41
0.07
3.56
4.29
1.71
1.73
00042600

A
Closure of salivary fistula
4.81
6.46
6.55
3.32
3.92
0.43
11.70
11.79
8.56
9.16
09042650

A
Dilation of salivary duct
0.77
1.20
1.13
0.61
0.69
0.07
2.04
1.97
1.45
1.53
00042660

A
Dilation of salivary duct
1.13
1.43
1.37
0.73
0.82
0.09
2.65
2.59
1.95
2.04
00042665

A
Ligation of salivary duct
2.53
4.71
4.31
2.20
2.49
0.23
7.47
7.07
4.96
5.25
09042699

C
Salivary surgery procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY42700

A
Drainage of tonsil abscess
1.62
2.74
2.67
1.51
1.65
0.13
4.49
4.42
3.26
3.40
01042720

A
Drainage of throat abscess
6.31
4.28
4.69
2.84
3.55
0.44
11.03
11.44
9.59
10.30
01042725

A
Drainage of throat abscess
12.22
NA
NA
6.56
7.81
0.91
NA
NA
19.69
20.94
09042800

A
Biopsy of throat
1.39
2.27
2.20
1.17
1.34
0.11
3.77
3.70
2.67
2.84
01042802

A
Biopsy of throat
1.54
3.83
4.53
1.52
1.93
0.12
5.49
6.19
3.18
3.59
01042804

A
Biopsy of upper nose/throat
1.24
3.33
3.64
1.37
1.64
0.10
4.67
4.98
2.71
2.98
01042806

A
Biopsy of upper nose/throat
1.58
3.55
3.94
1.47
1.82
0.13
5.26
5.65
3.18
3.53
01042808

A
Excise pharynx lesion
2.30
2.96
3.06
1.44
1.81
0.19
5.45
5.55
3.93
4.30
01042809

A
Remove pharynx foreign body
1.81
2.12
2.28
1.25
1.31
0.16
4.09
4.25
3.22
3.28
01042810

A
Excision of neck cyst
3.25
5.73
5.72
3.40
3.51
0.29
9.27
9.26
6.94
7.05
09042815

A
Excision of neck cyst
7.18
NA
NA
5.70
6.23
0.61
NA
NA
13.49
14.02
09042820

A
Remove tonsils and adenoids
4.15
NA
NA
2.53
3.10
0.31
NA
NA
6.99
7.56
09042821

A
Remove tonsils and adenoids
4.28
NA
NA
2.68
3.30
0.35
NA
NA
7.31
7.93
09042825

A
Removal of tonsils
3.41
NA
NA
2.42
2.98
0.25
NA
NA
6.08
6.64
09042826

A
Removal of tonsils
3.37
NA
NA
2.42
2.88
0.27
NA
NA
6.06
6.52
09042830

A
Removal of adenoids
2.57
NA
NA
2.19
2.47
0.20
NA
NA
4.96
5.24
09042831

A
Removal of adenoids
2.71
NA
NA
2.41
2.73
0.22
NA
NA
5.34
5.66
09042835

A
Removal of adenoids
2.30
NA
NA
1.79
2.29
0.21
NA
NA
4.30
4.80
09042836

A
Removal of adenoids
3.18
NA
NA
2.40
2.82
0.26
NA
NA
5.84
6.26
09042842

A
Extensive surgery of throat
11.94
NA
NA
10.96
10.98
0.71
NA
NA
23.61
23.63
09042844

A
Extensive surgery of throat
17.49
NA
NA
13.99
15.67
1.16
NA
NA
32.64
34.32
09042845

A
Extensive surgery of throat
32.27
NA
NA
19.00
22.14
1.98
NA
NA
53.25
56.39
09042860

A
Excision of tonsil tags
2.22
NA
NA
2.10
2.33
0.18
NA
NA
4.50
4.73
09042870

A
Excision of lingual tonsil
5.39
NA
NA
7.97
8.42
0.44
NA
NA
13.80
14.25
09042890

A
Partial removal of pharynx
18.84
NA
NA
13.79
14.06
1.05
NA
NA
33.68
33.95
09042892

A
Revision of pharyngeal walls
25.67
NA
NA
17.34
17.21
1.28
NA
NA
44.29
44.16
09042894

A
Revision of pharyngeal walls
33.49
NA
NA
21.04
21.78
1.86
NA
NA
56.39
57.13
09042900

A
Repair throat wound
5.24
NA
NA
2.70
3.42
0.50
NA
NA
8.44
9.16
01042950

A
Reconstruction of throat
8.09
NA
NA
10.21
11.46
0.72
NA
NA
19.02
20.27
09042953

A
Repair throat, esophagus
9.25
NA
NA
12.87
16.22
0.88
NA
NA
23.00
26.35
09042955

A
Surgical opening of throat
7.86
NA
NA
9.37
10.35
0.80
NA
NA
18.03
19.01
09042960

A
Control throat bleeding
2.33
NA
NA
1.59
1.87
0.19
NA
NA
4.11
4.39
01042961

A
Control throat bleeding
5.64
NA
NA
4.08
4.74
0.45
NA
NA
10.17
10.83
09042962

A
Control throat bleeding
7.25
NA
NA
4.69
5.61
0.58
NA
NA
12.52
13.44
09042970

A
Control nose/throat bleeding
5.72
NA
NA
3.49
4.01
0.39
NA
NA
9.60
10.12
09042971

A
Control nose/throat bleeding
6.50
NA
NA
4.08
4.86
0.51
NA
NA
11.09
11.87
09042972

A
Control nose/throat bleeding
7.49
NA
NA
4.42
5.38
0.62
NA
NA
12.53
13.49
09042999

C
Throat surgery procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY43020

A
Incision of esophagus
8.08
NA
NA
4.32
5.14
0.87
NA
NA
13.27
14.09
09043030

A
Throat muscle surgery
7.86
NA
NA
4.13
5.15
0.70
NA
NA
12.69
13.71
09043045

A
Incision of esophagus
21.63
NA
NA
10.07
10.54
2.58
NA
NA
34.28
34.75
09043100

A
Excision of esophagus lesion
9.48
NA
NA
5.07
5.93
0.93
NA
NA
15.48
16.34
09043101

A
Excision of esophagus lesion
16.94
NA
NA
7.27
7.73
2.31
NA
NA
26.52
26.98
09043107

A
Removal of esophagus
43.89
NA
NA
16.66
17.86
5.22
NA
NA
65.77
66.97
09043108

A
Removal of esophagus
63.23
NA
NA
20.50
15.78
4.07
NA
NA
87.80
83.08
09043112

A
Removal of esophagus
47.21
NA
NA
17.15
18.81
5.79
NA
NA
70.15
71.81
09043113

A
Removal of esophagus
46.95
NA
NA
17.99
15.83
4.42
NA
NA
69.36
67.20
09043116

A
Partial removal of esophagus
71.39
NA
NA
22.74
18.20
3.05
NA
NA
97.18
92.64
09043117

A
Partial removal of esophagus
43.46
NA
NA
15.40
16.80
5.17
NA
NA
64.03
65.43
09043118

A
Partial removal of esophagus
52.07
NA
NA
17.39
14.68
4.10
NA
NA
73.56
70.85
09043121

A
Partial removal of esophagus
46.35
NA
NA
17.01
14.51
3.90
NA
NA
67.26
64.76
09043122

A
Partial removal of esophagus
43.89
NA
NA
15.83
17.00
5.40
NA
NA
65.12
66.29
09043123

A
Partial removal of esophagus
63.83
NA
NA
21.00
15.83
4.15
NA
NA
88.98
83.81
09043124

A
Removal of esophagus
64.63
NA
NA
22.76
15.50
3.73
NA
NA
91.12
83.86
09043130

A
Removal of esophagus pouch
12.33
NA
NA
5.93
7.15
1.16
NA
NA
19.42
20.64
09043135

A
Removal of esophagus pouch
22.37
NA
NA
8.93
8.30
2.33
NA
NA
33.63
33.00
09043200

A
Esophagus endoscopy
1.59
3.53
3.98
0.91
1.03
0.13
5.25
5.70
2.63
2.75
00043201

A
Esoph scope w/submucous inj
2.09
5.56
4.86
1.18
1.12
0.15
7.80
7.10
3.42
3.36
000( print page 49140)43202

A
Esophagus endoscopy, biopsy
1.89
5.13
5.44
0.97
0.95
0.15
7.17
7.48
3.01
2.99
00043204

A
Esoph scope w/sclerosis inj
3.76
NA
NA
1.93
1.62
0.30
NA
NA
5.99
5.68
00043205

A
Esophagus endoscopy/ligation
3.78
NA
NA
2.02
1.65
0.28
NA
NA
6.08
5.71
00043215

A
Esophagus endoscopy
2.60
NA
NA
1.25
1.21
0.22
NA
NA
4.07
4.03
00043216

A
Esophagus endoscopy/lesion
2.40
3.00
1.55
1.21
1.10
0.20
5.60
4.15
3.81
3.70
00043217

A
Esophagus endoscopy
2.90
6.58
6.86
1.40
1.24
0.26
9.74
10.02
4.56
4.40
00043219

A
Esophagus endoscopy
2.80
NA
NA
1.53
1.40
0.24
NA
NA
4.57
4.44
00043220

A
Esoph endoscopy, dilation
2.10
NA
NA
1.12
1.01
0.17
NA
NA
3.39
3.28
00043226

A
Esoph endoscopy, dilation
2.34
NA
NA
1.27
1.09
0.19
NA
NA
3.80
3.62
00043227

A
Esoph endoscopy, repair
3.59
NA
NA
1.81
1.54
0.28
NA
NA
5.68
5.41
00043228

A
Esoph endoscopy, ablation
3.76
NA
NA
1.84
1.62
0.34
NA
NA
5.94
5.72
00043231

A
Esoph endoscopy w/us exam
3.19
NA
NA
1.72
1.41
0.23
NA
NA
5.14
4.83
00043232

A
Esoph endoscopy w/us fn bx
4.47
NA
NA
2.34
1.94
0.34
NA
NA
7.15
6.75
00043234

A
Upper GI endoscopy, exam
2.01
4.98
5.24
1.01
0.91
0.17
7.16
7.42
3.19
3.09
00043235

A
Uppr gi endoscopy, diagnosis
2.39
5.26
5.19
1.34
1.10
0.19
7.84
7.77
3.92
3.68
00043236

A
Uppr gi scope w/submuc inj
2.92
6.67
6.47
1.64
1.33
0.21
9.80
9.60
4.77
4.46
00043237

A
Endoscopic us exam, esoph
3.98
NA
NA
2.12
1.72
0.43
NA
NA
6.53
6.13
00043238

A
Uppr gi endoscopy w/us fn bx
5.02
NA
NA
2.52
2.10
0.43
NA
NA
7.97
7.55
00043239

A
Upper GI endoscopy, biopsy
2.87
6.01
5.79
1.54
1.28
0.22
9.10
8.88
4.63
4.37
00043240

A
Esoph endoscope w/drain cyst
6.85
NA
NA
3.41
2.80
0.56
NA
NA
10.82
10.21
00043241

A
Upper GI endoscopy with tube
2.59
NA
NA
1.40
1.18
0.21
NA
NA
4.20
3.98
00043242

A
Uppr gi endoscopy w/us fn bx
7.30
NA
NA
3.65
2.96
0.53
NA
NA
11.48
10.79
00043243

A
Upper gi endoscopy & inject
4.56
NA
NA
2.34
1.93
0.33
NA
NA
7.23
6.82
00043244

A
Upper GI endoscopy/ligation
5.04
NA
NA
2.62
2.13
0.37
NA
NA
8.03
7.54
00043245

A
Uppr gi scope dilate strictr
3.18
NA
NA
1.62
1.38
0.26
NA
NA
5.06
4.82
00043246

A
Place gastrostomy tube
4.32
NA
NA
2.10
1.79
0.34
NA
NA
6.76
6.45
00043247

A
Operative upper GI endoscopy
3.38
NA
NA
1.77
1.47
0.27
NA
NA
5.42
5.12
00043248

A
Uppr gi endoscopy/guide wire
3.15
NA
NA
1.76
1.42
0.23
NA
NA
5.14
4.80
00043249

A
Esoph endoscopy, dilation
2.90
NA
NA
1.61
1.31
0.22
NA
NA
4.73
4.43
00043250

A
Upper GI endoscopy/tumor
3.20
NA
NA
1.62
1.39
0.26
NA
NA
5.08
4.85
00043251

A
Operative upper GI endoscopy
3.69
NA
NA
1.91
1.59
0.29
NA
NA
5.89
5.57
00043255

A
Operative upper GI endoscopy
4.81
NA
NA
2.50
2.04
0.35
NA
NA
7.66
7.20
00043256

A
Uppr gi endoscopy w/stent
4.34
NA
NA
2.23
1.84
0.32
NA
NA
6.89
6.50
00043257

A
Uppr gi scope w/thrml txmnt
5.50
NA
NA
2.05
2.16
0.36
NA
NA
7.91
8.02
00043258

A
Operative upper GI endoscopy
4.54
NA
NA
2.36
1.93
0.33
NA
NA
7.23
6.80
00043259

A
Endoscopic ultrasound exam
5.19
NA
NA
2.66
2.16
0.35
NA
NA
8.20
7.70
00043260

A
Endo cholangiopancreatograph
5.95
NA
NA
3.04
2.47
0.43
NA
NA
9.42
8.85
00043261

A
Endo cholangiopancreatograph
6.26
NA
NA
3.19
2.59
0.46
NA
NA
9.91
9.31
00043262

A
Endo cholangiopancreatograph
7.38
NA
NA
3.69
3.01
0.54
NA
NA
11.61
10.93
00043263

A
Endo cholangiopancreatograph
7.28
NA
NA
3.70
3.00
0.54
NA
NA
11.52
10.82
00043264

A
Endo cholangiopancreatograph
8.89
NA
NA
4.41
3.59
0.65
NA
NA
13.95
13.13
00043265

A
Endo cholangiopancreatograph
10.00
NA
NA
4.90
3.99
0.73
NA
NA
15.63
14.72
00043267

A
Endo cholangiopancreatograph
7.38
NA
NA
3.60
2.99
0.54
NA
NA
11.52
10.91
00043268

A
Endo cholangiopancreatograph
7.38
NA
NA
3.85
3.12
0.54
NA
NA
11.77
11.04
00043269

A
Endo cholangiopancreatograph
8.20
NA
NA
4.07
3.32
0.60
NA
NA
12.87
12.12
00043271

A
Endo cholangiopancreatograph
7.38
NA
NA
3.70
3.01
0.54
NA
NA
11.62
10.93
00043272

A
Endo cholangiopancreatograph
7.38
NA
NA
3.77
3.03
0.54
NA
NA
11.69
10.95
00043280

A
Laparoscopy, fundoplasty
17.96
NA
NA
6.73
7.14
2.27
NA
NA
26.96
27.37
09043289

C
Laparoscope proc, esoph
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY43300

A
Repair of esophagus
9.13
NA
NA
5.17
6.07
1.12
NA
NA
15.42
16.32
09043305

A
Repair esophagus and fistula
17.90
NA
NA
7.46
9.88
1.54
NA
NA
26.90
29.32
09043310

A
Repair of esophagus
26.13
NA
NA
10.13
10.83
3.60
NA
NA
39.86
40.56
09043312

A
Repair esophagus and fistula
29.22
NA
NA
9.96
11.41
4.00
NA
NA
43.18
44.63
09043313

A
Esophagoplasty congenital
48.07
NA
NA
17.38
18.45
5.45
NA
NA
70.90
71.97
09043314

A
Tracheo-esophagoplasty cong
53.05
NA
NA
18.43
18.99
6.63
NA
NA
78.11
78.67
09043320

A
Fuse esophagus & stomach
23.12
NA
NA
8.85
9.11
2.73
NA
NA
34.70
34.96
090( print page 49141)43324

A
Revise esophagus & stomach
22.80
NA
NA
8.42
8.68
2.75
NA
NA
33.97
34.23
09043325

A
Revise esophagus & stomach
22.41
NA
NA
8.39
8.68
2.59
NA
NA
33.39
33.68
09043326

A
Revise esophagus & stomach
22.09
NA
NA
9.37
9.31
2.84
NA
NA
34.30
34.24
09043330

A
Repair of esophagus
22.00
NA
NA
8.27
8.47
2.62
NA
NA
32.89
33.09
09043331

A
Repair of esophagus
22.87
NA
NA
9.58
9.73
2.93
NA
NA
35.38
35.53
09043340

A
Fuse esophagus & intestine
22.80
NA
NA
9.09
8.99
2.45
NA
NA
34.34
34.24
09043341

A
Fuse esophagus & intestine
24.04
NA
NA
10.12
10.04
2.91
NA
NA
37.07
36.99
09043350

A
Surgical opening, esophagus
19.23
NA
NA
8.06
8.35
1.42
NA
NA
28.71
29.00
09043351

A
Surgical opening, esophagus
21.79
NA
NA
9.60
9.74
2.46
NA
NA
33.85
33.99
09043352

A
Surgical opening, esophagus
17.62
NA
NA
8.19
8.33
2.05
NA
NA
27.86
28.00
09043360

A
Gastrointestinal repair
39.82
NA
NA
15.81
15.26
4.96
NA
NA
60.59
60.04
09043361

A
Gastrointestinal repair
45.42
NA
NA
16.89
16.88
4.49
NA
NA
66.80
66.79
09043400

A
Ligate esophagus veins
25.41
NA
NA
13.74
10.51
1.95
NA
NA
41.10
37.87
09043401

A
Esophagus surgery for veins
26.30
NA
NA
9.49
9.48
3.04
NA
NA
38.83
38.82
09043405

A
Ligate/staple esophagus
24.47
NA
NA
10.42
9.79
2.83
NA
NA
37.72
37.09
09043410

A
Repair esophagus wound
16.22
NA
NA
7.53
7.61
1.71
NA
NA
25.46
25.54
09043415

A
Repair esophagus wound
28.62
NA
NA
11.99
11.80
3.52
NA
NA
44.13
43.94
09043420

A
Repair esophagus opening
16.59
NA
NA
6.86
7.27
1.43
NA
NA
24.88
25.29
09043425

A
Repair esophagus opening
24.85
NA
NA
10.38
10.07
3.02
NA
NA
38.25
37.94
09043450

A
Dilate esophagus
1.38
2.66
2.64
0.92
0.75
0.11
4.15
4.13
2.41
2.24
00043453

A
Dilate esophagus
1.51
6.29
6.12
1.00
0.80
0.11
7.91
7.74
2.62
2.42
00043456

A
Dilate esophagus
2.57
12.99
13.55
1.45
1.19
0.20
15.76
16.32
4.22
3.96
00043458

A
Dilate esophagus
3.06
6.93
6.72
1.61
1.36
0.24
10.23
10.02
4.91
4.66
00043460

A
Pressure treatment esophagus
3.79
NA
NA
1.70
1.54
0.31
NA
NA
5.80
5.64
00043496

C
Free jejunum flap, microvasc
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
09043499

C
Esophagus surgery procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY43500

A
Surgical opening of stomach
12.67
NA
NA
5.27
5.05
1.45
NA
NA
19.39
19.17
09043501

A
Surgical repair of stomach
22.41
NA
NA
8.18
8.27
2.64
NA
NA
33.23
33.32
09043502

A
Surgical repair of stomach
25.50
NA
NA
9.04
9.35
3.09
NA
NA
37.63
37.94
09043510

A
Surgical opening of stomach
14.95
NA
NA
6.89
6.66
1.48
NA
NA
23.32
23.09
09043520

A
Incision of pyloric muscle
11.17
NA
NA
4.89
5.16
1.36
NA
NA
17.42
17.69
09043600

A
Biopsy of stomach
1.91
NA
NA
0.80
0.70
0.14
NA
NA
2.85
2.75
00043605

A
Biopsy of stomach
13.60
NA
NA
5.46
5.33
1.58
NA
NA
20.64
20.51
09043610

A
Excision of stomach lesion
16.22
NA
NA
6.11
6.13
1.93
NA
NA
24.26
24.28
09043611

A
Excision of stomach lesion
20.19
NA
NA
7.61
7.57
2.35
NA
NA
30.15
30.11
09043620

A
Removal of stomach
33.85
NA
NA
11.16
11.63
3.95
NA
NA
48.96
49.43
09043621

A
Removal of stomach
39.34
NA
NA
12.57
12.12
4.03
NA
NA
55.94
55.49
09043622

A
Removal of stomach
39.84
NA
NA
12.71
12.61
4.29
NA
NA
56.84
56.74
09043631

A
Removal of stomach, partial
24.32
NA
NA
8.68
9.03
2.98
NA
NA
35.98
36.33
09043632

A
Removal of stomach, partial
34.95
NA
NA
11.43
9.72
2.98
NA
NA
49.36
47.65
09043633

A
Removal of stomach, partial
32.95
NA
NA
10.92
9.72
3.05
NA
NA
46.92
45.72
09043634

A
Removal of stomach, partial
36.45
NA
NA
11.97
10.55
3.32
NA
NA
51.74
50.32
09043635

A
Removal of stomach, partial
2.06
NA
NA
0.53
0.66
0.27
NA
NA
2.86
2.99
ZZZ43640

A
Vagotomy & pylorus repair
19.37
NA
NA
7.42
7.29
2.25
NA
NA
29.04
28.91
09043641

A
Vagotomy & pylorus repair
19.62
NA
NA
7.72
7.45
2.24
NA
NA
29.58
29.31
09043644

A
Lap gastric bypass/roux-en-y
29.18
NA
NA
10.29
10.98
3.15
NA
NA
42.62
43.31
09043645

A
Lap gastr bypass incl smll i
31.31
NA
NA
11.27
11.83
3.53
NA
NA
46.11
46.67
09043651

A
Laparoscopy, vagus nerve
10.13
NA
NA
4.67
4.74
1.33
NA
NA
16.13
16.20
09043652

A
Laparoscopy, vagus nerve
12.13
NA
NA
5.23
5.62
1.55
NA
NA
18.91
19.30
09043653

A
Laparoscopy, gastrostomy
8.34
NA
NA
4.43
4.24
1.01
NA
NA
13.78
13.59
09043659

C
Laparoscope proc, stom
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY43750

A
Place gastrostomy tube
4.60
NA
NA
1.96
2.13
0.43
NA
NA
6.99
7.16
01043752

A
Nasal/orogastric w/stent
0.81
NA
NA
0.24
0.26
0.02
NA
NA
1.07
1.09
00043760

A
Change gastrostomy tube
1.10
13.09
4.83
0.39
0.44
0.09
14.28
6.02
1.58
1.63
00043761

A
Reposition gastrostomy tube
2.01
0.98
1.12
0.64
0.66
0.13
3.12
3.26
2.78
2.80
00043770

A
Lap, place gastr adjust band
17.79
NA
NA
7.57
7.68
2.18
NA
NA
27.54
27.65
09043771

A
Lap, revise adjust gast band
20.58
NA
NA
8.22
8.50
2.54
NA
NA
31.34
31.62
09043772

A
Lap, remove adjust gast band
15.58
NA
NA
6.03
6.32
1.92
NA
NA
23.53
23.82
09043773

A
Lap, change adjust gast band
20.58
NA
NA
8.22
8.50
2.55
NA
NA
31.35
31.63
09043774

A
Lap remov adj gast band/port
15.62
NA
NA
6.22
6.48
1.84
NA
NA
23.68
23.94
09043800

A
Reconstruction of pylorus
15.31
NA
NA
5.91
5.90
1.81
NA
NA
23.03
23.02
09043810

A
Fusion of stomach and bowel
16.76
NA
NA
6.28
6.20
1.93
NA
NA
24.97
24.89
09043820

A
Fusion of stomach and bowel
22.34
NA
NA
8.19
6.85
2.03
NA
NA
32.56
31.22
09043825

A
Fusion of stomach and bowel
21.57
NA
NA
7.96
8.00
2.53
NA
NA
32.06
32.10
09043830

A
Place gastrostomy tube
10.71
NA
NA
5.22
4.94
1.25
NA
NA
17.18
16.90
09043831

A
Place gastrostomy tube
8.31
NA
NA
5.17
4.68
1.03
NA
NA
14.51
14.02
090( print page 49142)43832

A
Place gastrostomy tube
17.22
NA
NA
7.15
6.92
1.97
NA
NA
26.34
26.11
09043840

A
Repair of stomach lesion
22.64
NA
NA
8.26
7.14
2.05
NA
NA
32.95
31.83
09043842

N
V-band gastroplasty
20.84
NA
NA
7.81
7.80
2.44
NA
NA
31.09
31.08
09043843

A
Gastroplasty w/o v-band
21.02
NA
NA
7.88
7.79
2.45
NA
NA
31.35
31.26
09043845

A
Gastroplasty duodenal switch
33.04
NA
NA
12.63
11.24
4.05
NA
NA
49.72
48.33
09043846

A
Gastric bypass for obesity
27.15
NA
NA
10.09
10.04
3.18
NA
NA
40.42
40.37
09043847

A
Gastric bypass incl small i
30.02
NA
NA
10.72
10.85
3.55
NA
NA
44.29
44.42
09043848

A
Revision gastroplasty
32.49
NA
NA
11.41
11.71
3.87
NA
NA
47.77
48.07
09043850

A
Revise stomach-bowel fusion
27.39
NA
NA
9.48
9.73
3.27
NA
NA
40.14
40.39
09043855

A
Revise stomach-bowel fusion
28.50
NA
NA
9.83
10.20
3.46
NA
NA
41.79
42.16
09043860

A
Revise stomach-bowel fusion
27.70
NA
NA
9.57
9.86
3.30
NA
NA
40.57
40.86
09043865

A
Revise stomach-bowel fusion
28.86
NA
NA
10.17
10.42
3.50
NA
NA
42.53
42.78
09043870

A
Repair stomach opening
11.32
NA
NA
5.05
4.65
1.27
NA
NA
17.64
17.24
09043880

A
Repair stomach-bowel fistula
26.99
NA
NA
9.42
9.77
3.26
NA
NA
39.67
40.02
09043886

A
Revise gastric port, open
4.50
NA
NA
3.45
3.21
0.25
NA
NA
8.20
7.96
09043887

A
Remove gastric port, open
4.20
NA
NA
3.00
2.83
0.51
NA
NA
7.71
7.54
09043888

A
Change gastric port, open
6.30
NA
NA
3.94
3.81
0.70
NA
NA
10.94
10.81
09043999

C
Stomach surgery procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY44005

A
Freeing of bowel adhesion
18.34
NA
NA
6.67
6.70
2.14
NA
NA
27.15
27.18
09044010

A
Incision of small bowel
14.14
NA
NA
5.58
5.48
1.64
NA
NA
21.36
21.26
09044015

A
Insert needle cath bowel
2.62
NA
NA
0.69
0.83
0.35
NA
NA
3.66
3.80
ZZZ44020

A
Explore small intestine
16.10
NA
NA
6.06
5.96
1.85
NA
NA
24.01
23.91
09044021

A
Decompress small bowel
16.19
NA
NA
6.33
6.05
1.86
NA
NA
24.38
24.10
09044025

A
Incision of large bowel
16.39
NA
NA
6.19
6.06
1.89
NA
NA
24.47
24.34
09044050

A
Reduce bowel obstruction
15.40
NA
NA
5.89
5.94
1.85
NA
NA
23.14
23.19
09044055

A
Correct malrotation of bowel
25.49
NA
NA
8.60
8.69
2.90
NA
NA
36.99
37.08
09044100

A
Biopsy of bowel
2.01
NA
NA
0.88
0.75
0.17
NA
NA
3.06
2.93
00044110

A
Excise intestine lesion(s)
13.92
NA
NA
5.58
5.31
1.55
NA
NA
21.05
20.78
09044111

A
Excision of bowel lesion(s)
16.40
NA
NA
6.20
6.13
1.86
NA
NA
24.46
24.39
09044120

A
Removal of small intestine
20.70
NA
NA
7.24
7.11
2.24
NA
NA
30.18
30.05
09044121

A
Removal of small intestine
4.44
NA
NA
1.14
1.43
0.58
NA
NA
6.16
6.45
ZZZ44125

A
Removal of small intestine
19.89
NA
NA
7.10
7.21
2.26
NA
NA
29.25
29.36
09044126

A
Enterectomy w/o taper, cong
41.94
NA
NA
13.97
14.08
4.68
NA
NA
60.59
60.70
09044127

A
Enterectomy w/taper, cong
49.01
NA
NA
14.84
15.49
5.75
NA
NA
69.60
70.25
09044128

A
Enterectomy cong, add-on
4.44
NA
NA
1.07
1.42
0.61
NA
NA
6.12
6.47
ZZZ44130

A
Bowel to bowel fusion
21.92
NA
NA
8.05
6.67
1.87
NA
NA
31.84
30.46
09044137

C
Remove intestinal allograft
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX44139

A
Mobilization of colon
2.23
NA
NA
0.56
0.71
0.28
NA
NA
3.07
3.22
ZZZ44140

A
Partial removal of colon
22.40
NA
NA
8.17
8.52
2.70
NA
NA
33.27
33.62
09044141

A
Partial removal of colon
29.69
NA
NA
11.96
10.52
2.52
NA
NA
44.17
42.73
09044143

A
Partial removal of colon
27.57
NA
NA
10.40
10.61
3.04
NA
NA
41.01
41.22
09044144

A
Partial removal of colon
29.69
NA
NA
10.75
9.90
2.85
NA
NA
43.29
42.44
09044145

A
Partial removal of colon
28.39
NA
NA
9.58
10.50
3.28
NA
NA
41.25
42.17
09044146

A
Partial removal of colon
35.08
NA
NA
13.46
13.00
3.40
NA
NA
51.94
51.48
09044147

A
Partial removal of colon
33.50
NA
NA
11.06
9.28
2.55
NA
NA
47.11
45.33
09044150

A
Removal of colon
29.91
NA
NA
12.74
12.20
3.03
NA
NA
45.68
45.14
09044151

A
Removal of colon/ileostomy
34.65
NA
NA
14.19
13.59
3.48
NA
NA
52.32
51.72
09044152

A
Removal of colon/ileostomy
29.91
NA
NA
10.53
11.33
3.51
NA
NA
43.95
44.75
09044153

A
Removal of colon/ileostomy
33.18
NA
NA
14.40
14.38
3.54
NA
NA
51.12
51.10
09044155

A
Removal of colon/ileostomy
34.15
NA
NA
13.59
13.37
3.27
NA
NA
51.01
50.79
09044156

A
Removal of colon/ileostomy
37.15
NA
NA
14.84
14.98
3.94
NA
NA
55.93
56.07
09044160

A
Removal of colon
20.72
NA
NA
7.60
7.71
2.36
NA
NA
30.68
30.79
09044180

A
Lap, enterolysis
15.15
NA
NA
5.87
6.14
1.85
NA
NA
22.87
23.14
09044186

A
Lap, jejunostomy
10.26
NA
NA
4.63
4.75
1.27
NA
NA
16.16
16.28
09044187

A
Lap, ileo/jejuno-stomy
17.21
NA
NA
8.25
8.27
1.95
NA
NA
27.41
27.43
09044188

A
Lap, colostomy
19.14
NA
NA
8.82
8.84
2.23
NA
NA
30.19
30.21
090( print page 49143)44202

A
Lap, enterectomy
23.20
NA
NA
8.41
8.79
2.84
NA
NA
34.45
34.83
09044203

A
Lap resect s/intestine, addl
4.44
NA
NA
1.14
1.41
0.57
NA
NA
6.15
6.42
ZZZ44204

A
Laparo partial colectomy
26.23
NA
NA
9.00
9.71
3.10
NA
NA
38.33
39.04
09044205

A
Lap colectomy part w/ileum
22.80
NA
NA
7.89
8.60
2.74
NA
NA
33.43
34.14
09044206

A
Lap part colectomy w/stoma
29.57
NA
NA
10.60
11.09
3.45
NA
NA
43.62
44.11
09044207

A
L colectomy/coloproctostomy
31.73
NA
NA
10.22
11.17
3.66
NA
NA
45.61
46.56
09044208

A
L colectomy/coloproctostomy
33.80
NA
NA
12.15
12.89
3.87
NA
NA
49.82
50.56
09044210

A
Laparo total proctocolectomy
29.80
NA
NA
11.27
11.72
3.41
NA
NA
44.48
44.93
09044211

A
Laparo total proctocolectomy
36.79
NA
NA
13.90
14.48
4.16
NA
NA
54.85
55.43
09044212

A
Laparo total proctocolectomy
34.29
NA
NA
13.27
13.58
3.77
NA
NA
51.33
51.64
09044213

A
Lap, mobil splenic fl add-on
3.50
NA
NA
0.89
1.14
0.44
NA
NA
4.83
5.08
ZZZ44227

A
Lap, close enterostomy
28.43
NA
NA
9.59
10.36
3.37
NA
NA
41.39
42.16
09044238

C
Laparoscope proc, intestine
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY44300

A
Open bowel to skin
13.61
NA
NA
5.63
5.52
1.60
NA
NA
20.84
20.73
09044310

A
Ileostomy/jejunostomy
17.45
NA
NA
6.46
6.63
1.98
NA
NA
25.89
26.06
09044312

A
Revision of ileostomy
9.29
NA
NA
4.66
4.16
0.92
NA
NA
14.87
14.37
09044314

A
Revision of ileostomy
16.55
NA
NA
6.88
6.63
1.74
NA
NA
25.17
24.92
09044316

A
Devise bowel pouch
23.40
NA
NA
9.34
8.74
2.37
NA
NA
35.11
34.51
09044320

A
Colostomy
19.69
NA
NA
7.69
7.66
2.25
NA
NA
29.63
29.60
09044322

A
Colostomy with biopsies
13.04
NA
NA
9.47
8.80
1.54
NA
NA
24.05
23.38
09044340

A
Revision of colostomy
9.06
NA
NA
4.99
4.44
0.99
NA
NA
15.04
14.49
09044345

A
Revision of colostomy
17.00
NA
NA
6.98
6.91
1.96
NA
NA
25.94
25.87
09044346

A
Revision of colostomy
19.41
NA
NA
7.60
7.44
2.12
NA
NA
29.13
28.97
09044360

A
Small bowel endoscopy
2.59
NA
NA
1.50
1.20
0.19
NA
NA
4.28
3.98
00044361

A
Small bowel endoscopy/biopsy
2.87
NA
NA
1.63
1.31
0.21
NA
NA
4.71
4.39
00044363

A
Small bowel endoscopy
3.49
NA
NA
1.92
1.52
0.27
NA
NA
5.68
5.28
00044364

A
Small bowel endoscopy
3.73
NA
NA
2.00
1.62
0.27
NA
NA
6.00
5.62
00044365

A
Small bowel endoscopy
3.31
NA
NA
1.77
1.46
0.24
NA
NA
5.32
5.01
00044366

A
Small bowel endoscopy
4.40
NA
NA
2.37
1.89
0.32
NA
NA
7.09
6.61
00044369

A
Small bowel endoscopy
4.51
NA
NA
2.40
1.90
0.33
NA
NA
7.24
6.74
00044370

A
Small bowel endoscopy/stent
4.79
NA
NA
2.53
2.11
0.37
NA
NA
7.69
7.27
00044372

A
Small bowel endoscopy
4.40
NA
NA
2.12
1.83
0.35
NA
NA
6.87
6.58
00044373

A
Small bowel endoscopy
3.49
NA
NA
1.73
1.50
0.27
NA
NA
5.49
5.26
00044376

A
Small bowel endoscopy
5.25
NA
NA
2.44
2.13
0.42
NA
NA
8.11
7.80
00044377

A
Small bowel endoscopy/biopsy
5.52
NA
NA
2.77
2.29
0.40
NA
NA
8.69
8.21
00044378

A
Small bowel endoscopy
7.12
NA
NA
3.52
2.90
0.52
NA
NA
11.16
10.54
00044379

A
S bowel endoscope w/stent
7.46
NA
NA
3.28
3.00
0.62
NA
NA
11.36
11.08
00044380

A
Small bowel endoscopy
1.05
NA
NA
0.75
0.60
0.08
NA
NA
1.88
1.73
00044382

A
Small bowel endoscopy
1.27
NA
NA
0.79
0.67
0.12
NA
NA
2.18
2.06
00044383

A
Ileoscopy w/stent
2.94
NA
NA
1.63
1.36
0.21
NA
NA
4.78
4.51
00044385

A
Endoscopy of bowel pouch
1.82
4.90
3.74
0.89
0.79
0.15
6.87
5.71
2.86
2.76
00044386

A
Endoscopy, bowel pouch/biop
2.12
6.75
6.67
1.04
0.92
0.20
9.07
8.99
3.36
3.24
00044388

A
Colonoscopy
2.82
6.11
5.34
1.34
1.20
0.26
9.19
8.42
4.42
4.28
00044389

A
Colonoscopy with biopsy
3.13
7.07
6.73
1.56
1.34
0.27
10.47
10.13
4.96
4.74
00044390

A
Colonoscopy for foreign body
3.82
7.98
7.33
1.78
1.56
0.32
12.12
11.47
5.92
5.70
00044391

A
Colonoscopy for bleeding
4.31
8.93
8.77
2.19
1.82
0.34
13.58
13.42
6.84
6.47
00044392

A
Colonoscopy & polypectomy
3.81
7.38
6.78
1.71
1.55
0.34
11.53
10.93
5.86
5.70
00044393

A
Colonoscopy, lesion removal
4.83
7.89
7.15
2.04
1.91
0.42
13.14
12.40
7.29
7.16
00044394

A
Colonoscopy w/snare
4.42
8.47
7.98
2.05
1.80
0.38
13.27
12.78
6.85
6.60
00044397

A
Colonoscopy w/stent
4.70
NA
NA
2.28
1.91
0.39
NA
NA
7.37
7.00
00044500

A
Intro, gastrointestinal tube
0.49
NA
NA
0.15
0.16
0.03
NA
NA
0.67
0.68
00044602

A
Suture, small intestine
24.60
NA
NA
7.73
6.73
2.11
NA
NA
34.44
33.44
09044603

A
Suture, small intestine
27.97
NA
NA
9.10
7.73
2.41
NA
NA
39.48
38.11
09044604

A
Suture, large intestine
18.02
NA
NA
6.14
6.37
2.11
NA
NA
26.27
26.50
09044605

A
Repair of bowel lesion
21.96
NA
NA
7.98
8.29
2.51
NA
NA
32.45
32.76
09044615

A
Intestinal stricturoplasty
18.04
NA
NA
6.64
6.66
2.06
NA
NA
26.74
26.76
09044620

A
Repair bowel opening
14.31
NA
NA
5.55
5.38
1.51
NA
NA
21.37
21.20
09044625

A
Repair bowel opening
17.16
NA
NA
6.22
6.28
1.85
NA
NA
25.23
25.29
09044626

A
Repair bowel opening
27.78
NA
NA
9.02
9.61
3.26
NA
NA
40.06
40.65
09044640

A
Repair bowel-skin fistula
24.08
NA
NA
8.15
8.47
2.77
NA
NA
35.00
35.32
09044650

A
Repair bowel fistula
25.00
NA
NA
8.40
8.76
2.92
NA
NA
36.32
36.68
09044660

A
Repair bowel-bladder fistula
23.79
NA
NA
9.72
8.69
2.13
NA
NA
35.64
34.61
09044661

A
Repair bowel-bladder fistula
27.23
NA
NA
9.46
9.53
2.80
NA
NA
39.49
39.56
09044680

A
Surgical revision, intestine
17.84
NA
NA
6.64
6.49
1.99
NA
NA
26.47
26.32
09044700

A
Suspend bowel w/prosthesis
17.36
NA
NA
6.27
6.56
1.83
NA
NA
25.46
25.75
09044701

A
Intraop colon lavage add-on
3.10
NA
NA
0.78
0.99
0.37
NA
NA
4.25
4.46
ZZZ( print page 49144)44715

C
Prepare donor intestine
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX44720

A
Prep donor intestine/venous
5.00
NA
NA
1.25
1.60
0.37
NA
NA
6.62
6.97
XXX44721

A
Prep donor intestine/artery
7.00
NA
NA
1.81
2.25
0.97
NA
NA
9.78
10.22
XXX44799

C
Unlisted procedure intestine
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY44800

A
Excision of bowel pouch
11.87
NA
NA
5.56
5.43
1.47
NA
NA
18.90
18.77
09044820

A
Excision of mesentery lesion
13.59
NA
NA
5.66
5.53
1.59
NA
NA
20.84
20.71
09044850

A
Repair of mesentery
11.99
NA
NA
5.06
5.02
1.39
NA
NA
18.44
18.40
09044899

C
Bowel surgery procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY44900

A
Drain app abscess, open
12.38
NA
NA
5.07
4.79
1.33
NA
NA
18.78
18.50
09044901

A
Drain app abscess, percut
3.37
19.86
25.88
1.05
1.10
0.22
23.45
29.47
4.64
4.69
00044950

A
Appendectomy
10.48
NA
NA
4.09
4.26
1.31
NA
NA
15.88
16.05
09044955

A
Appendectomy add-on
1.53
NA
NA
0.40
0.51
0.20
NA
NA
2.13
2.24
ZZZ44960

A
Appendectomy
14.33
NA
NA
5.47
5.37
1.63
NA
NA
21.43
21.33
09044970

A
Laparoscopy, appendectomy
9.31
NA
NA
4.24
4.12
1.14
NA
NA
14.69
14.57
09044979

C
Laparoscope proc, app
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY45000

A
Drainage of pelvic abscess
6.16
NA
NA
3.56
3.11
0.52
NA
NA
10.24
9.79
09045005

A
Drainage of rectal abscess
1.99
4.00
4.04
1.60
1.59
0.25
6.24
6.28
3.84
3.83
01045020

A
Drainage of rectal abscess
8.37
NA
NA
4.58
3.60
0.55
NA
NA
13.50
12.52
09045100

A
Biopsy of rectum
3.92
NA
NA
2.84
2.48
0.44
NA
NA
7.20
6.84
09045108

A
Removal of anorectal lesion
5.00
NA
NA
3.08
2.85
0.59
NA
NA
8.67
8.44
09045110

A
Removal of rectum
30.49
NA
NA
11.98
12.29
3.35
NA
NA
45.82
46.13
09045111

A
Partial removal of rectum
17.81
NA
NA
7.08
7.14
2.06
NA
NA
26.95
27.01
09045112

A
Removal of rectum
32.99
NA
NA
10.39
11.42
3.42
NA
NA
46.80
47.83
09045113

A
Partial proctectomy
33.03
NA
NA
11.60
12.34
3.48
NA
NA
48.11
48.85
09045114

A
Partial removal of rectum
30.57
NA
NA
10.45
10.77
3.35
NA
NA
44.37
44.69
09045116

A
Partial removal of rectum
27.50
NA
NA
9.50
9.89
2.87
NA
NA
39.87
40.26
09045119

A
Remove rectum w/reservoir
33.29
NA
NA
11.71
12.27
3.35
NA
NA
48.35
48.91
09045120

A
Removal of rectum
26.15
NA
NA
9.44
9.95
2.89
NA
NA
38.48
38.99
09045121

A
Removal of rectum and colon
28.83
NA
NA
10.34
10.91
3.24
NA
NA
42.41
42.98
09045123

A
Partial proctectomy
18.64
NA
NA
7.07
6.91
1.85
NA
NA
27.56
27.40
09045126

A
Pelvic exenteration
48.81
NA
NA
17.39
18.75
4.32
NA
NA
70.52
71.88
09045130

A
Excision of rectal prolapse
18.31
NA
NA
6.73
6.75
1.79
NA
NA
26.83
26.85
09045135

A
Excision of rectal prolapse
22.07
NA
NA
9.28
8.63
2.35
NA
NA
33.70
33.05
09045136

A
Excise ileoanal reservior
30.55
NA
NA
11.86
12.35
2.81
NA
NA
45.22
45.71
09045150

A
Excision of rectal stricture
5.72
NA
NA
3.40
3.07
0.61
NA
NA
9.73
9.40
09045160

A
Excision of rectal lesion
16.11
NA
NA
6.59
6.63
1.67
NA
NA
24.37
24.41
09045170

A
Excision of rectal lesion
12.42
NA
NA
5.41
5.28
1.35
NA
NA
19.18
19.05
09045190

A
Destruction, rectal tumor
10.23
NA
NA
5.55
4.85
1.13
NA
NA
16.91
16.21
09045300

A
Proctosigmoidoscopy dx
0.38
2.00
1.65
0.35
0.30
0.04
2.42
2.07
0.77
0.72
00045303

A
Proctosigmoidoscopy dilate
0.44
19.63
18.92
0.38
0.34
0.05
20.12
19.41
0.87
0.83
00045305

A
Proctosigmoidoscopy w/bx
1.01
3.31
2.80
0.53
0.51
0.11
4.43
3.92
1.65
1.63
00045307

A
Proctosigmoidoscopy fb
0.94
3.52
3.15
0.51
0.49
0.11
4.57
4.20
1.56
1.54
00045308

A
Proctosigmoidoscopy removal
0.83
3.30
2.32
0.49
0.45
0.09
4.22
3.24
1.41
1.37
00045309

A
Proctosigmoidoscopy removal
2.01
3.73
3.04
0.83
0.84
0.22
5.96
5.27
3.06
3.07
00045315

A
Proctosigmoidoscopy removal
1.40
3.74
3.08
0.65
0.64
0.15
5.29
4.63
2.20
2.19
00045317

A
Proctosigmoidoscopy bleed
1.50
3.83
2.78
0.66
0.66
0.15
5.48
4.43
2.31
2.31
00045320

A
Proctosigmoidoscopy ablate
1.58
4.49
3.31
0.75
0.72
0.16
6.23
5.05
2.49
2.46
00045321

A
Proctosigmoidoscopy volvul
1.17
NA
NA
0.65
0.58
0.13
NA
NA
1.95
1.88
00045327

A
Proctosigmoidoscopy w/stent
1.65
NA
NA
0.83
0.73
0.16
NA
NA
2.64
2.54
00045330

A
Diagnostic sigmoidoscopy
0.96
2.49
2.33
0.61
0.53
0.08
3.53
3.37
1.65
1.57
00045331

A
Sigmoidoscopy and biopsy
1.15
3.24
3.11
0.78
0.64
0.09
4.48
4.35
2.02
1.88
00045332

A
Sigmoidoscopy w/fb removal
1.79
5.62
5.16
1.02
0.86
0.16
7.57
7.11
2.97
2.81
00045333

A
Sigmoidoscopy & polypectomy
1.79
5.63
5.06
0.98
0.85
0.15
7.57
7.00
2.92
2.79
00045334

A
Sigmoidoscopy for bleeding
2.73
NA
NA
1.52
1.24
0.20
NA
NA
4.45
4.17
00045335

A
Sigmoidoscopy w/submuc inj
1.46
5.32
3.74
0.90
0.74
0.11
6.89
5.31
2.47
2.31
00045337

A
Sigmoidoscopy & decompress
2.36
NA
NA
1.23
1.06
0.21
NA
NA
3.80
3.63
000( print page 49145)45338

A
Sigmoidoscopy w/tumr remove
2.34
5.85
5.37
1.26
1.07
0.19
8.38
7.90
3.79
3.60
00045339

A
Sigmoidoscopy w/ablate tumr
3.14
5.73
4.03
1.66
1.38
0.26
9.13
7.43
5.06
4.78
00045340

A
Sig w/balloon dilation
1.89
10.25
7.19
1.03
0.88
0.15
12.29
9.23
3.07
2.92
00045341

A
Sigmoidoscopy w/ultrasound
2.60
NA
NA
1.45
1.17
0.19
NA
NA
4.24
3.96
00045342

A
Sigmoidoscopy w/us guide bx
4.05
NA
NA
2.15
1.69
0.30
NA
NA
6.50
6.04
00045345

A
Sigmoidoscopy w/stent
2.92
NA
NA
1.53
1.25
0.23
NA
NA
4.68
4.40
00045355

A
Surgical colonoscopy
3.51
NA
NA
1.55
1.42
0.36
NA
NA
5.42
5.29
00045378

A
Diagnostic colonoscopy
3.69
6.36
6.20
1.81
1.56
0.30
10.35
10.19
5.80
5.55
00045378
53
A
Diagnostic colonoscopy
0.96
2.49
2.33
0.61
0.53
0.08
3.53
3.37
1.65
1.57
00045379

A
Colonoscopy w/fb removal
4.68
8.14
7.78
2.20
1.91
0.39
13.21
12.85
7.27
6.98
00045380

A
Colonoscopy and biopsy
4.43
7.71
7.32
2.22
1.85
0.35
12.49
12.10
7.00
6.63
00045381

A
Colonoscopy, submucous inj
4.19
7.68
7.25
2.14
1.77
0.30
12.17
11.74
6.63
6.26
00045382

A
Colonoscopy/control bleeding
5.68
10.31
10.03
2.87
2.35
0.41
16.40
16.12
8.96
8.44
00045383

A
Lesion removal colonoscopy
5.86
8.54
8.08
2.63
2.32
0.48
14.88
14.42
8.97
8.66
00045384

A
Lesion remove colonoscopy
4.69
7.20
6.90
2.19
1.91
0.38
12.27
11.97
7.26
6.98
00045385

A
Lesion removal colonoscopy
5.30
8.33
7.93
2.57
2.17
0.42
14.05
13.65
8.29
7.89
00045386

A
Colonoscopy dilate stricture
4.57
12.31
12.38
2.16
1.88
0.39
17.27
17.34
7.12
6.84
00045387

A
Colonoscopy w/stent
5.90
NA
NA
2.89
2.47
0.48
NA
NA
9.27
8.85
00045391

A
Colonoscopy w/endoscope us
5.09
NA
NA
2.54
2.11
0.42
NA
NA
8.05
7.62
00045392

A
Colonoscopy w/endoscopic fnb
6.54
NA
NA
3.10
2.64
0.42
NA
NA
10.06
9.60
00045395

A
Lap, removal of rectum
32.71
NA
NA
13.06
13.52
3.62
NA
NA
49.39
49.85
09045397

A
Lap, remove rectum w/pouch
36.21
NA
NA
13.59
14.09
3.66
NA
NA
53.46
53.96
09045400

A
Laparoscopic proctopexy
19.25
NA
NA
7.18
7.67
2.02
NA
NA
28.45
28.94
09045402

A
Lap proctopexy w/sig resect
26.32
NA
NA
8.87
9.70
2.81
NA
NA
38.00
38.83
09045499

C
Laparoscope proc, rectum
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY45500

A
Repair of rectum
7.58
NA
NA
4.35
3.74
0.75
NA
NA
12.68
12.07
09045505

A
Repair of rectum
8.14
NA
NA
5.11
4.17
0.86
NA
NA
14.11
13.17
09045520

A
Treatment of rectal prolapse
0.55
3.07
2.00
0.41
0.38
0.05
3.67
2.60
1.01
0.98
00045540

A
Correct rectal prolapse
17.98
NA
NA
5.89
6.57
1.84
NA
NA
25.71
26.39
09045541

A
Correct rectal prolapse
14.66
NA
NA
6.59
6.10
1.55
NA
NA
22.80
22.31
09045550

A
Repair rectum/remove sigmoid
24.61
NA
NA
9.02
9.16
2.61
NA
NA
36.24
36.38
09045560

A
Repair of rectocele
11.38
NA
NA
5.52
5.17
1.13
NA
NA
18.03
17.68
09045562

A
Exploration/repair of rectum
17.74
NA
NA
8.17
7.28
1.83
NA
NA
27.74
26.85
09045563

A
Exploration/repair of rectum
26.14
NA
NA
10.97
10.63
3.10
NA
NA
40.21
39.87
09045800

A
Repair rect/bladder fistula
20.12
NA
NA
9.23
7.87
1.85
NA
NA
31.20
29.84
09045805

A
Repair fistula w/colostomy
23.13
NA
NA
9.26
9.44
2.02
NA
NA
34.41
34.59
09045820

A
Repair rectourethral fistula
20.18
NA
NA
9.29
8.04
1.58
NA
NA
31.05
29.80
09045825

A
Repair fistula w/colostomy
23.93
NA
NA
10.94
10.09
2.31
NA
NA
37.18
36.33
09045900

A
Reduction of rectal prolapse
2.94
NA
NA
1.70
1.55
0.30
NA
NA
4.94
4.79
01045905

A
Dilation of anal sphincter
2.30
NA
NA
1.65
1.49
0.27
NA
NA
4.22
4.06
01045910

A
Dilation of rectal narrowing
2.80
NA
NA
1.80
1.70
0.30
NA
NA
4.90
4.80
01045915

A
Remove rectal obstruction
3.14
4.26
4.31
2.04
2.08
0.30
7.70
7.75
5.48
5.52
01045990

A
Surg dx exam, anorectal
1.80
NA
NA
0.78
0.79
0.17
NA
NA
2.75
2.76
00045999

C
Rectum surgery procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY46020

A
Placement of seton
2.90
3.29
2.57
2.37
1.98
0.31
6.50
5.78
5.58
5.19
01046030

A
Removal of rectal marker
1.23
1.90
1.49
0.81
0.74
0.14
3.27
2.86
2.18
2.11
01046040

A
Incision of rectal abscess
5.20
6.58
5.76
4.01
3.69
0.62
12.40
11.58
9.83
9.51
09046045

A
Incision of rectal abscess
5.75
NA
NA
3.93
3.15
0.54
NA
NA
10.22
9.44
09046050

A
Incision of anal abscess
1.19
3.21
2.71
0.98
0.88
0.14
4.54
4.04
2.31
2.21
01046060

A
Incision of rectal abscess
6.18
NA
NA
3.99
3.43
0.67
NA
NA
10.84
10.28
09046070

A
Incision of anal septum
2.71
NA
NA
2.35
1.96
0.36
NA
NA
5.42
5.03
09046080

A
Incision of anal sphincter
2.49
3.09
2.54
1.13
1.13
0.30
5.88
5.33
3.92
3.92
01046083

A
Incise external hemorrhoid
1.40
2.36
2.48
0.95
0.93
0.15
3.91
4.03
2.50
2.48
01046200

A
Removal of anal fissure
3.41
6.32
4.47
3.74
3.08
0.39
10.12
8.27
7.54
6.88
09046210

A
Removal of anal crypt
2.67
6.00
5.33
3.39
2.81
0.31
8.98
8.31
6.37
5.79
09046211

A
Removal of anal crypts
4.24
7.18
5.85
4.13
3.66
0.48
11.90
10.57
8.85
8.38
09046220

A
Removal of anal tag
1.56
3.01
2.47
1.10
0.99
0.17
4.74
4.20
2.83
2.72
01046221

A
Ligation of hemorrhoid(s)
2.29
3.75
2.92
2.00
1.81
0.23
6.27
5.44
4.52
4.33
01046230

A
Removal of anal tags
2.57
3.52
3.18
1.34
1.30
0.30
6.39
6.05
4.21
4.17
01046250

A
Hemorrhoidectomy
4.13
6.02
5.48
2.86
2.67
0.48
10.63
10.09
7.47
7.28
09046255

A
Hemorrhoidectomy
4.84
6.44
5.98
3.12
2.90
0.58
11.86
11.40
8.54
8.32
09046257

A
Remove hemorrhoids & fissure
5.64
NA
NA
3.80
3.10
0.64
NA
NA
10.08
9.38
09046258

A
Remove hemorrhoids & fistula
6.22
NA
NA
4.01
3.46
0.68
NA
NA
10.91
10.36
09046260

A
Hemorrhoidectomy
6.61
NA
NA
4.06
3.40
0.76
NA
NA
11.43
10.77
09046261

A
Remove hemorrhoids & fissure
7.57
NA
NA
4.32
3.78
0.79
NA
NA
12.68
12.14
09046262

A
Remove hemorrhoids & fistula
7.74
NA
NA
4.68
3.97
0.83
NA
NA
13.25
12.54
090( print page 49146)46270

A
Removal of anal fistula
4.75
6.33
5.33
3.91
3.10
0.46
11.54
10.54
9.12
8.31
09046275

A
Removal of anal fistula
5.25
6.66
5.14
4.00
3.23
0.52
12.43
10.91
9.77
9.00
09046280

A
Removal of anal fistula
6.22
NA
NA
4.26
3.50
0.66
NA
NA
11.14
10.38
09046285

A
Removal of anal fistula
5.25
6.54
4.46
3.95
3.04
0.44
12.23
10.15
9.64
8.73
09046288

A
Repair anal fistula
7.62
NA
NA
4.67
3.92
0.79
NA
NA
13.08
12.33
09046320

A
Removal of hemorrhoid clot
1.61
2.42
2.20
0.89
0.86
0.18
4.21
3.99
2.68
2.65
01046500

A
Injection into hemorrhoid(s)
1.61
3.61
2.49
1.25
1.18
0.16
5.38
4.26
3.02
2.95
01046505

A
Chemodenervation anal musc
3.11
3.30
3.11
2.31
2.05
0.14
6.55
6.36
5.56
5.30
01046600

A
Diagnostic anoscopy
0.50
1.48
1.54
0.37
0.35
0.05
2.03
2.09
0.92
0.90
00046604

A
Anoscopy and dilation
1.31
12.65
10.00
0.58
0.61
0.12
14.08
11.43
2.01
2.04
00046606

A
Anoscopy and biopsy
0.81
4.02
3.84
0.48
0.44
0.09
4.92
4.74
1.38
1.34
00046608

A
Anoscopy, remove for body
1.51
4.06
4.32
0.62
0.64
0.16
5.73
5.99
2.29
2.31
00046610

A
Anoscopy, remove lesion
1.32
4.29
4.10
0.66
0.62
0.15
5.76
5.57
2.13
2.09
00046611

A
Anoscopy
1.81
2.88
3.22
0.72
0.77
0.19
4.88
5.22
2.72
2.77
00046612

A
Anoscopy, remove lesions
2.34
5.51
5.26
0.95
0.97
0.28
8.13
7.88
3.57
3.59
00046614

A
Anoscopy, control bleeding
2.01
2.78
2.44
0.82
0.84
0.20
4.99
4.65
3.03
3.05
00046615

A
Anoscopy
2.68
2.43
2.47
0.97
1.05
0.33
5.44
5.48
3.98
4.06
00046700

A
Repair of anal stricture
9.62
NA
NA
4.72
4.33
0.94
NA
NA
15.28
14.89
09046705

A
Repair of anal stricture
7.25
NA
NA
4.08
3.78
0.91
NA
NA
12.24
11.94
09046706

A
Repr of anal fistula w/glue
2.39
NA
NA
1.45
1.30
0.28
NA
NA
4.12
3.97
01046710

A
Repr per/vag pouch sngl proc
16.95
NA
NA
7.79
7.76
1.38
NA
NA
26.12
26.09
09046712

A
Repr per/vag pouch dbl proc
36.26
NA
NA
14.16
14.82
3.66
NA
NA
54.08
54.74
09046715

A
Rep perf anoper fistu
7.49
NA
NA
3.77
3.62
0.92
NA
NA
12.18
12.03
09046716

A
Rep perf anoper/vestib fistu
17.04
NA
NA
9.66
8.39
1.58
NA
NA
28.28
27.01
09046730

A
Construction of absent anus
30.05
NA
NA
11.66
11.93
2.46
NA
NA
44.17
44.44
09046735

A
Construction of absent anus
35.54
NA
NA
13.36
13.50
3.20
NA
NA
52.10
52.24
09046740

A
Construction of absent anus
33.30
NA
NA
14.66
13.58
2.41
NA
NA
50.37
49.29
09046742

A
Repair of imperforated anus
39.54
NA
NA
16.19
17.08
3.19
NA
NA
58.92
59.81
09046744

A
Repair of cloacal anomaly
58.34
NA
NA
21.08
21.10
6.38
NA
NA
85.80
85.82
09046746

A
Repair of cloacal anomaly
64.79
NA
NA
19.85
23.82
7.68
NA
NA
92.32
96.29
09046748

A
Repair of cloacal anomaly
70.77
NA
NA
21.25
23.04
3.36
NA
NA
95.38
97.17
09046750

A
Repair of anal sphincter
11.96
NA
NA
5.81
5.24
1.10
NA
NA
18.87
18.30
09046751

A
Repair of anal sphincter
9.12
NA
NA
4.45
5.17
0.94
NA
NA
14.51
15.23
09046753

A
Reconstruction of anus
8.77
NA
NA
4.61
4.03
0.94
NA
NA
14.32
13.74
09046754

A
Removal of suture from anus
2.82
3.73
3.63
2.27
1.82
0.19
6.74
6.64
5.28
4.83
01046760

A
Repair of anal sphincter
17.11
NA
NA
8.26
7.38
1.59
NA
NA
26.96
26.08
09046761

A
Repair of anal sphincter
15.10
NA
NA
6.45
6.11
1.43
NA
NA
22.98
22.64
09046762

A
Implant artificial sphincter
14.58
NA
NA
6.79
5.83
1.24
NA
NA
22.61
21.65
09046900

A
Destruction, anal lesion(s)
1.91
3.62
2.84
1.30
1.28
0.17
5.70
4.92
3.38
3.36
01046910

A
Destruction, anal lesion(s)
1.86
3.88
3.15
1.20
1.10
0.19
5.93
5.20
3.25
3.15
01046916

A
Cryosurgery, anal lesion(s)
1.86
3.70
3.29
1.54
1.43
0.11
5.67
5.26
3.51
3.40
01046917

A
Laser surgery, anal lesions
1.86
8.73
9.02
1.21
1.14
0.21
10.80
11.09
3.28
3.21
01046922

A
Excision of anal lesion(s)
1.86
4.15
3.49
1.20
1.10
0.22
6.23
5.57
3.28
3.18
01046924

A
Destruction, anal lesion(s)
2.76
9.61
8.91
1.52
1.39
0.26
12.63
11.93
4.54
4.41
01046934

A
Destruction of hemorrhoids
3.75
5.41
5.16
2.80
2.91
0.32
9.48
9.23
6.87
6.98
09046935

A
Destruction of hemorrhoids
2.43
3.70
3.52
1.08
1.18
0.23
6.36
6.18
3.74
3.84
01046936

A
Destruction of hemorrhoids
3.68
6.16
5.19
2.60
2.52
0.34
10.18
9.21
6.62
6.54
09046937

A
Cryotherapy of rectal lesion
2.69
4.01
3.08
1.80
1.37
0.14
6.84
5.91
4.63
4.20
01046938

A
Cryotherapy of rectal lesion
4.65
5.85
4.46
3.66
3.20
0.58
11.08
9.69
8.89
8.43
09046940

A
Treatment of anal fissure
2.32
2.85
2.21
1.04
1.08
0.23
5.40
4.76
3.59
3.63
01046942

A
Treatment of anal fissure
2.04
2.80
2.07
0.95
1.00
0.19
5.03
4.30
3.18
3.23
01046945

A
Ligation of hemorrhoids
2.09
4.83
3.65
3.00
2.60
0.19
7.11
5.93
5.28
4.88
09046946

A
Ligation of hemorrhoids
2.58
4.65
3.95
2.66
2.46
0.27
7.50
6.80
5.51
5.31
09046947

A
Hemorrhoidopexy by stapling
5.45
NA
NA
3.12
2.81
0.75
NA
NA
9.32
9.01
09046999

C
Anus surgery procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY47000

A
Needle biopsy of liver
1.90
7.68
4.22
0.63
0.63
0.12
9.70
6.24
2.65
2.65
000( print page 49147)47001

A
Needle biopsy, liver add-on
1.90
NA
NA
0.49
0.61
0.25
NA
NA
2.64
2.76
ZZZ47010

A
Open drainage, liver lesion
19.21
NA
NA
8.34
8.38
1.80
NA
NA
29.35
29.39
09047011

A
Percut drain, liver lesion
3.69
NA
NA
1.18
1.20
0.22
NA
NA
5.09
5.11
00047015

A
Inject/aspirate liver cyst
18.31
NA
NA
7.92
7.59
1.83
NA
NA
28.06
27.73
09047100

A
Wedge biopsy of liver
12.72
NA
NA
6.39
6.12
1.53
NA
NA
20.64
20.37
09047120

A
Partial removal of liver
38.74
NA
NA
14.23
14.91
4.65
NA
NA
57.62
58.30
09047122

A
Extensive removal of liver
59.29
NA
NA
19.03
20.84
7.19
NA
NA
85.51
87.32
09047125

A
Partial removal of liver
52.85
NA
NA
17.27
18.94
6.45
NA
NA
76.57
78.24
09047130

A
Partial removal of liver
57.00
NA
NA
18.28
20.29
6.94
NA
NA
82.22
84.23
09047135

R
Transplantation of liver
83.15
NA
NA
28.01
30.63
9.93
NA
NA
121.09
123.71
09047136

R
Transplantation of liver
70.25
NA
NA
23.80
26.21
8.41
NA
NA
102.46
104.87
09047140

A
Partial removal, donor liver
59.14
NA
NA
21.89
22.18
5.17
NA
NA
86.20
86.49
09047141

A
Partial removal, donor liver
71.17
NA
NA
25.67
26.59
5.17
NA
NA
102.01
102.93
09047142

A
Partial removal, donor liver
79.11
NA
NA
27.72
29.03
5.17
NA
NA
112.00
113.31
09047143

C
Prep donor liver, whole
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX47144

C
Prep donor liver, 3-segment
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
09047145

C
Prep donor liver, lobe split
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
09047146

A
Prep donor liver/venous
6.00
NA
NA
1.54
1.92
0.83
NA
NA
8.37
8.75
XXX47147

A
Prep donor liver/arterial
7.00
NA
NA
1.80
2.24
0.97
NA
NA
9.77
10.21
XXX47300

A
Surgery for liver lesion
17.95
NA
NA
7.71
7.34
1.98
NA
NA
27.64
27.27
09047350

A
Repair liver wound
22.30
NA
NA
8.95
8.88
2.58
NA
NA
33.83
33.76
09047360

A
Repair liver wound
31.12
NA
NA
11.51
11.56
3.37
NA
NA
46.00
46.05
09047361

A
Repair liver wound
52.41
NA
NA
16.93
18.12
5.85
NA
NA
75.19
76.38
09047362

A
Repair liver wound
23.35
NA
NA
9.35
8.87
2.50
NA
NA
35.20
34.72
09047370

A
Laparo ablate liver tumor rf
20.61
NA
NA
7.75
8.04
2.55
NA
NA
30.91
31.20
09047371

A
Laparo ablate liver cryosurg
20.61
NA
NA
8.16
8.15
2.60
NA
NA
31.37
31.36
09047379

C
Laparoscope procedure, liver
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY47380

A
Open ablate liver tumor rf
24.37
NA
NA
8.69
9.19
2.86
NA
NA
35.92
36.42
09047381

A
Open ablate liver tumor cryo
24.64
NA
NA
9.23
9.49
2.84
NA
NA
36.71
36.97
09047382

A
Percut ablate liver rf
15.17
NA
NA
5.68
5.97
0.96
NA
NA
21.81
22.10
01047399

C
Liver surgery procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY47400

A
Incision of liver duct
36.17
NA
NA
13.24
13.38
3.07
NA
NA
52.48
52.62
09047420

A
Incision of bile duct
21.86
NA
NA
8.69
8.74
2.62
NA
NA
33.17
33.22
09047425

A
Incision of bile duct
22.14
NA
NA
8.70
8.78
2.61
NA
NA
33.45
33.53
09047460

A
Incise bile duct sphincter
20.35
NA
NA
9.06
8.54
2.20
NA
NA
31.61
31.09
09047480

A
Incision of gallbladder
13.06
NA
NA
6.72
6.11
1.42
NA
NA
21.20
20.59
09047490

A
Incision of gallbladder
8.00
NA
NA
5.02
5.43
0.43
NA
NA
13.45
13.86
09047500

A
Injection for liver x-rays
1.96
NA
NA
0.64
0.64
0.12
NA
NA
2.72
2.72
00047505

A
Injection for liver x-rays
0.76
NA
NA
0.25
0.25
0.04
NA
NA
1.05
1.05
00047510

A
Insert catheter, bile duct
7.88
NA
NA
4.35
4.85
0.46
NA
NA
12.69
13.19
09047511

A
Insert bile duct drain
10.72
NA
NA
4.67
4.98
0.62
NA
NA
16.01
16.32
09047525

A
Change bile duct catheter
5.54
14.92
15.05
2.51
2.73
0.33
20.79
20.92
8.38
8.60
01047530

A
Revise/reinsert bile tube
5.90
30.79
33.03
3.26
3.60
0.37
37.06
39.30
9.53
9.87
09047550

A
Bile duct endoscopy add-on
3.02
NA
NA
0.79
0.96
0.40
NA
NA
4.21
4.38
ZZZ47552

A
Biliary endoscopy thru skin
6.03
NA
NA
2.32
2.36
0.42
NA
NA
8.77
8.81
00047553

A
Biliary endoscopy thru skin
6.34
NA
NA
2.05
2.06
0.37
NA
NA
8.76
8.77
00047554

A
Biliary endoscopy thru skin
9.05
NA
NA
3.12
3.29
0.96
NA
NA
13.13
13.30
00047555

A
Biliary endoscopy thru skin
7.55
NA
NA
2.50
2.47
0.45
NA
NA
10.50
10.47
00047556

A
Biliary endoscopy thru skin
8.55
NA
NA
2.77
2.78
0.50
NA
NA
11.82
11.83
00047560

A
Laparoscopy w/cholangio
4.88
NA
NA
1.26
1.57
0.65
NA
NA
6.79
7.10
00047561

A
Laparo w/cholangio/biopsy
5.17
NA
NA
1.57
1.83
0.66
NA
NA
7.40
7.66
00047562

A
Laparoscopic cholecystectomy
11.57
NA
NA
5.32
5.07
1.46
NA
NA
18.35
18.10
09047563

A
Laparo cholecystectomy/graph
11.98
NA
NA
5.13
5.25
1.58
NA
NA
18.69
18.81
09047564

A
Laparo cholecystectomy/explr
14.21
NA
NA
5.50
5.83
1.88
NA
NA
21.59
21.92
09047570

A
Laparo cholecystoenterostomy
12.56
NA
NA
5.10
5.30
1.65
NA
NA
19.31
19.51
09047579

C
Laparoscope proc, biliary
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY47600

A
Removal of gallbladder
15.44
NA
NA
6.82
6.30
1.79
NA
NA
24.05
23.53
09047605

A
Removal of gallbladder
15.86
NA
NA
6.46
6.48
1.94
NA
NA
24.26
24.28
09047610

A
Removal of gallbladder
20.80
NA
NA
7.78
7.89
2.48
NA
NA
31.06
31.17
09047612

A
Removal of gallbladder
21.09
NA
NA
7.78
7.85
2.47
NA
NA
31.34
31.41
09047620

A
Removal of gallbladder
22.95
NA
NA
8.29
8.46
2.73
NA
NA
33.97
34.14
09047630

A
Remove bile duct stone
9.52
NA
NA
4.55
4.80
0.65
NA
NA
14.72
14.97
09047700

A
Exploration of bile ducts
16.32
NA
NA
7.33
7.38
2.06
NA
NA
25.71
25.76
09047701

A
Bile duct revision
28.55
NA
NA
10.18
11.15
3.67
NA
NA
42.40
43.37
09047711

A
Excision of bile duct tumor
25.71
NA
NA
9.68
9.85
3.04
NA
NA
38.43
38.60
09047712

A
Excision of bile duct tumor
33.53
NA
NA
11.69
12.22
3.92
NA
NA
49.14
49.67
090( print page 49148)47715

A
Excision of bile duct cyst
21.36
NA
NA
8.64
8.48
2.48
NA
NA
32.48
32.32
09047716

A
Fusion of bile duct cyst
19.01
NA
NA
7.99
7.86
2.14
NA
NA
29.14
29.01
09047720

A
Fuse gallbladder & bowel
18.15
NA
NA
7.80
7.55
2.10
NA
NA
28.05
27.80
09047721

A
Fuse upper gi structures
21.80
NA
NA
8.69
8.59
2.52
NA
NA
33.01
32.91
09047740

A
Fuse gallbladder & bowel
21.04
NA
NA
8.56
8.41
2.41
NA
NA
32.01
31.86
09047741

A
Fuse gallbladder & bowel
24.02
NA
NA
9.33
9.29
2.82
NA
NA
36.17
36.13
09047760

A
Fuse bile ducts and bowel
38.08
NA
NA
13.24
11.43
3.41
NA
NA
54.73
52.92
09047765

A
Fuse liver ducts & bowel
51.95
NA
NA
17.09
12.36
3.29
NA
NA
72.33
67.60
09047780

A
Fuse bile ducts and bowel
42.08
NA
NA
14.27
11.96
3.49
NA
NA
59.84
57.53
09047785

A
Fuse bile ducts and bowel
55.95
NA
NA
18.09
14.19
4.09
NA
NA
78.13
74.23
09047800

A
Reconstruction of bile ducts
25.98
NA
NA
9.84
9.99
3.07
NA
NA
38.89
39.04
09047801

A
Placement, bile duct support
17.41
NA
NA
8.19
8.15
1.16
NA
NA
26.76
26.72
09047802

A
Fuse liver duct & intestine
24.74
NA
NA
9.64
9.65
2.85
NA
NA
37.23
37.24
09047900

A
Suture bile duct injury
22.25
NA
NA
8.82
8.84
2.64
NA
NA
33.71
33.73
09047999

C
Bile tract surgery procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY48000

A
Drainage of abdomen
31.76
NA
NA
11.07
11.39
3.47
NA
NA
46.30
46.62
09048001

A
Placement of drain, pancreas
39.50
NA
NA
12.81
13.60
4.68
NA
NA
56.99
57.78
09048005

A
Resect/debride pancreas
48.97
NA
NA
16.10
16.43
5.54
NA
NA
70.61
70.94
09048020

A
Removal of pancreatic stone
18.90
NA
NA
7.68
7.39
2.12
NA
NA
28.70
28.41
09048100

A
Biopsy of pancreas, open
14.34
NA
NA
5.96
5.68
1.62
NA
NA
21.92
21.64
09048102

A
Needle biopsy, pancreas
4.67
9.57
8.36
1.74
1.89
0.28
14.52
13.31
6.69
6.84
01048120

A
Removal of pancreas lesion
18.29
NA
NA
6.98
6.88
2.09
NA
NA
27.36
27.26
09048140

A
Partial removal of pancreas
26.13
NA
NA
9.48
9.51
3.02
NA
NA
38.63
38.66
09048145

A
Partial removal of pancreas
27.20
NA
NA
9.83
9.82
3.17
NA
NA
40.20
40.19
09048146

A
Pancreatectomy
30.34
NA
NA
12.02
11.98
3.49
NA
NA
45.85
45.81
09048148

A
Removal of pancreatic duct
20.20
NA
NA
8.14
7.73
2.29
NA
NA
30.63
30.22
09048150

A
Partial removal of pancreas
52.55
NA
NA
18.29
19.18
6.30
NA
NA
77.14
78.03
09048152

A
Pancreatectomy
48.39
NA
NA
16.84
17.85
5.78
NA
NA
71.01
72.02
09048153

A
Pancreatectomy
52.53
NA
NA
18.15
19.18
6.29
NA
NA
76.97
78.00
09048154

A
Pancreatectomy
48.62
NA
NA
17.15
17.95
5.82
NA
NA
71.59
72.39
09048155

A
Removal of pancreas
29.19
NA
NA
12.09
11.76
3.26
NA
NA
44.54
44.21
09048180

A
Fuse pancreas and bowel
27.90
NA
NA
10.01
10.11
3.27
NA
NA
41.18
41.28
09048400

A
Injection, intraop add-on
1.95
NA
NA
0.84
0.69
0.15
NA
NA
2.94
2.79
ZZZ48500

A
Surgery of pancreatic cyst
17.97
NA
NA
8.12
7.52
2.02
NA
NA
28.11
27.51
09048510

A
Drain pancreatic pseudocyst
17.00
NA
NA
7.64
7.48
1.82
NA
NA
26.46
26.30
09048511

A
Drain pancreatic pseudocyst
3.99
20.24
20.73
1.27
1.30
0.24
24.47
24.96
5.50
5.53
00048520

A
Fuse pancreas cyst and bowel
18.03
NA
NA
6.85
6.73
2.05
NA
NA
26.93
26.81
09048540

A
Fuse pancreas cyst and bowel
21.82
NA
NA
7.81
8.03
2.60
NA
NA
32.23
32.45
09048545

A
Pancreatorrhaphy
22.04
NA
NA
8.16
8.02
2.37
NA
NA
32.57
32.43
09048547

A
Duodenal exclusion
30.19
NA
NA
10.36
10.44
3.41
NA
NA
43.96
44.04
09048551

C
Prep donor pancreas
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX48552

A
Prep donor pancreas/venous
4.30
NA
NA
1.14
1.38
0.31
NA
NA
5.75
5.99
XXX48554

R
Transpl allograft pancreas
36.77
NA
NA
20.69
18.86
4.18
NA
NA
61.64
59.81
09048556

A
Removal, allograft pancreas
19.16
NA
NA
9.48
8.42
2.07
NA
NA
30.71
29.65
09048999

C
Pancreas surgery procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY49000

A
Exploration of abdomen
12.40
NA
NA
5.25
5.34
1.52
NA
NA
19.17
19.26
09049002

A
Reopening of abdomen
17.51
NA
NA
6.47
5.38
1.37
NA
NA
25.35
24.26
09049010

A
Exploration behind abdomen
15.94
NA
NA
6.36
6.01
1.51
NA
NA
23.81
23.46
09049020

A
Drain abdominal abscess
26.38
NA
NA
9.95
10.12
2.84
NA
NA
39.17
39.34
09049021

A
Drain abdominal abscess
3.37
19.73
20.72
1.08
1.10
0.20
23.30
24.29
4.65
4.67
00049040

A
Drain, open, abdom abscess
16.35
NA
NA
6.57
6.45
1.69
NA
NA
24.61
24.49
09049041

A
Drain, percut, abdom abscess
3.99
19.97
19.63
1.28
1.30
0.24
24.20
23.86
5.51
5.53
00049060

A
Drain, open, retrop abscess
18.36
NA
NA
7.30
7.39
1.74
NA
NA
27.40
27.49
09049061

A
Drain, percut, retroper absc
3.69
19.83
19.67
1.18
1.20
0.22
23.74
23.58
5.09
5.11
00049062

A
Drain to peritoneal cavity
12.08
NA
NA
5.26
5.38
1.39
NA
NA
18.73
18.85
09049080

A
Puncture, peritoneal cavity
1.35
2.72
3.67
0.44
0.46
0.08
4.15
5.10
1.87
1.89
000( print page 49149)49081

A
Removal of abdominal fluid
1.26
2.93
2.67
0.44
0.43
0.09
4.28
4.02
1.79
1.78
00049085

A
Remove abdomen foreign body
13.97
NA
NA
5.61
5.52
1.62
NA
NA
21.20
21.11
09049180

A
Biopsy, abdominal mass
1.73
2.43
2.93
0.55
0.57
0.10
4.26
4.76
2.38
2.40
00049200

A
Removal of abdominal lesion
10.89
NA
NA
4.90
4.99
1.24
NA
NA
17.03
17.12
09049201

A
Remove abdom lesion, complex
15.60
NA
NA
6.48
6.89
1.87
NA
NA
23.95
24.36
09049215

A
Excise sacral spine tumor
37.60
NA
NA
12.80
13.73
4.37
NA
NA
54.77
55.70
09049220

A
Multiple surgery, abdomen
15.64
NA
NA
6.30
6.54
1.88
NA
NA
23.82
24.06
09049250

A
Excision of umbilicus
8.88
NA
NA
4.32
4.28
1.08
NA
NA
14.28
14.24
09049255

A
Removal of omentum
12.35
NA
NA
5.68
5.62
1.43
NA
NA
19.46
19.40
09049320

A
Diag laparo separate proc
5.34
NA
NA
2.54
2.61
0.65
NA
NA
8.53
8.60
01049321

A
Laparoscopy, biopsy
5.39
NA
NA
2.59
2.63
0.70
NA
NA
8.68
8.72
01049322

A
Laparoscopy, aspiration
5.94
NA
NA
2.66
2.91
0.71
NA
NA
9.31
9.56
01049323

A
Laparo drain lymphocele
10.09
NA
NA
4.72
4.55
1.20
NA
NA
16.01
15.84
09049329

C
Laparo proc, abdm/per/oment
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY49400

A
Air injection into abdomen
1.88
2.44
2.91
0.57
0.61
0.15
4.47
4.94
2.60
2.64
00049419

A
Insrt abdom cath for chemotx
7.01
NA
NA
3.49
3.54
0.81
NA
NA
11.31
11.36
09049420

A
Insert abdom drain, temp
2.22
NA
NA
1.16
1.11
0.21
NA
NA
3.59
3.54
00049421

A
Insert abdom drain, perm
5.83
NA
NA
3.16
3.15
0.74
NA
NA
9.73
9.72
09049422

A
Remove perm cannula/catheter
6.24
NA
NA
2.64
2.83
0.83
NA
NA
9.71
9.90
01049423

A
Exchange drainage catheter
1.46
13.26
13.87
0.51
0.52
0.09
14.81
15.42
2.06
2.07
00049424

A
Assess cyst, contrast inject
0.76
3.09
3.56
0.28
0.29
0.04
3.89
4.36
1.08
1.09
00049425

A
Insert abdomen-venous drain
12.07
NA
NA
5.32
5.52
1.54
NA
NA
18.93
19.13
09049426

A
Revise abdomen-venous shunt
10.28
NA
NA
4.55
4.71
1.28
NA
NA
16.11
16.27
09049427

A
Injection, abdominal shunt
0.89
NA
NA
0.28
0.30
0.07
NA
NA
1.24
1.26
00049428

A
Ligation of shunt
6.75
NA
NA
3.08
3.71
0.80
NA
NA
10.63
11.26
01049429

A
Removal of shunt
7.39
NA
NA
3.01
3.32
1.02
NA
NA
11.42
11.73
01049491

A
Rpr hern preemie reduc
12.36
NA
NA
5.47
5.16
1.40
NA
NA
19.23
18.92
09049492

A
Rpr ing hern premie, blocked
15.26
NA
NA
5.86
6.04
1.80
NA
NA
22.92
23.10
09049495

A
Rpr ing hernia baby, reduc
6.13
NA
NA
3.00
2.96
0.74
NA
NA
9.87
9.83
09049496

A
Rpr ing hernia baby, blocked
9.28
NA
NA
4.39
4.30
1.07
NA
NA
14.74
14.65
09049500

A
Rpr ing hernia, init, reduce
5.72
NA
NA
3.62
3.24
0.71
NA
NA
10.05
9.67
09049501

A
Rpr ing hernia, init blocked
9.24
NA
NA
4.28
4.22
1.12
NA
NA
14.64
14.58
09049505

A
Prp i/hern init reduc >5 yr
7.84
NA
NA
3.92
3.79
1.03
NA
NA
12.79
12.66
09049507

A
Prp i/hern init block >5 yr
9.93
NA
NA
4.50
4.46
1.27
NA
NA
15.70
15.66
09049520

A
Rerepair ing hernia, reduce
9.87
NA
NA
4.42
4.43
1.28
NA
NA
15.57
15.58
09049521

A
Rerepair ing hernia, blocked
12.32
NA
NA
5.04
5.18
1.59
NA
NA
18.95
19.09
09049525

A
Repair ing hernia, sliding
8.81
NA
NA
4.17
4.10
1.13
NA
NA
14.11
14.04
09049540

A
Repair lumbar hernia
10.62
NA
NA
4.67
4.72
1.37
NA
NA
16.66
16.71
09049550

A
Rpr rem hernia, init, reduce
8.87
NA
NA
4.15
4.13
1.14
NA
NA
14.16
14.14
09049553

A
Rpr fem hernia, init blocked
9.80
NA
NA
4.45
4.42
1.24
NA
NA
15.49
15.46
09049555

A
Rerepair fem hernia, reduce
9.27
NA
NA
4.26
4.26
1.20
NA
NA
14.73
14.73
09049557

A
Rerepair fem hernia, blocked
11.50
NA
NA
4.90
4.96
1.47
NA
NA
17.87
17.93
09049560

A
Rpr ventral hern init, reduc
11.80
NA
NA
4.93
5.09
1.52
NA
NA
18.25
18.41
09049561

A
Rpr ventral hern init, block
15.26
NA
NA
5.86
6.00
1.88
NA
NA
23.00
23.14
09049565

A
Rerepair ventrl hern, reduce
12.25
NA
NA
5.17
5.20
1.52
NA
NA
18.94
18.97
09049566

A
Rerepair ventrl hern, block
15.41
NA
NA
5.92
6.07
1.90
NA
NA
23.23
23.38
09049568

A
Hernia repair w/mesh
4.88
NA
NA
1.26
1.57
0.64
NA
NA
6.78
7.09
ZZZ49570

A
Rpr epigastric hern, reduce
5.93
NA
NA
3.36
3.21
0.75
NA
NA
10.04
9.89
09049572

A
Rpr epigastric hern, blocked
7.75
NA
NA
3.87
3.56
0.88
NA
NA
12.50
12.19
09049580

A
Rpr umbil hern, reduc < 5 yr
4.35
NA
NA
3.03
2.70
0.54
NA
NA
7.92
7.59
09049582

A
Rpr umbil hern, block < 5 yr
7.01
NA
NA
3.64
3.51
0.88
NA
NA
11.53
11.40
09049585

A
Rpr umbil hern, reduc > 5 yr
6.47
NA
NA
3.54
3.35
0.82
NA
NA
10.83
10.64
09049587

A
Rpr umbil hern, block > 5 yr
7.92
NA
NA
3.90
3.77
0.99
NA
NA
12.81
12.68
09049590

A
Repair spigelian hernia
8.78
NA
NA
4.14
4.10
1.13
NA
NA
14.05
14.01
09049600

A
Repair umbilical lesion
11.42
NA
NA
5.20
5.29
1.32
NA
NA
17.94
18.03
09049605

A
Repair umbilical lesion
86.79
NA
NA
26.58
28.02
9.36
NA
NA
122.73
124.17
09049606

A
Repair umbilical lesion
18.87
NA
NA
6.66
7.43
2.45
NA
NA
27.98
28.75
09049610

A
Repair umbilical lesion
10.78
NA
NA
4.73
5.08
1.07
NA
NA
16.58
16.93
09049611

A
Repair umbilical lesion
9.21
NA
NA
3.66
6.14
0.78
NA
NA
13.65
16.13
09049650

A
Laparo hernia repair initial
6.26
NA
NA
3.37
3.24
0.93
NA
NA
10.56
10.43
09049651

A
Laparo hernia repair recur
8.23
NA
NA
4.26
4.10
1.14
NA
NA
13.63
13.47
09049659

C
Laparo proc, hernia repair
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY49900

A
Repair of abdominal wall
12.26
NA
NA
6.35
6.25
1.62
NA
NA
20.23
20.13
09049904

A
Omental flap, extra-abdom
22.06
NA
NA
12.17
14.45
2.69
NA
NA
36.92
39.20
09049905

A
Omental flap, intra-abdom
6.54
NA
NA
1.74
2.15
0.75
NA
NA
9.03
9.44
ZZZ49906

C
Free omental flap, microvasc
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
090( print page 49150)49999

C
Abdomen surgery procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY50010

A
Exploration of kidney
12.07
NA
NA
6.90
5.63
0.93
NA
NA
19.90
18.63
09050020

A
Renal abscess, open drain
17.80
NA
NA
8.63
7.96
1.34
NA
NA
27.77
27.10
09050021

A
Renal abscess, percut drain
3.37
21.26
21.55
1.09
1.10
0.20
24.83
25.12
4.66
4.67
00050040

A
Drainage of kidney
16.40
NA
NA
8.91
7.33
1.03
NA
NA
26.34
24.76
09050045

A
Exploration of kidney
16.61
NA
NA
8.55
7.08
1.24
NA
NA
26.40
24.93
09050060

A
Removal of kidney stone
20.74
NA
NA
11.10
8.64
1.36
NA
NA
33.20
30.74
09050065

A
Incision of kidney
22.11
NA
NA
11.69
7.48
1.59
NA
NA
35.39
31.18
09050070

A
Incision of kidney
21.64
NA
NA
11.49
9.03
1.44
NA
NA
34.57
32.11
09050075

A
Removal of kidney stone
26.84
NA
NA
13.79
10.87
1.80
NA
NA
42.43
39.51
09050080

A
Removal of kidney stone
15.56
NA
NA
8.64
6.86
1.04
NA
NA
25.24
23.46
09050081

A
Removal of kidney stone
23.25
NA
NA
12.32
9.64
1.54
NA
NA
37.11
34.43
09050100

A
Revise kidney blood vessels
17.24
NA
NA
7.34
7.67
2.06
NA
NA
26.64
26.97
09050120

A
Exploration of kidney
17.00
NA
NA
8.80
7.27
1.21
NA
NA
27.01
25.48
09050125

A
Explore and drain kidney
17.61
NA
NA
9.85
7.68
1.43
NA
NA
28.89
26.72
09050130

A
Removal of kidney stone
18.61
NA
NA
10.12
7.90
1.22
NA
NA
29.95
27.73
09050135

A
Exploration of kidney
20.38
NA
NA
10.81
8.53
1.33
NA
NA
32.52
30.24
09050200

A
Biopsy of kidney
2.63
NA
NA
1.13
1.25
0.16
NA
NA
3.92
4.04
00050205

A
Biopsy of kidney
12.15
NA
NA
5.62
5.16
1.30
NA
NA
19.07
18.61
09050220

A
Remove kidney, open
18.47
NA
NA
9.64
7.83
1.35
NA
NA
29.46
27.65
09050225

A
Removal kidney open, complex
21.67
NA
NA
11.14
8.89
1.50
NA
NA
34.31
32.06
09050230

A
Removal kidney open, radical
23.63
NA
NA
11.81
9.38
1.55
NA
NA
36.99
34.56
09050234

A
Removal of kidney & ureter
23.84
NA
NA
12.20
9.67
1.59
NA
NA
37.63
35.10
09050236

A
Removal of kidney & ureter
26.66
NA
NA
14.10
11.21
1.76
NA
NA
42.52
39.63
09050240

A
Partial removal of kidney
23.93
NA
NA
12.78
9.95
1.55
NA
NA
38.26
35.43
09050250

A
Cryoablate renal mass open
21.98
NA
NA
11.01
9.62
1.39
NA
NA
34.38
32.99
09050280

A
Removal of kidney lesion
16.88
NA
NA
9.35
7.35
1.19
NA
NA
27.42
25.42
09050290

A
Removal of kidney lesion
15.94
NA
NA
8.19
6.89
1.41
NA
NA
25.54
24.24
09050320

A
Remove kidney, living donor
22.18
NA
NA
12.52
11.12
2.35
NA
NA
37.05
35.65
09050323

C
Prep cadaver renal allograft
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX50325

C
Prep donor renal graft
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX50327

A
Prep renal graft/venous
4.00
NA
NA
1.10
1.29
0.29
NA
NA
5.39
5.58
XXX50328

A
Prep renal graft/arterial
3.50
NA
NA
0.98
1.13
0.26
NA
NA
4.74
4.89
XXX50329

A
Prep renal graft/ureteral
3.34
NA
NA
0.97
1.09
0.25
NA
NA
4.56
4.68
XXX50340

A
Removal of kidney
13.79
NA
NA
7.70
6.79
1.65
NA
NA
23.14
22.23
09050360

A
Transplantation of kidney
40.27
NA
NA
18.95
16.34
3.81
NA
NA
63.03
60.42
09050365

A
Transplantation of kidney
45.50
NA
NA
19.63
18.55
4.42
NA
NA
69.55
68.47
09050370

A
Remove transplanted kidney
18.60
NA
NA
9.35
7.69
1.67
NA
NA
29.62
27.96
09050380

A
Reimplantation of kidney
29.48
NA
NA
16.43
13.12
2.50
NA
NA
48.41
45.10
09050382

A
Change ureter stent, percut
5.50
26.41
33.69
1.86
1.86
0.34
32.25
39.53
7.70
7.70
00050384

A
Remove ureter stent, percut
5.00
20.77
31.61
1.69
1.71
0.31
26.08
36.92
7.00
7.02
00050387

A
Change ext/int ureter stent
2.00
12.75
16.85
0.66
0.67
0.12
14.87
18.97
2.78
2.79
00050389

A
Remove renal tube w/fluoro
1.10
6.75
11.24
0.36
0.37
0.07
7.92
12.41
1.53
1.54
00050390

A
Drainage of kidney lesion
1.96
NA
NA
0.64
0.64
0.12
NA
NA
2.72
2.72
00050391

A
Instll rx agnt into rnal tub
1.96
1.51
1.56
0.79
0.67
0.14
3.61
3.66
2.89
2.77
00050392

A
Insert kidney drain
3.37
NA
NA
1.40
1.49
0.20
NA
NA
4.97
5.06
00050393

A
Insert ureteral tube
4.15
NA
NA
1.66
1.75
0.25
NA
NA
6.06
6.15
00050394

A
Injection for kidney x-ray
0.76
1.88
2.48
0.56
0.64
0.05
2.69
3.29
1.37
1.45
00050395

A
Create passage to kidney
3.37
NA
NA
1.48
1.50
0.21
NA
NA
5.06
5.08
00050396

A
Measure kidney pressure
2.09
NA
NA
1.02
1.07
0.13
NA
NA
3.24
3.29
00050398

A
Change kidney tube
1.46
11.99
15.23
0.52
0.52
0.09
13.54
16.78
2.07
2.07
00050400

A
Revision of kidney/ureter
21.06
NA
NA
11.12
8.68
1.38
NA
NA
33.56
31.12
09050405

A
Revision of kidney/ureter
25.61
NA
NA
13.16
10.06
1.78
NA
NA
40.55
37.45
09050500

A
Repair of kidney wound
21.01
NA
NA
9.29
8.61
2.01
NA
NA
32.31
31.63
09050520

A
Close kidney-skin fistula
18.67
NA
NA
9.40
7.92
1.49
NA
NA
29.56
28.08
09050525

A
Repair renal-abdomen fistula
24.14
NA
NA
10.99
9.49
1.83
NA
NA
36.96
35.46
090( print page 49151)50526

A
Repair renal-abdomen fistula
26.06
NA
NA
8.23
9.45
1.96
NA
NA
36.25
37.47
09050540

A
Revision of horseshoe kidney
20.89
NA
NA
10.79
8.94
1.36
NA
NA
33.04
31.19
09050541

A
Laparo ablate renal cyst
16.72
NA
NA
8.81
7.06
1.13
NA
NA
26.66
24.91
09050542

A
Laparo ablate renal mass
21.12
NA
NA
11.24
8.91
1.39
NA
NA
33.75
31.42
09050543

A
Laparo partial nephrectomy
27.10
NA
NA
14.20
11.19
1.80
NA
NA
43.10
40.09
09050544

A
Laparoscopy, pyeloplasty
23.23
NA
NA
11.51
9.27
1.58
NA
NA
36.32
34.08
09050545

A
Laparo radical nephrectomy
24.89
NA
NA
12.35
9.97
1.70
NA
NA
38.94
36.56
09050546

A
Laparoscopic nephrectomy
21.63
NA
NA
11.39
9.12
1.57
NA
NA
34.59
32.32
09050547

A
Laparo removal donor kidney
26.20
NA
NA
12.68
11.50
2.76
NA
NA
41.64
40.46
09050548

A
Laparo remove w/ureter
25.22
NA
NA
12.27
9.95
1.72
NA
NA
39.21
36.89
09050549

C
Laparoscope proc, renal
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY50551

A
Kidney endoscopy
5.59
4.61
4.26
2.66
2.14
0.40
10.60
10.25
8.65
8.13
00050553

A
Kidney endoscopy
5.98
4.45
4.38
2.55
2.27
0.39
10.82
10.75
8.92
8.64
00050555

A
Kidney endoscopy & biopsy
6.52
5.12
4.89
3.03
2.51
0.45
12.09
11.86
10.00
9.48
00050557

A
Kidney endoscopy & treatment
6.61
5.28
4.76
3.07
2.49
0.47
12.36
11.84
10.15
9.57
00050561

A
Kidney endoscopy & treatment
7.58
5.80
5.26
3.42
2.84
0.54
13.92
13.38
11.54
10.96
00050562

A
Renal scope w/tumor resect
10.90
NA
NA
5.42
4.59
0.73
NA
NA
17.05
16.22
09050570

A
Kidney endoscopy
9.53
NA
NA
4.27
3.48
0.68
NA
NA
14.48
13.69
00050572

A
Kidney endoscopy
10.33
NA
NA
4.60
3.78
0.85
NA
NA
15.78
14.96
00050574

A
Kidney endoscopy & biopsy
11.00
NA
NA
4.78
4.00
0.77
NA
NA
16.55
15.77
00050575

A
Kidney endoscopy
13.96
NA
NA
6.06
4.99
0.99
NA
NA
21.01
19.94
00050576

A
Kidney endoscopy & treatment
10.97
NA
NA
4.86
3.96
0.78
NA
NA
16.61
15.71
00050580

A
Kidney endoscopy & treatment
11.84
NA
NA
5.17
4.26
0.83
NA
NA
17.84
16.93
00050590

A
Fragmenting of kidney stone
9.58
17.26
13.61
6.19
4.63
0.65
27.49
23.84
16.42
14.86
09050592

A
Perc rf ablate renal tumor
6.75
77.05
131.0
2.81
2.94
0.43
84.23
138.2
9.99
10.12
01050600

A
Exploration of ureter
16.99
NA
NA
8.60
7.15
1.13
NA
NA
26.72
25.27
09050605

A
Insert ureteral support
16.61
NA
NA
8.00
7.05
1.45
NA
NA
26.06
25.11
09050610

A
Removal of ureter stone
17.07
NA
NA
9.12
7.50
1.43
NA
NA
27.62
26.00
09050620

A
Removal of ureter stone
16.25
NA
NA
8.97
6.99
1.07
NA
NA
26.29
24.31
09050630

A
Removal of ureter stone
16.03
NA
NA
8.30
6.78
1.09
NA
NA
25.42
23.90
09050650

A
Removal of ureter
18.61
NA
NA
10.15
7.95
1.23
NA
NA
29.99
27.79
09050660

A
Removal of ureter
20.81
NA
NA
10.87
8.68
1.38
NA
NA
33.06
30.87
09050684

A
Injection for ureter x-ray
0.76
4.12
4.76
0.64
0.51
0.05
4.93
5.57
1.45
1.32
00050686

A
Measure ureter pressure
1.51
2.07
3.10
0.71
0.79
0.11
3.69
4.72
2.33
2.41
00050688

A
Change of ureter tube/stent
1.17
NA
NA
0.92
1.03
0.07
NA
NA
2.16
2.27
01050690

A
Injection for ureter x-ray
1.16
1.43
1.72
0.72
0.72
0.07
2.66
2.95
1.95
1.95
00050700

A
Revision of ureter
16.48
NA
NA
8.46
7.45
1.27
NA
NA
26.21
25.20
09050715

A
Release of ureter
20.43
NA
NA
8.65
8.71
2.13
NA
NA
31.21
31.27
09050722

A
Release of ureter
17.74
NA
NA
8.02
7.86
1.90
NA
NA
27.66
27.50
09050725

A
Release/revise ureter
19.99
NA
NA
9.70
8.46
1.52
NA
NA
31.21
29.97
09050727

A
Revise ureter
8.17
NA
NA
5.78
4.65
0.61
NA
NA
14.56
13.43
09050728

A
Revise ureter
12.00
NA
NA
7.21
5.97
1.00
NA
NA
20.21
18.97
09050740

A
Fusion of ureter & kidney
19.86
NA
NA
9.03
8.06
1.96
NA
NA
30.85
29.88
09050750

A
Fusion of ureter & kidney
21.01
NA
NA
9.84
8.45
1.38
NA
NA
32.23
30.84
09050760

A
Fusion of ureters
19.86
NA
NA
9.84
8.21
1.55
NA
NA
31.25
29.62
09050770

A
Splicing of ureters
21.01
NA
NA
10.70
8.65
1.45
NA
NA
33.16
31.11
09050780

A
Reimplant ureter in bladder
19.74
NA
NA
10.14
8.22
1.51
NA
NA
31.39
29.47
09050782

A
Reimplant ureter in bladder
19.51
NA
NA
8.30
8.65
1.61
NA
NA
29.42
29.77
09050783

A
Reimplant ureter in bladder
20.52
NA
NA
10.07
8.68
1.98
NA
NA
32.57
31.18
09050785

A
Reimplant ureter in bladder
22.02
NA
NA
11.19
9.02
1.45
NA
NA
34.66
32.49
09050800

A
Implant ureter in bowel
16.16
NA
NA
9.32
7.18
1.19
NA
NA
26.67
24.53
09050810

A
Fusion of ureter & bowel
22.29
NA
NA
9.65
9.22
2.31
NA
NA
34.25
33.82
09050815

A
Urine shunt to intestine
21.98
NA
NA
11.63
9.24
1.54
NA
NA
35.15
32.76
09050820

A
Construct bowel bladder
23.82
NA
NA
12.00
9.47
1.89
NA
NA
37.71
35.18
09050825

A
Construct bowel bladder
30.40
NA
NA
15.09
12.11
2.07
NA
NA
47.56
44.58
09050830

A
Revise urine flow
33.49
NA
NA
15.92
13.10
2.37
NA
NA
51.78
48.96
09050840

A
Replace ureter by bowel
22.11
NA
NA
11.93
9.30
1.47
NA
NA
35.51
32.88
09050845

A
Appendico-vesicostomy
22.11
NA
NA
12.42
9.77
1.57
NA
NA
36.10
33.45
09050860

A
Transplant ureter to skin
16.87
NA
NA
9.05
7.22
1.29
NA
NA
27.21
25.38
09050900

A
Repair of ureter
14.83
NA
NA
8.10
6.62
1.14
NA
NA
24.07
22.59
09050920

A
Closure ureter/skin fistula
15.60
NA
NA
8.54
7.06
1.01
NA
NA
25.15
23.67
09050930

A
Closure ureter/bowel fistula
19.98
NA
NA
10.29
8.54
1.28
NA
NA
31.55
29.80
09050940

A
Release of ureter
15.72
NA
NA
8.27
6.86
1.26
NA
NA
25.25
23.84
09050945

A
Laparoscopy ureterolithotomy
17.83
NA
NA
8.78
7.47
1.36
NA
NA
27.97
26.66
09050947

A
Laparo new ureter/bladder
25.57
NA
NA
12.50
10.39
2.16
NA
NA
40.23
38.12
09050948

A
Laparo new ureter/bladder
23.65
NA
NA
12.02
9.52
1.70
NA
NA
37.37
34.87
090( print page 49152)50949

C
Laparoscope proc, ureter
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY50951

A
Endoscopy of ureter
5.83
4.87
4.44
2.79
2.24
0.41
11.11
10.68
9.03
8.48
00050953

A
Endoscopy of ureter
6.23
5.05
4.56
3.31
2.60
0.43
11.71
11.22
9.97
9.26
00050955

A
Ureter endoscopy & biopsy
6.74
5.28
6.13
3.52
2.89
0.48
12.50
13.35
10.74
10.11
00050957

A
Ureter endoscopy & treatment
6.78
5.37
4.76
3.15
2.57
0.48
12.63
12.02
10.41
9.83
00050961

A
Ureter endoscopy & treatment
6.04
4.85
4.48
2.82
2.34
0.41
11.30
10.93
9.27
8.79
00050970

A
Ureter endoscopy
7.13
NA
NA
3.30
2.67
0.52
NA
NA
10.95
10.32
00050972

A
Ureter endoscopy & catheter
6.88
NA
NA
3.14
2.63
0.49
NA
NA
10.51
10.00
00050974

A
Ureter endoscopy & biopsy
9.16
NA
NA
3.97
3.32
0.64
NA
NA
13.77
13.12
00050976

A
Ureter endoscopy & treatment
9.03
NA
NA
3.76
3.24
0.66
NA
NA
13.45
12.93
00050980

A
Ureter endoscopy & treatment
6.84
NA
NA
3.13
2.56
0.48
NA
NA
10.45
9.88
00051000

A
Drainage of bladder
0.78
0.94
1.69
0.28
0.25
0.05
1.77
2.52
1.11
1.08
00051005

A
Drainage of bladder
1.02
2.43
4.13
0.30
0.33
0.10
3.55
5.25
1.42
1.45
00051010

A
Drainage of bladder
4.25
4.78
5.40
2.38
2.00
0.28
9.31
9.93
6.91
6.53
01051020

A
Incise & treat bladder
7.51
NA
NA
5.35
4.23
0.47
NA
NA
13.33
12.21
09051030

A
Incise & treat bladder
7.63
NA
NA
4.80
4.18
0.58
NA
NA
13.01
12.39
09051040

A
Incise & drain bladder
4.39
NA
NA
3.72
3.00
0.31
NA
NA
8.42
7.70
09051045

A
Incise bladder/drain ureter
7.63
NA
NA
5.23
4.25
0.52
NA
NA
13.38
12.40
09051050

A
Removal of bladder stone
7.83
NA
NA
5.38
4.08
0.49
NA
NA
13.70
12.40
09051060

A
Removal of ureter stone
9.77
NA
NA
6.42
4.98
0.62
NA
NA
16.81
15.37
09051065

A
Remove ureter calculus
9.77
NA
NA
6.35
4.85
0.63
NA
NA
16.75
15.25
09051080

A
Drainage of bladder abscess
6.57
NA
NA
4.35
3.74
0.43
NA
NA
11.35
10.74
09051500

A
Removal of bladder cyst
10.87
NA
NA
5.85
5.21
1.03
NA
NA
17.75
17.11
09051520

A
Removal of bladder lesion
10.03
NA
NA
6.51
5.13
0.69
NA
NA
17.23
15.85
09051525

A
Removal of bladder lesion
15.24
NA
NA
8.66
6.76
0.99
NA
NA
24.89
22.99
09051530

A
Removal of bladder lesion
13.53
NA
NA
7.33
6.14
1.05
NA
NA
21.91
20.72
09051535

A
Repair of ureter lesion
13.72
NA
NA
7.54
6.46
1.23
NA
NA
22.49
21.41
09051550

A
Partial removal of bladder
17.05
NA
NA
8.91
7.27
1.31
NA
NA
27.27
25.63
09051555

A
Partial removal of bladder
22.97
NA
NA
11.51
9.37
1.69
NA
NA
36.17
34.03
09051565

A
Revise bladder & ureter(s)
23.43
NA
NA
12.07
9.73
1.63
NA
NA
37.13
34.79
09051570

A
Removal of bladder
27.25
NA
NA
13.39
10.65
1.71
NA
NA
42.35
39.61
09051575

A
Removal of bladder & nodes
33.93
NA
NA
16.79
13.21
2.16
NA
NA
52.88
49.30
09051580

A
Remove bladder/revise tract
35.05
NA
NA
17.64
13.77
2.24
NA
NA
54.93
51.06
09051585

A
Removal of bladder & nodes
39.32
NA
NA
19.63
15.18
2.48
NA
NA
61.43
56.98
09051590

A
Remove bladder/revise tract
36.08
NA
NA
17.47
13.82
2.27
NA
NA
55.82
52.17
09051595

A
Remove bladder/revise tract
41.04
NA
NA
19.79
15.54
2.59
NA
NA
63.42
59.17
09051596

A
Remove bladder/create pouch
43.91
NA
NA
21.37
16.76
2.77
NA
NA
68.04
63.44
09051597

A
Removal of pelvic structures
42.51
NA
NA
20.13
16.15
2.81
NA
NA
65.45
61.47
09051600

A
Injection for bladder x-ray
0.88
4.25
4.85
0.31
0.30
0.06
5.19
5.79
1.25
1.24
00051605

A
Preparation for bladder xray
0.64
NA
NA
0.42
0.37
0.04
NA
NA
1.10
1.05
00051610

A
Injection for bladder x-ray
1.05
1.93
2.19
0.70
0.63
0.07
3.05
3.31
1.82
1.75
00051700

A
Irrigation of bladder
0.88
1.52
1.58
0.34
0.30
0.06
2.46
2.52
1.28
1.24
00051701

A
Insert bladder catheter
0.50
1.05
1.45
0.25
0.21
0.04
1.59
1.99
0.79
0.75
00051702

A
Insert temp bladder cath
0.50
1.54
1.95
0.34
0.27
0.04
2.08
2.49
0.88
0.81
00051703

A
Insert bladder cath, complex
1.47
2.29
2.62
0.81
0.62
0.10
3.86
4.19
2.38
2.19
00051705

A
Change of bladder tube
1.02
2.04
2.21
0.85
0.67
0.07
3.13
3.30
1.94
1.76
01051710

A
Change of bladder tube
1.49
2.75
3.19
1.19
0.88
0.11
4.35
4.79
2.79
2.48
01051715

A
Endoscopic injection/implant
3.73
4.47
4.04
1.76
1.45
0.29
8.49
8.06
5.78
5.47
00051720

A
Treatment of bladder lesion
1.50
1.64
1.72
0.75
0.71
0.14
3.28
3.36
2.39
2.35
00051725

A
Simple cystometrogram
1.51
4.32
5.27
4.32
5.27
0.16
5.99
6.94
5.99
6.94
00051725
26
A
Simple cystometrogram
1.51
0.57
0.51
0.57
0.51
0.12
2.20
2.14
2.20
2.14
00051725
TC
A
Simple cystometrogram
0.00
3.75
4.76
3.75
4.76
0.04
3.79
4.80
3.79
4.80
00051726

A
Complex cystometrogram
1.71
7.18
7.42
7.18
7.42
0.18
9.07
9.31
9.07
9.31
00051726
26
A
Complex cystometrogram
1.71
0.65
0.58
0.65
0.58
0.13
2.49
2.42
2.49
2.42
00051726
TC
A
Complex cystometrogram
0.00
6.53
6.84
6.53
6.84
0.05
6.58
6.89
6.58
6.89
00051736

A
Urine flow measurement
0.61
0.91
0.66
0.91
0.66
0.06
1.58
1.33
1.58
1.33
000( print page 49153)51736
26
A
Urine flow measurement
0.61
0.23
0.21
0.23
0.21
0.05
0.89
0.87
0.89
0.87
00051736
TC
A
Urine flow measurement
0.00
0.68
0.46
0.68
0.46
0.01
0.69
0.47
0.69
0.47
00051741

A
Electro-uroflowmetry, first
1.14
1.27
0.91
1.27
0.91
0.11
2.52
2.16
2.52
2.16
00051741
26
A
Electro-uroflowmetry, first
1.14
0.44
0.39
0.44
0.39
0.09
1.67
1.62
1.67
1.62
00051741
TC
A
Electro-uroflowmetry, first
0.00
0.83
0.52
0.83
0.52
0.02
0.85
0.54
0.85
0.54
00051772

A
Urethra pressure profile
1.61
5.09
5.45
5.09
5.45
0.20
6.90
7.26
6.90
7.26
00051772
26
A
Urethra pressure profile
1.61
0.55
0.55
0.55
0.55
0.15
2.31
2.31
2.31
2.31
00051772
TC
A
Urethra pressure profile
0.00
4.54
4.91
4.54
4.91
0.05
4.59
4.96
4.59
4.96
00051784

A
Anal/urinary muscle study
1.53
3.85
3.95
3.85
3.95
0.16
5.54
5.64
5.54
5.64
00051784
26
A
Anal/urinary muscle study
1.53
0.52
0.51
0.52
0.51
0.12
2.17
2.16
2.17
2.16
00051784
TC
A
Anal/urinary muscle study
0.00
3.33
3.44
3.33
3.44
0.04
3.37
3.48
3.37
3.48
00051785

A
Anal/urinary muscle study
1.53
4.54
4.47
4.54
4.47
0.15
6.22
6.15
6.22
6.15
00051785
26
A
Anal/urinary muscle study
1.53
0.56
0.52
0.56
0.52
0.11
2.20
2.16
2.20
2.16
00051785
TC
A
Anal/urinary muscle study
0.00
3.97
3.95
3.97
3.95
0.04
4.01
3.99
4.01
3.99
00051792

A
Urinary reflex study
1.10
5.01
5.75
5.01
5.75
0.20
6.31
7.05
6.31
7.05
00051792
26
A
Urinary reflex study
1.10
0.40
0.41
0.40
0.41
0.07
1.57
1.58
1.57
1.58
00051792
TC
A
Urinary reflex study
0.00
4.61
5.34
4.61
5.34
0.13
4.74
5.47
4.74
5.47
00051795

A
Urine voiding pressure study
1.53
6.78
7.16
6.78
7.16
0.22
8.53
8.91
8.53
8.91
00051795
26
A
Urine voiding pressure study
1.53
0.58
0.52
0.58
0.52
0.12
2.23
2.17
2.23
2.17
00051795
TC
A
Urine voiding pressure study
0.00
6.21
6.65
6.21
6.65
0.10
6.31
6.75
6.31
6.75
00051797

A
Intraabdominal pressure test
1.60
4.88
5.56
4.88
5.56
0.17
6.65
7.33
6.65
7.33
00051797
26
A
Intraabdominal pressure test
1.60
0.60
0.55
0.60
0.55
0.12
2.32
2.27
2.32
2.27
00051797
TC
A
Intraabdominal pressure test
0.00
4.28
5.01
4.28
5.01
0.05
4.33
5.06
4.33
5.06
00051798

A
Us urine capacity measure
0.00
0.60
0.41
NA
NA
0.08
0.68
0.49
NA
NA
XXX51800

A
Revision of bladder/urethra
18.68
NA
NA
10.11
8.20
1.32
NA
NA
30.11
28.20
09051820

A
Revision of urinary tract
19.34
NA
NA
10.54
8.85
1.74
NA
NA
31.62
29.93
09051840

A
Attach bladder/urethra
11.23
NA
NA
5.81
5.62
1.06
NA
NA
18.10
17.91
09051841

A
Attach bladder/urethra
13.55
NA
NA
6.85
6.49
1.24
NA
NA
21.64
21.28
09051845

A
Repair bladder neck
10.02
NA
NA
5.88
5.03
0.79
NA
NA
16.69
15.84
09051860

A
Repair of bladder wound
12.42
NA
NA
6.83
6.02
1.16
NA
NA
20.41
19.60
09051865

A
Repair of bladder wound
15.62
NA
NA
8.47
7.12
1.23
NA
NA
25.32
23.97
09051880

A
Repair of bladder opening
7.77
NA
NA
4.73
4.15
0.72
NA
NA
13.22
12.64
09051900

A
Repair bladder/vagina lesion
14.42
NA
NA
8.04
6.56
1.21
NA
NA
23.67
22.19
09051920

A
Close bladder-uterus fistula
13.20
NA
NA
7.77
6.17
1.18
NA
NA
22.15
20.55
09051925

A
Hysterectomy/bladder repair
17.28
NA
NA
10.27
9.03
2.03
NA
NA
29.58
28.34
09051940

A
Correction of bladder defect
30.41
NA
NA
11.41
11.91
2.14
NA
NA
43.96
44.46
09051960

A
Revision of bladder & bowel
25.12
NA
NA
13.18
10.52
1.63
NA
NA
39.93
37.27
09051980

A
Construct bladder opening
12.39
NA
NA
7.29
5.85
0.86
NA
NA
20.54
19.10
09051990

A
Laparo urethral suspension
13.22
NA
NA
5.99
6.10
1.39
NA
NA
20.60
20.71
09051992

A
Laparo sling operation
14.73
NA
NA
6.65
6.31
1.41
NA
NA
22.79
22.45
09051999

C
Laparoscope proc, bladder
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY52000

A
Cystoscopy
2.23
3.70
3.40
1.33
0.90
0.14
6.07
5.77
3.70
3.27
00052001

A
Cystoscopy, removal of clots
5.44
5.14
5.09
2.62
2.05
0.39
10.97
10.92
8.45
7.88
00052005

A
Cystoscopy & ureter catheter
2.37
5.79
5.62
1.39
1.02
0.17
8.33
8.16
3.93
3.56
00052007

A
Cystoscopy and biopsy
3.02
10.83
15.04
1.64
1.27
0.22
14.07
18.28
4.88
4.51
00052010

A
Cystoscopy & duct catheter
3.02
8.20
10.11
1.65
1.28
0.21
11.43
13.34
4.88
4.51
00052204

A
Cystoscopy
2.59
8.39
12.98
1.40
1.03
0.17
11.15
15.74
4.16
3.79
00052214

A
Cystoscopy and treatment
3.70
20.07
33.59
1.86
1.46
0.26
24.03
37.55
5.82
5.42
00052224

A
Cystoscopy and treatment
3.14
19.25
32.15
1.63
1.27
0.22
22.61
35.51
4.99
4.63
00052234

A
Cystoscopy and treatment
4.62
NA
NA
2.31
1.82
0.33
NA
NA
7.26
6.77
00052235

A
Cystoscopy and treatment
5.44
NA
NA
2.68
2.12
0.39
NA
NA
8.51
7.95
00052240

A
Cystoscopy and treatment
9.71
NA
NA
4.42
3.58
0.69
NA
NA
14.82
13.98
00052250

A
Cystoscopy and radiotracer
4.49
NA
NA
2.35
1.83
0.32
NA
NA
7.16
6.64
00052260

A
Cystoscopy and treatment
3.91
NA
NA
1.97
1.56
0.28
NA
NA
6.16
5.75
00052265

A
Cystoscopy and treatment
2.94
7.74
11.94
1.53
1.22
0.22
10.90
15.10
4.69
4.38
00052270

A
Cystoscopy & revise urethra
3.36
7.08
10.04
1.77
1.37
0.24
10.68
13.64
5.37
4.97
00052275

A
Cystoscopy & revise urethra
4.69
9.39
14.01
2.31
1.82
0.33
14.41
19.03
7.33
6.84
00052276

A
Cystoscopy and treatment
4.99
NA
NA
2.48
1.96
0.35
NA
NA
7.82
7.30
00052277

A
Cystoscopy and treatment
6.16
NA
NA
2.91
2.39
0.44
NA
NA
9.51
8.99
00052281

A
Cystoscopy and treatment
2.80
5.34
6.65
1.56
1.20
0.20
8.34
9.65
4.56
4.20
00052282

A
Cystoscopy, implant stent
6.39
NA
NA
3.01
2.43
0.45
NA
NA
9.85
9.27
00052283

A
Cystoscopy and treatment
3.73
4.14
3.99
1.90
1.51
0.26
8.13
7.98
5.89
5.50
00052285

A
Cystoscopy and treatment
3.60
4.40
4.11
1.87
1.47
0.26
8.26
7.97
5.73
5.33
00052290

A
Cystoscopy and treatment
4.58
NA
NA
2.30
1.81
0.32
NA
NA
7.20
6.71
00052300

A
Cystoscopy and treatment
5.30
NA
NA
2.65
2.09
0.38
NA
NA
8.33
7.77
00052301

A
Cystoscopy and treatment
5.50
NA
NA
2.13
2.02
0.46
NA
NA
8.09
7.98
000( print page 49154)52305

A
Cystoscopy and treatment
5.30
NA
NA
2.53
2.02
0.38
NA
NA
8.21
7.70
00052310

A
Cystoscopy and treatment
2.81
4.05
4.53
1.45
1.14
0.20
7.06
7.54
4.46
4.15
00052315

A
Cystoscopy and treatment
5.20
6.70
8.17
2.51
2.00
0.37
12.27
13.74
8.08
7.57
00052317

A
Remove bladder stone
6.71
17.25
26.02
3.04
2.47
0.48
24.44
33.21
10.23
9.66
00052318

A
Remove bladder stone
9.18
NA
NA
4.11
3.35
0.65
NA
NA
13.94
13.18
00052320

A
Cystoscopy and treatment
4.69
NA
NA
2.24
1.78
0.33
NA
NA
7.26
6.80
00052325

A
Cystoscopy, stone removal
6.15
NA
NA
2.86
2.30
0.44
NA
NA
9.45
8.89
00052327

A
Cystoscopy, inject material
5.18
17.98
28.35
2.36
1.95
0.37
23.53
33.90
7.91
7.50
00052330

A
Cystoscopy and treatment
5.03
20.61
34.27
2.38
1.91
0.36
26.00
39.66
7.77
7.30
00052332

A
Cystoscopy and treatment
2.83
12.54
7.44
1.58
1.18
0.21
15.58
10.48
4.62
4.22
00052334

A
Create passage to kidney
4.82
NA
NA
2.34
1.88
0.35
NA
NA
7.51
7.05
00052341

A
Cysto w/ureter stricture tx
5.99
NA
NA
3.04
2.42
0.43
NA
NA
9.46
8.84
00052342

A
Cysto w/up stricture tx
6.49
NA
NA
3.26
2.57
0.46
NA
NA
10.21
9.52
00052343

A
Cysto w/renal stricture tx
7.19
NA
NA
3.54
2.82
0.51
NA
NA
11.24
10.52
00052344

A
Cysto/uretero, stricture tx
7.69
NA
NA
3.91
3.07
0.55
NA
NA
12.15
11.31
00052345

A
Cysto/uretero w/up stricture
8.19
NA
NA
4.12
3.24
0.58
NA
NA
12.89
12.01
00052346

A
Cystouretero w/renal strict
9.22
NA
NA
4.52
3.59
0.65
NA
NA
14.39
13.46
00052351

A
Cystouretero & or pyeloscope
5.85
NA
NA
3.00
2.36
0.41
NA
NA
9.26
8.62
00052352

A
Cystouretero w/stone remove
6.87
NA
NA
3.52
2.76
0.49
NA
NA
10.88
10.12
00052353

A
Cystouretero w/lithotripsy
7.96
NA
NA
3.96
3.13
0.57
NA
NA
12.49
11.66
00052354

A
Cystouretero w/biopsy
7.33
NA
NA
3.71
2.93
0.52
NA
NA
11.56
10.78
00052355

A
Cystouretero w/excise tumor
8.81
NA
NA
4.30
3.43
0.63
NA
NA
13.74
12.87
00052400

A
Cystouretero w/congen repr
10.04
NA
NA
5.47
4.17
0.68
NA
NA
16.19
14.89
09052402

A
Cystourethro cut ejacul duct
5.27
NA
NA
2.20
1.83
0.40
NA
NA
7.87
7.50
00052450

A
Incision of prostate
7.63
NA
NA
5.56
4.14
0.54
NA
NA
13.73
12.31
09052500

A
Revision of bladder neck
9.33
NA
NA
6.24
4.50
0.60
NA
NA
16.17
14.43
09052510

A
Dilation prostatic urethra
7.45
NA
NA
4.95
3.57
0.48
NA
NA
12.88
11.50
09052601

A
Prostatectomy (TURP)
15.07
NA
NA
8.54
5.96
0.87
NA
NA
24.48
21.90
09052606

A
Control postop bleeding
8.80
NA
NA
5.57
4.06
0.57
NA
NA
14.94
13.43
09052612

A
Prostatectomy, first stage
9.02
NA
NA
5.94
4.28
0.56
NA
NA
15.52
13.86
09052614

A
Prostatectomy, second stage
7.76
NA
NA
5.44
3.87
0.48
NA
NA
13.68
12.11
09052620

A
Remove residual prostate
7.16
NA
NA
4.64
3.40
0.47
NA
NA
12.27
11.03
09052630

A
Remove prostate regrowth
7.61
NA
NA
4.85
3.61
0.51
NA
NA
12.97
11.73
09052640

A
Relieve bladder contracture
6.85
NA
NA
4.45
3.33
0.47
NA
NA
11.77
10.65
09052647

A
Laser surgery of prostate
11.09
42.33
66.04
6.97
5.14
0.73
54.15
77.86
18.79
16.96
09052648

A
Laser surgery of prostate
11.94
42.86
66.17
7.30
5.42
0.79
55.59
78.90
20.03
18.15
09052700

A
Drainage of prostate abscess
7.35
NA
NA
5.00
3.64
0.48
NA
NA
12.83
11.47
09053000

A
Incision of urethra
2.28
NA
NA
1.81
1.61
0.16
NA
NA
4.25
4.05
01053010

A
Incision of urethra
4.31
NA
NA
3.83
3.14
0.24
NA
NA
8.38
7.69
09053020

A
Incision of urethra
1.77
NA
NA
0.96
0.74
0.13
NA
NA
2.86
2.64
00053025

A
Incision of urethra
1.13
NA
NA
0.68
0.55
0.08
NA
NA
1.89
1.76
00053040

A
Drainage of urethra abscess
6.45
NA
NA
4.45
3.69
0.45
NA
NA
11.35
10.59
09053060

A
Drainage of urethra abscess
2.63
2.01
2.06
1.47
1.40
0.28
4.92
4.97
4.38
4.31
01053080

A
Drainage of urinary leakage
6.78
NA
NA
4.94
5.70
0.52
NA
NA
12.24
13.00
09053085

A
Drainage of urinary leakage
11.00
NA
NA
4.54
6.69
0.92
NA
NA
16.46
18.60
09053200

A
Biopsy of urethra
2.59
1.71
1.42
1.30
1.06
0.20
4.50
4.21
4.09
3.85
00053210

A
Removal of urethra
13.54
NA
NA
7.80
6.32
0.89
NA
NA
22.23
20.75
09053215

A
Removal of urethra
16.67
NA
NA
9.22
7.27
1.10
NA
NA
26.99
25.04
09053220

A
Treatment of urethra lesion
7.49
NA
NA
5.04
4.04
0.49
NA
NA
13.02
12.02
09053230

A
Removal of urethra lesion
10.26
NA
NA
6.49
5.16
0.73
NA
NA
17.48
16.15
09053235

A
Removal of urethra lesion
10.81
NA
NA
6.96
5.42
0.72
NA
NA
18.49
16.95
09053240

A
Surgery for urethra pouch
6.94
NA
NA
4.80
3.84
0.52
NA
NA
12.26
11.30
09053250

A
Removal of urethra gland
6.38
NA
NA
4.72
3.65
0.49
NA
NA
11.59
10.52
09053260

A
Treatment of urethra lesion
2.98
2.48
2.30
1.86
1.53
0.25
5.71
5.53
5.09
4.76
01053265

A
Treatment of urethra lesion
3.12
2.98
2.78
2.02
1.57
0.24
6.34
6.14
5.38
4.93
01053270

A
Removal of urethra gland
3.09
2.31
2.23
1.72
1.59
0.30
5.70
5.62
5.11
4.98
010( print page 49155)53275

A
Repair of urethra defect
4.52
NA
NA
2.79
2.39
0.32
NA
NA
7.63
7.23
01053400

A
Revise urethra, stage 1
13.92
NA
NA
8.23
6.57
0.98
NA
NA
23.13
21.47
09053405

A
Revise urethra, stage 2
15.45
NA
NA
8.96
6.97
1.10
NA
NA
25.51
23.52
09053410

A
Reconstruction of urethra
17.47
NA
NA
9.84
7.75
1.16
NA
NA
28.47
26.38
09053415

A
Reconstruction of urethra
20.49
NA
NA
11.00
8.25
1.37
NA
NA
32.86
30.11
09053420

A
Reconstruct urethra, stage 1
14.99
NA
NA
6.51
6.34
0.96
NA
NA
22.46
22.29
09053425

A
Reconstruct urethra, stage 2
16.89
NA
NA
9.30
7.49
1.13
NA
NA
27.32
25.51
09053430

A
Reconstruction of urethra
17.25
NA
NA
8.73
7.43
1.15
NA
NA
27.13
25.83
09053431

A
Reconstruct urethra/bladder
20.97
NA
NA
11.08
8.81
1.41
NA
NA
33.46
31.19
09053440

A
Male sling procedure
15.33
NA
NA
9.31
6.81
0.96
NA
NA
25.60
23.10
09053442

A
Remove/revise male sling
13.28
NA
NA
8.50
6.20
0.82
NA
NA
22.60
20.30
09053444

A
Insert tandem cuff
14.00
NA
NA
8.09
6.43
0.94
NA
NA
23.03
21.37
09053445

A
Insert uro/ves nck sphincter
15.15
NA
NA
8.86
7.53
0.99
NA
NA
25.00
23.67
09053446

A
Remove uro sphincter
10.83
NA
NA
7.10
5.68
0.72
NA
NA
18.65
17.23
09053447

A
Remove/replace ur sphincter
14.09
NA
NA
8.48
6.94
0.95
NA
NA
23.52
21.98
09053448

A
Remov/replc ur sphinctr comp
23.20
NA
NA
12.52
9.91
1.50
NA
NA
37.22
34.61
09053449

A
Repair uro sphincter
10.38
NA
NA
6.70
5.22
0.68
NA
NA
17.76
16.28
09053450

A
Revision of urethra
6.63
NA
NA
4.81
3.67
0.43
NA
NA
11.87
10.73
09053460

A
Revision of urethra
7.61
NA
NA
5.17
4.06
0.50
NA
NA
13.28
12.17
09053500

A
Urethrlys, transvag w/scope
12.81
NA
NA
7.47
6.52
0.90
NA
NA
21.18
20.23
09053502

A
Repair of urethra injury
8.12
NA
NA
5.06
4.25
0.62
NA
NA
13.80
12.99
09053505

A
Repair of urethra injury
8.12
NA
NA
5.45
4.26
0.54
NA
NA
14.11
12.92
09053510

A
Repair of urethra injury
10.78
NA
NA
6.78
5.57
0.74
NA
NA
18.30
17.08
09053515

A
Repair of urethra injury
14.04
NA
NA
7.89
6.41
1.05
NA
NA
22.98
21.50
09053520

A
Repair of urethra defect
9.30
NA
NA
6.17
4.90
0.61
NA
NA
16.08
14.81
09053600

A
Dilate urethra stricture
1.21
1.16
1.15
0.57
0.47
0.09
2.46
2.45
1.87
1.77
00053601

A
Dilate urethra stricture
0.98
1.38
1.30
0.53
0.41
0.07
2.43
2.35
1.58
1.46
00053605

A
Dilate urethra stricture
1.28
NA
NA
0.52
0.44
0.09
NA
NA
1.89
1.81
00053620

A
Dilate urethra stricture
1.62
1.72
1.92
0.84
0.65
0.11
3.45
3.65
2.57
2.38
00053621

A
Dilate urethra stricture
1.35
1.83
2.01
0.68
0.54
0.10
3.28
3.46
2.13
1.99
00053660

A
Dilation of urethra
0.71
1.33
1.32
0.46
0.35
0.05
2.09
2.08
1.22
1.11
00053661

A
Dilation of urethra
0.72
1.31
1.30
0.42
0.32
0.05
2.08
2.07
1.19
1.09
00053665

A
Dilation of urethra
0.76
NA
NA
0.27
0.26
0.06
NA
NA
1.09
1.08
00053850

A
Prostatic microwave thermotx
9.94
49.68
82.97
5.94
4.44
0.67
60.29
93.58
16.55
15.05
09053852

A
Prostatic rf thermotx
10.62
46.82
78.28
6.74
4.96
0.70
58.14
89.60
18.06
16.28
09053853

A
Prostatic water thermother
5.48
29.37
48.85
4.39
3.24
0.37
35.22
54.70
10.24
9.09
09053899

C
Urology surgery procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY54000

A
Slitting of prepuce
1.54
2.72
2.86
1.49
1.07
0.11
4.37
4.51
3.14
2.72
01054001

A
Slitting of prepuce
2.19
3.07
3.15
1.67
1.25
0.15
5.41
5.49
4.01
3.59
01054015

A
Drain penis lesion
5.31
NA
NA
3.22
2.72
0.38
NA
NA
8.91
8.41
01054050

A
Destruction, penis lesion(s)
1.24
2.05
1.76
1.35
1.11
0.08
3.37
3.08
2.67
2.43
01054055

A
Destruction, penis lesion(s)
1.22
1.97
1.67
1.23
0.91
0.08
3.27
2.97
2.53
2.21
01054056

A
Cryosurgery, penis lesion(s)
1.24
2.29
1.84
1.48
1.22
0.06
3.59
3.14
2.78
2.52
01054057

A
Laser surg, penis lesion(s)
1.24
2.61
2.31
1.36
0.96
0.09
3.94
3.64
2.69
2.29
01054060

A
Excision of penis lesion(s)
1.93
3.11
3.10
1.64
1.21
0.13
5.17
5.16
3.70
3.27
01054065

A
Destruction, penis lesion(s)
2.42
3.22
2.78
1.94
1.41
0.13
5.77
5.33
4.49
3.96
01054100

A
Biopsy of penis
1.90
3.30
2.93
1.34
0.95
0.10
5.30
4.93
3.34
2.95
00054105

A
Biopsy of penis
3.49
4.03
4.22
2.47
2.07
0.25
7.77
7.96
6.21
5.81
01054110

A
Treatment of penis lesion
10.74
NA
NA
6.58
5.21
0.72
NA
NA
18.03
16.67
09054111

A
Treat penis lesion, graft
14.24
NA
NA
8.13
6.35
0.96
NA
NA
23.33
21.55
09054112

A
Treat penis lesion, graft
16.77
NA
NA
9.42
7.45
1.11
NA
NA
27.30
25.33
09054115

A
Treatment of penis lesion
6.77
5.87
4.75
5.03
3.85
0.43
13.07
11.95
12.23
11.05
09054120

A
Partial removal of penis
10.83
NA
NA
6.81
5.21
0.68
NA
NA
18.32
16.72
09054125

A
Removal of penis
14.38
NA
NA
8.25
6.43
0.95
NA
NA
23.58
21.76
09054130

A
Remove penis & nodes
21.59
NA
NA
11.40
8.98
1.52
NA
NA
34.51
32.09
09054135

A
Remove penis & nodes
27.92
NA
NA
14.31
11.20
1.87
NA
NA
44.10
40.99
09054150

A
Circumcision
1.81
2.56
3.90
0.57
0.67
0.16
4.53
5.87
2.54
2.64
00054152

A
Circumcision
2.31
NA
NA
1.72
1.33
0.19
NA
NA
4.22
3.83
01054160

A
Circumcision
2.48
3.69
4.03
1.45
1.18
0.19
6.36
6.70
4.12
3.85
01054161

A
Circumcision
3.27
NA
NA
2.22
1.73
0.23
NA
NA
5.72
5.23
01054162

A
Lysis penil circumic lesion
3.25
4.02
4.49
2.27
1.65
0.21
7.48
7.95
5.73
5.11
01054163

A
Repair of circumcision
3.25
NA
NA
2.89
2.22
0.21
NA
NA
6.35
5.68
01054164

A
Frenulotomy of penis
2.75
NA
NA
2.65
2.04
0.18
NA
NA
5.58
4.97
01054200

A
Treatment of penis lesion
1.06
2.03
1.85
1.31
1.06
0.08
3.17
2.99
2.45
2.20
01054205

A
Treatment of penis lesion
8.79
NA
NA
6.12
5.04
0.56
NA
NA
15.47
14.39
09054220

A
Treatment of penis lesion
2.42
3.35
3.72
1.37
1.06
0.17
5.94
6.31
3.96
3.65
000( print page 49156)54230

A
Prepare penis study
1.34
1.41
1.16
0.91
0.70
0.09
2.84
2.59
2.34
2.13
00054231

A
Dynamic cavernosometry
2.04
1.87
1.50
1.18
0.95
0.16
4.07
3.70
3.38
3.15
00054235

A
Penile injection
1.19
1.40
1.07
0.90
0.66
0.08
2.67
2.34
2.17
1.93
00054240

A
Penis study
1.31
1.55
1.16
1.55
1.16
0.17
3.03
2.64
3.03
2.64
00054240
26
A
Penis study
1.31
0.50
0.45
0.50
0.45
0.11
1.92
1.87
1.92
1.87
00054240
TC
A
Penis study
0.00
1.05
0.71
1.05
0.71
0.06
1.11
0.77
1.11
0.77
00054250

A
Penis study
2.22
1.25
1.00
1.25
1.00
0.18
3.65
3.40
3.65
3.40
00054250
26
A
Penis study
2.22
0.88
0.75
0.88
0.75
0.16
3.26
3.13
3.26
3.13
00054250
TC
A
Penis study
0.00
0.37
0.24
0.37
0.24
0.02
0.39
0.26
0.39
0.26
00054300

A
Revision of penis
11.02
NA
NA
6.80
5.87
0.76
NA
NA
18.58
17.65
09054304

A
Revision of penis
13.10
NA
NA
7.89
6.71
0.88
NA
NA
21.87
20.69
09054308

A
Reconstruction of urethra
12.44
NA
NA
7.58
6.36
0.84
NA
NA
20.86
19.64
09054312

A
Reconstruction of urethra
14.30
NA
NA
8.58
7.38
1.24
NA
NA
24.12
22.92
09054316

A
Reconstruction of urethra
17.84
NA
NA
10.07
8.47
1.21
NA
NA
29.12
27.52
09054318

A
Reconstruction of urethra
12.22
NA
NA
6.25
5.90
1.39
NA
NA
19.86
19.51
09054322

A
Reconstruction of urethra
13.80
NA
NA
7.94
6.82
0.92
NA
NA
22.66
21.54
09054324

A
Reconstruction of urethra
17.34
NA
NA
9.83
8.42
1.14
NA
NA
28.31
26.90
09054326

A
Reconstruction of urethra
16.81
NA
NA
9.65
8.24
1.11
NA
NA
27.57
26.16
09054328

A
Revise penis/urethra
16.68
NA
NA
9.73
7.86
0.98
NA
NA
27.39
25.52
09054332

A
Revise penis/urethra
18.16
NA
NA
10.20
8.34
1.21
NA
NA
29.57
27.71
09054336

A
Revise penis/urethra
21.37
NA
NA
11.88
10.68
2.20
NA
NA
35.45
34.25
09054340

A
Secondary urethral surgery
9.53
NA
NA
6.43
5.38
0.63
NA
NA
16.58
15.54
09054344

A
Secondary urethral surgery
16.85
NA
NA
9.79
8.25
1.54
NA
NA
28.18
26.64
09054348

A
Secondary urethral surgery
18.11
NA
NA
6.40
7.86
1.23
NA
NA
25.74
27.20
09054352

A
Reconstruct urethra/penis
25.88
NA
NA
13.72
11.81
2.24
NA
NA
41.84
39.93
09054360

A
Penis plastic surgery
12.60
NA
NA
7.54
6.40
0.84
NA
NA
20.98
19.84
09054380

A
Repair penis
13.97
NA
NA
5.59
6.35
0.93
NA
NA
20.49
21.25
09054385

A
Repair penis
16.31
NA
NA
8.37
8.28
0.86
NA
NA
25.54
25.45
09054390

A
Repair penis and bladder
22.52
NA
NA
7.49
8.92
1.54
NA
NA
31.55
32.98
09054400

A
Insert semi-rigid prosthesis
9.04
NA
NA
5.80
4.71
0.64
NA
NA
15.48
14.39
09054401

A
Insert self-contd prosthesis
10.26
NA
NA
8.26
6.36
0.73
NA
NA
19.25
17.35
09054405

A
Insert multi-comp penis pros
14.34
NA
NA
8.22
6.49
0.95
NA
NA
23.51
21.78
09054406

A
Remove muti-comp penis pros
12.70
NA
NA
7.70
5.98
0.86
NA
NA
21.26
19.54
09054408

A
Repair multi-comp penis pros
13.67
NA
NA
8.31
6.37
0.90
NA
NA
22.88
20.94
09054410

A
Remove/replace penis prosth
16.42
NA
NA
9.45
7.32
1.10
NA
NA
26.97
24.84
09054411

A
Remov/replc penis pros, comp
18.06
NA
NA
10.50
7.90
1.13
NA
NA
29.69
27.09
09054415

A
Remove self-contd penis pros
8.69
NA
NA
6.06
4.66
0.58
NA
NA
15.33
13.93
09054416

A
Remv/repl penis contain pros
11.79
NA
NA
7.96
6.01
0.77
NA
NA
20.52
18.57
09054417

A
Remv/replc penis pros, compl
15.88
NA
NA
9.22
6.93
1.00
NA
NA
26.10
23.81
09054420

A
Revision of penis
12.21
NA
NA
7.61
6.07
0.81
NA
NA
20.63
19.08
09054430

A
Revision of penis
10.88
NA
NA
6.99
5.57
0.72
NA
NA
18.58
17.17
09054435

A
Revision of penis
6.67
NA
NA
4.98
3.95
0.43
NA
NA
12.08
11.05
09054440

C
Repair of penis
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
09054450

A
Preputial stretching
1.12
0.86
0.93
0.49
0.45
0.08
2.06
2.13
1.69
1.65
00054500

A
Biopsy of testis
1.31
NA
NA
0.80
0.62
0.10
NA
NA
2.21
2.03
00054505

A
Biopsy of testis
3.45
NA
NA
2.41
2.04
0.27
NA
NA
6.13
5.76
01054512

A
Excise lesion testis
9.19
NA
NA
5.72
4.52
0.67
NA
NA
15.58
14.38
09054520

A
Removal of testis
5.22
NA
NA
3.76
3.03
0.50
NA
NA
9.48
8.75
09054522

A
Orchiectomy, partial
10.11
NA
NA
5.80
5.10
0.89
NA
NA
16.80
16.10
09054530

A
Removal of testis
9.26
NA
NA
6.13
4.71
0.66
NA
NA
16.05
14.63
09054535

A
Extensive testis surgery
13.01
NA
NA
7.59
6.05
0.95
NA
NA
21.55
20.01
09054550

A
Exploration for testis
8.27
NA
NA
5.38
4.20
0.59
NA
NA
14.24
13.06
09054560

A
Exploration for testis
11.92
NA
NA
6.32
5.44
0.90
NA
NA
19.14
18.26
09054600

A
Reduce testis torsion
7.50
NA
NA
5.18
3.95
0.51
NA
NA
13.19
11.96
09054620

A
Suspension of testis
5.14
NA
NA
3.28
2.64
0.37
NA
NA
8.79
8.15
01054640

A
Suspension of testis
7.53
NA
NA
5.50
4.17
0.62
NA
NA
13.65
12.32
090( print page 49157)54650

A
Orchiopexy (Fowler-Stephens)
12.18
NA
NA
7.72
5.97
1.16
NA
NA
21.06
19.31
09054660

A
Revision of testis
5.60
NA
NA
4.44
3.35
0.44
NA
NA
10.48
9.39
09054670

A
Repair testis injury
6.52
NA
NA
4.84
3.86
0.47
NA
NA
11.83
10.85
09054680

A
Relocation of testis(es)
13.86
NA
NA
7.78
6.55
1.16
NA
NA
22.80
21.57
09054690

A
Laparoscopy, orchiectomy
11.56
NA
NA
6.20
5.25
1.02
NA
NA
18.78
17.83
09054692

A
Laparoscopy, orchiopexy
13.60
NA
NA
7.66
5.98
1.30
NA
NA
22.56
20.88
09054699

C
Laparoscope proc, testis
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY54700

A
Drainage of scrotum
3.42
NA
NA
2.40
2.05
0.28
NA
NA
6.10
5.75
01054800

A
Biopsy of epididymis
2.33
NA
NA
1.00
0.93
0.23
NA
NA
3.56
3.49
00054820

A
Exploration of epididymis
5.63
NA
NA
4.32
3.28
0.40
NA
NA
10.35
9.31
09054830

A
Remove epididymis lesion
5.87
NA
NA
4.48
3.38
0.41
NA
NA
10.76
9.66
09054840

A
Remove epididymis lesion
5.19
NA
NA
3.84
3.04
0.37
NA
NA
9.40
8.60
09054860

A
Removal of epididymis
6.81
NA
NA
4.92
3.71
0.45
NA
NA
12.18
10.97
09054861

A
Removal of epididymis
9.52
NA
NA
6.32
4.81
0.63
NA
NA
16.47
14.96
09054900

A
Fusion of spermatic ducts
13.99
NA
NA
5.29
5.66
0.93
NA
NA
20.21
20.58
09054901

A
Fusion of spermatic ducts
18.85
NA
NA
6.64
7.29
1.82
NA
NA
27.31
27.96
09055000

A
Drainage of hydrocele
1.43
1.86
2.01
0.92
0.72
0.11
3.40
3.55
2.46
2.26
00055040

A
Removal of hydrocele
5.35
NA
NA
3.98
3.16
0.43
NA
NA
9.76
8.94
09055041

A
Removal of hydroceles
8.36
NA
NA
5.74
4.41
0.60
NA
NA
14.70
13.37
09055060

A
Repair of hydrocele
6.01
NA
NA
4.47
3.42
0.46
NA
NA
10.94
9.89
09055100

A
Drainage of scrotum abscess
2.38
3.52
3.63
2.12
1.70
0.17
6.07
6.18
4.67
4.25
01055110

A
Explore scrotum
6.19
NA
NA
4.52
3.47
0.43
NA
NA
11.14
10.09
09055120

A
Removal of scrotum lesion
5.58
NA
NA
4.30
3.28
0.39
NA
NA
10.27
9.25
09055150

A
Removal of scrotum
7.96
NA
NA
5.49
4.25
0.56
NA
NA
14.01
12.77
09055175

A
Revision of scrotum
5.73
NA
NA
4.38
3.35
0.37
NA
NA
10.48
9.45
09055180

A
Revision of scrotum
11.57
NA
NA
7.32
5.84
0.90
NA
NA
19.79
18.31
09055200

A
Incision of sperm duct
4.48
8.27
11.30
3.38
2.62
0.33
13.08
16.11
8.19
7.43
09055250

A
Removal of sperm duct(s)
3.29
7.74
10.54
3.00
2.41
0.25
11.28
14.08
6.54
5.95
09055300

A
Prepare, sperm duct x-ray
3.50
NA
NA
1.63
1.39
0.25
NA
NA
5.38
5.14
00055400

A
Repair of sperm duct
8.48
NA
NA
5.50
4.41
0.64
NA
NA
14.62
13.53
09055450

A
Ligation of sperm duct
4.36
6.00
6.74
2.86
2.11
0.29
10.65
11.39
7.51
6.76
01055500

A
Removal of hydrocele
6.08
NA
NA
4.26
3.38
0.55
NA
NA
10.89
10.01
09055520

A
Removal of sperm cord lesion
6.52
NA
NA
3.86
3.40
0.75
NA
NA
11.13
10.67
09055530

A
Revise spermatic cord veins
5.65
NA
NA
4.16
3.29
0.45
NA
NA
10.26
9.39
09055535

A
Revise spermatic cord veins
7.05
NA
NA
4.88
3.76
0.47
NA
NA
12.40
11.28
09055540

A
Revise hernia & sperm veins
8.16
NA
NA
4.32
3.92
0.94
NA
NA
13.42
13.02
09055550

A
Laparo ligate spermatic vein
7.06
NA
NA
4.58
3.61
0.57
NA
NA
12.21
11.24
09055559

C
Laparo proc, spermatic cord
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY55600

A
Incise sperm duct pouch
6.87
NA
NA
4.95
3.73
0.62
NA
NA
12.44
11.22
09055605

A
Incise sperm duct pouch
8.58
NA
NA
4.94
4.45
0.64
NA
NA
14.16
13.67
09055650

A
Remove sperm duct pouch
12.47
NA
NA
7.31
5.77
0.92
NA
NA
20.70
19.16
09055680

A
Remove sperm pouch lesion
5.56
NA
NA
3.90
3.20
0.47
NA
NA
9.93
9.23
09055700

A
Biopsy of prostate
2.58
3.75
4.08
1.34
0.82
0.11
6.44
6.77
4.03
3.51
00055705

A
Biopsy of prostate
4.56
NA
NA
2.89
2.44
0.32
NA
NA
7.77
7.32
01055720

A
Drainage of prostate abscess
7.63
NA
NA
4.84
4.07
0.95
NA
NA
13.42
12.65
09055725

A
Drainage of prostate abscess
9.84
NA
NA
6.41
4.96
0.70
NA
NA
16.95
15.50
09055801

A
Removal of prostate
19.55
NA
NA
10.68
8.37
1.34
NA
NA
31.57
29.26
09055810

A
Extensive prostate surgery
24.08
NA
NA
12.49
9.81
1.60
NA
NA
38.17
35.49
09055812

A
Extensive prostate surgery
29.61
NA
NA
15.07
11.99
2.04
NA
NA
46.72
43.64
09055815

A
Extensive prostate surgery
32.67
NA
NA
16.50
13.03
2.16
NA
NA
51.33
47.86
09055821

A
Removal of prostate
15.58
NA
NA
8.79
6.84
1.01
NA
NA
25.38
23.43
09055831

A
Removal of prostate
17.01
NA
NA
9.37
7.32
1.10
NA
NA
27.48
25.43
09055840

A
Extensive prostate surgery
24.38
NA
NA
12.82
10.15
1.61
NA
NA
38.81
36.14
09055842

A
Extensive prostate surgery
26.24
NA
NA
13.67
10.78
1.72
NA
NA
41.63
38.74
09055845

A
Extensive prostate surgery
30.46
NA
NA
14.90
11.91
2.02
NA
NA
47.38
44.39
09055859

A
Percut/needle insert, pros
13.25
NA
NA
7.90
6.35
0.89
NA
NA
22.04
20.49
09055860

A
Surgical exposure, prostate
15.66
NA
NA
8.73
6.98
1.02
NA
NA
25.41
23.66
09055862

A
Extensive prostate surgery
19.83
NA
NA
10.84
8.58
1.49
NA
NA
32.16
29.90
09055865

A
Extensive prostate surgery
24.32
NA
NA
12.97
10.17
1.63
NA
NA
38.92
36.12
09055866

A
Laparo radical prostatectomy
32.17
NA
NA
16.15
12.81
2.16
NA
NA
50.48
47.14
09055870

A
Electroejaculation
2.58
2.47
1.77
1.44
1.17
0.16
5.21
4.51
4.18
3.91
00055873

A
Cryoablate prostate
20.19
NA
NA
11.44
9.56
1.38
NA
NA
33.01
31.13
09055899

C
Genital surgery procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY56405

A
I & D of vulva/perineum
1.44
1.18
1.29
1.16
1.15
0.17
2.79
2.90
2.77
2.76
01056420

A
Drainage of gland abscess
1.39
1.52
2.08
0.78
0.98
0.16
3.07
3.63
2.33
2.53
01056440

A
Surgery for vulva lesion
2.84
NA
NA
1.54
1.67
0.34
NA
NA
4.72
4.85
010( print page 49158)56441

A
Lysis of labial lesion(s)
1.97
1.71
1.79
1.56
1.45
0.20
3.88
3.96
3.73
3.62
01056501

A
Destroy, vulva lesions, sim
1.53
1.64
1.75
1.22
1.24
0.18
3.35
3.46
2.93
2.95
01056515

A
Destroy vulva lesion/s compl
3.01
2.37
2.50
1.73
1.79
0.33
5.71
5.84
5.07
5.13
01056605

A
Biopsy of vulva/perineum
1.10
0.91
1.03
0.35
0.43
0.13
2.14
2.26
1.58
1.66
00056606

A
Biopsy of vulva/perineum
0.55
0.36
0.46
0.16
0.21
0.07
0.98
1.08
0.78
0.83
ZZZ56620

A
Partial removal of vulva
8.39
NA
NA
4.41
4.70
0.90
NA
NA
13.70
13.99
09056625

A
Complete removal of vulva
9.50
NA
NA
4.77
5.18
1.02
NA
NA
15.28
15.70
09056630

A
Extensive vulva surgery
14.62
NA
NA
6.28
6.69
1.49
NA
NA
22.39
22.80
09056631

A
Extensive vulva surgery
18.75
NA
NA
7.74
8.54
1.95
NA
NA
28.44
29.24
09056632

A
Extensive vulva surgery
21.51
NA
NA
9.30
9.46
2.38
NA
NA
33.19
33.35
09056633

A
Extensive vulva surgery
19.41
NA
NA
7.79
8.39
1.97
NA
NA
29.17
29.77
09056634

A
Extensive vulva surgery
20.42
NA
NA
8.18
9.11
2.16
NA
NA
30.76
31.69
09056637

A
Extensive vulva surgery
24.51
NA
NA
9.20
10.60
2.60
NA
NA
36.31
37.71
09056640

A
Extensive vulva surgery
24.60
NA
NA
9.07
10.23
2.88
NA
NA
36.55
37.71
09056700

A
Partial removal of hymen
2.77
NA
NA
1.77
1.82
0.30
NA
NA
4.84
4.89
01056720

A
Incision of hymen
0.68
NA
NA
0.52
0.51
0.08
NA
NA
1.28
1.27
00056740

A
Remove vagina gland lesion
4.81
NA
NA
2.32
2.50
0.56
NA
NA
7.69
7.87
01056800

A
Repair of vagina
3.88
NA
NA
2.00
2.14
0.44
NA
NA
6.32
6.46
01056805

A
Repair clitoris
19.69
NA
NA
9.28
9.38
2.14
NA
NA
31.11
31.21
09056810

A
Repair of perineum
4.24
NA
NA
2.06
2.23
0.49
NA
NA
6.79
6.96
01056820

A
Exam of vulva w/scope
1.50
1.20
1.28
0.53
0.62
0.18
2.88
2.96
2.21
2.30
00056821

A
Exam/biopsy of vulva w/scope
2.05
1.55
1.70
0.69
0.86
0.25
3.85
4.00
2.99
3.16
00057000

A
Exploration of vagina
2.97
NA
NA
1.72
1.72
0.31
NA
NA
5.00
5.00
01057010

A
Drainage of pelvic abscess
6.70
NA
NA
3.85
3.81
0.71
NA
NA
11.26
11.22
09057020

A
Drainage of pelvic fluid
1.50
0.76
0.90
0.45
0.56
0.18
2.44
2.58
2.13
2.24
00057022

A
I & d vaginal hematoma, pp
2.68
NA
NA
1.44
1.48
0.26
NA
NA
4.38
4.42
01057023

A
I & d vag hematoma, non-ob
5.11
NA
NA
2.40
2.53
0.58
NA
NA
8.09
8.22
01057061

A
Destroy vag lesions, simple
1.25
1.52
1.62
1.12
1.12
0.15
2.92
3.02
2.52
2.52
01057065

A
Destroy vag lesions, complex
2.61
2.03
2.23
1.49
1.63
0.31
4.95
5.15
4.41
4.55
01057100

A
Biopsy of vagina
1.20
0.93
1.04
0.37
0.45
0.14
2.27
2.38
1.71
1.79
00057105

A
Biopsy of vagina
1.69
1.59
1.74
1.34
1.40
0.20
3.48
3.63
3.23
3.29
01057106

A
Remove vagina wall, partial
7.29
NA
NA
4.26
4.20
0.73
NA
NA
12.28
12.22
09057107

A
Remove vagina tissue, part
24.37
NA
NA
9.11
10.12
2.71
NA
NA
36.19
37.20
09057109

A
Vaginectomy partial w/nodes
28.19
NA
NA
10.34
11.02
3.21
NA
NA
41.74
42.42
09057110

A
Remove vagina wall, complete
15.34
NA
NA
6.27
7.02
1.73
NA
NA
23.34
24.09
09057111

A
Remove vagina tissue, compl
28.19
NA
NA
10.26
12.02
3.17
NA
NA
41.62
43.38
09057112

A
Vaginectomy w/nodes, compl
30.31
NA
NA
11.58
11.96
3.07
NA
NA
44.96
45.34
09057120

A
Closure of vagina
8.14
NA
NA
4.21
4.50
0.89
NA
NA
13.24
13.53
09057130

A
Remove vagina lesion
2.43
1.99
2.11
1.49
1.53
0.29
4.71
4.83
4.21
4.25
01057135

A
Remove vagina lesion
2.67
2.03
2.20
1.54
1.62
0.31
5.01
5.18
4.52
4.60
01057150

A
Treat vagina infection
0.55
0.58
0.97
0.16
0.20
0.07
1.20
1.59
0.78
0.82
00057155

A
Insert uteri tandems/ovoids
6.75
NA
NA
3.11
4.20
0.43
NA
NA
10.29
11.38
09057160

A
Insert pessary/other device
0.89
1.05
1.02
0.26
0.32
0.10
2.04
2.01
1.25
1.31
00057170

A
Fitting of diaphragm/cap
0.91
0.57
1.25
0.25
0.31
0.11
1.59
2.27
1.27
1.33
00057180

A
Treat vaginal bleeding
1.58
1.85
2.08
0.92
1.18
0.19
3.62
3.85
2.69
2.95
01057200

A
Repair of vagina
4.31
NA
NA
2.95
2.91
0.46
NA
NA
7.72
7.68
09057210

A
Repair vagina/perineum
5.60
NA
NA
3.28
3.39
0.62
NA
NA
9.50
9.61
09057220

A
Revision of urethra
4.74
NA
NA
3.03
3.08
0.51
NA
NA
8.28
8.33
09057230

A
Repair of urethral lesion
6.19
NA
NA
3.78
3.50
0.54
NA
NA
10.51
10.23
09057240

A
Repair bladder & vagina
11.38
NA
NA
5.47
4.23
0.62
NA
NA
17.47
16.23
09057250

A
Repair rectum & vagina
11.38
NA
NA
5.04
3.94
0.65
NA
NA
17.07
15.97
09057260

A
Repair of vagina
14.32
NA
NA
5.86
5.09
0.97
NA
NA
21.15
20.38
09057265

A
Extensive repair of vagina
15.82
NA
NA
6.33
6.11
1.32
NA
NA
23.47
23.25
09057267

A
Insert mesh/pelvic flr addon
4.88
NA
NA
1.52
1.86
0.64
NA
NA
7.04
7.38
ZZZ57268

A
Repair of bowel bulge
7.43
NA
NA
4.31
4.22
0.79
NA
NA
12.53
12.44
09057270

A
Repair of bowel pouch
13.53
NA
NA
5.71
6.11
1.42
NA
NA
20.66
21.06
090( print page 49159)57280

A
Suspension of vagina
16.58
NA
NA
7.02
7.28
1.67
NA
NA
25.27
25.53
09057282

A
Colpopexy, extraperitoneal
7.79
NA
NA
4.43
4.48
1.02
NA
NA
13.24
13.29
09057283

A
Colpopexy, intraperitoneal
11.54
NA
NA
5.24
5.74
1.02
NA
NA
17.80
18.30
09057284

A
Repair paravaginal defect
13.43
NA
NA
6.77
7.05
1.41
NA
NA
21.61
21.89
09057287

A
Revise/remove sling repair
11.43
NA
NA
6.47
5.72
0.90
NA
NA
18.80
18.05
09057288

A
Repair bladder defect
13.95
NA
NA
7.09
6.20
1.12
NA
NA
22.16
21.27
09057289

A
Repair bladder & vagina
12.63
NA
NA
6.23
6.08
1.21
NA
NA
20.07
19.92
09057291

A
Construction of vagina
8.50
NA
NA
4.39
4.79
0.93
NA
NA
13.82
14.22
09057292

A
Construct vagina with graft
13.87
NA
NA
5.99
6.70
1.58
NA
NA
21.44
22.15
09057295

A
Change vaginal graft
7.70
NA
NA
3.77
4.27
0.91
NA
NA
12.38
12.88
09057300

A
Repair rectum-vagina fistula
8.53
NA
NA
4.48
4.33
0.87
NA
NA
13.88
13.73
09057305

A
Repair rectum-vagina fistula
15.18
NA
NA
6.20
6.25
1.72
NA
NA
23.10
23.15
09057307

A
Fistula repair & colostomy
16.96
NA
NA
7.04
7.00
2.01
NA
NA
26.01
25.97
09057308

A
Fistula repair, transperine
10.42
NA
NA
4.88
5.04
1.14
NA
NA
16.44
16.60
09057310

A
Repair urethrovaginal lesion
7.51
NA
NA
5.05
4.14
0.54
NA
NA
13.10
12.19
09057311

A
Repair urethrovaginal lesion
8.77
NA
NA
5.16
4.37
0.65
NA
NA
14.58
13.79
09057320

A
Repair bladder-vagina lesion
8.74
NA
NA
5.34
4.61
0.69
NA
NA
14.77
14.04
09057330

A
Repair bladder-vagina lesion
13.07
NA
NA
7.18
6.07
1.06
NA
NA
21.31
20.20
09057335

A
Repair vagina
19.81
NA
NA
8.80
8.97
1.91
NA
NA
30.52
30.69
09057400

A
Dilation of vagina
2.27
NA
NA
0.99
1.08
0.26
NA
NA
3.52
3.61
00057410

A
Pelvic examination
1.75
NA
NA
0.92
0.90
0.18
NA
NA
2.85
2.83
00057415

A
Remove vaginal foreign body
2.42
NA
NA
1.51
1.44
0.24
NA
NA
4.17
4.10
01057420

A
Exam of vagina w/scope
1.60
1.24
1.32
0.57
0.65
0.19
3.03
3.11
2.36
2.44
00057421

A
Exam/biopsy of vag w/scope
2.20
1.60
1.78
0.73
0.90
0.27
4.07
4.25
3.20
3.37
00057425

A
Laparoscopy, surg, colpopexy
16.89
NA
NA
7.00
6.72
1.75
NA
NA
25.64
25.36
09057452

A
Exam of cervix w/scope
1.50
1.19
1.26
0.75
0.76
0.18
2.87
2.94
2.43
2.44
00057454

A
Bx/curett of cervix w/scope
2.33
1.41
1.58
0.97
1.11
0.28
4.02
4.19
3.58
3.72
00057455

A
Biopsy of cervix w/scope
1.99
1.51
1.67
0.67
0.82
0.24
3.74
3.90
2.90
3.05
00057456

A
Endocerv curettage w/scope
1.85
1.47
1.61
0.63
0.77
0.22
3.54
3.68
2.70
2.84
00057460

A
Bx of cervix w/scope, leep
2.83
4.33
5.46
1.11
1.31
0.34
7.50
8.63
4.28
4.48
00057461

A
Conz of cervix w/scope, leep
3.43
4.63
5.73
1.08
1.37
0.41
8.47
9.57
4.92
5.21
00057500

A
Biopsy of cervix
1.20
2.03
2.41
0.65
0.64
0.12
3.35
3.73
1.97
1.96
00057505

A
Endocervical curettage
1.14
1.32
1.43
1.07
1.09
0.14
2.60
2.71
2.35
2.37
01057510

A
Cauterization of cervix
1.90
1.32
1.50
0.91
1.01
0.23
3.45
3.63
3.04
3.14
01057511

A
Cryocautery of cervix
1.90
1.61
1.77
1.27
1.35
0.23
3.74
3.90
3.40
3.48
01057513

A
Laser surgery of cervix
1.90
1.57
1.68
1.28
1.37
0.23
3.70
3.81
3.41
3.50
01057520

A
Conization of cervix
4.03
3.39
3.80
2.52
2.78
0.49
7.91
8.32
7.04
7.30
09057522

A
Conization of cervix
3.60
2.79
3.06
2.27
2.41
0.41
6.80
7.07
6.28
6.42
09057530

A
Removal of cervix
5.16
NA
NA
3.12
3.32
0.58
NA
NA
8.86
9.06
09057531

A
Removal of cervix, radical
29.71
NA
NA
10.66
12.54
3.34
NA
NA
43.71
45.59
09057540

A
Removal of residual cervix
13.15
NA
NA
5.61
6.08
1.49
NA
NA
20.25
20.72
09057545

A
Remove cervix/repair pelvis
13.96
NA
NA
6.23
6.56
1.52
NA
NA
21.71
22.04
09057550

A
Removal of residual cervix
6.20
NA
NA
3.65
3.78
0.67
NA
NA
10.52
10.65
09057555

A
Remove cervix/repair vagina
9.80
NA
NA
4.80
5.01
1.09
NA
NA
15.69
15.90
09057556

A
Remove cervix, repair bowel
9.22
NA
NA
4.68
4.81
0.92
NA
NA
14.82
14.95
09057700

A
Revision of cervix
4.17
NA
NA
3.31
3.15
0.41
NA
NA
7.89
7.73
09057720

A
Revision of cervix
4.50
NA
NA
2.92
3.06
0.49
NA
NA
7.91
8.05
09057800

A
Dilation of cervical canal
0.77
0.71
0.75
0.42
0.46
0.09
1.57
1.61
1.28
1.32
00057820

A
D & c of residual cervix
1.67
1.35
1.44
1.05
1.12
0.20
3.22
3.31
2.92
2.99
01058100

A
Biopsy of uterus lining
1.53
1.14
1.28
0.59
0.69
0.18
2.85
2.99
2.30
2.40
00058110

A
Bx done w/colposcopy add-on
0.77
0.40
0.51
0.21
0.29
0.09
1.26
1.37
1.07
1.15
ZZZ58120

A
Dilation and curettage
3.52
2.72
2.41
1.67
1.82
0.39
6.63
6.32
5.58
5.73
01058140

A
Myomectomy abdom method
15.65
NA
NA
6.25
6.89
1.81
NA
NA
23.71
24.35
09058145

A
Myomectomy vag method
8.77
NA
NA
4.28
4.66
0.97
NA
NA
14.02
14.40
09058146

A
Myomectomy abdom complex
20.20
NA
NA
7.36
8.59
2.32
NA
NA
29.88
31.11
09058150

A
Total hysterectomy
17.17
NA
NA
6.59
7.26
1.84
NA
NA
25.60
26.27
09058152

A
Total hysterectomy
21.68
NA
NA
8.18
9.43
2.47
NA
NA
32.33
33.58
09058180

A
Partial hysterectomy
16.46
NA
NA
6.38
7.18
1.64
NA
NA
24.48
25.28
09058200

A
Extensive hysterectomy
22.96
NA
NA
8.15
9.53
2.54
NA
NA
33.65
35.03
09058210

A
Extensive hysterectomy
30.70
NA
NA
10.71
12.57
3.37
NA
NA
44.78
46.64
09058240

A
Removal of pelvis contents
43.13
NA
NA
15.92
17.19
4.22
NA
NA
63.27
64.54
09058260

A
Vaginal hysterectomy
13.98
NA
NA
5.83
6.48
1.57
NA
NA
21.38
22.03
09058262

A
Vag hyst including t/o
15.77
NA
NA
6.31
7.11
1.79
NA
NA
23.87
24.67
09058263

A
Vag hyst w/t/o & vag repair
17.06
NA
NA
6.67
7.58
1.94
NA
NA
25.67
26.58
09058267

A
Vag hyst w/urinary repair
18.18
NA
NA
7.06
8.04
2.06
NA
NA
27.30
28.28
09058270

A
Vag hyst w/enterocele repair
15.16
NA
NA
5.99
6.79
1.73
NA
NA
22.88
23.68
090( print page 49160)58275

A
Hysterectomy/revise vagina
16.85
NA
NA
6.70
7.50
1.91
NA
NA
25.46
26.26
09058280

A
Hysterectomy/revise vagina
18.15
NA
NA
7.08
7.96
2.06
NA
NA
27.28
28.17
09058285

A
Extensive hysterectomy
23.26
NA
NA
7.96
9.45
2.70
NA
NA
33.92
35.41
09058290

A
Vag hyst complex
20.13
NA
NA
7.44
8.70
2.29
NA
NA
29.86
31.12
09058291

A
Vag hyst incl t/o, complex
21.92
NA
NA
7.87
9.37
2.52
NA
NA
32.31
33.81
09058292

A
Vag hyst t/o & repair, compl
23.21
NA
NA
8.34
9.86
2.67
NA
NA
34.22
35.74
09058293

A
Vag hyst w/uro repair, compl
24.19
NA
NA
8.55
10.13
2.78
NA
NA
35.52
37.10
09058294

A
Vag hyst w/enterocele, compl
21.41
NA
NA
7.22
8.97
2.39
NA
NA
31.02
32.77
09058300

N
Insert intrauterine device
1.01
0.63
1.22
0.24
0.35
0.12
1.76
2.35
1.37
1.48
XXX58301

A
Remove intrauterine device
1.27
1.06
1.26
0.35
0.45
0.15
2.48
2.68
1.77
1.87
00058321

A
Artificial insemination
0.92
0.98
1.11
0.25
0.34
0.10
2.00
2.13
1.27
1.36
00058322

A
Artificial insemination
1.10
1.05
1.16
0.31
0.39
0.13
2.28
2.39
1.54
1.62
00058323

A
Sperm washing
0.23
0.15
0.44
0.07
0.09
0.03
0.41
0.70
0.33
0.35
00058340

A
Catheter for hysterography
0.88
2.17
2.91
0.57
0.63
0.09
3.14
3.88
1.54
1.60
00058345

A
Reopen fallopian tube
4.65
NA
NA
2.08
2.34
0.41
NA
NA
7.14
7.40
01058346

A
Insert heyman uteri capsule
7.44
NA
NA
3.34
3.78
0.56
NA
NA
11.34
11.78
09058350

A
Reopen fallopian tube
1.01
1.34
1.45
0.87
0.91
0.12
2.47
2.58
2.00
2.04
01058353

A
Endometr ablate, thermal
3.55
23.12
32.53
1.72
1.97
0.43
27.10
36.51
5.70
5.95
01058356

A
Endometrial cryoablation
6.36
43.78
57.02
1.86
2.48
0.82
50.96
64.20
9.04
9.66
01058400

A
Suspension of uterus
7.03
NA
NA
3.85
3.91
0.75
NA
NA
11.63
11.69
09058410

A
Suspension of uterus
13.66
NA
NA
5.91
6.30
1.45
NA
NA
21.02
21.41
09058520

A
Repair of ruptured uterus
13.34
NA
NA
5.48
5.89
1.47
NA
NA
20.29
20.70
09058540

A
Revision of uterus
15.57
NA
NA
6.25
6.78
1.78
NA
NA
23.60
24.13
09058545

A
Laparoscopic myomectomy
15.65
NA
NA
6.03
6.89
1.77
NA
NA
23.45
24.31
09058546

A
Laparo-myomectomy, complex
20.20
NA
NA
7.26
8.50
2.30
NA
NA
29.76
31.00
09058550

A
Laparo-asst vag hysterectomy
14.91
NA
NA
6.20
7.02
1.72
NA
NA
22.83
23.65
09058552

A
Laparo-vag hyst incl t/o
16.23
NA
NA
6.49
7.63
1.72
NA
NA
24.44
25.58
09058553

A
Laparo-vag hyst, complex
20.13
NA
NA
7.24
8.49
2.30
NA
NA
29.67
30.92
09058554

A
Laparo-vag hyst w/t/o, compl
23.13
NA
NA
8.41
9.90
2.27
NA
NA
33.81
35.30
09058555

A
Hysteroscopy, dx, sep proc
3.33
2.76
2.33
1.25
1.48
0.40
6.49
6.06
4.98
5.21
00058558

A
Hysteroscopy, biopsy
4.74
3.63
2.54
1.68
2.05
0.57
8.94
7.85
6.99
7.36
00058559

A
Hysteroscopy, lysis
6.16
NA
NA
2.07
2.57
0.74
NA
NA
8.97
9.47
00058560

A
Hysteroscopy, resect septum
6.99
NA
NA
2.31
2.89
0.84
NA
NA
10.14
10.72
00058561

A
Hysteroscopy, remove myoma
9.99
NA
NA
3.16
4.00
1.21
NA
NA
14.36
15.20
00058562

A
Hysteroscopy, remove fb
5.20
3.53
2.65
1.78
2.21
0.63
9.36
8.48
7.61
8.04
00058563

A
Hysteroscopy, ablation
6.16
37.70
51.57
2.08
2.58
0.74
44.60
58.47
8.98
9.48
00058565

A
Hysteroscopy, sterilization
7.02
34.73
45.85
3.39
3.77
1.19
42.94
54.06
11.60
11.98
09058578

C
Laparo proc, uterus
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY58579

C
Hysteroscope procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY58600

A
Division of fallopian tube
5.84
NA
NA
2.94
3.23
0.66
NA
NA
9.44
9.73
09058605

A
Division of fallopian tube
5.23
NA
NA
2.69
3.01
0.59
NA
NA
8.51
8.83
09058611

A
Ligate oviduct(s) add-on
1.45
NA
NA
0.40
0.53
0.18
NA
NA
2.03
2.16
ZZZ58615

A
Occlude fallopian tube(s)
3.89
NA
NA
2.00
2.53
0.47
NA
NA
6.36
6.89
01058660

A
Laparoscopy, lysis
11.52
NA
NA
4.56
5.08
1.40
NA
NA
17.48
18.00
09058661

A
Laparoscopy, remove adnexa
11.28
NA
NA
4.04
4.85
1.34
NA
NA
16.66
17.47
01058662

A
Laparoscopy, excise lesions
12.06
NA
NA
4.83
5.54
1.43
NA
NA
18.32
19.03
09058670

A
Laparoscopy, tubal cautery
5.84
NA
NA
2.98
3.20
0.67
NA
NA
9.49
9.71
09058671

A
Laparoscopy, tubal block
5.84
NA
NA
2.97
3.20
0.68
NA
NA
9.49
9.72
09058672

A
Laparoscopy, fimbrioplasty
12.86
NA
NA
4.79
5.83
1.60
NA
NA
19.25
20.29
09058673

A
Laparoscopy, salpingostomy
13.97
NA
NA
5.23
6.24
1.69
NA
NA
20.89
21.90
09058679

C
Laparo proc, oviduct-ovary
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY58700

A
Removal of fallopian tube
12.80
NA
NA
5.56
5.88
1.51
NA
NA
19.87
20.19
09058720

A
Removal of ovary/tube(s)
12.04
NA
NA
5.13
5.61
1.39
NA
NA
18.56
19.04
09058740

A
Revise fallopian tube(s)
14.75
NA
NA
6.11
6.88
1.71
NA
NA
22.57
23.34
09058750

A
Repair oviduct
15.52
NA
NA
6.14
7.06
1.84
NA
NA
23.50
24.42
09058752

A
Revise ovarian tube(s)
15.52
NA
NA
6.04
6.72
1.80
NA
NA
23.36
24.04
090( print page 49161)58760

A
Remove tubal obstruction
13.81
NA
NA
5.66
6.45
1.79
NA
NA
21.26
22.05
09058770

A
Create new tubal opening
14.65
NA
NA
5.81
6.63
1.73
NA
NA
22.19
23.01
09058800

A
Drainage of ovarian cyst(s)
4.51
3.20
3.53
2.68
2.85
0.43
8.14
8.47
7.62
7.79
09058805

A
Drainage of ovarian cyst(s)
6.31
NA
NA
3.49
3.50
0.69
NA
NA
10.49
10.50
09058820

A
Drain ovary abscess, open
4.59
NA
NA
2.89
3.19
0.52
NA
NA
8.00
8.30
09058822

A
Drain ovary abscess, percut
11.67
NA
NA
5.18
5.20
1.16
NA
NA
18.01
18.03
09058823

A
Drain pelvic abscess, percut
3.37
20.10
21.02
1.04
1.10
0.24
23.71
24.63
4.65
4.71
00058825

A
Transposition, ovary(s)
11.66
NA
NA
4.98
5.59
1.32
NA
NA
17.96
18.57
09058900

A
Biopsy of ovary(s)
6.48
NA
NA
3.49
3.55
0.69
NA
NA
10.66
10.72
09058920

A
Partial removal of ovary(s)
11.84
NA
NA
5.24
5.49
1.43
NA
NA
18.51
18.76
09058925

A
Removal of ovarian cyst(s)
12.29
NA
NA
5.31
5.59
1.41
NA
NA
19.01
19.29
09058940

A
Removal of ovary(s)
8.08
NA
NA
4.07
4.09
0.91
NA
NA
13.06
13.08
09058943

A
Removal of ovary(s)
19.38
NA
NA
7.25
8.29
2.22
NA
NA
28.85
29.89
09058950

A
Resect ovarian malignancy
18.18
NA
NA
7.29
8.12
2.04
NA
NA
27.51
28.34
09058951

A
Resect ovarian malignancy
24.11
NA
NA
8.61
9.98
2.63
NA
NA
35.35
36.72
09058952

A
Resect ovarian malignancy
27.09
NA
NA
9.81
11.27
3.02
NA
NA
39.92
41.38
09058953

A
Tah, rad dissect for debulk
33.91
NA
NA
11.63
13.81
3.83
NA
NA
49.37
51.55
09058954

A
Tah rad debulk/lymph remove
36.91
NA
NA
12.49
14.90
4.17
NA
NA
53.57
55.98
09058956

A
Bso, omentectomy w/tah
22.59
NA
NA
8.59
9.88
4.00
NA
NA
35.18
36.47
09058960

A
Exploration of abdomen
15.64
NA
NA
6.29
7.09
1.79
NA
NA
23.72
24.52
09058970

A
Retrieval of oocyte
3.52
1.83
2.19
1.26
1.43
0.43
5.78
6.14
5.21
5.38
00058974

C
Transfer of embryo
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
00058976

A
Transfer of embryo
3.82
1.96
2.50
1.22
1.67
0.47
6.25
6.79
5.51
5.96
00058999

C
Genital surgery procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY59000

A
Amniocentesis, diagnostic
1.30
1.75
1.99
0.56
0.64
0.31
3.36
3.60
2.17
2.25
00059001

A
Amniocentesis, therapeutic
3.00
NA
NA
1.09
1.33
0.71
NA
NA
4.80
5.04
00059012

A
Fetal cord puncture,prenatal
3.44
NA
NA
1.16
1.45
0.82
NA
NA
5.42
5.71
00059015

A
Chorion biopsy
2.20
1.43
1.52
0.81
0.98
0.52
4.15
4.24
3.53
3.70
00059020

A
Fetal contract stress test
0.66
1.08
0.86
1.08
0.86
0.26
2.00
1.78
2.00
1.78
00059020
26
A
Fetal contract stress test
0.66
0.19
0.24
0.19
0.24
0.16
1.01
1.06
1.01
1.06
00059020
TC
A
Fetal contract stress test
0.00
0.90
0.62
0.90
0.62
0.10
1.00
0.72
1.00
0.72
00059025

A
Fetal non-stress test
0.53
0.63
0.49
0.63
0.49
0.15
1.31
1.17
1.31
1.17
00059025
26
A
Fetal non-stress test
0.53
0.15
0.20
0.15
0.20
0.13
0.81
0.86
0.81
0.86
00059025
TC
A
Fetal non-stress test
0.00
0.49
0.30
0.49
0.30
0.02
0.51
0.32
0.51
0.32
00059030

A
Fetal scalp blood sample
1.99
NA
NA
0.56
0.72
0.47
NA
NA
3.02
3.18
00059050

A
Fetal monitor w/report
0.89
NA
NA
0.26
0.33
0.21
NA
NA
1.36
1.43
XXX59051

A
Fetal monitor/interpret only
0.74
NA
NA
0.21
0.27
0.17
NA
NA
1.12
1.18
XXX59070

A
Transabdom amnioinfus w/us
5.24
4.48
4.98
1.83
2.19
0.28
10.00
10.50
7.35
7.71
00059072

A
Umbilical cord occlud w/us
8.99
NA
NA
2.88
3.06
0.16
NA
NA
12.03
12.21
00059074

A
Fetal fluid drainage w/us
5.24
3.91
4.41
1.71
2.16
0.28
9.43
9.93
7.23
7.68
00059076

A
Fetal shunt placement, w/us
8.99
NA
NA
2.42
2.95
0.16
NA
NA
11.57
12.10
00059100

A
Remove uterus lesion
13.22
NA
NA
5.80
6.29
2.94
NA
NA
21.96
22.45
09059120

A
Treat ectopic pregnancy
12.52
NA
NA
5.47
6.05
2.72
NA
NA
20.71
21.29
09059121

A
Treat ectopic pregnancy
12.60
NA
NA
5.42
6.10
2.78
NA
NA
20.80
21.48
09059130

A
Treat ectopic pregnancy
14.94
NA
NA
6.09
5.12
3.38
NA
NA
24.41
23.44
09059135

A
Treat ectopic pregnancy
14.78
NA
NA
5.12
6.70
3.30
NA
NA
23.20
24.78
09059136

A
Treat ectopic pregnancy
14.11
NA
NA
5.77
6.39
3.13
NA
NA
23.01
23.63
09059140

A
Treat ectopic pregnancy
5.83
NA
NA
2.91
2.39
1.29
NA
NA
10.03
9.51
09059150

A
Treat ectopic pregnancy
12.15
NA
NA
5.26
5.81
2.78
NA
NA
20.19
20.74
09059151

A
Treat ectopic pregnancy
11.97
NA
NA
4.93
5.77
2.73
NA
NA
19.63
20.47
09059160

A
D & c after delivery
2.71
2.00
2.97
1.19
1.90
0.64
5.35
6.32
4.54
5.25
01059200

A
Insert cervical dilator
0.79
0.95
1.13
0.22
0.28
0.19
1.93
2.11
1.20
1.26
00059300

A
Episiotomy or vaginal repair
2.41
2.21
2.18
1.03
0.98
0.57
5.19
5.16
4.01
3.96
00059320

A
Revision of cervix
2.48
NA
NA
1.02
1.19
0.59
NA
NA
4.09
4.26
00059325

A
Revision of cervix
4.06
NA
NA
1.24
1.73
0.88
NA
NA
6.18
6.67
00059350

A
Repair of uterus
4.94
NA
NA
1.41
1.76
1.17
NA
NA
7.52
7.87
00059400

A
Obstetrical care
26.53
NA
NA
14.36
15.08
5.48
NA
NA
46.37
47.09
MMM59409

A
Obstetrical care
13.48
NA
NA
3.76
4.92
3.21
NA
NA
20.45
21.61
MMM59410

A
Obstetrical care
15.26
NA
NA
4.97
5.97
3.51
NA
NA
23.74
24.74
MMM59412

A
Antepartum manipulation
1.71
NA
NA
0.65
0.77
0.40
NA
NA
2.76
2.88
MMM59414

A
Deliver placenta
1.61
NA
NA
0.44
0.59
0.38
NA
NA
2.43
2.58
MMM59425

A
Antepartum care only
6.12
4.25
4.21
1.68
1.81
1.14
11.51
11.47
8.94
9.07
MMM59426

A
Antepartum care only
10.84
7.82
7.61
2.97
3.16
1.97
20.63
20.42
15.78
15.97
MMM59430

A
Care after delivery
2.13
1.04
1.18
0.66
0.87
0.50
3.67
3.81
3.29
3.50
MMM59510

A
Cesarean delivery
30.05
NA
NA
16.03
16.95
6.23
NA
NA
52.31
53.23
MMM59514

A
Cesarean delivery only
15.95
NA
NA
4.51
5.79
3.79
NA
NA
24.25
25.53
MMM( print page 49162)59515

A
Cesarean delivery
18.21
NA
NA
6.25
7.44
4.12
NA
NA
28.58
29.77
MMM59525

A
Remove uterus after cesarean
8.53
NA
NA
2.40
3.08
1.94
NA
NA
12.87
13.55
ZZZ59610

A
Vbac delivery
27.95
NA
NA
14.66
15.56
5.85
NA
NA
48.46
49.36
MMM59612

A
Vbac delivery only
15.04
NA
NA
4.28
5.61
3.58
NA
NA
22.90
24.23
MMM59614

A
Vbac care after delivery
16.57
NA
NA
5.19
6.50
3.88
NA
NA
25.64
26.95
MMM59618

A
Attempted vbac delivery
31.48
NA
NA
16.38
17.77
6.59
NA
NA
54.45
55.84
MMM59620

A
Attempted vbac delivery only
17.50
NA
NA
4.80
6.27
4.16
NA
NA
26.46
27.93
MMM59622

A
Attempted vbac after care
19.64
NA
NA
6.69
8.15
4.49
NA
NA
30.82
32.28
MMM59812

A
Treatment of miscarriage
4.37
3.12
2.69
2.38
2.50
0.95
8.44
8.01
7.70
7.82
09059820

A
Care of miscarriage
4.64
4.10
4.34
3.49
3.54
0.95
9.69
9.93
9.08
9.13
09059821

A
Treatment of miscarriage
4.94
3.85
4.17
3.19
3.35
1.06
9.85
10.17
9.19
9.35
09059830

A
Treat uterus infection
6.48
NA
NA
3.47
3.85
1.44
NA
NA
11.39
11.77
09059840

R
Abortion
3.01
2.04
2.10
1.81
2.04
0.71
5.76
5.82
5.53
5.76
01059841

R
Abortion
5.55
3.19
3.42
2.61
2.88
1.24
9.98
10.21
9.40
9.67
01059850

R
Abortion
5.90
NA
NA
2.66
3.10
1.28
NA
NA
9.84
10.28
09059851

R
Abortion
5.92
NA
NA
3.33
3.64
1.28
NA
NA
10.53
10.84
09059852

R
Abortion
8.23
NA
NA
3.84
4.74
1.80
NA
NA
13.87
14.77
09059855

R
Abortion
6.36
NA
NA
3.00
3.41
1.45
NA
NA
10.81
11.22
09059856

R
Abortion
7.72
NA
NA
3.85
4.01
1.78
NA
NA
13.35
13.51
09059857

R
Abortion
9.28
NA
NA
3.17
4.33
2.01
NA
NA
14.46
15.62
09059866

R
Abortion (mpr)
3.99
NA
NA
1.26
1.73
0.87
NA
NA
6.12
6.59
00059870

A
Evacuate mole of uterus
6.32
NA
NA
4.31
4.44
1.42
NA
NA
12.05
12.18
09059871

A
Remove cerclage suture
2.13
NA
NA
0.94
1.08
0.50
NA
NA
3.57
3.71
00059897

C
Fetal invas px w/us
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY59898

C
Laparo proc, ob care/deliver
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY59899

C
Maternity care procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY60000

A
Drain thyroid/tongue cyst
1.76
2.06
1.96
1.67
1.70
0.15
3.97
3.87
3.58
3.61
01060001

A
Aspirate/inject thyriod cyst
0.97
1.93
1.54
0.28
0.32
0.07
2.97
2.58
1.32
1.36
00060100

A
Biopsy of thyroid
1.56
1.27
1.37
0.47
0.52
0.10
2.93
3.03
2.13
2.18
00060200

A
Remove thyroid lesion
9.84
NA
NA
5.20
5.79
1.01
NA
NA
16.05
16.64
09060210

A
Partial thyroid excision
11.11
NA
NA
5.04
5.48
1.23
NA
NA
17.38
17.82
09060212

A
Partial thyroid excision
16.26
NA
NA
6.55
7.39
1.94
NA
NA
24.75
25.59
09060220

A
Partial removal of thyroid
12.25
NA
NA
5.37
5.95
1.32
NA
NA
18.94
19.52
09060225

A
Partial removal of thyroid
14.59
NA
NA
6.65
7.21
1.64
NA
NA
22.88
23.44
09060240

A
Removal of thyroid
16.16
NA
NA
6.14
7.22
1.85
NA
NA
24.15
25.23
09060252

A
Removal of thyroid
21.82
NA
NA
8.38
9.66
2.29
NA
NA
32.49
33.77
09060254

A
Extensive thyroid surgery
28.23
NA
NA
10.28
13.18
2.60
NA
NA
41.11
44.01
09060260

A
Repeat thyroid surgery
18.14
NA
NA
6.96
8.22
1.93
NA
NA
27.03
28.29
09060270

A
Removal of thyroid
23.01
NA
NA
8.90
10.06
2.32
NA
NA
34.23
35.39
09060271

A
Removal of thyroid
17.50
NA
NA
6.77
8.13
1.74
NA
NA
26.01
27.37
09060280

A
Remove thyroid duct lesion
5.98
NA
NA
4.07
4.51
0.54
NA
NA
10.59
11.03
09060281

A
Remove thyroid duct lesion
8.64
NA
NA
4.63
5.53
0.73
NA
NA
14.00
14.90
09060500

A
Explore parathyroid glands
16.63
NA
NA
6.74
7.24
2.00
NA
NA
25.37
25.87
09060502

A
Re-explore parathyroids
20.92
NA
NA
8.47
9.13
2.53
NA
NA
31.92
32.58
09060505

A
Explore parathyroid glands
22.81
NA
NA
9.23
10.50
2.64
NA
NA
34.68
35.95
09060512

A
Autotransplant parathyroid
4.44
NA
NA
1.18
1.51
0.53
NA
NA
6.15
6.48
ZZZ60520

A
Removal of thymus gland
17.03
NA
NA
6.97
7.96
2.19
NA
NA
26.19
27.18
09060521

A
Removal of thymus gland
19.09
NA
NA
8.31
9.23
2.81
NA
NA
30.21
31.13
09060522

A
Removal of thymus gland
23.31
NA
NA
9.80
10.90
3.26
NA
NA
36.37
37.47
09060540

A
Explore adrenal gland
17.84
NA
NA
8.14
7.72
1.74
NA
NA
27.72
27.30
09060545

A
Explore adrenal gland
20.75
NA
NA
8.92
8.63
2.07
NA
NA
31.74
31.45
09060600

A
Remove carotid body lesion
24.95
NA
NA
8.78
10.42
2.19
NA
NA
35.92
37.56
09060605

A
Remove carotid body lesion
31.82
NA
NA
12.29
12.26
2.49
NA
NA
46.60
46.57
09060650

A
Laparoscopy adrenalectomy
20.59
NA
NA
8.20
8.04
2.28
NA
NA
31.07
30.91
09060659

C
Laparo proc, endocrine
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY60699

C
Endocrine surgery procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY( print page 49163)61000

A
Remove cranial cavity fluid
1.58
NA
NA
1.23
1.02
0.13
NA
NA
2.94
2.73
00061001

A
Remove cranial cavity fluid
1.49
NA
NA
1.20
1.10
0.16
NA
NA
2.85
2.75
00061020

A
Remove brain cavity fluid
1.51
NA
NA
1.58
1.40
0.34
NA
NA
3.43
3.25
00061026

A
Injection into brain canal
1.69
NA
NA
1.49
1.42
0.33
NA
NA
3.51
3.44
00061050

A
Remove brain canal fluid
1.51
NA
NA
1.13
1.24
0.11
NA
NA
2.75
2.86
00061055

A
Injection into brain canal
2.10
NA
NA
1.29
1.39
0.17
NA
NA
3.56
3.66
00061070

A
Brain canal shunt procedure
0.89
NA
NA
1.17
1.05
0.17
NA
NA
2.23
2.11
00061105

A
Twist drill hole
5.38
NA
NA
4.89
4.17
1.32
NA
NA
11.59
10.87
09061107

A
Drill skull for implantation
4.99
NA
NA
1.85
2.36
1.29
NA
NA
8.13
8.64
00061108

A
Drill skull for drainage
11.46
NA
NA
8.43
7.46
2.63
NA
NA
22.52
21.55
09061120

A
Burr hole for puncture
9.49
NA
NA
6.69
6.17
2.09
NA
NA
18.27
17.75
09061140

A
Pierce skull for biopsy
17.05
NA
NA
10.39
10.01
4.11
NA
NA
31.55
31.17
09061150

A
Pierce skull for drainage
18.76
NA
NA
10.73
10.46
4.31
NA
NA
33.80
33.53
09061151

A
Pierce skull for drainage
13.38
NA
NA
8.49
7.98
3.00
NA
NA
24.87
24.36
09061154

A
Pierce skull & remove clot
16.86
NA
NA
10.76
9.80
4.20
NA
NA
31.82
30.86
09061156

A
Pierce skull for drainage
17.34
NA
NA
9.88
9.84
4.22
NA
NA
31.44
31.40
09061210

A
Pierce skull, implant device
5.83
NA
NA
2.18
2.73
1.50
NA
NA
9.51
10.06
00061215

A
Insert brain-fluid device
5.74
NA
NA
5.44
4.36
1.26
NA
NA
12.44
11.36
09061250

A
Pierce skull & explore
11.38
NA
NA
7.49
7.01
2.76
NA
NA
21.63
21.15
09061253

A
Pierce skull & explore
13.38
NA
NA
7.80
7.74
2.61
NA
NA
23.79
23.73
09061304

A
Open skull for exploration
23.27
NA
NA
12.61
12.78
5.61
NA
NA
41.49
41.66
09061305

A
Open skull for exploration
28.46
NA
NA
15.07
15.25
6.07
NA
NA
49.60
49.78
09061312

A
Open skull for drainage
30.03
NA
NA
15.34
15.12
6.34
NA
NA
51.71
51.49
09061313

A
Open skull for drainage
27.88
NA
NA
15.48
14.97
6.43
NA
NA
49.79
49.28
09061314

A
Open skull for drainage
25.72
NA
NA
14.22
13.33
6.26
NA
NA
46.20
45.31
09061315

A
Open skull for drainage
29.47
NA
NA
15.56
15.90
7.14
NA
NA
52.17
52.51
09061316

A
Implt cran bone flap to abdo
1.39
NA
NA
0.52
0.58
0.35
NA
NA
2.26
2.32
ZZZ61320

A
Open skull for drainage
27.28
NA
NA
14.29
14.64
6.60
NA
NA
48.17
48.52
09061321

A
Open skull for drainage
30.35
NA
NA
14.29
15.66
7.12
NA
NA
51.76
53.13
09061322

A
Decompressive craniotomy
34.00
NA
NA
17.78
16.19
7.61
NA
NA
59.39
57.80
09061323

A
Decompressive lobectomy
34.87
NA
NA
17.00
16.31
8.01
NA
NA
59.88
59.19
09061330

A
Decompress eye socket
25.12
NA
NA
11.88
13.26
2.31
NA
NA
39.31
40.69
09061332

A
Explore/biopsy eye socket
28.46
NA
NA
13.45
15.06
4.82
NA
NA
46.73
48.34
09061333

A
Explore orbit/remove lesion
29.13
NA
NA
13.31
15.01
3.91
NA
NA
46.35
48.05
09061334

A
Explore orbit/remove object
19.46
NA
NA
9.11
10.25
1.74
NA
NA
30.31
31.45
09061340

A
Subtemporal decompression
19.97
NA
NA
11.40
11.19
4.83
NA
NA
36.20
35.99
09061343

A
Incise skull (press relief)
31.68
NA
NA
16.14
16.64
7.62
NA
NA
55.44
55.94
09061345

A
Relieve cranial pressure
29.05
NA
NA
15.24
15.35
7.02
NA
NA
51.31
51.42
09061440

A
Incise skull for surgery
28.48
NA
NA
14.06
14.17
6.88
NA
NA
49.42
49.53
09061450

A
Incise skull for surgery
27.55
NA
NA
12.70
13.89
5.77
NA
NA
46.02
47.21
09061458

A
Incise skull for brain wound
28.66
NA
NA
15.01
15.39
7.01
NA
NA
50.68
51.06
09061460

A
Incise skull for surgery
30.06
NA
NA
15.14
16.09
6.02
NA
NA
51.22
52.17
09061470

A
Incise skull for surgery
27.48
NA
NA
13.11
13.67
5.88
NA
NA
46.47
47.03
09061480

A
Incise skull for surgery
27.91
NA
NA
8.23
13.51
6.71
NA
NA
42.85
48.13
09061490

A
Incise skull for surgery
27.08
NA
NA
14.34
14.33
6.90
NA
NA
48.32
48.31
09061500

A
Removal of skull lesion
19.00
NA
NA
10.64
10.76
4.10
NA
NA
33.74
33.86
09061501

A
Remove infected skull bone
16.17
NA
NA
9.52
9.28
3.21
NA
NA
28.90
28.66
09061510

A
Removal of brain lesion
30.55
NA
NA
17.08
16.79
7.33
NA
NA
54.96
54.67
09061512

A
Remove brain lining lesion
36.93
NA
NA
18.56
19.39
9.05
NA
NA
64.54
65.37
09061514

A
Removal of brain abscess
27.05
NA
NA
14.53
14.46
6.52
NA
NA
48.10
48.03
09061516

A
Removal of brain lesion
26.40
NA
NA
14.28
14.27
6.33
NA
NA
47.01
47.00
09061517

A
Implt brain chemotx add-on
1.38
NA
NA
0.51
0.61
0.35
NA
NA
2.24
2.34
ZZZ61518

A
Removal of brain lesion
39.61
NA
NA
20.45
20.93
9.62
NA
NA
69.68
70.16
09061519

A
Remove brain lining lesion
43.22
NA
NA
20.82
22.19
10.60
NA
NA
74.64
76.01
09061520

A
Removal of brain lesion
56.81
NA
NA
25.64
29.15
11.18
NA
NA
93.63
97.14
09061521

A
Removal of brain lesion
46.78
NA
NA
22.16
23.70
11.36
NA
NA
80.30
81.84
09061522

A
Removal of brain abscess
31.36
NA
NA
15.56
16.20
7.60
NA
NA
54.52
55.16
09061524

A
Removal of brain lesion
29.71
NA
NA
15.78
15.69
7.14
NA
NA
52.63
52.54
09061526

A
Removal of brain lesion
53.84
NA
NA
21.66
27.53
7.05
NA
NA
82.55
88.42
09061530

A
Removal of brain lesion
45.38
NA
NA
18.18
23.33
6.13
NA
NA
69.69
74.84
09061531

A
Implant brain electrodes
16.24
NA
NA
10.26
9.41
3.78
NA
NA
30.28
29.43
09061533

A
Implant brain electrodes
21.32
NA
NA
11.76
11.59
5.10
NA
NA
38.18
38.01
09061534

A
Removal of brain lesion
22.83
NA
NA
13.21
12.36
5.42
NA
NA
41.46
40.61
09061535

A
Remove brain electrodes
13.01
NA
NA
8.93
7.80
3.01
NA
NA
24.95
23.82
09061536

A
Removal of brain lesion
37.54
NA
NA
18.46
19.45
9.18
NA
NA
65.18
66.17
09061537

A
Removal of brain tissue
36.31
NA
NA
17.52
15.44
6.92
NA
NA
60.75
58.67
090( print page 49164)61538

A
Removal of brain tissue
39.31
NA
NA
18.80
16.18
6.92
NA
NA
65.03
62.41
09061539

A
Removal of brain tissue
34.10
NA
NA
15.51
17.20
8.30
NA
NA
57.91
59.60
09061540

A
Removal of brain tissue
31.24
NA
NA
15.91
16.91
8.30
NA
NA
55.45
56.45
09061541

A
Incision of brain tissue
30.76
NA
NA
16.10
16.18
6.58
NA
NA
53.44
53.52
09061542

A
Removal of brain tissue
32.98
NA
NA
16.23
17.42
8.01
NA
NA
57.22
58.41
09061543

A
Removal of brain tissue
31.13
NA
NA
16.35
16.37
7.54
NA
NA
55.02
55.04
09061544

A
Remove & treat brain lesion
27.22
NA
NA
14.39
13.96
5.95
NA
NA
47.56
47.13
09061545

A
Excision of brain tumor
46.15
NA
NA
22.36
23.75
10.60
NA
NA
79.11
80.50
09061546

A
Removal of pituitary gland
33.26
NA
NA
16.62
17.27
7.65
NA
NA
57.53
58.17
09061548

A
Removal of pituitary gland
23.23
NA
NA
11.37
12.43
3.42
NA
NA
38.02
39.08
09061550

A
Release of skull seams
15.38
NA
NA
5.70
6.62
0.98
NA
NA
22.06
22.98
09061552

A
Release of skull seams
20.22
NA
NA
6.71
8.51
1.06
NA
NA
27.99
29.78
09061556

A
Incise skull/sutures
23.96
NA
NA
12.76
11.71
4.64
NA
NA
41.36
40.31
09061557

A
Incise skull/sutures
23.10
NA
NA
13.73
13.65
5.78
NA
NA
42.61
42.53
09061558

A
Excision of skull/sutures
26.29
NA
NA
8.24
12.70
1.36
NA
NA
35.89
40.35
09061559

A
Excision of skull/sutures
33.74
NA
NA
18.83
19.19
8.48
NA
NA
61.05
61.41
09061563

A
Excision of skull tumor
28.31
NA
NA
14.31
15.01
5.15
NA
NA
47.77
48.47
09061564

A
Excision of skull tumor
34.53
NA
NA
16.25
17.77
8.75
NA
NA
59.53
61.05
09061566

A
Removal of brain tissue
32.26
NA
NA
16.65
17.49
6.92
NA
NA
55.83
56.67
09061567

A
Incision of brain tissue
36.76
NA
NA
16.84
19.71
6.52
NA
NA
60.12
62.99
09061570

A
Remove foreign body, brain
26.33
NA
NA
14.16
13.97
5.86
NA
NA
46.35
46.16
09061571

A
Incise skull for brain wound
28.24
NA
NA
15.21
15.16
6.77
NA
NA
50.22
50.17
09061575

A
Skull base/brainstem surgery
36.38
NA
NA
15.53
18.61
5.32
NA
NA
57.23
60.31
09061576

A
Skull base/brainstem surgery
55.03
NA
NA
25.88
32.52
5.56
NA
NA
86.47
93.11
09061580

A
Craniofacial approach, skull
34.26
NA
NA
20.69
24.36
3.36
NA
NA
58.31
61.98
09061581

A
Craniofacial approach, skull
38.78
NA
NA
24.86
23.80
3.91
NA
NA
67.55
66.49
09061582

A
Craniofacial approach, skull
34.83
NA
NA
30.37
28.07
7.19
NA
NA
72.39
70.09
09061583

A
Craniofacial approach, skull
38.37
NA
NA
25.79
25.28
9.18
NA
NA
73.34
72.83
09061584

A
Orbitocranial approach/skull
37.57
NA
NA
25.56
24.78
8.16
NA
NA
71.29
70.51
09061585

A
Orbitocranial approach/skull
42.40
NA
NA
24.83
26.08
7.01
NA
NA
74.24
75.49
09061586

A
Resect nasopharynx, skull
27.20
NA
NA
23.97
22.93
4.36
NA
NA
55.53
54.49
09061590

A
Infratemporal approach/skull
46.79
NA
NA
23.16
27.26
5.29
NA
NA
75.24
79.34
09061591

A
Infratemporal approach/skull
46.81
NA
NA
23.73
28.07
5.64
NA
NA
76.18
80.52
09061592

A
Orbitocranial approach/skull
42.94
NA
NA
27.58
26.77
10.04
NA
NA
80.56
79.75
09061595

A
Transtemporal approach/skull
33.49
NA
NA
19.29
21.59
3.97
NA
NA
56.75
59.05
09061596

A
Transcochlear approach/skull
39.25
NA
NA
18.52
22.96
3.39
NA
NA
61.16
65.60
09061597

A
Transcondylar approach/skull
40.67
NA
NA
22.86
22.96
8.81
NA
NA
72.34
72.44
09061598

A
Transpetrosal approach/skull
36.35
NA
NA
20.81
22.63
5.68
NA
NA
62.84
64.66
09061600

A
Resect/excise cranial lesion
29.76
NA
NA
18.31
19.41
3.78
NA
NA
51.85
52.95
09061601

A
Resect/excise cranial lesion
31.00
NA
NA
22.32
20.95
6.61
NA
NA
59.93
58.56
09061605

A
Resect/excise cranial lesion
32.32
NA
NA
17.57
20.86
2.85
NA
NA
52.74
56.03
09061606

A
Resect/excise cranial lesion
41.88
NA
NA
24.31
24.94
8.94
NA
NA
75.13
75.76
09061607

A
Resect/excise cranial lesion
40.76
NA
NA
20.51
22.96
6.88
NA
NA
68.15
70.60
09061608

A
Resect/excise cranial lesion
45.39
NA
NA
26.51
26.56
10.72
NA
NA
82.62
82.67
09061609

A
Transect artery, sinus
9.88
NA
NA
3.73
4.57
2.55
NA
NA
16.16
17.00
ZZZ61610

A
Transect artery, sinus
29.63
NA
NA
11.19
12.65
7.66
NA
NA
48.48
49.94
ZZZ61611

A
Transect artery, sinus
7.41
NA
NA
2.80
3.57
1.88
NA
NA
12.09
12.86
ZZZ61612

A
Transect artery, sinus
27.84
NA
NA
8.15
12.02
4.30
NA
NA
40.29
44.16
ZZZ61613

A
Remove aneurysm, sinus
44.88
NA
NA
27.54
26.58
8.42
NA
NA
80.84
79.88
09061615

A
Resect/excise lesion, skull
35.57
NA
NA
19.35
21.88
4.72
NA
NA
59.64
62.17
09061616

A
Resect/excise lesion, skull
46.54
NA
NA
26.45
28.10
8.24
NA
NA
81.23
82.88
09061618

A
Repair dura
18.52
NA
NA
10.11
10.36
3.71
NA
NA
32.34
32.59
09061619

A
Repair dura
21.95
NA
NA
10.97
11.92
3.94
NA
NA
36.86
37.81
09061623

A
Endovasc tempory vessel occl
9.95
NA
NA
3.40
3.91
1.05
NA
NA
14.40
14.91
00061624

A
Transcath occlusion, cns
20.12
NA
NA
6.80
6.87
1.95
NA
NA
28.87
28.94
00061626

A
Transcath occlusion, non-cns
16.60
NA
NA
5.43
5.49
1.24
NA
NA
23.27
23.33
000( print page 49165)61630

N
Intracranial angioplasty
22.03
NA
NA
6.50
10.99
2.01
NA
NA
30.54
35.03
09061635

N
Intracran angioplsty w/stent
24.24
NA
NA
7.02
11.91
2.20
NA
NA
33.46
38.35
09061680

A
Intracranial vessel surgery
32.34
NA
NA
16.85
17.29
7.93
NA
NA
57.12
57.56
09061682

A
Intracranial vessel surgery
63.27
NA
NA
27.31
30.99
15.85
NA
NA
106.43
110.11
09061684

A
Intracranial vessel surgery
41.43
NA
NA
20.46
21.62
10.28
NA
NA
72.17
73.33
09061686

A
Intracranial vessel surgery
67.26
NA
NA
30.29
33.61
16.66
NA
NA
114.21
117.53
09061690

A
Intracranial vessel surgery
31.14
NA
NA
15.88
16.51
6.92
NA
NA
53.94
54.57
09061692

A
Intracranial vessel surgery
54.39
NA
NA
24.71
26.78
13.39
NA
NA
92.49
94.56
09061697

A
Brain aneurysm repr, complx
63.16
NA
NA
28.85
28.22
12.81
NA
NA
104.82
104.19
09061698

A
Brain aneurysm repr, complx
69.39
NA
NA
30.92
27.75
12.50
NA
NA
112.81
109.64
09061700

A
Brain aneurysm repr, simple
50.44
NA
NA
24.03
26.86
12.98
NA
NA
87.45
90.28
09061702

A
Inner skull vessel surgery
59.80
NA
NA
27.94
26.51
10.76
NA
NA
98.50
97.07
09061703

A
Clamp neck artery
18.66
NA
NA
10.84
10.56
4.05
NA
NA
33.55
33.27
09061705

A
Revise circulation to head
37.92
NA
NA
17.61
18.84
8.84
NA
NA
64.37
65.60
09061708

A
Revise circulation to head
37.02
NA
NA
13.19
14.66
2.50
NA
NA
52.71
54.18
09061710

A
Revise circulation to head
31.15
NA
NA
13.35
13.57
4.51
NA
NA
49.01
49.23
09061711

A
Fusion of skull arteries
38.05
NA
NA
18.57
19.49
9.39
NA
NA
66.01
66.93
09061720

A
Incise skull/brain surgery
17.48
NA
NA
8.13
9.51
2.78
NA
NA
28.39
29.77
09061735

A
Incise skull/brain surgery
22.17
NA
NA
11.32
11.95
2.72
NA
NA
36.21
36.84
09061750

A
Incise skull/brain biopsy
19.69
NA
NA
10.97
10.70
4.71
NA
NA
35.37
35.10
09061751

A
Brain biopsy w/ct/mr guide
18.58
NA
NA
11.42
10.97
4.55
NA
NA
34.55
34.10
09061760

A
Implant brain electrodes
22.24
NA
NA
11.94
9.52
5.40
NA
NA
39.58
37.16
09061770

A
Incise skull for treatment
23.05
NA
NA
9.87
11.66
3.54
NA
NA
36.46
38.25
09061790

A
Treat trigeminal nerve
11.46
NA
NA
7.79
6.38
2.81
NA
NA
22.06
20.65
09061791

A
Treat trigeminal tract
15.27
NA
NA
7.61
8.59
3.39
NA
NA
26.27
27.25
09061793

A
Focus radiation beam
17.71
NA
NA
9.79
10.04
4.45
NA
NA
31.95
32.20
09061795

A
Brain surgery using computer
4.03
NA
NA
1.37
1.87
0.79
NA
NA
6.19
6.69
ZZZ61850

A
Implant neuroelectrodes
13.23
NA
NA
5.56
7.14
3.21
NA
NA
22.00
23.58
09061860

A
Implant neuroelectrodes
22.12
NA
NA
11.19
11.84
4.94
NA
NA
38.25
38.90
09061863

A
Implant neuroelectrode
20.50
NA
NA
12.48
11.95
5.41
NA
NA
38.39
37.86
09061864

A
Implant neuroelectrde, addl
4.49
NA
NA
1.70
2.14
5.41
NA
NA
11.60
12.04
ZZZ61867

A
Implant neuroelectrode
32.82
NA
NA
16.69
17.69
5.41
NA
NA
54.92
55.92
09061868

A
Implant neuroelectrde, addIl
7.91
NA
NA
2.96
3.75
5.41
NA
NA
16.28
17.07
ZZZ61870

A
Implant neuroelectrodes
16.20
NA
NA
8.63
9.43
3.86
NA
NA
28.69
29.49
09061875

A
Implant neuroelectrodes
16.32
NA
NA
5.38
7.77
2.94
NA
NA
24.64
27.03
09061880

A
Revise/remove neuroelectrode
6.84
NA
NA
5.47
4.80
1.66
NA
NA
13.97
13.30
09061885

A
Insrt/redo neurostim 1 array
7.29
NA
NA
7.42
5.83
1.59
NA
NA
16.30
14.71
09061886

A
Implant neurostim arrays
9.65
NA
NA
8.74
6.95
1.96
NA
NA
20.35
18.56
09061888

A
Revise/remove neuroreceiver
5.18
NA
NA
3.59
3.65
1.33
NA
NA
10.10
10.16
01062000

A
Treat skull fracture
13.79
NA
NA
7.21
5.94
1.06
NA
NA
22.06
20.79
09062005

A
Treat skull fracture
17.49
NA
NA
9.47
8.96
3.86
NA
NA
30.82
30.31
09062010

A
Treatment of head injury
21.25
NA
NA
11.91
11.76
5.12
NA
NA
38.28
38.13
09062100

A
Repair brain fluid leakage
23.35
NA
NA
11.84
12.55
4.83
NA
NA
40.02
40.73
09062115

A
Reduction of skull defect
22.63
NA
NA
13.97
12.22
5.49
NA
NA
42.09
40.34
09062116

A
Reduction of skull defect
24.82
NA
NA
13.12
13.30
6.09
NA
NA
44.03
44.21
09062117

A
Reduction of skull defect
28.20
NA
NA
14.69
15.20
4.52
NA
NA
47.41
47.92
09062120

A
Repair skull cavity lesion
24.31
NA
NA
15.76
17.80
2.99
NA
NA
43.06
45.10
09062121

A
Incise skull repair
22.89
NA
NA
14.03
15.10
4.16
NA
NA
41.08
42.15
09062140

A
Repair of skull defect
14.41
NA
NA
8.60
8.39
3.46
NA
NA
26.47
26.26
09062141

A
Repair of skull defect
15.93
NA
NA
9.30
9.11
3.75
NA
NA
28.98
28.79
09062142

A
Remove skull plate/flap
11.69
NA
NA
7.72
7.17
2.72
NA
NA
22.13
21.58
09062143

A
Replace skull plate/flap
14.01
NA
NA
8.79
8.23
3.36
NA
NA
26.16
25.60
09062145

A
Repair of skull & brain
19.95
NA
NA
10.20
10.72
4.49
NA
NA
34.64
35.16
09062146

A
Repair of skull with graft
17.14
NA
NA
9.04
9.48
3.61
NA
NA
29.79
30.23
09062147

A
Repair of skull with graft
20.53
NA
NA
10.59
11.12
4.31
NA
NA
35.43
35.96
09062148

A
Retr bone flap to fix skull
2.00
NA
NA
0.76
0.84
0.48
NA
NA
3.24
3.32
ZZZ62160

A
Neuroendoscopy add-on
3.00
NA
NA
1.12
1.43
0.77
NA
NA
4.89
5.20
ZZZ62161

A
Dissect brain w/scope
21.04
NA
NA
12.12
12.10
5.17
NA
NA
38.33
38.31
09062162

A
Remove colloid cyst w/scope
26.61
NA
NA
13.85
14.60
5.89
NA
NA
46.35
47.10
09062163

A
Neuroendoscopy w/fb removal
16.34
NA
NA
10.53
10.07
4.00
NA
NA
30.87
30.41
09062164

A
Remove brain tumor w/scope
29.19
NA
NA
14.93
14.95
5.36
NA
NA
49.48
49.50
09062165

A
Remove pituit tumor w/scope
23.04
NA
NA
11.46
12.90
3.00
NA
NA
37.50
38.94
09062180

A
Establish brain cavity shunt
22.41
NA
NA
12.00
12.21
4.97
NA
NA
39.38
39.59
09062190

A
Establish brain cavity shunt
12.03
NA
NA
7.67
7.23
2.79
NA
NA
22.49
22.05
09062192

A
Establish brain cavity shunt
13.21
NA
NA
8.40
7.82
3.01
NA
NA
24.62
24.04
09062194

A
Replace/irrigate catheter
5.64
NA
NA
3.81
2.78
0.92
NA
NA
10.37
9.34
010( print page 49166)62200

A
Establish brain cavity shunt
19.15
NA
NA
10.69
10.80
4.64
NA
NA
34.48
34.59
09062201

A
Brain cavity shunt w/scope
15.83
NA
NA
10.52
9.71
3.67
NA
NA
30.02
29.21
09062220

A
Establish brain cavity shunt
13.96
NA
NA
8.39
8.08
3.34
NA
NA
25.69
25.38
09062223

A
Establish brain cavity shunt
13.84
NA
NA
9.42
8.54
3.13
NA
NA
26.39
25.51
09062225

A
Replace/irrigate catheter
6.08
NA
NA
5.49
4.44
1.39
NA
NA
12.96
11.91
09062230

A
Replace/revise brain shunt
11.32
NA
NA
7.28
6.68
2.70
NA
NA
21.30
20.70
09062252

A
Csf shunt reprogram
0.74
1.78
1.55
NA
NA
0.21
2.73
2.50
NA
NA
XXX62252
26
A
Csf shunt reprogram
0.74
0.27
0.35
0.27
0.35
0.19
1.20
1.28
1.20
1.28
XXX62252
TC
A
Csf shunt reprogram
0.00
1.51
1.20
NA
NA
0.02
1.53
1.22
NA
NA
XXX62256

A
Remove brain cavity shunt
7.27
NA
NA
5.88
4.99
1.71
NA
NA
14.86
13.97
09062258

A
Replace brain cavity shunt
15.50
NA
NA
9.25
8.85
3.73
NA
NA
28.48
28.08
09062263

A
Epidural lysis mult sessions
6.37
9.18
11.81
2.88
3.11
0.41
15.96
18.59
9.66
9.89
01062264

A
Epidural lysis on single day
4.42
5.78
7.24
1.31
1.39
0.27
10.47
11.93
6.00
6.08
01062268

A
Drain spinal cord cyst
4.73
6.76
10.34
1.74
2.04
0.43
11.92
15.50
6.90
7.20
00062269

A
Needle biopsy, spinal cord
5.01
6.84
12.72
1.67
1.90
0.37
12.22
18.10
7.05
7.28
00062270

A
Spinal fluid tap, diagnostic
1.37
2.38
2.84
0.55
0.56
0.08
3.83
4.29
2.00
2.01
00062272

A
Drain cerebro spinal fluid
1.35
3.14
3.49
0.61
0.69
0.18
4.67
5.02
2.14
2.22
00062273

A
Inject epidural patch
2.15
1.70
2.46
0.58
0.68
0.13
3.98
4.74
2.86
2.96
00062280

A
Treat spinal cord lesion
2.63
4.30
6.27
1.07
1.03
0.30
7.23
9.20
4.00
3.96
01062281

A
Treat spinal cord lesion
2.66
3.79
5.19
0.91
0.90
0.19
6.64
8.04
3.76
3.75
01062282

A
Treat spinal canal lesion
2.33
3.97
7.26
1.07
0.96
0.17
6.47
9.76
3.57
3.46
01062284

A
Injection for myelogram
1.54
3.79
4.67
0.67
0.68
0.13
5.46
6.34
2.34
2.35
00062287

A
Percutaneous diskectomy
8.82
NA
NA
4.24
5.22
0.58
NA
NA
13.64
14.62
09062290

A
Inject for spine disk x-ray
3.00
4.46
6.46
1.13
1.32
0.23
7.69
9.69
4.36
4.55
00062291

A
Inject for spine disk x-ray
2.91
4.25
5.51
1.07
1.19
0.26
7.42
8.68
4.24
4.36
00062292

A
Injection into disk lesion
9.10
NA
NA
3.19
4.15
0.82
NA
NA
13.11
14.07
09062294

A
Injection into spinal artery
12.73
NA
NA
5.63
5.59
1.24
NA
NA
19.60
19.56
09062310

A
Inject spine c/t
1.91
3.06
4.37
0.58
0.63
0.12
5.09
6.40
2.61
2.66
00062311

A
Inject spine l/s (cd)
1.54
2.70
4.37
0.54
0.58
0.09
4.33
6.00
2.17
2.21
00062318

A
Inject spine w/cath, c/t
2.04
3.24
5.10
0.48
0.61
0.12
5.40
7.26
2.64
2.77
00062319

A
Inject spine w/cath l/s (cd)
1.87
2.90
4.46
0.47
0.58
0.11
4.88
6.44
2.45
2.56
00062350

A
Implant spinal canal cath
7.96
NA
NA
4.19
4.00
1.02
NA
NA
13.17
12.98
09062351

A
Implant spinal canal cath
11.46
NA
NA
7.73
7.27
2.24
NA
NA
21.43
20.97
09062355

A
Remove spinal canal catheter
6.54
NA
NA
3.61
3.27
0.71
NA
NA
10.86
10.52
09062360

A
Insert spine infusion device
3.60
NA
NA
3.46
2.88
0.34
NA
NA
7.40
6.82
09062361

A
Implant spine infusion pump
6.51
NA
NA
4.00
3.94
0.80
NA
NA
11.31
11.25
09062362

A
Implant spine infusion pump
8.50
NA
NA
4.78
4.47
1.18
NA
NA
14.46
14.15
09062365

A
Remove spine infusion device
6.51
NA
NA
3.85
3.65
0.86
NA
NA
11.22
11.02
09062367

A
Analyze spine infusion pump
0.48
0.41
0.56
0.11
0.10
0.03
0.92
1.07
0.62
0.61
XXX62368

A
Analyze spine infusion pump
0.75
0.60
0.67
0.19
0.18
0.06
1.41
1.48
1.00
0.99
XXX63001

A
Removal of spinal lamina
17.47
NA
NA
9.89
9.61
3.76
NA
NA
31.12
30.84
09063003

A
Removal of spinal lamina
17.60
NA
NA
9.80
9.85
3.72
NA
NA
31.12
31.17
09063005

A
Removal of spinal lamina
16.22
NA
NA
9.78
9.92
3.34
NA
NA
29.34
29.48
09063011

A
Removal of spinal lamina
15.73
NA
NA
9.22
8.51
3.37
NA
NA
28.32
27.61
09063012

A
Removal of spinal lamina
16.67
NA
NA
9.84
10.05
3.48
NA
NA
29.99
30.20
09063015

A
Removal of spinal lamina
20.64
NA
NA
12.01
11.91
4.75
NA
NA
37.40
37.30
09063016

A
Removal of spinal lamina
21.85
NA
NA
11.95
11.82
4.58
NA
NA
38.38
38.25
09063017

A
Removal of spinal lamina
17.12
NA
NA
10.43
10.40
3.63
NA
NA
31.18
31.15
09063020

A
Neck spine disk surgery
15.99
NA
NA
9.99
9.75
3.71
NA
NA
29.69
29.45
09063030

A
Low back disk surgery
12.97
NA
NA
8.67
8.48
3.00
NA
NA
24.64
24.45
09063035

A
Spinal disk surgery add-on
3.15
NA
NA
1.21
1.50
0.79
NA
NA
5.15
5.44
ZZZ63040

A
Laminotomy, single cervical
20.13
NA
NA
11.08
11.40
4.67
NA
NA
35.88
36.20
09063042

A
Laminotomy, single lumbar
18.55
NA
NA
10.68
11.18
4.25
NA
NA
33.48
33.98
09063043

C
Laminotomy, addIl cervical
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
ZZZ63044

C
Laminotomy, addIl lumbar
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
ZZZ63045

A
Removal of spinal lamina
17.77
NA
NA
10.41
10.37
3.98
NA
NA
32.16
32.12
090( print page 49167)63046

A
Removal of spinal lamina
17.07
NA
NA
9.88
10.11
3.55
NA
NA
30.50
30.73
09063047

A
Removal of spinal lamina
15.16
NA
NA
9.41
9.77
3.23
NA
NA
27.80
28.16
09063048

A
Remove spinal lamina add-on
3.26
NA
NA
1.25
1.56
0.72
NA
NA
5.23
5.54
ZZZ63050

A
Cervical laminoplasty
21.82
NA
NA
8.87
11.10
4.66
NA
NA
35.35
37.58
09063051

A
C-laminoplasty w/graft/plate
25.32
NA
NA
11.71
13.03
4.66
NA
NA
41.69
43.01
09063055

A
Decompress spinal cord
23.37
NA
NA
12.40
12.95
5.27
NA
NA
41.04
41.59
09063056

A
Decompress spinal cord
21.68
NA
NA
11.41
12.27
4.75
NA
NA
37.84
38.70
09063057

A
Decompress spine cord add-on
5.25
NA
NA
1.97
2.47
1.22
NA
NA
8.44
8.94
ZZZ63064

A
Decompress spinal cord
26.04
NA
NA
13.41
14.17
5.69
NA
NA
45.14
45.90
09063066

A
Decompress spine cord add-on
3.26
NA
NA
1.24
1.56
0.69
NA
NA
5.19
5.51
ZZZ63075

A
Neck spine disk surgery
19.41
NA
NA
11.11
11.84
4.62
NA
NA
35.14
35.87
09063076

A
Neck spine disk surgery
4.04
NA
NA
1.53
1.92
0.96
NA
NA
6.53
6.92
ZZZ63077

A
Spine disk surgery, thorax
22.70
NA
NA
11.20
12.39
3.98
NA
NA
37.88
39.07
09063078

A
Spine disk surgery, thorax
3.28
NA
NA
1.20
1.53
0.66
NA
NA
5.14
5.47
ZZZ63081

A
Removal of vertebral body
25.92
NA
NA
13.62
14.15
5.54
NA
NA
45.08
45.61
09063082

A
Remove vertebral body add-on
4.36
NA
NA
1.66
2.08
1.02
NA
NA
7.04
7.46
ZZZ63085

A
Removal of vertebral body
29.29
NA
NA
13.77
15.05
4.48
NA
NA
47.54
48.82
09063086

A
Remove vertebral body add-on
3.19
NA
NA
1.17
1.49
0.59
NA
NA
4.95
5.27
ZZZ63087

A
Removal of vertebral body
37.32
NA
NA
16.85
18.80
6.20
NA
NA
60.37
62.32
09063088

A
Remove vertebral body add-on
4.32
NA
NA
1.64
2.04
0.82
NA
NA
6.78
7.18
ZZZ63090

A
Removal of vertebral body
30.72
NA
NA
14.16
15.56
4.21
NA
NA
49.09
50.49
09063091

A
Remove vertebral body add-on
3.03
NA
NA
1.13
1.38
0.48
NA
NA
4.64
4.89
ZZZ63101

A
Removal of vertebral body
33.84
NA
NA
17.18
18.75
5.69
NA
NA
56.71
58.28
09063102

A
Removal of vertebral body
33.84
NA
NA
16.90
18.68
5.69
NA
NA
56.43
58.21
09063103

A
Remove vertebral body add-on
4.82
NA
NA
1.78
2.32
0.69
NA
NA
7.29
7.83
ZZZ63170

A
Incise spinal cord tract(s)
22.03
NA
NA
12.64
12.06
4.86
NA
NA
39.53
38.95
09063172

A
Drainage of spinal cyst
19.62
NA
NA
11.31
10.81
4.48
NA
NA
35.41
34.91
09063173

A
Drainage of spinal cyst
24.13
NA
NA
13.38
12.95
5.68
NA
NA
43.19
42.76
09063180

A
Revise spinal cord ligaments
20.35
NA
NA
10.94
10.97
3.95
NA
NA
35.24
35.27
09063182

A
Revise spinal cord ligaments
22.64
NA
NA
7.25
10.03
5.30
NA
NA
35.19
37.97
09063185

A
Incise spinal column/nerves
16.31
NA
NA
10.11
8.60
2.79
NA
NA
29.21
27.70
09063190

A
Incise spinal column/nerves
18.71
NA
NA
10.16
10.14
3.24
NA
NA
32.11
32.09
09063191

A
Incise spinal column/nerves
18.74
NA
NA
10.78
10.55
6.34
NA
NA
35.86
35.63
09063194

A
Incise spinal column & cord
21.92
NA
NA
8.65
10.95
3.26
NA
NA
33.83
36.13
09063195

A
Incise spinal column & cord
21.50
NA
NA
12.18
11.33
4.87
NA
NA
38.55
37.70
09063196

A
Incise spinal column & cord
25.09
NA
NA
13.88
13.51
5.76
NA
NA
44.73
44.36
09063197

A
Incise spinal column & cord
23.90
NA
NA
13.43
12.51
5.36
NA
NA
42.69
41.77
09063198

A
Incise spinal column & cord
29.69
NA
NA
9.01
8.58
6.43
NA
NA
45.13
44.70
09063199

A
Incise spinal column & cord
31.26
NA
NA
9.38
13.62
1.40
NA
NA
42.04
46.28
09063200

A
Release of spinal cord
21.26
NA
NA
11.74
11.40
4.96
NA
NA
37.96
37.62
09063250

A
Revise spinal cord vessels
43.68
NA
NA
21.09
20.21
9.01
NA
NA
73.78
72.90
09063251

A
Revise spinal cord vessels
44.43
NA
NA
21.36
22.28
10.41
NA
NA
76.20
77.12
09063252

A
Revise spinal cord vessels
44.42
NA
NA
21.41
22.03
10.64
NA
NA
76.47
77.09
09063265

A
Excise intraspinal lesion
23.64
NA
NA
13.10
12.85
5.43
NA
NA
42.17
41.92
09063266

A
Excise intraspinal lesion
24.50
NA
NA
13.27
13.20
5.54
NA
NA
43.31
43.24
09063267

A
Excise intraspinal lesion
19.27
NA
NA
11.22
11.11
4.37
NA
NA
34.86
34.75
09063268

A
Excise intraspinal lesion
19.84
NA
NA
10.84
10.48
3.69
NA
NA
34.37
34.01
09063270

A
Excise intraspinal lesion
29.62
NA
NA
15.73
15.53
6.82
NA
NA
52.17
51.97
09063271

A
Excise intraspinal lesion
29.74
NA
NA
15.34
15.51
6.90
NA
NA
51.98
52.15
09063272

A
Excise intraspinal lesion
27.32
NA
NA
14.33
14.59
6.18
NA
NA
47.83
48.09
09063273

A
Excise intraspinal lesion
26.29
NA
NA
13.84
14.21
5.74
NA
NA
45.87
46.24
09063275

A
Biopsy/excise spinal tumor
25.68
NA
NA
13.51
13.70
5.80
NA
NA
44.99
45.18
09063276

A
Biopsy/excise spinal tumor
25.51
NA
NA
13.73
13.69
5.83
NA
NA
45.07
45.03
09063277

A
Biopsy/excise spinal tumor
22.21
NA
NA
12.17
12.43
5.01
NA
NA
39.39
39.65
09063278

A
Biopsy/excise spinal tumor
21.94
NA
NA
12.07
12.30
4.55
NA
NA
38.56
38.79
09063280

A
Biopsy/excise spinal tumor
30.08
NA
NA
16.02
16.23
7.27
NA
NA
53.37
53.58
09063281

A
Biopsy/excise spinal tumor
29.78
NA
NA
15.82
16.08
7.17
NA
NA
52.77
53.03
09063282

A
Biopsy/excise spinal tumor
27.94
NA
NA
15.14
15.28
6.76
NA
NA
49.84
49.98
09063283

A
Biopsy/excise spinal tumor
26.55
NA
NA
14.20
14.54
6.26
NA
NA
47.01
47.35
09063285

A
Biopsy/excise spinal tumor
37.84
NA
NA
19.05
19.71
9.18
NA
NA
66.07
66.73
09063286

A
Biopsy/excise spinal tumor
37.41
NA
NA
18.80
19.62
9.21
NA
NA
65.42
66.24
09063287

A
Biopsy/excise spinal tumor
39.87
NA
NA
19.48
20.18
9.39
NA
NA
68.74
69.43
09063290

A
Biopsy/excise spinal tumor
40.61
NA
NA
20.06
20.45
9.02
NA
NA
69.68
70.07
09063295

A
Repair of laminectomy defect
5.25
NA
NA
1.33
1.94
1.03
NA
NA
7.61
8.22
ZZZ63300

A
Removal of vertebral body
26.62
NA
NA
13.54
14.10
5.97
NA
NA
46.13
46.69
09063301

A
Removal of vertebral body
31.36
NA
NA
15.06
15.42
5.39
NA
NA
51.81
52.17
090( print page 49168)63302

A
Removal of vertebral body
30.94
NA
NA
14.83
15.59
5.53
NA
NA
51.30
52.06
09063303

A
Removal of vertebral body
33.37
NA
NA
14.68
16.35
4.68
NA
NA
52.73
54.40
09063304

A
Removal of vertebral body
33.64
NA
NA
17.05
17.21
6.41
NA
NA
57.10
57.26
09063305

A
Removal of vertebral body
36.03
NA
NA
17.60
17.93
5.71
NA
NA
59.34
59.67
09063306

A
Removal of vertebral body
35.34
NA
NA
15.77
17.29
8.33
NA
NA
59.43
60.96
09063307

A
Removal of vertebral body
34.75
NA
NA
17.66
17.02
4.46
NA
NA
56.87
56.23
09063308

A
Remove vertebral body add-on
5.24
NA
NA
1.93
2.43
1.29
NA
NA
8.46
8.96
ZZZ63600

A
Remove spinal cord lesion
14.98
NA
NA
4.61
5.20
1.52
NA
NA
21.11
21.70
09063610

A
Stimulation of spinal cord
8.72
14.20
48.31
1.58
2.08
0.86
23.78
57.89
11.16
11.66
00063615

A
Remove lesion of spinal cord
17.18
NA
NA
5.98
8.44
2.84
NA
NA
26.00
28.46
09063650

A
Implant neuroelectrodes
7.53
NA
NA
2.98
3.12
0.53
NA
NA
11.04
11.18
09063655

A
Implant neuroelectrodes
11.38
NA
NA
7.84
7.13
2.43
NA
NA
21.65
20.94
09063660

A
Revise/remove neuroelectrode
6.83
NA
NA
3.36
3.55
0.78
NA
NA
10.97
11.16
09063685

A
Insrt/redo spine n generator
7.83
NA
NA
3.74
4.04
1.05
NA
NA
12.62
12.92
09063688

A
Revise/remove neuroreceiver
6.06
NA
NA
3.60
3.56
0.89
NA
NA
10.55
10.51
09063700

A
Repair of spinal herniation
17.26
NA
NA
9.78
10.17
3.52
NA
NA
30.56
30.95
09063702

A
Repair of spinal herniation
19.20
NA
NA
10.93
11.01
4.12
NA
NA
34.25
34.33
09063704

A
Repair of spinal herniation
22.15
NA
NA
12.60
12.83
4.57
NA
NA
39.32
39.55
09063706

A
Repair of spinal herniation
25.07
NA
NA
15.07
13.95
6.23
NA
NA
46.37
45.25
09063707

A
Repair spinal fluid leakage
12.47
NA
NA
7.90
7.75
2.51
NA
NA
22.88
22.73
09063709

A
Repair spinal fluid leakage
15.47
NA
NA
9.06
9.31
3.09
NA
NA
27.62
27.87
09063710

A
Graft repair of spine defect
15.22
NA
NA
9.26
9.09
3.40
NA
NA
27.88
27.71
09063740

A
Install spinal shunt
12.45
NA
NA
8.25
7.57
2.93
NA
NA
23.63
22.95
09063741

A
Install spinal shunt
8.98
NA
NA
4.85
4.78
1.66
NA
NA
15.49
15.42
09063744

A
Revision of spinal shunt
8.83
NA
NA
6.06
5.45
1.89
NA
NA
16.78
16.17
09063746

A
Removal of spinal shunt
7.22
NA
NA
4.75
4.02
1.53
NA
NA
13.50
12.77
09064400

A
N block inj, trigeminal
1.11
1.41
1.77
0.45
0.44
0.07
2.59
2.95
1.63
1.62
00064402

A
N block inj, facial
1.25
1.46
1.57
0.53
0.58
0.09
2.80
2.91
1.87
1.92
00064405

A
N block inj, occipital
1.32
1.17
1.39
0.51
0.47
0.08
2.57
2.79
1.91
1.87
00064408

A
N block inj, vagus
1.41
1.45
1.55
0.70
0.81
0.10
2.96
3.06
2.21
2.32
00064410

A
N block inj, phrenic
1.43
1.82
2.33
0.52
0.48
0.09
3.34
3.85
2.04
2.00
00064412

A
N block inj, spinal accessor
1.18
2.05
2.50
0.55
0.46
0.08
3.31
3.76
1.81
1.72
00064413

A
N block inj, cervical plexus
1.40
1.30
1.71
0.47
0.49
0.08
2.78
3.19
1.95
1.97
00064415

A
N block inj, brachial plexus
1.48
1.50
2.48
0.34
0.43
0.09
3.07
4.05
1.91
2.00
00064416

A
N block cont infuse, b plex
3.85
NA
NA
0.57
0.74
0.31
NA
NA
4.73
4.90
01064417

A
N block inj, axillary
1.44
1.51
2.65
0.35
0.46
0.11
3.06
4.20
1.90
2.01
00064418

A
N block inj, suprascapular
1.32
1.90
2.44
0.52
0.46
0.07
3.29
3.83
1.91
1.85
00064420

A
N block inj, intercost, sng
1.18
2.40
3.51
0.44
0.43
0.08
3.66
4.77
1.70
1.69
00064421

A
N block inj, intercost, mlt
1.68
3.55
5.45
0.53
0.52
0.11
5.34
7.24
2.32
2.31
00064425

A
N block inj, ilio-ing/hypogi
1.75
1.34
1.57
0.56
0.55
0.13
3.22
3.45
2.44
2.43
00064430

A
N block inj, pudendal
1.46
2.41
2.49
0.78
0.61
0.10
3.97
4.05
2.34
2.17
00064435

A
N block inj, paracervical
1.45
2.00
2.39
0.56
0.66
0.16
3.61
4.00
2.17
2.27
00064445

A
N block inj, sciatic, sng
1.48
1.67
2.42
0.52
0.51
0.10
3.25
4.00
2.10
2.09
00064446

A
N blk inj, sciatic, cont inf
3.61
NA
NA
0.59
0.90
0.20
NA
NA
4.40
4.71
01064447

A
N block inj fem, single
1.50
NA
NA
0.21
0.38
0.09
NA
NA
1.80
1.97
00064448

A
N block inj fem, cont inf
3.36
NA
NA
0.47
0.73
0.18
NA
NA
4.01
4.27
01064449

A
N block inj, lumbar plexus
3.24
NA
NA
0.49
0.84
0.15
NA
NA
3.88
4.23
01064450

A
N block, other peripheral
1.27
1.29
1.25
0.50
0.49
0.13
2.69
2.65
1.90
1.89
00064470

A
Inj paravertebral c/t
1.85
3.87
6.39
0.71
0.71
0.11
5.83
8.35
2.67
2.67
00064472

A
Inj paravertebral c/t add-on
1.29
1.23
2.06
0.34
0.34
0.08
2.60
3.43
1.71
1.71
ZZZ64475

A
Inj paravertebral l/s
1.41
3.72
6.09
0.60
0.62
0.10
5.23
7.60
2.11
2.13
00064476

A
Inj paravertebral l/s add-on
0.98
1.12
1.87
0.23
0.24
0.07
2.17
2.92
1.28
1.29
ZZZ64479

A
Inj foramen epidural c/t
2.20
3.81
6.57
0.82
0.87
0.12
6.13
8.89
3.14
3.19
00064480

A
Inj foramen epidural add-on
1.54
1.50
2.51
0.38
0.45
0.10
3.14
4.15
2.02
2.09
ZZZ64483

A
Inj foramen epidural l/s
1.90
3.85
6.88
0.76
0.81
0.11
5.86
8.89
2.77
2.82
00064484

A
Inj foramen epidural add-on
1.33
1.63
2.87
0.32
0.36
0.08
3.04
4.28
1.73
1.77
ZZZ( print page 49169)64505

A
N block, spenopalatine gangl
1.36
1.11
1.21
0.73
0.68
0.10
2.57
2.67
2.19
2.14
00064508

A
N block, carotid sinus s/p
1.12
1.89
2.96
0.48
0.68
0.07
3.08
4.15
1.67
1.87
00064510

A
N block, stellate ganglion
1.22
1.92
3.07
0.44
0.49
0.07
3.21
4.36
1.73
1.78
00064517

A
N block inj, hypogas plxs
2.20
1.70
2.47
0.67
0.82
0.11
4.01
4.78
2.98
3.13
00064520

A
N block, lumbar/thoracic
1.35
2.62
4.51
0.52
0.54
0.08
4.05
5.94
1.95
1.97
00064530

A
N block inj, celiac pelus
1.58
2.65
4.00
0.60
0.64
0.10
4.33
5.68
2.28
2.32
00064550

A
Apply neurostimulator
0.18
0.20
0.26
0.06
0.05
0.01
0.39
0.45
0.25
0.24
00064553

A
Implant neuroelectrodes
2.31
2.50
2.75
1.35
1.73
0.18
4.99
5.24
3.84
4.22
01064555

A
Implant neuroelectrodes
2.27
2.57
2.97
1.36
1.23
0.19
5.03
5.43
3.82
3.69
01064560

A
Implant neuroelectrodes
2.36
2.49
2.60
1.33
1.29
0.22
5.07
5.18
3.91
3.87
01064561

A
Implant neuroelectrodes
7.05
20.04
27.55
3.87
3.05
0.51
27.60
35.11
11.43
10.61
01064565

A
Implant neuroelectrodes
1.76
2.47
3.08
1.28
1.27
0.13
4.36
4.97
3.17
3.16
01064573

A
Implant neuroelectrodes
8.11
NA
NA
5.44
5.29
1.60
NA
NA
15.15
15.00
09064575

A
Implant neuroelectrodes
4.34
NA
NA
2.00
2.50
0.61
NA
NA
6.95
7.45
09064577

A
Implant neuroelectrodes
4.61
NA
NA
2.87
3.18
1.04
NA
NA
8.52
8.83
09064580

A
Implant neuroelectrodes
4.11
NA
NA
2.69
3.34
0.36
NA
NA
7.16
7.81
09064581

A
Implant neuroelectrodes
14.13
NA
NA
6.72
5.71
1.05
NA
NA
21.90
20.89
09064585

A
Revise/remove neuroelectrode
2.06
5.79
9.91
2.24
2.16
0.20
8.05
12.17
4.50
4.42
01064590

A
Insrt/redo perph n generator
2.40
6.44
6.97
2.47
2.33
0.19
9.03
9.56
5.06
4.92
01064595

A
Revise/remove neuroreceiver
1.73
6.52
9.42
2.20
1.99
0.19
8.44
11.34
4.12
3.91
01064600

A
Injection treatment of nerve
3.44
5.28
8.33
1.58
1.63
0.34
9.06
12.11
5.36
5.41
01064605

A
Injection treatment of nerve
5.60
7.65
9.08
2.39
2.23
0.79
14.04
15.47
8.78
8.62
01064610

A
Injection treatment of nerve
7.15
9.41
9.00
3.52
3.66
1.58
18.14
17.73
12.25
12.39
01064612

A
Destroy nerve, face muscle
1.96
1.61
2.26
1.36
1.33
0.11
3.68
4.33
3.43
3.40
01064613

A
Destroy nerve, neck muscle
1.96
1.36
2.54
1.13
1.20
0.11
3.43
4.61
3.20
3.27
01064614

A
Destroy nerve, extrem musc
2.20
1.62
2.82
1.31
1.31
0.10
3.92
5.12
3.61
3.61
01064620

A
Injection treatment of nerve
2.84
3.44
4.66
1.17
1.29
0.20
6.48
7.70
4.21
4.33
01064622

A
Destr paravertebrl nerve l/s
3.00
4.10
6.85
1.27
1.35
0.18
7.28
10.03
4.45
4.53
01064623

A
Destr paravertebral n add-on
0.99
1.65
2.63
0.22
0.22
0.06
2.70
3.68
1.27
1.27
ZZZ64626

A
Destr paravertebrl nerve c/t
3.78
4.74
7.02
1.87
1.94
0.20
8.72
11.00
5.85
5.92
01064627

A
Destr paravertebral n add-on
1.16
2.38
3.99
0.25
0.27
0.07
3.61
5.22
1.48
1.50
ZZZ64630

A
Injection treatment of nerve
3.00
2.81
2.75
1.88
1.53
0.22
6.03
5.97
5.10
4.75
01064640

A
Injection treatment of nerve
2.76
2.45
3.75
1.44
1.74
0.29
5.50
6.80
4.49
4.79
01064650

A
Chemodenerv eccrine glands
0.70
0.78
0.85
0.18
0.27
0.06
1.54
1.61
0.94
1.03
00064653

A
Chemodenerv eccrine glands
0.88
0.83
0.90
0.22
0.34
0.08
1.79
1.86
1.18
1.30
00064680

A
Injection treatment of nerve
2.62
4.01
6.04
1.09
1.35
0.18
6.81
8.84
3.89
4.15
01064681

A
Injection treatment of nerve
3.78
4.92
8.20
1.32
1.88
0.28
8.98
12.26
5.38
5.94
01064702

A
Revise finger/toe nerve
6.02
NA
NA
5.27
4.21
0.61
NA
NA
11.90
10.84
09064704

A
Revise hand/foot nerve
4.56
NA
NA
3.20
3.28
0.61
NA
NA
8.37
8.45
09064708

A
Revise arm/leg nerve
6.17
NA
NA
4.29
4.72
0.96
NA
NA
11.42
11.85
09064712

A
Revision of sciatic nerve
7.92
NA
NA
4.55
4.86
0.95
NA
NA
13.42
13.73
09064713

A
Revision of arm nerve(s)
11.22
NA
NA
6.47
6.02
1.82
NA
NA
19.51
19.06
09064714

A
Revise low back nerve(s)
10.37
NA
NA
4.91
4.38
1.19
NA
NA
16.47
15.94
09064716

A
Revision of cranial nerve
6.80
NA
NA
5.15
5.77
0.63
NA
NA
12.58
13.20
09064718

A
Revise ulnar nerve at elbow
6.98
NA
NA
6.23
6.05
1.05
NA
NA
14.26
14.08
09064719

A
Revise ulnar nerve at wrist
4.84
NA
NA
4.16
4.43
0.77
NA
NA
9.77
10.04
09064721

A
Carpal tunnel surgery
4.78
4.72
5.20
4.66
5.19
0.73
10.23
10.71
10.17
10.70
09064722

A
Relieve pressure on nerve(s)
4.69
NA
NA
2.83
2.99
0.48
NA
NA
8.00
8.16
09064726

A
Release foot/toe nerve
4.17
NA
NA
2.73
2.78
0.54
NA
NA
7.44
7.49
09064727

A
Internal nerve revision
3.10
NA
NA
1.23
1.43
0.48
NA
NA
4.81
5.01
ZZZ64732

A
Incision of brow nerve
4.78
NA
NA
4.27
3.69
0.98
NA
NA
10.03
9.45
09064734

A
Incision of cheek nerve
5.41
NA
NA
4.64
4.20
0.89
NA
NA
10.94
10.50
09064736

A
Incision of chin nerve
5.09
NA
NA
3.87
3.98
0.52
NA
NA
9.48
9.59
09064738

A
Incision of jaw nerve
6.22
NA
NA
4.22
4.51
1.08
NA
NA
11.52
11.81
09064740

A
Incision of tongue nerve
6.08
NA
NA
4.41
4.94
0.69
NA
NA
11.18
11.71
09064742

A
Incision of facial nerve
6.71
NA
NA
4.35
4.61
0.73
NA
NA
11.79
12.05
09064744

A
Incise nerve, back of head
5.61
NA
NA
4.59
3.98
1.16
NA
NA
11.36
10.75
09064746

A
Incise diaphragm nerve
6.42
NA
NA
3.88
4.35
0.82
NA
NA
11.12
11.59
09064752

A
Incision of vagus nerve
7.55
NA
NA
4.06
4.23
0.93
NA
NA
12.54
12.71
09064755

A
Incision of stomach nerves
14.93
NA
NA
5.84
5.68
1.83
NA
NA
22.60
22.44
09064760

A
Incision of vagus nerve
7.45
NA
NA
3.85
3.55
0.81
NA
NA
12.11
11.81
09064761

A
Incision of pelvis nerve
6.90
NA
NA
3.99
3.64
0.53
NA
NA
11.42
11.07
09064763

A
Incise hip/thigh nerve
7.42
NA
NA
5.07
5.16
0.94
NA
NA
13.43
13.52
09064766

A
Incise hip/thigh nerve
9.29
NA
NA
5.31
5.26
1.06
NA
NA
15.66
15.61
09064771

A
Sever cranial nerve
7.97
NA
NA
5.28
5.48
1.23
NA
NA
14.48
14.68
09064772

A
Incision of spinal nerve
7.70
NA
NA
5.32
5.02
1.40
NA
NA
14.42
14.12
090( print page 49170)64774

A
Remove skin nerve lesion
5.66
NA
NA
3.97
3.87
0.74
NA
NA
10.37
10.27
09064776

A
Remove digit nerve lesion
5.49
NA
NA
3.73
3.69
0.76
NA
NA
9.98
9.94
09064778

A
Digit nerve surgery add-on
3.11
NA
NA
1.19
1.42
0.46
NA
NA
4.76
4.99
ZZZ64782

A
Remove limb nerve lesion
6.72
NA
NA
4.11
3.86
0.86
NA
NA
11.69
11.44
09064783

A
Limb nerve surgery add-on
3.71
NA
NA
1.41
1.73
0.51
NA
NA
5.63
5.95
ZZZ64784

A
Remove nerve lesion
10.44
NA
NA
6.20
6.49
1.38
NA
NA
18.01
18.30
09064786

A
Remove sciatic nerve lesion
16.07
NA
NA
8.97
9.62
2.60
NA
NA
27.64
28.29
09064787

A
Implant nerve end
4.29
NA
NA
1.60
1.99
0.58
NA
NA
6.47
6.86
ZZZ64788

A
Remove skin nerve lesion
5.10
NA
NA
3.87
3.56
0.73
NA
NA
9.70
9.39
09064790

A
Removal of nerve lesion
11.92
NA
NA
6.81
7.10
2.10
NA
NA
20.83
21.12
09064792

A
Removal of nerve lesion
15.65
NA
NA
8.40
8.72
2.48
NA
NA
26.53
26.85
09064795

A
Biopsy of nerve
3.01
NA
NA
1.44
1.53
0.52
NA
NA
4.97
5.06
00064802

A
Remove sympathetic nerves
10.19
NA
NA
4.22
4.90
1.29
NA
NA
15.70
16.38
09064804

A
Remove sympathetic nerves
15.73
NA
NA
6.10
6.90
2.14
NA
NA
23.97
24.77
09064809

A
Remove sympathetic nerves
14.57
NA
NA
6.60
5.97
1.50
NA
NA
22.67
22.04
09064818

A
Remove sympathetic nerves
11.20
NA
NA
4.36
5.05
1.33
NA
NA
16.89
17.58
09064820

A
Remove sympathetic nerves
10.60
NA
NA
7.04
7.10
1.49
NA
NA
19.13
19.19
09064821

A
Remove sympathetic nerves
9.11
NA
NA
6.64
7.17
1.24
NA
NA
16.99
17.52
09064822

A
Remove sympathetic nerves
9.11
NA
NA
6.45
7.04
1.30
NA
NA
16.86
17.45
09064823

A
Remove sympathetic nerves
10.72
NA
NA
7.11
7.88
1.57
NA
NA
19.40
20.17
09064831

A
Repair of digit nerve
10.18
NA
NA
6.67
6.97
1.41
NA
NA
18.26
18.56
09064832

A
Repair nerve add-on
5.65
NA
NA
2.36
2.79
0.85
NA
NA
8.86
9.29
ZZZ64834

A
Repair of hand or foot nerve
10.67
NA
NA
6.57
6.96
1.54
NA
NA
18.78
19.17
09064835

A
Repair of hand or foot nerve
11.55
NA
NA
7.32
7.60
1.73
NA
NA
20.60
20.88
09064836

A
Repair of hand or foot nerve
11.55
NA
NA
7.04
7.51
1.67
NA
NA
20.26
20.73
09064837

A
Repair nerve add-on
6.25
NA
NA
2.67
3.09
0.97
NA
NA
9.89
10.31
ZZZ64840

A
Repair of leg nerve
13.81
NA
NA
5.07
7.46
1.37
NA
NA
20.25
22.64
09064856

A
Repair/transpose nerve
14.89
NA
NA
8.60
9.04
2.12
NA
NA
25.61
26.05
09064857

A
Repair arm/leg nerve
15.64
NA
NA
8.93
9.46
2.21
NA
NA
26.78
27.31
09064858

A
Repair sciatic nerve
17.64
NA
NA
10.15
10.62
3.33
NA
NA
31.12
31.58
09064859

A
Nerve surgery
4.25
NA
NA
1.88
2.11
0.67
NA
NA
6.80
7.03
ZZZ64861

A
Repair of arm nerves
20.68
NA
NA
10.04
11.34
4.08
NA
NA
34.80
36.10
09064862

A
Repair of low back nerves
20.88
NA
NA
6.83
10.66
4.31
NA
NA
32.02
35.85
09064864

A
Repair of facial nerve
13.27
NA
NA
7.03
8.33
1.26
NA
NA
21.56
22.86
09064865

A
Repair of facial nerve
15.91
NA
NA
9.89
12.61
1.50
NA
NA
27.30
30.02
09064866

A
Fusion of facial/other nerve
16.65
NA
NA
12.27
12.94
2.04
NA
NA
30.96
31.63
09064868

A
Fusion of facial/other nerve
14.76
NA
NA
9.07
10.84
1.43
NA
NA
25.26
27.03
09064870

A
Fusion of facial/other nerve
16.90
NA
NA
8.42
8.65
1.30
NA
NA
26.62
26.85
09064872

A
Subsequent repair of nerve
1.99
NA
NA
0.81
1.01
0.29
NA
NA
3.09
3.29
ZZZ64874

A
Repair & revise nerve add-on
2.98
NA
NA
1.21
1.45
0.42
NA
NA
4.61
4.85
ZZZ64876

A
Repair nerve/shorten bone
3.37
NA
NA
0.78
1.50
0.47
NA
NA
4.62
5.34
ZZZ64885

A
Nerve graft, head or neck
17.50
NA
NA
8.84
10.91
1.63
NA
NA
27.97
30.04
09064886

A
Nerve graft, head or neck
20.72
NA
NA
9.68
12.58
2.08
NA
NA
32.48
35.38
09064890

A
Nerve graft, hand or foot
16.06
NA
NA
9.05
9.76
2.29
NA
NA
27.40
28.11
09064891

A
Nerve graft, hand or foot
17.17
NA
NA
9.87
8.15
1.63
NA
NA
28.67
26.95
09064892

A
Nerve graft, arm or leg
15.56
NA
NA
8.95
8.88
2.47
NA
NA
26.98
26.91
09064893

A
Nerve graft, arm or leg
16.69
NA
NA
9.67
9.81
2.61
NA
NA
28.97
29.11
09064895

A
Nerve graft, hand or foot
20.21
NA
NA
10.02
9.74
2.57
NA
NA
32.80
32.52
09064896

A
Nerve graft, hand or foot
21.75
NA
NA
11.89
11.21
3.16
NA
NA
36.80
36.12
09064897

A
Nerve graft, arm or leg
19.20
NA
NA
10.43
10.63
2.54
NA
NA
32.17
32.37
09064898

A
Nerve graft, arm or leg
20.76
NA
NA
11.28
11.66
2.77
NA
NA
34.81
35.19
09064901

A
Nerve graft add-on
10.20
NA
NA
3.82
4.90
1.37
NA
NA
15.39
16.47
ZZZ64902

A
Nerve graft add-on
11.81
NA
NA
4.25
5.53
1.55
NA
NA
17.61
18.89
ZZZ64905

A
Nerve pedicle transfer
14.93
NA
NA
6.84
8.08
2.00
NA
NA
23.77
25.01
09064907

A
Nerve pedicle transfer
19.85
NA
NA
6.41
10.99
3.16
NA
NA
29.42
34.00
09064999

C
Nervous system surgery
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY( print page 49171)65091

A
Revise eye
7.08
NA
NA
6.91
7.99
0.32
NA
NA
14.31
15.39
09065093

A
Revise eye with implant
6.86
NA
NA
7.00
8.28
0.34
NA
NA
14.20
15.48
09065101

A
Removal of eye
8.02
NA
NA
8.15
9.18
0.35
NA
NA
16.52
17.55
09065103

A
Remove eye/insert implant
8.56
NA
NA
8.37
9.39
0.37
NA
NA
17.30
18.32
09065105

A
Remove eye/attach implant
9.61
NA
NA
9.06
10.11
0.42
NA
NA
19.09
20.14
09065110

A
Removal of eye
15.31
NA
NA
11.58
13.15
0.81
NA
NA
27.70
29.27
09065112

A
Remove eye/revise socket
18.05
NA
NA
13.05
15.36
1.30
NA
NA
32.40
34.71
09065114

A
Remove eye/revise socket
19.19
NA
NA
13.69
15.68
1.02
NA
NA
33.90
35.89
09065125

A
Revise ocular implant
3.12
6.82
8.31
3.18
3.50
0.19
10.13
11.62
6.49
6.81
09065130

A
Insert ocular implant
8.14
NA
NA
7.92
8.85
0.35
NA
NA
16.41
17.34
09065135

A
Insert ocular implant
8.32
NA
NA
7.97
8.98
0.36
NA
NA
16.65
17.66
09065140

A
Attach ocular implant
9.14
NA
NA
8.59
9.55
0.40
NA
NA
18.13
19.09
09065150

A
Revise ocular implant
6.25
NA
NA
6.47
7.60
0.31
NA
NA
13.03
14.16
09065155

A
Reinsert ocular implant
9.78
NA
NA
8.85
10.07
0.50
NA
NA
19.13
20.35
09065175

A
Removal of ocular implant
7.15
NA
NA
7.27
8.18
0.31
NA
NA
14.73
15.64
09065205

A
Remove foreign body from eye
0.71
0.59
0.63
0.33
0.30
0.03
1.33
1.37
1.07
1.04
00065210

A
Remove foreign body from eye
0.84
0.74
0.79
0.41
0.39
0.04
1.62
1.67
1.29
1.27
00065220

A
Remove foreign body from eye
0.71
0.60
0.63
0.29
0.28
0.05
1.36
1.39
1.05
1.04
00065222

A
Remove foreign body from eye
0.93
0.81
0.87
0.43
0.39
0.04
1.78
1.84
1.40
1.36
00065235

A
Remove foreign body from eye
8.69
NA
NA
6.99
6.80
0.37
NA
NA
16.05
15.86
09065260

A
Remove foreign body from eye
12.19
NA
NA
9.03
9.50
0.57
NA
NA
21.79
22.26
09065265

A
Remove foreign body from eye
13.95
NA
NA
9.90
10.44
0.62
NA
NA
24.47
25.01
09065270

A
Repair of eye wound
1.90
3.88
4.89
1.22
1.35
0.09
5.87
6.88
3.21
3.34
01065272

A
Repair of eye wound
4.44
6.50
7.41
3.27
3.29
0.19
11.13
12.04
7.90
7.92
09065273

A
Repair of eye wound
4.98
NA
NA
3.43
3.54
0.22
NA
NA
8.63
8.74
09065275

A
Repair of eye wound
6.08
6.43
6.34
3.99
3.95
0.26
12.77
12.68
10.33
10.29
09065280

A
Repair of eye wound
8.78
NA
NA
6.02
6.18
0.38
NA
NA
15.18
15.34
09065285

A
Repair of eye wound
14.32
NA
NA
8.70
9.08
0.64
NA
NA
23.66
24.04
09065286

A
Repair of eye wound
6.38
8.96
10.60
4.53
4.60
0.27
15.61
17.25
11.18
11.25
09065290

A
Repair of eye socket wound
6.28
NA
NA
4.55
4.69
0.31
NA
NA
11.14
11.28
09065400

A
Removal of eye lesion
7.18
7.66
8.16
6.03
6.10
0.30
15.14
15.64
13.51
13.58
09065410

A
Biopsy of cornea
1.47
1.72
2.01
0.90
0.95
0.07
3.26
3.55
2.44
2.49
00065420

A
Removal of eye lesion
4.16
7.03
8.40
4.07
4.35
0.21
11.40
12.77
8.44
8.72
09065426

A
Removal of eye lesion
5.85
8.41
9.73
4.71
4.87
0.25
14.51
15.83
10.81
10.97
09065430

A
Corneal smear
1.47
1.13
1.25
0.90
0.96
0.07
2.67
2.79
2.44
2.50
00065435

A
Curette/treat cornea
0.92
0.89
0.97
0.67
0.70
0.04
1.85
1.93
1.63
1.66
00065436

A
Curette/treat cornea
4.68
3.88
4.04
3.55
3.64
0.21
8.77
8.93
8.44
8.53
09065450

A
Treatment of corneal lesion
3.27
3.76
3.99
3.68
3.88
0.16
7.19
7.42
7.11
7.31
09065600

A
Revision of cornea
4.02
4.58
4.90
3.51
3.39
0.17
8.77
9.09
7.70
7.58
09065710

A
Corneal transplant
13.97
NA
NA
10.49
11.02
0.61
NA
NA
25.07
25.60
09065730

A
Corneal transplant
15.87
NA
NA
11.29
11.84
0.70
NA
NA
27.86
28.41
09065750

A
Corneal transplant
16.48
NA
NA
11.00
11.73
0.74
NA
NA
28.22
28.95
09065755

A
Corneal transplant
16.37
NA
NA
10.97
11.66
0.73
NA
NA
28.07
28.76
09065770

A
Revise cornea with implant
19.28
NA
NA
12.09
12.92
0.87
NA
NA
32.24
33.07
09065772

A
Correction of astigmatism
4.91
4.99
5.40
4.04
4.11
0.21
10.11
10.52
9.16
9.23
09065775

A
Correction of astigmatism
6.66
NA
NA
5.46
5.83
0.28
NA
NA
12.40
12.77
09065780

A
Ocular reconst, transplant
10.23
NA
NA
9.18
10.01
0.44
NA
NA
19.85
20.68
09065781

A
Ocular reconst, transplant
17.64
NA
NA
11.94
13.24
0.44
NA
NA
30.02
31.32
09065782

A
Ocular reconst, transplant
14.98
NA
NA
10.53
11.63
0.44
NA
NA
25.95
27.05
09065800

A
Drainage of eye
1.91
1.45
1.71
1.07
1.15
0.09
3.45
3.71
3.07
3.15
00065805

A
Drainage of eye
1.91
1.76
2.07
1.07
1.16
0.09
3.76
4.07
3.07
3.16
00065810

A
Drainage of eye
5.61
NA
NA
4.82
4.73
0.24
NA
NA
10.67
10.58
09065815

A
Drainage of eye
5.79
8.14
9.54
4.72
4.79
0.25
14.18
15.58
10.76
10.83
09065820

A
Relieve inner eye pressure
8.62
NA
NA
7.88
8.76
0.40
NA
NA
16.90
17.78
09065850

A
Incision of eye
11.14
NA
NA
7.56
8.22
0.52
NA
NA
19.22
19.88
09065855

A
Laser surgery of eye
3.84
3.59
4.13
2.71
3.00
0.19
7.62
8.16
6.74
7.03
01065860

A
Incise inner eye adhesions
3.54
3.37
3.87
2.16
2.42
0.18
7.09
7.59
5.88
6.14
09065865

A
Incise inner eye adhesions
5.59
NA
NA
4.84
5.43
0.28
NA
NA
10.71
11.30
09065870

A
Incise inner eye adhesions
7.14
NA
NA
5.88
6.28
0.31
NA
NA
13.33
13.73
09065875

A
Incise inner eye adhesions
7.53
NA
NA
6.33
6.68
0.32
NA
NA
14.18
14.53
09065880

A
Incise inner eye adhesions
8.08
NA
NA
6.54
6.91
0.35
NA
NA
14.97
15.34
09065900

A
Remove eye lesion
12.16
NA
NA
9.15
9.98
0.54
NA
NA
21.85
22.68
09065920

A
Remove implant of eye
9.64
NA
NA
7.72
8.06
0.41
NA
NA
17.77
18.11
09065930

A
Remove blood clot from eye
8.18
NA
NA
5.98
6.62
0.37
NA
NA
14.53
15.17
09066020

A
Injection treatment of eye
1.59
2.49
2.96
1.31
1.41
0.08
4.16
4.63
2.98
3.08
01066030

A
Injection treatment of eye
1.25
2.36
2.81
1.18
1.26
0.06
3.67
4.12
2.49
2.57
010( print page 49172)66130

A
Remove eye lesion
7.68
7.75
9.15
5.04
5.47
0.38
15.81
17.21
13.10
13.53
09066150

A
Glaucoma surgery
10.04
NA
NA
9.04
9.31
0.46
NA
NA
19.54
19.81
09066155

A
Glaucoma surgery
10.03
NA
NA
9.02
9.27
0.41
NA
NA
19.46
19.71
09066160

A
Glaucoma surgery
11.90
NA
NA
9.78
10.09
0.50
NA
NA
22.18
22.49
09066165

A
Glaucoma surgery
9.75
NA
NA
8.97
9.17
0.40
NA
NA
19.12
19.32
09066170

A
Glaucoma surgery
14.39
NA
NA
11.90
12.14
0.60
NA
NA
26.89
27.13
09066172

A
Incision of eye
18.02
NA
NA
15.09
15.17
0.74
NA
NA
33.85
33.93
09066180

A
Implant eye shunt
15.91
NA
NA
10.05
10.58
0.71
NA
NA
26.67
27.20
09066185

A
Revise eye shunt
9.26
NA
NA
7.28
7.36
0.40
NA
NA
16.94
17.01
09066220

A
Repair eye lesion
8.89
NA
NA
7.21
7.13
0.40
NA
NA
16.50
16.42
09066225

A
Repair/graft eye lesion
12.28
NA
NA
8.41
8.65
0.55
NA
NA
21.24
21.48
09066250

A
Follow-up surgery of eye
6.85
9.51
11.15
5.42
5.47
0.30
16.66
18.30
12.57
12.62
09066500

A
Incision of iris
3.70
NA
NA
4.07
4.50
0.18
NA
NA
7.95
8.38
09066505

A
Incision of iris
4.07
NA
NA
4.43
4.85
0.20
NA
NA
8.70
9.12
09066600

A
Remove iris and lesion
9.80
NA
NA
8.55
8.30
0.43
NA
NA
18.78
18.53
09066605

A
Removal of iris
13.90
NA
NA
9.43
9.87
0.77
NA
NA
24.10
24.54
09066625

A
Removal of iris
5.12
NA
NA
4.34
4.63
0.26
NA
NA
9.72
10.01
09066630

A
Removal of iris
7.03
NA
NA
5.52
5.66
0.31
NA
NA
12.86
13.00
09066635

A
Removal of iris
7.12
NA
NA
5.55
5.69
0.31
NA
NA
12.98
13.12
09066680

A
Repair iris & ciliary body
6.18
NA
NA
5.23
5.26
0.27
NA
NA
11.68
11.71
09066682

A
Repair iris & ciliary body
7.08
NA
NA
6.92
6.69
0.31
NA
NA
14.31
14.08
09066700

A
Destruction, ciliary body
5.02
4.96
5.17
3.73
3.88
0.24
10.22
10.43
8.99
9.14
09066710

A
Ciliary transsleral therapy
5.02
4.73
5.06
3.71
3.81
0.23
9.98
10.31
8.96
9.06
09066711

A
Ciliary endoscopic ablation
7.60
NA
NA
6.49
6.48
0.30
NA
NA
14.39
14.38
09066720

A
Destruction, ciliary body
4.77
5.47
5.71
4.40
4.64
0.26
10.50
10.74
9.43
9.67
09066740

A
Destruction, ciliary body
5.02
4.68
4.99
3.73
3.91
0.23
9.93
10.24
8.98
9.16
09066761

A
Revision of iris
4.81
5.17
5.49
4.32
4.31
0.20
10.18
10.50
9.33
9.32
09066762

A
Revision of iris
5.20
5.26
5.55
4.20
4.27
0.23
10.69
10.98
9.63
9.70
09066770

A
Removal of inner eye lesion
5.92
5.71
5.99
4.74
4.79
0.26
11.89
12.17
10.92
10.97
09066820

A
Incision, secondary cataract
3.88
NA
NA
4.76
5.55
0.19
NA
NA
8.83
9.62
09066821

A
After cataract laser surgery
3.28
3.93
4.05
3.51
3.59
0.11
7.32
7.44
6.90
6.98
09066825

A
Reposition intraocular lens
8.72
NA
NA
8.01
8.80
0.40
NA
NA
17.13
17.92
09066830

A
Removal of lens lesion
9.19
NA
NA
6.57
6.86
0.36
NA
NA
16.12
16.41
09066840

A
Removal of lens material
8.90
NA
NA
6.51
6.77
0.39
NA
NA
15.80
16.06
09066850

A
Removal of lens material
10.23
NA
NA
7.31
7.56
0.45
NA
NA
17.99
18.24
09066852

A
Removal of lens material
11.09
NA
NA
7.65
7.99
0.49
NA
NA
19.23
19.57
09066920

A
Extraction of lens
9.85
NA
NA
6.87
7.19
0.44
NA
NA
17.16
17.48
09066930

A
Extraction of lens
11.29
NA
NA
7.73
8.04
0.49
NA
NA
19.51
19.82
09066940

A
Extraction of lens
10.05
NA
NA
7.25
7.51
0.43
NA
NA
17.73
17.99
09066982

A
Cataract surgery, complex
14.73
NA
NA
9.28
9.72
0.63
NA
NA
24.64
25.08
09066983

A
Cataract surg w/iol, 1 stage
10.11
NA
NA
6.30
6.16
0.14
NA
NA
16.55
16.41
09066984

A
Cataract surg w/iol, 1 stage
10.28
NA
NA
6.62
7.22
0.39
NA
NA
17.29
17.89
09066985

A
Insert lens prosthesis
9.63
NA
NA
7.33
7.42
0.36
NA
NA
17.32
17.41
09066986

A
Exchange lens prosthesis
12.26
NA
NA
8.38
8.97
0.60
NA
NA
21.24
21.83
09066990

A
Ophthalmic endoscope add-on
1.51
NA
NA
0.57
0.66
0.07
NA
NA
2.15
2.24
ZZZ66999

C
Eye surgery procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY67005

A
Partial removal of eye fluid
5.69
NA
NA
4.72
4.83
0.28
NA
NA
10.69
10.80
09067010

A
Partial removal of eye fluid
6.86
NA
NA
5.16
5.35
0.34
NA
NA
12.36
12.55
09067015

A
Release of eye fluid
6.91
NA
NA
5.88
6.31
0.34
NA
NA
13.13
13.56
09067025

A
Replace eye fluid
7.83
8.11
8.94
6.11
6.19
0.34
16.28
17.11
14.28
14.36
09067027

A
Implant eye drug system
11.33
NA
NA
7.61
7.90
0.54
NA
NA
19.48
19.77
09067028

A
Injection eye drug
2.52
2.23
2.58
1.30
1.42
0.12
4.87
5.22
3.94
4.06
00067030

A
Incise inner eye strands
5.83
NA
NA
5.77
5.83
0.24
NA
NA
11.84
11.90
09067031

A
Laser surgery, eye strands
4.29
4.21
4.50
3.53
3.61
0.18
8.68
8.97
8.00
8.08
09067036

A
Removal of inner eye fluid
13.00
NA
NA
8.35
8.93
0.58
NA
NA
21.93
22.51
09067038

A
Strip retinal membrane
23.15
NA
NA
13.97
15.11
1.04
NA
NA
38.16
39.30
090( print page 49173)67039

A
Laser treatment of retina
16.25
NA
NA
11.08
11.91
0.71
NA
NA
28.04
28.87
09067040

A
Laser treatment of retina
19.08
NA
NA
12.45
13.37
0.85
NA
NA
32.38
33.30
09067101

A
Repair detached retina
8.52
8.75
9.03
6.38
6.49
0.37
17.64
17.92
15.27
15.38
09067105

A
Repair detached retina
8.28
7.65
7.97
5.99
6.11
0.37
16.30
16.62
14.64
14.75
09067107

A
Repair detached retina
16.26
NA
NA
10.74
11.16
0.73
NA
NA
27.73
28.15
09067108

A
Repair detached retina
22.39
NA
NA
13.45
14.18
1.02
NA
NA
36.86
37.59
09067110

A
Repair detached retina
9.93
9.22
9.98
7.20
7.34
0.44
19.59
20.35
17.57
17.71
09067112

A
Rerepair detached retina
18.33
NA
NA
11.27
11.68
0.83
NA
NA
30.43
30.84
09067115

A
Release encircling material
5.86
NA
NA
5.07
5.08
0.25
NA
NA
11.18
11.19
09067120

A
Remove eye implant material
6.85
7.57
8.33
5.45
5.51
0.29
14.71
15.47
12.59
12.65
09067121

A
Remove eye implant material
11.90
NA
NA
8.25
8.46
0.53
NA
NA
20.68
20.89
09067141

A
Treatment of retina
5.94
5.59
5.79
4.81
4.85
0.26
11.79
11.99
11.01
11.05
09067145

A
Treatment of retina
6.11
5.51
5.67
4.87
4.92
0.27
11.89
12.05
11.25
11.30
09067208

A
Treatment of retinal lesion
7.44
5.84
6.05
5.38
5.48
0.33
13.61
13.82
13.15
13.25
09067210

A
Treatment of retinal lesion
9.31
6.14
6.46
5.65
5.82
0.44
15.89
16.21
15.40
15.57
09067218

A
Treatment of retinal lesion
20.14
NA
NA
11.08
11.88
0.92
NA
NA
32.14
32.94
09067220

A
Treatment of choroid lesion
14.11
9.55
10.20
8.47
8.88
0.65
24.31
24.96
23.23
23.64
09067221

R
Ocular photodynamic ther
3.45
3.03
4.01
1.45
1.71
0.20
6.68
7.66
5.10
5.36
00067225

A
Eye photodynamic ther add-on
0.47
0.24
0.25
0.18
0.20
0.02
0.73
0.74
0.67
0.69
ZZZ67227

A
Treatment of retinal lesion
7.32
6.19
6.48
5.33
5.47
0.33
13.84
14.13
12.98
13.12
09067228

A
Treatment of retinal lesion
13.60
10.27
11.18
7.98
8.40
0.63
24.50
25.41
22.21
22.63
09067250

A
Reinforce eye wall
9.40
NA
NA
7.90
8.85
0.47
NA
NA
17.77
18.72
09067255

A
Reinforce/graft eye wall
9.89
NA
NA
8.71
9.60
0.44
NA
NA
19.04
19.93
09067299

C
Eye surgery procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY67311

A
Revise eye muscle
7.52
NA
NA
5.68
5.94
0.37
NA
NA
13.57
13.83
09067312

A
Revise two eye muscles
9.41
NA
NA
6.42
6.67
0.43
NA
NA
16.26
16.51
09067314

A
Revise eye muscle
8.51
NA
NA
6.37
6.51
0.39
NA
NA
15.27
15.41
09067316

A
Revise two eye muscles
10.65
NA
NA
7.18
7.42
0.49
NA
NA
18.32
18.56
09067318

A
Revise eye muscle(s)
8.84
NA
NA
6.76
6.89
0.41
NA
NA
16.01
16.14
09067320

A
Revise eye muscle(s) add-on
4.32
NA
NA
1.62
1.87
0.22
NA
NA
6.16
6.41
ZZZ67331

A
Eye surgery follow-up add-on
4.05
NA
NA
1.51
1.75
0.21
NA
NA
5.77
6.01
ZZZ67332

A
Rerevise eye muscles add-on
4.48
NA
NA
1.68
1.94
0.23
NA
NA
6.39
6.65
ZZZ67334

A
Revise eye muscle w/suture
3.97
NA
NA
1.48
1.71
0.20
NA
NA
5.65
5.88
ZZZ67335

A
Eye suture during surgery
2.49
NA
NA
0.93
1.07
0.13
NA
NA
3.55
3.69
ZZZ67340

A
Revise eye muscle add-on
4.92
NA
NA
1.84
2.11
0.25
NA
NA
7.01
7.28
ZZZ67343

A
Release eye tissue
8.22
NA
NA
6.25
6.45
0.37
NA
NA
14.84
15.04
09067345

A
Destroy nerve of eye muscle
2.96
2.27
2.50
1.77
1.95
0.17
5.40
5.63
4.90
5.08
01067350

A
Biopsy eye muscle
2.87
NA
NA
1.69
1.83
0.15
NA
NA
4.71
4.85
00067399

C
Eye muscle surgery procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY67400

A
Explore/biopsy eye socket
10.88
NA
NA
9.71
10.87
0.56
NA
NA
21.15
22.31
09067405

A
Explore/drain eye socket
8.92
NA
NA
8.48
9.45
0.44
NA
NA
17.84
18.81
09067412

A
Explore/treat eye socket
10.12
NA
NA
8.81
10.40
0.48
NA
NA
19.41
21.00
09067413

A
Explore/treat eye socket
9.99
NA
NA
8.94
10.31
0.50
NA
NA
19.43
20.80
09067414

A
Explr/decompress eye socket
17.72
NA
NA
11.99
12.03
0.65
NA
NA
30.36
30.40
09067415

A
Aspiration, orbital contents
1.76
NA
NA
0.63
0.73
0.09
NA
NA
2.48
2.58
00067420

A
Explore/treat eye socket
21.52
NA
NA
14.59
16.69
1.15
NA
NA
37.26
39.36
09067430

A
Explore/treat eye socket
14.87
NA
NA
12.66
14.33
0.86
NA
NA
28.39
30.06
09067440

A
Explore/drain eye socket
14.45
NA
NA
12.12
13.73
0.70
NA
NA
27.27
28.88
09067445

A
Explr/decompress eye socket
18.90
NA
NA
12.58
13.58
0.90
NA
NA
32.38
33.38
09067450

A
Explore/biopsy eye socket
14.99
NA
NA
12.63
14.18
0.68
NA
NA
28.30
29.85
09067500

A
Inject/treat eye socket
1.44
0.61
0.66
0.48
0.34
0.05
2.10
2.15
1.97
1.83
00067505

A
Inject/treat eye socket
1.27
0.53
0.65
0.40
0.33
0.05
1.85
1.97
1.72
1.65
00067515

A
Inject/treat eye socket
1.40
0.81
0.65
0.64
0.45
0.03
2.24
2.08
2.07
1.88
00067550

A
Insert eye socket implant
11.42
NA
NA
10.04
10.99
0.72
NA
NA
22.18
23.13
09067560

A
Revise eye socket implant
11.83
NA
NA
10.07
11.05
0.60
NA
NA
22.50
23.48
09067570

A
Decompress optic nerve
14.13
NA
NA
11.33
13.02
0.68
NA
NA
26.14
27.83
09067599

C
Orbit surgery procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY67700

A
Drainage of eyelid abscess
1.35
4.42
5.62
1.21
1.26
0.07
5.84
7.04
2.63
2.68
01067710

A
Incision of eyelid
1.02
3.79
4.98
1.10
1.18
0.05
4.86
6.05
2.17
2.25
01067715

A
Incision of eyelid fold
1.22
3.91
5.01
1.18
1.26
0.06
5.19
6.29
2.46
2.54
01067800

A
Remove eyelid lesion
1.38
1.44
1.58
0.93
1.01
0.07
2.89
3.03
2.38
2.46
01067801

A
Remove eyelid lesions
1.88
1.73
1.90
1.12
1.23
0.09
3.70
3.87
3.09
3.20
01067805

A
Remove eyelid lesions
2.22
2.25
2.45
1.46
1.60
0.11
4.58
4.78
3.79
3.93
01067808

A
Remove eyelid lesion(s)
4.42
NA
NA
3.70
3.75
0.19
NA
NA
8.31
8.36
09067810

A
Biopsy of eyelid
1.48
3.87
3.47
0.66
0.68
0.06
5.41
5.01
2.20
2.22
00067820

A
Revise eyelashes
0.71
0.45
0.56
0.52
0.55
0.04
1.20
1.31
1.27
1.30
000( print page 49174)67825

A
Revise eyelashes
1.38
1.44
1.66
1.30
1.38
0.07
2.89
3.11
2.75
2.83
01067830

A
Revise eyelashes
1.70
4.10
5.17
1.36
1.47
0.08
5.88
6.95
3.14
3.25
01067835

A
Revise eyelashes
5.55
NA
NA
4.18
4.51
0.28
NA
NA
10.01
10.34
09067840

A
Remove eyelid lesion
2.04
4.01
5.11
1.50
1.61
0.10
6.15
7.25
3.64
3.75
01067850

A
Treat eyelid lesion
1.69
3.26
3.34
1.43
1.46
0.07
5.02
5.10
3.19
3.22
01067875

A
Closure of eyelid by suture
1.35
2.45
3.09
0.86
0.92
0.07
3.87
4.51
2.28
2.34
00067880

A
Revision of eyelid
4.42
5.58
6.35
3.67
3.77
0.19
10.19
10.96
8.28
8.38
09067882

A
Revision of eyelid
5.81
6.56
7.36
4.62
4.76
0.25
12.62
13.42
10.68
10.82
09067900

A
Repair brow defect
6.63
7.52
8.68
4.72
5.12
0.38
14.53
15.69
11.73
12.13
09067901

A
Repair eyelid defect
7.39
9.25
6.36
5.46
5.42
0.54
17.18
14.29
13.39
13.35
09067902

A
Repair eyelid defect
9.60
NA
NA
6.58
5.74
0.60
NA
NA
16.78
15.94
09067903

A
Repair eyelid defect
6.36
6.82
8.88
4.48
5.25
0.47
13.65
15.71
11.31
12.08
09067904

A
Repair eyelid defect
7.75
8.47
9.34
5.54
5.31
0.41
16.63
17.50
13.70
13.47
09067906

A
Repair eyelid defect
6.78
NA
NA
4.63
4.93
0.46
NA
NA
11.87
12.17
09067908

A
Repair eyelid defect
5.12
5.71
6.40
4.25
5.07
0.28
11.11
11.80
9.65
10.47
09067909

A
Revise eyelid defect
5.39
6.39
7.62
4.31
4.79
0.31
12.09
13.32
10.01
10.49
09067911

A
Revise eyelid defect
7.30
NA
NA
5.21
4.89
0.31
NA
NA
12.82
12.50
09067912

A
Correction eyelid w/implant
6.17
13.18
17.49
4.74
5.33
0.28
19.63
23.94
11.19
11.78
09067914

A
Repair eyelid defect
3.67
4.88
5.98
2.76
2.98
0.19
8.74
9.84
6.62
6.84
09067915

A
Repair eyelid defect
3.18
4.54
5.62
2.57
2.74
0.16
7.88
8.96
5.91
6.08
09067916

A
Repair eyelid defect
5.30
6.53
7.67
4.26
4.64
0.28
12.11
13.25
9.84
10.22
09067917

A
Repair eyelid defect
6.01
6.91
8.07
4.54
4.94
0.36
13.28
14.44
10.91
11.31
09067921

A
Repair eyelid defect
3.39
4.75
5.83
2.64
2.83
0.17
8.31
9.39
6.20
6.39
09067922

A
Repair eyelid defect
3.06
4.44
5.54
2.51
2.69
0.15
7.65
8.75
5.72
5.90
09067923

A
Repair eyelid defect
5.87
6.63
7.75
4.46
4.84
0.30
12.80
13.92
10.63
11.01
09067924

A
Repair eyelid defect
5.78
7.11
8.47
4.19
4.56
0.30
13.19
14.55
10.27
10.64
09067930

A
Repair eyelid wound
3.60
4.50
5.41
1.85
2.09
0.19
8.29
9.20
5.64
5.88
01067935

A
Repair eyelid wound
6.21
6.95
8.13
3.70
4.23
0.39
13.55
14.73
10.30
10.83
09067938

A
Remove eyelid foreign body
1.33
3.95
5.02
1.27
1.26
0.06
5.34
6.41
2.66
2.65
01067950

A
Revision of eyelid
5.81
6.80
8.17
4.47
5.03
0.36
12.97
14.34
10.64
11.20
09067961

A
Revision of eyelid
5.68
7.00
8.26
4.43
4.88
0.33
13.01
14.27
10.44
10.89
09067966

A
Revision of eyelid
8.75
8.29
8.92
5.93
5.65
0.37
17.41
18.04
15.05
14.77
09067971

A
Reconstruction of eyelid
9.78
NA
NA
6.40
7.06
0.53
NA
NA
16.71
17.37
09067973

A
Reconstruction of eyelid
12.85
NA
NA
8.02
8.99
0.75
NA
NA
21.62
22.59
09067974

A
Reconstruction of eyelid
12.82
NA
NA
8.04
8.93
0.75
NA
NA
21.61
22.50
09067975

A
Reconstruction of eyelid
9.12
NA
NA
6.16
6.75
0.50
NA
NA
15.78
16.37
09067999

C
Revision of eyelid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY68020

A
Incise/drain eyelid lining
1.37
1.28
1.38
1.09
1.18
0.06
2.71
2.81
2.52
2.61
01068040

A
Treatment of eyelid lesions
0.85
0.62
0.69
0.37
0.42
0.04
1.51
1.58
1.26
1.31
00068100

A
Biopsy of eyelid lining
1.35
2.41
3.04
0.88
0.93
0.07
3.83
4.46
2.30
2.35
00068110

A
Remove eyelid lining lesion
1.77
3.15
3.86
1.52
1.62
0.09
5.01
5.72
3.38
3.48
01068115

A
Remove eyelid lining lesion
2.36
4.44
5.58
1.74
1.87
0.12
6.92
8.06
4.22
4.35
01068130

A
Remove eyelid lining lesion
4.92
6.84
8.24
4.16
4.49
0.24
12.00
13.40
9.32
9.65
09068135

A
Remove eyelid lining lesion
1.84
1.63
1.77
1.51
1.62
0.09
3.56
3.70
3.44
3.55
01068200

A
Treat eyelid by injection
0.49
0.47
0.52
0.30
0.32
0.02
0.98
1.03
0.81
0.83
00068320

A
Revise/graft eyelid lining
6.36
9.42
10.82
5.47
5.51
0.27
16.05
17.45
12.10
12.14
09068325

A
Revise/graft eyelid lining
8.35
NA
NA
6.16
6.45
0.44
NA
NA
14.95
15.24
09068326

A
Revise/graft eyelid lining
8.14
NA
NA
6.12
6.34
0.35
NA
NA
14.61
14.83
09068328

A
Revise/graft eyelid lining
9.17
NA
NA
6.66
7.13
0.54
NA
NA
16.37
16.84
09068330

A
Revise eyelid lining
5.57
7.64
8.97
4.59
4.69
0.24
13.45
14.78
10.40
10.50
09068335

A
Revise/graft eyelid lining
8.18
NA
NA
6.13
6.32
0.36
NA
NA
14.67
14.86
09068340

A
Separate eyelid adhesions
4.79
7.07
8.42
3.99
4.07
0.21
12.07
13.42
8.99
9.07
09068360

A
Revise eyelid lining
4.99
6.60
7.68
4.07
4.15
0.22
11.81
12.89
9.28
9.36
09068362

A
Revise eyelid lining
8.33
NA
NA
6.18
6.35
0.36
NA
NA
14.87
15.04
09068371

A
Harvest eye tissue, alograft
4.89
NA
NA
4.18
4.59
0.44
NA
NA
9.51
9.92
01068399

C
Eyelid lining surgery
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY( print page 49175)68400

A
Incise/drain tear gland
1.69
4.44
5.54
1.22
1.67
0.08
6.21
7.31
2.99
3.44
01068420

A
Incise/drain tear sac
2.30
4.70
5.82
1.46
1.94
0.11
7.11
8.23
3.87
4.35
01068440

A
Incise tear duct opening
0.94
1.28
1.88
1.21
1.26
0.05
2.27
2.87
2.20
2.25
01068500

A
Removal of tear gland
12.38
NA
NA
8.97
9.54
0.55
NA
NA
21.90
22.47
09068505

A
Partial removal, tear gland
12.30
NA
NA
9.11
10.27
0.55
NA
NA
21.96
23.12
09068510

A
Biopsy of tear gland
4.60
5.37
6.84
2.11
2.10
0.23
10.20
11.67
6.94
6.93
00068520

A
Removal of tear sac
8.50
NA
NA
6.68
7.24
0.37
NA
NA
15.55
16.11
09068525

A
Biopsy of tear sac
4.42
NA
NA
1.64
1.93
0.22
NA
NA
6.28
6.57
00068530

A
Clearance of tear duct
3.65
5.75
7.57
2.14
2.52
0.18
9.58
11.40
5.97
6.35
01068540

A
Remove tear gland lesion
11.83
NA
NA
8.71
9.22
0.52
NA
NA
21.06
21.57
09068550

A
Remove tear gland lesion
14.74
NA
NA
10.52
11.14
0.80
NA
NA
26.06
26.68
09068700

A
Repair tear ducts
7.59
NA
NA
5.74
5.92
0.32
NA
NA
13.65
13.83
09068705

A
Revise tear duct opening
2.06
3.12
3.91
1.63
1.75
0.10
5.28
6.07
3.79
3.91
01068720

A
Create tear sac drain
9.70
NA
NA
7.10
7.67
0.44
NA
NA
17.24
17.81
09068745

A
Create tear duct drain
9.62
NA
NA
7.45
7.76
0.52
NA
NA
17.59
17.90
09068750

A
Create tear duct drain
9.78
NA
NA
7.64
8.11
0.43
NA
NA
17.85
18.32
09068760

A
Close tear duct opening
1.73
2.66
3.32
1.50
1.60
0.09
4.48
5.14
3.32
3.42
01068761

A
Close tear duct opening
1.36
1.88
2.17
1.28
1.31
0.06
3.30
3.59
2.70
2.73
01068770

A
Close tear system fistula
8.01
NA
NA
5.88
3.86
0.35
NA
NA
14.24
12.22
09068801

A
Dilate tear duct opening
0.94
1.82
1.91
1.45
1.47
0.05
2.81
2.90
2.44
2.46
01068810

A
Probe nasolacrimal duct
2.59
3.49
3.62
2.76
2.69
0.10
6.18
6.31
5.45
5.38
01068811

A
Probe nasolacrimal duct
2.35
NA
NA
2.17
2.35
0.13
NA
NA
4.65
4.83
01068815

A
Probe nasolacrimal duct
3.20
6.57
7.82
2.49
2.73
0.17
9.94
11.19
5.86
6.10
01068840

A
Explore/irrigate tear ducts
1.25
1.56
1.59
1.32
1.17
0.06
2.87
2.90
2.63
2.48
01068850

A
Injection for tear sac x-ray
0.80
0.72
0.84
0.60
0.66
0.04
1.56
1.68
1.44
1.50
00068899

C
Tear duct system surgery
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY69000

A
Drain external ear lesion
1.45
2.70
2.84
1.24
1.33
0.12
4.27
4.41
2.81
2.90
01069005

A
Drain external ear lesion
2.11
2.74
2.88
1.45
1.74
0.17
5.02
5.16
3.73
4.02
01069020

A
Drain outer ear canal lesion
1.48
3.84
3.95
1.76
1.99
0.12
5.44
5.55
3.36
3.59
01069100

A
Biopsy of external ear
0.81
1.80
1.73
0.38
0.39
0.03
2.64
2.57
1.22
1.23
00069105

A
Biopsy of external ear canal
0.85
2.47
2.37
0.65
0.74
0.07
3.39
3.29
1.57
1.66
00069110

A
Remove external ear, partial
3.43
7.50
6.93
4.23
4.41
0.30
11.23
10.66
7.96
8.14
09069120

A
Removal of external ear
4.04
NA
NA
5.09
5.91
0.38
NA
NA
9.51
10.33
09069140

A
Remove ear canal lesion(s)
7.96
NA
NA
12.30
13.04
0.65
NA
NA
20.91
21.65
09069145

A
Remove ear canal lesion(s)
2.62
6.53
5.97
3.10
3.25
0.21
9.36
8.80
5.93
6.08
09069150

A
Extensive ear canal surgery
13.41
NA
NA
10.55
12.69
1.22
NA
NA
25.18
27.32
09069155

A
Extensive ear/neck surgery
22.96
NA
NA
15.01
18.41
1.92
NA
NA
39.89
43.29
09069200

A
Clear outer ear canal
0.77
2.03
2.29
0.57
0.56
0.06
2.86
3.12
1.40
1.39
00069205

A
Clear outer ear canal
1.20
NA
NA
1.14
1.31
0.10
NA
NA
2.44
2.61
01069210

A
Remove impacted ear wax
0.61
0.55
0.61
0.16
0.21
0.05
1.21
1.27
0.82
0.87
00069220

A
Clean out mastoid cavity
0.83
2.37
2.36
0.61
0.70
0.07
3.27
3.26
1.51
1.60
00069222

A
Clean out mastoid cavity
1.40
3.66
3.80
1.73
1.98
0.12
5.18
5.32
3.25
3.50
01069300

R
Revise external ear
6.35
9.61
5.57
4.51
4.29
0.72
16.68
12.64
11.58
11.36
YYY69310

A
Rebuild outer ear canal
10.77
NA
NA
14.19
15.76
0.85
NA
NA
25.81
27.38
09069320

A
Rebuild outer ear canal
16.93
NA
NA
18.16
20.92
1.37
NA
NA
36.46
39.22
09069399

C
Outer ear surgery procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY69400

A
Inflate middle ear canal
0.83
2.60
2.27
0.61
0.66
0.07
3.50
3.17
1.51
1.56
00069401

A
Inflate middle ear canal
0.63
1.46
1.30
0.56
0.63
0.05
2.14
1.98
1.24
1.31
00069405

A
Catheterize middle ear canal
2.63
3.38
3.47
1.78
2.18
0.21
6.22
6.31
4.62
5.02
01069420

A
Incision of eardrum
1.33
3.05
3.13
1.41
1.55
0.11
4.49
4.57
2.85
2.99
01069421

A
Incision of eardrum
1.73
NA
NA
1.68
2.04
0.15
NA
NA
3.56
3.92
01069424

A
Remove ventilating tube
0.85
2.18
2.18
0.62
0.67
0.07
3.10
3.10
1.54
1.59
00069433

A
Create eardrum opening
1.52
3.06
3.08
1.44
1.59
0.13
4.71
4.73
3.09
3.24
01069436

A
Create eardrum opening
1.96
NA
NA
1.72
2.15
0.19
NA
NA
3.87
4.30
01069440

A
Exploration of middle ear
7.56
NA
NA
8.31
8.66
0.61
NA
NA
16.48
16.83
09069450

A
Eardrum revision
5.56
NA
NA
6.96
7.01
0.45
NA
NA
12.97
13.02
09069501

A
Mastoidectomy
9.06
NA
NA
7.80
8.70
0.73
NA
NA
17.59
18.49
09069502

A
Mastoidectomy
12.36
NA
NA
10.02
11.20
1.00
NA
NA
23.38
24.56
09069505

A
Remove mastoid structures
12.97
NA
NA
14.81
16.60
1.05
NA
NA
28.83
30.62
09069511

A
Extensive mastoid surgery
13.50
NA
NA
14.89
16.83
1.09
NA
NA
29.48
31.42
09069530

A
Extensive mastoid surgery
20.15
NA
NA
17.97
20.72
1.54
NA
NA
39.66
42.41
09069535

A
Remove part of temporal bone
37.17
NA
NA
24.19
30.02
2.92
NA
NA
64.28
70.11
09069540

A
Remove ear lesion
1.20
3.62
3.71
1.70
1.90
0.10
4.92
5.01
3.00
3.20
01069550

A
Remove ear lesion
10.97
NA
NA
13.06
14.41
0.89
NA
NA
24.92
26.27
09069552

A
Remove ear lesion
19.61
NA
NA
16.55
19.64
1.59
NA
NA
37.75
40.84
09069554

A
Remove ear lesion
35.63
NA
NA
22.41
28.35
2.91
NA
NA
60.95
66.89
090( print page 49176)69601

A
Mastoid surgery revision
13.22
NA
NA
10.84
12.21
1.07
NA
NA
25.13
26.50
09069602

A
Mastoid surgery revision
13.56
NA
NA
11.56
12.81
1.10
NA
NA
26.22
27.47
09069603

A
Mastoid surgery revision
14.00
NA
NA
15.03
17.53
1.14
NA
NA
30.17
32.67
09069604

A
Mastoid surgery revision
14.00
NA
NA
11.67
13.19
1.14
NA
NA
26.81
28.33
09069605

A
Mastoid surgery revision
18.46
NA
NA
17.50
20.09
1.50
NA
NA
37.46
40.05
09069610

A
Repair of eardrum
4.42
4.47
5.28
2.30
3.03
0.36
9.25
10.06
7.08
7.81
01069620

A
Repair of eardrum
5.88
10.04
10.85
5.29
6.04
0.48
16.40
17.21
11.65
12.40
09069631

A
Repair eardrum structures
9.85
NA
NA
10.50
11.03
0.80
NA
NA
21.15
21.68
09069632

A
Rebuild eardrum structures
12.73
NA
NA
12.08
13.12
1.03
NA
NA
25.84
26.88
09069633

A
Rebuild eardrum structures
12.08
NA
NA
11.91
12.77
0.98
NA
NA
24.97
25.83
09069635

A
Repair eardrum structures
13.31
NA
NA
14.83
16.26
1.08
NA
NA
29.22
30.65
09069636

A
Rebuild eardrum structures
15.20
NA
NA
16.60
18.63
1.23
NA
NA
33.03
35.06
09069637

A
Rebuild eardrum structures
15.09
NA
NA
16.58
18.56
1.22
NA
NA
32.89
34.87
09069641

A
Revise middle ear & mastoid
12.69
NA
NA
11.31
12.41
1.03
NA
NA
25.03
26.13
09069642

A
Revise middle ear & mastoid
16.81
NA
NA
14.05
15.72
1.36
NA
NA
32.22
33.89
09069643

A
Revise middle ear & mastoid
15.36
NA
NA
12.81
14.32
1.24
NA
NA
29.41
30.92
09069644

A
Revise middle ear & mastoid
17.00
NA
NA
17.09
19.57
1.37
NA
NA
35.46
37.94
09069645

A
Revise middle ear & mastoid
16.48
NA
NA
17.01
19.27
1.33
NA
NA
34.82
37.08
09069646

A
Revise middle ear & mastoid
18.14
NA
NA
17.42
19.93
1.46
NA
NA
37.02
39.53
09069650

A
Release middle ear bone
9.65
NA
NA
8.64
9.59
0.78
NA
NA
19.07
20.02
09069660

A
Revise middle ear bone
11.88
NA
NA
9.52
10.77
0.96
NA
NA
22.36
23.61
09069661

A
Revise middle ear bone
15.72
NA
NA
12.17
14.07
1.27
NA
NA
29.16
31.06
09069662

A
Revise middle ear bone
15.42
NA
NA
11.29
13.14
1.25
NA
NA
27.96
29.81
09069666

A
Repair middle ear structures
9.74
NA
NA
8.92
9.71
0.79
NA
NA
19.45
20.24
09069667

A
Repair middle ear structures
9.75
NA
NA
8.83
9.69
0.79
NA
NA
19.37
20.23
09069670

A
Remove mastoid air cells
11.55
NA
NA
10.15
11.32
0.93
NA
NA
22.63
23.80
09069676

A
Remove middle ear nerve
9.51
NA
NA
9.63
10.47
0.81
NA
NA
19.95
20.79
09069700

A
Close mastoid fistula
8.22
NA
NA
7.65
8.84
0.67
NA
NA
16.54
17.73
09069711

A
Remove/repair hearing aid
10.42
NA
NA
9.42
10.45
0.83
NA
NA
20.67
21.70
09069714

A
Implant temple bone w/stimul
14.23
NA
NA
10.56
12.14
1.13
NA
NA
25.92
27.50
09069715

A
Temple bne implnt w/stimulat
18.72
NA
NA
11.94
14.26
1.48
NA
NA
32.14
34.46
09069717

A
Temple bone implant revision
15.21
NA
NA
11.31
13.68
0.90
NA
NA
27.42
29.79
09069718

A
Revise temple bone implant
18.97
NA
NA
20.26
16.54
3.21
NA
NA
42.44
38.72
09069720

A
Release facial nerve
14.48
NA
NA
12.75
14.08
1.16
NA
NA
28.39
29.72
09069725

A
Release facial nerve
27.36
NA
NA
16.30
19.17
2.44
NA
NA
46.10
48.97
09069740

A
Repair facial nerve
16.12
NA
NA
11.17
12.85
1.27
NA
NA
28.56
30.24
09069745

A
Repair facial nerve
16.84
NA
NA
11.87
14.20
1.14
NA
NA
29.85
32.18
09069799

C
Middle ear surgery procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY69801

A
Incise inner ear
8.55
NA
NA
8.75
9.28
0.69
NA
NA
17.99
18.52
09069802

A
Incise inner ear
13.32
NA
NA
10.54
11.88
1.06
NA
NA
24.92
26.26
09069805

A
Explore inner ear
14.49
NA
NA
9.80
11.36
1.12
NA
NA
25.41
26.97
09069806

A
Explore inner ear
12.45
NA
NA
9.37
10.62
1.00
NA
NA
22.82
24.07
09069820

A
Establish inner ear window
10.32
NA
NA
9.83
10.87
0.90
NA
NA
21.05
22.09
09069840

A
Revise inner ear window
10.24
NA
NA
11.67
12.80
0.79
NA
NA
22.70
23.83
09069905

A
Remove inner ear
11.08
NA
NA
10.08
11.03
0.90
NA
NA
22.06
23.01
09069910

A
Remove inner ear & mastoid
13.73
NA
NA
9.79
11.39
1.07
NA
NA
24.59
26.19
09069915

A
Incise inner ear nerve
22.57
NA
NA
13.38
15.69
1.69
NA
NA
37.64
39.95
09069930

A
Implant cochlear device
17.54
NA
NA
11.81
14.02
1.36
NA
NA
30.71
32.92
09069949

C
Inner ear surgery procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY69950

A
Incise inner ear nerve
27.38
NA
NA
15.12
17.96
2.28
NA
NA
44.78
47.62
09069955

A
Release facial nerve
29.14
NA
NA
17.30
20.36
2.48
NA
NA
48.92
51.98
09069960

A
Release inner ear canal
29.14
NA
NA
15.41
18.89
2.17
NA
NA
46.72
50.20
09069970

A
Remove inner ear lesion
32.13
NA
NA
17.78
21.90
2.41
NA
NA
52.32
56.44
09069979

C
Temporal bone surgery
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYY69990

R
Microsurgery add-on
3.46
NA
NA
1.29
1.67
0.89
NA
NA
5.64
6.02
ZZZ70010

A
Contrast x-ray of brain
1.19
2.77
4.23
NA
NA
0.27
4.23
5.69
NA
NA
XXX( print page 49177)70010
26
A
Contrast x-ray of brain
1.19
0.37
0.39
0.37
0.39
0.05
1.61
1.63
1.61
1.63
XXX70010
TC
A
Contrast x-ray of brain
0.00
2.40
3.85
NA
NA
0.22
2.62
4.07
NA
NA
XXX70015

A
Contrast x-ray of brain
1.19
2.85
2.01
NA
NA
0.16
4.20
3.36
NA
NA
XXX70015
26
A
Contrast x-ray of brain
1.19
0.38
0.39
0.38
0.39
0.08
1.65
1.66
1.65
1.66
XXX70015
TC
A
Contrast x-ray of brain
0.00
2.47
1.63
NA
NA
0.08
2.55
1.71
NA
NA
XXX70030

A
X-ray eye for foreign body
0.17
0.60
0.51
NA
NA
0.03
0.80
0.71
NA
NA
XXX70030
26
A
X-ray eye for foreign body
0.17
0.05
0.06
0.05
0.06
0.01
0.23
0.24
0.23
0.24
XXX70030
TC
A
X-ray eye for foreign body
0.00
0.55
0.45
NA
NA
0.02
0.57
0.47
NA
NA
XXX70100

A
X-ray exam of jaw
0.18
0.63
0.59
NA
NA
0.03
0.84
0.80
NA
NA
XXX70100
26
A
X-ray exam of jaw
0.18
0.05
0.06
0.05
0.06
0.01
0.24
0.25
0.24
0.25
XXX70100
TC
A
X-ray exam of jaw
0.00
0.58
0.54
NA
NA
0.02
0.60
0.56
NA
NA
XXX70110

A
X-ray exam of jaw
0.25
0.80
0.73
NA
NA
0.05
1.10
1.03
NA
NA
XXX70110
26
A
X-ray exam of jaw
0.25
0.08
0.08
0.08
0.08
0.01
0.34
0.34
0.34
0.34
XXX70110
TC
A
X-ray exam of jaw
0.00
0.72
0.65
NA
NA
0.04
0.76
0.69
NA
NA
XXX70120

A
X-ray exam of mastoids
0.18
0.69
0.68
NA
NA
0.05
0.92
0.91
NA
NA
XXX70120
26
A
X-ray exam of mastoids
0.18
0.05
0.06
0.05
0.06
0.01
0.24
0.25
0.24
0.25
XXX70120
TC
A
X-ray exam of mastoids
0.00
0.64
0.63
NA
NA
0.04
0.68
0.67
NA
NA
XXX70130

A
X-ray exam of mastoids
0.34
1.16
0.96
NA
NA
0.07
1.57
1.37
NA
NA
XXX70130
26
A
X-ray exam of mastoids
0.34
0.10
0.11
0.10
0.11
0.02
0.46
0.47
0.46
0.47
XXX70130
TC
A
X-ray exam of mastoids
0.00
1.06
0.85
NA
NA
0.05
1.11
0.90
NA
NA
XXX70134

A
X-ray exam of middle ear
0.34
0.92
0.86
NA
NA
0.07
1.33
1.27
NA
NA
XXX70134
26
A
X-ray exam of middle ear
0.34
0.11
0.11
0.11
0.11
0.02
0.47
0.47
0.47
0.47
XXX70134
TC
A
X-ray exam of middle ear
0.00
0.82
0.75
NA
NA
0.05
0.87
0.80
NA
NA
XXX70140

A
X-ray exam of facial bones
0.19
0.55
0.65
NA
NA
0.05
0.79
0.89
NA
NA
XXX70140
26
A
X-ray exam of facial bones
0.19
0.05
0.06
0.05
0.06
0.01
0.25
0.26
0.25
0.26
XXX70140
TC
A
X-ray exam of facial bones
0.00
0.50
0.59
NA
NA
0.04
0.54
0.63
NA
NA
XXX70150

A
X-ray exam of facial bones
0.26
0.85
0.86
NA
NA
0.06
1.17
1.18
NA
NA
XXX70150
26
A
X-ray exam of facial bones
0.26
0.07
0.08
0.07
0.08
0.01
0.34
0.35
0.34
0.35
XXX70150
TC
A
X-ray exam of facial bones
0.00
0.77
0.78
NA
NA
0.05
0.82
0.83
NA
NA
XXX70160

A
X-ray exam of nasal bones
0.17
0.70
0.61
NA
NA
0.03
0.90
0.81
NA
NA
XXX70160
26
A
X-ray exam of nasal bones
0.17
0.05
0.06
0.05
0.06
0.01
0.23
0.24
0.23
0.24
XXX70160
TC
A
X-ray exam of nasal bones
0.00
0.65
0.55
NA
NA
0.02
0.67
0.57
NA
NA
XXX70170

A
X-ray exam of tear duct
0.30
NA
NA
NA
NA
0.07
NA
NA
NA
NA
XXX70170
26
A
X-ray exam of tear duct
0.30
0.09
0.10
0.09
0.10
0.01
0.40
0.41
0.40
0.41
XXX70170
TC
A
X-ray exam of tear duct
0.00
NA
NA
NA
NA
0.06
NA
NA
NA
NA
XXX70190

A
X-ray exam of eye sockets
0.21
0.72
0.70
NA
NA
0.05
0.98
0.96
NA
NA
XXX70190
26
A
X-ray exam of eye sockets
0.21
0.06
0.07
0.06
0.07
0.01
0.28
0.29
0.28
0.29
XXX70190
TC
A
X-ray exam of eye sockets
0.00
0.66
0.63
NA
NA
0.04
0.70
0.67
NA
NA
XXX70200

A
X-ray exam of eye sockets
0.28
0.87
0.87
NA
NA
0.06
1.21
1.21
NA
NA
XXX70200
26
A
X-ray exam of eye sockets
0.28
0.08
0.09
0.08
0.09
0.01
0.37
0.38
0.37
0.38
XXX70200
TC
A
X-ray exam of eye sockets
0.00
0.79
0.78
NA
NA
0.05
0.84
0.83
NA
NA
XXX70210

A
X-ray exam of sinuses
0.17
0.57
0.65
NA
NA
0.05
0.79
0.87
NA
NA
XXX70210
26
A
X-ray exam of sinuses
0.17
0.05
0.06
0.05
0.06
0.01
0.23
0.24
0.23
0.24
XXX70210
TC
A
X-ray exam of sinuses
0.00
0.52
0.60
NA
NA
0.04
0.56
0.64
NA
NA
XXX70220

A
X-ray exam of sinuses
0.25
0.72
0.83
NA
NA
0.06
1.03
1.14
NA
NA
XXX70220
26
A
X-ray exam of sinuses
0.25
0.07
0.08
0.07
0.08
0.01
0.33
0.34
0.33
0.34
XXX70220
TC
A
X-ray exam of sinuses
0.00
0.65
0.75
NA
NA
0.05
0.70
0.80
NA
NA
XXX70240

A
X-ray exam, pituitary saddle
0.19
0.61
0.51
NA
NA
0.03
0.83
0.73
NA
NA
XXX70240
26
A
X-ray exam, pituitary saddle
0.19
0.06
0.06
0.06
0.06
0.01
0.26
0.26
0.26
0.26
XXX70240
TC
A
X-ray exam, pituitary saddle
0.00
0.55
0.45
NA
NA
0.02
0.57
0.47
NA
NA
XXX70250

A
X-ray exam of skull
0.24
0.70
0.70
NA
NA
0.05
0.99
0.99
NA
NA
XXX70250
26
A
X-ray exam of skull
0.24
0.07
0.08
0.07
0.08
0.01
0.32
0.33
0.32
0.33
XXX70250
TC
A
X-ray exam of skull
0.00
0.64
0.63
NA
NA
0.04
0.68
0.67
NA
NA
XXX70260

A
X-ray exam of skull
0.34
0.88
0.97
NA
NA
0.08
1.30
1.39
NA
NA
XXX70260
26
A
X-ray exam of skull
0.34
0.10
0.11
0.10
0.11
0.02
0.46
0.47
0.46
0.47
XXX70260
TC
A
X-ray exam of skull
0.00
0.78
0.86
NA
NA
0.06
0.84
0.92
NA
NA
XXX70300

A
X-ray exam of teeth
0.10
0.24
0.29
NA
NA
0.03
0.37
0.42
NA
NA
XXX70300
26
A
X-ray exam of teeth
0.10
0.03
0.05
0.03
0.05
0.01
0.14
0.16
0.14
0.16
XXX70300
TC
A
X-ray exam of teeth
0.00
0.21
0.25
NA
NA
0.02
0.23
0.27
NA
NA
XXX70310

A
X-ray exam of teeth
0.16
0.82
0.58
NA
NA
0.03
1.01
0.77
NA
NA
XXX70310
26
A
X-ray exam of teeth
0.16
0.05
0.07
0.05
0.07
0.01
0.22
0.24
0.22
0.24
XXX70310
TC
A
X-ray exam of teeth
0.00
0.77
0.51
NA
NA
0.02
0.79
0.53
NA
NA
XXX70320

A
Full mouth x-ray of teeth
0.22
0.98
0.89
NA
NA
0.06
1.26
1.17
NA
NA
XXX70320
26
A
Full mouth x-ray of teeth
0.22
0.06
0.08
0.06
0.08
0.01
0.29
0.31
0.29
0.31
XXX70320
TC
A
Full mouth x-ray of teeth
0.00
0.91
0.81
NA
NA
0.05
0.96
0.86
NA
NA
XXX70328

A
X-ray exam of jaw joint
0.18
0.62
0.57
NA
NA
0.03
0.83
0.78
NA
NA
XXX( print page 49178)70328
26
A
X-ray exam of jaw joint
0.18
0.05
0.06
0.05
0.06
0.01
0.24
0.25
0.24
0.25
XXX70328
TC
A
X-ray exam of jaw joint
0.00
0.57
0.51
NA
NA
0.02
0.59
0.53
NA
NA
XXX70330

A
X-ray exam of jaw joints
0.24
1.01
0.94
NA
NA
0.06
1.31
1.24
NA
NA
XXX70330
26
A
X-ray exam of jaw joints
0.24
0.07
0.08
0.07
0.08
0.01
0.32
0.33
0.32
0.33
XXX70330
TC
A
X-ray exam of jaw joints
0.00
0.94
0.87
NA
NA
0.05
0.99
0.92
NA
NA
XXX70332

A
X-ray exam of jaw joint
0.54
1.46
2.09
NA
NA
0.14
2.14
2.77
NA
NA
XXX70332
26
A
X-ray exam of jaw joint
0.54
0.16
0.19
0.16
0.19
0.02
0.72
0.75
0.72
0.75
XXX70332
TC
A
X-ray exam of jaw joint
0.00
1.30
1.90
NA
NA
0.12
1.42
2.02
NA
NA
XXX70336

A
Magnetic image, jaw joint
1.48
12.60
11.92
NA
NA
0.66
14.74
14.06
NA
NA
XXX70336
26
A
Magnetic image, jaw joint
1.48
0.50
0.49
0.50
0.49
0.07
2.05
2.04
2.05
2.04
XXX70336
TC
A
Magnetic image, jaw joint
0.00
12.10
11.43
NA
NA
0.59
12.69
12.02
NA
NA
XXX70350

A
X-ray head for orthodontia
0.17
0.33
0.42
NA
NA
0.03
0.53
0.62
NA
NA
XXX70350
26
A
X-ray head for orthodontia
0.17
0.05
0.07
0.05
0.07
0.01
0.23
0.25
0.23
0.25
XXX70350
TC
A
X-ray head for orthodontia
0.00
0.27
0.35
NA
NA
0.02
0.29
0.37
NA
NA
XXX70355

A
Panoramic x-ray of jaws
0.20
0.30
0.56
NA
NA
0.05
0.55
0.81
NA
NA
XXX70355
26
A
Panoramic x-ray of jaws
0.20
0.06
0.07
0.06
0.07
0.01
0.27
0.28
0.27
0.28
XXX70355
TC
A
Panoramic x-ray of jaws
0.00
0.24
0.49
NA
NA
0.04
0.28
0.53
NA
NA
XXX70360

A
X-ray exam of neck
0.17
0.58
0.51
NA
NA
0.03
0.78
0.71
NA
NA
XXX70360
26
A
X-ray exam of neck
0.17
0.05
0.06
0.05
0.06
0.01
0.23
0.24
0.23
0.24
XXX70360
TC
A
X-ray exam of neck
0.00
0.52
0.45
NA
NA
0.02
0.54
0.47
NA
NA
XXX70370

A
Throat x-ray & fluoroscopy
0.32
1.65
1.47
NA
NA
0.08
2.05
1.87
NA
NA
XXX70370
26
A
Throat x-ray & fluoroscopy
0.32
0.09
0.10
0.09
0.10
0.01
0.42
0.43
0.42
0.43
XXX70370
TC
A
Throat x-ray & fluoroscopy
0.00
1.56
1.37
NA
NA
0.07
1.63
1.44
NA
NA
XXX70371

A
Speech evaluation, complex
0.84
1.50
2.16
NA
NA
0.16
2.50
3.16
NA
NA
XXX70371
26
A
Speech evaluation, complex
0.84
0.26
0.28
0.26
0.28
0.04
1.14
1.16
1.14
1.16
XXX70371
TC
A
Speech evaluation, complex
0.00
1.24
1.89
NA
NA
0.12
1.36
2.01
NA
NA
XXX70373

A
Contrast x-ray of larynx
0.44
1.71
1.87
NA
NA
0.13
2.28
2.44
NA
NA
XXX70373
26
A
Contrast x-ray of larynx
0.44
0.13
0.14
0.13
0.14
0.02
0.59
0.60
0.59
0.60
XXX70373
TC
A
Contrast x-ray of larynx
0.00
1.58
1.73
NA
NA
0.11
1.69
1.84
NA
NA
XXX70380

A
X-ray exam of salivary gland
0.17
0.82
0.75
NA
NA
0.05
1.04
0.97
NA
NA
XXX70380
26
A
X-ray exam of salivary gland
0.17
0.05
0.06
0.05
0.06
0.01
0.23
0.24
0.23
0.24
XXX70380
TC
A
X-ray exam of salivary gland
0.00
0.76
0.69
NA
NA
0.04
0.80
0.73
NA
NA
XXX70390

A
X-ray exam of salivary duct
0.38
2.34
2.01
NA
NA
0.13
2.85
2.52
NA
NA
XXX70390
26
A
X-ray exam of salivary duct
0.38
0.12
0.12
0.12
0.12
0.02
0.52
0.52
0.52
0.52
XXX70390
TC
A
X-ray exam of salivary duct
0.00
2.22
1.89
NA
NA
0.11
2.33
2.00
NA
NA
XXX70450

A
Ct head/brain w/o dye
0.85
4.90
4.98
NA
NA
0.29
6.04
6.12
NA
NA
XXX70450
26
A
Ct head/brain w/o dye
0.85
0.27
0.28
0.27
0.28
0.04
1.16
1.17
1.16
1.17
XXX70450
TC
A
Ct head/brain w/o dye
0.00
4.64
4.70
NA
NA
0.25
4.89
4.95
NA
NA
XXX70460

A
Ct head/brain w/dye
1.13
6.52
6.15
NA
NA
0.35
8.00
7.63
NA
NA
XXX70460
26
A
Ct head/brain w/dye
1.13
0.36
0.37
0.36
0.37
0.05
1.54
1.55
1.54
1.55
XXX70460
TC
A
Ct head/brain w/dye
0.00
6.16
5.79
NA
NA
0.30
6.46
6.09
NA
NA
XXX70470

A
Ct head/brain w/o & w/dye
1.27
7.96
7.61
NA
NA
0.43
9.66
9.31
NA
NA
XXX70470
26
A
Ct head/brain w/o & w/dye
1.27
0.40
0.42
0.40
0.42
0.06
1.73
1.75
1.73
1.75
XXX70470
TC
A
Ct head/brain w/o & w/dye
0.00
7.56
7.19
NA
NA
0.37
7.93
7.56
NA
NA
XXX70480

A
Ct orbit/ear/fossa w/o dye
1.28
8.52
5.99
NA
NA
0.31
10.11
7.58
NA
NA
XXX70480
26
A
Ct orbit/ear/fossa w/o dye
1.28
0.41
0.42
0.41
0.42
0.06
1.75
1.76
1.75
1.76
XXX70480
TC
A
Ct orbit/ear/fossa w/o dye
0.00
8.11
5.57
NA
NA
0.25
8.36
5.82
NA
NA
XXX70481

A
Ct orbit/ear/fossa w/dye
1.38
10.04
7.09
NA
NA
0.36
11.78
8.83
NA
NA
XXX70481
26
A
Ct orbit/ear/fossa w/dye
1.38
0.44
0.45
0.44
0.45
0.06
1.88
1.89
1.88
1.89
XXX70481
TC
A
Ct orbit/ear/fossa w/dye
0.00
9.60
6.65
NA
NA
0.30
9.90
6.95
NA
NA
XXX70482

A
Ct orbit/ear/fossa w/o&w/dye
1.45
11.56
8.55
NA
NA
0.43
13.44
10.43
NA
NA
XXX70482
26
A
Ct orbit/ear/fossa w/o&w/dye
1.45
0.47
0.48
0.47
0.48
0.06
1.98
1.99
1.98
1.99
XXX70482
TC
A
Ct orbit/ear/fossa w/o&w/dye
0.00
11.09
8.08
NA
NA
0.37
11.46
8.45
NA
NA
XXX70486

A
Ct maxillofacial w/o dye
1.14
6.81
5.52
NA
NA
0.30
8.25
6.96
NA
NA
XXX70486
26
A
Ct maxillofacial w/o dye
1.14
0.36
0.37
0.36
0.37
0.05
1.55
1.56
1.55
1.56
XXX70486
TC
A
Ct maxillofacial w/o dye
0.00
6.44
5.15
NA
NA
0.25
6.69
5.40
NA
NA
XXX( print page 49179)70487

A
Ct maxillofacial w/dye
1.30
8.39
6.67
NA
NA
0.36
10.05
8.33
NA
NA
XXX70487
26
A
Ct maxillofacial w/dye
1.30
0.42
0.43
0.42
0.43
0.06
1.78
1.79
1.78
1.79
XXX70487
TC
A
Ct maxillofacial w/dye
0.00
7.97
6.24
NA
NA
0.30
8.27
6.54
NA
NA
XXX70488

A
Ct maxillofacial w/o & w/dye
1.42
10.48
8.27
NA
NA
0.43
12.33
10.12
NA
NA
XXX70488
26
A
Ct maxillofacial w/o & w/dye
1.42
0.46
0.46
0.46
0.46
0.06
1.94
1.94
1.94
1.94
XXX70488
TC
A
Ct maxillofacial w/o & w/dye
0.00
10.03
7.81
NA
NA
0.37
10.40
8.18
NA
NA
XXX70490

A
Ct soft tissue neck w/o dye
1.28
6.52
5.49
NA
NA
0.31
8.11
7.08
NA
NA
XXX70490
26
A
Ct soft tissue neck w/o dye
1.28
0.41
0.42
0.41
0.42
0.06
1.75
1.76
1.75
1.76
XXX70490
TC
A
Ct soft tissue neck w/o dye
0.00
6.11
5.07
NA
NA
0.25
6.36
5.32
NA
NA
XXX70491

A
Ct soft tissue neck w/dye
1.38
8.06
6.60
NA
NA
0.36
9.80
8.34
NA
NA
XXX70491
26
A
Ct soft tissue neck w/dye
1.38
0.44
0.45
0.44
0.45
0.06
1.88
1.89
1.88
1.89
XXX70491
TC
A
Ct soft tissue neck w/dye
0.00
7.62
6.15
NA
NA
0.30
7.92
6.45
NA
NA
XXX70492

A
Ct sft tsue nck w/o & w/dye
1.45
10.18
8.20
NA
NA
0.43
12.06
10.08
NA
NA
XXX70492
26
A
Ct sft tsue nck w/o & w/dye
1.45
0.47
0.47
0.47
0.47
0.06
1.98
1.98
1.98
1.98
XXX70492
TC
A
Ct sft tsue nck w/o & w/dye
0.00
9.71
7.73
NA
NA
0.37
10.08
8.10
NA
NA
XXX70496

A
Ct angiography, head
1.75
17.16
12.67
NA
NA
0.66
19.57
15.08
NA
NA
XXX70496
26
A
Ct angiography, head
1.75
0.57
0.57
0.57
0.57
0.08
2.40
2.40
2.40
2.40
XXX70496
TC
A
Ct angiography, head
0.00
16.59
12.10
NA
NA
0.58
17.17
12.68
NA
NA
XXX70498

A
Ct angiography, neck
1.75
17.26
12.69
NA
NA
0.66
19.67
15.10
NA
NA
XXX70498
26
A
Ct angiography, neck
1.75
0.58
0.57
0.58
0.57
0.08
2.41
2.40
2.41
2.40
XXX70498
TC
A
Ct angiography, neck
0.00
16.68
12.12
NA
NA
0.58
17.26
12.70
NA
NA
XXX70540

A
Mri orbit/face/neck w/o dye
1.35
14.58
12.38
NA
NA
0.45
16.38
14.18
NA
NA
XXX70540
26
A
Mri orbit/face/neck w/o dye
1.35
0.45
0.44
0.45
0.44
0.06
1.86
1.85
1.86
1.85
XXX70540
TC
A
Mri orbit/face/neck w/o dye
0.00
14.13
11.93
NA
NA
0.39
14.52
12.32
NA
NA
XXX70542

A
Mri orbit/face/neck w/dye
1.62
15.53
14.36
NA
NA
0.54
17.69
16.52
NA
NA
XXX70542
26
A
Mri orbit/face/neck w/dye
1.62
0.53
0.53
0.53
0.53
0.07
2.22
2.22
2.22
2.22
XXX70542
TC
A
Mri orbit/face/neck w/dye
0.00
15.00
13.83
NA
NA
0.47
15.47
14.30
NA
NA
XXX70543

A
Mri orbt/fac/nck w/o & w/dye
2.15
19.26
24.01
NA
NA
0.94
22.35
27.10
NA
NA
XXX70543
26
A
Mri orbt/fac/nck w/o & w/dye
2.15
0.72
0.71
0.72
0.71
0.10
2.97
2.96
2.97
2.96
XXX70543
TC
A
Mri orbt/fac/nck w/o & w/dye
0.00
18.54
23.30
NA
NA
0.84
19.38
24.14
NA
NA
XXX70544

A
Mr angiography head w/o dye
1.20
16.05
12.71
NA
NA
0.64
17.89
14.55
NA
NA
XXX70544
26
A
Mr angiography head w/o dye
1.20
0.39
0.40
0.39
0.40
0.05
1.64
1.65
1.64
1.65
XXX70544
TC
A
Mr angiography head w/o dye
0.00
15.67
12.32
NA
NA
0.59
16.26
12.91
NA
NA
XXX70545

A
Mr angiography head w/dye
1.20
15.97
12.69
NA
NA
0.64
17.81
14.53
NA
NA
XXX70545
26
A
Mr angiography head w/dye
1.20
0.38
0.39
0.38
0.39
0.05
1.63
1.64
1.63
1.64
XXX70545
TC
A
Mr angiography head w/dye
0.00
15.59
12.30
NA
NA
0.59
16.18
12.89
NA
NA
XXX70546

A
Mr angiograph head w/o&w/dye
1.80
24.49
23.37
NA
NA
0.67
26.96
25.84
NA
NA
XXX70546
26
A
Mr angiograph head w/o&w/dye
1.80
0.58
0.59
0.58
0.59
0.08
2.46
2.47
2.46
2.47
XXX70546
TC
A
Mr angiograph head w/o&w/dye
0.00
23.91
22.79
NA
NA
0.59
24.50
23.38
NA
NA
XXX70547

A
Mr angiography neck w/o dye
1.20
16.09
12.72
NA
NA
0.64
17.93
14.56
NA
NA
XXX70547
26
A
Mr angiography neck w/o dye
1.20
0.39
0.39
0.39
0.39
0.05
1.64
1.64
1.64
1.64
XXX70547
TC
A
Mr angiography neck w/o dye
0.00
15.70
12.33
NA
NA
0.59
16.29
12.92
NA
NA
XXX70548

A
Mr angiography neck w/dye
1.20
16.79
12.89
NA
NA
0.64
18.63
14.73
NA
NA
XXX70548
26
A
Mr angiography neck w/dye
1.20
0.38
0.39
0.38
0.39
0.05
1.63
1.64
1.63
1.64
XXX70548
TC
A
Mr angiography neck w/dye
0.00
16.41
12.50
NA
NA
0.59
17.00
13.09
NA
NA
XXX70549

A
Mr angiograph neck w/o&w/dye
1.80
24.41
23.35
NA
NA
0.67
26.88
25.82
NA
NA
XXX70549
26
A
Mr angiograph neck w/o&w/dye
1.80
0.58
0.59
0.58
0.59
0.08
2.46
2.47
2.46
2.47
XXX70549
TC
A
Mr angiograph neck w/o&w/dye
0.00
23.83
22.77
NA
NA
0.59
24.42
23.36
NA
NA
XXX70551

A
Mri brain w/o dye
1.48
14.69
12.44
NA
NA
0.66
16.83
14.58
NA
NA
XXX70551
26
A
Mri brain w/o dye
1.48
0.48
0.49
0.48
0.49
0.07
2.03
2.04
2.03
2.04
XXX70551
TC
A
Mri brain w/o dye
0.00
14.22
11.96
NA
NA
0.59
14.81
12.55
NA
NA
XXX70552

A
Mri brain w/dye
1.78
15.73
14.46
NA
NA
0.78
18.29
17.02
NA
NA
XXX70552
26
A
Mri brain w/dye
1.78
0.57
0.59
0.57
0.59
0.08
2.43
2.45
2.43
2.45
XXX70552
TC
A
Mri brain w/dye
0.00
15.16
13.87
NA
NA
0.70
15.86
14.57
NA
NA
XXX70553

A
Mri brain w/o & w/dye
2.36
18.37
23.84
NA
NA
1.41
22.14
27.61
NA
NA
XXX70553
26
A
Mri brain w/o & w/dye
2.36
0.76
0.78
0.76
0.78
0.10
3.22
3.24
3.22
3.24
XXX70553
TC
A
Mri brain w/o & w/dye
0.00
17.61
23.06
NA
NA
1.31
18.92
24.37
NA
NA
XXX70557

C
Mri brain w/o dye
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX70557
26
A
Mri brain w/o dye
2.90
0.92
1.08
0.92
1.08
0.08
3.90
4.06
3.90
4.06
XXX70557
TC
C
Mri brain w/o dye
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX70558

C
Mri brain w/dye
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX70558
26
A
Mri brain w/dye
3.20
1.15
1.22
1.15
1.22
0.10
4.45
4.52
4.45
4.52
XXX70558
TC
C
Mri brain w/dye
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX70559

C
Mri brain w/o & w/dye
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX70559
26
A
Mri brain w/o & w/dye
3.20
1.03
1.19
1.03
1.19
0.12
4.35
4.51
4.35
4.51
XXX70559
TC
C
Mri brain w/o & w/dye
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX( print page 49180)71010

A
Chest x-ray
0.18
0.43
0.51
NA
NA
0.03
0.64
0.72
NA
NA
XXX71010
26
A
Chest x-ray
0.18
0.05
0.06
0.05
0.06
0.01
0.24
0.25
0.24
0.25
XXX71010
TC
A
Chest x-ray
0.00
0.37
0.45
NA
NA
0.02
0.39
0.47
NA
NA
XXX71015

A
Chest x-ray
0.21
0.57
0.59
NA
NA
0.03
0.81
0.83
NA
NA
XXX71015
26
A
Chest x-ray
0.21
0.07
0.07
0.07
0.07
0.01
0.29
0.29
0.29
0.29
XXX71015
TC
A
Chest x-ray
0.00
0.51
0.52
NA
NA
0.02
0.53
0.54
NA
NA
XXX71020

A
Chest x-ray
0.22
0.57
0.66
NA
NA
0.05
0.84
0.93
NA
NA
XXX71020
26
A
Chest x-ray
0.22
0.07
0.07
0.07
0.07
0.01
0.30
0.30
0.30
0.30
XXX71020
TC
A
Chest x-ray
0.00
0.50
0.59
NA
NA
0.04
0.54
0.63
NA
NA
XXX71021

A
Chest x-ray
0.27
0.71
0.79
NA
NA
0.06
1.04
1.12
NA
NA
XXX71021
26
A
Chest x-ray
0.27
0.08
0.09
0.08
0.09
0.01
0.36
0.37
0.36
0.37
XXX71021
TC
A
Chest x-ray
0.00
0.63
0.71
NA
NA
0.05
0.68
0.76
NA
NA
XXX71022

A
Chest x-ray
0.31
0.89
0.85
NA
NA
0.06
1.26
1.22
NA
NA
XXX71022
26
A
Chest x-ray
0.31
0.09
0.10
0.09
0.10
0.01
0.41
0.42
0.41
0.42
XXX71022
TC
A
Chest x-ray
0.00
0.80
0.75
NA
NA
0.05
0.85
0.80
NA
NA
XXX71023

A
Chest x-ray and fluoroscopy
0.38
1.57
1.08
NA
NA
0.06
2.01
1.52
NA
NA
XXX71023
26
A
Chest x-ray and fluoroscopy
0.38
0.14
0.13
0.14
0.13
0.01
0.53
0.52
0.53
0.52
XXX71023
TC
A
Chest x-ray and fluoroscopy
0.00
1.42
0.94
NA
NA
0.05
1.47
0.99
NA
NA
XXX71030

A
Chest x-ray
0.31
0.91
0.89
NA
NA
0.06
1.28
1.26
NA
NA
XXX71030
26
A
Chest x-ray
0.31
0.09
0.10
0.09
0.10
0.01
0.41
0.42
0.41
0.42
XXX71030
TC
A
Chest x-ray
0.00
0.82
0.79
NA
NA
0.05
0.87
0.84
NA
NA
XXX71034

A
Chest x-ray and fluoroscopy
0.46
2.04
1.71
NA
NA
0.10
2.60
2.27
NA
NA
XXX71034
26
A
Chest x-ray and fluoroscopy
0.46
0.18
0.17
0.18
0.17
0.02
0.66
0.65
0.66
0.65
XXX71034
TC
A
Chest x-ray and fluoroscopy
0.00
1.86
1.55
NA
NA
0.08
1.94
1.63
NA
NA
XXX71035

A
Chest x-ray
0.18
0.77
0.63
NA
NA
0.03
0.98
0.84
NA
NA
XXX71035
26
A
Chest x-ray
0.18
0.06
0.06
0.06
0.06
0.01
0.25
0.25
0.25
0.25
XXX71035
TC
A
Chest x-ray
0.00
0.72
0.57
NA
NA
0.02
0.74
0.59
NA
NA
XXX71040

A
Contrast x-ray of bronchi
0.58
2.08
1.76
NA
NA
0.11
2.77
2.45
NA
NA
XXX71040
26
A
Contrast x-ray of bronchi
0.58
0.16
0.18
0.16
0.18
0.03
0.77
0.79
0.77
0.79
XXX71040
TC
A
Contrast x-ray of bronchi
0.00
1.92
1.58
NA
NA
0.08
2.00
1.66
NA
NA
XXX71060

A
Contrast x-ray of bronchi
0.74
3.07
2.60
NA
NA
0.16
3.97
3.50
NA
NA
XXX71060
26
A
Contrast x-ray of bronchi
0.74
0.23
0.24
0.23
0.24
0.03
1.00
1.01
1.00
1.01
XXX71060
TC
A
Contrast x-ray of bronchi
0.00
2.84
2.36
NA
NA
0.13
2.97
2.49
NA
NA
XXX71090

A
X-ray & pacemaker insertion
0.54
NA
NA
NA
NA
0.13
NA
NA
NA
NA
XXX71090
26
A
X-ray & pacemaker insertion
0.54
0.28
0.23
0.28
0.23
0.02
0.84
0.79
0.84
0.79
XXX71090
TC
A
X-ray & pacemaker insertion
0.00
NA
NA
NA
NA
0.11
NA
NA
NA
NA
XXX71100

A
X-ray exam of ribs
0.22
0.62
0.64
NA
NA
0.05
0.89
0.91
NA
NA
XXX71100
26
A
X-ray exam of ribs
0.22
0.06
0.07
0.06
0.07
0.01
0.29
0.30
0.29
0.30
XXX71100
TC
A
X-ray exam of ribs
0.00
0.55
0.57
NA
NA
0.04
0.59
0.61
NA
NA
XXX71101

A
X-ray exam of ribs/chest
0.27
0.76
0.76
NA
NA
0.05
1.08
1.08
NA
NA
XXX71101
26
A
X-ray exam of ribs/chest
0.27
0.08
0.09
0.08
0.09
0.01
0.36
0.37
0.36
0.37
XXX71101
TC
A
X-ray exam of ribs/chest
0.00
0.68
0.67
NA
NA
0.04
0.72
0.71
NA
NA
XXX71110

A
X-ray exam of ribs
0.27
0.78
0.85
NA
NA
0.06
1.11
1.18
NA
NA
XXX71110
26
A
X-ray exam of ribs
0.27
0.08
0.09
0.08
0.09
0.01
0.36
0.37
0.36
0.37
XXX71110
TC
A
X-ray exam of ribs
0.00
0.70
0.76
NA
NA
0.05
0.75
0.81
NA
NA
XXX71111

A
X-ray exam of ribs/chest
0.32
1.06
1.01
NA
NA
0.07
1.45
1.40
NA
NA
XXX71111
26
A
X-ray exam of ribs/chest
0.32
0.09
0.10
0.09
0.10
0.01
0.42
0.43
0.42
0.43
XXX71111
TC
A
X-ray exam of ribs/chest
0.00
0.97
0.91
NA
NA
0.06
1.03
0.97
NA
NA
XXX71120

A
X-ray exam of breastbone
0.20
0.62
0.70
NA
NA
0.05
0.87
0.95
NA
NA
XXX71120
26
A
X-ray exam of breastbone
0.20
0.06
0.07
0.06
0.07
0.01
0.27
0.28
0.27
0.28
XXX71120
TC
A
X-ray exam of breastbone
0.00
0.56
0.63
NA
NA
0.04
0.60
0.67
NA
NA
XXX71130

A
X-ray exam of breastbone
0.22
0.75
0.77
NA
NA
0.05
1.02
1.04
NA
NA
XXX71130
26
A
X-ray exam of breastbone
0.22
0.07
0.07
0.07
0.07
0.01
0.30
0.30
0.30
0.30
XXX71130
TC
A
X-ray exam of breastbone
0.00
0.68
0.70
NA
NA
0.04
0.72
0.74
NA
NA
XXX71250

A
Ct thorax w/o dye
1.16
6.47
6.34
NA
NA
0.36
7.99
7.86
NA
NA
XXX71250
26
A
Ct thorax w/o dye
1.16
0.37
0.38
0.37
0.38
0.05
1.58
1.59
1.58
1.59
XXX( print page 49181)71250
TC
A
Ct thorax w/o dye
0.00
6.10
5.96
NA
NA
0.31
6.41
6.27
NA
NA
XXX71260

A
Ct thorax w/dye
1.24
8.01
7.61
NA
NA
0.42
9.67
9.27
NA
NA
XXX71260
26
A
Ct thorax w/dye
1.24
0.39
0.41
0.39
0.41
0.05
1.68
1.70
1.68
1.70
XXX71260
TC
A
Ct thorax w/dye
0.00
7.61
7.21
NA
NA
0.37
7.98
7.58
NA
NA
XXX71270

A
Ct thorax w/o & w/dye
1.38
10.15
9.51
NA
NA
0.52
12.05
11.41
NA
NA
XXX71270
26
A
Ct thorax w/o & w/dye
1.38
0.44
0.45
0.44
0.45
0.06
1.88
1.89
1.88
1.89
XXX71270
TC
A
Ct thorax w/o & w/dye
0.00
9.71
9.07
NA
NA
0.46
10.17
9.53
NA
NA
XXX71275

A
Ct angiography, chest
1.92
11.77
12.70
NA
NA
0.48
14.17
15.10
NA
NA
XXX71275
26
A
Ct angiography, chest
1.92
0.62
0.63
0.62
0.63
0.09
2.63
2.64
2.63
2.64
XXX71275
TC
A
Ct angiography, chest
0.00
11.14
12.07
NA
NA
0.39
11.53
12.46
NA
NA
XXX71550

A
Mri chest w/o dye
1.46
16.75
12.95
NA
NA
0.51
18.72
14.92
NA
NA
XXX71550
26
A
Mri chest w/o dye
1.46
0.48
0.48
0.48
0.48
0.06
2.00
2.00
2.00
2.00
XXX71550
TC
A
Mri chest w/o dye
0.00
16.27
12.47
NA
NA
0.45
16.72
12.92
NA
NA
XXX71551

A
Mri chest w/dye
1.73
18.16
15.05
NA
NA
0.60
20.49
17.38
NA
NA
XXX71551
26
A
Mri chest w/dye
1.73
0.56
0.57
0.56
0.57
0.08
2.37
2.38
2.37
2.38
XXX71551
TC
A
Mri chest w/dye
0.00
17.59
14.48
NA
NA
0.52
18.11
15.00
NA
NA
XXX71552

A
Mri chest w/o & w/dye
2.26
22.91
24.94
NA
NA
0.78
25.95
27.98
NA
NA
XXX71552
26
A
Mri chest w/o & w/dye
2.26
0.75
0.74
0.75
0.74
0.10
3.11
3.10
3.11
3.10
XXX71552
TC
A
Mri chest w/o & w/dye
0.00
22.16
24.20
NA
NA
0.68
22.84
24.88
NA
NA
XXX71555

R
Mri angio chest w or w/o dye
1.81
15.55
12.74
NA
NA
0.67
18.03
15.22
NA
NA
XXX71555
26
R
Mri angio chest w or w/o dye
1.81
0.62
0.61
0.62
0.61
0.08
2.51
2.50
2.51
2.50
XXX71555
TC
R
Mri angio chest w or w/o dye
0.00
14.94
12.14
NA
NA
0.59
15.53
12.73
NA
NA
XXX72010

A
X-ray exam of spine
0.45
1.45
1.24
NA
NA
0.08
1.98
1.77
NA
NA
XXX72010
26
A
X-ray exam of spine
0.45
0.13
0.15
0.13
0.15
0.02
0.60
0.62
0.60
0.62
XXX72010
TC
A
X-ray exam of spine
0.00
1.32
1.10
NA
NA
0.06
1.38
1.16
NA
NA
XXX72020

A
X-ray exam of spine
0.15
0.46
0.47
NA
NA
0.03
0.64
0.65
NA
NA
XXX72020
26
A
X-ray exam of spine
0.15
0.05
0.05
0.05
0.05
0.01
0.21
0.21
0.21
0.21
XXX72020
TC
A
X-ray exam of spine
0.00
0.42
0.42
NA
NA
0.02
0.44
0.44
NA
NA
XXX72040

A
X-ray exam of neck spine
0.22
0.77
0.70
NA
NA
0.05
1.04
0.97
NA
NA
XXX72040
26
A
X-ray exam of neck spine
0.22
0.07
0.07
0.07
0.07
0.01
0.30
0.30
0.30
0.30
XXX72040
TC
A
X-ray exam of neck spine
0.00
0.70
0.63
NA
NA
0.04
0.74
0.67
NA
NA
XXX72050

A
X-ray exam of neck spine
0.31
1.07
1.01
NA
NA
0.07
1.45
1.39
NA
NA
XXX72050
26
A
X-ray exam of neck spine
0.31
0.10
0.10
0.10
0.10
0.01
0.42
0.42
0.42
0.42
XXX72050
TC
A
X-ray exam of neck spine
0.00
0.97
0.91
NA
NA
0.06
1.03
0.97
NA
NA
XXX72052

A
X-ray exam of neck spine
0.36
1.39
1.29
NA
NA
0.08
1.83
1.73
NA
NA
XXX72052
26
A
X-ray exam of neck spine
0.36
0.11
0.12
0.11
0.12
0.02
0.49
0.50
0.49
0.50
XXX72052
TC
A
X-ray exam of neck spine
0.00
1.27
1.17
NA
NA
0.06
1.33
1.23
NA
NA
XXX72069

A
X-ray exam of trunk spine
0.22
0.77
0.62
NA
NA
0.03
1.02
0.87
NA
NA
XXX72069
26
A
X-ray exam of trunk spine
0.22
0.08
0.08
0.08
0.08
0.01
0.31
0.31
0.31
0.31
XXX72069
TC
A
X-ray exam of trunk spine
0.00
0.69
0.54
NA
NA
0.02
0.71
0.56
NA
NA
XXX72070

A
X-ray exam of thoracic spine
0.22
0.64
0.70
NA
NA
0.05
0.91
0.97
NA
NA
XXX72070
26
A
X-ray exam of thoracic spine
0.22
0.07
0.07
0.07
0.07
0.01
0.30
0.30
0.30
0.30
XXX72070
TC
A
X-ray exam of thoracic spine
0.00
0.57
0.63
NA
NA
0.04
0.61
0.67
NA
NA
XXX72072

A
X-ray exam of thoracic spine
0.22
0.77
0.79
NA
NA
0.06
1.05
1.07
NA
NA
XXX72072
26
A
X-ray exam of thoracic spine
0.22
0.07
0.07
0.07
0.07
0.01
0.30
0.30
0.30
0.30
XXX72072
TC
A
X-ray exam of thoracic spine
0.00
0.70
0.72
NA
NA
0.05
0.75
0.77
NA
NA
XXX72074

A
X-ray exam of thoracic spine
0.22
0.95
0.97
NA
NA
0.07
1.24
1.26
NA
NA
XXX72074
26
A
X-ray exam of thoracic spine
0.22
0.07
0.07
0.07
0.07
0.01
0.30
0.30
0.30
0.30
XXX72074
TC
A
X-ray exam of thoracic spine
0.00
0.88
0.90
NA
NA
0.06
0.94
0.96
NA
NA
XXX72080

A
X-ray exam of trunk spine
0.22
0.70
0.73
NA
NA
0.05
0.97
1.00
NA
NA
XXX72080
26
A
X-ray exam of trunk spine
0.22
0.07
0.07
0.07
0.07
0.01
0.30
0.30
0.30
0.30
XXX72080
TC
A
X-ray exam of trunk spine
0.00
0.62
0.66
NA
NA
0.04
0.66
0.70
NA
NA
XXX72090

A
X-ray exam of trunk spine
0.28
1.01
0.82
NA
NA
0.05
1.34
1.15
NA
NA
XXX72090
26
A
X-ray exam of trunk spine
0.28
0.10
0.09
0.10
0.09
0.01
0.39
0.38
0.39
0.38
XXX72090
TC
A
X-ray exam of trunk spine
0.00
0.92
0.73
NA
NA
0.04
0.96
0.77
NA
NA
XXX72100

A
X-ray exam of lower spine
0.22
0.81
0.76
NA
NA
0.05
1.08
1.03
NA
NA
XXX72100
26
A
X-ray exam of lower spine
0.22
0.07
0.07
0.07
0.07
0.01
0.30
0.30
0.30
0.30
XXX72100
TC
A
X-ray exam of lower spine
0.00
0.74
0.69
NA
NA
0.04
0.78
0.73
NA
NA
XXX72110

A
X-ray exam of lower spine
0.31
1.14
1.04
NA
NA
0.07
1.52
1.42
NA
NA
XXX72110
26
A
X-ray exam of lower spine
0.31
0.10
0.10
0.10
0.10
0.01
0.42
0.42
0.42
0.42
XXX72110
TC
A
X-ray exam of lower spine
0.00
1.04
0.94
NA
NA
0.06
1.10
1.00
NA
NA
XXX72114

A
X-ray exam of lower spine
0.36
1.57
1.38
NA
NA
0.08
2.01
1.82
NA
NA
XXX72114
26
A
X-ray exam of lower spine
0.36
0.12
0.12
0.12
0.12
0.02
0.50
0.50
0.50
0.50
XXX72114
TC
A
X-ray exam of lower spine
0.00
1.45
1.26
NA
NA
0.06
1.51
1.32
NA
NA
XXX72120

A
X-ray exam of lower spine
0.22
1.07
0.99
NA
NA
0.07
1.36
1.28
NA
NA
XXX72120
26
A
X-ray exam of lower spine
0.22
0.08
0.07
0.08
0.07
0.01
0.31
0.30
0.31
0.30
XXX( print page 49182)72120
TC
A
X-ray exam of lower spine
0.00
1.00
0.92
NA
NA
0.06
1.06
0.98
NA
NA
XXX72125

A
Ct neck spine w/o dye
1.16
6.46
6.33
NA
NA
0.36
7.98
7.85
NA
NA
XXX72125
26
A
Ct neck spine w/o dye
1.16
0.37
0.38
0.37
0.38
0.05
1.58
1.59
1.58
1.59
XXX72125
TC
A
Ct neck spine w/o dye
0.00
6.09
5.96
NA
NA
0.31
6.40
6.27
NA
NA
XXX72126

A
Ct neck spine w/dye
1.22
8.04
7.61
NA
NA
0.42
9.68
9.25
NA
NA
XXX72126
26
A
Ct neck spine w/dye
1.22
0.39
0.40
0.39
0.40
0.05
1.66
1.67
1.66
1.67
XXX72126
TC
A
Ct neck spine w/dye
0.00
7.65
7.22
NA
NA
0.37
8.02
7.59
NA
NA
XXX72127

A
Ct neck spine w/o & w/dye
1.27
10.17
9.50
NA
NA
0.52
11.96
11.29
NA
NA
XXX72127
26
A
Ct neck spine w/o & w/dye
1.27
0.43
0.42
0.43
0.42
0.06
1.76
1.75
1.76
1.75
XXX72127
TC
A
Ct neck spine w/o & w/dye
0.00
9.73
9.07
NA
NA
0.46
10.19
9.53
NA
NA
XXX72128

A
Ct chest spine w/o dye
1.16
6.47
6.34
NA
NA
0.36
7.99
7.86
NA
NA
XXX72128
26
A
Ct chest spine w/o dye
1.16
0.37
0.38
0.37
0.38
0.05
1.58
1.59
1.58
1.59
XXX72128
TC
A
Ct chest spine w/o dye
0.00
6.10
5.96
NA
NA
0.31
6.41
6.27
NA
NA
XXX72129

A
Ct chest spine w/dye
1.22
8.03
7.61
NA
NA
0.42
9.67
9.25
NA
NA
XXX72129
26
A
Ct chest spine w/dye
1.22
0.39
0.40
0.39
0.40
0.05
1.66
1.67
1.66
1.67
XXX72129
TC
A
Ct chest spine w/dye
0.00
7.64
7.21
NA
NA
0.37
8.01
7.58
NA
NA
XXX72130

A
Ct chest spine w/o & w/dye
1.27
10.14
9.49
NA
NA
0.52
11.93
11.28
NA
NA
XXX72130
26
A
Ct chest spine w/o & w/dye
1.27
0.43
0.42
0.43
0.42
0.06
1.76
1.75
1.76
1.75
XXX72130
TC
A
Ct chest spine w/o & w/dye
0.00
9.70
9.06
NA
NA
0.46
10.16
9.52
NA
NA
XXX72131

A
Ct lumbar spine w/o dye
1.16
6.47
6.34
NA
NA
0.36
7.99
7.86
NA
NA
XXX72131
26
A
Ct lumbar spine w/o dye
1.16
0.37
0.38
0.37
0.38
0.05
1.58
1.59
1.58
1.59
XXX72131
TC
A
Ct lumbar spine w/o dye
0.00
6.10
5.96
NA
NA
0.31
6.41
6.27
NA
NA
XXX72132

A
Ct lumbar spine w/dye
1.22
8.03
7.61
NA
NA
0.42
9.67
9.25
NA
NA
XXX72132
26
A
Ct lumbar spine w/dye
1.22
0.39
0.40
0.39
0.40
0.05
1.66
1.67
1.66
1.67
XXX72132
TC
A
Ct lumbar spine w/dye
0.00
7.64
7.21
NA
NA
0.37
8.01
7.58
NA
NA
XXX72133

A
Ct lumbar spine w/o & w/dye
1.27
10.21
9.51
NA
NA
0.52
12.00
11.30
NA
NA
XXX72133
26
A
Ct lumbar spine w/o & w/dye
1.27
0.41
0.42
0.41
0.42
0.06
1.74
1.75
1.74
1.75
XXX72133
TC
A
Ct lumbar spine w/o & w/dye
0.00
9.79
9.09
NA
NA
0.46
10.25
9.55
NA
NA
XXX72141

A
Mri neck spine w/o dye
1.60
12.80
12.00
NA
NA
0.66
15.06
14.26
NA
NA
XXX72141
26
A
Mri neck spine w/o dye
1.60
0.53
0.53
0.53
0.53
0.07
2.20
2.20
2.20
2.20
XXX72141
TC
A
Mri neck spine w/o dye
0.00
12.26
11.47
NA
NA
0.59
12.85
12.06
NA
NA
XXX72142

A
Mri neck spine w/dye
1.92
15.86
14.53
NA
NA
0.79
18.57
17.24
NA
NA
XXX72142
26
A
Mri neck spine w/dye
1.92
0.63
0.64
0.63
0.64
0.09
2.64
2.65
2.64
2.65
XXX72142
TC
A
Mri neck spine w/dye
0.00
15.24
13.89
NA
NA
0.70
15.94
14.59
NA
NA
XXX72146

A
Mri chest spine w/o dye
1.60
12.77
12.92
NA
NA
0.71
15.08
15.23
NA
NA
XXX72146
26
A
Mri chest spine w/o dye
1.60
0.53
0.53
0.53
0.53
0.07
2.20
2.20
2.20
2.20
XXX72146
TC
A
Mri chest spine w/o dye
0.00
12.24
12.39
NA
NA
0.64
12.88
13.03
NA
NA
XXX72147

A
Mri chest spine w/dye
1.92
13.70
13.98
NA
NA
0.79
16.41
16.69
NA
NA
XXX72147
26
A
Mri chest spine w/dye
1.92
0.62
0.63
0.62
0.63
0.09
2.63
2.64
2.63
2.64
XXX72147
TC
A
Mri chest spine w/dye
0.00
13.08
13.35
NA
NA
0.70
13.78
14.05
NA
NA
XXX72148

A
Mri lumbar spine w/o dye
1.48
12.77
12.89
NA
NA
0.71
14.96
15.08
NA
NA
XXX72148
26
A
Mri lumbar spine w/o dye
1.48
0.50
0.49
0.50
0.49
0.07
2.05
2.04
2.05
2.04
XXX72148
TC
A
Mri lumbar spine w/o dye
0.00
12.28
12.40
NA
NA
0.64
12.92
13.04
NA
NA
XXX72149

A
Mri lumbar spine w/dye
1.78
15.83
14.49
NA
NA
0.78
18.39
17.05
NA
NA
XXX72149
26
A
Mri lumbar spine w/dye
1.78
0.59
0.60
0.59
0.60
0.08
2.45
2.46
2.45
2.46
XXX72149
TC
A
Mri lumbar spine w/dye
0.00
15.25
13.89
NA
NA
0.70
15.95
14.59
NA
NA
XXX72156

A
Mri neck spine w/o & w/dye
2.57
18.13
23.83
NA
NA
1.42
22.12
27.82
NA
NA
XXX72156
26
A
Mri neck spine w/o & w/dye
2.57
0.84
0.85
0.84
0.85
0.11
3.52
3.53
3.52
3.53
XXX72156
TC
A
Mri neck spine w/o & w/dye
0.00
17.29
22.98
NA
NA
1.31
18.60
24.29
NA
NA
XXX72157

A
Mri chest spine w/o & w/dye
2.57
16.43
23.40
NA
NA
1.42
20.42
27.39
NA
NA
XXX72157
26
A
Mri chest spine w/o & w/dye
2.57
0.83
0.84
0.83
0.84
0.11
3.51
3.52
3.51
3.52
XXX72157
TC
A
Mri chest spine w/o & w/dye
0.00
15.60
22.56
NA
NA
1.31
16.91
23.87
NA
NA
XXX72158

A
Mri lumbar spine w/o & w/dye
2.36
18.10
23.77
NA
NA
1.41
21.87
27.54
NA
NA
XXX72158
26
A
Mri lumbar spine w/o & w/dye
2.36
0.78
0.78
0.78
0.78
0.10
3.24
3.24
3.24
3.24
XXX72158
TC
A
Mri lumbar spine w/o & w/dye
0.00
17.32
22.99
NA
NA
1.31
18.63
24.30
NA
NA
XXX72159

N
Mr angio spine w/o&w/dye
1.80
14.79
13.39
NA
NA
0.74
17.33
15.93
NA
NA
XXX( print page 49183)72159
26
N
Mr angio spine w/o&w/dye
1.80
0.42
0.62
0.42
0.62
0.10
2.32
2.52
2.32
2.52
XXX72159
TC
N
Mr angio spine w/o&w/dye
0.00
14.37
12.77
NA
NA
0.64
15.01
13.41
NA
NA
XXX72170

A
X-ray exam of pelvis
0.17
0.50
0.56
NA
NA
0.03
0.70
0.76
NA
NA
XXX72170
26
A
X-ray exam of pelvis
0.17
0.06
0.06
0.06
0.06
0.01
0.24
0.24
0.24
0.24
XXX72170
TC
A
X-ray exam of pelvis
0.00
0.44
0.50
NA
NA
0.02
0.46
0.52
NA
NA
XXX72190

A
X-ray exam of pelvis
0.21
0.85
0.77
NA
NA
0.05
1.11
1.03
NA
NA
XXX72190
26
A
X-ray exam of pelvis
0.21
0.07
0.07
0.07
0.07
0.01
0.29
0.29
0.29
0.29
XXX72190
TC
A
X-ray exam of pelvis
0.00
0.78
0.70
NA
NA
0.04
0.82
0.74
NA
NA
XXX72191

A
Ct angiograph pelv w/o&w/dye
1.81
11.43
12.32
NA
NA
0.47
13.71
14.60
NA
NA
XXX72191
26
A
Ct angiograph pelv w/o&w/dye
1.81
0.60
0.60
0.60
0.60
0.08
2.49
2.49
2.49
2.49
XXX72191
TC
A
Ct angiograph pelv w/o&w/dye
0.00
10.83
11.73
NA
NA
0.39
11.22
12.12
NA
NA
XXX72192

A
Ct pelvis w/o dye
1.09
6.02
6.21
NA
NA
0.36
7.47
7.66
NA
NA
XXX72192
26
A
Ct pelvis w/o dye
1.09
0.34
0.36
0.34
0.36
0.05
1.48
1.50
1.48
1.50
XXX72192
TC
A
Ct pelvis w/o dye
0.00
5.68
5.85
NA
NA
0.31
5.99
6.16
NA
NA
XXX72193

A
Ct pelvis w/dye
1.16
7.55
7.30
NA
NA
0.41
9.12
8.87
NA
NA
XXX72193
26
A
Ct pelvis w/dye
1.16
0.37
0.38
0.37
0.38
0.05
1.58
1.59
1.58
1.59
XXX72193
TC
A
Ct pelvis w/dye
0.00
7.18
6.93
NA
NA
0.36
7.54
7.29
NA
NA
XXX72194

A
Ct pelvis w/o & w/dye
1.22
10.18
9.21
NA
NA
0.48
11.88
10.91
NA
NA
XXX72194
26
A
Ct pelvis w/o & w/dye
1.22
0.39
0.40
0.39
0.40
0.05
1.66
1.67
1.66
1.67
XXX72194
TC
A
Ct pelvis w/o & w/dye
0.00
9.78
8.81
NA
NA
0.43
10.21
9.24
NA
NA
XXX72195

A
Mri pelvis w/o dye
1.46
14.74
12.45
NA
NA
0.51
16.71
14.42
NA
NA
XXX72195
26
A
Mri pelvis w/o dye
1.46
0.48
0.48
0.48
0.48
0.06
2.00
2.00
2.00
2.00
XXX72195
TC
A
Mri pelvis w/o dye
0.00
14.25
11.96
NA
NA
0.45
14.70
12.41
NA
NA
XXX72196

A
Mri pelvis w/dye
1.73
15.67
14.43
NA
NA
0.60
18.00
16.76
NA
NA
XXX72196
26
A
Mri pelvis w/dye
1.73
0.56
0.57
0.56
0.57
0.08
2.37
2.38
2.37
2.38
XXX72196
TC
A
Mri pelvis w/dye
0.00
15.11
13.86
NA
NA
0.52
15.63
14.38
NA
NA
XXX72197

A
Mri pelvis w/o & w/dye
2.26
19.28
24.04
NA
NA
1.02
22.56
27.32
NA
NA
XXX72197
26
A
Mri pelvis w/o & w/dye
2.26
0.74
0.74
0.74
0.74
0.10
3.10
3.10
3.10
3.10
XXX72197
TC
A
Mri pelvis w/o & w/dye
0.00
18.54
23.30
NA
NA
0.92
19.46
24.22
NA
NA
XXX72198

A
Mr angio pelvis w/o & w/dye
1.80
15.34
12.68
NA
NA
0.67
17.81
15.15
NA
NA
XXX72198
26
A
Mr angio pelvis w/o & w/dye
1.80
0.60
0.59
0.60
0.59
0.08
2.48
2.47
2.48
2.47
XXX72198
TC
A
Mr angio pelvis w/o & w/dye
0.00
14.75
12.09
NA
NA
0.59
15.34
12.68
NA
NA
XXX72200

A
X-ray exam sacroiliac joints
0.17
0.60
0.59
NA
NA
0.03
0.80
0.79
NA
NA
XXX72200
26
A
X-ray exam sacroiliac joints
0.17
0.05
0.06
0.05
0.06
0.01
0.23
0.24
0.23
0.24
XXX72200
TC
A
X-ray exam sacroiliac joints
0.00
0.55
0.53
NA
NA
0.02
0.57
0.55
NA
NA
XXX72202

A
X-ray exam sacroiliac joints
0.19
0.74
0.70
NA
NA
0.05
0.98
0.94
NA
NA
XXX72202
26
A
X-ray exam sacroiliac joints
0.19
0.06
0.06
0.06
0.06
0.01
0.26
0.26
0.26
0.26
XXX72202
TC
A
X-ray exam sacroiliac joints
0.00
0.68
0.64
NA
NA
0.04
0.72
0.68
NA
NA
XXX72220

A
X-ray exam of tailbone
0.17
0.58
0.62
NA
NA
0.05
0.80
0.84
NA
NA
XXX72220
26
A
X-ray exam of tailbone
0.17
0.05
0.06
0.05
0.06
0.01
0.23
0.24
0.23
0.24
XXX72220
TC
A
X-ray exam of tailbone
0.00
0.53
0.56
NA
NA
0.04
0.57
0.60
NA
NA
XXX72240

A
Contrast x-ray of neck spine
0.91
2.53
4.41
NA
NA
0.29
3.73
5.61
NA
NA
XXX72240
26
A
Contrast x-ray of neck spine
0.91
0.28
0.29
0.28
0.29
0.04
1.23
1.24
1.23
1.24
XXX72240
TC
A
Contrast x-ray of neck spine
0.00
2.25
4.13
NA
NA
0.25
2.50
4.38
NA
NA
XXX72255

A
Contrast x-ray, thorax spine
0.91
2.27
4.02
NA
NA
0.26
3.44
5.19
NA
NA
XXX72255
26
A
Contrast x-ray, thorax spine
0.91
0.27
0.27
0.27
0.27
0.04
1.22
1.22
1.22
1.22
XXX72255
TC
A
Contrast x-ray, thorax spine
0.00
2.00
3.75
NA
NA
0.22
2.22
3.97
NA
NA
XXX72265

A
Contrast x-ray, lower spine
0.83
2.50
3.87
NA
NA
0.26
3.59
4.96
NA
NA
XXX72265
26
A
Contrast x-ray, lower spine
0.83
0.26
0.25
0.26
0.25
0.04
1.13
1.12
1.13
1.12
XXX72265
TC
A
Contrast x-ray, lower spine
0.00
2.24
3.61
NA
NA
0.22
2.46
3.83
NA
NA
XXX72270

A
Contrast x-ray, spine
1.33
3.95
5.88
NA
NA
0.39
5.67
7.60
NA
NA
XXX72270
26
A
Contrast x-ray, spine
1.33
0.43
0.42
0.43
0.42
0.06
1.82
1.81
1.82
1.81
XXX72270
TC
A
Contrast x-ray, spine
0.00
3.52
5.46
NA
NA
0.33
3.85
5.79
NA
NA
XXX72275

A
Epidurography
0.76
1.71
2.15
NA
NA
0.26
2.73
3.17
NA
NA
XXX72275
26
A
Epidurography
0.76
0.19
0.20
0.19
0.20
0.04
0.99
1.00
0.99
1.00
XXX72275
TC
A
Epidurography
0.00
1.52
1.96
NA
NA
0.22
1.74
2.18
NA
NA
XXX72285

A
X-ray c/t spine disk
1.16
1.42
6.90
NA
NA
0.50
3.08
8.56
NA
NA
XXX72285
26
A
X-ray c/t spine disk
1.16
0.29
0.34
0.29
0.34
0.07
1.52
1.57
1.52
1.57
XXX72285
TC
A
X-ray c/t spine disk
0.00
1.13
6.57
NA
NA
0.43
1.56
7.00
NA
NA
XXX72295

A
X-ray of lower spine disk
0.83
1.41
6.45
NA
NA
0.46
2.70
7.74
NA
NA
XXX72295
26
A
X-ray of lower spine disk
0.83
0.23
0.26
0.23
0.26
0.06
1.12
1.15
1.12
1.15
XXX72295
TC
A
X-ray of lower spine disk
0.00
1.18
6.19
NA
NA
0.40
1.58
6.59
NA
NA
XXX73000

A
X-ray exam of collar bone
0.16
0.56
0.57
NA
NA
0.03
0.75
0.76
NA
NA
XXX73000
26
A
X-ray exam of collar bone
0.16
0.05
0.05
0.05
0.05
0.01
0.22
0.22
0.22
0.22
XXX73000
TC
A
X-ray exam of collar bone
0.00
0.50
0.52
NA
NA
0.02
0.52
0.54
NA
NA
XXX73010

A
X-ray exam of shoulder blade
0.17
0.58
0.58
NA
NA
0.03
0.78
0.78
NA
NA
XXX( print page 49184)73010
26
A
X-ray exam of shoulder blade
0.17
0.06
0.06
0.06
0.06
0.01
0.24
0.24
0.24
0.24
XXX73010
TC
A
X-ray exam of shoulder blade
0.00
0.53
0.52
NA
NA
0.02
0.55
0.54
NA
NA
XXX73020

A
X-ray exam of shoulder
0.15
0.45
0.50
NA
NA
0.03
0.63
0.68
NA
NA
XXX73020
26
A
X-ray exam of shoulder
0.15
0.05
0.05
0.05
0.05
0.01
0.21
0.21
0.21
0.21
XXX73020
TC
A
X-ray exam of shoulder
0.00
0.40
0.45
NA
NA
0.02
0.42
0.47
NA
NA
XXX73030

A
X-ray exam of shoulder
0.18
0.57
0.62
NA
NA
0.05
0.80
0.85
NA
NA
XXX73030
26
A
X-ray exam of shoulder
0.18
0.06
0.06
0.06
0.06
0.01
0.25
0.25
0.25
0.25
XXX73030
TC
A
X-ray exam of shoulder
0.00
0.51
0.56
NA
NA
0.04
0.55
0.60
NA
NA
XXX73040

A
Contrast x-ray of shoulder
0.54
2.24
2.27
NA
NA
0.14
2.92
2.95
NA
NA
XXX73040
26
A
Contrast x-ray of shoulder
0.54
0.17
0.18
0.17
0.18
0.02
0.73
0.74
0.73
0.74
XXX73040
TC
A
Contrast x-ray of shoulder
0.00
2.06
2.09
NA
NA
0.12
2.18
2.21
NA
NA
XXX73050

A
X-ray exam of shoulders
0.20
0.74
0.74
NA
NA
0.05
0.99
0.99
NA
NA
XXX73050
26
A
X-ray exam of shoulders
0.20
0.07
0.07
0.07
0.07
0.01
0.28
0.28
0.28
0.28
XXX73050
TC
A
X-ray exam of shoulders
0.00
0.66
0.67
NA
NA
0.04
0.70
0.71
NA
NA
XXX73060

A
X-ray exam of humerus
0.17
0.57
0.62
NA
NA
0.05
0.79
0.84
NA
NA
XXX73060
26
A
X-ray exam of humerus
0.17
0.05
0.06
0.05
0.06
0.01
0.23
0.24
0.23
0.24
XXX73060
TC
A
X-ray exam of humerus
0.00
0.52
0.56
NA
NA
0.04
0.56
0.60
NA
NA
XXX73070

A
X-ray exam of elbow
0.15
0.56
0.57
NA
NA
0.03
0.74
0.75
NA
NA
XXX73070
26
A
X-ray exam of elbow
0.15
0.05
0.05
0.05
0.05
0.01
0.21
0.21
0.21
0.21
XXX73070
TC
A
X-ray exam of elbow
0.00
0.51
0.52
NA
NA
0.02
0.53
0.54
NA
NA
XXX73080

A
X-ray exam of elbow
0.17
0.75
0.66
NA
NA
0.05
0.97
0.88
NA
NA
XXX73080
26
A
X-ray exam of elbow
0.17
0.05
0.06
0.05
0.06
0.01
0.23
0.24
0.23
0.24
XXX73080
TC
A
X-ray exam of elbow
0.00
0.70
0.60
NA
NA
0.04
0.74
0.64
NA
NA
XXX73085

A
Contrast x-ray of elbow
0.54
1.82
2.17
NA
NA
0.14
2.50
2.85
NA
NA
XXX73085
26
A
Contrast x-ray of elbow
0.54
0.17
0.19
0.17
0.19
0.02
0.73
0.75
0.73
0.75
XXX73085
TC
A
Contrast x-ray of elbow
0.00
1.65
1.99
NA
NA
0.12
1.77
2.11
NA
NA
XXX73090

A
X-ray exam of forearm
0.16
0.55
0.57
NA
NA
0.03
0.74
0.76
NA
NA
XXX73090
26
A
X-ray exam of forearm
0.16
0.05
0.05
0.05
0.05
0.01
0.22
0.22
0.22
0.22
XXX73090
TC
A
X-ray exam of forearm
0.00
0.50
0.52
NA
NA
0.02
0.52
0.54
NA
NA
XXX73092

A
X-ray exam of arm, infant
0.16
0.59
0.55
NA
NA
0.03
0.78
0.74
NA
NA
XXX73092
26
A
X-ray exam of arm, infant
0.16
0.05
0.05
0.05
0.05
0.01
0.22
0.22
0.22
0.22
XXX73092
TC
A
X-ray exam of arm, infant
0.00
0.54
0.50
NA
NA
0.02
0.56
0.52
NA
NA
XXX73100

A
X-ray exam of wrist
0.16
0.61
0.56
NA
NA
0.03
0.80
0.75
NA
NA
XXX73100
26
A
X-ray exam of wrist
0.16
0.06
0.05
0.06
0.05
0.01
0.23
0.22
0.23
0.22
XXX73100
TC
A
X-ray exam of wrist
0.00
0.55
0.51
NA
NA
0.02
0.57
0.53
NA
NA
XXX73110

A
X-ray exam of wrist
0.17
0.78
0.64
NA
NA
0.03
0.98
0.84
NA
NA
XXX73110
26
A
X-ray exam of wrist
0.17
0.05
0.06
0.05
0.06
0.01
0.23
0.24
0.23
0.24
XXX73110
TC
A
X-ray exam of wrist
0.00
0.72
0.58
NA
NA
0.02
0.74
0.60
NA
NA
XXX73115

A
Contrast x-ray of wrist
0.54
2.38
1.91
NA
NA
0.12
3.04
2.57
NA
NA
XXX73115
26
A
Contrast x-ray of wrist
0.54
0.18
0.18
0.18
0.18
0.02
0.74
0.74
0.74
0.74
XXX73115
TC
A
Contrast x-ray of wrist
0.00
2.20
1.74
NA
NA
0.10
2.30
1.84
NA
NA
XXX73120

A
X-ray exam of hand
0.16
0.56
0.55
NA
NA
0.03
0.75
0.74
NA
NA
XXX73120
26
A
X-ray exam of hand
0.16
0.05
0.05
0.05
0.05
0.01
0.22
0.22
0.22
0.22
XXX73120
TC
A
X-ray exam of hand
0.00
0.51
0.50
NA
NA
0.02
0.53
0.52
NA
NA
XXX73130

A
X-ray exam of hand
0.17
0.66
0.61
NA
NA
0.03
0.86
0.81
NA
NA
XXX73130
26
A
X-ray exam of hand
0.17
0.05
0.06
0.05
0.06
0.01
0.23
0.24
0.23
0.24
XXX73130
TC
A
X-ray exam of hand
0.00
0.61
0.55
NA
NA
0.02
0.63
0.57
NA
NA
XXX73140

A
X-ray exam of finger(s)
0.13
0.68
0.52
NA
NA
0.03
0.84
0.68
NA
NA
XXX73140
26
A
X-ray exam of finger(s)
0.13
0.04
0.04
0.04
0.04
0.01
0.18
0.18
0.18
0.18
XXX73140
TC
A
X-ray exam of finger(s)
0.00
0.64
0.48
NA
NA
0.02
0.66
0.50
NA
NA
XXX73200

A
Ct upper extremity w/o dye
1.09
6.45
5.60
NA
NA
0.30
7.84
6.99
NA
NA
XXX73200
26
A
Ct upper extremity w/o dye
1.09
0.35
0.36
0.35
0.36
0.05
1.49
1.50
1.49
1.50
XXX73200
TC
A
Ct upper extremity w/o dye
0.00
6.10
5.25
NA
NA
0.25
6.35
5.50
NA
NA
XXX73201

A
Ct upper extremity w/dye
1.16
7.97
6.71
NA
NA
0.36
9.49
8.23
NA
NA
XXX73201
26
A
Ct upper extremity w/dye
1.16
0.37
0.38
0.37
0.38
0.05
1.58
1.59
1.58
1.59
XXX73201
TC
A
Ct upper extremity w/dye
0.00
7.60
6.33
NA
NA
0.31
7.91
6.64
NA
NA
XXX( print page 49185)73202

A
Ct uppr extremity w/o&w/dye
1.22
10.74
8.55
NA
NA
0.44
12.40
10.21
NA
NA
XXX73202
26
A
Ct uppr extremity w/o&w/dye
1.22
0.39
0.40
0.39
0.40
0.05
1.66
1.67
1.66
1.67
XXX73202
TC
A
Ct uppr extremity w/o&w/dye
0.00
10.35
8.15
NA
NA
0.39
10.74
8.54
NA
NA
XXX73206

A
Ct angio upr extrm w/o&w/dye
1.81
10.85
11.38
NA
NA
0.47
13.13
13.66
NA
NA
XXX73206
26
A
Ct angio upr extrm w/o&w/dye
1.81
0.60
0.59
0.60
0.59
0.08
2.49
2.48
2.49
2.48
XXX73206
TC
A
Ct angio upr extrm w/o&w/dye
0.00
10.25
10.78
NA
NA
0.39
10.64
11.17
NA
NA
XXX73218

A
Mri upper extremity w/o dye
1.35
15.03
12.49
NA
NA
0.45
16.83
14.29
NA
NA
XXX73218
26
A
Mri upper extremity w/o dye
1.35
0.45
0.44
0.45
0.44
0.06
1.86
1.85
1.86
1.85
XXX73218
TC
A
Mri upper extremity w/o dye
0.00
14.58
12.05
NA
NA
0.39
14.97
12.44
NA
NA
XXX73219

A
Mri upper extremity w/dye
1.62
15.68
14.41
NA
NA
0.54
17.84
16.57
NA
NA
XXX73219
26
A
Mri upper extremity w/dye
1.62
0.53
0.54
0.53
0.54
0.07
2.22
2.23
2.22
2.23
XXX73219
TC
A
Mri upper extremity w/dye
0.00
15.15
13.87
NA
NA
0.47
15.62
14.34
NA
NA
XXX73220

A
Mri uppr extremity w/o&w/dye
2.15
19.37
24.04
NA
NA
0.94
22.46
27.13
NA
NA
XXX73220
26
A
Mri uppr extremity w/o&w/dye
2.15
0.70
0.71
0.70
0.71
0.10
2.95
2.96
2.95
2.96
XXX73220
TC
A
Mri uppr extremity w/o&w/dye
0.00
18.67
23.33
NA
NA
0.84
19.51
24.17
NA
NA
XXX73221

A
Mri joint upr extrem w/o dye
1.35
13.95
12.22
NA
NA
0.45
15.75
14.02
NA
NA
XXX73221
26
A
Mri joint upr extrem w/o dye
1.35
0.46
0.45
0.46
0.45
0.06
1.87
1.86
1.87
1.86
XXX73221
TC
A
Mri joint upr extrem w/o dye
0.00
13.49
11.77
NA
NA
0.39
13.88
12.16
NA
NA
XXX73222

A
Mri joint upr extrem w/dye
1.62
14.71
14.16
NA
NA
0.54
16.87
16.32
NA
NA
XXX73222
26
A
Mri joint upr extrem w/dye
1.62
0.55
0.54
0.55
0.54
0.07
2.24
2.23
2.24
2.23
XXX73222
TC
A
Mri joint upr extrem w/dye
0.00
14.16
13.62
NA
NA
0.47
14.63
14.09
NA
NA
XXX73223

A
Mri joint upr extr w/o&w/dye
2.15
18.04
23.70
NA
NA
0.94
21.13
26.79
NA
NA
XXX73223
26
A
Mri joint upr extr w/o&w/dye
2.15
0.71
0.71
0.71
0.71
0.10
2.96
2.96
2.96
2.96
XXX73223
TC
A
Mri joint upr extr w/o&w/dye
0.00
17.33
22.99
NA
NA
0.84
18.17
23.83
NA
NA
XXX73225

N
Mr angio upr extr w/o&w/dye
1.73
14.77
12.45
NA
NA
0.69
17.19
14.87
NA
NA
XXX73225
26
N
Mr angio upr extr w/o&w/dye
1.73
0.40
0.60
0.40
0.60
0.10
2.23
2.43
2.23
2.43
XXX73225
TC
N
Mr angio upr extr w/o&w/dye
0.00
14.37
11.85
NA
NA
0.59
14.96
12.44
NA
NA
XXX73500

A
X-ray exam of hip
0.17
0.49
0.52
NA
NA
0.03
0.69
0.72
NA
NA
XXX73500
26
A
X-ray exam of hip
0.17
0.06
0.06
0.06
0.06
0.01
0.24
0.24
0.24
0.24
XXX73500
TC
A
X-ray exam of hip
0.00
0.43
0.46
NA
NA
0.02
0.45
0.48
NA
NA
XXX73510

A
X-ray exam of hip
0.21
0.78
0.68
NA
NA
0.05
1.04
0.94
NA
NA
XXX73510
26
A
X-ray exam of hip
0.21
0.07
0.07
0.07
0.07
0.01
0.29
0.29
0.29
0.29
XXX73510
TC
A
X-ray exam of hip
0.00
0.71
0.61
NA
NA
0.04
0.75
0.65
NA
NA
XXX73520

A
X-ray exam of hips
0.26
0.79
0.77
NA
NA
0.05
1.10
1.08
NA
NA
XXX73520
26
A
X-ray exam of hips
0.26
0.08
0.09
0.08
0.09
0.01
0.35
0.36
0.35
0.36
XXX73520
TC
A
X-ray exam of hips
0.00
0.71
0.68
NA
NA
0.04
0.75
0.72
NA
NA
XXX73525

A
Contrast x-ray of hip
0.54
1.79
2.16
NA
NA
0.15
2.48
2.85
NA
NA
XXX73525
26
A
Contrast x-ray of hip
0.54
0.17
0.18
0.17
0.18
0.03
0.74
0.75
0.74
0.75
XXX73525
TC
A
Contrast x-ray of hip
0.00
1.62
1.98
NA
NA
0.12
1.74
2.10
NA
NA
XXX73530

A
X-ray exam of hip
0.29
NA
NA
NA
NA
0.03
NA
NA
NA
NA
XXX73530
26
A
X-ray exam of hip
0.29
0.09
0.10
0.09
0.10
0.01
0.39
0.40
0.39
0.40
XXX73530
TC
A
X-ray exam of hip
0.00
NA
NA
NA
NA
0.02
NA
NA
NA
NA
XXX73540

A
X-ray exam of pelvis & hips
0.20
0.80
0.68
NA
NA
0.05
1.05
0.93
NA
NA
XXX73540
26
A
X-ray exam of pelvis & hips
0.20
0.07
0.07
0.07
0.07
0.01
0.28
0.28
0.28
0.28
XXX73540
TC
A
X-ray exam of pelvis & hips
0.00
0.73
0.61
NA
NA
0.04
0.77
0.65
NA
NA
XXX73542

A
X-ray exam, sacroiliac joint
0.59
1.12
1.98
NA
NA
0.15
1.86
2.72
NA
NA
XXX73542
26
A
X-ray exam, sacroiliac joint
0.59
0.14
0.16
0.14
0.16
0.03
0.76
0.78
0.76
0.78
XXX73542
TC
A
X-ray exam, sacroiliac joint
0.00
0.98
1.82
NA
NA
0.12
1.10
1.94
NA
NA
XXX73550

A
X-ray exam of thigh
0.17
0.54
0.61
NA
NA
0.05
0.76
0.83
NA
NA
XXX73550
26
A
X-ray exam of thigh
0.17
0.05
0.06
0.05
0.06
0.01
0.23
0.24
0.23
0.24
XXX73550
TC
A
X-ray exam of thigh
0.00
0.49
0.55
NA
NA
0.04
0.53
0.59
NA
NA
XXX73560

A
X-ray exam of knee, 1 or 2
0.17
0.59
0.58
NA
NA
0.03
0.79
0.78
NA
NA
XXX73560
26
A
X-ray exam of knee, 1 or 2
0.17
0.06
0.06
0.06
0.06
0.01
0.24
0.24
0.24
0.24
XXX73560
TC
A
X-ray exam of knee, 1 or 2
0.00
0.53
0.52
NA
NA
0.02
0.55
0.54
NA
NA
XXX73562

A
X-ray exam of knee, 3
0.18
0.73
0.66
NA
NA
0.05
0.96
0.89
NA
NA
XXX73562
26
A
X-ray exam of knee, 3
0.18
0.06
0.06
0.06
0.06
0.01
0.25
0.25
0.25
0.25
XXX73562
TC
A
X-ray exam of knee, 3
0.00
0.67
0.60
NA
NA
0.04
0.71
0.64
NA
NA
XXX73564

A
X-ray exam, knee, 4 or more
0.22
0.87
0.74
NA
NA
0.05
1.14
1.01
NA
NA
XXX73564
26
A
X-ray exam, knee, 4 or more
0.22
0.08
0.07
0.08
0.07
0.01
0.31
0.30
0.31
0.30
XXX73564
TC
A
X-ray exam, knee, 4 or more
0.00
0.79
0.66
NA
NA
0.04
0.83
0.70
NA
NA
XXX73565

A
X-ray exam of knees
0.17
0.65
0.58
NA
NA
0.03
0.85
0.78
NA
NA
XXX73565
26
A
X-ray exam of knees
0.17
0.06
0.06
0.06
0.06
0.01
0.24
0.24
0.24
0.24
XXX73565
TC
A
X-ray exam of knees
0.00
0.59
0.52
NA
NA
0.02
0.61
0.54
NA
NA
XXX73580

A
Contrast x-ray of knee joint
0.54
2.40
2.69
NA
NA
0.17
3.11
3.40
NA
NA
XXX73580
26
A
Contrast x-ray of knee joint
0.54
0.18
0.17
0.18
0.17
0.03
0.75
0.74
0.75
0.74
XXX73580
TC
A
Contrast x-ray of knee joint
0.00
2.22
2.52
NA
NA
0.14
2.36
2.66
NA
NA
XXX( print page 49186)73590

A
X-ray exam of lower leg
0.17
0.54
0.57
NA
NA
0.03
0.74
0.77
NA
NA
XXX73590
26
A
X-ray exam of lower leg
0.17
0.05
0.06
0.05
0.06
0.01
0.23
0.24
0.23
0.24
XXX73590
TC
A
X-ray exam of lower leg
0.00
0.49
0.51
NA
NA
0.02
0.51
0.53
NA
NA
XXX73592

A
X-ray exam of leg, infant
0.16
0.60
0.56
NA
NA
0.03
0.79
0.75
NA
NA
XXX73592
26
A
X-ray exam of leg, infant
0.16
0.05
0.05
0.05
0.05
0.01
0.22
0.22
0.22
0.22
XXX73592
TC
A
X-ray exam of leg, infant
0.00
0.55
0.51
NA
NA
0.02
0.57
0.53
NA
NA
XXX73600

A
X-ray exam of ankle
0.16
0.57
0.55
NA
NA
0.03
0.76
0.74
NA
NA
XXX73600
26
A
X-ray exam of ankle
0.16
0.05
0.05
0.05
0.05
0.01
0.22
0.22
0.22
0.22
XXX73600
TC
A
X-ray exam of ankle
0.00
0.51
0.50
NA
NA
0.02
0.53
0.52
NA
NA
XXX73610

A
X-ray exam of ankle
0.17
0.67
0.61
NA
NA
0.03
0.87
0.81
NA
NA
XXX73610
26
A
X-ray exam of ankle
0.17
0.05
0.06
0.05
0.06
0.01
0.23
0.24
0.23
0.24
XXX73610
TC
A
X-ray exam of ankle
0.00
0.62
0.55
NA
NA
0.02
0.64
0.57
NA
NA
XXX73615

A
Contrast x-ray of ankle
0.54
1.89
2.18
NA
NA
0.15
2.58
2.87
NA
NA
XXX73615
26
A
Contrast x-ray of ankle
0.54
0.17
0.18
0.17
0.18
0.03
0.74
0.75
0.74
0.75
XXX73615
TC
A
Contrast x-ray of ankle
0.00
1.72
2.01
NA
NA
0.12
1.84
2.13
NA
NA
XXX73620

A
X-ray exam of foot
0.16
0.53
0.54
NA
NA
0.03
0.72
0.73
NA
NA
XXX73620
26
A
X-ray exam of foot
0.16
0.04
0.05
0.04
0.05
0.01
0.21
0.22
0.21
0.22
XXX73620
TC
A
X-ray exam of foot
0.00
0.49
0.49
NA
NA
0.02
0.51
0.51
NA
NA
XXX73630

A
X-ray exam of foot
0.17
0.66
0.61
NA
NA
0.03
0.86
0.81
NA
NA
XXX73630
26
A
X-ray exam of foot
0.17
0.05
0.06
0.05
0.06
0.01
0.23
0.24
0.23
0.24
XXX73630
TC
A
X-ray exam of foot
0.00
0.60
0.55
NA
NA
0.02
0.62
0.57
NA
NA
XXX73650

A
X-ray exam of heel
0.16
0.56
0.53
NA
NA
0.03
0.75
0.72
NA
NA
XXX73650
26
A
X-ray exam of heel
0.16
0.05
0.05
0.05
0.05
0.01
0.22
0.22
0.22
0.22
XXX73650
TC
A
X-ray exam of heel
0.00
0.51
0.48
NA
NA
0.02
0.53
0.50
NA
NA
XXX73660

A
X-ray exam of toe(s)
0.13
0.64
0.51
NA
NA
0.03
0.80
0.67
NA
NA
XXX73660
26
A
X-ray exam of toe(s)
0.13
0.04
0.04
0.04
0.04
0.01
0.18
0.18
0.18
0.18
XXX73660
TC
A
X-ray exam of toe(s)
0.00
0.60
0.47
NA
NA
0.02
0.62
0.49
NA
NA
XXX73700

A
Ct lower extremity w/o dye
1.09
6.44
5.59
NA
NA
0.30
7.83
6.98
NA
NA
XXX73700
26
A
Ct lower extremity w/o dye
1.09
0.35
0.36
0.35
0.36
0.05
1.49
1.50
1.49
1.50
XXX73700
TC
A
Ct lower extremity w/o dye
0.00
6.09
5.24
NA
NA
0.25
6.34
5.49
NA
NA
XXX73701

A
Ct lower extremity w/dye
1.16
7.95
6.71
NA
NA
0.36
9.47
8.23
NA
NA
XXX73701
26
A
Ct lower extremity w/dye
1.16
0.36
0.38
0.36
0.38
0.05
1.57
1.59
1.57
1.59
XXX73701
TC
A
Ct lower extremity w/dye
0.00
7.59
6.33
NA
NA
0.31
7.90
6.64
NA
NA
XXX73702

A
Ct lwr extremity w/o&w/dye
1.22
10.81
8.57
NA
NA
0.44
12.47
10.23
NA
NA
XXX73702
26
A
Ct lwr extremity w/o&w/dye
1.22
0.40
0.40
0.40
0.40
0.05
1.67
1.67
1.67
1.67
XXX73702
TC
A
Ct lwr extremity w/o&w/dye
0.00
10.41
8.17
NA
NA
0.39
10.80
8.56
NA
NA
XXX73706

A
Ct angio lwr extr w/o&w/dye
1.90
12.39
11.78
NA
NA
0.47
14.76
14.15
NA
NA
XXX73706
26
A
Ct angio lwr extr w/o&w/dye
1.90
0.66
0.63
0.66
0.63
0.08
2.64
2.61
2.64
2.61
XXX73706
TC
A
Ct angio lwr extr w/o&w/dye
0.00
11.73
11.15
NA
NA
0.39
12.12
11.54
NA
NA
XXX73718

A
Mri lower extremity w/o dye
1.35
14.74
12.42
NA
NA
0.45
16.54
14.22
NA
NA
XXX73718
26
A
Mri lower extremity w/o dye
1.35
0.46
0.45
0.46
0.45
0.06
1.87
1.86
1.87
1.86
XXX73718
TC
A
Mri lower extremity w/o dye
0.00
14.28
11.97
NA
NA
0.39
14.67
12.36
NA
NA
XXX73719

A
Mri lower extremity w/dye
1.62
15.59
14.38
NA
NA
0.54
17.75
16.54
NA
NA
XXX73719
26
A
Mri lower extremity w/dye
1.62
0.52
0.53
0.52
0.53
0.07
2.21
2.22
2.21
2.22
XXX73719
TC
A
Mri lower extremity w/dye
0.00
15.07
13.85
NA
NA
0.47
15.54
14.32
NA
NA
XXX73720

A
Mri lwr extremity w/o&w/dye
2.15
19.28
24.01
NA
NA
0.94
22.37
27.10
NA
NA
XXX73720
26
A
Mri lwr extremity w/o&w/dye
2.15
0.69
0.70
0.69
0.70
0.10
2.94
2.95
2.94
2.95
XXX73720
TC
A
Mri lwr extremity w/o&w/dye
0.00
18.59
23.31
NA
NA
0.84
19.43
24.15
NA
NA
XXX73721

A
Mri jnt of lwr extre w/o dye
1.35
14.27
12.30
NA
NA
0.45
16.07
14.10
NA
NA
XXX73721
26
A
Mri jnt of lwr extre w/o dye
1.35
0.46
0.45
0.46
0.45
0.06
1.87
1.86
1.87
1.86
XXX73721
TC
A
Mri jnt of lwr extre w/o dye
0.00
13.81
11.85
NA
NA
0.39
14.20
12.24
NA
NA
XXX73722

A
Mri joint of lwr extr w/dye
1.62
14.86
14.19
NA
NA
0.54
17.02
16.35
NA
NA
XXX73722
26
A
Mri joint of lwr extr w/dye
1.62
0.54
0.53
0.54
0.53
0.07
2.23
2.22
2.23
2.22
XXX73722
TC
A
Mri joint of lwr extr w/dye
0.00
14.32
13.66
NA
NA
0.47
14.79
14.13
NA
NA
XXX73723

A
Mri joint lwr extr w/o&w/dye
2.15
17.91
23.67
NA
NA
0.94
21.00
26.76
NA
NA
XXX73723
26
A
Mri joint lwr extr w/o&w/dye
2.15
0.70
0.71
0.70
0.71
0.10
2.95
2.96
2.95
2.96
XXX( print page 49187)73723
TC
A
Mri joint lwr extr w/o&w/dye
0.00
17.21
22.96
NA
NA
0.84
18.05
23.80
NA
NA
XXX73725

R
Mr ang lwr ext w or w/o dye
1.82
15.34
12.69
NA
NA
0.67
17.83
15.18
NA
NA
XXX73725
26
R
Mr ang lwr ext w or w/o dye
1.82
0.60
0.60
0.60
0.60
0.08
2.50
2.50
2.50
2.50
XXX73725
TC
R
Mr ang lwr ext w or w/o dye
0.00
14.75
12.09
NA
NA
0.59
15.34
12.68
NA
NA
XXX74000

A
X-ray exam of abdomen
0.18
0.46
0.55
NA
NA
0.03
0.67
0.76
NA
NA
XXX74000
26
A
X-ray exam of abdomen
0.18
0.05
0.06
0.05
0.06
0.01
0.24
0.25
0.24
0.25
XXX74000
TC
A
X-ray exam of abdomen
0.00
0.40
0.49
NA
NA
0.02
0.42
0.51
NA
NA
XXX74010

A
X-ray exam of abdomen
0.23
0.79
0.69
NA
NA
0.05
1.07
0.97
NA
NA
XXX74010
26
A
X-ray exam of abdomen
0.23
0.07
0.08
0.07
0.08
0.01
0.31
0.32
0.31
0.32
XXX74010
TC
A
X-ray exam of abdomen
0.00
0.72
0.61
NA
NA
0.04
0.76
0.65
NA
NA
XXX74020

A
X-ray exam of abdomen
0.27
0.80
0.73
NA
NA
0.05
1.12
1.05
NA
NA
XXX74020
26
A
X-ray exam of abdomen
0.27
0.08
0.09
0.08
0.09
0.01
0.36
0.37
0.36
0.37
XXX74020
TC
A
X-ray exam of abdomen
0.00
0.71
0.64
NA
NA
0.04
0.75
0.68
NA
NA
XXX74022

A
X-ray exam series, abdomen
0.32
0.97
0.87
NA
NA
0.06
1.35
1.25
NA
NA
XXX74022
26
A
X-ray exam series, abdomen
0.32
0.10
0.10
0.10
0.10
0.01
0.43
0.43
0.43
0.43
XXX74022
TC
A
X-ray exam series, abdomen
0.00
0.87
0.77
NA
NA
0.05
0.92
0.82
NA
NA
XXX74150

A
Ct abdomen w/o dye
1.19
6.06
6.05
NA
NA
0.35
7.60
7.59
NA
NA
XXX74150
26
A
Ct abdomen w/o dye
1.19
0.38
0.39
0.38
0.39
0.05
1.62
1.63
1.62
1.63
XXX74150
TC
A
Ct abdomen w/o dye
0.00
5.68
5.67
NA
NA
0.30
5.98
5.97
NA
NA
XXX74160

A
Ct abdomen w/dye
1.27
8.83
7.65
NA
NA
0.42
10.52
9.34
NA
NA
XXX74160
26
A
Ct abdomen w/dye
1.27
0.40
0.42
0.40
0.42
0.06
1.73
1.75
1.73
1.75
XXX74160
TC
A
Ct abdomen w/dye
0.00
8.43
7.24
NA
NA
0.36
8.79
7.60
NA
NA
XXX74170

A
Ct abdomen w/o & w/dye
1.40
12.27
9.77
NA
NA
0.49
14.16
11.66
NA
NA
XXX74170
26
A
Ct abdomen w/o & w/dye
1.40
0.45
0.46
0.45
0.46
0.06
1.91
1.92
1.91
1.92
XXX74170
TC
A
Ct abdomen w/o & w/dye
0.00
11.82
9.32
NA
NA
0.43
12.25
9.75
NA
NA
XXX74175

A
Ct angio abdom w/o & w/dye
1.90
12.34
12.57
NA
NA
0.47
14.71
14.94
NA
NA
XXX74175
26
A
Ct angio abdom w/o & w/dye
1.90
0.63
0.62
0.63
0.62
0.08
2.61
2.60
2.61
2.60
XXX74175
TC
A
Ct angio abdom w/o & w/dye
0.00
11.71
11.95
NA
NA
0.39
12.10
12.34
NA
NA
XXX74181

A
Mri abdomen w/o dye
1.46
12.60
11.91
NA
NA
0.51
14.57
13.88
NA
NA
XXX74181
26
A
Mri abdomen w/o dye
1.46
0.47
0.48
0.47
0.48
0.06
1.99
2.00
1.99
2.00
XXX74181
TC
A
Mri abdomen w/o dye
0.00
12.13
11.43
NA
NA
0.45
12.58
11.88
NA
NA
XXX74182

A
Mri abdomen w/dye
1.73
17.59
14.91
NA
NA
0.60
19.92
17.24
NA
NA
XXX74182
26
A
Mri abdomen w/dye
1.73
0.55
0.57
0.55
0.57
0.08
2.36
2.38
2.36
2.38
XXX74182
TC
A
Mri abdomen w/dye
0.00
17.04
14.34
NA
NA
0.52
17.56
14.86
NA
NA
XXX74183

A
Mri abdomen w/o & w/dye
2.26
19.27
24.03
NA
NA
1.02
22.55
27.31
NA
NA
XXX74183
26
A
Mri abdomen w/o & w/dye
2.26
0.73
0.74
0.73
0.74
0.10
3.09
3.10
3.09
3.10
XXX74183
TC
A
Mri abdomen w/o & w/dye
0.00
18.54
23.30
NA
NA
0.92
19.46
24.22
NA
NA
XXX74185

R
Mri angio, abdom w orw/o dye
1.80
15.31
12.67
NA
NA
0.67
17.78
15.14
NA
NA
XXX74185
26
R
Mri angio, abdom w orw/o dye
1.80
0.59
0.59
0.59
0.59
0.08
2.47
2.47
2.47
2.47
XXX74185
TC
R
Mri angio, abdom w orw/o dye
0.00
14.72
12.08
NA
NA
0.59
15.31
12.67
NA
NA
XXX74190

A
X-ray exam of peritoneum
0.48
NA
NA
NA
NA
0.09
NA
NA
NA
NA
XXX74190
26
A
X-ray exam of peritoneum
0.48
0.15
0.16
0.15
0.16
0.02
0.65
0.66
0.65
0.66
XXX74190
TC
A
X-ray exam of peritoneum
0.00
NA
NA
NA
NA
0.07
NA
NA
NA
NA
XXX74210

A
Contrst x-ray exam of throat
0.36
1.76
1.42
NA
NA
0.08
2.20
1.86
NA
NA
XXX74210
26
A
Contrst x-ray exam of throat
0.36
0.11
0.12
0.11
0.12
0.02
0.49
0.50
0.49
0.50
XXX74210
TC
A
Contrst x-ray exam of throat
0.00
1.65
1.31
NA
NA
0.06
1.71
1.37
NA
NA
XXX74220

A
Contrast x-ray, esophagus
0.46
2.01
1.51
NA
NA
0.08
2.55
2.05
NA
NA
XXX74220
26
A
Contrast x-ray, esophagus
0.46
0.14
0.15
0.14
0.15
0.02
0.62
0.63
0.62
0.63
XXX74220
TC
A
Contrast x-ray, esophagus
0.00
1.87
1.36
NA
NA
0.06
1.93
1.42
NA
NA
XXX74230

A
Cine/vid x-ray, throat/esoph
0.53
1.93
1.59
NA
NA
0.09
2.55
2.21
NA
NA
XXX74230
26
A
Cine/vid x-ray, throat/esoph
0.53
0.17
0.17
0.17
0.17
0.02
0.72
0.72
0.72
0.72
XXX74230
TC
A
Cine/vid x-ray, throat/esoph
0.00
1.76
1.42
NA
NA
0.07
1.83
1.49
NA
NA
XXX74235

C
Remove esophagus obstruction
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX74235
26
A
Remove esophagus obstruction
1.19
0.40
0.39
0.40
0.39
0.05
1.64
1.63
1.64
1.63
XXX74235
TC
C
Remove esophagus obstruction
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX74240

A
X-ray exam, upper gi tract
0.69
2.28
1.84
NA
NA
0.11
3.08
2.64
NA
NA
XXX74240
26
A
X-ray exam, upper gi tract
0.69
0.22
0.23
0.22
0.23
0.03
0.94
0.95
0.94
0.95
XXX74240
TC
A
X-ray exam, upper gi tract
0.00
2.07
1.61
NA
NA
0.08
2.15
1.69
NA
NA
XXX74241

A
X-ray exam, upper gi tract
0.69
2.55
1.93
NA
NA
0.11
3.35
2.73
NA
NA
XXX74241
26
A
X-ray exam, upper gi tract
0.69
0.21
0.23
0.21
0.23
0.03
0.93
0.95
0.93
0.95
XXX74241
TC
A
X-ray exam, upper gi tract
0.00
2.34
1.70
NA
NA
0.08
2.42
1.78
NA
NA
XXX74245

A
X-ray exam, upper gi tract
0.91
3.94
3.00
NA
NA
0.17
5.02
4.08
NA
NA
XXX74245
26
A
X-ray exam, upper gi tract
0.91
0.29
0.30
0.29
0.30
0.04
1.24
1.25
1.24
1.25
XXX74245
TC
A
X-ray exam, upper gi tract
0.00
3.65
2.70
NA
NA
0.13
3.78
2.83
NA
NA
XXX74246

A
Contrst x-ray uppr gi tract
0.69
2.78
2.09
NA
NA
0.13
3.60
2.91
NA
NA
XXX74246
26
A
Contrst x-ray uppr gi tract
0.69
0.22
0.23
0.22
0.23
0.03
0.94
0.95
0.94
0.95
XXX( print page 49188)74246
TC
A
Contrst x-ray uppr gi tract
0.00
2.57
1.87
NA
NA
0.10
2.67
1.97
NA
NA
XXX74247

A
Contrst x-ray uppr gi tract
0.69
3.21
2.23
NA
NA
0.14
4.04
3.06
NA
NA
XXX74247
26
A
Contrst x-ray uppr gi tract
0.69
0.22
0.23
0.22
0.23
0.03
0.94
0.95
0.94
0.95
XXX74247
TC
A
Contrst x-ray uppr gi tract
0.00
2.99
2.01
NA
NA
0.11
3.10
2.12
NA
NA
XXX74249

A
Contrst x-ray uppr gi tract
0.91
4.33
3.24
NA
NA
0.18
5.42
4.33
NA
NA
XXX74249
26
A
Contrst x-ray uppr gi tract
0.91
0.29
0.30
0.29
0.30
0.04
1.24
1.25
1.24
1.25
XXX74249
TC
A
Contrst x-ray uppr gi tract
0.00
4.05
2.94
NA
NA
0.14
4.19
3.08
NA
NA
XXX74250

A
X-ray exam of small bowel
0.47
2.48
1.72
NA
NA
0.09
3.04
2.28
NA
NA
XXX74250
26
A
X-ray exam of small bowel
0.47
0.15
0.15
0.15
0.15
0.02
0.64
0.64
0.64
0.64
XXX74250
TC
A
X-ray exam of small bowel
0.00
2.33
1.57
NA
NA
0.07
2.40
1.64
NA
NA
XXX74251

A
X-ray exam of small bowel
0.69
10.01
3.66
NA
NA
0.10
10.80
4.45
NA
NA
XXX74251
26
A
X-ray exam of small bowel
0.69
0.22
0.23
0.22
0.23
0.03
0.94
0.95
0.94
0.95
XXX74251
TC
A
X-ray exam of small bowel
0.00
9.80
3.43
NA
NA
0.07
9.87
3.50
NA
NA
XXX74260

A
X-ray exam of small bowel
0.50
8.32
3.32
NA
NA
0.10
8.92
3.92
NA
NA
XXX74260
26
A
X-ray exam of small bowel
0.50
0.15
0.16
0.15
0.16
0.02
0.67
0.68
0.67
0.68
XXX74260
TC
A
X-ray exam of small bowel
0.00
8.17
3.16
NA
NA
0.08
8.25
3.24
NA
NA
XXX74270

A
Contrast x-ray exam of colon
0.69
3.57
2.33
NA
NA
0.14
4.40
3.16
NA
NA
XXX74270
26
A
Contrast x-ray exam of colon
0.69
0.22
0.23
0.22
0.23
0.03
0.94
0.95
0.94
0.95
XXX74270
TC
A
Contrast x-ray exam of colon
0.00
3.35
2.11
NA
NA
0.11
3.46
2.22
NA
NA
XXX74280

A
Contrast x-ray exam of colon
0.99
4.94
3.15
NA
NA
0.17
6.10
4.31
NA
NA
XXX74280
26
A
Contrast x-ray exam of colon
0.99
0.31
0.32
0.31
0.32
0.04
1.34
1.35
1.34
1.35
XXX74280
TC
A
Contrast x-ray exam of colon
0.00
4.63
2.83
NA
NA
0.13
4.76
2.96
NA
NA
XXX74283

A
Contrast x-ray exam of colon
2.02
3.42
3.27
NA
NA
0.23
5.67
5.52
NA
NA
XXX74283
26
A
Contrast x-ray exam of colon
2.02
0.61
0.65
0.61
0.65
0.09
2.72
2.76
2.72
2.76
XXX74283
TC
A
Contrast x-ray exam of colon
0.00
2.80
2.62
NA
NA
0.14
2.94
2.76
NA
NA
XXX74290

A
Contrast x-ray, gallbladder
0.32
1.56
1.01
NA
NA
0.06
1.94
1.39
NA
NA
XXX74290
26
A
Contrast x-ray, gallbladder
0.32
0.10
0.10
0.10
0.10
0.01
0.43
0.43
0.43
0.43
XXX74290
TC
A
Contrast x-ray, gallbladder
0.00
1.46
0.91
NA
NA
0.05
1.51
0.96
NA
NA
XXX74291

A
Contrast x-rays, gallbladder
0.20
1.60
0.77
NA
NA
0.03
1.83
1.00
NA
NA
XXX74291
26
A
Contrast x-rays, gallbladder
0.20
0.06
0.07
0.06
0.07
0.01
0.27
0.28
0.27
0.28
XXX74291
TC
A
Contrast x-rays, gallbladder
0.00
1.54
0.70
NA
NA
0.02
1.56
0.72
NA
NA
XXX74300

C
X-ray bile ducts/pancreas
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX74300
26
A
X-ray bile ducts/pancreas
0.36
0.11
0.12
0.11
0.12
0.02
0.49
0.50
0.49
0.50
XXX74300
TC
C
X-ray bile ducts/pancreas
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX74301

C
X-rays at surgery add-on
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
ZZZ74301
26
A
X-rays at surgery add-on
0.21
0.07
0.07
0.07
0.07
0.01
0.29
0.29
0.29
0.29
ZZZ74301
TC
C
X-rays at surgery add-on
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
ZZZ74305

A
X-ray bile ducts/pancreas
0.42
NA
NA
NA
NA
0.07
NA
NA
NA
NA
XXX74305
26
A
X-ray bile ducts/pancreas
0.42
0.14
0.14
0.14
0.14
0.02
0.58
0.58
0.58
0.58
XXX74305
TC
A
X-ray bile ducts/pancreas
0.00
NA
NA
NA
NA
0.05
NA
NA
NA
NA
XXX74320

A
Contrast x-ray of bile ducts
0.54
2.13
3.03
NA
NA
0.19
2.86
3.76
NA
NA
XXX74320
26
A
Contrast x-ray of bile ducts
0.54
0.17
0.18
0.17
0.18
0.02
0.73
0.74
0.73
0.74
XXX74320
TC
A
Contrast x-ray of bile ducts
0.00
1.95
2.85
NA
NA
0.17
2.12
3.02
NA
NA
XXX74327

A
X-ray bile stone removal
0.70
2.99
2.24
NA
NA
0.14
3.83
3.08
NA
NA
XXX74327
26
A
X-ray bile stone removal
0.70
0.23
0.23
0.23
0.23
0.03
0.96
0.96
0.96
0.96
XXX74327
TC
A
X-ray bile stone removal
0.00
2.76
2.01
NA
NA
0.11
2.87
2.12
NA
NA
XXX74328

A
X-ray bile duct endoscopy
0.70
NA
NA
NA
NA
0.20
NA
NA
NA
NA
XXX74328
26
A
X-ray bile duct endoscopy
0.70
0.23
0.23
0.23
0.23
0.03
0.96
0.96
0.96
0.96
XXX74328
TC
A
X-ray bile duct endoscopy
0.00
NA
NA
NA
NA
0.17
NA
NA
NA
NA
XXX74329

C
X-ray for pancreas endoscopy
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX74329
26
A
X-ray for pancreas endoscopy
0.70
0.23
0.23
0.23
0.23
0.03
0.96
0.96
0.96
0.96
XXX74329
TC
C
X-ray for pancreas endoscopy
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX74330

A
X-ray bile/panc endoscopy
0.90
NA
NA
NA
NA
0.21
NA
NA
NA
NA
XXX74330
26
A
X-ray bile/panc endoscopy
0.90
0.30
0.29
0.30
0.29
0.04
1.24
1.23
1.24
1.23
XXX74330
TC
A
X-ray bile/panc endoscopy
0.00
NA
NA
NA
NA
0.17
NA
NA
NA
NA
XXX74340

A
X-ray guide for GI tube
0.54
NA
NA
NA
NA
0.16
NA
NA
NA
NA
XXX( print page 49189)74340
26
A
X-ray guide for GI tube
0.54
0.17
0.18
0.17
0.18
0.02
0.73
0.74
0.73
0.74
XXX74340
TC
A
X-ray guide for GI tube
0.00
NA
NA
NA
NA
0.14
NA
NA
NA
NA
XXX74350

A
X-ray guide, stomach tube
0.76
2.22
3.11
NA
NA
0.20
3.18
4.07
NA
NA
XXX74350
26
A
X-ray guide, stomach tube
0.76
0.25
0.25
0.25
0.25
0.03
1.04
1.04
1.04
1.04
XXX74350
TC
A
X-ray guide, stomach tube
0.00
1.97
2.86
NA
NA
0.17
2.14
3.03
NA
NA
XXX74355

A
X-ray guide, intestinal tube
0.76
NA
NA
NA
NA
0.17
NA
NA
NA
NA
XXX74355
26
A
X-ray guide, intestinal tube
0.76
0.25
0.25
0.25
0.25
0.03
1.04
1.04
1.04
1.04
XXX74355
TC
A
X-ray guide, intestinal tube
0.00
NA
NA
NA
NA
0.14
NA
NA
NA
NA
XXX74360

A
X-ray guide, GI dilation
0.54
NA
NA
NA
NA
0.19
NA
NA
NA
NA
XXX74360
26
A
X-ray guide, GI dilation
0.54
0.24
0.20
0.24
0.20
0.02
0.80
0.76
0.80
0.76
XXX74360
TC
A
X-ray guide, GI dilation
0.00
NA
NA
NA
NA
0.17
NA
NA
NA
NA
XXX74363

C
X-ray, bile duct dilation
0.00
NA
NA
NA
NA
0.00
NA
NA
NA
NA
XXX74363
26
A
X-ray, bile duct dilation
0.88
0.29
0.29
0.29
0.29
0.04
1.21
1.21
1.21
1.21
XXX74363
TC
C
X-ray, bile duct dilation
0.00
NA
NA
NA
NA
0.00
NA
NA
NA
NA
XXX74400

A
Contrst x-ray, urinary tract
0.49
2.60
2.02
NA
NA
0.13
3.22
2.64
NA
NA
XXX74400
26
A
Contrst x-ray, urinary tract
0.49
0.16
0.16
0.16
0.16
0.02
0.67
0.67
0.67
0.67
XXX74400
TC
A
Contrst x-ray, urinary tract
0.00
2.44
1.87
NA
NA
0.11
2.55
1.98
NA
NA
XXX74410

A
Contrst x-ray, urinary tract
0.49
2.73
2.27
NA
NA
0.13
3.35
2.89
NA
NA
XXX74410
26
A
Contrst x-ray, urinary tract
0.49
0.17
0.16
0.17
0.16
0.02
0.68
0.67
0.68
0.67
XXX74410
TC
A
Contrst x-ray, urinary tract
0.00
2.56
2.10
NA
NA
0.11
2.67
2.21
NA
NA
XXX74415

A
Contrst x-ray, urinary tract
0.49
3.29
2.53
NA
NA
0.14
3.92
3.16
NA
NA
XXX74415
26
A
Contrst x-ray, urinary tract
0.49
0.16
0.16
0.16
0.16
0.02
0.67
0.67
0.67
0.67
XXX74415
TC
A
Contrst x-ray, urinary tract
0.00
3.13
2.37
NA
NA
0.12
3.25
2.49
NA
NA
XXX74420

A
Contrst x-ray, urinary tract
0.36
NA
NA
NA
NA
0.16
NA
NA
NA
NA
XXX74420
26
A
Contrst x-ray, urinary tract
0.36
0.13
0.12
0.13
0.12
0.02
0.51
0.50
0.51
0.50
XXX74420
TC
A
Contrst x-ray, urinary tract
0.00
NA
NA
NA
NA
0.14
NA
NA
NA
NA
XXX74425

A
Contrst x-ray, urinary tract
0.36
NA
NA
NA
NA
0.09
NA
NA
NA
NA
XXX74425
26
A
Contrst x-ray, urinary tract
0.36
0.12
0.12
0.12
0.12
0.02
0.50
0.50
0.50
0.50
XXX74425
TC
A
Contrst x-ray, urinary tract
0.00
NA
NA
NA
NA
0.07
NA
NA
NA
NA
XXX74430

A
Contrast x-ray, bladder
0.32
1.96
1.35
NA
NA
0.08
2.36
1.75
NA
NA
XXX74430
26
A
Contrast x-ray, bladder
0.32
0.11
0.10
0.11
0.10
0.02
0.45
0.44
0.45
0.44
XXX74430
TC
A
Contrast x-ray, bladder
0.00
1.85
1.25
NA
NA
0.06
1.91
1.31
NA
NA
XXX74440

A
X-ray, male genital tract
0.38
2.20
1.49
NA
NA
0.08
2.66
1.95
NA
NA
XXX74440
26
A
X-ray, male genital tract
0.38
0.15
0.13
0.15
0.13
0.02
0.55
0.53
0.55
0.53
XXX74440
TC
A
X-ray, male genital tract
0.00
2.06
1.36
NA
NA
0.06
2.12
1.42
NA
NA
XXX74445

A
X-ray exam of penis
1.14
NA
NA
NA
NA
0.13
NA
NA
NA
NA
XXX74445
26
A
X-ray exam of penis
1.14
0.44
0.39
0.44
0.39
0.07
1.65
1.60
1.65
1.60
XXX74445
TC
A
X-ray exam of penis
0.00
NA
NA
NA
NA
0.06
NA
NA
NA
NA
XXX74450

A
X-ray, urethra/bladder
0.33
NA
NA
NA
NA
0.10
NA
NA
NA
NA
XXX74450
26
A
X-ray, urethra/bladder
0.33
0.11
0.11
0.11
0.11
0.02
0.46
0.46
0.46
0.46
XXX74450
TC
A
X-ray, urethra/bladder
0.00
NA
NA
NA
NA
0.08
NA
NA
NA
NA
XXX74455

A
X-ray, urethra/bladder
0.33
2.18
1.81
NA
NA
0.12
2.63
2.26
NA
NA
XXX74455
26
A
X-ray, urethra/bladder
0.33
0.12
0.11
0.12
0.11
0.02
0.47
0.46
0.47
0.46
XXX74455
TC
A
X-ray, urethra/bladder
0.00
2.06
1.70
NA
NA
0.10
2.16
1.80
NA
NA
XXX74470

A
X-ray exam of kidney lesion
0.54
NA
NA
NA
NA
0.09
NA
NA
NA
NA
XXX74470
26
A
X-ray exam of kidney lesion
0.54
0.16
0.18
0.16
0.18
0.02
0.72
0.74
0.72
0.74
XXX74470
TC
A
X-ray exam of kidney lesion
0.00
NA
NA
NA
NA
0.07
NA
NA
NA
NA
XXX74475

A
X-ray control, cath insert
0.54
2.12
3.72
NA
NA
0.24
2.90
4.50
NA
NA
XXX74475
26
A
X-ray control, cath insert
0.54
0.18
0.18
0.18
0.18
0.02
0.74
0.74
0.74
0.74
XXX74475
TC
A
X-ray control, cath insert
0.00
1.94
3.54
NA
NA
0.22
2.16
3.76
NA
NA
XXX74480

A
X-ray control, cath insert
0.54
2.13
3.72
NA
NA
0.24
2.91
4.50
NA
NA
XXX74480
26
A
X-ray control, cath insert
0.54
0.18
0.18
0.18
0.18
0.02
0.74
0.74
0.74
0.74
XXX74480
TC
A
X-ray control, cath insert
0.00
1.95
3.54
NA
NA
0.22
2.17
3.76
NA
NA
XXX74485

A
X-ray guide, GU dilation
0.54
2.29
3.06
NA
NA
0.20
3.03
3.80
NA
NA
XXX74485
26
A
X-ray guide, GU dilation
0.54
0.19
0.18
0.19
0.18
0.03
0.76
0.75
0.76
0.75
XXX74485
TC
A
X-ray guide, GU dilation
0.00
2.10
2.89
NA
NA
0.17
2.27
3.06
NA
NA
XXX74710

A
X-ray measurement of pelvis
0.34
0.64
1.03
NA
NA
0.08
1.06
1.45
NA
NA
XXX74710
26
A
X-ray measurement of pelvis
0.34
0.11
0.11
0.11
0.11
0.02
0.47
0.47
0.47
0.47
XXX74710
TC
A
X-ray measurement of pelvis
0.00
0.53
0.92
NA
NA
0.06
0.59
0.98
NA
NA
XXX74740

A
X-ray, female genital tract
0.38
1.77
1.52
NA
NA
0.09
2.24
1.99
NA
NA
XXX74740
26
A
X-ray, female genital tract
0.38
0.12
0.13
0.12
0.13
0.02
0.52
0.53
0.52
0.53
XXX74740
TC
A
X-ray, female genital tract
0.00
1.65
1.40
NA
NA
0.07
1.72
1.47
NA
NA
XXX74742

C
X-ray, fallopian tube
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX74742
26
A
X-ray, fallopian tube
0.61
0.17
0.19
0.17
0.19
0.03
0.81
0.83
0.81
0.83
XXX74742
TC
C
X-ray, fallopian tube
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX74775

A
X-ray exam of perineum
0.62
NA
NA
NA
NA
0.11
NA
NA
NA
NA
XXX( print page 49190)74775
26
A
X-ray exam of perineum
0.62
0.19
0.21
0.19
0.21
0.03
0.84
0.86
0.84
0.86
XXX74775
TC
A
X-ray exam of perineum
0.00
NA
NA
NA
NA
0.08
NA
NA
NA
NA
XXX75552

A
Heart mri for morph w/o dye
1.60
19.30
13.62
NA
NA
0.66
21.56
15.88
NA
NA
XXX75552
26
A
Heart mri for morph w/o dye
1.60
0.57
0.54
0.57
0.54
0.07
2.24
2.21
2.24
2.21
XXX75552
TC
A
Heart mri for morph w/o dye
0.00
18.73
13.08
NA
NA
0.59
19.32
13.67
NA
NA
XXX75553

A
Heart mri for morph w/dye
2.00
24.28
14.96
NA
NA
0.66
26.94
17.62
NA
NA
XXX75553
26
A
Heart mri for morph w/dye
2.00
0.94
0.72
0.94
0.72
0.07
3.01
2.79
3.01
2.79
XXX75553
TC
A
Heart mri for morph w/dye
0.00
23.34
14.24
NA
NA
0.59
23.93
14.83
NA
NA
XXX75554

A
Cardiac MRI/function
1.83
27.20
15.68
NA
NA
0.66
29.69
18.17
NA
NA
XXX75554
26
A
Cardiac MRI/function
1.83
0.79
0.68
0.79
0.68
0.07
2.69
2.58
2.69
2.58
XXX75554
TC
A
Cardiac MRI/function
0.00
26.41
15.00
NA
NA
0.59
27.00
15.59
NA
NA
XXX75555

A
Cardiac MRI/limited study
1.74
27.64
15.79
NA
NA
0.66
30.04
18.19
NA
NA
XXX75555
26
A
Cardiac MRI/limited study
1.74
0.84
0.69
0.84
0.69
0.07
2.65
2.50
2.65
2.50
XXX75555
TC
A
Cardiac MRI/limited study
0.00
26.80
15.10
NA
NA
0.59
27.39
15.69
NA
NA
XXX75600

A
Contrast x-ray exam of aorta
0.49
6.49
11.22
NA
NA
0.67
7.65
12.38
NA
NA
XXX75600
26
A
Contrast x-ray exam of aorta
0.49
0.25
0.21
0.25
0.21
0.02
0.76
0.72
0.76
0.72
XXX75600
TC
A
Contrast x-ray exam of aorta
0.00
6.24
11.01
NA
NA
0.65
6.89
11.66
NA
NA
XXX75605

A
Contrast x-ray exam of aorta
1.14
3.63
10.66
NA
NA
0.70
5.47
12.50
NA
NA
XXX75605
26
A
Contrast x-ray exam of aorta
1.14
0.51
0.43
0.51
0.43
0.05
1.70
1.62
1.70
1.62
XXX75605
TC
A
Contrast x-ray exam of aorta
0.00
3.13
10.23
NA
NA
0.65
3.78
10.88
NA
NA
XXX75625

A
Contrast x-ray exam of aorta
1.14
3.38
10.58
NA
NA
0.71
5.23
12.43
NA
NA
XXX75625
26
A
Contrast x-ray exam of aorta
1.14
0.42
0.39
0.42
0.39
0.06
1.62
1.59
1.62
1.59
XXX75625
TC
A
Contrast x-ray exam of aorta
0.00
2.96
10.19
NA
NA
0.65
3.61
10.84
NA
NA
XXX75630

A
X-ray aorta, leg arteries
1.79
3.80
11.26
NA
NA
0.80
6.39
13.85
NA
NA
XXX75630
26
A
X-ray aorta, leg arteries
1.79
0.72
0.64
0.72
0.64
0.11
2.62
2.54
2.62
2.54
XXX75630
TC
A
X-ray aorta, leg arteries
0.00
3.08
10.62
NA
NA
0.69
3.77
11.31
NA
NA
XXX75635

A
Ct angio abdominal arteries
2.40
12.87
15.74
NA
NA
0.50
15.77
18.64
NA
NA
XXX75635
26
A
Ct angio abdominal arteries
2.40
0.83
0.80
0.83
0.80
0.11
3.34
3.31
3.34
3.31
XXX75635
TC
A
Ct angio abdominal arteries
0.00
12.04
14.94
NA
NA
0.39
12.43
15.33
NA
NA
XXX75650

A
Artery x-rays, head & neck
1.49
3.53
10.70
NA
NA
0.72
5.74
12.91
NA
NA
XXX75650
26
A
Artery x-rays, head & neck
1.49
0.55
0.51
0.55
0.51
0.07
2.11
2.07
2.11
2.07
XXX75650
TC
A
Artery x-rays, head & neck
0.00
2.97
10.19
NA
NA
0.65
3.62
10.84
NA
NA
XXX75658

A
Artery x-rays, arm
1.31
3.86
10.77
NA
NA
0.72
5.89
12.80
NA
NA
XXX75658
26
A
Artery x-rays, arm
1.31
0.48
0.47
0.48
0.47
0.07
1.86
1.85
1.86
1.85
XXX75658
TC
A
Artery x-rays, arm
0.00
3.37
10.29
NA
NA
0.65
4.02
10.94
NA
NA
XXX75660

A
Artery x-rays, head & neck
1.31
3.94
10.77
NA
NA
0.71
5.96
12.79
NA
NA
XXX75660
26
A
Artery x-rays, head & neck
1.31
0.49
0.45
0.49
0.45
0.06
1.86
1.82
1.86
1.82
XXX75660
TC
A
Artery x-rays, head & neck
0.00
3.45
10.31
NA
NA
0.65
4.10
10.96
NA
NA
XXX75662

A
Artery x-rays, head & neck
1.66
5.11
11.17
NA
NA
0.71
7.48
13.54
NA
NA
XXX75662
26
A
Artery x-rays, head & neck
1.66
0.72
0.62
0.72
0.62
0.06
2.44
2.34
2.44
2.34
XXX75662
TC
A
Artery x-rays, head & neck
0.00
4.39
10.55
NA
NA
0.65
5.04
11.20
NA
NA
XXX75665

A
Artery x-rays, head & neck
1.31
4.10
10.81
NA
NA
0.74
6.15
12.86
NA
NA
XXX75665
26
A
Artery x-rays, head & neck
1.31
0.46
0.45
0.46
0.45
0.09
1.86
1.85
1.86
1.85
XXX75665
TC
A
Artery x-rays, head & neck
0.00
3.64
10.36
NA
NA
0.65
4.29
11.01
NA
NA
XXX75671

A
Artery x-rays, head & neck
1.66
5.09
11.14
NA
NA
0.72
7.47
13.52
NA
NA
XXX75671
26
A
Artery x-rays, head & neck
1.66
0.61
0.57
0.61
0.57
0.07
2.34
2.30
2.34
2.30
XXX75671
TC
A
Artery x-rays, head & neck
0.00
4.48
10.57
NA
NA
0.65
5.13
11.22
NA
NA
XXX75676

A
Artery x-rays, neck
1.31
3.86
10.75
NA
NA
0.72
5.89
12.78
NA
NA
XXX75676
26
A
Artery x-rays, neck
1.31
0.47
0.45
0.47
0.45
0.07
1.85
1.83
1.85
1.83
XXX75676
TC
A
Artery x-rays, neck
0.00
3.40
10.30
NA
NA
0.65
4.05
10.95
NA
NA
XXX75680

A
Artery x-rays, neck
1.66
4.61
11.02
NA
NA
0.72
6.99
13.40
NA
NA
XXX75680
26
A
Artery x-rays, neck
1.66
0.64
0.57
0.64
0.57
0.07
2.37
2.30
2.37
2.30
XXX75680
TC
A
Artery x-rays, neck
0.00
3.98
10.45
NA
NA
0.65
4.63
11.10
NA
NA
XXX75685

A
Artery x-rays, spine
1.31
3.90
10.75
NA
NA
0.71
5.92
12.77
NA
NA
XXX75685
26
A
Artery x-rays, spine
1.31
0.49
0.45
0.49
0.45
0.06
1.86
1.82
1.86
1.82
XXX75685
TC
A
Artery x-rays, spine
0.00
3.41
10.30
NA
NA
0.65
4.06
10.95
NA
NA
XXX( print page 49191)75705

A
Artery x-rays, spine
2.18
4.07
11.02
NA
NA
0.78
7.03
13.98
NA
NA
XXX75705
26
A
Artery x-rays, spine
2.18
0.72
0.73
0.72
0.73
0.13
3.03
3.04
3.03
3.04
XXX75705
TC
A
Artery x-rays, spine
0.00
3.35
10.29
NA
NA
0.65
4.00
10.94
NA
NA
XXX75710

A
Artery x-rays, arm/leg
1.14
3.99
10.74
NA
NA
0.72
5.85
12.60
NA
NA
XXX75710
26
A
Artery x-rays, arm/leg
1.14
0.42
0.40
0.42
0.40
0.07
1.63
1.61
1.63
1.61
XXX75710
TC
A
Artery x-rays, arm/leg
0.00
3.57
10.34
NA
NA
0.65
4.22
10.99
NA
NA
XXX75716

A
Artery x-rays, arms/legs
1.31
4.94
11.01
NA
NA
0.72
6.97
13.04
NA
NA
XXX75716
26
A
Artery x-rays, arms/legs
1.31
0.49
0.45
0.49
0.45
0.07
1.87
1.83
1.87
1.83
XXX75716
TC
A
Artery x-rays, arms/legs
0.00
4.45
10.56
NA
NA
0.65
5.10
11.21
NA
NA
XXX75722

A
Artery x-rays, kidney
1.14
3.89
10.72
NA
NA
0.70
5.73
12.56
NA
NA
XXX75722
26
A
Artery x-rays, kidney
1.14
0.47
0.42
0.47
0.42
0.05
1.66
1.61
1.66
1.61
XXX75722
TC
A
Artery x-rays, kidney
0.00
3.42
10.31
NA
NA
0.65
4.07
10.96
NA
NA
XXX75724

A
Artery x-rays, kidneys
1.49
5.20
11.17
NA
NA
0.70
7.39
13.36
NA
NA
XXX75724
26
A
Artery x-rays, kidneys
1.49
0.75
0.61
0.75
0.61
0.05
2.29
2.15
2.29
2.15
XXX75724
TC
A
Artery x-rays, kidneys
0.00
4.44
10.56
NA
NA
0.65
5.09
11.21
NA
NA
XXX75726

A
Artery x-rays, abdomen
1.14
3.73
10.66
NA
NA
0.70
5.57
12.50
NA
NA
XXX75726
26
A
Artery x-rays, abdomen
1.14
0.38
0.37
0.38
0.37
0.05
1.57
1.56
1.57
1.56
XXX75726
TC
A
Artery x-rays, abdomen
0.00
3.35
10.29
NA
NA
0.65
4.00
10.94
NA
NA
XXX75731

A
Artery x-rays, adrenal gland
1.14
3.90
10.70
NA
NA
0.71
5.75
12.55
NA
NA
XXX75731
26
A
Artery x-rays, adrenal gland
1.14
0.42
0.38
0.42
0.38
0.06
1.62
1.58
1.62
1.58
XXX75731
TC
A
Artery x-rays, adrenal gland
0.00
3.48
10.32
NA
NA
0.65
4.13
10.97
NA
NA
XXX75733

A
Artery x-rays, adrenals
1.31
5.27
11.10
NA
NA
0.71
7.29
13.12
NA
NA
XXX75733
26
A
Artery x-rays, adrenals
1.31
0.59
0.48
0.59
0.48
0.06
1.96
1.85
1.96
1.85
XXX75733
TC
A
Artery x-rays, adrenals
0.00
4.68
10.62
NA
NA
0.65
5.33
11.27
NA
NA
XXX75736

A
Artery x-rays, pelvis
1.14
3.87
10.70
NA
NA
0.71
5.72
12.55
NA
NA
XXX75736
26
A
Artery x-rays, pelvis
1.14
0.41
0.39
0.41
0.39
0.06
1.61
1.59
1.61
1.59
XXX75736
TC
A
Artery x-rays, pelvis
0.00
3.46
10.32
NA
NA
0.65
4.11
10.97
NA
NA
XXX75741

A
Artery x-rays, lung
1.31
3.14
10.56
NA
NA
0.71
5.16
12.58
NA
NA
XXX75741
26
A
Artery x-rays, lung
1.31
0.45
0.44
0.45
0.44
0.06
1.82
1.81
1.82
1.81
XXX75741
TC
A
Artery x-rays, lung
0.00
2.70
10.13
NA
NA
0.65
3.35
10.78
NA
NA
XXX75743

A
Artery x-rays, lungs
1.66
3.53
10.74
NA
NA
0.72
5.91
13.12
NA
NA
XXX75743
26
A
Artery x-rays, lungs
1.66
0.57
0.55
0.57
0.55
0.07
2.30
2.28
2.30
2.28
XXX75743
TC
A
Artery x-rays, lungs
0.00
2.96
10.19
NA
NA
0.65
3.61
10.84
NA
NA
XXX75746

A
Artery x-rays, lung
1.14
3.46
10.60
NA
NA
0.70
5.30
12.44
NA
NA
XXX75746
26
A
Artery x-rays, lung
1.14
0.36
0.38
0.36
0.38
0.05
1.55
1.57
1.55
1.57
XXX75746
TC
A
Artery x-rays, lung
0.00
3.10
10.23
NA
NA
0.65
3.75
10.88
NA
NA
XXX75756

A
Artery x-rays, chest
1.14
4.45
10.90
NA
NA
0.69
6.28
12.73
NA
NA
XXX75756
26
A
Artery x-rays, chest
1.14
0.60
0.49
0.60
0.49
0.04
1.78
1.67
1.78
1.67
XXX75756
TC
A
Artery x-rays, chest
0.00
3.84
10.41
NA
NA
0.65
4.49
11.06
NA
NA
XXX75774

A
Artery x-ray, each vessel
0.36
2.53
10.17
2.53
10.17
0.67
3.56
11.20
3.56
11.20
ZZZ75774
26
A
Artery x-ray, each vessel
0.36
0.13
0.12
0.13
0.12
0.02
0.51
0.50
0.51
0.50
ZZZ75774
TC
A
Artery x-ray, each vessel
0.00
2.40
10.05
2.40
10.05
0.65
3.05
10.70
3.05
10.70
ZZZ75790

A
Visualize A-V shunt
1.84
3.11
2.23
NA
NA
0.17
5.12
4.24
NA
NA
XXX75790
26
A
Visualize A-V shunt
1.84
0.57
0.59
0.57
0.59
0.09
2.50
2.52
2.50
2.52
XXX75790
TC
A
Visualize A-V shunt
0.00
2.54
1.65
NA
NA
0.08
2.62
1.73
NA
NA
XXX75801

A
Lymph vessel x-ray, arm/leg
0.81
NA
NA
NA
NA
0.37
NA
NA
NA
NA
XXX75801
26
A
Lymph vessel x-ray, arm/leg
0.81
0.22
0.26
0.22
0.26
0.08
1.11
1.15
1.11
1.15
XXX75801
TC
A
Lymph vessel x-ray, arm/leg
0.00
NA
NA
NA
NA
0.29
NA
NA
NA
NA
XXX75803

A
Lymph vessel x-ray,arms/legs
1.17
NA
NA
NA
NA
0.34
NA
NA
NA
NA
XXX75803
26
A
Lymph vessel x-ray,arms/legs
1.17
0.35
0.37
0.35
0.37
0.05
1.57
1.59
1.57
1.59
XXX75803
TC
A
Lymph vessel x-ray,arms/legs
0.00
NA
NA
NA
NA
0.29
NA
NA
NA
NA
XXX75805

A
Lymph vessel x-ray, trunk
0.81
NA
NA
NA
NA
0.38
NA
NA
NA
NA
XXX75805
26
A
Lymph vessel x-ray, trunk
0.81
0.23
0.26
0.23
0.26
0.05
1.09
1.12
1.09
1.12
XXX75805
TC
A
Lymph vessel x-ray, trunk
0.00
NA
NA
NA
NA
0.33
NA
NA
NA
NA
XXX75807

C
Lymph vessel x-ray, trunk
0.00
NA
NA
NA
NA
0.00
NA
NA
NA
NA
XXX75807
26
A
Lymph vessel x-ray, trunk
1.17
0.37
0.38
0.37
0.38
0.05
1.59
1.60
1.59
1.60
XXX75807
TC
C
Lymph vessel x-ray, trunk
0.00
NA
NA
NA
NA
0.00
NA
NA
NA
NA
XXX75809

A
Nonvascular shunt, x-ray
0.47
2.18
1.24
NA
NA
0.07
2.72
1.78
NA
NA
XXX75809
26
A
Nonvascular shunt, x-ray
0.47
0.15
0.15
0.15
0.15
0.02
0.64
0.64
0.64
0.64
XXX75809
TC
A
Nonvascular shunt, x-ray
0.00
2.03
1.09
NA
NA
0.05
2.08
1.14
NA
NA
XXX75810

A
Vein x-ray, spleen/liver
1.14
NA
NA
NA
NA
0.70
NA
NA
NA
NA
XXX75810
26
A
Vein x-ray, spleen/liver
1.14
0.39
0.38
0.39
0.38
0.05
1.58
1.57
1.58
1.57
XXX75810
TC
A
Vein x-ray, spleen/liver
0.00
NA
NA
NA
NA
0.65
NA
NA
NA
NA
XXX75820

A
Vein x-ray, arm/leg
0.70
3.02
1.64
NA
NA
0.09
3.81
2.43
NA
NA
XXX75820
26
A
Vein x-ray, arm/leg
0.70
0.28
0.24
0.28
0.24
0.03
1.01
0.97
1.01
0.97
XXX75820
TC
A
Vein x-ray, arm/leg
0.00
2.74
1.40
NA
NA
0.06
2.80
1.46
NA
NA
XXX( print page 49192)75822

A
Vein x-ray, arms/legs
1.06
3.18
2.16
NA
NA
0.13
4.37
3.35
NA
NA
XXX75822
26
A
Vein x-ray, arms/legs
1.06
0.35
0.35
0.35
0.35
0.05
1.46
1.46
1.46
1.46
XXX75822
TC
A
Vein x-ray, arms/legs
0.00
2.83
1.82
NA
NA
0.08
2.91
1.90
NA
NA
XXX75825

A
Vein x-ray, trunk
1.14
2.93
10.46
NA
NA
0.72
4.79
12.32
NA
NA
XXX75825
26
A
Vein x-ray, trunk
1.14
0.36
0.37
0.36
0.37
0.07
1.57
1.58
1.57
1.58
XXX75825
TC
A
Vein x-ray, trunk
0.00
2.57
10.09
NA
NA
0.65
3.22
10.74
NA
NA
XXX75827

A
Vein x-ray, chest
1.14
2.98
10.47
NA
NA
0.70
4.82
12.31
NA
NA
XXX75827
26
A
Vein x-ray, chest
1.14
0.36
0.37
0.36
0.37
0.05
1.55
1.56
1.55
1.56
XXX75827
TC
A
Vein x-ray, chest
0.00
2.61
10.10
NA
NA
0.65
3.26
10.75
NA
NA
XXX75831

A
Vein x-ray, kidney
1.14
3.05
10.49
NA
NA
0.71
4.90
12.34
NA
NA
XXX75831
26
A
Vein x-ray, kidney
1.14
0.36
0.37
0.36
0.37
0.06
1.56
1.57
1.56
1.57
XXX75831
TC
A
Vein x-ray, kidney
0.00
2.69
10.12
NA
NA
0.65
3.34
10.77
NA
NA
XXX75833

A
Vein x-ray, kidneys
1.49
3.71
10.75
NA
NA
0.74
5.94
12.98
NA
NA
XXX75833
26
A
Vein x-ray, kidneys
1.49
0.48
0.49
0.48
0.49
0.09
2.06
2.07
2.06
2.07
XXX75833
TC
A
Vein x-ray, kidneys
0.00
3.23
10.26
NA
NA
0.65
3.88
10.91
NA
NA
XXX75840

A
Vein x-ray, adrenal gland
1.14
3.29
10.56
NA
NA
0.72
5.15
12.42
NA
NA
XXX75840
26
A
Vein x-ray, adrenal gland
1.14
0.45
0.40
0.45
0.40
0.07
1.66
1.61
1.66
1.61
XXX75840
TC
A
Vein x-ray, adrenal gland
0.00
2.84
10.16
NA
NA
0.65
3.49
10.81
NA
NA
XXX75842

A
Vein x-ray, adrenal glands
1.49
3.68
10.73
NA
NA
0.72
5.89
12.94
NA
NA
XXX75842
26
A
Vein x-ray, adrenal glands
1.49
0.49
0.48
0.49
0.48
0.07
2.05
2.04
2.05
2.04
XXX75842
TC
A
Vein x-ray, adrenal glands
0.00
3.19
10.25
NA
NA
0.65
3.84
10.90
NA
NA
XXX75860

A
Vein x-ray, neck
1.14
3.45
10.61
NA
NA
0.69
5.28
12.44
NA
NA
XXX75860
26
A
Vein x-ray, neck
1.14
0.50
0.42
0.50
0.42
0.04
1.68
1.60
1.68
1.60
XXX75860
TC
A
Vein x-ray, neck
0.00
2.96
10.19
NA
NA
0.65
3.61
10.84
NA
NA
XXX75870

A
Vein x-ray, skull
1.14
3.23
10.55
NA
NA
0.70
5.07
12.39
NA
NA
XXX75870
26
A
Vein x-ray, skull
1.14
0.39
0.39
0.39
0.39
0.05
1.58
1.58
1.58
1.58
XXX75870
TC
A
Vein x-ray, skull
0.00
2.84
10.16
NA
NA
0.65
3.49
10.81
NA
NA
XXX75872

A
Vein x-ray, skull
1.14
3.91
10.71
NA
NA
0.79
5.84
12.64
NA
NA
XXX75872
26
A
Vein x-ray, skull
1.14
0.42
0.38
0.42
0.38
0.14
1.70
1.66
1.70
1.66
XXX75872
TC
A
Vein x-ray, skull
0.00
3.48
10.32
NA
NA
0.65
4.13
10.97
NA
NA
XXX75880

A
Vein x-ray, eye socket
0.70
2.99
1.63
NA
NA
0.09
3.78
2.42
NA
NA
XXX75880
26
A
Vein x-ray, eye socket
0.70
0.23
0.23
0.23
0.23
0.03
0.96
0.96
0.96
0.96
XXX75880
TC
A
Vein x-ray, eye socket
0.00
2.76
1.40
NA
NA
0.06
2.82
1.46
NA
NA
XXX75885

A
Vein x-ray, liver
1.44
3.17
10.60
NA
NA
0.71
5.32
12.75
NA
NA
XXX75885
26
A
Vein x-ray, liver
1.44
0.47
0.47
0.47
0.47
0.06
1.97
1.97
1.97
1.97
XXX75885
TC
A
Vein x-ray, liver
0.00
2.70
10.13
NA
NA
0.65
3.35
10.78
NA
NA
XXX75887

A
Vein x-ray, liver
1.44
3.35
10.64
NA
NA
0.71
5.50
12.79
NA
NA
XXX75887
26
A
Vein x-ray, liver
1.44
0.51
0.48
0.51
0.48
0.06
2.01
1.98
2.01
1.98
XXX75887
TC
A
Vein x-ray, liver
0.00
2.84
10.16
NA
NA
0.65
3.49
10.81
NA
NA
XXX75889

A
Vein x-ray, liver
1.14
3.07
10.50
NA
NA
0.70
4.91
12.34
NA
NA
XXX75889
26
A
Vein x-ray, liver
1.14
0.38
0.37
0.38
0.37
0.05
1.57
1.56
1.57
1.56
XXX75889
TC
A
Vein x-ray, liver
0.00
2.70
10.13
NA
NA
0.65
3.35
10.78
NA
NA
XXX75891

A
Vein x-ray, liver
1.14
3.05
10.49
NA
NA
0.70
4.89
12.33
NA
NA
XXX75891
26
A
Vein x-ray, liver
1.14
0.37
0.37
0.37
0.37
0.05
1.56
1.56
1.56
1.56
XXX75891
TC
A
Vein x-ray, liver
0.00
2.68
10.12
NA
NA
0.65
3.33
10.77
NA
NA
XXX75893

A
Venous sampling by catheter
0.54
2.87
10.30
NA
NA
0.67
4.08
11.51
NA
NA
XXX75893
26
A
Venous sampling by catheter
0.54
0.18
0.18
0.18
0.18
0.02
0.74
0.74
0.74
0.74
XXX75893
TC
A
Venous sampling by catheter
0.00
2.69
10.12
NA
NA
0.65
3.34
10.77
NA
NA
XXX75894

A
X-rays, transcath therapy
1.31
NA
NA
NA
NA
1.35
NA
NA
NA
NA
XXX75894
26
A
X-rays, transcath therapy
1.31
0.42
0.43
0.42
0.43
0.08
1.81
1.82
1.81
1.82
XXX75894
TC
A
X-rays, transcath therapy
0.00
NA
NA
NA
NA
1.27
NA
NA
NA
NA
XXX75896

A
X-rays, transcath therapy
1.31
NA
NA
NA
NA
1.15
NA
NA
NA
NA
XXX75896
26
A
X-rays, transcath therapy
1.31
0.51
0.47
0.51
0.47
0.05
1.87
1.83
1.87
1.83
XXX75896
TC
A
X-rays, transcath therapy
0.00
NA
NA
NA
NA
1.10
NA
NA
NA
NA
XXX75898

A
Follow-up angiography
1.65
NA
NA
NA
NA
0.13
NA
NA
NA
NA
XXX75898
26
A
Follow-up angiography
1.65
0.60
0.56
0.60
0.56
0.07
2.32
2.28
2.32
2.28
XXX( print page 49193)75898
TC
A
Follow-up angiography
0.00
NA
NA
NA
NA
0.06
NA
NA
NA
NA
XXX75900

C
Intravascular cath exchange
0.00
NA
NA
NA
NA
0.00
NA
NA
NA
NA
XXX75900
26
A
Intravascular cath exchange
0.49
0.16
0.16
0.16
0.16
0.03
0.68
0.68
0.68
0.68
XXX75900
TC
C
Intravascular cath exchange
0.00
NA
NA
NA
NA
0.00
NA
NA
NA
NA
XXX75901

A
Remove cva device obstruct
0.49
4.20
2.15
NA
NA
0.85
5.54
3.49
NA
NA
XXX75901
26
A
Remove cva device obstruct
0.49
0.16
0.16
0.16
0.16
0.02
0.67
0.67
0.67
0.67
XXX75901
TC
A
Remove cva device obstruct
0.00
4.04
1.99
NA
NA
0.83
4.87
2.82
NA
NA
XXX75902

A
Remove cva lumen obstruct
0.39
1.64
1.49
NA
NA
0.85
2.88
2.73
NA
NA
XXX75902
26
A
Remove cva lumen obstruct
0.39
0.13
0.13
0.13
0.13
0.02
0.54
0.54
0.54
0.54
XXX75902
TC
A
Remove cva lumen obstruct
0.00
1.52
1.36
NA
NA
0.83
2.35
2.19
NA
NA
XXX75940

A
X-ray placement, vein filter
0.54
NA
NA
NA
NA
0.69
NA
NA
NA
NA
XXX75940
26
A
X-ray placement, vein filter
0.54
0.17
0.18
0.17
0.18
0.04
0.75
0.76
0.75
0.76
XXX75940
TC
A
X-ray placement, vein filter
0.00
NA
NA
NA
NA
0.65
NA
NA
NA
NA
XXX75945

A
Intravascular us
0.40
NA
NA
NA
NA
0.28
NA
NA
NA
NA
XXX75945
26
A
Intravascular us
0.40
0.15
0.14
0.15
0.14
0.04
0.59
0.58
0.59
0.58
XXX75945
TC
A
Intravascular us
0.00
NA
NA
NA
NA
0.24
NA
NA
NA
NA
XXX75946

C
Intravascular us add-on
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
ZZZ75946
26
A
Intravascular us add-on
0.40
0.13
0.14
0.13
0.14
0.05
0.58
0.59
0.58
0.59
ZZZ75946
TC
C
Intravascular us add-on
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
ZZZ75952

C
Endovasc repair abdom aorta
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX75952
26
A
Endovasc repair abdom aorta
4.49
1.31
1.45
1.31
1.45
0.43
6.23
6.37
6.23
6.37
XXX75952
TC
C
Endovasc repair abdom aorta
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX75953

C
Abdom aneurysm endovas rpr
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX75953
26
A
Abdom aneurysm endovas rpr
1.36
0.40
0.44
0.40
0.44
0.13
1.89
1.93
1.89
1.93
XXX75953
TC
C
Abdom aneurysm endovas rpr
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX75954

C
Iliac aneurysm endovas rpr
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX75954
26
A
Iliac aneurysm endovas rpr
2.25
0.66
0.75
0.66
0.75
0.15
3.06
3.15
3.06
3.15
XXX75954
TC
C
Iliac aneurysm endovas rpr
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX75956

C
Xray, endovasc thor ao repr
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX75956
26
A
Xray, endovasc thor ao repr
7.00
1.63
2.43
1.63
2.43
0.69
9.32
10.12
9.32
10.12
XXX75956
TC
C
Xray, endovasc thor ao repr
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX75957

C
Xray, endovasc thor ao repr
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX75957
26
A
Xray, endovasc thor ao repr
6.00
1.40
2.08
1.40
2.08
0.59
7.99
8.67
7.99
8.67
XXX75957
TC
C
Xray, endovasc thor ao repr
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX75958

C
Xray, place prox ext thor ao
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX75958
26
A
Xray, place prox ext thor ao
4.00
0.93
1.40
0.93
1.40
0.39
5.32
5.79
5.32
5.79
XXX75958
TC
C
Xray, place prox ext thor ao
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX75959

C
Xray, place dist ext thor ao
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX75959
26
A
Xray, place dist ext thor ao
3.50
0.82
1.23
0.82
1.23
0.34
4.66
5.07
4.66
5.07
XXX75959
TC
C
Xray, place dist ext thor ao
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX75960

A
Transcath iv stent rs&i
0.82
NA
NA
NA
NA
0.82
NA
NA
NA
NA
XXX75960
26
A
Transcath iv stent rs&i
0.82
0.32
0.29
0.32
0.29
0.05
1.19
1.16
1.19
1.16
XXX75960
TC
A
Transcath iv stent rs&i
0.00
NA
NA
NA
NA
0.77
NA
NA
NA
NA
XXX75961

A
Retrieval, broken catheter
4.24
4.59
10.07
NA
NA
0.73
9.56
15.04
NA
NA
XXX75961
26
A
Retrieval, broken catheter
4.24
1.38
1.39
1.38
1.39
0.18
5.80
5.81
5.80
5.81
XXX75961
TC
A
Retrieval, broken catheter
0.00
3.20
8.68
NA
NA
0.55
3.75
9.23
NA
NA
XXX75962

A
Repair arterial blockage
0.54
3.54
12.83
NA
NA
0.86
4.94
14.23
NA
NA
XXX75962
26
A
Repair arterial blockage
0.54
0.20
0.19
0.20
0.19
0.03
0.77
0.76
0.77
0.76
XXX75962
TC
A
Repair arterial blockage
0.00
3.34
12.64
NA
NA
0.83
4.17
13.47
NA
NA
XXX75964

A
Repair artery blockage, each
0.36
2.38
6.98
2.38
6.98
0.46
3.20
7.80
3.20
7.80
ZZZ75964
26
A
Repair artery blockage, each
0.36
0.13
0.12
0.13
0.12
0.03
0.52
0.51
0.52
0.51
ZZZ75964
TC
A
Repair artery blockage, each
0.00
2.26
6.86
2.26
6.86
0.43
2.69
7.29
2.69
7.29
ZZZ75966

A
Repair arterial blockage
1.31
4.21
13.20
NA
NA
0.89
6.41
15.40
NA
NA
XXX75966
26
A
Repair arterial blockage
1.31
0.57
0.49
0.57
0.49
0.06
1.94
1.86
1.94
1.86
XXX75966
TC
A
Repair arterial blockage
0.00
3.64
12.72
NA
NA
0.83
4.47
13.55
NA
NA
XXX75968

A
Repair artery blockage, each
0.36
2.44
7.00
2.44
7.00
0.45
3.25
7.81
3.25
7.81
ZZZ75968
26
A
Repair artery blockage, each
0.36
0.16
0.14
0.16
0.14
0.02
0.54
0.52
0.54
0.52
ZZZ75968
TC
A
Repair artery blockage, each
0.00
2.29
6.87
2.29
6.87
0.43
2.72
7.30
2.72
7.30
ZZZ75970

A
Vascular biopsy
0.83
NA
NA
NA
NA
0.64
NA
NA
NA
NA
XXX75970
26
A
Vascular biopsy
0.83
0.28
0.28
0.28
0.28
0.04
1.15
1.15
1.15
1.15
XXX75970
TC
A
Vascular biopsy
0.00
NA
NA
NA
NA
0.60
NA
NA
NA
NA
XXX75978

A
Repair venous blockage
0.54
3.27
12.76
NA
NA
0.85
4.66
14.15
NA
NA
XXX75978
26
A
Repair venous blockage
0.54
0.17
0.18
0.17
0.18
0.02
0.73
0.74
0.73
0.74
XXX75978
TC
A
Repair venous blockage
0.00
3.11
12.58
NA
NA
0.83
3.94
13.41
NA
NA
XXX75980

A
Contrast xray exam bile duct
1.44
NA
NA
NA
NA
0.35
NA
NA
NA
NA
XXX75980
26
A
Contrast xray exam bile duct
1.44
0.47
0.47
0.47
0.47
0.06
1.97
1.97
1.97
1.97
XXX( print page 49194)75980
TC
A
Contrast xray exam bile duct
0.00
NA
NA
NA
NA
0.29
NA
NA
NA
NA
XXX75982

C
Contrast xray exam bile duct
0.00
NA
NA
NA
NA
0.00
NA
NA
NA
NA
XXX75982
26
A
Contrast xray exam bile duct
1.44
0.47
0.47
0.47
0.47
0.06
1.97
1.97
1.97
1.97
XXX75982
TC
C
Contrast xray exam bile duct
0.00
NA
NA
NA
NA
0.00
NA
NA
NA
NA
XXX75984

A
Xray control catheter change
0.72
2.31
2.21
NA
NA
0.14
3.17
3.07
NA
NA
XXX75984
26
A
Xray control catheter change
0.72
0.24
0.23
0.24
0.23
0.03
0.99
0.98
0.99
0.98
XXX75984
TC
A
Xray control catheter change
0.00
2.08
1.98
NA
NA
0.11
2.19
2.09
NA
NA
XXX75989

A
Abscess drainage under x-ray
1.19
2.21
3.21
NA
NA
0.22
3.62
4.62
NA
NA
XXX75989
26
A
Abscess drainage under x-ray
1.19
0.38
0.39
0.38
0.39
0.05
1.62
1.63
1.62
1.63
XXX75989
TC
A
Abscess drainage under x-ray
0.00
1.83
2.82
NA
NA
0.17
2.00
2.99
NA
NA
XXX75992

A
Atherectomy, x-ray exam
0.54
NA
NA
NA
NA
0.86
NA
NA
NA
NA
XXX75992
26
A
Atherectomy, x-ray exam
0.54
0.23
0.20
0.23
0.20
0.03
0.80
0.77
0.80
0.77
XXX75992
TC
A
Atherectomy, x-ray exam
0.00
NA
NA
NA
NA
0.83
NA
NA
NA
NA
XXX75993

C
Atherectomy, x-ray exam
0.00
NA
NA
NA
NA
0.00
NA
NA
NA
NA
ZZZ75993
26
A
Atherectomy, x-ray exam
0.36
0.15
0.14
0.15
0.14
0.02
0.53
0.52
0.53
0.52
ZZZ75993
TC
C
Atherectomy, x-ray exam
0.00
NA
NA
NA
NA
0.00
NA
NA
NA
NA
ZZZ75994

C
Atherectomy, x-ray exam
0.00
NA
NA
NA
NA
0.00
NA
NA
NA
NA
XXX75994
26
A
Atherectomy, x-ray exam
1.31
0.62
0.50
0.62
0.50
0.07
2.00
1.88
2.00
1.88
XXX75994
TC
C
Atherectomy, x-ray exam
0.00
NA
NA
NA
NA
0.00
NA
NA
NA
NA
XXX75995

C
Atherectomy, x-ray exam
0.00
NA
NA
NA
NA
0.00
NA
NA
NA
NA
XXX75995
26
A
Atherectomy, x-ray exam
1.31
0.51
0.48
0.51
0.48
0.05
1.87
1.84
1.87
1.84
XXX75995
TC
C
Atherectomy, x-ray exam
0.00
NA
NA
NA
NA
0.00
NA
NA
NA
NA
XXX75996

C
Atherectomy, x-ray exam
0.00
NA
NA
NA
NA
0.00
NA
NA
NA
NA
ZZZ75996
26
A
Atherectomy, x-ray exam
0.36
0.15
0.13
0.15
0.13
0.02
0.53
0.51
0.53
0.51
ZZZ75996
TC
C
Atherectomy, x-ray exam
0.00
NA
NA
NA
NA
0.00
NA
NA
NA
NA
ZZZ75998

A
Fluoroguide for vein device
0.38
2.73
1.76
NA
NA
0.11
3.22
2.25
NA
NA
ZZZ75998
26
A
Fluoroguide for vein device
0.38
0.12
0.13
0.12
0.13
0.01
0.51
0.52
0.51
0.52
ZZZ75998
TC
A
Fluoroguide for vein device
0.00
2.61
1.64
NA
NA
0.10
2.71
1.74
NA
NA
ZZZ76000

A
Fluoroscope examination
0.17
2.75
1.71
NA
NA
0.08
3.00
1.96
NA
NA
XXX76000
26
A
Fluoroscope examination
0.17
0.06
0.05
0.06
0.05
0.01
0.24
0.23
0.24
0.23
XXX76000
TC
A
Fluoroscope examination
0.00
2.70
1.66
NA
NA
0.07
2.77
1.73
NA
NA
XXX76001

A
Fluoroscope exam, extensive
0.67
NA
NA
NA
NA
0.19
NA
NA
NA
NA
XXX76001
26
A
Fluoroscope exam, extensive
0.67
0.22
0.22
0.22
0.22
0.05
0.94
0.94
0.94
0.94
XXX76001
TC
A
Fluoroscope exam, extensive
0.00
NA
NA
NA
NA
0.14
NA
NA
NA
NA
XXX76003

A
Needle localization by x-ray
0.54
1.21
1.41
NA
NA
0.09
1.84
2.04
NA
NA
XXX76003
26
A
Needle localization by x-ray
0.54
0.15
0.17
0.15
0.17
0.02
0.71
0.73
0.71
0.73
XXX76003
TC
A
Needle localization by x-ray
0.00
1.06
1.25
NA
NA
0.07
1.13
1.32
NA
NA
XXX76005

A
Fluoroguide for spine inject
0.60
0.76
1.29
NA
NA
0.10
1.46
1.99
NA
NA
XXX76005
26
A
Fluoroguide for spine inject
0.60
0.14
0.15
0.14
0.15
0.03
0.77
0.78
0.77
0.78
XXX76005
TC
A
Fluoroguide for spine inject
0.00
0.62
1.14
NA
NA
0.07
0.69
1.21
NA
NA
XXX76006

A
X-ray stress view
0.41
0.77
0.33
0.77
0.33
0.06
1.24
0.80
1.24
0.80
XXX76010

A
X-ray, nose to rectum
0.18
0.55
0.57
NA
NA
0.03
0.76
0.78
NA
NA
XXX76010
26
A
X-ray, nose to rectum
0.18
0.06
0.06
0.06
0.06
0.01
0.25
0.25
0.25
0.25
XXX76010
TC
A
X-ray, nose to rectum
0.00
0.49
0.51
NA
NA
0.02
0.51
0.53
NA
NA
XXX76012

C
Percut vertebroplasty fluor
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX76012
26
A
Percut vertebroplasty fluor
1.31
0.44
0.46
0.44
0.46
0.10
1.85
1.87
1.85
1.87
XXX76012
TC
C
Percut vertebroplasty fluor
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX76013

C
Percut vertebroplasty, ct
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX76013
26
A
Percut vertebroplasty, ct
1.38
0.45
0.47
0.45
0.47
0.07
1.90
1.92
1.90
1.92
XXX76013
TC
C
Percut vertebroplasty, ct
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX76020

A
X-rays for bone age
0.19
0.42
0.54
NA
NA
0.03
0.64
0.76
NA
NA
XXX76020
26
A
X-rays for bone age
0.19
0.06
0.06
0.06
0.06
0.01
0.26
0.26
0.26
0.26
XXX76020
TC
A
X-rays for bone age
0.00
0.36
0.48
NA
NA
0.02
0.38
0.50
NA
NA
XXX76040

A
X-rays, bone evaluation
0.27
0.67
0.82
NA
NA
0.06
1.00
1.15
NA
NA
XXX76040
26
A
X-rays, bone evaluation
0.27
0.10
0.09
0.10
0.09
0.01
0.38
0.37
0.38
0.37
XXX76040
TC
A
X-rays, bone evaluation
0.00
0.57
0.73
NA
NA
0.05
0.62
0.78
NA
NA
XXX( print page 49195)76061

A
X-rays, bone survey
0.45
1.43
1.22
NA
NA
0.08
1.96
1.75
NA
NA
XXX76061
26
A
X-rays, bone survey
0.45
0.14
0.15
0.14
0.15
0.02
0.61
0.62
0.61
0.62
XXX76061
TC
A
X-rays, bone survey
0.00
1.28
1.07
NA
NA
0.06
1.34
1.13
NA
NA
XXX76062

A
X-rays, bone survey
0.54
2.28
1.79
NA
NA
0.10
2.92
2.43
NA
NA
XXX76062
26
A
X-rays, bone survey
0.54
0.17
0.18
0.17
0.18
0.02
0.73
0.74
0.73
0.74
XXX76062
TC
A
X-rays, bone survey
0.00
2.10
1.61
NA
NA
0.08
2.18
1.69
NA
NA
XXX76065

A
X-rays, bone evaluation
0.70
2.01
1.22
NA
NA
0.08
2.79
2.00
NA
NA
XXX76065
26
A
X-rays, bone evaluation
0.70
0.20
0.22
0.20
0.22
0.03
0.93
0.95
0.93
0.95
XXX76065
TC
A
X-rays, bone evaluation
0.00
1.81
1.00
NA
NA
0.05
1.86
1.05
NA
NA
XXX76066

A
Joint survey, single view
0.31
0.65
1.07
NA
NA
0.08
1.04
1.46
NA
NA
XXX76066
26
A
Joint survey, single view
0.31
0.11
0.10
0.11
0.10
0.02
0.44
0.43
0.44
0.43
XXX76066
TC
A
Joint survey, single view
0.00
0.55
0.97
NA
NA
0.06
0.61
1.03
NA
NA
XXX76070

A
Ct bone density, axial
0.25
4.78
3.47
NA
NA
0.17
5.20
3.89
NA
NA
XXX76070
26
A
Ct bone density, axial
0.25
0.08
0.08
0.08
0.08
0.01
0.34
0.34
0.34
0.34
XXX76070
TC
A
Ct bone density, axial
0.00
4.70
3.39
NA
NA
0.16
4.86
3.55
NA
NA
XXX76071

A
Ct bone density, peripheral
0.22
0.78
2.46
NA
NA
0.06
1.06
2.74
NA
NA
XXX76071
26
A
Ct bone density, peripheral
0.22
0.07
0.07
0.07
0.07
0.01
0.30
0.30
0.30
0.30
XXX76071
TC
A
Ct bone density, peripheral
0.00
0.71
2.39
NA
NA
0.05
0.76
2.44
NA
NA
XXX76075

A
Dxa bone density,  axial
0.20
0.53
2.53
NA
NA
0.18
0.91
2.91
NA
NA
XXX76075
26
A
Dxa bone density,  axial
0.20
0.06
0.09
0.06
0.09
0.01
0.27
0.30
0.27
0.30
XXX76075
TC
A
Dxa bone density,  axial
0.00
0.47
2.44
NA
NA
0.17
0.64
2.61
NA
NA
XXX76076

A
Dxa bone density/peripheral
0.22
0.57
0.77
NA
NA
0.06
0.85
1.05
NA
NA
XXX76076
26
A
Dxa bone density/peripheral
0.22
0.06
0.08
0.06
0.08
0.01
0.29
0.31
0.29
0.31
XXX76076
TC
A
Dxa bone density/peripheral
0.00
0.50
0.69
NA
NA
0.05
0.55
0.74
NA
NA
XXX76077

A
Dxa bone density/v-fracture
0.17
0.41
0.71
NA
NA
0.06
0.64
0.94
NA
NA
XXX76077
26
A
Dxa bone density/v-fracture
0.17
0.05
0.06
0.05
0.06
0.01
0.23
0.24
0.23
0.24
XXX76077
TC
A
Dxa bone density/v-fracture
0.00
0.36
0.65
NA
NA
0.05
0.41
0.70
NA
NA
XXX76078

A
Radiographic absorptiometry
0.20
0.38
0.71
NA
NA
0.06
0.64
0.97
NA
NA
XXX76078
26
A
Radiographic absorptiometry
0.20
0.05
0.07
0.05
0.07
0.01
0.26
0.28
0.26
0.28
XXX76078
TC
A
Radiographic absorptiometry
0.00
0.33
0.65
NA
NA
0.05
0.38
0.70
NA
NA
XXX76080

A
X-ray exam of fistula
0.54
1.08
1.19
NA
NA
0.08
1.70
1.81
NA
NA
XXX76080
26
A
X-ray exam of fistula
0.54
0.17
0.18
0.17
0.18
0.02
0.73
0.74
0.73
0.74
XXX76080
TC
A
X-ray exam of fistula
0.00
0.90
1.01
NA
NA
0.06
0.96
1.07
NA
NA
XXX76082

A
Computer mammogram add-on
0.06
0.20
0.38
0.20
0.38
0.02
0.28
0.46
0.28
0.46
ZZZ76082
26
A
Computer mammogram add-on
0.06
0.02
0.02
0.02
0.02
0.01
0.09
0.09
0.09
0.09
ZZZ76082
TC
A
Computer mammogram add-on
0.00
0.18
0.36
0.18
0.36
0.01
0.19
0.37
0.19
0.37
ZZZ76083

A
Computer mammogram add-on
0.06
0.20
0.38
0.20
0.38
0.02
0.28
0.46
0.28
0.46
ZZZ76083
26
A
Computer mammogram add-on
0.06
0.02
0.02
0.02
0.02
0.01
0.09
0.09
0.09
0.09
ZZZ76083
TC
A
Computer mammogram add-on
0.00
0.18
0.36
0.18
0.36
0.01
0.19
0.37
0.19
0.37
ZZZ76086

A
X-ray of mammary duct
0.36
1.22
2.36
NA
NA
0.16
1.74
2.88
NA
NA
XXX76086
26
A
X-ray of mammary duct
0.36
0.11
0.12
0.11
0.12
0.02
0.49
0.50
0.49
0.50
XXX76086
TC
A
X-ray of mammary duct
0.00
1.11
2.24
NA
NA
0.14
1.25
2.38
NA
NA
XXX76088

A
X-ray of mammary ducts
0.45
1.66
3.27
NA
NA
0.21
2.32
3.93
NA
NA
XXX76088
26
A
X-ray of mammary ducts
0.45
0.14
0.15
0.14
0.15
0.02
0.61
0.62
0.61
0.62
XXX76088
TC
A
X-ray of mammary ducts
0.00
1.52
3.13
NA
NA
0.19
1.71
3.32
NA
NA
XXX76090

A
Mammogram, one breast
0.70
1.62
1.37
NA
NA
0.09
2.41
2.16
NA
NA
XXX76090
26
A
Mammogram, one breast
0.70
0.22
0.23
0.22
0.23
0.03
0.95
0.96
0.95
0.96
XXX76090
TC
A
Mammogram, one breast
0.00
1.40
1.14
NA
NA
0.06
1.46
1.20
NA
NA
XXX76091

A
Mammogram, both breasts
0.87
2.11
1.72
NA
NA
0.11
3.09
2.70
NA
NA
XXX76091
26
A
Mammogram, both breasts
0.87
0.27
0.28
0.27
0.28
0.04
1.18
1.19
1.18
1.19
XXX76091
TC
A
Mammogram, both breasts
0.00
1.84
1.44
NA
NA
0.07
1.91
1.51
NA
NA
XXX76092

A
Mammogram, screening
0.70
1.42
1.45
NA
NA
0.10
2.22
2.25
NA
NA
XXX76092
26
A
Mammogram, screening
0.70
0.22
0.23
0.22
0.23
0.03
0.95
0.96
0.95
0.96
XXX76092
TC
A
Mammogram, screening
0.00
1.20
1.22
NA
NA
0.07
1.27
1.29
NA
NA
XXX76093

A
Magnetic image, breast
1.63
22.03
19.12
NA
NA
0.99
24.65
21.74
NA
NA
XXX76093
26
A
Magnetic image, breast
1.63
0.53
0.53
0.53
0.53
0.07
2.23
2.23
2.23
2.23
XXX76093
TC
A
Magnetic image, breast
0.00
21.50
18.59
NA
NA
0.92
22.42
19.51
NA
NA
XXX76094

A
Magnetic image, both breasts
1.63
22.03
23.84
NA
NA
1.31
24.97
26.78
NA
NA
XXX76094
26
A
Magnetic image, both breasts
1.63
0.53
0.53
0.53
0.53
0.07
2.23
2.23
2.23
2.23
XXX76094
TC
A
Magnetic image, both breasts
0.00
21.50
23.31
NA
NA
1.24
22.74
24.55
NA
NA
XXX76095

A
Stereotactic breast biopsy
1.59
1.82
6.22
NA
NA
0.46
3.87
8.27
NA
NA
XXX76095
26
A
Stereotactic breast biopsy
1.59
0.48
0.51
0.48
0.51
0.09
2.16
2.19
2.16
2.19
XXX76095
TC
A
Stereotactic breast biopsy
0.00
1.34
5.71
NA
NA
0.37
1.71
6.08
NA
NA
XXX76096

A
X-ray of needle wire, breast
0.56
0.82
1.32
NA
NA
0.09
1.47
1.97
NA
NA
XXX76096
26
A
X-ray of needle wire, breast
0.56
0.18
0.18
0.18
0.18
0.02
0.76
0.76
0.76
0.76
XXX76096
TC
A
X-ray of needle wire, breast
0.00
0.64
1.14
NA
NA
0.07
0.71
1.21
NA
NA
XXX( print page 49196)76098

A
X-ray exam, breast specimen
0.16
0.32
0.43
NA
NA
0.03
0.51
0.62
NA
NA
XXX76098
26
A
X-ray exam, breast specimen
0.16
0.05
0.05
0.05
0.05
0.01
0.22
0.22
0.22
0.22
XXX76098
TC
A
X-ray exam, breast specimen
0.00
0.27
0.38
NA
NA
0.02
0.29
0.40
NA
NA
XXX76100

A
X-ray exam of body section
0.58
3.54
1.97
NA
NA
0.10
4.22
2.65
NA
NA
XXX76100
26
A
X-ray exam of body section
0.58
0.20
0.19
0.20
0.19
0.03
0.81
0.80
0.81
0.80
XXX76100
TC
A
X-ray exam of body section
0.00
3.35
1.78
NA
NA
0.07
3.42
1.85
NA
NA
XXX76101

A
Complex body section x-ray
0.58
5.35
2.55
NA
NA
0.11
6.04
3.24
NA
NA
XXX76101
26
A
Complex body section x-ray
0.58
0.19
0.19
0.19
0.19
0.03
0.80
0.80
0.80
0.80
XXX76101
TC
A
Complex body section x-ray
0.00
5.16
2.36
NA
NA
0.08
5.24
2.44
NA
NA
XXX76102

A
Complex body section x-rays
0.58
7.74
3.38
NA
NA
0.14
8.46
4.10
NA
NA
XXX76102
26
A
Complex body section x-rays
0.58
0.18
0.19
0.18
0.19
0.03
0.79
0.80
0.79
0.80
XXX76102
TC
A
Complex body section x-rays
0.00
7.56
3.19
NA
NA
0.11
7.67
3.30
NA
NA
XXX76120

A
Cine/video x-rays
0.38
2.00
1.39
NA
NA
0.08
2.46
1.85
NA
NA
XXX76120
26
A
Cine/video x-rays
0.38
0.15
0.14
0.15
0.14
0.02
0.55
0.54
0.55
0.54
XXX76120
TC
A
Cine/video x-rays
0.00
1.85
1.25
NA
NA
0.06
1.91
1.31
NA
NA
XXX76125

A
Cine/video x-rays add-on
0.27
NA
NA
NA
NA
0.06
NA
NA
NA
NA
ZZZ76125
26
A
Cine/video x-rays add-on
0.27
0.10
0.09
0.10
0.09
0.01
0.38
0.37
0.38
0.37
ZZZ76125
TC
A
Cine/video x-rays add-on
0.00
NA
NA
NA
NA
0.05
NA
NA
NA
NA
ZZZ76150

A
X-ray exam, dry process
0.00
0.68
0.49
NA
NA
0.02
0.70
0.51
NA
NA
XXX76350

C
Special x-ray contrast study
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX76355

A
Ct scan for localization
1.21
20.46
11.60
NA
NA
0.47
22.14
13.28
NA
NA
XXX76355
26
A
Ct scan for localization
1.21
0.37
0.39
0.37
0.39
0.05
1.63
1.65
1.63
1.65
XXX76355
TC
A
Ct scan for localization
0.00
20.09
11.22
NA
NA
0.42
20.51
11.64
NA
NA
XXX76360

A
Ct scan for needle biopsy
1.16
2.30
7.05
NA
NA
0.47
3.93
8.68
NA
NA
XXX76360
26
A
Ct scan for needle biopsy
1.16
0.37
0.38
0.37
0.38
0.05
1.58
1.59
1.58
1.59
XXX76360
TC
A
Ct scan for needle biopsy
0.00
1.93
6.68
NA
NA
0.42
2.35
7.10
NA
NA
XXX76362

A
Ct guide for tissue ablation
3.99
NA
NA
NA
NA
1.64
NA
NA
NA
NA
XXX76362
26
A
Ct guide for tissue ablation
3.99
1.25
1.29
1.25
1.29
0.18
5.42
5.46
5.42
5.46
XXX76362
TC
A
Ct guide for tissue ablation
0.00
NA
NA
NA
NA
1.46
NA
NA
NA
NA
XXX76370

A
Ct scan for therapy guide
0.85
4.43
3.53
NA
NA
0.20
5.48
4.58
NA
NA
XXX76370
26
A
Ct scan for therapy guide
0.85
0.24
0.27
0.24
0.27
0.04
1.13
1.16
1.13
1.16
XXX76370
TC
A
Ct scan for therapy guide
0.00
4.19
3.26
NA
NA
0.16
4.35
3.42
NA
NA
XXX76376

A
3d render w/o postprocess
0.20
1.40
2.97
NA
NA
0.10
1.70
3.27
NA
NA
XXX76376
26
A
3d render w/o postprocess
0.20
0.06
0.07
0.06
0.07
0.02
0.28
0.29
0.28
0.29
XXX76376
TC
A
3d render w/o postprocess
0.00
1.34
2.90
NA
NA
0.08
1.42
2.98
NA
NA
XXX76377

A
3d rendering w/postprocess
0.79
1.38
3.11
NA
NA
0.39
2.56
4.29
NA
NA
XXX76377
26
A
3d rendering w/postprocess
0.79
0.25
0.27
0.25
0.27
0.08
1.12
1.14
1.12
1.14
XXX76377
TC
A
3d rendering w/postprocess
0.00
1.13
2.85
NA
NA
0.31
1.44
3.16
NA
NA
XXX76380

A
CAT scan follow-up study
0.98
4.72
4.05
NA
NA
0.22
5.92
5.25
NA
NA
XXX76380
26
A
CAT scan follow-up study
0.98
0.31
0.32
0.31
0.32
0.04
1.33
1.34
1.33
1.34
XXX76380
TC
A
CAT scan follow-up study
0.00
4.42
3.73
NA
NA
0.18
4.60
3.91
NA
NA
XXX76390

N
Mr spectroscopy
1.40
9.51
10.99
NA
NA
0.66
11.57
13.05
NA
NA
XXX76390
26
N
Mr spectroscopy
1.40
0.33
0.44
0.33
0.44
0.07
1.80
1.91
1.80
1.91
XXX76390
TC
N
Mr spectroscopy
0.00
9.19
10.56
NA
NA
0.59
9.78
11.15
NA
NA
XXX76393

A
Mr guidance for needle place
1.50
9.83
11.23
NA
NA
0.64
11.97
13.37
NA
NA
XXX76393
26
A
Mr guidance for needle place
1.50
0.49
0.50
0.49
0.50
0.09
2.08
2.09
2.08
2.09
XXX76393
TC
A
Mr guidance for needle place
0.00
9.34
10.74
NA
NA
0.55
9.89
11.29
NA
NA
XXX76394

A
Mri for tissue ablation
4.24
NA
NA
NA
NA
1.81
NA
NA
NA
NA
XXX76394
26
A
Mri for tissue ablation
4.24
1.34
1.37
1.34
1.37
0.24
5.82
5.85
5.82
5.85
XXX76394
TC
A
Mri for tissue ablation
0.00
NA
NA
NA
NA
1.57
NA
NA
NA
NA
XXX76400

A
Magnetic image, bone marrow
1.60
14.85
12.50
NA
NA
0.66
17.11
14.76
NA
NA
XXX76400
26
A
Magnetic image, bone marrow
1.60
0.56
0.53
0.56
0.53
0.07
2.23
2.20
2.23
2.20
XXX76400
TC
A
Magnetic image, bone marrow
0.00
14.30
11.98
NA
NA
0.59
14.89
12.57
NA
NA
XXX76496

C
Fluoroscopic procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX76496
26
C
Fluoroscopic procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX76496
TC
C
Fluoroscopic procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX( print page 49197)76497

C
Ct procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX76497
26
C
Ct procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX76497
TC
C
Ct procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX76498

C
Mri procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX76498
26
C
Mri procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX76498
TC
C
Mri procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX76499

C
Radiographic procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX76499
26
C
Radiographic procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX76499
TC
C
Radiographic procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX76506

A
Echo exam of head
0.63
2.83
1.95
NA
NA
0.14
3.60
2.72
NA
NA
XXX76506
26
A
Echo exam of head
0.63
0.20
0.23
0.20
0.23
0.06
0.89
0.92
0.89
0.92
XXX76506
TC
A
Echo exam of head
0.00
2.63
1.72
NA
NA
0.08
2.71
1.80
NA
NA
XXX76510

A
Ophth us, b & quant a
1.55
2.31
2.72
NA
NA
0.10
3.96
4.37
NA
NA
XXX76510
26
A
Ophth us, b & quant a
1.55
0.58
0.66
0.58
0.66
0.03
2.16
2.24
2.16
2.24
XXX76510
TC
A
Ophth us, b & quant a
0.00
1.73
2.07
NA
NA
0.07
1.80
2.14
NA
NA
XXX76511

A
Ophth us, quant a only
0.94
1.39
2.17
NA
NA
0.10
2.43
3.21
NA
NA
XXX76511
26
A
Ophth us, quant a only
0.94
0.35
0.39
0.35
0.39
0.03
1.32
1.36
1.32
1.36
XXX76511
TC
A
Ophth us, quant a only
0.00
1.05
1.79
NA
NA
0.07
1.12
1.86
NA
NA
XXX76512

A
Ophth us, b w/non-quant a
0.94
1.19
1.97
NA
NA
0.12
2.25
3.03
NA
NA
XXX76512
26
A
Ophth us, b w/non-quant a
0.94
0.35
0.40
0.35
0.40
0.02
1.31
1.36
1.31
1.36
XXX76512
TC
A
Ophth us, b w/non-quant a
0.00
0.85
1.57
NA
NA
0.10
0.95
1.67
NA
NA
XXX76513

A
Echo exam of eye, water bath
0.66
1.58
1.75
NA
NA
0.12
2.36
2.53
NA
NA
XXX76513
26
A
Echo exam of eye, water bath
0.66
0.25
0.28
0.25
0.28
0.02
0.93
0.96
0.93
0.96
XXX76513
TC
A
Echo exam of eye, water bath
0.00
1.33
1.47
NA
NA
0.10
1.43
1.57
NA
NA
XXX76514

A
Echo exam of eye, thickness
0.17
0.17
0.14
NA
NA
0.02
0.36
0.33
NA
NA
XXX76514
26
A
Echo exam of eye, thickness
0.17
0.06
0.08
0.06
0.08
0.01
0.24
0.26
0.24
0.26
XXX76514
TC
A
Echo exam of eye, thickness
0.00
0.11
0.07
NA
NA
0.01
0.12
0.08
NA
NA
XXX76516

A
Echo exam of eye
0.54
1.19
1.39
NA
NA
0.08
1.81
2.01
NA
NA
XXX76516
26
A
Echo exam of eye
0.54
0.19
0.23
0.19
0.23
0.01
0.74
0.78
0.74
0.78
XXX76516
TC
A
Echo exam of eye
0.00
1.00
1.17
NA
NA
0.07
1.07
1.24
NA
NA
XXX76519

A
Echo exam of eye
0.54
1.33
1.50
NA
NA
0.08
1.95
2.12
NA
NA
XXX76519
26
A
Echo exam of eye
0.54
0.20
0.23
0.20
0.23
0.01
0.75
0.78
0.75
0.78
XXX76519
TC
A
Echo exam of eye
0.00
1.12
1.26
NA
NA
0.07
1.19
1.33
NA
NA
XXX76529

A
Echo exam of eye
0.57
1.19
1.33
NA
NA
0.10
1.86
2.00
NA
NA
XXX76529
26
A
Echo exam of eye
0.57
0.21
0.23
0.21
0.23
0.02
0.80
0.82
0.80
0.82
XXX76529
TC
A
Echo exam of eye
0.00
0.98
1.09
NA
NA
0.08
1.06
1.17
NA
NA
XXX76536

A
Us exam of head and neck
0.56
2.69
1.87
NA
NA
0.10
3.35
2.53
NA
NA
XXX76536
26
A
Us exam of head and neck
0.56
0.17
0.18
0.17
0.18
0.02
0.75
0.76
0.75
0.76
XXX76536
TC
A
Us exam of head and neck
0.00
2.52
1.70
NA
NA
0.08
2.60
1.78
NA
NA
XXX76604

A
Us exam, chest, b-scan
0.55
1.81
1.57
NA
NA
0.09
2.45
2.21
NA
NA
XXX76604
26
A
Us exam, chest, b-scan
0.55
0.17
0.18
0.17
0.18
0.02
0.74
0.75
0.74
0.75
XXX76604
TC
A
Us exam, chest, b-scan
0.00
1.64
1.39
NA
NA
0.07
1.71
1.46
NA
NA
XXX76645

A
Us exam, breast(s)
0.54
2.11
1.45
NA
NA
0.08
2.73
2.07
NA
NA
XXX76645
26
A
Us exam, breast(s)
0.54
0.17
0.18
0.17
0.18
0.02
0.73
0.74
0.73
0.74
XXX76645
TC
A
Us exam, breast(s)
0.00
1.94
1.27
NA
NA
0.06
2.00
1.33
NA
NA
XXX76700

A
Us exam, abdom, complete
0.81
3.04
2.44
NA
NA
0.15
4.00
3.40
NA
NA
XXX76700
26
A
Us exam, abdom, complete
0.81
0.26
0.27
0.26
0.27
0.04
1.11
1.12
1.11
1.12
XXX76700
TC
A
Us exam, abdom, complete
0.00
2.78
2.17
NA
NA
0.11
2.89
2.28
NA
NA
XXX76705

A
Echo exam of abdomen
0.59
2.34
1.79
NA
NA
0.11
3.04
2.49
NA
NA
XXX76705
26
A
Echo exam of abdomen
0.59
0.19
0.19
0.19
0.19
0.03
0.81
0.81
0.81
0.81
XXX76705
TC
A
Echo exam of abdomen
0.00
2.16
1.61
NA
NA
0.08
2.24
1.69
NA
NA
XXX76770

A
Us exam abdo back wall, comp
0.74
2.94
2.39
NA
NA
0.14
3.82
3.27
NA
NA
XXX76770
26
A
Us exam abdo back wall, comp
0.74
0.24
0.24
0.24
0.24
0.03
1.01
1.01
1.01
1.01
XXX76770
TC
A
Us exam abdo back wall, comp
0.00
2.70
2.15
NA
NA
0.11
2.81
2.26
NA
NA
XXX76775

A
Us exam abdo back wall, lim
0.58
2.42
1.81
NA
NA
0.11
3.11
2.50
NA
NA
XXX76775
26
A
Us exam abdo back wall, lim
0.58
0.19
0.19
0.19
0.19
0.03
0.80
0.80
0.80
0.80
XXX76775
TC
A
Us exam abdo back wall, lim
0.00
2.23
1.62
NA
NA
0.08
2.31
1.70
NA
NA
XXX76778

A
Us exam kidney transplant
0.74
3.21
2.46
NA
NA
0.14
4.09
3.34
NA
NA
XXX76778
26
A
Us exam kidney transplant
0.74
0.23
0.24
0.23
0.24
0.03
1.00
1.01
1.00
1.01
XXX76778
TC
A
Us exam kidney transplant
0.00
2.98
2.22
NA
NA
0.11
3.09
2.33
NA
NA
XXX76800

A
Us exam, spinal canal
1.13
2.34
1.90
NA
NA
0.13
3.60
3.16
NA
NA
XXX76800
26
A
Us exam, spinal canal
1.13
0.30
0.33
0.30
0.33
0.05
1.48
1.51
1.48
1.51
XXX76800
TC
A
Us exam, spinal canal
0.00
2.04
1.58
NA
NA
0.08
2.12
1.66
NA
NA
XXX76801

A
Ob us < 14 wks, single fetus
0.99
2.46
2.45
NA
NA
0.16
3.61
3.60
NA
NA
XXX76801
26
A
Ob us < 14 wks, single fetus
0.99
0.30
0.33
0.30
0.33
0.04
1.33
1.36
1.33
1.36
XXX76801
TC
A
Ob us < 14 wks, single fetus
0.00
2.16
2.12
NA
NA
0.12
2.28
2.24
NA
NA
XXX( print page 49198)76802

A
Ob us < 14 wks, addIl fetus
0.83
0.97
1.25
0.97
1.25
0.16
1.96
2.24
1.96
2.24
ZZZ76802
26
A
Ob us < 14 wks, addIl fetus
0.83
0.25
0.28
0.25
0.28
0.04
1.12
1.15
1.12
1.15
ZZZ76802
TC
A
Ob us < 14 wks, addIl fetus
0.00
0.72
0.97
0.72
0.97
0.12
0.84
1.09
0.84
1.09
ZZZ76805

A
Ob us >/= 14 wks, sngl fetus
0.99
3.05
2.59
NA
NA
0.16
4.20
3.74
NA
NA
XXX76805
26
A
Ob us >/= 14 wks, sngl fetus
0.99
0.29
0.33
0.29
0.33
0.04
1.32
1.36
1.32
1.36
XXX76805
TC
A
Ob us >/= 14 wks, sngl fetus
0.00
2.75
2.26
NA
NA
0.12
2.87
2.38
NA
NA
XXX76810

A
Ob us >/= 14 wks, addl fetus
0.98
1.66
1.46
1.66
1.46
0.26
2.90
2.70
2.90
2.70
ZZZ76810
26
A
Ob us >/= 14 wks, addl fetus
0.98
0.29
0.33
0.29
0.33
0.04
1.31
1.35
1.31
1.35
ZZZ76810
TC
A
Ob us >/= 14 wks, addl fetus
0.00
1.37
1.13
1.37
1.13
0.22
1.59
1.35
1.59
1.35
ZZZ76811

A
Ob us, detailed, sngl fetus
1.90
3.07
3.95
NA
NA
0.52
5.49
6.37
NA
NA
XXX76811
26
A
Ob us, detailed, sngl fetus
1.90
0.54
0.67
0.54
0.67
0.09
2.53
2.66
2.53
2.66
XXX76811
TC
A
Ob us, detailed, sngl fetus
0.00
2.53
3.28
NA
NA
0.43
2.96
3.71
NA
NA
XXX76812

A
Ob us, detailed, addl fetus
1.78
3.98
2.28
3.98
2.28
0.49
6.25
4.55
6.25
4.55
ZZZ76812
26
A
Ob us, detailed, addl fetus
1.78
0.51
0.62
0.51
0.62
0.08
2.37
2.48
2.37
2.48
ZZZ76812
TC
A
Ob us, detailed, addl fetus
0.00
3.47
1.66
3.47
1.66
0.41
3.88
2.07
3.88
2.07
ZZZ76815

A
Ob us, limited, fetus(s)
0.65
1.80
1.69
NA
NA
0.11
2.56
2.45
NA
NA
XXX76815
26
A
Ob us, limited, fetus(s)
0.65
0.19
0.22
0.19
0.22
0.03
0.87
0.90
0.87
0.90
XXX76815
TC
A
Ob us, limited, fetus(s)
0.00
1.61
1.47
NA
NA
0.08
1.69
1.55
NA
NA
XXX76816

A
Ob us, follow-up, per fetus
0.85
2.40
1.67
NA
NA
0.10
3.35
2.62
NA
NA
XXX76816
26
A
Ob us, follow-up, per fetus
0.85
0.24
0.30
0.24
0.30
0.04
1.13
1.19
1.13
1.19
XXX76816
TC
A
Ob us, follow-up, per fetus
0.00
2.15
1.37
NA
NA
0.06
2.21
1.43
NA
NA
XXX76817

A
Transvaginal us, obstetric
0.75
2.02
1.83
NA
NA
0.09
2.86
2.67
NA
NA
XXX76817
26
A
Transvaginal us, obstetric
0.75
0.22
0.25
0.22
0.25
0.03
1.00
1.03
1.00
1.03
XXX76817
TC
A
Transvaginal us, obstetric
0.00
1.80
1.59
NA
NA
0.06
1.86
1.65
NA
NA
XXX76818

A
Fetal biophys profile w/nst
1.05
2.22
2.05
NA
NA
0.15
3.42
3.25
NA
NA
XXX76818
26
A
Fetal biophys profile w/nst
1.05
0.30
0.37
0.30
0.37
0.05
1.40
1.47
1.40
1.47
XXX76818
TC
A
Fetal biophys profile w/nst
0.00
1.92
1.69
NA
NA
0.10
2.02
1.79
NA
NA
XXX76819

A
Fetal biophys profil w/o nst
0.77
1.63
1.82
NA
NA
0.13
2.53
2.72
NA
NA
XXX76819
26
A
Fetal biophys profil w/o nst
0.77
0.23
0.27
0.23
0.27
0.03
1.03
1.07
1.03
1.07
XXX76819
TC
A
Fetal biophys profil w/o nst
0.00
1.41
1.56
NA
NA
0.10
1.51
1.66
NA
NA
XXX76820

A
Umbilical artery echo
0.50
0.57
1.49
NA
NA
0.15
1.22
2.14
NA
NA
XXX76820
26
A
Umbilical artery echo
0.50
0.14
0.18
0.14
0.18
0.03
0.67
0.71
0.67
0.71
XXX76820
TC
A
Umbilical artery echo
0.00
0.43
1.32
NA
NA
0.12
0.55
1.44
NA
NA
XXX76821

A
Middle cerebral artery echo
0.70
1.88
1.87
NA
NA
0.15
2.73
2.72
NA
NA
XXX76821
26
A
Middle cerebral artery echo
0.70
0.20
0.25
0.20
0.25
0.03
0.93
0.98
0.93
0.98
XXX76821
TC
A
Middle cerebral artery echo
0.00
1.68
1.63
NA
NA
0.12
1.80
1.75
NA
NA
XXX76825

A
Echo exam of fetal heart
1.67
4.37
3.02
NA
NA
0.18
6.22
4.87
NA
NA
XXX76825
26
A
Echo exam of fetal heart
1.67
0.49
0.57
0.49
0.57
0.07
2.23
2.31
2.23
2.31
XXX76825
TC
A
Echo exam of fetal heart
0.00
3.88
2.45
NA
NA
0.11
3.99
2.56
NA
NA
XXX76826

A
Echo exam of fetal heart
0.83
2.75
1.44
NA
NA
0.08
3.66
2.35
NA
NA
XXX76826
26
A
Echo exam of fetal heart
0.83
0.24
0.28
0.24
0.28
0.03
1.10
1.14
1.10
1.14
XXX76826
TC
A
Echo exam of fetal heart
0.00
2.51
1.16
NA
NA
0.05
2.56
1.21
NA
NA
XXX76827

A
Echo exam of fetal heart
0.58
1.07
1.71
NA
NA
0.14
1.79
2.43
NA
NA
XXX76827
26
A
Echo exam of fetal heart
0.58
0.17
0.20
0.17
0.20
0.02
0.77
0.80
0.77
0.80
XXX76827
TC
A
Echo exam of fetal heart
0.00
0.90
1.52
NA
NA
0.12
1.02
1.64
NA
NA
XXX76828

A
Echo exam of fetal heart
0.56
0.64
1.16
NA
NA
0.11
1.31
1.83
NA
NA
XXX76828
26
A
Echo exam of fetal heart
0.56
0.16
0.21
0.16
0.21
0.03
0.75
0.80
0.75
0.80
XXX76828
TC
A
Echo exam of fetal heart
0.00
0.48
0.95
NA
NA
0.08
0.56
1.03
NA
NA
XXX76830

A
Transvaginal us, non-ob
0.69
2.77
2.00
NA
NA
0.13
3.59
2.82
NA
NA
XXX76830
26
A
Transvaginal us, non-ob
0.69
0.21
0.23
0.21
0.23
0.03
0.93
0.95
0.93
0.95
XXX76830
TC
A
Transvaginal us, non-ob
0.00
2.56
1.78
NA
NA
0.10
2.66
1.88
NA
NA
XXX76831

A
Echo exam, uterus
0.72
2.76
2.01
NA
NA
0.13
3.61
2.86
NA
NA
XXX76831
26
A
Echo exam, uterus
0.72
0.21
0.24
0.21
0.24
0.03
0.96
0.99
0.96
0.99
XXX76831
TC
A
Echo exam, uterus
0.00
2.55
1.78
NA
NA
0.10
2.65
1.88
NA
NA
XXX76856

A
Us exam, pelvic, complete
0.69
2.81
2.01
NA
NA
0.13
3.63
2.83
NA
NA
XXX76856
26
A
Us exam, pelvic, complete
0.69
0.22
0.23
0.22
0.23
0.03
0.94
0.95
0.94
0.95
XXX( print page 49199)76856
TC
A
Us exam, pelvic, complete
0.00
2.59
1.79
NA
NA
0.10
2.69
1.89
NA
NA
XXX76857

A
Us exam, pelvic, limited
0.38
2.53
2.00
NA
NA
0.08
2.99
2.46
NA
NA
XXX76857
26
A
Us exam, pelvic, limited
0.38
0.14
0.13
0.14
0.13
0.02
0.54
0.53
0.54
0.53
XXX76857
TC
A
Us exam, pelvic, limited
0.00
2.38
1.88
NA
NA
0.06
2.44
1.94
NA
NA
XXX76870

A
Us exam, scrotum
0.64
2.83
2.00
NA
NA
0.13
3.60
2.77
NA
NA
XXX76870
26
A
Us exam, scrotum
0.64
0.21
0.21
0.21
0.21
0.03
0.88
0.88
0.88
0.88
XXX76870
TC
A
Us exam, scrotum
0.00
2.62
1.80
NA
NA
0.10
2.72
1.90
NA
NA
XXX76872

A
Us, transrectal
0.69
3.43
2.54
NA
NA
0.14
4.26
3.37
NA
NA
XXX76872
26
A
Us, transrectal
0.69
0.27
0.23
0.27
0.23
0.04
1.00
0.96
1.00
0.96
XXX76872
TC
A
Us, transrectal
0.00
3.16
2.31
NA
NA
0.10
3.26
2.41
NA
NA
XXX76873

A
Echograp trans r, pros study
1.55
3.39
2.80
NA
NA
0.25
5.19
4.60
NA
NA
XXX76873
26
A
Echograp trans r, pros study
1.55
0.51
0.50
0.51
0.50
0.09
2.15
2.14
2.15
2.14
XXX76873
TC
A
Echograp trans r, pros study
0.00
2.87
2.29
NA
NA
0.16
3.03
2.45
NA
NA
XXX76880

A
Us exam, extremity
0.59
3.19
2.01
NA
NA
0.11
3.89
2.71
NA
NA
XXX76880
26
A
Us exam, extremity
0.59
0.18
0.19
0.18
0.19
0.03
0.80
0.81
0.80
0.81
XXX76880
TC
A
Us exam, extremity
0.00
3.01
1.82
NA
NA
0.08
3.09
1.90
NA
NA
XXX76885

A
Us exam infant hips, dynamic
0.74
3.21
2.12
NA
NA
0.13
4.08
2.99
NA
NA
XXX76885
26
A
Us exam infant hips, dynamic
0.74
0.22
0.24
0.22
0.24
0.03
0.99
1.01
0.99
1.01
XXX76885
TC
A
Us exam infant hips, dynamic
0.00
2.99
1.89
NA
NA
0.10
3.09
1.99
NA
NA
XXX76886

A
Us exam infant hips, static
0.62
2.30
1.79
NA
NA
0.11
3.03
2.52
NA
NA
XXX76886
26
A
Us exam infant hips, static
0.62
0.18
0.20
0.18
0.20
0.03
0.83
0.85
0.83
0.85
XXX76886
TC
A
Us exam infant hips, static
0.00
2.12
1.60
NA
NA
0.08
2.20
1.68
NA
NA
XXX76930

A
Echo guide, cardiocentesis
0.67
2.11
1.85
NA
NA
0.12
2.90
2.64
NA
NA
XXX76930
26
A
Echo guide, cardiocentesis
0.67
0.34
0.27
0.34
0.27
0.02
1.03
0.96
1.03
0.96
XXX76930
TC
A
Echo guide, cardiocentesis
0.00
1.76
1.58
NA
NA
0.10
1.86
1.68
NA
NA
XXX76932

A
Echo guide for heart biopsy
0.67
NA
NA
NA
NA
0.12
NA
NA
NA
NA
XXX76932
26
A
Echo guide for heart biopsy
0.67
0.35
0.28
0.35
0.28
0.02
1.04
0.97
1.04
0.97
XXX76932
TC
A
Echo guide for heart biopsy
0.00
NA
NA
NA
NA
0.10
NA
NA
NA
NA
XXX76936

A
Echo guide for artery repair
1.99
6.05
6.73
NA
NA
0.47
8.51
9.19
NA
NA
XXX76936
26
A
Echo guide for artery repair
1.99
0.67
0.66
0.67
0.66
0.13
2.79
2.78
2.79
2.78
XXX76936
TC
A
Echo guide for artery repair
0.00
5.38
6.06
NA
NA
0.34
5.72
6.40
NA
NA
XXX76937

A
Us guide, vascular access
0.30
0.61
0.51
0.61
0.51
0.13
1.04
0.94
1.04
0.94
ZZZ76937
26
A
Us guide, vascular access
0.30
0.09
0.10
0.09
0.10
0.03
0.42
0.43
0.42
0.43
ZZZ76937
TC
A
Us guide, vascular access
0.00
0.52
0.42
0.52
0.42
0.10
0.62
0.52
0.62
0.52
ZZZ76940

A
Us guide, tissue ablation
2.00
NA
NA
NA
NA
0.60
NA
NA
NA
NA
XXX76940
26
A
Us guide, tissue ablation
2.00
0.60
0.64
0.60
0.64
0.31
2.91
2.95
2.91
2.95
XXX76940
TC
A
Us guide, tissue ablation
0.00
NA
NA
NA
NA
0.29
NA
NA
NA
NA
XXX76941

A
Echo guide for transfusion
1.34
NA
NA
NA
NA
0.15
NA
NA
NA
NA
XXX76941
26
A
Echo guide for transfusion
1.34
0.44
0.46
0.44
0.46
0.07
1.85
1.87
1.85
1.87
XXX76941
TC
A
Echo guide for transfusion
0.00
NA
NA
NA
NA
0.08
NA
NA
NA
NA
XXX76942

A
Echo guide for biopsy
0.67
4.83
3.48
NA
NA
0.13
5.63
4.28
NA
NA
XXX76942
26
A
Echo guide for biopsy
0.67
0.23
0.22
0.23
0.22
0.03
0.93
0.92
0.93
0.92
XXX76942
TC
A
Echo guide for biopsy
0.00
4.60
3.26
NA
NA
0.10
4.70
3.36
NA
NA
XXX76945

A
Echo guide, villus sampling
0.67
NA
NA
NA
NA
0.11
NA
NA
NA
NA
XXX76945
26
A
Echo guide, villus sampling
0.67
0.21
0.22
0.21
0.22
0.03
0.91
0.92
0.91
0.92
XXX76945
TC
A
Echo guide, villus sampling
0.00
NA
NA
NA
NA
0.08
NA
NA
NA
NA
XXX76946

A
Echo guide for amniocentesis
0.38
0.45
1.36
NA
NA
0.12
0.95
1.86
NA
NA
XXX76946
26
A
Echo guide for amniocentesis
0.38
0.11
0.13
0.11
0.13
0.02
0.51
0.53
0.51
0.53
XXX76946
TC
A
Echo guide for amniocentesis
0.00
0.34
1.23
NA
NA
0.10
0.44
1.33
NA
NA
XXX76948

A
Echo guide, ova aspiration
0.38
0.45
1.35
NA
NA
0.12
0.95
1.85
NA
NA
XXX76948
26
A
Echo guide, ova aspiration
0.38
0.11
0.13
0.11
0.13
0.02
0.51
0.53
0.51
0.53
XXX76948
TC
A
Echo guide, ova aspiration
0.00
0.34
1.23
NA
NA
0.10
0.44
1.33
NA
NA
XXX76950

A
Echo guidance radiotherapy
0.58
1.16
1.42
NA
NA
0.10
1.84
2.10
NA
NA
XXX76950
26
A
Echo guidance radiotherapy
0.58
0.16
0.18
0.16
0.18
0.03
0.77
0.79
0.77
0.79
XXX76950
TC
A
Echo guidance radiotherapy
0.00
1.00
1.23
NA
NA
0.07
1.07
1.30
NA
NA
XXX76965

A
Echo guidance radiotherapy
1.34
1.18
4.80
NA
NA
0.37
2.89
6.51
NA
NA
XXX76965
26
A
Echo guidance radiotherapy
1.34
0.48
0.44
0.48
0.44
0.08
1.90
1.86
1.90
1.86
XXX76965
TC
A
Echo guidance radiotherapy
0.00
0.70
4.35
NA
NA
0.29
0.99
4.64
NA
NA
XXX76970

A
Ultrasound exam follow-up
0.40
2.14
1.42
NA
NA
0.08
2.62
1.90
NA
NA
XXX76970
26
A
Ultrasound exam follow-up
0.40
0.11
0.13
0.11
0.13
0.02
0.53
0.55
0.53
0.55
XXX76970
TC
A
Ultrasound exam follow-up
0.00
2.03
1.30
NA
NA
0.06
2.09
1.36
NA
NA
XXX76975

A
GI endoscopic ultrasound
0.81
NA
NA
NA
NA
0.14
NA
NA
NA
NA
XXX76975
26
A
GI endoscopic ultrasound
0.81
0.29
0.28
0.29
0.28
0.04
1.14
1.13
1.14
1.13
XXX76975
TC
A
GI endoscopic ultrasound
0.00
NA
NA
NA
NA
0.10
NA
NA
NA
NA
XXX76977

A
Us bone density measure
0.05
0.11
0.66
NA
NA
0.06
0.22
0.77
NA
NA
XXX76977
26
A
Us bone density measure
0.05
0.01
0.02
0.01
0.02
0.01
0.07
0.08
0.07
0.08
XXX( print page 49200)76977
TC
A
Us bone density measure
0.00
0.09
0.64
NA
NA
0.05
0.14
0.69
NA
NA
XXX76986

A
Ultrasound guide intraoper
1.20
NA
NA
NA
NA
0.27
NA
NA
NA
NA
XXX76986
26
A
Ultrasound guide intraoper
1.20
0.35
0.39
0.35
0.39
0.13
1.68
1.72
1.68
1.72
XXX76986
TC
A
Ultrasound guide intraoper
0.00
NA
NA
NA
NA
0.14
NA
NA
NA
NA
XXX76999

C
Echo examination procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX76999
26
C
Echo examination procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX76999
TC
C
Echo examination procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX77261

A
Radiation therapy planning
1.39
0.41
0.49
0.41
0.49
0.07
1.87
1.95
1.87
1.95
XXX77262

A
Radiation therapy planning
2.11
0.58
0.71
0.58
0.71
0.11
2.80
2.93
2.80
2.93
XXX77263

A
Radiation therapy planning
3.14
0.86
1.05
0.86
1.05
0.16
4.16
4.35
4.16
4.35
XXX77280

A
Set radiation therapy field
0.70
4.35
3.86
NA
NA
0.22
5.27
4.78
NA
NA
XXX77280
26
A
Set radiation therapy field
0.70
0.19
0.21
0.19
0.21
0.04
0.93
0.95
0.93
0.95
XXX77280
TC
A
Set radiation therapy field
0.00
4.16
3.64
NA
NA
0.18
4.34
3.82
NA
NA
XXX77285

A
Set radiation therapy field
1.05
7.91
6.41
NA
NA
0.35
9.31
7.81
NA
NA
XXX77285
26
A
Set radiation therapy field
1.05
0.29
0.33
0.29
0.33
0.05
1.39
1.43
1.39
1.43
XXX77285
TC
A
Set radiation therapy field
0.00
7.62
6.08
NA
NA
0.30
7.92
6.38
NA
NA
XXX77290

A
Set radiation therapy field
1.56
13.23
8.57
NA
NA
0.43
15.22
10.56
NA
NA
XXX77290
26
A
Set radiation therapy field
1.56
0.43
0.48
0.43
0.48
0.08
2.07
2.12
2.07
2.12
XXX77290
TC
A
Set radiation therapy field
0.00
12.81
8.09
NA
NA
0.35
13.16
8.44
NA
NA
XXX77295

A
Set radiation therapy field
4.56
6.90
23.76
NA
NA
1.71
13.17
30.03
NA
NA
XXX77295
26
A
Set radiation therapy field
4.56
1.25
1.41
1.25
1.41
0.23
6.04
6.20
6.04
6.20
XXX77295
TC
A
Set radiation therapy field
0.00
5.65
22.36
NA
NA
1.48
7.13
23.84
NA
NA
XXX77299

C
Radiation therapy planning
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX77299
26
C
Radiation therapy planning
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX77299
TC
C
Radiation therapy planning
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX77300

A
Radiation therapy dose plan
0.62
1.08
1.43
NA
NA
0.10
1.80
2.15
NA
NA
XXX77300
26
A
Radiation therapy dose plan
0.62
0.17
0.19
0.17
0.19
0.03
0.82
0.84
0.82
0.84
XXX77300
TC
A
Radiation therapy dose plan
0.00
0.91
1.23
NA
NA
0.07
0.98
1.30
NA
NA
XXX77301

A
Radiotherapy dose plan, imrt
7.99
53.43
36.23
NA
NA
1.88
63.30
46.10
NA
NA
XXX77301
26
A
Radiotherapy dose plan, imrt
7.99
2.19
2.47
2.19
2.47
0.40
10.58
10.86
10.58
10.86
XXX77301
TC
A
Radiotherapy dose plan, imrt
0.00
51.24
33.76
NA
NA
1.48
52.72
35.24
NA
NA
XXX77305

A
Teletx isodose plan simple
0.70
0.85
1.78
NA
NA
0.15
1.70
2.63
NA
NA
XXX77305
26
A
Teletx isodose plan simple
0.70
0.19
0.22
0.19
0.22
0.04
0.93
0.96
0.93
0.96
XXX77305
TC
A
Teletx isodose plan simple
0.00
0.65
1.56
NA
NA
0.11
0.76
1.67
NA
NA
XXX77310

A
Teletx isodose plan intermed
1.05
1.17
2.30
NA
NA
0.18
2.40
3.53
NA
NA
XXX77310
26
A
Teletx isodose plan intermed
1.05
0.28
0.33
0.28
0.33
0.05
1.38
1.43
1.38
1.43
XXX77310
TC
A
Teletx isodose plan intermed
0.00
0.89
1.97
NA
NA
0.13
1.02
2.10
NA
NA
XXX77315

A
Teletx isodose plan complex
1.56
1.97
2.86
NA
NA
0.22
3.75
4.64
NA
NA
XXX77315
26
A
Teletx isodose plan complex
1.56
0.43
0.48
0.43
0.48
0.08
2.07
2.12
2.07
2.12
XXX77315
TC
A
Teletx isodose plan complex
0.00
1.54
2.38
NA
NA
0.14
1.68
2.52
NA
NA
XXX77321

A
Special teletx port plan
0.95
1.38
3.60
NA
NA
0.26
2.59
4.81
NA
NA
XXX77321
26
A
Special teletx port plan
0.95
0.26
0.29
0.26
0.29
0.05
1.26
1.29
1.26
1.29
XXX77321
TC
A
Special teletx port plan
0.00
1.12
3.31
NA
NA
0.21
1.33
3.52
NA
NA
XXX77326

A
Brachytx isodose calc simp
0.93
2.78
2.69
NA
NA
0.18
3.89
3.80
NA
NA
XXX77326
26
A
Brachytx isodose calc simp
0.93
0.25
0.29
0.25
0.29
0.05
1.23
1.27
1.23
1.27
XXX77326
TC
A
Brachytx isodose calc simp
0.00
2.53
2.40
NA
NA
0.13
2.66
2.53
NA
NA
XXX77327

A
Brachytx isodose calc interm
1.39
3.84
3.89
NA
NA
0.25
5.48
5.53
NA
NA
XXX77327
26
A
Brachytx isodose calc interm
1.39
0.38
0.43
0.38
0.43
0.07
1.84
1.89
1.84
1.89
XXX77327
TC
A
Brachytx isodose calc interm
0.00
3.46
3.47
NA
NA
0.18
3.64
3.65
NA
NA
XXX77328

A
Brachytx isodose plan compl
2.09
4.93
5.45
NA
NA
0.36
7.38
7.90
NA
NA
XXX77328
26
A
Brachytx isodose plan compl
2.09
0.57
0.65
0.57
0.65
0.11
2.77
2.85
2.77
2.85
XXX77328
TC
A
Brachytx isodose plan compl
0.00
4.36
4.81
NA
NA
0.25
4.61
5.06
NA
NA
XXX77331

A
Special radiation dosimetry
0.87
0.72
0.77
NA
NA
0.06
1.65
1.70
NA
NA
XXX77331
26
A
Special radiation dosimetry
0.87
0.24
0.27
0.24
0.27
0.04
1.15
1.18
1.15
1.18
XXX77331
TC
A
Special radiation dosimetry
0.00
0.49
0.50
NA
NA
0.02
0.51
0.52
NA
NA
XXX77332

A
Radiation treatment aid(s)
0.54
1.52
1.51
NA
NA
0.10
2.16
2.15
NA
NA
XXX( print page 49201)77332
26
A
Radiation treatment aid(s)
0.54
0.15
0.17
0.15
0.17
0.03
0.72
0.74
0.72
0.74
XXX77332
TC
A
Radiation treatment aid(s)
0.00
1.37
1.35
NA
NA
0.07
1.44
1.42
NA
NA
XXX77333

A
Radiation treatment aid(s)
0.84
0.46
1.74
NA
NA
0.15
1.45
2.73
NA
NA
XXX77333
26
A
Radiation treatment aid(s)
0.84
0.23
0.26
0.23
0.26
0.04
1.11
1.14
1.11
1.14
XXX77333
TC
A
Radiation treatment aid(s)
0.00
0.23
1.48
NA
NA
0.11
0.34
1.59
NA
NA
XXX77334

A
Radiation treatment aid(s)
1.24
2.61
3.39
NA
NA
0.23
4.08
4.86
NA
NA
XXX77334
26
A
Radiation treatment aid(s)
1.24
0.34
0.39
0.34
0.39
0.06
1.64
1.69
1.64
1.69
XXX77334
TC
A
Radiation treatment aid(s)
0.00
2.27
3.01
NA
NA
0.17
2.44
3.18
NA
NA
XXX77336

A
Radiation physics consult
0.00
0.92
2.47
NA
NA
0.16
1.08
2.63
NA
NA
XXX77370

A
Radiation physics consult
0.00
2.33
3.20
NA
NA
0.18
2.51
3.38
NA
NA
XXX77399

C
External radiation dosimetry
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX77399
26
C
External radiation dosimetry
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX77399
TC
C
External radiation dosimetry
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX77401

A
Radiation treatment delivery
0.00
0.49
1.45
NA
NA
0.11
0.60
1.56
NA
NA
XXX77402

A
Radiation treatment delivery
0.00
4.15
2.37
NA
NA
0.11
4.26
2.48
NA
NA
XXX77403

A
Radiation treatment delivery
0.00
3.73
2.26
NA
NA
0.11
3.84
2.37
NA
NA
XXX77404

A
Radiation treatment delivery
0.00
4.19
2.38
NA
NA
0.11
4.30
2.49
NA
NA
XXX77406

A
Radiation treatment delivery
0.00
4.18
2.37
NA
NA
0.11
4.29
2.48
NA
NA
XXX77407

A
Radiation treatment delivery
0.00
5.39
2.92
NA
NA
0.12
5.51
3.04
NA
NA
XXX77408

A
Radiation treatment delivery
0.00
5.18
2.86
NA
NA
0.12
5.30
2.98
NA
NA
XXX77409

A
Radiation treatment delivery
0.00
5.78
3.01
NA
NA
0.12
5.90
3.13
NA
NA
XXX77411

A
Radiation treatment delivery
0.00
5.68
2.99
NA
NA
0.12
5.80
3.11
NA
NA
XXX77412

A
Radiation treatment delivery
0.00
6.78
3.44
NA
NA
0.13
6.91
3.57
NA
NA
XXX77413

A
Radiation treatment delivery
0.00
6.80
3.45
NA
NA
0.13
6.93
3.58
NA
NA
XXX77414

A
Radiation treatment delivery
0.00
7.66
3.66
NA
NA
0.13
7.79
3.79
NA
NA
XXX77416

A
Radiation treatment delivery
0.00
7.65
3.66
NA
NA
0.13
7.78
3.79
NA
NA
XXX77417

A
Radiology port film(s)
0.00
0.35
0.53
NA
NA
0.04
0.39
0.57
NA
NA
XXX77418

A
Radiation tx delivery, imrt
0.00
13.02
16.77
NA
NA
0.13
13.15
16.90
NA
NA
XXX77421

A
Stereoscopic x-ray guidance
0.39
1.95
3.10
NA
NA
0.12
2.46
3.61
NA
NA
XXX77421
26
A
Stereoscopic x-ray guidance
0.39
0.11
0.13
0.11
0.13
0.02
0.52
0.54
0.52
0.54
XXX77421
TC
A
Stereoscopic x-ray guidance
0.00
1.84
2.97
NA
NA
0.10
1.94
3.07
NA
NA
XXX77422

A
Neutron beam tx, simple
0.00
11.79
4.23
NA
NA
0.13
11.92
4.36
NA
NA
XXX77423

A
Neutron beam tx, complex
0.00
7.83
3.65
NA
NA
0.13
7.96
3.78
NA
NA
XXX77427

A
Radiation tx management, x5
3.31
1.08
1.07
1.08
1.07
0.17
4.56
4.55
4.56
4.55
XXX77431

A
Radiation therapy management
1.81
0.68
0.68
0.68
0.68
0.09
2.58
2.58
2.58
2.58
XXX77432

A
Stereotactic radiation trmt
7.92
2.17
2.72
2.17
2.72
0.41
10.50
11.05
10.50
11.05
XXX77470

A
Special radiation treatment
2.09
1.76
9.31
NA
NA
0.70
4.55
12.10
NA
NA
XXX77470
26
A
Special radiation treatment
2.09
0.57
0.65
0.57
0.65
0.11
2.77
2.85
2.77
2.85
XXX77470
TC
A
Special radiation treatment
0.00
1.19
8.66
NA
NA
0.59
1.78
9.25
NA
NA
XXX77499

C
Radiation therapy management
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX77499
26
C
Radiation therapy management
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX77499
TC
C
Radiation therapy management
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX77520

C
Proton trmt, simple w/o comp
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX77522

C
Proton trmt, simple w/comp
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX77523

C
Proton trmt, intermediate
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX77525

C
Proton treatment, complex
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX77600

R
Hyperthermia treatment
1.56
9.32
4.99
NA
NA
0.24
11.12
6.79
NA
NA
XXX77600
26
R
Hyperthermia treatment
1.56
0.35
0.46
0.35
0.46
0.08
1.99
2.10
1.99
2.10
XXX77600
TC
R
Hyperthermia treatment
0.00
8.97
4.53
NA
NA
0.16
9.13
4.69
NA
NA
XXX77605

R
Hyperthermia treatment
2.09
16.90
7.77
NA
NA
0.38
19.37
10.24
NA
NA
XXX77605
26
R
Hyperthermia treatment
2.09
0.53
0.63
0.53
0.63
0.16
2.78
2.88
2.78
2.88
XXX77605
TC
R
Hyperthermia treatment
0.00
16.36
7.14
NA
NA
0.22
16.58
7.36
NA
NA
XXX77610

R
Hyperthermia treatment
1.56
16.54
6.81
NA
NA
0.24
18.34
8.61
NA
NA
XXX77610
26
R
Hyperthermia treatment
1.56
0.43
0.49
0.43
0.49
0.08
2.07
2.13
2.07
2.13
XXX77610
TC
R
Hyperthermia treatment
0.00
16.12
6.32
NA
NA
0.16
16.28
6.48
NA
NA
XXX77615

R
Hyperthermia treatment
2.09
24.51
9.67
NA
NA
0.33
26.93
12.09
NA
NA
XXX77615
26
R
Hyperthermia treatment
2.09
0.55
0.63
0.55
0.63
0.11
2.75
2.83
2.75
2.83
XXX77615
TC
R
Hyperthermia treatment
0.00
23.95
9.03
NA
NA
0.22
24.17
9.25
NA
NA
XXX77620

R
Hyperthermia treatment
1.56
9.58
5.07
NA
NA
0.36
11.50
6.99
NA
NA
XXX77620
26
R
Hyperthermia treatment
1.56
0.41
0.49
0.41
0.49
0.20
2.17
2.25
2.17
2.25
XXX77620
TC
R
Hyperthermia treatment
0.00
9.18
4.58
NA
NA
0.16
9.34
4.74
NA
NA
XXX77750

A
Infuse radioactive materials
4.90
4.19
3.22
4.19
3.22
0.32
9.41
8.44
9.41
8.44
09077750
26
A
Infuse radioactive materials
4.90
1.35
1.52
1.35
1.52
0.25
6.50
6.67
6.50
6.67
09077750
TC
A
Infuse radioactive materials
0.00
2.84
1.71
2.84
1.71
0.07
2.91
1.78
2.91
1.78
09077761

A
Apply intrcav radiat simple
3.80
5.59
4.09
5.59
4.09
0.33
9.72
8.22
9.72
8.22
09077761
26
A
Apply intrcav radiat simple
3.80
1.05
1.08
1.05
1.08
0.19
5.04
5.07
5.04
5.07
090( print page 49202)77761
TC
A
Apply intrcav radiat simple
0.00
4.54
3.01
4.54
3.01
0.14
4.68
3.15
4.68
3.15
09077762

A
Apply intrcav radiat interm
5.71
6.58
5.73
6.58
5.73
0.48
12.77
11.92
12.77
11.92
09077762
26
A
Apply intrcav radiat interm
5.71
1.56
1.76
1.56
1.76
0.29
7.56
7.76
7.56
7.76
09077762
TC
A
Apply intrcav radiat interm
0.00
5.03
3.97
5.03
3.97
0.19
5.22
4.16
5.22
4.16
09077763

A
Apply intrcav radiat compl
8.56
8.87
7.64
8.87
7.64
0.66
18.09
16.86
18.09
16.86
09077763
26
A
Apply intrcav radiat compl
8.56
2.33
2.64
2.33
2.64
0.43
11.32
11.63
11.32
11.63
09077763
TC
A
Apply intrcav radiat compl
0.00
6.54
5.00
6.54
5.00
0.23
6.77
5.23
6.77
5.23
09077776

A
Apply interstit radiat simpl
4.65
6.66
4.01
6.66
4.01
0.57
11.88
9.23
11.88
9.23
09077776
26
A
Apply interstit radiat simpl
4.65
1.54
1.10
1.54
1.10
0.44
6.63
6.19
6.63
6.19
09077776
TC
A
Apply interstit radiat simpl
0.00
5.12
2.92
5.12
2.92
0.13
5.25
3.05
5.25
3.05
09077777

A
Apply interstit radiat inter
7.47
6.93
6.68
6.93
6.68
0.61
15.01
14.76
15.01
14.76
09077777
26
A
Apply interstit radiat inter
7.47
2.18
2.32
2.18
2.32
0.39
10.04
10.18
10.04
10.18
09077778

A
Apply interstit radiat compl
11.17
9.61
8.92
9.61
8.92
0.84
21.62
20.93
21.62
20.93
09077778
26
A
Apply interstit radiat compl
11.17
3.08
3.45
3.08
3.45
0.57
14.82
15.19
14.82
15.19
09077778
TC
A
Apply interstit radiat compl
0.00
6.54
5.48
6.54
5.48
0.27
6.81
5.75
6.81
5.75
09077781

A
High intensity brachytherapy
1.21
4.23
16.68
NA
NA
1.14
6.58
19.03
NA
NA
XXX77781
26
A
High intensity brachytherapy
1.21
0.33
0.48
0.33
0.48
0.08
1.62
1.77
1.62
1.77
XXX77781
TC
A
High intensity brachytherapy
0.00
3.90
16.20
NA
NA
1.06
4.96
17.26
NA
NA
XXX77782

A
High intensity brachytherapy
2.04
12.03
18.83
NA
NA
1.19
15.26
22.06
NA
NA
XXX77782
26
A
High intensity brachytherapy
2.04
0.55
0.74
0.55
0.74
0.13
2.72
2.91
2.72
2.91
XXX77782
TC
A
High intensity brachytherapy
0.00
11.48
18.10
NA
NA
1.06
12.54
19.16
NA
NA
XXX77783

A
High intensity brachytherapy
3.27
23.55
22.01
NA
NA
1.25
28.07
26.53
NA
NA
XXX77783
26
A
High intensity brachytherapy
3.27
0.89
1.12
0.89
1.12
0.19
4.35
4.58
4.35
4.58
XXX77783
TC
A
High intensity brachytherapy
0.00
22.67
20.89
NA
NA
1.06
23.73
21.95
NA
NA
XXX77784

A
High intensity brachytherapy
5.15
44.52
27.71
NA
NA
1.35
51.02
34.21
NA
NA
XXX77784
26
A
High intensity brachytherapy
5.15
1.40
1.69
1.40
1.69
0.29
6.84
7.13
6.84
7.13
XXX77784
TC
A
High intensity brachytherapy
0.00
43.12
26.01
NA
NA
1.06
44.18
27.07
NA
NA
XXX77789

A
Apply surface radiation
1.12
1.95
1.10
1.95
1.10
0.08
3.15
2.30
3.15
2.30
00077789
26
A
Apply surface radiation
1.12
0.35
0.37
0.35
0.37
0.06
1.53
1.55
1.53
1.55
00077789
TC
A
Apply surface radiation
0.00
1.60
0.74
1.60
0.74
0.02
1.62
0.76
1.62
0.76
00077790

A
Radiation handling
1.05
1.16
0.92
NA
NA
0.07
2.28
2.04
NA
NA
XXX77790
26
A
Radiation handling
1.05
0.29
0.33
0.29
0.33
0.05
1.39
1.43
1.39
1.43
XXX77790
TC
A
Radiation handling
0.00
0.87
0.59
NA
NA
0.02
0.89
0.61
NA
NA
XXX77799

C
Radium/radioisotope therapy
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX77799
26
C
Radium/radioisotope therapy
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX77799
TC
C
Radium/radioisotope therapy
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX78000

A
Thyroid, single uptake
0.19
1.85
1.24
NA
NA
0.07
2.11
1.50
NA
NA
XXX78000
26
A
Thyroid, single uptake
0.19
0.06
0.06
0.06
0.06
0.01
0.26
0.26
0.26
0.26
XXX78000
TC
A
Thyroid, single uptake
0.00
1.79
1.18
NA
NA
0.06
1.85
1.24
NA
NA
XXX78001

A
Thyroid, multiple uptakes
0.26
2.27
1.62
NA
NA
0.08
2.61
1.96
NA
NA
XXX78001
26
A
Thyroid, multiple uptakes
0.26
0.08
0.09
0.08
0.09
0.01
0.35
0.36
0.35
0.36
XXX78001
TC
A
Thyroid, multiple uptakes
0.00
2.19
1.53
NA
NA
0.07
2.26
1.60
NA
NA
XXX78003

A
Thyroid suppress/stimul
0.33
1.89
1.28
NA
NA
0.07
2.29
1.68
NA
NA
XXX78003
26
A
Thyroid suppress/stimul
0.33
0.10
0.11
0.10
0.11
0.01
0.44
0.45
0.44
0.45
XXX78003
TC
A
Thyroid suppress/stimul
0.00
1.78
1.17
NA
NA
0.06
1.84
1.23
NA
NA
XXX78006

A
Thyroid imaging with uptake
0.49
6.24
3.47
NA
NA
0.15
6.88
4.11
NA
NA
XXX78006
26
A
Thyroid imaging with uptake
0.49
0.15
0.16
0.15
0.16
0.02
0.66
0.67
0.66
0.67
XXX78006
TC
A
Thyroid imaging with uptake
0.00
6.08
3.31
NA
NA
0.13
6.21
3.44
NA
NA
XXX78007

A
Thyroid image, mult uptakes
0.50
3.02
2.81
NA
NA
0.16
3.68
3.47
NA
NA
XXX78007
26
A
Thyroid image, mult uptakes
0.50
0.16
0.17
0.16
0.17
0.02
0.68
0.69
0.68
0.69
XXX78007
TC
A
Thyroid image, mult uptakes
0.00
2.86
2.64
NA
NA
0.14
3.00
2.78
NA
NA
XXX78010

A
Thyroid imaging
0.39
4.20
2.51
NA
NA
0.13
4.72
3.03
NA
NA
XXX78010
26
A
Thyroid imaging
0.39
0.12
0.13
0.12
0.13
0.02
0.53
0.54
0.53
0.54
XXX78010
TC
A
Thyroid imaging
0.00
4.08
2.39
NA
NA
0.11
4.19
2.50
NA
NA
XXX78011

A
Thyroid imaging with flow
0.45
4.55
3.06
NA
NA
0.15
5.15
3.66
NA
NA
XXX78011
26
A
Thyroid imaging with flow
0.45
0.14
0.15
0.14
0.15
0.02
0.61
0.62
0.61
0.62
XXX( print page 49203)78011
TC
A
Thyroid imaging with flow
0.00
4.41
2.91
NA
NA
0.13
4.54
3.04
NA
NA
XXX78015

A
Thyroid met imaging
0.67
5.43
3.46
NA
NA
0.17
6.27
4.30
NA
NA
XXX78015
26
A
Thyroid met imaging
0.67
0.21
0.23
0.21
0.23
0.03
0.91
0.93
0.91
0.93
XXX78015
TC
A
Thyroid met imaging
0.00
5.22
3.23
NA
NA
0.14
5.36
3.37
NA
NA
XXX78016

A
Thyroid met imaging/studies
0.82
8.63
4.98
NA
NA
0.21
9.66
6.01
NA
NA
XXX78016
26
A
Thyroid met imaging/studies
0.82
0.26
0.28
0.26
0.28
0.03
1.11
1.13
1.11
1.13
XXX78016
TC
A
Thyroid met imaging/studies
0.00
8.37
4.70
NA
NA
0.18
8.55
4.88
NA
NA
XXX78018

A
Thyroid met imaging, body
0.86
7.96
6.28
NA
NA
0.33
9.15
7.47
NA
NA
XXX78018
26
A
Thyroid met imaging, body
0.86
0.27
0.29
0.27
0.29
0.04
1.17
1.19
1.17
1.19
XXX78018
TC
A
Thyroid met imaging, body
0.00
7.69
5.99
NA
NA
0.29
7.98
6.28
NA
NA
XXX78020

A
Thyroid met uptake
0.60
1.79
1.59
1.79
1.59
0.16
2.55
2.35
2.55
2.35
ZZZ78020
26
A
Thyroid met uptake
0.60
0.18
0.20
0.18
0.20
0.02
0.80
0.82
0.80
0.82
ZZZ78020
TC
A
Thyroid met uptake
0.00
1.60
1.38
1.60
1.38
0.14
1.74
1.52
1.74
1.52
ZZZ78070

A
Parathyroid nuclear imaging
0.82
3.43
4.27
NA
NA
0.15
4.40
5.24
NA
NA
XXX78070
26
A
Parathyroid nuclear imaging
0.82
0.26
0.28
0.26
0.28
0.04
1.12
1.14
1.12
1.14
XXX78070
TC
A
Parathyroid nuclear imaging
0.00
3.17
4.00
NA
NA
0.11
3.28
4.11
NA
NA
XXX78075

A
Adrenal nuclear imaging
0.74
11.67
7.18
NA
NA
0.32
12.73
8.24
NA
NA
XXX78075
26
A
Adrenal nuclear imaging
0.74
0.23
0.25
0.23
0.25
0.03
1.00
1.02
1.00
1.02
XXX78075
TC
A
Adrenal nuclear imaging
0.00
11.44
6.93
NA
NA
0.29
11.73
7.22
NA
NA
XXX78099

C
Endocrine nuclear procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX78099
26
C
Endocrine nuclear procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX78099
TC
C
Endocrine nuclear procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX78102

A
Bone marrow imaging, ltd
0.55
4.17
2.72
NA
NA
0.14
4.86
3.41
NA
NA
XXX78102
26
A
Bone marrow imaging, ltd
0.55
0.17
0.19
0.17
0.19
0.02
0.74
0.76
0.74
0.76
XXX78102
TC
A
Bone marrow imaging, ltd
0.00
4.00
2.53
NA
NA
0.12
4.12
2.65
NA
NA
XXX78103

A
Bone marrow imaging, mult
0.75
5.43
3.93
NA
NA
0.20
6.38
4.88
NA
NA
XXX78103
26
A
Bone marrow imaging, mult
0.75
0.23
0.25
0.23
0.25
0.03
1.01
1.03
1.01
1.03
XXX78103
TC
A
Bone marrow imaging, mult
0.00
5.20
3.68
NA
NA
0.17
5.37
3.85
NA
NA
XXX78104

A
Bone marrow imaging, body
0.80
6.30
4.83
NA
NA
0.25
7.35
5.88
NA
NA
XXX78104
26
A
Bone marrow imaging, body
0.80
0.27
0.27
0.27
0.27
0.03
1.10
1.10
1.10
1.10
XXX78104
TC
A
Bone marrow imaging, body
0.00
6.02
4.56
NA
NA
0.22
6.24
4.78
NA
NA
XXX78110

A
Plasma volume, single
0.19
2.16
1.31
NA
NA
0.07
2.42
1.57
NA
NA
XXX78110
26
A
Plasma volume, single
0.19
0.06
0.07
0.06
0.07
0.01
0.26
0.27
0.26
0.27
XXX78110
TC
A
Plasma volume, single
0.00
2.10
1.24
NA
NA
0.06
2.16
1.30
NA
NA
XXX78111

A
Plasma volume, multiple
0.22
2.16
2.53
NA
NA
0.15
2.53
2.90
NA
NA
XXX78111
26
A
Plasma volume, multiple
0.22
0.07
0.08
0.07
0.08
0.01
0.30
0.31
0.30
0.31
XXX78111
TC
A
Plasma volume, multiple
0.00
2.09
2.45
NA
NA
0.14
2.23
2.59
NA
NA
XXX78120

A
Red cell mass, single
0.23
2.09
1.88
NA
NA
0.12
2.44
2.23
NA
NA
XXX78120
26
A
Red cell mass, single
0.23
0.07
0.08
0.07
0.08
0.01
0.31
0.32
0.31
0.32
XXX78120
TC
A
Red cell mass, single
0.00
2.02
1.80
NA
NA
0.11
2.13
1.91
NA
NA
XXX78121

A
Red cell mass, multiple
0.32
2.19
2.81
NA
NA
0.15
2.66
3.28
NA
NA
XXX78121
26
A
Red cell mass, multiple
0.32
0.10
0.11
0.10
0.11
0.01
0.43
0.44
0.43
0.44
XXX78121
TC
A
Red cell mass, multiple
0.00
2.10
2.71
NA
NA
0.14
2.24
2.85
NA
NA
XXX78122

A
Blood volume
0.45
2.25
4.13
NA
NA
0.26
2.96
4.84
NA
NA
XXX78122
26
A
Blood volume
0.45
0.14
0.16
0.14
0.16
0.02
0.61
0.63
0.61
0.63
XXX78122
TC
A
Blood volume
0.00
2.11
3.98
NA
NA
0.24
2.35
4.22
NA
NA
XXX78130

A
Red cell survival study
0.61
3.55
3.18
NA
NA
0.17
4.33
3.96
NA
NA
XXX78130
26
A
Red cell survival study
0.61
0.20
0.21
0.20
0.21
0.03
0.84
0.85
0.84
0.85
XXX78130
TC
A
Red cell survival study
0.00
3.35
2.98
NA
NA
0.14
3.49
3.12
NA
NA
XXX78135

A
Red cell survival kinetics
0.64
8.59
5.97
NA
NA
0.28
9.51
6.89
NA
NA
XXX78135
26
A
Red cell survival kinetics
0.64
0.20
0.22
0.20
0.22
0.03
0.87
0.89
0.87
0.89
XXX78135
TC
A
Red cell survival kinetics
0.00
8.39
5.75
NA
NA
0.25
8.64
6.00
NA
NA
XXX78140

A
Red cell sequestration
0.61
2.87
3.82
NA
NA
0.24
3.72
4.67
NA
NA
XXX78140
26
A
Red cell sequestration
0.61
0.19
0.20
0.19
0.20
0.03
0.83
0.84
0.83
0.84
XXX78140
TC
A
Red cell sequestration
0.00
2.68
3.62
NA
NA
0.21
2.89
3.83
NA
NA
XXX78185

A
Spleen imaging
0.40
5.22
3.18
NA
NA
0.15
5.77
3.73
NA
NA
XXX78185
26
A
Spleen imaging
0.40
0.12
0.14
0.12
0.14
0.02
0.54
0.56
0.54
0.56
XXX78185
TC
A
Spleen imaging
0.00
5.10
3.05
NA
NA
0.13
5.23
3.18
NA
NA
XXX78190

A
Platelet survival, kinetics
1.09
9.05
6.84
NA
NA
0.38
10.52
8.31
NA
NA
XXX78190
26
A
Platelet survival, kinetics
1.09
0.34
0.38
0.34
0.38
0.08
1.51
1.55
1.51
1.55
XXX78190
TC
A
Platelet survival, kinetics
0.00
8.71
6.46
NA
NA
0.30
9.01
6.76
NA
NA
XXX78191

A
Platelet survival
0.61
3.43
6.51
NA
NA
0.40
4.44
7.52
NA
NA
XXX78191
26
A
Platelet survival
0.61
0.19
0.20
0.19
0.20
0.03
0.83
0.84
0.83
0.84
XXX78191
TC
A
Platelet survival
0.00
3.24
6.32
NA
NA
0.37
3.61
6.69
NA
NA
XXX78195

A
Lymph system imaging
1.20
8.66
5.53
NA
NA
0.28
10.14
7.01
NA
NA
XXX78195
26
A
Lymph system imaging
1.20
0.37
0.40
0.37
0.40
0.06
1.63
1.66
1.63
1.66
XXX( print page 49204)78195
TC
A
Lymph system imaging
0.00
8.29
5.13
NA
NA
0.22
8.51
5.35
NA
NA
XXX78199

C
Blood/lymph nuclear exam
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX78199
26
C
Blood/lymph nuclear exam
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX78199
TC
C
Blood/lymph nuclear exam
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX78201

A
Liver imaging
0.44
4.75
3.07
NA
NA
0.15
5.34
3.66
NA
NA
XXX78201
26
A
Liver imaging
0.44
0.13
0.15
0.13
0.15
0.02
0.59
0.61
0.59
0.61
XXX78201
TC
A
Liver imaging
0.00
4.61
2.92
NA
NA
0.13
4.74
3.05
NA
NA
XXX78202

A
Liver imaging with flow
0.51
5.34
3.62
NA
NA
0.16
6.01
4.29
NA
NA
XXX78202
26
A
Liver imaging with flow
0.51
0.16
0.17
0.16
0.17
0.02
0.69
0.70
0.69
0.70
XXX78202
TC
A
Liver imaging with flow
0.00
5.19
3.46
NA
NA
0.14
5.33
3.60
NA
NA
XXX78205

A
Liver imaging (3D)
0.71
5.26
5.93
NA
NA
0.34
6.31
6.98
NA
NA
XXX78205
26
A
Liver imaging (3D)
0.71
0.22
0.24
0.22
0.24
0.03
0.96
0.98
0.96
0.98
XXX78205
TC
A
Liver imaging (3D)
0.00
5.04
5.69
NA
NA
0.31
5.35
6.00
NA
NA
XXX78206

A
Liver image (3d) with flow
0.96
14.57
8.32
NA
NA
0.15
15.68
9.43
NA
NA
XXX78206
26
A
Liver image (3d) with flow
0.96
0.30
0.32
0.30
0.32
0.04
1.30
1.32
1.30
1.32
XXX78206
TC
A
Liver image (3d) with flow
0.00
14.26
8.00
NA
NA
0.11
14.37
8.11
NA
NA
XXX78215

A
Liver and spleen imaging
0.49
4.81
3.53
NA
NA
0.16
5.46
4.18
NA
NA
XXX78215
26
A
Liver and spleen imaging
0.49
0.15
0.16
0.15
0.16
0.02
0.66
0.67
0.66
0.67
XXX78215
TC
A
Liver and spleen imaging
0.00
4.66
3.37
NA
NA
0.14
4.80
3.51
NA
NA
XXX78216

A
Liver & spleen image/flow
0.57
2.82
3.46
NA
NA
0.20
3.59
4.23
NA
NA
XXX78216
26
A
Liver & spleen image/flow
0.57
0.18
0.19
0.18
0.19
0.02
0.77
0.78
0.77
0.78
XXX78216
TC
A
Liver & spleen image/flow
0.00
2.64
3.27
NA
NA
0.18
2.82
3.45
NA
NA
XXX78220

A
Liver function study
0.49
3.04
3.67
NA
NA
0.21
3.74
4.37
NA
NA
XXX78220
26
A
Liver function study
0.49
0.15
0.16
0.15
0.16
0.02
0.66
0.67
0.66
0.67
XXX78220
TC
A
Liver function study
0.00
2.89
3.51
NA
NA
0.19
3.08
3.70
NA
NA
XXX78223

A
Hepatobiliary imaging
0.84
8.49
5.08
NA
NA
0.23
9.56
6.15
NA
NA
XXX78223
26
A
Hepatobiliary imaging
0.84
0.26
0.28
0.26
0.28
0.04
1.14
1.16
1.14
1.16
XXX78223
TC
A
Hepatobiliary imaging
0.00
8.23
4.80
NA
NA
0.19
8.42
4.99
NA
NA
XXX78230

A
Salivary gland imaging
0.45
4.16
2.79
NA
NA
0.15
4.76
3.39
NA
NA
XXX78230
26
A
Salivary gland imaging
0.45
0.14
0.15
0.14
0.15
0.02
0.61
0.62
0.61
0.62
XXX78230
TC
A
Salivary gland imaging
0.00
4.02
2.64
NA
NA
0.13
4.15
2.77
NA
NA
XXX78231

A
Serial salivary imaging
0.52
2.81
3.22
NA
NA
0.19
3.52
3.93
NA
NA
XXX78231
26
A
Serial salivary imaging
0.52
0.16
0.18
0.16
0.18
0.02
0.70
0.72
0.70
0.72
XXX78231
TC
A
Serial salivary imaging
0.00
2.64
3.04
NA
NA
0.17
2.81
3.21
NA
NA
XXX78232

A
Salivary gland function exam
0.47
2.78
3.47
NA
NA
0.20
3.45
4.14
NA
NA
XXX78232
26
A
Salivary gland function exam
0.47
0.15
0.16
0.15
0.16
0.02
0.64
0.65
0.64
0.65
XXX78232
TC
A
Salivary gland function exam
0.00
2.64
3.32
NA
NA
0.18
2.82
3.50
NA
NA
XXX78258

A
Esophageal motility study
0.74
5.83
3.81
NA
NA
0.17
6.74
4.72
NA
NA
XXX78258
26
A
Esophageal motility study
0.74
0.27
0.26
0.27
0.26
0.03
1.04
1.03
1.04
1.03
XXX78258
TC
A
Esophageal motility study
0.00
5.56
3.55
NA
NA
0.14
5.70
3.69
NA
NA
XXX78261

A
Gastric mucosa imaging
0.69
6.07
4.77
NA
NA
0.25
7.01
5.71
NA
NA
XXX78261
26
A
Gastric mucosa imaging
0.69
0.22
0.24
0.22
0.24
0.03
0.94
0.96
0.94
0.96
XXX78261
TC
A
Gastric mucosa imaging
0.00
5.85
4.54
NA
NA
0.22
6.07
4.76
NA
NA
XXX78262

A
Gastroesophageal reflux exam
0.68
5.94
4.85
NA
NA
0.25
6.87
5.78
NA
NA
XXX78262
26
A
Gastroesophageal reflux exam
0.68
0.20
0.22
0.20
0.22
0.03
0.91
0.93
0.91
0.93
XXX78262
TC
A
Gastroesophageal reflux exam
0.00
5.74
4.62
NA
NA
0.22
5.96
4.84
NA
NA
XXX78264

A
Gastric emptying study
0.78
7.16
5.08
NA
NA
0.25
8.19
6.11
NA
NA
XXX78264
26
A
Gastric emptying study
0.78
0.25
0.26
0.25
0.26
0.03
1.06
1.07
1.06
1.07
XXX78264
TC
A
Gastric emptying study
0.00
6.91
4.83
NA
NA
0.22
7.13
5.05
NA
NA
XXX78270

A
Vit B-12 absorption exam
0.20
1.94
1.70
NA
NA
0.11
2.25
2.01
NA
NA
XXX78270
26
A
Vit B-12 absorption exam
0.20
0.06
0.07
0.06
0.07
0.01
0.27
0.28
0.27
0.28
XXX78270
TC
A
Vit B-12 absorption exam
0.00
1.88
1.63
NA
NA
0.10
1.98
1.73
NA
NA
XXX78271

A
Vit b-12 absrp exam, int fac
0.20
1.90
1.76
NA
NA
0.11
2.21
2.07
NA
NA
XXX78271
26
A
Vit b-12 absrp exam, int fac
0.20
0.05
0.07
0.05
0.07
0.01
0.26
0.28
0.26
0.28
XXX78271
TC
A
Vit b-12 absrp exam, int fac
0.00
1.85
1.69
NA
NA
0.10
1.95
1.79
NA
NA
XXX78272

A
Vit B-12 absorp, combined
0.27
2.02
2.31
NA
NA
0.14
2.43
2.72
NA
NA
XXX( print page 49205)78272
26
A
Vit B-12 absorp, combined
0.27
0.07
0.09
0.07
0.09
0.01
0.35
0.37
0.35
0.37
XXX78272
TC
A
Vit B-12 absorp, combined
0.00
1.95
2.23
NA
NA
0.13
2.08
2.36
NA
NA
XXX78278

A
Acute GI blood loss imaging
0.99
8.57
6.04
NA
NA
0.29
9.85
7.32
NA
NA
XXX78278
26
A
Acute GI blood loss imaging
0.99
0.31
0.33
0.31
0.33
0.04
1.34
1.36
1.34
1.36
XXX78278
TC
A
Acute GI blood loss imaging
0.00
8.26
5.72
NA
NA
0.25
8.51
5.97
NA
NA
XXX78282

C
GI protein loss exam
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX78282
26
A
GI protein loss exam
0.38
0.12
0.13
0.12
0.13
0.02
0.52
0.53
0.52
0.53
XXX78282
TC
C
GI protein loss exam
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX78290

A
MeckelIs divert exam
0.68
8.46
4.58
NA
NA
0.19
9.33
5.45
NA
NA
XXX78290
26
A
MeckelIs divert exam
0.68
0.21
0.23
0.21
0.23
0.03
0.92
0.94
0.92
0.94
XXX78290
TC
A
MeckelIs divert exam
0.00
8.25
4.35
NA
NA
0.16
8.41
4.51
NA
NA
XXX78291

A
Leveen/shunt patency exam
0.88
6.17
4.06
NA
NA
0.20
7.25
5.14
NA
NA
XXX78291
26
A
Leveen/shunt patency exam
0.88
0.27
0.29
0.27
0.29
0.04
1.19
1.21
1.19
1.21
XXX78291
TC
A
Leveen/shunt patency exam
0.00
5.90
3.77
NA
NA
0.16
6.06
3.93
NA
NA
XXX78299

C
GI nuclear procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX78299
26
C
GI nuclear procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX78299
TC
C
GI nuclear procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX78300

A
Bone imaging, limited area
0.62
4.20
3.07
NA
NA
0.17
4.99
3.86
NA
NA
XXX78300
26
A
Bone imaging, limited area
0.62
0.19
0.21
0.19
0.21
0.03
0.84
0.86
0.84
0.86
XXX78300
TC
A
Bone imaging, limited area
0.00
4.01
2.86
NA
NA
0.14
4.15
3.00
NA
NA
XXX78305

A
Bone imaging, multiple areas
0.83
5.46
4.32
NA
NA
0.23
6.52
5.38
NA
NA
XXX78305
26
A
Bone imaging, multiple areas
0.83
0.26
0.28
0.26
0.28
0.04
1.13
1.15
1.13
1.15
XXX78305
TC
A
Bone imaging, multiple areas
0.00
5.20
4.05
NA
NA
0.19
5.39
4.24
NA
NA
XXX78306

A
Bone imaging, whole body
0.86
6.05
4.93
NA
NA
0.26
7.17
6.05
NA
NA
XXX78306
26
A
Bone imaging, whole body
0.86
0.27
0.29
0.27
0.29
0.04
1.17
1.19
1.17
1.19
XXX78306
TC
A
Bone imaging, whole body
0.00
5.78
4.65
NA
NA
0.22
6.00
4.87
NA
NA
XXX78315

A
Bone imaging, 3 phase
1.02
8.59
5.99
NA
NA
0.29
9.90
7.30
NA
NA
XXX78315
26
A
Bone imaging, 3 phase
1.02
0.32
0.34
0.32
0.34
0.04
1.38
1.40
1.38
1.40
XXX78315
TC
A
Bone imaging, 3 phase
0.00
8.27
5.65
NA
NA
0.25
8.52
5.90
NA
NA
XXX78320

A
Bone imaging (3D)
1.04
5.36
6.04
NA
NA
0.35
6.75
7.43
NA
NA
XXX78320
26
A
Bone imaging (3D)
1.04
0.33
0.35
0.33
0.35
0.04
1.41
1.43
1.41
1.43
XXX78320
TC
A
Bone imaging (3D)
0.00
5.03
5.69
NA
NA
0.31
5.34
6.00
NA
NA
XXX78350

A
Bone mineral, single photon
0.22
0.56
0.76
NA
NA
0.06
0.84
1.04
NA
NA
XXX78350
26
A
Bone mineral, single photon
0.22
0.06
0.07
0.06
0.07
0.01
0.29
0.30
0.29
0.30
XXX78350
TC
A
Bone mineral, single photon
0.00
0.49
0.69
NA
NA
0.05
0.54
0.74
NA
NA
XXX78351

N
Bone mineral, dual photon
0.30
2.80
1.99
0.07
0.11
0.01
3.11
2.30
0.38
0.42
XXX78399

C
Musculoskeletal nuclear exam
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX78399
26
C
Musculoskeletal nuclear exam
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX78399
TC
C
Musculoskeletal nuclear exam
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX78414

C
Non-imaging heart function
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX78414
26
A
Non-imaging heart function
0.45
0.14
0.16
0.14
0.16
0.02
0.61
0.63
0.61
0.63
XXX78414
TC
C
Non-imaging heart function
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX78428

A
Cardiac shunt imaging
0.78
5.36
3.25
NA
NA
0.16
6.30
4.19
NA
NA
XXX78428
26
A
Cardiac shunt imaging
0.78
0.38
0.31
0.38
0.31
0.03
1.19
1.12
1.19
1.12
XXX78428
TC
A
Cardiac shunt imaging
0.00
4.98
2.93
NA
NA
0.13
5.11
3.06
NA
NA
XXX78445

A
Vascular flow imaging
0.49
4.63
2.68
NA
NA
0.13
5.25
3.30
NA
NA
XXX78445
26
A
Vascular flow imaging
0.49
0.18
0.17
0.18
0.17
0.02
0.69
0.68
0.69
0.68
XXX78445
TC
A
Vascular flow imaging
0.00
4.45
2.51
NA
NA
0.11
4.56
2.62
NA
NA
XXX78456

A
Acute venous thrombus image
1.00
10.04
5.75
NA
NA
0.33
11.37
7.08
NA
NA
XXX78456
26
A
Acute venous thrombus image
1.00
0.50
0.38
0.50
0.38
0.04
1.54
1.42
1.54
1.42
XXX78456
TC
A
Acute venous thrombus image
0.00
9.54
5.37
NA
NA
0.29
9.83
5.66
NA
NA
XXX78457

A
Venous thrombosis imaging
0.77
4.73
3.38
NA
NA
0.17
5.67
4.32
NA
NA
XXX78457
26
A
Venous thrombosis imaging
0.77
0.24
0.26
0.24
0.26
0.03
1.04
1.06
1.04
1.06
XXX78457
TC
A
Venous thrombosis imaging
0.00
4.49
3.12
NA
NA
0.14
4.63
3.26
NA
NA
XXX78458

A
Ven thrombosis images, bilat
0.90
4.59
4.40
NA
NA
0.25
5.74
5.55
NA
NA
XXX78458
26
A
Ven thrombosis images, bilat
0.90
0.28
0.31
0.28
0.31
0.04
1.22
1.25
1.22
1.25
XXX78458
TC
A
Ven thrombosis images, bilat
0.00
4.31
4.09
NA
NA
0.21
4.52
4.30
NA
NA
XXX78459

C
Heart muscle imaging (PET)
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX78459
26
A
Heart muscle imaging (PET)
1.50
0.55
0.57
0.55
0.57
0.05
2.10
2.12
2.10
2.12
XXX78459
TC
C
Heart muscle imaging (PET)
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX78460

A
Heart muscle blood, single
0.86
4.68
3.16
NA
NA
0.17
5.71
4.19
NA
NA
XXX78460
26
A
Heart muscle blood, single
0.86
0.29
0.29
0.29
0.29
0.04
1.19
1.19
1.19
1.19
XXX78460
TC
A
Heart muscle blood, single
0.00
4.39
2.87
NA
NA
0.13
4.52
3.00
NA
NA
XXX78461

A
Heart muscle blood, multiple
1.23
4.01
4.87
NA
NA
0.30
5.54
6.40
NA
NA
XXX78461
26
A
Heart muscle blood, multiple
1.23
0.42
0.43
0.42
0.43
0.05
1.70
1.71
1.70
1.71
XXX78461
TC
A
Heart muscle blood, multiple
0.00
3.59
4.44
NA
NA
0.25
3.84
4.69
NA
NA
XXX( print page 49206)78464

A
Heart image (3d), single
1.09
5.91
7.07
NA
NA
0.41
7.41
8.57
NA
NA
XXX78464
26
A
Heart image (3d), single
1.09
0.49
0.41
0.49
0.41
0.04
1.62
1.54
1.62
1.54
XXX78464
TC
A
Heart image (3d), single
0.00
5.42
6.66
NA
NA
0.37
5.79
7.03
NA
NA
XXX78465

A
Heart image (3d), multiple
1.46
11.58
12.12
NA
NA
0.67
13.71
14.25
NA
NA
XXX78465
26
A
Heart image (3d), multiple
1.46
0.71
0.57
0.71
0.57
0.05
2.22
2.08
2.22
2.08
XXX78465
TC
A
Heart image (3d), multiple
0.00
10.87
11.56
NA
NA
0.62
11.49
12.18
NA
NA
XXX78466

A
Heart infarct image
0.69
4.52
3.28
NA
NA
0.17
5.38
4.14
NA
NA
XXX78466
26
A
Heart infarct image
0.69
0.25
0.24
0.25
0.24
0.03
0.97
0.96
0.97
0.96
XXX78466
TC
A
Heart infarct image
0.00
4.27
3.03
NA
NA
0.14
4.41
3.17
NA
NA
XXX78468

A
Heart infarct image (ef)
0.80
6.06
4.46
NA
NA
0.22
7.08
5.48
NA
NA
XXX78468
26
A
Heart infarct image (ef)
0.80
0.42
0.31
0.42
0.31
0.03
1.25
1.14
1.25
1.14
XXX78468
TC
A
Heart infarct image (ef)
0.00
5.64
4.16
NA
NA
0.19
5.83
4.35
NA
NA
XXX78469

A
Heart infarct image (3D)
0.92
6.29
5.72
NA
NA
0.31
7.52
6.95
NA
NA
XXX78469
26
A
Heart infarct image (3D)
0.92
0.43
0.34
0.43
0.34
0.03
1.38
1.29
1.38
1.29
XXX78469
TC
A
Heart infarct image (3D)
0.00
5.85
5.38
NA
NA
0.28
6.13
5.66
NA
NA
XXX78472

A
Gated heart, planar, single
0.98
6.15
5.93
NA
NA
0.34
7.47
7.25
NA
NA
XXX78472
26
A
Gated heart, planar, single
0.98
0.40
0.36
0.40
0.36
0.04
1.42
1.38
1.42
1.38
XXX78472
TC
A
Gated heart, planar, single
0.00
5.75
5.57
NA
NA
0.30
6.05
5.87
NA
NA
XXX78473

A
Gated heart, multiple
1.47
7.79
8.52
NA
NA
0.48
9.74
10.47
NA
NA
XXX78473
26
A
Gated heart, multiple
1.47
0.62
0.54
0.62
0.54
0.06
2.15
2.07
2.15
2.07
XXX78473
TC
A
Gated heart, multiple
0.00
7.17
7.99
NA
NA
0.42
7.59
8.41
NA
NA
XXX78478

A
Heart wall motion add-on
0.50
0.81
1.54
NA
NA
0.12
1.43
2.16
NA
NA
XXX78478
26
A
Heart wall motion add-on
0.50
0.24
0.23
0.24
0.23
0.02
0.76
0.75
0.76
0.75
XXX78478
TC
A
Heart wall motion add-on
0.00
0.57
1.31
NA
NA
0.10
0.67
1.41
NA
NA
XXX78480

A
Heart function add-on
0.30
0.71
1.51
NA
NA
0.12
1.13
1.93
NA
NA
XXX78480
26
A
Heart function add-on
0.30
0.15
0.20
0.15
0.20
0.02
0.47
0.52
0.47
0.52
XXX78480
TC
A
Heart function add-on
0.00
0.57
1.31
NA
NA
0.10
0.67
1.41
NA
NA
XXX78481

A
Heart first pass, single
0.98
5.12
5.47
NA
NA
0.31
6.41
6.76
NA
NA
XXX78481
26
A
Heart first pass, single
0.98
0.49
0.39
0.49
0.39
0.03
1.50
1.40
1.50
1.40
XXX78481
TC
A
Heart first pass, single
0.00
4.62
5.07
NA
NA
0.28
4.90
5.35
NA
NA
XXX78483

A
Heart first pass, multiple
1.47
6.93
8.04
NA
NA
0.46
8.86
9.97
NA
NA
XXX78483
26
A
Heart first pass, multiple
1.47
0.79
0.60
0.79
0.60
0.05
2.31
2.12
2.31
2.12
XXX78483
TC
A
Heart first pass, multiple
0.00
6.14
7.44
NA
NA
0.41
6.55
7.85
NA
NA
XXX78491

C
Heart image (pet), single
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX78491
26
A
Heart image (pet), single
1.50
0.62
0.60
0.62
0.60
0.06
2.18
2.16
2.18
2.16
XXX78491
TC
C
Heart image (pet), single
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX78492

C
Heart image (pet), multiple
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX78492
26
A
Heart image (pet), multiple
1.87
0.91
0.78
0.91
0.78
0.07
2.85
2.72
2.85
2.72
XXX78492
TC
C
Heart image (pet), multiple
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX78494

A
Heart image, spect
1.19
6.30
7.19
NA
NA
0.35
7.84
8.73
NA
NA
XXX78494
26
A
Heart image, spect
1.19
0.54
0.45
0.54
0.45
0.05
1.78
1.69
1.78
1.69
XXX78494
TC
A
Heart image, spect
0.00
5.75
6.74
NA
NA
0.30
6.05
7.04
NA
NA
XXX78496

A
Heart first pass add-on
0.50
0.93
5.67
0.93
5.67
0.32
1.75
6.49
1.75
6.49
ZZZ78496
26
A
Heart first pass add-on
0.50
0.25
0.20
0.25
0.20
0.02
0.77
0.72
0.77
0.72
ZZZ78496
TC
A
Heart first pass add-on
0.00
0.68
5.47
0.68
5.47
0.30
0.98
5.77
0.98
5.77
ZZZ78499

C
Cardiovascular nuclear exam
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX78499
26
C
Cardiovascular nuclear exam
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX78499
TC
C
Cardiovascular nuclear exam
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX78580

A
Lung perfusion imaging
0.74
5.12
4.04
NA
NA
0.21
6.07
4.99
NA
NA
XXX78580
26
A
Lung perfusion imaging
0.74
0.24
0.25
0.24
0.25
0.03
1.01
1.02
1.01
1.02
XXX78580
TC
A
Lung perfusion imaging
0.00
4.88
3.79
NA
NA
0.18
5.06
3.97
NA
NA
XXX78584

A
Lung V/Q image single breath
0.99
2.93
3.38
NA
NA
0.21
4.13
4.58
NA
NA
XXX78584
26
A
Lung V/Q image single breath
0.99
0.31
0.33
0.31
0.33
0.04
1.34
1.36
1.34
1.36
XXX78584
TC
A
Lung V/Q image single breath
0.00
2.62
3.06
NA
NA
0.17
2.79
3.23
NA
NA
XXX78585

A
Lung V/Q imaging
1.09
8.60
6.65
NA
NA
0.35
10.04
8.09
NA
NA
XXX78585
26
A
Lung V/Q imaging
1.09
0.34
0.36
0.34
0.36
0.05
1.48
1.50
1.48
1.50
XXX( print page 49207)78585
TC
A
Lung V/Q imaging
0.00
8.26
6.30
NA
NA
0.30
8.56
6.60
NA
NA
XXX78586

A
Aerosol lung image, single
0.40
4.13
3.07
NA
NA
0.16
4.69
3.63
NA
NA
XXX78586
26
A
Aerosol lung image, single
0.40
0.12
0.13
0.12
0.13
0.02
0.54
0.55
0.54
0.55
XXX78586
TC
A
Aerosol lung image, single
0.00
4.01
2.95
NA
NA
0.14
4.15
3.09
NA
NA
XXX78587

A
Aerosol lung image, multiple
0.49
5.43
3.59
NA
NA
0.16
6.08
4.24
NA
NA
XXX78587
26
A
Aerosol lung image, multiple
0.49
0.15
0.17
0.15
0.17
0.02
0.66
0.68
0.66
0.68
XXX78587
TC
A
Aerosol lung image, multiple
0.00
5.27
3.42
NA
NA
0.14
5.41
3.56
NA
NA
XXX78588

A
Perfusion lung image
1.09
8.63
4.83
NA
NA
0.23
9.95
6.15
NA
NA
XXX78588
26
A
Perfusion lung image
1.09
0.34
0.36
0.34
0.36
0.05
1.48
1.50
1.48
1.50
XXX78588
TC
A
Perfusion lung image
0.00
8.29
4.47
NA
NA
0.18
8.47
4.65
NA
NA
XXX78591

A
Vent image, 1 breath, 1 proj
0.40
4.12
3.27
NA
NA
0.16
4.68
3.83
NA
NA
XXX78591
26
A
Vent image, 1 breath, 1 proj
0.40
0.12
0.13
0.12
0.13
0.02
0.54
0.55
0.54
0.55
XXX78591
TC
A
Vent image, 1 breath, 1 proj
0.00
4.00
3.14
NA
NA
0.14
4.14
3.28
NA
NA
XXX78593

A
Vent image, 1 proj, gas
0.49
4.79
3.91
NA
NA
0.20
5.48
4.60
NA
NA
XXX78593
26
A
Vent image, 1 proj, gas
0.49
0.15
0.16
0.15
0.16
0.02
0.66
0.67
0.66
0.67
XXX78593
TC
A
Vent image, 1 proj, gas
0.00
4.64
3.75
NA
NA
0.18
4.82
3.93
NA
NA
XXX78594

A
Vent image, mult proj, gas
0.53
5.29
5.19
NA
NA
0.27
6.09
5.99
NA
NA
XXX78594
26
A
Vent image, mult proj, gas
0.53
0.16
0.18
0.16
0.18
0.02
0.71
0.73
0.71
0.73
XXX78594
TC
A
Vent image, mult proj, gas
0.00
5.13
5.02
NA
NA
0.25
5.38
5.27
NA
NA
XXX78596

A
Lung differential function
1.27
8.73
7.80
NA
NA
0.42
10.42
9.49
NA
NA
XXX78596
26
A
Lung differential function
1.27
0.37
0.41
0.37
0.41
0.05
1.69
1.73
1.69
1.73
XXX78596
TC
A
Lung differential function
0.00
8.36
7.39
NA
NA
0.37
8.73
7.76
NA
NA
XXX78599

C
Respiratory nuclear exam
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX78599
26
C
Respiratory nuclear exam
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX78599
TC
C
Respiratory nuclear exam
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX78600

A
Brain imaging, ltd static
0.44
7.30
4.10
NA
NA
0.16
7.90
4.70
NA
NA
XXX78600
26
A
Brain imaging, ltd static
0.44
0.14
0.15
0.14
0.15
0.02
0.60
0.61
0.60
0.61
XXX78600
TC
A
Brain imaging, ltd static
0.00
7.16
3.95
NA
NA
0.14
7.30
4.09
NA
NA
XXX78601

A
Brain imaging, ltd w/flow
0.51
5.35
4.02
NA
NA
0.20
6.06
4.73
NA
NA
XXX78601
26
A
Brain imaging, ltd w/flow
0.51
0.16
0.17
0.16
0.17
0.02
0.69
0.70
0.69
0.70
XXX78601
TC
A
Brain imaging, ltd w/flow
0.00
5.19
3.85
NA
NA
0.18
5.37
4.03
NA
NA
XXX78605

A
Brain imaging, complete
0.53
4.75
3.87
NA
NA
0.20
5.48
4.60
NA
NA
XXX78605
26
A
Brain imaging, complete
0.53
0.17
0.18
0.17
0.18
0.02
0.72
0.73
0.72
0.73
XXX78605
TC
A
Brain imaging, complete
0.00
4.59
3.70
NA
NA
0.18
4.77
3.88
NA
NA
XXX78606

A
Brain imaging, compl w/flow
0.64
8.54
5.20
NA
NA
0.24
9.42
6.08
NA
NA
XXX78606
26
A
Brain imaging, compl w/flow
0.64
0.20
0.21
0.20
0.21
0.03
0.87
0.88
0.87
0.88
XXX78606
TC
A
Brain imaging, compl w/flow
0.00
8.34
4.99
NA
NA
0.21
8.55
5.20
NA
NA
XXX78607

A
Brain imaging (3D)
1.23
15.23
9.04
NA
NA
0.40
16.86
10.67
NA
NA
XXX78607
26
A
Brain imaging (3D)
1.23
0.38
0.42
0.38
0.42
0.05
1.66
1.70
1.66
1.70
XXX78607
TC
A
Brain imaging (3D)
0.00
14.85
8.63
NA
NA
0.35
15.20
8.98
NA
NA
XXX78608

C
Brain imaging (PET)
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX78608
26
A
Brain imaging (PET)
1.50
0.47
0.50
0.47
0.50
0.06
2.03
2.06
2.03
2.06
XXX78608
TC
C
Brain imaging (PET)
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX78609

C
Brain imaging (PET)
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX78609
26
A
Brain imaging (PET)
1.50
0.47
0.50
0.47
0.50
0.06
2.03
2.06
2.03
2.06
XXX78609
TC
C
Brain imaging (PET)
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX78610

A
Brain flow imaging only
0.30
4.44
2.38
NA
NA
0.11
4.85
2.79
NA
NA
XXX78610
26
A
Brain flow imaging only
0.30
0.09
0.11
0.09
0.11
0.01
0.40
0.42
0.40
0.42
XXX78610
TC
A
Brain flow imaging only
0.00
4.35
2.27
NA
NA
0.10
4.45
2.37
NA
NA
XXX78615

A
Cerebral vascular flow image
0.42
5.34
4.34
NA
NA
0.23
5.99
4.99
NA
NA
XXX78615
26
A
Cerebral vascular flow image
0.42
0.13
0.15
0.13
0.15
0.02
0.57
0.59
0.57
0.59
XXX78615
TC
A
Cerebral vascular flow image
0.00
5.21
4.19
NA
NA
0.21
5.42
4.40
NA
NA
XXX78630

A
Cerebrospinal fluid scan
0.68
8.61
6.10
NA
NA
0.30
9.59
7.08
NA
NA
XXX78630
26
A
Cerebrospinal fluid scan
0.68
0.21
0.23
0.21
0.23
0.03
0.92
0.94
0.92
0.94
XXX78630
TC
A
Cerebrospinal fluid scan
0.00
8.40
5.88
NA
NA
0.27
8.67
6.15
NA
NA
XXX78635

A
CSF ventriculography
0.61
8.54
4.21
NA
NA
0.16
9.31
4.98
NA
NA
XXX78635
26
A
CSF ventriculography
0.61
0.19
0.22
0.19
0.22
0.02
0.82
0.85
0.82
0.85
XXX78635
TC
A
CSF ventriculography
0.00
8.35
3.99
NA
NA
0.14
8.49
4.13
NA
NA
XXX78645

A
CSF shunt evaluation
0.57
8.43
4.82
NA
NA
0.20
9.20
5.59
NA
NA
XXX78645
26
A
CSF shunt evaluation
0.57
0.18
0.19
0.18
0.19
0.02
0.77
0.78
0.77
0.78
XXX78645
TC
A
CSF shunt evaluation
0.00
8.25
4.64
NA
NA
0.18
8.43
4.82
NA
NA
XXX78647

A
Cerebrospinal fluid scan
0.90
14.31
8.24
NA
NA
0.35
15.56
9.49
NA
NA
XXX78647
26
A
Cerebrospinal fluid scan
0.90
0.27
0.30
0.27
0.30
0.04
1.21
1.24
1.21
1.24
XXX78647
TC
A
Cerebrospinal fluid scan
0.00
14.05
7.95
NA
NA
0.31
14.36
8.26
NA
NA
XXX78650

A
CSF leakage imaging
0.61
8.62
5.79
NA
NA
0.27
9.50
6.67
NA
NA
XXX78650
26
A
CSF leakage imaging
0.61
0.19
0.21
0.19
0.21
0.03
0.83
0.85
0.83
0.85
XXX( print page 49208)78650
TC
A
CSF leakage imaging
0.00
8.43
5.59
NA
NA
0.24
8.67
5.83
NA
NA
XXX78660

A
Nuclear exam of tear flow
0.53
4.24
2.79
NA
NA
0.14
4.91
3.46
NA
NA
XXX78660
26
A
Nuclear exam of tear flow
0.53
0.17
0.18
0.17
0.18
0.02
0.72
0.73
0.72
0.73
XXX78660
TC
A
Nuclear exam of tear flow
0.00
4.07
2.61
NA
NA
0.12
4.19
2.73
NA
NA
XXX78699

C
Nervous system nuclear exam
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX78699
26
C
Nervous system nuclear exam
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX78699
TC
C
Nervous system nuclear exam
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX78700

A
Kidney imaging, static
0.45
4.47
3.52
NA
NA
0.18
5.10
4.15
NA
NA
XXX78700
26
A
Kidney imaging, static
0.45
0.15
0.15
0.15
0.15
0.02
0.62
0.62
0.62
0.62
XXX78700
TC
A
Kidney imaging, static
0.00
4.32
3.37
NA
NA
0.16
4.48
3.53
NA
NA
XXX78701

A
Kidney imaging with flow
0.49
5.36
4.13
NA
NA
0.20
6.05
4.82
NA
NA
XXX78701
26
A
Kidney imaging with flow
0.49
0.15
0.16
0.15
0.16
0.02
0.66
0.67
0.66
0.67
XXX78701
TC
A
Kidney imaging with flow
0.00
5.21
3.97
NA
NA
0.18
5.39
4.15
NA
NA
XXX78704

A
Imaging renogram
0.74
5.42
4.51
NA
NA
0.24
6.40
5.49
NA
NA
XXX78704
26
A
Imaging renogram
0.74
0.23
0.25
0.23
0.25
0.03
1.00
1.02
1.00
1.02
XXX78704
TC
A
Imaging renogram
0.00
5.19
4.26
NA
NA
0.21
5.40
4.47
NA
NA
XXX78707

A
Kidney flow/function image
0.96
5.48
4.96
NA
NA
0.27
6.71
6.19
NA
NA
XXX78707
26
A
Kidney flow/function image
0.96
0.30
0.32
0.30
0.32
0.04
1.30
1.32
1.30
1.32
XXX78707
TC
A
Kidney flow/function image
0.00
5.18
4.65
NA
NA
0.23
5.41
4.88
NA
NA
XXX78708

A
Kidney flow/function image
1.21
3.41
4.51
NA
NA
0.28
4.90
6.00
NA
NA
XXX78708
26
A
Kidney flow/function image
1.21
0.38
0.40
0.38
0.40
0.05
1.64
1.66
1.64
1.66
XXX78708
TC
A
Kidney flow/function image
0.00
3.03
4.11
NA
NA
0.23
3.26
4.34
NA
NA
XXX78709

A
Kidney flow/function image
1.41
8.88
5.93
NA
NA
0.29
10.58
7.63
NA
NA
XXX78709
26
A
Kidney flow/function image
1.41
0.45
0.47
0.45
0.47
0.06
1.92
1.94
1.92
1.94
XXX78709
TC
A
Kidney flow/function image
0.00
8.43
5.46
NA
NA
0.23
8.66
5.69
NA
NA
XXX78710

A
Kidney imaging (3D)
0.66
5.29
5.92
NA
NA
0.34
6.29
6.92
NA
NA
XXX78710
26
A
Kidney imaging (3D)
0.66
0.21
0.22
0.21
0.22
0.03
0.90
0.91
0.90
0.91
XXX78710
TC
A
Kidney imaging (3D)
0.00
5.08
5.70
NA
NA
0.31
5.39
6.01
NA
NA
XXX78715

A
Renal vascular flow exam
0.30
4.82
2.47
NA
NA
0.11
5.23
2.88
NA
NA
XXX78715
26
A
Renal vascular flow exam
0.30
0.13
0.12
0.13
0.12
0.01
0.44
0.43
0.44
0.43
XXX78715
TC
A
Renal vascular flow exam
0.00
4.69
2.36
NA
NA
0.10
4.79
2.46
NA
NA
XXX78725

A
Kidney function study
0.38
2.35
2.02
NA
NA
0.13
2.86
2.53
NA
NA
XXX78725
26
A
Kidney function study
0.38
0.12
0.13
0.12
0.13
0.02
0.52
0.53
0.52
0.53
XXX78725
TC
A
Kidney function study
0.00
2.23
1.89
NA
NA
0.11
2.34
2.00
NA
NA
XXX78730

A
Urinary bladder retention
0.36
1.85
1.65
1.85
1.65
0.10
2.31
2.11
2.31
2.11
XXX78730
26
A
Urinary bladder retention
0.36
0.14
0.13
0.14
0.13
0.02
0.52
0.51
0.52
0.51
XXX78730
TC
A
Urinary bladder retention
0.00
1.71
1.52
1.71
1.52
0.08
1.79
1.60
1.79
1.60
XXX78740

A
Ureteral reflux study
0.57
5.48
3.10
NA
NA
0.15
6.20
3.82
NA
NA
XXX78740
26
A
Ureteral reflux study
0.57
0.18
0.19
0.18
0.19
0.03
0.78
0.79
0.78
0.79
XXX78740
TC
A
Ureteral reflux study
0.00
5.30
2.92
NA
NA
0.12
5.42
3.04
NA
NA
XXX78760

A
Testicular imaging
0.66
4.52
3.31
NA
NA
0.17
5.35
4.14
NA
NA
XXX78760
26
A
Testicular imaging
0.66
0.22
0.22
0.22
0.22
0.03
0.91
0.91
0.91
0.91
XXX78760
TC
A
Testicular imaging
0.00
4.30
3.09
NA
NA
0.14
4.44
3.23
NA
NA
XXX78761

A
Testicular imaging/flow
0.71
4.96
3.82
NA
NA
0.20
5.87
4.73
NA
NA
XXX78761
26
A
Testicular imaging/flow
0.71
0.23
0.24
0.23
0.24
0.03
0.97
0.98
0.97
0.98
XXX78761
TC
A
Testicular imaging/flow
0.00
4.72
3.58
NA
NA
0.17
4.89
3.75
NA
NA
XXX78799

C
Genitourinary nuclear exam
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX78799
26
C
Genitourinary nuclear exam
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX78799
TC
C
Genitourinary nuclear exam
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX78800

A
Tumor imaging, limited area
0.66
4.29
3.79
NA
NA
0.22
5.17
4.67
NA
NA
XXX78800
26
A
Tumor imaging, limited area
0.66
0.20
0.22
0.20
0.22
0.04
0.90
0.92
0.90
0.92
XXX78800
TC
A
Tumor imaging, limited area
0.00
4.09
3.57
NA
NA
0.18
4.27
3.75
NA
NA
XXX78801

A
Tumor imaging, mult areas
0.79
6.10
4.89
NA
NA
0.27
7.16
5.95
NA
NA
XXX78801
26
A
Tumor imaging, mult areas
0.79
0.24
0.26
0.24
0.26
0.05
1.08
1.10
1.08
1.10
XXX78801
TC
A
Tumor imaging, mult areas
0.00
5.86
4.63
NA
NA
0.22
6.08
4.85
NA
NA
XXX78802

A
Tumor imaging, whole body
0.86
8.17
6.41
NA
NA
0.34
9.37
7.61
NA
NA
XXX( print page 49209)78802
26
A
Tumor imaging, whole body
0.86
0.27
0.29
0.27
0.29
0.04
1.17
1.19
1.17
1.19
XXX78802
TC
A
Tumor imaging, whole body
0.00
7.90
6.12
NA
NA
0.30
8.20
6.42
NA
NA
XXX78803

A
Tumor imaging (3D)
1.09
15.02
8.95
NA
NA
0.40
16.51
10.44
NA
NA
XXX78803
26
A
Tumor imaging (3D)
1.09
0.34
0.37
0.34
0.37
0.05
1.48
1.51
1.48
1.51
XXX78803
TC
A
Tumor imaging (3D)
0.00
14.67
8.58
NA
NA
0.35
15.02
8.93
NA
NA
XXX78804

A
Tumor imaging, whole body
1.07
14.91
12.30
NA
NA
0.34
16.32
13.71
NA
NA
XXX78804
26
A
Tumor imaging, whole body
1.07
0.34
0.36
0.34
0.36
0.04
1.45
1.47
1.45
1.47
XXX78804
TC
A
Tumor imaging, whole body
0.00
14.58
11.94
NA
NA
0.30
14.88
12.24
NA
NA
XXX78805

A
Abscess imaging, ltd area
0.73
4.20
3.79
NA
NA
0.21
5.14
4.73
NA
NA
XXX78805
26
A
Abscess imaging, ltd area
0.73
0.23
0.25
0.23
0.25
0.03
0.99
1.01
0.99
1.01
XXX78805
TC
A
Abscess imaging, ltd area
0.00
3.97
3.54
NA
NA
0.18
4.15
3.72
NA
NA
XXX78806

A
Abscess imaging, whole body
0.86
8.35
7.13
NA
NA
0.39
9.60
8.38
NA
NA
XXX78806
26
A
Abscess imaging, whole body
0.86
0.27
0.29
0.27
0.29
0.04
1.17
1.19
1.17
1.19
XXX78806
TC
A
Abscess imaging, whole body
0.00
8.08
6.84
NA
NA
0.35
8.43
7.19
NA
NA
XXX78807

A
Nuclear localization/abscess
1.09
14.28
8.78
NA
NA
0.39
15.76
10.26
NA
NA
XXX78807
26
A
Nuclear localization/abscess
1.09
0.34
0.38
0.34
0.38
0.04
1.47
1.51
1.47
1.51
XXX78807
TC
A
Nuclear localization/abscess
0.00
13.94
8.40
NA
NA
0.35
14.29
8.75
NA
NA
XXX78811

C
Tumor imaging (pet), limited
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX78811
26
A
Tumor imaging (pet), limited
1.54
0.48
0.52
0.48
0.52
0.11
2.13
2.17
2.13
2.17
XXX78811
TC
C
Tumor imaging (pet), limited
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX78812

C
Tumor image (pet)/skul-thigh
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX78812
26
A
Tumor image (pet)/skul-thigh
1.93
0.61
0.65
0.61
0.65
0.11
2.65
2.69
2.65
2.69
XXX78812
TC
C
Tumor image (pet)/skul-thigh
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX78813

C
Tumor image (pet) full body
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX78813
26
A
Tumor image (pet) full body
2.00
0.62
0.67
0.62
0.67
0.11
2.73
2.78
2.73
2.78
XXX78813
TC
C
Tumor image (pet) full body
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX78814

C
Tumor image pet/ct, limited
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX78814
26
A
Tumor image pet/ct, limited
2.20
0.68
0.74
0.68
0.74
0.11
2.99
3.05
2.99
3.05
XXX78814
TC
C
Tumor image pet/ct, limited
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX78815

C
Tumorimage pet/ct skul-thigh
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX78815
26
A
Tumorimage pet/ct skul-thigh
2.44
0.77
0.82
0.77
0.82
0.11
3.32
3.37
3.32
3.37
XXX78815
TC
C
Tumorimage pet/ct skul-thigh
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX78816

C
Tumor image pet/ct full body
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX78816
26
A
Tumor image pet/ct full body
2.50
0.78
0.84
0.78
0.84
0.11
3.39
3.45
3.39
3.45
XXX78816
TC
C
Tumor image pet/ct full body
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX78890

B
Nuclear medicine data proc
0.05
0.39
1.10
NA
NA
0.07
0.51
1.22
NA
NA
XXX78890
26
B
Nuclear medicine data proc
0.05
0.01
0.02
0.01
0.02
0.01
0.07
0.08
0.07
0.08
XXX78890
TC
B
Nuclear medicine data proc
0.00
0.38
1.08
NA
NA
0.06
0.44
1.14
NA
NA
XXX78891

B
Nuclear med data proc
0.10
0.89
2.22
NA
NA
0.14
1.13
2.46
NA
NA
XXX78891
26
B
Nuclear med data proc
0.10
0.02
0.04
0.02
0.04
0.01
0.13
0.15
0.13
0.15
XXX78891
TC
B
Nuclear med data proc
0.00
0.86
2.18
NA
NA
0.13
0.99
2.31
NA
NA
XXX78999

C
Nuclear diagnostic exam
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX78999
26
C
Nuclear diagnostic exam
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX78999
TC
C
Nuclear diagnostic exam
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX79005

A
Nuclear rx, oral admin
1.80
1.78
2.86
NA
NA
0.22
3.80
4.88
NA
NA
XXX79005
26
A
Nuclear rx, oral admin
1.80
0.53
0.58
0.53
0.58
0.08
2.41
2.46
2.41
2.46
XXX79005
TC
A
Nuclear rx, oral admin
0.00
1.25
2.28
NA
NA
0.14
1.39
2.42
NA
NA
XXX79101

A
Nuclear rx, iv admin
1.96
2.10
2.99
NA
NA
0.22
4.28
5.17
NA
NA
XXX79101
26
A
Nuclear rx, iv admin
1.96
0.68
0.67
0.68
0.67
0.08
2.72
2.71
2.72
2.71
XXX79101
TC
A
Nuclear rx, iv admin
0.00
1.41
2.32
NA
NA
0.14
1.55
2.46
NA
NA
XXX79200

A
Nuclear rx, intracav admin
1.99
2.18
3.03
NA
NA
0.23
4.40
5.25
NA
NA
XXX79200
26
A
Nuclear rx, intracav admin
1.99
0.59
0.67
0.59
0.67
0.09
2.67
2.75
2.67
2.75
XXX79200
TC
A
Nuclear rx, intracav admin
0.00
1.60
2.37
NA
NA
0.14
1.74
2.51
NA
NA
XXX79300

C
Nuclr rx, interstit colloid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX79300
26
A
Nuclr rx, interstit colloid
1.60
0.46
0.54
0.46
0.54
0.13
2.19
2.27
2.19
2.27
XXX79300
TC
C
Nuclr rx, interstit colloid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX79403

A
Hematopoietic nuclear tx
2.25
2.83
4.58
NA
NA
0.24
5.32
7.07
NA
NA
XXX79403
26
A
Hematopoietic nuclear tx
2.25
0.68
0.84
0.68
0.84
0.10
3.03
3.19
3.03
3.19
XXX79403
TC
A
Hematopoietic nuclear tx
0.00
2.15
3.74
NA
NA
0.14
2.29
3.88
NA
NA
XXX79440

A
Nuclear rx, intra-articular
1.99
1.77
2.95
NA
NA
0.22
3.98
5.16
NA
NA
XXX79440
26
A
Nuclear rx, intra-articular
1.99
0.61
0.69
0.61
0.69
0.08
2.68
2.76
2.68
2.76
XXX79440
TC
A
Nuclear rx, intra-articular
0.00
1.16
2.26
NA
NA
0.14
1.30
2.40
NA
NA
XXX79445

C
Nuclear rx, intra-arterial
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX79445
26
A
Nuclear rx, intra-arterial
2.40
0.77
0.81
0.77
0.81
0.12
3.29
3.33
3.29
3.33
XXX79445
TC
C
Nuclear rx, intra-arterial
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX79999

C
Nuclear medicine therapy
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX( print page 49210)79999
26
C
Nuclear medicine therapy
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX79999
TC
C
Nuclear medicine therapy
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX80500

A
Lab pathology consultation
0.37
0.20
0.21
0.11
0.15
0.01
0.58
0.59
0.49
0.53
XXX80502

A
Lab pathology consultation
1.33
0.31
0.48
0.25
0.47
0.04
1.68
1.85
1.62
1.84
XXX83020
26
A
Hemoglobin electrophoresis
0.37
0.12
0.14
0.12
0.14
0.01
0.50
0.52
0.50
0.52
XXX83912
26
A
Genetic examination
0.37
0.11
0.12
0.11
0.12
0.01
0.49
0.50
0.49
0.50
XXX84165
26
A
Protein e-phoresis, serum
0.37
0.12
0.14
0.12
0.14
0.01
0.50
0.52
0.50
0.52
XXX84166
26
A
Protein e-phoresis/urine/csf
0.37
0.12
0.14
0.12
0.14
0.01
0.50
0.52
0.50
0.52
XXX84181
26
A
Western blot test
0.37
0.12
0.14
0.12
0.14
0.01
0.50
0.52
0.50
0.52
XXX84182
26
A
Protein, western blot test
0.37
0.12
0.15
0.12
0.15
0.02
0.51
0.54
0.51
0.54
XXX85060

A
Blood smear interpretation
0.45
0.14
0.17
0.14
0.17
0.02
0.61
0.64
0.61
0.64
XXX85097

A
Bone marrow interpretation
0.94
1.30
1.76
0.28
0.38
0.04
2.28
2.74
1.26
1.36
XXX85390
26
A
Fibrinolysins screen
0.37
0.12
0.13
0.12
0.13
0.01
0.50
0.51
0.50
0.51
XXX85396

A
Clotting assay, whole blood
0.37
NA
NA
0.05
0.13
0.04
NA
NA
0.46
0.54
XXX85576
26
A
Blood platelet aggregation
0.37
0.12
0.15
0.12
0.15
0.01
0.50
0.53
0.50
0.53
XXX86077

A
Physician blood bank service
0.94
0.38
0.39
0.29
0.37
0.03
1.35
1.36
1.26
1.34
XXX86078

A
Physician blood bank service
0.94
0.38
0.44
0.29
0.37
0.03
1.35
1.41
1.26
1.34
XXX86079

A
Physician blood bank service
0.94
0.38
0.43
0.30
0.38
0.03
1.35
1.40
1.27
1.35
XXX86255
26
A
Fluorescent antibody, screen
0.37
0.12
0.14
0.12
0.14
0.01
0.50
0.52
0.50
0.52
XXX86256
26
A
Fluorescent antibody, titer
0.37
0.12
0.14
0.12
0.14
0.01
0.50
0.52
0.50
0.52
XXX86320
26
A
Serum immunoelectrophoresis
0.37
0.12
0.14
0.12
0.14
0.01
0.50
0.52
0.50
0.52
XXX86325
26
A
Other immunoelectrophoresis
0.37
0.11
0.13
0.11
0.13
0.01
0.49
0.51
0.49
0.51
XXX86327
26
A
Immunoelectrophoresis assay
0.42
0.13
0.17
0.13
0.17
0.02
0.57
0.61
0.57
0.61
XXX86334
26
A
Immunofix e-phoresis, serum
0.37
0.12
0.14
0.12
0.14
0.01
0.50
0.52
0.50
0.52
XXX86335
26
A
Immunfix e-phorsis/urine/csf
0.37
0.12
0.14
0.12
0.14
0.01
0.50
0.52
0.50
0.52
XXX86485

C
Skin test, candida
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX86490

A
Coccidioidomycosis skin test
0.00
0.12
0.25
NA
NA
0.02
0.14
0.27
NA
NA
XXX86510

A
Histoplasmosis skin test
0.00
0.14
0.28
NA
NA
0.02
0.16
0.30
NA
NA
XXX86580

A
TB intradermal test
0.00
0.16
0.23
NA
NA
0.02
0.18
0.25
NA
NA
XXX87164
26
A
Dark field examination
0.37
0.12
0.12
0.12
0.12
0.01
0.50
0.50
0.50
0.50
XXX87207
26
A
Smear, special stain
0.37
0.11
0.15
0.11
0.15
0.01
0.49
0.53
0.49
0.53
XXX88104

A
Cytopathology, fluids
0.56
1.16
0.93
NA
NA
0.04
1.76
1.53
NA
NA
XXX88104
26
A
Cytopathology, fluids
0.56
0.16
0.22
0.16
0.22
0.02
0.74
0.80
0.74
0.80
XXX88104
TC
A
Cytopathology, fluids
0.00
1.01
0.71
NA
NA
0.02
1.03
0.73
NA
NA
XXX88106

A
Cytopathology, fluids
0.56
1.52
1.39
NA
NA
0.04
2.12
1.99
NA
NA
XXX88106
26
A
Cytopathology, fluids
0.56
0.15
0.22
0.15
0.22
0.02
0.73
0.80
0.73
0.80
XXX88106
TC
A
Cytopathology, fluids
0.00
1.36
1.17
NA
NA
0.02
1.38
1.19
NA
NA
XXX88107

A
Cytopathology, fluids
0.76
2.02
1.66
NA
NA
0.05
2.83
2.47
NA
NA
XXX88107
26
A
Cytopathology, fluids
0.76
0.23
0.31
0.23
0.31
0.03
1.02
1.10
1.02
1.10
XXX88107
TC
A
Cytopathology, fluids
0.00
1.79
1.36
NA
NA
0.02
1.81
1.38
NA
NA
XXX88108

A
Cytopath, concentrate tech
0.56
1.49
1.28
NA
NA
0.04
2.09
1.88
NA
NA
XXX88108
26
A
Cytopath, concentrate tech
0.56
0.16
0.22
0.16
0.22
0.02
0.74
0.80
0.74
0.80
XXX88108
TC
A
Cytopath, concentrate tech
0.00
1.33
1.06
NA
NA
0.02
1.35
1.08
NA
NA
XXX88112

A
Cytopath, cell enhance tech
1.18
1.53
1.85
NA
NA
0.04
2.75
3.07
NA
NA
XXX88112
26
A
Cytopath, cell enhance tech
1.18
0.31
0.46
0.31
0.46
0.02
1.51
1.66
1.51
1.66
XXX88112
TC
A
Cytopath, cell enhance tech
0.00
1.22
1.40
NA
NA
0.02
1.24
1.42
NA
NA
XXX88125

A
Forensic cytopathology
0.26
0.25
0.27
NA
NA
0.02
0.53
0.55
NA
NA
XXX88125
26
A
Forensic cytopathology
0.26
0.06
0.10
0.06
0.10
0.01
0.33
0.37
0.33
0.37
XXX88125
TC
A
Forensic cytopathology
0.00
0.20
0.17
NA
NA
0.01
0.21
0.18
NA
NA
XXX88141

A
Cytopath, c/v, interpret
0.42
0.38
0.21
0.38
0.21
0.02
0.82
0.65
0.82
0.65
XXX88160

A
Cytopath smear, other source
0.50
0.91
0.85
NA
NA
0.04
1.45
1.39
NA
NA
XXX88160
26
A
Cytopath smear, other source
0.50
0.13
0.19
0.13
0.19
0.02
0.65
0.71
0.65
0.71
XXX88160
TC
A
Cytopath smear, other source
0.00
0.78
0.66
NA
NA
0.02
0.80
0.68
NA
NA
XXX88161

A
Cytopath smear, other source
0.50
1.13
0.99
NA
NA
0.04
1.67
1.53
NA
NA
XXX88161
26
A
Cytopath smear, other source
0.50
0.15
0.20
0.15
0.20
0.02
0.67
0.72
0.67
0.72
XXX88161
TC
A
Cytopath smear, other source
0.00
0.98
0.79
NA
NA
0.02
1.00
0.81
NA
NA
XXX( print page 49211)88162

A
Cytopath smear, other source
0.76
1.18
1.06
NA
NA
0.05
1.99
1.87
NA
NA
XXX88162
26
A
Cytopath smear, other source
0.76
0.17
0.29
0.17
0.29
0.03
0.96
1.08
0.96
1.08
XXX88162
TC
A
Cytopath smear, other source
0.00
1.01
0.77
NA
NA
0.02
1.03
0.79
NA
NA
XXX88172

A
Cytopathology eval of fna
0.60
0.86
0.76
NA
NA
0.04
1.50
1.40
NA
NA
XXX88172
26
A
Cytopathology eval of fna
0.60
0.18
0.24
0.18
0.24
0.02
0.80
0.86
0.80
0.86
XXX88172
TC
A
Cytopathology eval of fna
0.00
0.68
0.52
NA
NA
0.02
0.70
0.54
NA
NA
XXX88173

A
Cytopath eval, fna, report
1.39
2.33
2.18
NA
NA
0.07
3.79
3.64
NA
NA
XXX88173
26
A
Cytopath eval, fna, report
1.39
0.40
0.54
0.40
0.54
0.05
1.84
1.98
1.84
1.98
XXX88173
TC
A
Cytopath eval, fna, report
0.00
1.93
1.65
NA
NA
0.02
1.95
1.67
NA
NA
XXX88182

A
Cell marker study
0.77
1.97
1.97
NA
NA
0.07
2.81
2.81
NA
NA
XXX88182
26
A
Cell marker study
0.77
0.13
0.28
0.13
0.28
0.03
0.93
1.08
0.93
1.08
XXX88182
TC
A
Cell marker study
0.00
1.85
1.70
NA
NA
0.04
1.89
1.74
NA
NA
XXX88184

A
Flowcytometry/tc, 1 marker
0.00
2.51
1.62
NA
NA
0.02
2.53
1.64
NA
NA
XXX88185

A
Flowcytometry/tc, add-on
0.00
1.52
0.86
NA
NA
0.02
1.54
0.88
NA
NA
ZZZ88187

A
Flowcytometry/read, 2-8
1.36
0.39
0.44
0.39
0.44
0.01
1.76
1.81
1.76
1.81
XXX88188

A
Flowcytometry/read, 9-15
1.69
0.44
0.54
0.44
0.54
0.01
2.14
2.24
2.14
2.24
XXX88189

A
Flowcytometry/read, 16 & >
2.23
0.49
0.69
0.49
0.69
0.01
2.73
2.93
2.73
2.93
XXX88199

C
Cytopathology procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX88199
26
C
Cytopathology procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX88199
TC
C
Cytopathology procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX88291

A
Cyto/molecular report
0.52
0.28
0.20
0.28
0.20
0.02
0.82
0.74
0.82
0.74
XXX88299

C
Cytogenetic study
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX88300

A
Surgical path, gross
0.08
0.60
0.49
NA
NA
0.02
0.70
0.59
NA
NA
XXX88300
26
A
Surgical path, gross
0.08
0.02
0.03
0.02
0.03
0.01
0.11
0.12
0.11
0.12
XXX88300
TC
A
Surgical path, gross
0.00
0.57
0.46
NA
NA
0.01
0.58
0.47
NA
NA
XXX88302

A
Tissue exam by pathologist
0.13
1.30
1.10
NA
NA
0.03
1.46
1.26
NA
NA
XXX88302
26
A
Tissue exam by pathologist
0.13
0.04
0.06
0.04
0.06
0.01
0.18
0.20
0.18
0.20
XXX88302
TC
A
Tissue exam by pathologist
0.00
1.27
1.05
NA
NA
0.02
1.29
1.07
NA
NA
XXX88304

A
Tissue exam by pathologist
0.22
1.57
1.38
NA
NA
0.03
1.82
1.63
NA
NA
XXX88304
26
A
Tissue exam by pathologist
0.22
0.06
0.08
0.06
0.08
0.01
0.29
0.31
0.29
0.31
XXX88304
TC
A
Tissue exam by pathologist
0.00
1.50
1.30
NA
NA
0.02
1.52
1.32
NA
NA
XXX88305

A
Tissue exam by pathologist
0.75
2.20
1.98
NA
NA
0.07
3.02
2.80
NA
NA
XXX88305
26
A
Tissue exam by pathologist
0.75
0.21
0.30
0.21
0.30
0.03
0.99
1.08
0.99
1.08
XXX88305
TC
A
Tissue exam by pathologist
0.00
1.99
1.68
NA
NA
0.04
2.03
1.72
NA
NA
XXX88307

A
Tissue exam by pathologist
1.59
4.54
3.50
NA
NA
0.12
6.25
5.21
NA
NA
XXX88307
26
A
Tissue exam by pathologist
1.59
0.48
0.63
0.48
0.63
0.06
2.13
2.28
2.13
2.28
XXX88307
TC
A
Tissue exam by pathologist
0.00
4.06
2.87
NA
NA
0.06
4.12
2.93
NA
NA
XXX88309

A
Tissue exam by pathologist
2.80
6.37
4.89
NA
NA
0.14
9.31
7.83
NA
NA
XXX88309
26
A
Tissue exam by pathologist
2.80
0.84
0.94
0.84
0.94
0.08
3.72
3.82
3.72
3.82
XXX88309
TC
A
Tissue exam by pathologist
0.00
5.52
3.95
NA
NA
0.06
5.58
4.01
NA
NA
XXX88311

A
Decalcify tissue
0.24
0.26
0.24
NA
NA
0.02
0.52
0.50
NA
NA
XXX88311
26
A
Decalcify tissue
0.24
0.07
0.09
0.07
0.09
0.01
0.32
0.34
0.32
0.34
XXX88311
TC
A
Decalcify tissue
0.00
0.18
0.14
NA
NA
0.01
0.19
0.15
NA
NA
XXX88312

A
Special stains
0.54
2.51
1.77
NA
NA
0.03
3.08
2.34
NA
NA
XXX88312
26
A
Special stains
0.54
0.15
0.21
0.15
0.21
0.02
0.71
0.77
0.71
0.77
XXX88312
TC
A
Special stains
0.00
2.36
1.56
NA
NA
0.01
2.37
1.57
NA
NA
XXX88313

A
Special stains
0.24
1.96
1.43
NA
NA
0.02
2.22
1.69
NA
NA
XXX88313
26
A
Special stains
0.24
0.06
0.09
0.06
0.09
0.01
0.31
0.34
0.31
0.34
XXX88313
TC
A
Special stains
0.00
1.90
1.34
NA
NA
0.01
1.91
1.35
NA
NA
XXX88314

A
Histochemical stain
0.45
1.96
2.04
NA
NA
0.04
2.45
2.53
NA
NA
XXX88314
26
A
Histochemical stain
0.45
0.14
0.18
0.14
0.18
0.02
0.61
0.65
0.61
0.65
XXX88314
TC
A
Histochemical stain
0.00
1.83
1.86
NA
NA
0.02
1.85
1.88
NA
NA
XXX88318

A
Chemical histochemistry
0.42
3.01
1.99
NA
NA
0.03
3.46
2.44
NA
NA
XXX88318
26
A
Chemical histochemistry
0.42
0.13
0.17
0.13
0.17
0.02
0.57
0.61
0.57
0.61
XXX88318
TC
A
Chemical histochemistry
0.00
2.89
1.83
NA
NA
0.01
2.90
1.84
NA
NA
XXX88319

A
Enzyme histochemistry
0.53
3.29
3.38
NA
NA
0.04
3.86
3.95
NA
NA
XXX88319
26
A
Enzyme histochemistry
0.53
0.15
0.20
0.15
0.20
0.02
0.70
0.75
0.70
0.75
XXX88319
TC
A
Enzyme histochemistry
0.00
3.14
3.18
NA
NA
0.02
3.16
3.20
NA
NA
XXX88321

A
Microslide consultation
1.63
0.74
0.78
0.48
0.54
0.05
2.42
2.46
2.16
2.22
XXX88323

A
Microslide consultation
1.83
2.23
1.89
NA
NA
0.07
4.13
3.79
NA
NA
XXX88323
26
A
Microslide consultation
1.83
0.47
0.55
0.47
0.55
0.05
2.35
2.43
2.35
2.43
XXX88323
TC
A
Microslide consultation
0.00
1.77
1.35
NA
NA
0.02
1.79
1.37
NA
NA
XXX88325

A
Comprehensive review of data
2.50
2.27
2.77
0.63
0.87
0.07
4.84
5.34
3.20
3.44
XXX88329

A
Path consult introp
0.67
0.69
0.66
0.21
0.27
0.02
1.38
1.35
0.90
0.96
XXX88331

A
Path consult intraop, 1 bloc
1.19
1.25
1.14
NA
NA
0.08
2.52
2.41
NA
NA
XXX88331
26
A
Path consult intraop, 1 bloc
1.19
0.37
0.48
0.37
0.48
0.04
1.60
1.71
1.60
1.71
XXX( print page 49212)88331
TC
A
Path consult intraop, 1 bloc
0.00
0.88
0.66
NA
NA
0.04
0.92
0.70
NA
NA
XXX88332

A
Path consult intraop, addIl
0.59
0.48
0.47
NA
NA
0.04
1.11
1.10
NA
NA
XXX88332
26
A
Path consult intraop, addIl
0.59
0.18
0.23
0.18
0.23
0.02
0.79
0.84
0.79
0.84
XXX88332
TC
A
Path consult intraop, addIl
0.00
0.30
0.23
NA
NA
0.02
0.32
0.25
NA
NA
XXX88333

A
Intraop cyto path consult, 1
1.20
1.36
1.15
NA
NA
0.08
2.64
2.43
NA
NA
XXX88333
26
A
Intraop cyto path consult, 1
1.20
0.38
0.49
0.38
0.49
0.04
1.62
1.73
1.62
1.73
XXX88333
TC
A
Intraop cyto path consult, 1
0.00
0.98
0.66
NA
NA
0.04
1.02
0.70
NA
NA
XXX88334

A
Intraop cyto path consult, 2
0.59
0.75
0.64
NA
NA
0.04
1.38
1.27
NA
NA
XXX88334
26
A
Intraop cyto path consult, 2
0.59
0.18
0.24
0.18
0.24
0.02
0.79
0.85
0.79
0.85
XXX88334
TC
A
Intraop cyto path consult, 2
0.00
0.57
0.40
NA
NA
0.02
0.59
0.42
NA
NA
XXX88342

A
Immunohistochemistry
0.85
2.05
1.61
NA
NA
0.05
2.95
2.51
NA
NA
XXX88342
26
A
Immunohistochemistry
0.85
0.23
0.33
0.23
0.33
0.03
1.11
1.21
1.11
1.21
XXX88342
TC
A
Immunohistochemistry
0.00
1.82
1.28
NA
NA
0.02
1.84
1.30
NA
NA
XXX88346

A
Immunofluorescent study
0.86
1.97
1.67
NA
NA
0.05
2.88
2.58
NA
NA
XXX88346
26
A
Immunofluorescent study
0.86
0.23
0.33
0.23
0.33
0.03
1.12
1.22
1.12
1.22
XXX88346
TC
A
Immunofluorescent study
0.00
1.74
1.34
NA
NA
0.02
1.76
1.36
NA
NA
XXX88347

A
Immunofluorescent study
0.86
1.30
1.27
NA
NA
0.05
2.21
2.18
NA
NA
XXX88347
26
A
Immunofluorescent study
0.86
0.18
0.31
0.18
0.31
0.03
1.07
1.20
1.07
1.20
XXX88347
TC
A
Immunofluorescent study
0.00
1.12
0.96
NA
NA
0.02
1.14
0.98
NA
NA
XXX88348

A
Electron microscopy
1.51
18.27
11.58
NA
NA
0.13
19.91
13.22
NA
NA
XXX88348
26
A
Electron microscopy
1.51
0.42
0.59
0.42
0.59
0.06
1.99
2.16
1.99
2.16
XXX88348
TC
A
Electron microscopy
0.00
17.85
11.00
NA
NA
0.07
17.92
11.07
NA
NA
XXX88349

A
Scanning electron microscopy
0.76
8.97
4.91
NA
NA
0.09
9.82
5.76
NA
NA
XXX88349
26
A
Scanning electron microscopy
0.76
0.22
0.30
0.22
0.30
0.03
1.01
1.09
1.01
1.09
XXX88349
TC
A
Scanning electron microscopy
0.00
8.75
4.61
NA
NA
0.06
8.81
4.67
NA
NA
XXX88355

A
Analysis, skeletal muscle
1.85
3.40
7.42
NA
NA
0.13
5.38
9.40
NA
NA
XXX88355
26
A
Analysis, skeletal muscle
1.85
0.40
0.69
0.40
0.69
0.07
2.32
2.61
2.32
2.61
XXX88355
TC
A
Analysis, skeletal muscle
0.00
2.99
6.73
NA
NA
0.06
3.05
6.79
NA
NA
XXX88356

A
Analysis, nerve
3.02
6.75
4.82
NA
NA
0.19
9.96
8.03
NA
NA
XXX88356
26
A
Analysis, nerve
3.02
0.79
1.14
0.79
1.14
0.12
3.93
4.28
3.93
4.28
XXX88356
TC
A
Analysis, nerve
0.00
5.96
3.68
NA
NA
0.07
6.03
3.75
NA
NA
XXX88358

A
Analysis, tumor
0.95
1.14
0.92
NA
NA
0.17
2.26
2.04
NA
NA
XXX88358
26
A
Analysis, tumor
0.95
0.17
0.34
0.17
0.34
0.10
1.22
1.39
1.22
1.39
XXX88358
TC
A
Analysis, tumor
0.00
0.97
0.57
NA
NA
0.07
1.04
0.64
NA
NA
XXX88360

A
Tumor immunohistochem/manual
1.10
2.33
1.87
NA
NA
0.08
3.51
3.05
NA
NA
XXX88360
26
A
Tumor immunohistochem/manual
1.10
0.28
0.42
0.28
0.42
0.06
1.44
1.58
1.44
1.58
XXX88360
TC
A
Tumor immunohistochem/manual
0.00
2.04
1.46
NA
NA
0.02
2.06
1.48
NA
NA
XXX88361

A
Tumor immunohistochem/comput
1.18
2.79
2.96
NA
NA
0.17
4.14
4.31
NA
NA
XXX88361
26
A
Tumor immunohistochem/comput
1.18
0.26
0.43
0.26
0.43
0.10
1.54
1.71
1.54
1.71
XXX88361
TC
A
Tumor immunohistochem/comput
0.00
2.53
2.53
NA
NA
0.07
2.60
2.60
NA
NA
XXX88362

A
Nerve teasing preparations
2.17
5.31
4.85
NA
NA
0.15
7.63
7.17
NA
NA
XXX88362
26
A
Nerve teasing preparations
2.17
0.61
0.84
0.61
0.84
0.09
2.87
3.10
2.87
3.10
XXX88362
TC
A
Nerve teasing preparations
0.00
4.71
4.01
NA
NA
0.06
4.77
4.07
NA
NA
XXX88365

A
Insitu hybridization (fish)
1.20
2.99
2.34
NA
NA
0.05
4.24
3.59
NA
NA
XXX88365
26
A
Insitu hybridization (fish)
1.20
0.25
0.45
0.25
0.45
0.03
1.48
1.68
1.48
1.68
XXX88365
TC
A
Insitu hybridization (fish)
0.00
2.74
1.90
NA
NA
0.02
2.76
1.92
NA
NA
XXX88367

A
Insitu hybridization, auto
1.30
5.30
4.35
NA
NA
0.12
6.72
5.77
NA
NA
XXX88367
26
A
Insitu hybridization, auto
1.30
0.23
0.46
0.23
0.46
0.06
1.59
1.82
1.59
1.82
XXX88367
TC
A
Insitu hybridization, auto
0.00
5.06
3.88
NA
NA
0.06
5.12
3.94
NA
NA
XXX88368

A
Insitu hybridization, manual
1.40
4.83
3.00
NA
NA
0.12
6.35
4.52
NA
NA
XXX88368
26
A
Insitu hybridization, manual
1.40
0.22
0.51
0.22
0.51
0.06
1.68
1.97
1.68
1.97
XXX88368
TC
A
Insitu hybridization, manual
0.00
4.60
2.49
NA
NA
0.06
4.66
2.55
NA
NA
XXX88371
26
A
Protein, western blot tissue
0.37
0.10
0.12
0.10
0.12
0.01
0.48
0.50
0.48
0.50
XXX88372
26
A
Protein analysis w/probe
0.37
0.11
0.15
0.11
0.15
0.01
0.49
0.53
0.49
0.53
XXX88380

C
Microdissection
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX88380
26
C
Microdissection
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX( print page 49213)88380
TC
C
Microdissection
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX88384

C
Eval molecular probes, 11-50
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX88384
26
C
Eval molecular probes, 11-50
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX88384
TC
C
Eval molecular probes, 11-50
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX88385

A
Eval  molecul probes, 51-250
1.50
14.75
9.00
NA
NA
0.12
16.37
10.62
NA
NA
XXX88385
26
A
Eval  molecul probes, 51-250
1.50
0.24
0.55
0.24
0.55
0.06
1.80
2.11
1.80
2.11
XXX88385
TC
A
Eval  molecul probes, 51-250
0.00
14.51
8.45
NA
NA
0.06
14.57
8.51
NA
NA
XXX88386

A
Eval molecul probes, 251-500
1.88
14.65
8.94
NA
NA
0.16
16.69
10.98
NA
NA
XXX88386
26
A
Eval molecul probes, 251-500
1.88
0.30
0.69
0.30
0.69
0.08
2.26
2.65
2.26
2.65
XXX88386
TC
A
Eval molecul probes, 251-500
0.00
14.35
8.25
NA
NA
0.08
14.43
8.33
NA
NA
XXX88399

C
Surgical pathology procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX88399
26
C
Surgical pathology procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX88399
TC
C
Surgical pathology procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX89049

A
Chct for mal hyperthermia
1.40
3.62
3.57
0.20
0.25
0.06
5.08
5.03
1.66
1.71
XXX89060
26
A
Exam,synovial fluid crystals
0.37
0.12
0.15
0.12
0.15
0.01
0.50
0.53
0.50
0.53
XXX89100

A
Sample intestinal contents
0.60
8.87
3.59
0.59
0.31
0.03
9.50
4.22
1.22
0.94
XXX89105

A
Sample intestinal contents
0.50
7.68
3.59
0.45
0.24
0.02
8.20
4.11
0.97
0.76
XXX89130

A
Sample stomach contents
0.45
6.95
3.04
0.39
0.20
0.02
7.42
3.51
0.86
0.67
XXX89132

A
Sample stomach contents
0.19
6.51
2.79
0.29
0.12
0.01
6.71
2.99
0.49
0.32
XXX89135

A
Sample stomach contents
0.79
8.87
3.64
0.67
0.36
0.04
9.70
4.47
1.50
1.19
XXX89136

A
Sample stomach contents
0.21
7.13
3.08
0.32
0.15
0.01
7.35
3.30
0.54
0.37
XXX89140

A
Sample stomach contents
0.94
6.89
3.28
0.50
0.33
0.04
7.87
4.26
1.48
1.31
XXX89141

A
Sample stomach contents
0.85
5.54
3.48
0.40
0.35
0.03
6.42
4.36
1.28
1.23
XXX89220

A
Sputum specimen collection
0.00
0.36
0.41
NA
NA
0.02
0.38
0.43
NA
NA
XXX89230

A
Collect sweat for test
0.00
0.08
0.10
NA
NA
0.02
0.10
0.12
NA
NA
XXX89240

C
Pathology lab procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX90465

A
Immune admin 1 inj, < 8 yrs
0.17
0.45
0.35
NA
NA
0.01
0.63
0.53
NA
NA
XXX90466

A
Immune admin addl inj, < 8 y
0.15
0.12
0.13
0.04
0.11
0.01
0.28
0.29
0.20
0.27
ZZZ90467

R
Immune admin o or n, < 8 yrs
0.17
0.17
0.17
0.07
0.09
0.01
0.35
0.35
0.25
0.27
XXX90468

R
Immune admin o/n, addl < 8 y
0.15
0.10
0.11
0.03
0.05
0.01
0.26
0.27
0.19
0.21
ZZZ90471

A
Immunization admin
0.17
0.45
0.35
NA
NA
0.01
0.63
0.53
NA
NA
XXX90472

A
Immunization admin, each add
0.15
0.12
0.13
0.04
0.11
0.01
0.28
0.29
0.20
0.27
ZZZ90473

R
Immune admin oral/nasal
0.17
0.16
0.18
0.04
0.06
0.01
0.34
0.36
0.22
0.24
XXX90474

R
Immune admin oral/nasal addl
0.15
0.08
0.10
0.03
0.05
0.01
0.24
0.26
0.19
0.21
ZZZ90760

A
Hydration iv infusion, init
0.17
1.31
1.40
NA
NA
0.07
1.55
1.64
NA
NA
XXX90761

A
Hydrate iv infusion, add-on
0.09
0.32
0.38
NA
NA
0.04
0.45
0.51
NA
NA
ZZZ90765

A
Ther/proph/diag iv inf, init
0.21
1.62
1.72
NA
NA
0.07
1.90
2.00
NA
NA
XXX90766

A
Ther/proph/dg iv inf, add-on
0.18
0.37
0.44
NA
NA
0.04
0.59
0.66
NA
NA
ZZZ90767

A
Tx/proph/dg addl seq iv inf
0.19
0.69
0.84
NA
NA
0.04
0.92
1.07
NA
NA
ZZZ90768

A
Ther/diag concurrent inf
0.17
0.33
0.41
NA
NA
0.04
0.54
0.62
NA
NA
ZZZ90772

A
Ther/proph/diag inj, sc/im
0.17
0.45
0.35
NA
NA
0.01
0.63
0.53
NA
NA
XXX90773

A
Ther/proph/diag inj, ia
0.17
0.30
0.31
NA
NA
0.02
0.49
0.50
NA
NA
XXX90774

A
Ther/proph/diag inj, iv push
0.18
1.34
1.31
NA
NA
0.04
1.56
1.53
NA
NA
XXX90775

A
Ther/proph/diag inj add-on
0.10
0.51
0.56
NA
NA
0.04
0.65
0.70
NA
NA
ZZZ90779

C
Ther/prop/diag inj/inf proc
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX90801

A
Psy dx interview
2.80
1.47
1.25
0.59
0.85
0.06
4.33
4.11
3.45
3.71
XXX90802

A
Intac psy dx interview
3.01
1.51
1.28
0.65
0.90
0.07
4.59
4.36
3.73
3.98
XXX90804

A
Psytx, office, 20-30 min
1.21
0.54
0.50
0.21
0.34
0.03
1.78
1.74
1.45
1.58
XXX90805

A
Psytx, off, 20-30 min w/e&m
1.37
0.59
0.52
0.24
0.38
0.03
1.99
1.92
1.64
1.78
XXX90806

A
Psytx, off, 45-50 min
1.86
0.51
0.65
0.32
0.53
0.04
2.41
2.55
2.22
2.43
XXX90807

A
Psytx, off, 45-50 min w/e&m
2.02
0.70
0.70
0.35
0.56
0.05
2.77
2.77
2.42
2.63
XXX90808

A
Psytx, office, 75-80 min
2.79
0.67
0.94
0.48
0.80
0.06
3.52
3.79
3.33
3.65
XXX90809

A
Psytx, off, 75-80, w/e&m
2.95
0.85
0.96
0.51
0.82
0.07
3.87
3.98
3.53
3.84
XXX90810

A
Intac psytx, off, 20-30 min
1.32
0.51
0.51
0.23
0.37
0.04
1.87
1.87
1.59
1.73
XXX90811

A
Intac psytx, 20-30, w/e&m
1.48
0.72
0.61
0.26
0.41
0.04
2.24
2.13
1.78
1.93
XXX90812

A
Intac psytx, off, 45-50 min
1.97
0.63
0.75
0.33
0.56
0.04
2.64
2.76
2.34
2.57
XXX90813

A
Intac psytx, 45-50 min w/e&m
2.13
0.82
0.78
0.37
0.60
0.05
3.00
2.96
2.55
2.78
XXX90814

A
Intac psytx, off, 75-80 min
2.90
0.77
1.02
0.50
0.86
0.06
3.73
3.98
3.46
3.82
XXX90815

A
Intac psytx, 75-80 w/e&m
3.06
0.98
1.03
0.53
0.85
0.07
4.11
4.16
3.66
3.98
XXX90816

A
Psytx, hosp, 20-30 min
1.25
NA
NA
0.31
0.42
0.03
NA
NA
1.59
1.70
XXX90817

A
Psytx, hosp, 20-30 min w/e&m
1.41
NA
NA
0.35
0.43
0.03
NA
NA
1.79
1.87
XXX90818

A
Psytx, hosp, 45-50 min
1.89
NA
NA
0.42
0.62
0.04
NA
NA
2.35
2.55
XXX90819

A
Psytx, hosp, 45-50 min w/e&m
2.05
NA
NA
0.46
0.60
0.05
NA
NA
2.56
2.70
XXX90821

A
Psytx, hosp, 75-80 min
2.83
NA
NA
0.58
0.90
0.06
NA
NA
3.47
3.79
XXX90822

A
Psytx, hosp, 75-80 min w/e&m
2.99
NA
NA
0.62
0.87
0.08
NA
NA
3.69
3.94
XXX90823

A
Intac psytx, hosp, 20-30 min
1.36
NA
NA
0.33
0.44
0.03
NA
NA
1.72
1.83
XXX( print page 49214)90824

A
Intac psytx, hsp 20-30 w/e&m
1.52
NA
NA
0.37
0.46
0.04
NA
NA
1.93
2.02
XXX90826

A
Intac psytx, hosp, 45-50 min
2.01
NA
NA
0.44
0.65
0.05
NA
NA
2.50
2.71
XXX90827

A
Intac psytx, hsp 45-50 w/e&m
2.16
NA
NA
0.48
0.63
0.05
NA
NA
2.69
2.84
XXX90828

A
Intac psytx, hosp, 75-80 min
2.94
NA
NA
0.60
0.95
0.06
NA
NA
3.60
3.95
XXX90829

A
Intac psytx, hsp 75-80 w/e&m
3.10
NA
NA
0.64
0.90
0.07
NA
NA
3.81
4.07
XXX90845

A
Psychoanalysis
1.79
0.38
0.53
0.31
0.49
0.04
2.21
2.36
2.14
2.32
XXX90846

R
Family psytx w/o patient
1.83
0.50
0.61
0.42
0.59
0.04
2.37
2.48
2.29
2.46
XXX90847

R
Family psytx w/patient
2.21
0.72
0.80
0.48
0.69
0.05
2.98
3.06
2.74
2.95
XXX90849

R
Multiple family group psytx
0.59
0.30
0.28
0.20
0.23
0.02
0.91
0.89
0.81
0.84
XXX90853

A
Group psychotherapy
0.59
0.27
0.26
0.20
0.22
0.01
0.87
0.86
0.80
0.82
XXX90857

A
Intac group psytx
0.63
0.36
0.31
0.20
0.24
0.01
1.00
0.95
0.84
0.88
XXX90862

A
Medication management
0.95
0.62
0.46
0.27
0.31
0.02
1.59
1.43
1.24
1.28
XXX90865

A
Narcosynthesis
2.84
1.18
1.32
0.63
0.84
0.12
4.14
4.28
3.59
3.80
XXX90870

A
Electroconvulsive therapy
1.88
1.90
1.92
0.38
0.54
0.04
3.82
3.84
2.30
2.46
00090875

N
Psychophysiological therapy
1.20
0.53
0.81
0.28
0.42
0.04
1.77
2.05
1.52
1.66
XXX90876

N
Psychophysiological therapy
1.90
0.68
1.04
0.44
0.66
0.05
2.63
2.99
2.39
2.61
XXX90880

A
Hypnotherapy
2.19
0.56
0.92
0.37
0.61
0.05
2.80
3.16
2.61
2.85
XXX90885

B
Psy evaluation of records
0.97
0.23
0.34
0.23
0.34
0.02
1.22
1.33
1.22
1.33
XXX90887

B
Consultation with family
1.48
0.62
0.77
0.34
0.51
0.04
2.14
2.29
1.86
2.03
XXX90899

C
Psychiatric service/therapy
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX90901

A
Biofeedback train, any meth
0.41
0.48
0.61
0.11
0.13
0.02
0.91
1.04
0.54
0.56
00090911

A
Biofeedback peri/uro/rectal
0.89
1.38
1.52
0.30
0.31
0.06
2.33
2.47
1.25
1.26
00090918

I
ESRD related services, month
11.16
4.75
5.77
3.78
5.53
0.36
16.27
17.29
15.30
17.05
XXX90919

I
ESRD related services, month
8.53
3.06
3.77
2.58
3.65
0.29
11.88
12.59
11.40
12.47
XXX90920

I
ESRD related services, month
7.26
2.77
3.51
2.29
3.39
0.23
10.26
11.00
9.78
10.88
XXX90921

I
ESRD related services, month
4.46
1.73
2.26
1.63
2.24
0.14
6.33
6.86
6.23
6.84
XXX90922

I
ESRD related services, day
0.37
0.16
0.20
0.13
0.19
0.01
0.54
0.58
0.51
0.57
XXX90923

I
Esrd related services, day
0.28
0.10
0.12
0.08
0.12
0.01
0.39
0.41
0.37
0.41
XXX90924

I
Esrd related services, day
0.24
0.09
0.11
0.08
0.11
0.01
0.34
0.36
0.33
0.36
XXX90925

I
Esrd related services, day
0.15
0.06
0.08
0.05
0.07
0.01
0.22
0.24
0.21
0.23
XXX90935

A
Hemodialysis, one evaluation
1.22
NA
NA
0.54
0.64
0.04
NA
NA
1.80
1.90
00090937

A
Hemodialysis, repeated eval
2.11
NA
NA
0.78
0.92
0.07
NA
NA
2.96
3.10
00090945

A
Dialysis, one evaluation
1.28
NA
NA
0.56
0.66
0.04
NA
NA
1.88
1.98
00090947

A
Dialysis, repeated eval
2.16
NA
NA
0.80
0.94
0.07
NA
NA
3.03
3.17
00090997

A
Hemoperfusion
1.84
NA
NA
0.50
0.62
0.06
NA
NA
2.40
2.52
00090999

C
Dialysis procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX91000

A
Esophageal intubation
0.73
2.22
0.80
2.22
0.80
0.04
2.99
1.57
2.99
1.57
00091000
26
A
Esophageal intubation
0.73
0.24
0.25
0.24
0.25
0.03
1.00
1.01
1.00
1.01
00091000
TC
A
Esophageal intubation
0.00
1.98
0.56
1.98
0.56
0.01
1.99
0.57
1.99
0.57
00091010

A
Esophagus motility study
1.25
3.66
4.22
3.66
4.22
0.12
5.03
5.59
5.03
5.59
00091010
26
A
Esophagus motility study
1.25
0.55
0.47
0.55
0.47
0.06
1.86
1.78
1.86
1.78
00091010
TC
A
Esophagus motility study
0.00
3.11
3.76
3.11
3.76
0.06
3.17
3.82
3.17
3.82
00091011

A
Esophagus motility study
1.50
5.31
5.24
5.31
5.24
0.13
6.94
6.87
6.94
6.87
00091011
26
A
Esophagus motility study
1.50
0.70
0.57
0.70
0.57
0.07
2.27
2.14
2.27
2.14
00091011
TC
A
Esophagus motility study
0.00
4.61
4.68
4.61
4.68
0.06
4.67
4.74
4.67
4.74
00091012

A
Esophagus motility study
1.46
5.49
5.69
5.49
5.69
0.13
7.08
7.28
7.08
7.28
00091012
26
A
Esophagus motility study
1.46
0.68
0.55
0.68
0.55
0.06
2.20
2.07
2.20
2.07
00091012
TC
A
Esophagus motility study
0.00
4.81
5.13
4.81
5.13
0.07
4.88
5.20
4.88
5.20
00091020

A
Gastric motility studies
1.44
4.79
4.59
4.79
4.59
0.13
6.36
6.16
6.36
6.16
00091020
26
A
Gastric motility studies
1.44
0.61
0.52
0.61
0.52
0.07
2.12
2.03
2.12
2.03
00091020
TC
A
Gastric motility studies
0.00
4.19
4.07
4.19
4.07
0.06
4.25
4.13
4.25
4.13
00091022

A
Duodenal motility study
1.44
3.09
4.07
3.09
4.07
0.13
4.66
5.64
4.66
5.64
00091022
26
A
Duodenal motility study
1.44
0.61
0.54
0.61
0.54
0.07
2.12
2.05
2.12
2.05
00091022
TC
A
Duodenal motility study
0.00
2.48
3.54
2.48
3.54
0.06
2.54
3.60
2.54
3.60
00091030

A
Acid perfusion of esophagus
0.91
2.92
2.55
2.92
2.55
0.06
3.89
3.52
3.89
3.52
00091030
26
A
Acid perfusion of esophagus
0.91
0.43
0.35
0.43
0.35
0.04
1.38
1.30
1.38
1.30
000( print page 49215)91030
TC
A
Acid perfusion of esophagus
0.00
2.49
2.21
2.49
2.21
0.02
2.51
2.23
2.51
2.23
00091034

A
Gastroesophageal reflux test
0.97
4.12
4.95
4.12
4.95
0.12
5.21
6.04
5.21
6.04
00091034
26
A
Gastroesophageal reflux test
0.97
0.41
0.36
0.41
0.36
0.06
1.44
1.39
1.44
1.39
00091034
TC
A
Gastroesophageal reflux test
0.00
3.70
4.60
3.70
4.60
0.06
3.76
4.66
3.76
4.66
00091035

A
G-esoph reflx tst w/electrod
1.59
11.33
10.93
11.33
10.93
0.12
13.04
12.64
13.04
12.64
00091035
26
A
G-esoph reflx tst w/electrod
1.59
0.70
0.60
0.70
0.60
0.06
2.35
2.25
2.35
2.25
00091035
TC
A
G-esoph reflx tst w/electrod
0.00
10.63
10.34
10.63
10.34
0.06
10.69
10.40
10.69
10.40
00091037

A
Esoph imped function test
0.97
3.41
3.05
3.41
3.05
0.12
4.50
4.14
4.50
4.14
00091037
26
A
Esoph imped function test
0.97
0.42
0.36
0.42
0.36
0.06
1.45
1.39
1.45
1.39
00091037
TC
A
Esoph imped function test
0.00
2.99
2.69
2.99
2.69
0.06
3.05
2.75
3.05
2.75
00091038

A
Esoph imped funct test > 1h
1.10
2.78
2.36
2.78
2.36
0.12
4.00
3.58
4.00
3.58
00091038
26
A
Esoph imped funct test > 1h
1.10
0.50
0.42
0.50
0.42
0.06
1.66
1.58
1.66
1.58
00091038
TC
A
Esoph imped funct test > 1h
0.00
2.28
1.94
2.28
1.94
0.06
2.34
2.00
2.34
2.00
00091040

A
Esoph balloon distension tst
0.97
9.35
10.69
9.35
10.69
0.12
10.44
11.78
10.44
11.78
00091040
26
A
Esoph balloon distension tst
0.97
0.37
0.35
0.37
0.35
0.06
1.40
1.38
1.40
1.38
00091040
TC
A
Esoph balloon distension tst
0.00
8.97
10.34
8.97
10.34
0.06
9.03
10.40
9.03
10.40
00091052

A
Gastric analysis test
0.79
2.99
2.59
2.99
2.59
0.05
3.83
3.43
3.83
3.43
00091052
26
A
Gastric analysis test
0.79
0.37
0.30
0.37
0.30
0.03
1.19
1.12
1.19
1.12
00091052
TC
A
Gastric analysis test
0.00
2.62
2.28
2.62
2.28
0.02
2.64
2.30
2.64
2.30
00091055

A
Gastric intubation for smear
0.94
2.44
2.82
2.44
2.82
0.07
3.45
3.83
3.45
3.83
00091055
26
A
Gastric intubation for smear
0.94
0.27
0.27
0.27
0.27
0.05
1.26
1.26
1.26
1.26
00091055
TC
A
Gastric intubation for smear
0.00
2.17
2.55
2.17
2.55
0.02
2.19
2.57
2.19
2.57
00091060

A
Gastric saline load test
0.45
1.65
1.88
1.65
1.88
0.05
2.15
2.38
2.15
2.38
00091060
26
A
Gastric saline load test
0.45
0.11
0.13
0.11
0.13
0.03
0.59
0.61
0.59
0.61
00091060
TC
A
Gastric saline load test
0.00
1.54
1.75
1.54
1.75
0.02
1.56
1.77
1.56
1.77
00091065

A
Breath hydrogen test
0.20
1.41
1.45
1.41
1.45
0.03
1.64
1.68
1.64
1.68
00091065
26
A
Breath hydrogen test
0.20
0.07
0.07
0.07
0.07
0.01
0.28
0.28
0.28
0.28
00091065
TC
A
Breath hydrogen test
0.00
1.34
1.38
1.34
1.38
0.02
1.36
1.40
1.36
1.40
00091100

A
Pass intestine bleeding tube
1.08
2.15
2.63
0.37
0.30
0.07
3.30
3.78
1.52
1.45
00091105

A
Gastric intubation treatment
0.37
1.76
2.02
0.07
0.09
0.03
2.16
2.42
0.47
0.49
00091110

A
Gi tract capsule endoscopy
3.64
20.55
21.77
NA
NA
0.16
24.35
25.57
NA
NA
XXX91110
26
A
Gi tract capsule endoscopy
3.64
1.66
1.38
1.66
1.38
0.09
5.39
5.11
5.39
5.11
XXX91110
TC
A
Gi tract capsule endoscopy
0.00
18.90
20.40
NA
NA
0.07
18.97
20.47
NA
NA
XXX91120

A
Rectal sensation test
0.97
9.12
10.52
9.12
10.52
0.11
10.20
11.60
10.20
11.60
XXX91120
26
A
Rectal sensation test
0.97
0.30
0.33
0.30
0.33
0.07
1.34
1.37
1.34
1.37
XXX91120
TC
A
Rectal sensation test
0.00
8.82
10.19
8.82
10.19
0.04
8.86
10.23
8.86
10.23
XXX91122

A
Anal pressure record
1.77
3.76
4.77
3.76
4.77
0.21
5.74
6.75
5.74
6.75
00091122
26
A
Anal pressure record
1.77
0.52
0.58
0.52
0.58
0.13
2.42
2.48
2.42
2.48
00091122
TC
A
Anal pressure record
0.00
3.24
4.19
3.24
4.19
0.08
3.32
4.27
3.32
4.27
00091132

C
Electrogastrography
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX91132
26
A
Electrogastrography
0.52
0.25
0.20
0.25
0.20
0.02
0.79
0.74
0.79
0.74
XXX91132
TC
C
Electrogastrography
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX91133

C
Electrogastrography w/test
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX91133
26
A
Electrogastrography w/test
0.66
0.30
0.25
0.30
0.25
0.03
0.99
0.94
0.99
0.94
XXX91133
TC
C
Electrogastrography w/test
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX91299

C
Gastroenterology procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX91299
26
C
Gastroenterology procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX91299
TC
C
Gastroenterology procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX92002

A
Eye exam, new patient
0.88
0.97
0.97
0.27
0.32
0.02
1.87
1.87
1.17
1.22
XXX92004

A
Eye exam, new patient
1.67
1.59
1.67
0.54
0.65
0.04
3.30
3.38
2.25
2.36
XXX92012

A
Eye exam established pat
0.67
0.94
1.01
0.24
0.28
0.02
1.63
1.70
0.93
0.97
XXX92014

A
Eye exam & treatment
1.10
1.32
1.39
0.38
0.45
0.03
2.45
2.52
1.51
1.58
XXX92015

N
Refraction
0.38
0.10
1.14
0.09
0.14
0.01
0.49
1.53
0.48
0.53
XXX92018

A
New eye exam & treatment
2.50
NA
NA
0.91
1.03
0.07
NA
NA
3.48
3.60
XXX92019

A
Eye exam & treatment
1.31
NA
NA
0.44
0.53
0.03
NA
NA
1.78
1.87
XXX92020

A
Special eye evaluation
0.37
0.26
0.32
0.13
0.15
0.01
0.64
0.70
0.51
0.53
XXX92060

A
Special eye evaluation
0.69
0.79
0.75
NA
NA
0.03
1.51
1.47
NA
NA
XXX92060
26
A
Special eye evaluation
0.69
0.23
0.28
0.23
0.28
0.02
0.94
0.99
0.94
0.99
XXX92060
TC
A
Special eye evaluation
0.00
0.56
0.47
NA
NA
0.01
0.57
0.48
NA
NA
XXX92065

A
Orthoptic/pleoptic training
0.37
0.89
0.62
NA
NA
0.02
1.28
1.01
NA
NA
XXX92065
26
A
Orthoptic/pleoptic training
0.37
0.09
0.14
0.09
0.14
0.01
0.47
0.52
0.47
0.52
XXX92065
TC
A
Orthoptic/pleoptic training
0.00
0.79
0.48
NA
NA
0.01
0.80
0.49
NA
NA
XXX92070

A
Fitting of contact lens
0.70
0.94
1.04
0.24
0.30
0.02
1.66
1.76
0.96
1.02
XXX92081

A
Visual field examination(s)
0.36
0.97
0.95
NA
NA
0.02
1.35
1.33
NA
NA
XXX92081
26
A
Visual field examination(s)
0.36
0.11
0.14
0.11
0.14
0.01
0.48
0.51
0.48
0.51
XXX92081
TC
A
Visual field examination(s)
0.00
0.86
0.81
NA
NA
0.01
0.87
0.82
NA
NA
XXX( print page 49216)92082

A
Visual field examination(s)
0.44
1.36
1.26
NA
NA
0.02
1.82
1.72
NA
NA
XXX92082
26
A
Visual field examination(s)
0.44
0.14
0.18
0.14
0.18
0.01
0.59
0.63
0.59
0.63
XXX92082
TC
A
Visual field examination(s)
0.00
1.22
1.09
NA
NA
0.01
1.23
1.10
NA
NA
XXX92083

A
Visual field examination(s)
0.50
1.56
1.46
NA
NA
0.02
2.08
1.98
NA
NA
XXX92083
26
A
Visual field examination(s)
0.50
0.17
0.21
0.17
0.21
0.01
0.68
0.72
0.68
0.72
XXX92083
TC
A
Visual field examination(s)
0.00
1.39
1.26
NA
NA
0.01
1.40
1.27
NA
NA
XXX92100

A
Serial tonometry exam(s)
0.92
1.28
1.33
0.29
0.34
0.02
2.22
2.27
1.23
1.28
XXX92120

A
Tonography & eye evaluation
0.81
1.00
1.05
0.26
0.31
0.02
1.83
1.88
1.09
1.14
XXX92130

A
Water provocation tonography
0.81
1.21
1.26
0.28
0.35
0.02
2.04
2.09
1.11
1.18
XXX92135

A
Opthalmic dx imaging
0.35
0.81
0.80
NA
NA
0.02
1.18
1.17
NA
NA
XXX92135
26
A
Opthalmic dx imaging
0.35
0.12
0.14
0.12
0.14
0.01
0.48
0.50
0.48
0.50
XXX92135
TC
A
Opthalmic dx imaging
0.00
0.69
0.65
NA
NA
0.01
0.70
0.66
NA
NA
XXX92136

A
Ophthalmic biometry
0.54
1.46
1.60
NA
NA
0.08
2.08
2.22
NA
NA
XXX92136
26
A
Ophthalmic biometry
0.54
0.20
0.23
0.20
0.23
0.01
0.75
0.78
0.75
0.78
XXX92136
TC
A
Ophthalmic biometry
0.00
1.26
1.37
NA
NA
0.07
1.33
1.44
NA
NA
XXX92140

A
Glaucoma provocative tests
0.50
0.92
0.97
0.15
0.20
0.01
1.43
1.48
0.66
0.71
XXX92225

A
Special eye exam, initial
0.38
0.25
0.23
0.13
0.15
0.01
0.64
0.62
0.52
0.54
XXX92226

A
Special eye exam, subsequent
0.33
0.24
0.22
0.12
0.14
0.01
0.58
0.56
0.46
0.48
XXX92230

A
Eye exam with photos
0.60
0.73
1.33
0.21
0.20
0.02
1.35
1.95
0.83
0.82
XXX92235

A
Eye exam with photos
0.81
2.33
2.54
NA
NA
0.08
3.22
3.43
NA
NA
XXX92235
26
A
Eye exam with photos
0.81
0.30
0.35
0.30
0.35
0.02
1.13
1.18
1.13
1.18
XXX92235
TC
A
Eye exam with photos
0.00
2.02
2.19
NA
NA
0.06
2.08
2.25
NA
NA
XXX92240

A
Icg angiography
1.10
4.51
5.70
NA
NA
0.09
5.70
6.89
NA
NA
XXX92240
26
A
Icg angiography
1.10
0.41
0.48
0.41
0.48
0.03
1.54
1.61
1.54
1.61
XXX92240
TC
A
Icg angiography
0.00
4.09
5.22
NA
NA
0.06
4.15
5.28
NA
NA
XXX92250

A
Eye exam with photos
0.44
1.34
1.48
NA
NA
0.02
1.80
1.94
NA
NA
XXX92250
26
A
Eye exam with photos
0.44
0.15
0.18
0.15
0.18
0.01
0.60
0.63
0.60
0.63
XXX92250
TC
A
Eye exam with photos
0.00
1.19
1.30
NA
NA
0.01
1.20
1.31
NA
NA
XXX92260

A
Ophthalmoscopy/dynamometry
0.20
0.23
0.25
0.07
0.09
0.01
0.44
0.46
0.28
0.30
XXX92265

A
Eye muscle evaluation
0.81
1.01
1.37
NA
NA
0.06
1.88
2.24
NA
NA
XXX92265
26
A
Eye muscle evaluation
0.81
0.24
0.27
0.24
0.27
0.04
1.09
1.12
1.09
1.12
XXX92265
TC
A
Eye muscle evaluation
0.00
0.76
1.10
NA
NA
0.02
0.78
1.12
NA
NA
XXX92270

A
Electro-oculography
0.81
1.42
1.50
NA
NA
0.05
2.28
2.36
NA
NA
XXX92270
26
A
Electro-oculography
0.81
0.24
0.31
0.24
0.31
0.03
1.08
1.15
1.08
1.15
XXX92270
TC
A
Electro-oculography
0.00
1.17
1.19
NA
NA
0.02
1.19
1.21
NA
NA
XXX92275

A
Electroretinography
1.01
2.48
2.07
NA
NA
0.05
3.54
3.13
NA
NA
XXX92275
26
A
Electroretinography
1.01
0.36
0.41
0.36
0.41
0.03
1.40
1.45
1.40
1.45
XXX92275
TC
A
Electroretinography
0.00
2.12
1.66
NA
NA
0.02
2.14
1.68
NA
NA
XXX92283

A
Color vision examination
0.17
1.02
0.89
NA
NA
0.02
1.21
1.08
NA
NA
XXX92283
26
A
Color vision examination
0.17
0.05
0.07
0.05
0.07
0.01
0.23
0.25
0.23
0.25
XXX92283
TC
A
Color vision examination
0.00
0.96
0.82
NA
NA
0.01
0.97
0.83
NA
NA
XXX92284

A
Dark adaptation eye exam
0.24
1.25
1.72
NA
NA
0.02
1.51
1.98
NA
NA
XXX92284
26
A
Dark adaptation eye exam
0.24
0.09
0.08
0.09
0.08
0.01
0.34
0.33
0.34
0.33
XXX92284
TC
A
Dark adaptation eye exam
0.00
1.16
1.64
NA
NA
0.01
1.17
1.65
NA
NA
XXX92285

A
Eye photography
0.20
0.82
0.95
NA
NA
0.02
1.04
1.17
NA
NA
XXX92285
26
A
Eye photography
0.20
0.07
0.09
0.07
0.09
0.01
0.28
0.30
0.28
0.30
XXX92285
TC
A
Eye photography
0.00
0.75
0.86
NA
NA
0.01
0.76
0.87
NA
NA
XXX92286

A
Internal eye photography
0.66
2.16
2.83
NA
NA
0.04
2.86
3.53
NA
NA
XXX92286
26
A
Internal eye photography
0.66
0.24
0.28
0.24
0.28
0.02
0.92
0.96
0.92
0.96
XXX92286
TC
A
Internal eye photography
0.00
1.92
2.55
NA
NA
0.02
1.94
2.57
NA
NA
XXX92287

A
Internal eye photography
0.81
1.98
2.28
0.30
0.31
0.02
2.81
3.11
1.13
1.14
XXX92310

N
Contact lens fitting
1.17
1.07
1.11
0.27
0.41
0.04
2.28
2.32
1.48
1.62
XXX92311

A
Contact lens fitting
1.08
1.31
1.15
0.32
0.34
0.03
2.42
2.26
1.43
1.45
XXX92312

A
Contact lens fitting
1.26
1.51
1.19
0.36
0.47
0.03
2.80
2.48
1.65
1.76
XXX92313

A
Contact lens fitting
0.92
1.49
1.17
0.33
0.30
0.02
2.43
2.11
1.27
1.24
XXX92314

N
Prescription of contact lens
0.69
1.15
0.99
0.16
0.24
0.01
1.85
1.69
0.86
0.94
XXX( print page 49217)92315

A
Prescription of contact lens
0.45
1.35
0.98
0.13
0.15
0.01
1.81
1.44
0.59
0.61
XXX92316

A
Prescription of contact lens
0.68
1.69
1.11
0.24
0.28
0.02
2.39
1.81
0.94
0.98
XXX92317

A
Prescription of contact lens
0.45
1.46
1.07
0.14
0.15
0.01
1.92
1.53
0.60
0.61
XXX92325

A
Modification of contact lens
0.00
0.85
0.51
NA
NA
0.01
0.86
0.52
NA
NA
XXX92326

A
Replacement of contact lens
0.00
0.76
1.41
NA
NA
0.06
0.82
1.47
NA
NA
XXX92340

N
Fitting of spectacles
0.37
0.45
0.64
0.09
0.13
0.01
0.83
1.02
0.47
0.51
XXX92341

N
Fitting of spectacles
0.47
0.47
0.67
0.11
0.16
0.01
0.95
1.15
0.59
0.64
XXX92342

N
Fitting of spectacles
0.53
0.48
0.69
0.12
0.19
0.01
1.02
1.23
0.66
0.73
XXX92352

B
Special spectacles fitting
0.37
0.57
0.65
0.09
0.13
0.01
0.95
1.03
0.47
0.51
XXX92353

B
Special spectacles fitting
0.50
0.60
0.70
0.12
0.17
0.02
1.12
1.22
0.64
0.69
XXX92354

B
Special spectacles fitting
0.00
0.29
6.72
NA
NA
0.10
0.39
6.82
NA
NA
XXX92355

B
Special spectacles fitting
0.00
0.45
3.36
NA
NA
0.01
0.46
3.37
NA
NA
XXX92358

B
Eye prosthesis service
0.00
0.24
0.79
NA
NA
0.05
0.29
0.84
NA
NA
XXX92370

N
Repair & adjust spectacles
0.32
0.39
0.51
0.07
0.12
0.02
0.73
0.85
0.41
0.46
XXX92371

B
Repair & adjust spectacles
0.00
0.24
0.53
NA
NA
0.02
0.26
0.55
NA
NA
XXX92499

C
Eye service or procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX92499
26
C
Eye service or procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX92499
TC
C
Eye service or procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX92502

A
Ear and throat examination
1.51
NA
NA
0.77
1.03
0.05
NA
NA
2.33
2.59
00092504

A
Ear microscopy examination
0.18
0.55
0.51
0.05
0.08
0.01
0.74
0.70
0.24
0.27
XXX92506

A
Speech/hearing evaluation
0.86
3.28
2.76
0.24
0.36
0.03
4.17
3.65
1.13
1.25
XXX92507

A
Speech/hearing therapy
0.52
1.19
1.13
0.14
0.21
0.02
1.73
1.67
0.68
0.75
XXX92508

A
Speech/hearing therapy
0.26
0.52
0.51
0.08
0.11
0.01
0.79
0.78
0.35
0.38
XXX92511

A
Nasopharyngoscopy
0.84
2.92
3.21
0.61
0.74
0.03
3.79
4.08
1.48
1.61
00092512

A
Nasal function studies
0.55
0.93
1.09
0.15
0.17
0.02
1.50
1.66
0.72
0.74
XXX92516

A
Facial nerve function test
0.43
1.15
1.19
0.12
0.20
0.01
1.59
1.63
0.56
0.64
XXX92520

A
Laryngeal function studies
0.75
0.91
0.61
0.23
0.35
0.03
1.69
1.39
1.01
1.13
XXX92526

A
Oral function therapy
0.55
1.68
1.65
0.16
0.19
0.02
2.25
2.22
0.73
0.76
XXX92541

A
Spontaneous nystagmus test
0.40
1.16
1.06
NA
NA
0.04
1.60
1.50
NA
NA
XXX92541
26
A
Spontaneous nystagmus test
0.40
0.12
0.17
0.12
0.17
0.02
0.54
0.59
0.54
0.59
XXX92541
TC
A
Spontaneous nystagmus test
0.00
1.04
0.89
NA
NA
0.02
1.06
0.91
NA
NA
XXX92542

A
Positional nystagmus test
0.33
1.30
1.18
NA
NA
0.03
1.66
1.54
NA
NA
XXX92542
26
A
Positional nystagmus test
0.33
0.10
0.15
0.10
0.15
0.01
0.44
0.49
0.44
0.49
XXX92542
TC
A
Positional nystagmus test
0.00
1.20
1.04
NA
NA
0.02
1.22
1.06
NA
NA
XXX92543

A
Caloric vestibular test
0.10
0.66
0.59
NA
NA
0.02
0.78
0.71
NA
NA
XXX92543
26
A
Caloric vestibular test
0.10
0.03
0.05
0.03
0.05
0.01
0.14
0.16
0.14
0.16
XXX92543
TC
A
Caloric vestibular test
0.00
0.63
0.55
NA
NA
0.01
0.64
0.56
NA
NA
XXX92544

A
Optokinetic nystagmus test
0.26
1.06
0.94
NA
NA
0.03
1.35
1.23
NA
NA
XXX92544
26
A
Optokinetic nystagmus test
0.26
0.08
0.11
0.08
0.11
0.01
0.35
0.38
0.35
0.38
XXX92544
TC
A
Optokinetic nystagmus test
0.00
0.98
0.83
NA
NA
0.02
1.00
0.85
NA
NA
XXX92545

A
Oscillating tracking test
0.23
1.03
0.86
NA
NA
0.03
1.29
1.12
NA
NA
XXX92545
26
A
Oscillating tracking test
0.23
0.07
0.10
0.07
0.10
0.01
0.31
0.34
0.31
0.34
XXX92545
TC
A
Oscillating tracking test
0.00
0.96
0.76
NA
NA
0.02
0.98
0.78
NA
NA
XXX92546

A
Sinusoidal rotational test
0.29
1.90
1.96
NA
NA
0.03
2.22
2.28
NA
NA
XXX92546
26
A
Sinusoidal rotational test
0.29
0.09
0.12
0.09
0.12
0.01
0.39
0.42
0.39
0.42
XXX92546
TC
A
Sinusoidal rotational test
0.00
1.81
1.84
NA
NA
0.02
1.83
1.86
NA
NA
XXX92547

A
Supplemental electrical test
0.00
0.11
0.09
0.11
0.09
0.06
0.17
0.15
0.17
0.15
ZZZ92548

A
Posturography
0.50
1.72
2.12
NA
NA
0.15
2.37
2.77
NA
NA
XXX92548
26
A
Posturography
0.50
0.15
0.23
0.15
0.23
0.02
0.67
0.75
0.67
0.75
XXX92548
TC
A
Posturography
0.00
1.57
1.89
NA
NA
0.13
1.70
2.02
NA
NA
XXX92552

A
Pure tone audiometry, air
0.00
0.56
0.47
NA
NA
0.04
0.60
0.51
NA
NA
XXX92553

A
Audiometry, air & bone
0.00
0.71
0.67
NA
NA
0.06
0.77
0.73
NA
NA
XXX92555

A
Speech threshold audiometry
0.00
0.38
0.38
NA
NA
0.04
0.42
0.42
NA
NA
XXX92556

A
Speech audiometry, complete
0.00
0.52
0.56
NA
NA
0.06
0.58
0.62
NA
NA
XXX92557

A
Comprehensive hearing test
0.00
1.27
1.21
NA
NA
0.12
1.39
1.33
NA
NA
XXX92561

A
Bekesy audiometry, diagnosis
0.00
0.79
0.74
NA
NA
0.06
0.85
0.80
NA
NA
XXX92562

A
Loudness balance test
0.00
0.67
0.48
NA
NA
0.04
0.71
0.52
NA
NA
XXX92563

A
Tone decay hearing test
0.00
0.53
0.42
NA
NA
0.04
0.57
0.46
NA
NA
XXX92564

A
Sisi hearing test
0.00
0.51
0.48
NA
NA
0.05
0.56
0.53
NA
NA
XXX92565

A
Stenger test, pure tone
0.00
0.27
0.37
NA
NA
0.04
0.31
0.41
NA
NA
XXX92567

A
Tympanometry
0.00
0.50
0.52
NA
NA
0.06
0.56
0.58
NA
NA
XXX92568

A
Acoustic refl threshold tst
0.00
0.15
0.32
NA
NA
0.04
0.19
0.36
NA
NA
XXX92569

A
Acoustic reflex decay test
0.00
0.16
0.35
NA
NA
0.04
0.20
0.39
NA
NA
XXX92571

A
Filtered speech hearing test
0.00
0.40
0.39
NA
NA
0.04
0.44
0.43
NA
NA
XXX92572

A
Staggered spondaic word test
0.00
0.61
0.22
NA
NA
0.01
0.62
0.23
NA
NA
XXX92573

A
Lombard test
0.00
0.49
0.39
NA
NA
0.04
0.53
0.43
NA
NA
XXX( print page 49218)92575

A
Sensorineural acuity test
0.00
1.10
0.50
NA
NA
0.02
1.12
0.52
NA
NA
XXX92576

A
Synthetic sentence test
0.00
0.54
0.47
NA
NA
0.05
0.59
0.52
NA
NA
XXX92577

A
Stenger test, speech
0.00
0.28
0.61
NA
NA
0.07
0.35
0.68
NA
NA
XXX92579

A
Visual audiometry (vra)
0.00
0.84
0.76
NA
NA
0.06
0.90
0.82
NA
NA
XXX92582

A
Conditioning play audiometry
0.00
1.08
0.82
NA
NA
0.06
1.14
0.88
NA
NA
XXX92583

A
Select picture audiometry
0.00
0.70
0.84
NA
NA
0.08
0.78
0.92
NA
NA
XXX92584

A
Electrocochleography
0.00
1.28
2.17
NA
NA
0.21
1.49
2.38
NA
NA
XXX92585

A
Auditor evoke potent, compre
0.50
2.01
2.05
NA
NA
0.17
2.68
2.72
NA
NA
XXX92585
26
A
Auditor evoke potent, compre
0.50
0.15
0.20
0.15
0.20
0.03
0.68
0.73
0.68
0.73
XXX92585
TC
A
Auditor evoke potent, compre
0.00
1.86
1.85
NA
NA
0.14
2.00
1.99
NA
NA
XXX92586

A
Auditor evoke potent, limit
0.00
1.41
1.74
NA
NA
0.14
1.55
1.88
NA
NA
XXX92587

A
Evoked auditory test
0.13
0.61
1.18
NA
NA
0.12
0.86
1.43
NA
NA
XXX92587
26
A
Evoked auditory test
0.13
0.04
0.06
0.04
0.06
0.01
0.18
0.20
0.18
0.20
XXX92587
TC
A
Evoked auditory test
0.00
0.58
1.13
NA
NA
0.11
0.69
1.24
NA
NA
XXX92588

A
Evoked auditory test
0.36
1.05
1.49
NA
NA
0.14
1.55
1.99
NA
NA
XXX92588
26
A
Evoked auditory test
0.36
0.11
0.15
0.11
0.15
0.01
0.48
0.52
0.48
0.52
XXX92588
TC
A
Evoked auditory test
0.00
0.95
1.34
NA
NA
0.13
1.08
1.47
NA
NA
XXX92596

A
Ear protector evaluation
0.00
0.93
0.68
NA
NA
0.06
0.99
0.74
NA
NA
XXX92597

A
Oral speech device eval
0.86
1.69
1.69
0.24
0.40
0.03
2.58
2.58
1.13
1.29
XXX92601

A
Cochlear implt f/up exam < 7
0.00
4.87
3.84
NA
NA
0.07
4.94
3.91
NA
NA
XXX92602

A
Reprogram cochlear implt < 7
0.00
3.34
2.62
NA
NA
0.07
3.41
2.69
NA
NA
XXX92603

A
Cochlear implt f/up exam 7 >
0.00
3.17
2.40
NA
NA
0.07
3.24
2.47
NA
NA
XXX92604

A
Reprogram cochlear implt 7 >
0.00
2.09
1.54
NA
NA
0.07
2.16
1.61
NA
NA
XXX92607

A
Ex for speech device rx, 1hr
0.00
4.28
3.38
NA
NA
0.05
4.33
3.43
NA
NA
XXX92608

A
Ex for speech device rx addl
0.00
0.87
0.63
NA
NA
0.05
0.92
0.68
NA
NA
XXX92609

A
Use of speech device service
0.00
2.30
1.77
NA
NA
0.04
2.34
1.81
NA
NA
XXX92610

A
Evaluate swallowing function
0.00
1.62
2.98
NA
NA
0.08
1.70
3.06
NA
NA
XXX92611

A
Motion fluoroscopy/swallow
0.00
1.90
3.05
NA
NA
0.08
1.98
3.13
NA
NA
XXX92612

A
Endoscopy swallow tst (fees)
1.27
2.74
2.74
0.36
0.59
0.04
4.05
4.05
1.67
1.90
XXX92613

A
Endoscopy swallow tst (fees)
0.71
0.22
0.36
0.22
0.35
0.05
0.98
1.12
0.98
1.11
XXX92614

A
Laryngoscopic sensory test
1.27
2.23
2.43
0.36
0.59
0.04
3.54
3.74
1.67
1.90
XXX92615

A
Eval laryngoscopy sense tst
0.63
0.18
0.31
0.18
0.31
0.05
0.86
0.99
0.86
0.99
XXX92616

A
Fees w/laryngeal sense test
1.88
2.91
3.27
0.53
0.88
0.06
4.85
5.21
2.47
2.82
XXX92617

A
Interprt fees/laryngeal test
0.79
0.22
0.39
0.22
0.39
0.05
1.06
1.23
1.06
1.23
XXX92620

A
Auditory function, 60 min
0.00
1.87
1.32
NA
NA
0.06
1.93
1.38
NA
NA
XXX92621

A
Auditory function, + 15 min
0.00
0.40
0.29
NA
NA
0.06
0.46
0.35
NA
NA
ZZZ92625

A
Tinnitus assessment
0.00
1.82
1.30
1.82
1.30
0.06
1.88
1.36
1.88
1.36
XXX92626

A
Eval aud rehab status
0.00
1.85
2.11
NA
NA
0.06
1.91
2.17
NA
NA
XXX92627

A
Eval aud status rehab add-on
0.00
0.42
0.52
0.42
0.52
0.02
0.44
0.54
0.44
0.54
ZZZ92700

C
Ent procedure/service
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX92950

A
Heart/lung resuscitation cpr
3.79
3.24
3.96
0.77
0.92
0.28
7.31
8.03
4.84
4.99
00092953

A
Temporary external pacing
0.23
NA
NA
0.07
0.07
0.02
NA
NA
0.32
0.32
00092960

A
Cardioversion electric, ext
2.25
4.42
5.84
1.47
1.25
0.07
6.74
8.16
3.79
3.57
00092961

A
Cardioversion, electric, int
4.59
NA
NA
2.49
2.18
0.29
NA
NA
7.37
7.06
00092970

A
Cardioassist, internal
3.51
NA
NA
1.61
1.20
0.16
NA
NA
5.28
4.87
00092971

A
Cardioassist, external
1.77
NA
NA
1.08
0.91
0.06
NA
NA
2.91
2.74
00092973

A
Percut coronary thrombectomy
3.28
NA
NA
1.79
1.42
0.23
NA
NA
5.30
4.93
ZZZ92974

A
Cath place, cardio brachytx
3.00
NA
NA
1.67
1.30
0.21
NA
NA
4.88
4.51
ZZZ92975

A
Dissolve clot, heart vessel
7.24
NA
NA
3.88
3.08
0.50
NA
NA
11.62
10.82
00092977

A
Dissolve clot, heart vessel
0.00
1.73
6.47
NA
NA
0.46
2.19
6.93
NA
NA
XXX92978

A
Intravasc us, heart add-on
1.80
NA
NA
NA
NA
0.30
NA
NA
NA
NA
ZZZ92978
26
A
Intravasc us, heart add-on
1.80
0.98
0.78
0.98
0.78
0.06
2.84
2.64
2.84
2.64
ZZZ92978
TC
A
Intravasc us, heart add-on
0.00
NA
NA
NA
NA
0.24
NA
NA
NA
NA
ZZZ92979

A
Intravasc us, heart add-on
1.44
NA
NA
NA
NA
0.19
NA
NA
NA
NA
ZZZ92979
26
A
Intravasc us, heart add-on
1.44
0.78
0.62
0.78
0.62
0.06
2.28
2.12
2.28
2.12
ZZZ92979
TC
A
Intravasc us, heart add-on
0.00
NA
NA
NA
NA
0.13
NA
NA
NA
NA
ZZZ( print page 49219)92980

A
Insert intracoronary stent
14.82
NA
NA
8.29
6.61
1.03
NA
NA
24.14
22.46
00092981

A
Insert intracoronary stent
4.16
NA
NA
2.27
1.79
0.29
NA
NA
6.72
6.24
ZZZ92982

A
Coronary artery dilation
10.96
NA
NA
6.20
4.95
0.76
NA
NA
17.92
16.67
00092984

A
Coronary artery dilation
2.97
NA
NA
1.61
1.27
0.21
NA
NA
4.79
4.45
ZZZ92986

A
Revision of aortic valve
22.64
NA
NA
15.66
12.79
1.51
NA
NA
39.81
36.94
09092987

A
Revision of mitral valve
23.42
NA
NA
16.09
13.18
1.59
NA
NA
41.10
38.19
09092990

A
Revision of pulmonary valve
18.06
NA
NA
11.18
10.14
1.20
NA
NA
30.44
29.40
09092992

C
Revision of heart chamber
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
09092993

C
Revision of heart chamber
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
09092995

A
Coronary atherectomy
12.07
NA
NA
6.81
5.42
0.84
NA
NA
19.72
18.33
00092996

A
Coronary atherectomy add-on
3.26
NA
NA
1.78
1.40
0.10
NA
NA
5.14
4.76
ZZZ92997

A
Pul art balloon repr, percut
11.98
NA
NA
5.18
4.91
0.40
NA
NA
17.56
17.29
00092998

A
Pul art balloon repr, percut
5.99
NA
NA
2.74
2.34
0.28
NA
NA
9.01
8.61
ZZZ93000

A
Electrocardiogram, complete
0.17
0.35
0.47
0.35
0.47
0.03
0.55
0.67
0.55
0.67
XXX93005

A
Electrocardiogram, tracing
0.00
0.28
0.41
NA
NA
0.02
0.30
0.43
NA
NA
XXX93010

A
Electrocardiogram report
0.17
0.07
0.06
0.07
0.06
0.01
0.25
0.24
0.25
0.24
XXX93012

A
Transmission of ecg
0.00
1.65
4.92
NA
NA
0.18
1.83
5.10
NA
NA
XXX93014

A
Report on transmitted ecg
0.52
0.21
0.20
0.21
0.20
0.02
0.75
0.74
0.75
0.74
XXX93015

A
Cardiovascular stress test
0.75
1.93
1.95
1.93
1.95
0.14
2.82
2.84
2.82
2.84
XXX93016

A
Cardiovascular stress test
0.45
0.23
0.19
0.23
0.19
0.02
0.70
0.66
0.70
0.66
XXX93017

A
Cardiovascular stress test
0.00
1.55
1.65
NA
NA
0.11
1.66
1.76
NA
NA
XXX93018

A
Cardiovascular stress test
0.30
0.15
0.12
0.15
0.12
0.01
0.46
0.43
0.46
0.43
XXX93024

A
Cardiac drug stress test
1.17
2.42
1.78
NA
NA
0.12
3.71
3.07
NA
NA
XXX93024
26
A
Cardiac drug stress test
1.17
0.59
0.49
0.59
0.49
0.04
1.80
1.70
1.80
1.70
XXX93024
TC
A
Cardiac drug stress test
0.00
1.84
1.30
NA
NA
0.08
1.92
1.38
NA
NA
XXX93025

A
Microvolt t-wave assess
0.75
3.94
6.68
NA
NA
0.14
4.83
7.57
NA
NA
XXX93025
26
A
Microvolt t-wave assess
0.75
0.38
0.31
0.38
0.31
0.03
1.16
1.09
1.16
1.09
XXX93025
TC
A
Microvolt t-wave assess
0.00
3.56
6.37
NA
NA
0.11
3.67
6.48
NA
NA
XXX93040

A
Rhythm ECG with report
0.16
0.19
0.20
0.19
0.20
0.02
0.37
0.38
0.37
0.38
XXX93041

A
Rhythm ECG, tracing
0.00
0.14
0.15
NA
NA
0.01
0.15
0.16
NA
NA
XXX93042

A
Rhythm ECG, report
0.16
0.05
0.05
0.05
0.05
0.01
0.22
0.22
0.22
0.22
XXX93224

A
ECG monitor/report, 24 hrs
0.52
1.99
3.21
1.99
3.21
0.24
2.75
3.97
2.75
3.97
XXX93225

A
ECG monitor/record, 24 hrs
0.00
1.08
1.20
NA
NA
0.08
1.16
1.28
NA
NA
XXX93226

A
ECG monitor/report, 24 hrs
0.00
0.62
1.79
NA
NA
0.14
0.76
1.93
NA
NA
XXX93227

A
ECG monitor/review, 24 hrs
0.52
0.28
0.21
0.28
0.21
0.02
0.82
0.75
0.82
0.75
XXX93230

A
ECG monitor/report, 24 hrs
0.52
1.79
3.37
1.79
3.37
0.26
2.57
4.15
2.57
4.15
XXX93231

A
Ecg monitor/record, 24 hrs
0.00
0.94
1.38
NA
NA
0.11
1.05
1.49
NA
NA
XXX93232

A
ECG monitor/report, 24 hrs
0.00
0.62
1.79
NA
NA
0.13
0.75
1.92
NA
NA
XXX93233

A
ECG monitor/review, 24 hrs
0.52
0.23
0.20
0.23
0.20
0.02
0.77
0.74
0.77
0.74
XXX93235

A
ECG monitor/report, 24 hrs
0.45
0.21
2.14
0.21
2.14
0.16
0.82
2.75
0.82
2.75
XXX93236

C
ECG monitor/report, 24 hrs
0.00
0.00
0.00
NA
NA
0.00
0.00
0.00
NA
NA
XXX93237

A
ECG monitor/review, 24 hrs
0.45
0.21
0.17
0.21
0.17
0.02
0.68
0.64
0.68
0.64
XXX93268

A
ECG record/review
0.52
0.83
5.79
0.83
5.79
0.28
1.63
6.59
1.63
6.59
XXX93270

A
ECG recording
0.00
0.31
1.01
NA
NA
0.08
0.39
1.09
NA
NA
XXX93271

A
Ecg/monitoring and analysis
0.00
1.99
5.01
NA
NA
0.18
2.17
5.19
NA
NA
XXX93272

A
Ecg/review, interpret only
0.52
0.24
0.20
0.24
0.20
0.02
0.78
0.74
0.78
0.74
XXX93278

A
ECG/signal-averaged
0.25
0.59
1.09
NA
NA
0.12
0.96
1.46
NA
NA
XXX93278
26
A
ECG/signal-averaged
0.25
0.10
0.10
0.10
0.10
0.01
0.36
0.36
0.36
0.36
XXX93278
TC
A
ECG/signal-averaged
0.00
0.49
0.99
NA
NA
0.11
0.60
1.10
NA
NA
XXX93303

A
Echo transthoracic
1.30
4.65
4.42
NA
NA
0.27
6.22
5.99
NA
NA
XXX93303
26
A
Echo transthoracic
1.30
0.57
0.50
0.57
0.50
0.04
1.91
1.84
1.91
1.84
XXX93303
TC
A
Echo transthoracic
0.00
4.07
3.91
NA
NA
0.23
4.30
4.14
NA
NA
XXX93304

A
Echo transthoracic
0.75
3.18
2.46
NA
NA
0.15
4.08
3.36
NA
NA
XXX93304
26
A
Echo transthoracic
0.75
0.31
0.29
0.31
0.29
0.02
1.08
1.06
1.08
1.06
XXX93304
TC
A
Echo transthoracic
0.00
2.87
2.17
NA
NA
0.13
3.00
2.30
NA
NA
XXX93307

A
Echo exam of heart
0.92
3.78
4.10
NA
NA
0.26
4.96
5.28
NA
NA
XXX93307
26
A
Echo exam of heart
0.92
0.46
0.38
0.46
0.38
0.03
1.41
1.33
1.41
1.33
XXX93307
TC
A
Echo exam of heart
0.00
3.32
3.73
NA
NA
0.23
3.55
3.96
NA
NA
XXX93308

A
Echo exam of heart
0.53
2.65
2.27
NA
NA
0.15
3.33
2.95
NA
NA
XXX93308
26
A
Echo exam of heart
0.53
0.27
0.22
0.27
0.22
0.02
0.82
0.77
0.82
0.77
XXX93308
TC
A
Echo exam of heart
0.00
2.38
2.05
NA
NA
0.13
2.51
2.18
NA
NA
XXX93312

A
Echo transesophageal
2.20
7.55
5.32
NA
NA
0.37
10.12
7.89
NA
NA
XXX93312
26
A
Echo transesophageal
2.20
1.01
0.85
1.01
0.85
0.08
3.29
3.13
3.29
3.13
XXX93312
TC
A
Echo transesophageal
0.00
6.54
4.47
NA
NA
0.29
6.83
4.76
NA
NA
XXX93313

A
Echo transesophageal
0.95
NA
NA
0.14
0.19
0.06
NA
NA
1.15
1.20
XXX93314

A
Echo transesophageal
1.25
7.28
5.01
NA
NA
0.33
8.86
6.59
NA
NA
XXX( print page 49220)93314
26
A
Echo transesophageal
1.25
0.57
0.50
0.57
0.50
0.04
1.86
1.79
1.86
1.79
XXX93314
TC
A
Echo transesophageal
0.00
6.71
4.51
NA
NA
0.29
7.00
4.80
NA
NA
XXX93315

C
Echo transesophageal
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX93315
26
A
Echo transesophageal
2.78
1.32
1.09
1.32
1.09
0.09
4.19
3.96
4.19
3.96
XXX93315
TC
C
Echo transesophageal
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX93316

A
Echo transesophageal
0.95
NA
NA
0.26
0.25
0.05
NA
NA
1.26
1.25
XXX93317

C
Echo transesophageal
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX93317
26
A
Echo transesophageal
1.83
0.74
0.69
0.74
0.69
0.08
2.65
2.60
2.65
2.60
XXX93317
TC
C
Echo transesophageal
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX93318

C
Echo transesophageal intraop
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX93318
26
A
Echo transesophageal intraop
2.20
0.89
0.58
0.89
0.58
0.14
3.23
2.92
3.23
2.92
XXX93318
TC
C
Echo transesophageal intraop
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX93320

A
Doppler echo exam, heart
0.38
1.70
1.81
1.70
1.81
0.13
2.21
2.32
2.21
2.32
ZZZ93320
26
A
Doppler echo exam, heart
0.38
0.19
0.16
0.19
0.16
0.01
0.58
0.55
0.58
0.55
ZZZ93320
TC
A
Doppler echo exam, heart
0.00
1.51
1.66
1.51
1.66
0.12
1.63
1.78
1.63
1.78
ZZZ93321

A
Doppler echo exam, heart
0.15
0.62
1.03
0.62
1.03
0.09
0.86
1.27
0.86
1.27
ZZZ93321
26
A
Doppler echo exam, heart
0.15
0.08
0.07
0.08
0.07
0.01
0.24
0.23
0.24
0.23
ZZZ93321
TC
A
Doppler echo exam, heart
0.00
0.55
0.97
0.55
0.97
0.08
0.63
1.05
0.63
1.05
ZZZ93325

A
Doppler color flow add-on
0.07
0.67
2.37
0.67
2.37
0.22
0.96
2.66
0.96
2.66
ZZZ93325
26
A
Doppler color flow add-on
0.07
0.04
0.03
0.04
0.03
0.01
0.12
0.11
0.12
0.11
ZZZ93325
TC
A
Doppler color flow add-on
0.00
0.64
2.34
0.64
2.34
0.21
0.85
2.55
0.85
2.55
ZZZ93350

A
Echo transthoracic
1.48
5.16
3.04
NA
NA
0.18
6.82
4.70
NA
NA
XXX93350
26
A
Echo transthoracic
1.48
0.78
0.62
0.78
0.62
0.05
2.31
2.15
2.31
2.15
XXX93350
TC
A
Echo transthoracic
0.00
4.38
2.42
NA
NA
0.13
4.51
2.55
NA
NA
XXX93501

A
Right heart catheterization
3.02
23.11
19.32
23.11
19.32
1.26
27.39
23.60
27.39
23.60
00093501
26
A
Right heart catheterization
3.02
1.61
1.27
1.61
1.27
0.21
4.84
4.50
4.84
4.50
00093501
TC
A
Right heart catheterization
0.00
21.49
18.05
21.49
18.05
1.05
22.54
19.10
22.54
19.10
00093503

A
Insert/place heart catheter
2.91
NA
NA
0.49
0.63
0.20
NA
NA
3.60
3.74
00093505

A
Biopsy of heart lining
4.37
25.12
9.03
25.12
9.03
0.46
29.95
13.86
29.95
13.86
00093505
26
A
Biopsy of heart lining
4.37
2.33
1.84
2.33
1.84
0.30
7.00
6.51
7.00
6.51
00093505
TC
A
Biopsy of heart lining
0.00
22.78
7.18
22.78
7.18
0.16
22.94
7.34
22.94
7.34
00093508

A
Cath placement, angiography
4.09
18.46
15.63
18.46
15.63
0.93
23.48
20.65
23.48
20.65
00093508
26
A
Cath placement, angiography
4.09
2.23
2.12
2.23
2.12
0.28
6.60
6.49
6.60
6.49
00093508
TC
A
Cath placement, angiography
0.00
16.23
13.51
16.23
13.51
0.65
16.88
14.16
16.88
14.16
00093510

C
Left heart catheterization
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
00093510
26
A
Left heart catheterization
4.32
2.35
2.22
2.35
2.22
0.30
6.97
6.84
6.97
6.84
00093510
TC
C
Left heart catheterization
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
00093511

C
Left heart catheterization
0.00
NA
NA
0.00
0.00
0.00
NA
NA
0.00
0.00
00093511
26
A
Left heart catheterization
5.02
2.66
2.50
2.66
2.50
0.35
8.03
7.87
8.03
7.87
00093511
TC
C
Left heart catheterization
0.00
NA
NA
0.00
0.00
0.00
NA
NA
0.00
0.00
00093514

C
Left heart catheterization
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
00093514
26
A
Left heart catheterization
7.04
3.22
3.15
3.22
3.15
0.49
10.75
10.68
10.75
10.68
00093514
TC
C
Left heart catheterization
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
00093524

C
Left heart catheterization
0.00
NA
NA
0.00
0.00
0.00
NA
NA
0.00
0.00
00093524
26
A
Left heart catheterization
6.94
3.72
3.31
3.72
3.31
0.48
11.14
10.73
11.14
10.73
00093524
TC
C
Left heart catheterization
0.00
NA
NA
0.00
0.00
0.00
NA
NA
0.00
0.00
00093526

C
Rt & Lt heart catheters
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
00093526
26
A
Rt & Lt heart catheters
5.98
3.25
2.92
3.25
2.92
0.42
9.65
9.32
9.65
9.32
00093526
TC
C
Rt & Lt heart catheters
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
00093527

C
Rt & Lt heart catheters
0.00
NA
NA
0.00
0.00
0.00
NA
NA
0.00
0.00
00093527
26
A
Rt & Lt heart catheters
7.27
3.99
3.48
3.99
3.48
0.51
11.77
11.26
11.77
11.26
00093527
TC
C
Rt & Lt heart catheters
0.00
NA
NA
0.00
0.00
0.00
NA
NA
0.00
0.00
00093528

C
Rt & Lt heart catheters
0.00
NA
NA
0.00
0.00
0.00
NA
NA
0.00
0.00
00093528
26
A
Rt & Lt heart catheters
8.99
4.69
4.20
4.69
4.20
0.62
14.30
13.81
14.30
13.81
00093528
TC
C
Rt & Lt heart catheters
0.00
NA
NA
0.00
0.00
0.00
NA
NA
0.00
0.00
00093529

C
Rt, lt heart catheterization
0.00
NA
NA
0.00
0.00
0.00
NA
NA
0.00
0.00
000( print page 49221)93529
26
A
Rt, lt heart catheterization
4.79
2.62
2.36
2.62
2.36
0.33
7.74
7.48
7.74
7.48
00093529
TC
C
Rt, lt heart catheterization
0.00
NA
NA
0.00
0.00
0.00
NA
NA
0.00
0.00
00093530

C
Rt heart cath, congenital
0.00
NA
NA
0.00
0.00
0.00
NA
NA
0.00
0.00
00093530
26
A
Rt heart cath, congenital
4.22
1.84
1.91
1.84
1.91
0.29
6.35
6.42
6.35
6.42
00093530
TC
C
Rt heart cath, congenital
0.00
NA
NA
0.00
0.00
0.00
NA
NA
0.00
0.00
00093531

C
R & l heart cath, congenital
0.00
NA
NA
0.00
0.00
0.00
NA
NA
0.00
0.00
00093531
26
A
R & l heart cath, congenital
8.34
3.72
3.62
3.72
3.62
0.58
12.64
12.54
12.64
12.54
00093531
TC
C
R & l heart cath, congenital
0.00
NA
NA
0.00
0.00
0.00
NA
NA
0.00
0.00
00093532

C
R & l heart cath, congenital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
00093532
26
A
R & l heart cath, congenital
9.99
4.60
4.34
4.60
4.34
0.69
15.28
15.02
15.28
15.02
00093532
TC
C
R & l heart cath, congenital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
00093533

C
R & l heart cath, congenital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
00093533
26
A
R & l heart cath, congenital
6.69
3.03
2.85
3.03
2.85
0.47
10.19
10.01
10.19
10.01
00093533
TC
C
R & l heart cath, congenital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
00093539

A
Injection, cardiac cath
0.40
NA
NA
0.22
0.18
0.01
NA
NA
0.63
0.59
00093540

A
Injection, cardiac cath
0.43
NA
NA
0.24
0.19
0.01
NA
NA
0.68
0.63
00093541

A
Injection for lung angiogram
0.29
NA
NA
0.15
0.12
0.01
NA
NA
0.45
0.42
00093542

A
Injection for heart x-rays
0.29
NA
NA
0.15
0.12
0.01
NA
NA
0.45
0.42
00093543

A
Injection for heart x-rays
0.29
NA
NA
0.16
0.12
0.01
NA
NA
0.46
0.42
00093544

A
Injection for aortography
0.25
NA
NA
0.14
0.11
0.01
NA
NA
0.40
0.37
00093545

A
Inject for coronary x-rays
0.40
NA
NA
0.22
0.18
0.01
NA
NA
0.63
0.59
00093555

A
Imaging, cardiac cath
0.81
0.65
5.11
NA
NA
0.37
1.83
6.29
NA
NA
XXX93555
26
A
Imaging, cardiac cath
0.81
0.44
0.35
0.44
0.35
0.03
1.28
1.19
1.28
1.19
XXX93555
TC
A
Imaging, cardiac cath
0.00
0.21
4.76
NA
NA
0.34
0.55
5.10
NA
NA
XXX93556

A
Imaging, cardiac cath
0.83
0.93
7.89
NA
NA
0.54
2.30
9.26
NA
NA
XXX93556
26
A
Imaging, cardiac cath
0.83
0.45
0.35
0.45
0.35
0.03
1.31
1.21
1.31
1.21
XXX93556
TC
A
Imaging, cardiac cath
0.00
0.48
7.54
NA
NA
0.51
0.99
8.05
NA
NA
XXX93561

A
Cardiac output measurement
0.50
NA
NA
NA
NA
0.08
NA
NA
NA
NA
00093561
26
A
Cardiac output measurement
0.50
0.14
0.16
0.14
0.16
0.02
0.66
0.68
0.66
0.68
00093561
TC
A
Cardiac output measurement
0.00
NA
NA
NA
NA
0.06
NA
NA
NA
NA
00093562

A
Cardiac output measurement
0.16
NA
NA
NA
NA
0.05
NA
NA
NA
NA
00093562
26
A
Cardiac output measurement
0.16
0.03
0.05
0.03
0.05
0.01
0.20
0.22
0.20
0.22
00093562
TC
A
Cardiac output measurement
0.00
NA
NA
NA
NA
0.04
NA
NA
NA
NA
00093571

A
Heart flow reserve measure
1.80
NA
NA
NA
NA
0.30
NA
NA
NA
NA
ZZZ93571
26
A
Heart flow reserve measure
1.80
0.98
0.76
0.98
0.76
0.06
2.84
2.62
2.84
2.62
ZZZ93571
TC
A
Heart flow reserve measure
0.00
NA
NA
NA
NA
0.24
NA
NA
NA
NA
ZZZ93572

C
Heart flow reserve measure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
ZZZ93572
26
A
Heart flow reserve measure
1.44
0.74
0.56
0.74
0.56
0.04
2.22
2.04
2.22
2.04
ZZZ93572
TC
C
Heart flow reserve measure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
ZZZ93580

A
Transcath closure of asd
17.97
NA
NA
9.50
7.91
1.25
NA
NA
28.72
27.13
00093581

A
Transcath closure of vsd
24.39
NA
NA
13.17
10.34
1.71
NA
NA
39.27
36.44
00093600

A
Bundle of His recording
2.12
NA
NA
NA
NA
0.29
NA
NA
NA
NA
00093600
26
A
Bundle of His recording
2.12
1.09
0.90
1.09
0.90
0.16
3.37
3.18
3.37
3.18
00093600
TC
A
Bundle of His recording
0.00
NA
NA
NA
NA
0.13
NA
NA
NA
NA
00093602

A
Intra-atrial recording
2.12
NA
NA
NA
NA
0.24
NA
NA
NA
NA
00093602
26
A
Intra-atrial recording
2.12
1.07
0.88
1.07
0.88
0.17
3.36
3.17
3.36
3.17
00093602
TC
A
Intra-atrial recording
0.00
NA
NA
NA
NA
0.07
NA
NA
NA
NA
00093603

A
Right ventricular recording
2.12
NA
NA
NA
NA
0.29
NA
NA
NA
NA
00093603
26
A
Right ventricular recording
2.12
1.06
0.87
1.06
0.87
0.18
3.36
3.17
3.36
3.17
00093603
TC
A
Right ventricular recording
0.00
NA
NA
NA
NA
0.11
NA
NA
NA
NA
00093609

A
Map tachycardia, add-on
4.99
NA
NA
NA
NA
0.52
NA
NA
NA
NA
ZZZ93609
26
A
Map tachycardia, add-on
4.99
2.68
2.13
2.68
2.13
0.35
8.02
7.47
8.02
7.47
ZZZ93609
TC
A
Map tachycardia, add-on
0.00
NA
NA
NA
NA
0.17
NA
NA
NA
NA
ZZZ93610

A
Intra-atrial pacing
3.02
NA
NA
NA
NA
0.34
NA
NA
NA
NA
00093610
26
A
Intra-atrial pacing
3.02
1.50
1.25
1.50
1.25
0.24
4.76
4.51
4.76
4.51
00093610
TC
A
Intra-atrial pacing
0.00
NA
NA
NA
NA
0.10
NA
NA
NA
NA
00093612

A
Intraventricular pacing
3.02
NA
NA
NA
NA
0.36
NA
NA
NA
NA
00093612
26
A
Intraventricular pacing
3.02
1.45
1.23
1.45
1.23
0.25
4.72
4.50
4.72
4.50
00093612
TC
A
Intraventricular pacing
0.00
NA
NA
NA
NA
0.11
NA
NA
NA
NA
00093613

A
Electrophys map 3d, add-on
6.99
NA
NA
3.78
3.02
0.49
NA
NA
11.26
10.50
ZZZ93615

A
Esophageal recording
0.99
NA
NA
NA
NA
0.05
NA
NA
NA
NA
00093615
26
A
Esophageal recording
0.99
0.49
0.33
0.49
0.33
0.03
1.51
1.35
1.51
1.35
00093615
TC
A
Esophageal recording
0.00
NA
NA
NA
NA
0.02
NA
NA
NA
NA
00093616

C
Esophageal recording
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
00093616
26
A
Esophageal recording
1.49
0.37
0.42
0.37
0.42
0.09
1.95
2.00
1.95
2.00
00093616
TC
C
Esophageal recording
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
000( print page 49222)93618

A
Heart rhythm pacing
4.25
NA
NA
NA
NA
0.54
NA
NA
NA
NA
00093618
26
A
Heart rhythm pacing
4.25
2.32
1.83
2.32
1.83
0.30
6.87
6.38
6.87
6.38
00093618
TC
A
Heart rhythm pacing
0.00
NA
NA
NA
NA
0.24
NA
NA
NA
NA
00093619

A
Electrophysiology evaluation
7.31
NA
NA
NA
NA
0.98
NA
NA
NA
NA
00093619
26
A
Electrophysiology evaluation
7.31
3.87
3.35
3.87
3.35
0.51
11.69
11.17
11.69
11.17
00093619
TC
A
Electrophysiology evaluation
0.00
NA
NA
NA
NA
0.47
NA
NA
NA
NA
00093620

C
Electrophysiology evaluation
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
00093620
26
A
Electrophysiology evaluation
11.57
6.24
5.19
6.24
5.19
0.80
18.61
17.56
18.61
17.56
00093620
TC
C
Electrophysiology evaluation
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
00093621

C
Electrophysiology evaluation
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
ZZZ93621
26
A
Electrophysiology evaluation
2.10
1.13
0.90
1.13
0.90
0.15
3.38
3.15
3.38
3.15
ZZZ93621
TC
C
Electrophysiology evaluation
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
ZZZ93622

C
Electrophysiology evaluation
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
ZZZ93622
26
A
Electrophysiology evaluation
3.10
1.68
1.33
1.68
1.33
0.22
5.00
4.65
5.00
4.65
ZZZ93622
TC
C
Electrophysiology evaluation
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
ZZZ93623

C
Stimulation, pacing heart
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
ZZZ93623
26
A
Stimulation, pacing heart
2.85
1.54
1.22
1.54
1.22
0.20
4.59
4.27
4.59
4.27
ZZZ93623
TC
C
Stimulation, pacing heart
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
ZZZ93624

A
Electrophysiologic study
4.80
NA
NA
.
4.18
0.46
NA
NA
5.26
9.44
00093624
26
A
Electrophysiologic study
4.80
2.63
2.30
2.63
2.30
0.33
7.76
7.43
7.76
7.43
00093624
TC
A
Electrophysiologic study
0.00
NA
NA
.
1.98
0.13
NA
NA
0.13
2.11
00093631

C
Heart pacing, mapping
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
00093631
26
A
Heart pacing, mapping
7.59
2.74
2.76
2.74
2.76
0.97
11.30
11.32
11.30
11.32
00093631
TC
C
Heart pacing, mapping
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
00093640

A
Evaluation heart device
3.51
NA
NA
NA
NA
0.66
NA
NA
NA
NA
00093640
26
A
Evaluation heart device
3.51
1.89
1.49
1.89
1.49
0.24
5.64
5.24
5.64
5.24
00093640
TC
A
Evaluation heart device
0.00
NA
NA
NA
NA
0.42
NA
NA
NA
NA
00093641

A
Electrophysiology evaluation
5.92
NA
NA
NA
NA
0.83
NA
NA
NA
NA
00093641
26
A
Electrophysiology evaluation
5.92
3.18
2.53
3.18
2.53
0.41
9.51
8.86
9.51
8.86
00093641
TC
A
Electrophysiology evaluation
0.00
NA
NA
NA
NA
0.42
NA
NA
NA
NA
00093642

A
Electrophysiology evaluation
4.88
7.45
8.90
7.45
8.90
0.57
12.90
14.35
12.90
14.35
00093642
26
A
Electrophysiology evaluation
4.88
2.63
2.32
2.63
2.32
0.15
7.66
7.35
7.66
7.35
00093642
TC
A
Electrophysiology evaluation
0.00
4.81
6.58
4.81
6.58
0.42
5.23
7.00
5.23
7.00
00093650

A
Ablate heart dysrhythm focus
10.49
NA
NA
5.97
4.82
0.73
NA
NA
17.19
16.04
00093651

A
Ablate heart dysrhythm focus
16.23
NA
NA
8.75
6.93
1.13
NA
NA
26.11
24.29
00093652

A
Ablate heart dysrhythm focus
17.65
NA
NA
9.52
7.54
1.23
NA
NA
28.40
26.42
00093660

A
Tilt table evaluation
1.89
3.05
2.57
3.05
2.57
0.08
5.02
4.54
5.02
4.54
00093660
26
A
Tilt table evaluation
1.89
0.99
0.80
0.99
0.80
0.06
2.94
2.75
2.94
2.75
00093660
TC
A
Tilt table evaluation
0.00
2.06
1.78
2.06
1.78
0.02
2.08
1.80
2.08
1.80
00093662

C
Intracardiac ecg (ice)
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
ZZZ93662
26
A
Intracardiac ecg (ice)
2.80
1.51
1.21
1.51
1.21
0.09
4.40
4.10
4.40
4.10
ZZZ93662
TC
C
Intracardiac ecg (ice)
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
ZZZ93701

A
Bioimpedance, thoracic
0.17
0.70
0.91
NA
NA
0.02
0.89
1.10
NA
NA
XXX93701
26
A
Bioimpedance, thoracic
0.17
0.06
0.07
0.06
0.07
0.01
0.24
0.25
0.24
0.25
XXX93701
TC
A
Bioimpedance, thoracic
0.00
0.64
0.84
NA
NA
0.01
0.65
0.85
NA
NA
XXX93720

A
Total body plethysmography
0.17
1.30
0.90
1.30
0.90
0.07
1.54
1.14
1.54
1.14
XXX93721

A
Plethysmography tracing
0.00
1.15
0.82
NA
NA
0.06
1.21
0.88
NA
NA
XXX93722

A
Plethysmography report
0.17
0.04
0.05
0.04
0.05
0.01
0.22
0.23
0.22
0.23
XXX93724

A
Analyze pacemaker system
4.88
3.49
5.28
3.49
5.28
0.39
8.76
10.55
8.76
10.55
00093724
26
A
Analyze pacemaker system
4.88
2.58
2.08
2.58
2.08
0.15
7.61
7.11
7.61
7.11
00093724
TC
A
Analyze pacemaker system
0.00
0.92
3.20
0.92
3.20
0.24
1.16
3.44
1.16
3.44
00093727

A
Analyze ilr system
0.52
0.65
0.31
0.65
0.31
0.02
1.19
0.85
1.19
0.85
XXX93731

A
Analyze pacemaker system
0.45
0.80
0.70
NA
NA
0.05
1.30
1.20
NA
NA
XXX93731
26
A
Analyze pacemaker system
0.45
0.24
0.19
0.24
0.19
0.01
0.70
0.65
0.70
0.65
XXX93731
TC
A
Analyze pacemaker system
0.00
0.56
0.51
NA
NA
0.04
0.60
0.55
NA
NA
XXX93732

A
Analyze pacemaker system
0.92
1.17
0.94
NA
NA
0.07
2.16
1.93
NA
NA
XXX( print page 49223)93732
26
A
Analyze pacemaker system
0.92
0.49
0.39
0.49
0.39
0.03
1.44
1.34
1.44
1.34
XXX93732
TC
A
Analyze pacemaker system
0.00
0.68
0.55
NA
NA
0.04
0.72
0.59
NA
NA
XXX93733

A
Telephone analy, pacemaker
0.17
0.32
0.68
NA
NA
0.07
0.56
0.92
NA
NA
XXX93733
26
A
Telephone analy, pacemaker
0.17
0.09
0.08
0.09
0.08
0.01
0.27
0.26
0.27
0.26
XXX93733
TC
A
Telephone analy, pacemaker
0.00
0.23
0.61
NA
NA
0.06
0.29
0.67
NA
NA
XXX93734

A
Analyze pacemaker system
0.38
0.71
0.55
NA
NA
0.03
1.12
0.96
NA
NA
XXX93734
26
A
Analyze pacemaker system
0.38
0.20
0.16
0.20
0.16
0.01
0.59
0.55
0.59
0.55
XXX93734
TC
A
Analyze pacemaker system
0.00
0.51
0.39
NA
NA
0.02
0.53
0.41
NA
NA
XXX93735

A
Analyze pacemaker system
0.74
0.97
0.78
NA
NA
0.06
1.77
1.58
NA
NA
XXX93735
26
A
Analyze pacemaker system
0.74
0.39
0.31
0.39
0.31
0.02
1.15
1.07
1.15
1.07
XXX93735
TC
A
Analyze pacemaker system
0.00
0.58
0.48
NA
NA
0.04
0.62
0.52
NA
NA
XXX93736

A
Telephonic analy, pacemaker
0.15
0.28
0.59
NA
NA
0.07
0.50
0.81
NA
NA
XXX93736
26
A
Telephonic analy, pacemaker
0.15
0.08
0.07
0.08
0.07
0.01
0.24
0.23
0.24
0.23
XXX93736
TC
A
Telephonic analy, pacemaker
0.00
0.21
0.53
NA
NA
0.06
0.27
0.59
NA
NA
XXX93740

B
Temperature gradient studies
0.16
0.04
0.15
NA
NA
0.02
0.22
0.33
NA
NA
XXX93740
26
B
Temperature gradient studies
0.16
0.04
0.04
0.04
0.04
0.01
0.21
0.21
0.21
0.21
XXX93740
TC
B
Temperature gradient studies
0.00
0.00
0.11
NA
NA
0.01
0.01
0.12
NA
NA
XXX93741

A
Analyze ht pace device sngl
0.80
1.04
1.00
NA
NA
0.07
1.91
1.87
NA
NA
XXX93741
26
A
Analyze ht pace device sngl
0.80
0.43
0.34
0.43
0.34
0.03
1.26
1.17
1.26
1.17
XXX93741
TC
A
Analyze ht pace device sngl
0.00
0.60
0.65
NA
NA
0.04
0.64
0.69
NA
NA
XXX93742

A
Analyze ht pace device sngl
0.91
1.17
1.07
NA
NA
0.07
2.15
2.05
NA
NA
XXX93742
26
A
Analyze ht pace device sngl
0.91
0.50
0.40
0.50
0.40
0.03
1.44
1.34
1.44
1.34
XXX93742
TC
A
Analyze ht pace device sngl
0.00
0.68
0.67
NA
NA
0.04
0.72
0.71
NA
NA
XXX93743

A
Analyze ht pace device dual
1.03
1.21
1.15
NA
NA
0.07
2.31
2.25
NA
NA
XXX93743
26
A
Analyze ht pace device dual
1.03
0.56
0.44
0.56
0.44
0.03
1.62
1.50
1.62
1.50
XXX93743
TC
A
Analyze ht pace device dual
0.00
0.65
0.71
NA
NA
0.04
0.69
0.75
NA
NA
XXX93744

A
Analyze ht pace device dual
1.18
1.36
1.19
NA
NA
0.08
2.62
2.45
NA
NA
XXX93744
26
A
Analyze ht pace device dual
1.18
0.64
0.51
0.64
0.51
0.04
1.86
1.73
1.86
1.73
XXX93744
TC
A
Analyze ht pace device dual
0.00
0.73
0.69
NA
NA
0.04
0.77
0.73
NA
NA
XXX93745

C
Set-up cardiovert-defibrill
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX93745
26
C
Set-up cardiovert-defibrill
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX93745
TC
C
Set-up cardiovert-defibrill
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX93770

B
Measure venous pressure
0.16
0.04
0.07
NA
NA
0.02
0.22
0.25
NA
NA
XXX93770
26
B
Measure venous pressure
0.16
0.04
0.05
0.04
0.05
0.01
0.21
0.22
0.21
0.22
XXX93770
TC
B
Measure venous pressure
0.00
0.00
0.02
NA
NA
0.01
0.01
0.03
NA
NA
XXX93784

A
Ambulatory BP monitoring
0.38
1.36
1.50
1.36
1.50
0.03
1.77
1.91
1.77
1.91
XXX93786

A
Ambulatory BP recording
0.00
1.09
0.96
NA
NA
0.01
1.10
0.97
NA
NA
XXX93788

A
Ambulatory BP analysis
0.00
0.73
0.57
NA
NA
0.01
0.74
0.58
NA
NA
XXX93790

A
Review/report BP recording
0.38
0.14
0.13
0.14
0.13
0.01
0.53
0.52
0.53
0.52
XXX93797

A
Cardiac rehab
0.18
0.32
0.31
0.09
0.08
0.01
0.51
0.50
0.28
0.27
00093798

A
Cardiac rehab/monitor
0.28
0.44
0.46
0.13
0.12
0.01
0.73
0.75
0.42
0.41
00093799

C
Cardiovascular procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX93799
26
C
Cardiovascular procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX93799
TC
C
Cardiovascular procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX93875

A
Extracranial study
0.22
2.65
2.41
NA
NA
0.12
2.99
2.75
NA
NA
XXX93875
26
A
Extracranial study
0.22
0.08
0.08
0.08
0.08
0.01
0.31
0.31
0.31
0.31
XXX93875
TC
A
Extracranial study
0.00
2.57
2.33
NA
NA
0.11
2.68
2.44
NA
NA
XXX93880

A
Extracranial study
0.60
6.23
5.72
NA
NA
0.39
7.22
6.71
NA
NA
XXX93880
26
A
Extracranial study
0.60
0.21
0.20
0.21
0.20
0.04
0.85
0.84
0.85
0.84
XXX93880
TC
A
Extracranial study
0.00
6.03
5.52
NA
NA
0.35
6.38
5.87
NA
NA
XXX93882

A
Extracranial study
0.40
4.17
3.67
NA
NA
0.26
4.83
4.33
NA
NA
XXX93882
26
A
Extracranial study
0.40
0.12
0.14
0.12
0.14
0.04
0.56
0.58
0.56
0.58
XXX93882
TC
A
Extracranial study
0.00
4.05
3.53
NA
NA
0.22
4.27
3.75
NA
NA
XXX93886

A
Intracranial study
0.94
7.31
6.88
NA
NA
0.45
8.70
8.27
NA
NA
XXX93886
26
A
Intracranial study
0.94
0.31
0.36
0.31
0.36
0.06
1.31
1.36
1.31
1.36
XXX93886
TC
A
Intracranial study
0.00
7.00
6.53
NA
NA
0.39
7.39
6.92
NA
NA
XXX93888

A
Intracranial study
0.62
4.91
4.41
NA
NA
0.32
5.85
5.35
NA
NA
XXX93888
26
A
Intracranial study
0.62
0.20
0.22
0.20
0.22
0.05
0.87
0.89
0.87
0.89
XXX93888
TC
A
Intracranial study
0.00
4.71
4.19
NA
NA
0.27
4.98
4.46
NA
NA
XXX93890

A
Tcd, vasoreactivity study
1.00
6.47
5.29
NA
NA
0.45
7.92
6.74
NA
NA
XXX93890
26
A
Tcd, vasoreactivity study
1.00
0.33
0.38
0.33
0.38
0.06
1.39
1.44
1.39
1.44
XXX93890
TC
A
Tcd, vasoreactivity study
0.00
6.13
4.91
NA
NA
0.39
6.52
5.30
NA
NA
XXX93892

A
Tcd, emboli detect w/o inj
1.15
7.00
5.62
NA
NA
0.45
8.60
7.22
NA
NA
XXX93892
26
A
Tcd, emboli detect w/o inj
1.15
0.38
0.44
0.38
0.44
0.06
1.59
1.65
1.59
1.65
XXX93892
TC
A
Tcd, emboli detect w/o inj
0.00
6.62
5.18
NA
NA
0.39
7.01
5.57
NA
NA
XXX93893

A
Tcd, emboli detect w/inj
1.15
6.67
5.44
NA
NA
0.45
8.27
7.04
NA
NA
XXX( print page 49224)93893
26
A
Tcd, emboli detect w/inj
1.15
0.38
0.44
0.38
0.44
0.06
1.59
1.65
1.59
1.65
XXX93893
TC
A
Tcd, emboli detect w/inj
0.00
6.29
5.00
NA
NA
0.39
6.68
5.39
NA
NA
XXX93922

A
Extremity study
0.25
3.16
2.80
NA
NA
0.15
3.56
3.20
NA
NA
XXX93922
26
A
Extremity study
0.25
0.08
0.08
0.08
0.08
0.02
0.35
0.35
0.35
0.35
XXX93922
TC
A
Extremity study
0.00
3.08
2.72
NA
NA
0.13
3.21
2.85
NA
NA
XXX93923

A
Extremity study
0.45
4.80
4.22
NA
NA
0.26
5.51
4.93
NA
NA
XXX93923
26
A
Extremity study
0.45
0.14
0.15
0.14
0.15
0.04
0.63
0.64
0.63
0.64
XXX93923
TC
A
Extremity study
0.00
4.66
4.08
NA
NA
0.22
4.88
4.30
NA
NA
XXX93924

A
Extremity study
0.50
6.06
5.11
NA
NA
0.30
6.86
5.91
NA
NA
XXX93924
26
A
Extremity study
0.50
0.17
0.17
0.17
0.17
0.05
0.72
0.72
0.72
0.72
XXX93924
TC
A
Extremity study
0.00
5.89
4.94
NA
NA
0.25
6.14
5.19
NA
NA
XXX93925

A
Lower extremity study
0.58
8.24
7.15
NA
NA
0.39
9.21
8.12
NA
NA
XXX93925
26
A
Lower extremity study
0.58
0.20
0.20
0.20
0.20
0.04
0.82
0.82
0.82
0.82
XXX93925
TC
A
Lower extremity study
0.00
8.04
6.95
NA
NA
0.35
8.39
7.30
NA
NA
XXX93926

A
Lower extremity study
0.39
5.25
4.35
NA
NA
0.27
5.91
5.01
NA
NA
XXX93926
26
A
Lower extremity study
0.39
0.12
0.13
0.12
0.13
0.04
0.55
0.56
0.55
0.56
XXX93926
TC
A
Lower extremity study
0.00
5.13
4.22
NA
NA
0.23
5.36
4.45
NA
NA
XXX93930

A
Upper extremity study
0.46
6.35
5.60
NA
NA
0.41
7.22
6.47
NA
NA
XXX93930
26
A
Upper extremity study
0.46
0.15
0.16
0.15
0.16
0.04
0.65
0.66
0.65
0.66
XXX93930
TC
A
Upper extremity study
0.00
6.20
5.44
NA
NA
0.37
6.57
5.81
NA
NA
XXX93931

A
Upper extremity study
0.31
4.32
3.69
NA
NA
0.27
4.90
4.27
NA
NA
XXX93931
26
A
Upper extremity study
0.31
0.10
0.10
0.10
0.10
0.03
0.44
0.44
0.44
0.44
XXX93931
TC
A
Upper extremity study
0.00
4.22
3.59
NA
NA
0.24
4.46
3.83
NA
NA
XXX93965

A
Extremity study
0.35
3.13
2.88
NA
NA
0.14
3.62
3.37
NA
NA
XXX93965
26
A
Extremity study
0.35
0.12
0.12
0.12
0.12
0.02
0.49
0.49
0.49
0.49
XXX93965
TC
A
Extremity study
0.00
3.02
2.76
NA
NA
0.12
3.14
2.88
NA
NA
XXX93970

A
Extremity study
0.68
6.32
5.51
NA
NA
0.46
7.46
6.65
NA
NA
XXX93970
26
A
Extremity study
0.68
0.21
0.23
0.21
0.23
0.06
0.95
0.97
0.95
0.97
XXX93970
TC
A
Extremity study
0.00
6.11
5.29
NA
NA
0.40
6.51
5.69
NA
NA
XXX93971

A
Extremity study
0.45
4.12
3.72
NA
NA
0.30
4.87
4.47
NA
NA
XXX93971
26
A
Extremity study
0.45
0.14
0.15
0.14
0.15
0.03
0.62
0.63
0.62
0.63
XXX93971
TC
A
Extremity study
0.00
3.98
3.58
NA
NA
0.27
4.25
3.85
NA
NA
XXX93975

A
Vascular study
1.80
8.56
7.86
NA
NA
0.56
10.92
10.22
NA
NA
XXX93975
26
A
Vascular study
1.80
0.62
0.61
0.62
0.61
0.13
2.55
2.54
2.55
2.54
XXX93975
TC
A
Vascular study
0.00
7.95
7.26
NA
NA
0.43
8.38
7.69
NA
NA
XXX93976

A
Vascular study
1.21
4.57
4.39
NA
NA
0.35
6.13
5.95
NA
NA
XXX93976
26
A
Vascular study
1.21
0.39
0.40
0.39
0.40
0.05
1.65
1.66
1.65
1.66
XXX93976
TC
A
Vascular study
0.00
4.18
3.99
NA
NA
0.30
4.48
4.29
NA
NA
XXX93978

A
Vascular study
0.65
6.15
4.92
NA
NA
0.43
7.23
6.00
NA
NA
XXX93978
26
A
Vascular study
0.65
0.23
0.22
0.23
0.22
0.06
0.94
0.93
0.94
0.93
XXX93978
TC
A
Vascular study
0.00
5.93
4.70
NA
NA
0.37
6.30
5.07
NA
NA
XXX93979

A
Vascular study
0.44
4.40
3.51
NA
NA
0.27
5.11
4.22
NA
NA
XXX93979
26
A
Vascular study
0.44
0.16
0.15
0.16
0.15
0.03
0.63
0.62
0.63
0.62
XXX93979
TC
A
Vascular study
0.00
4.23
3.35
NA
NA
0.24
4.47
3.59
NA
NA
XXX93980

A
Penile vascular study
1.25
3.49
3.01
NA
NA
0.42
5.16
4.68
NA
NA
XXX93980
26
A
Penile vascular study
1.25
0.44
0.42
0.44
0.42
0.08
1.77
1.75
1.77
1.75
XXX93980
TC
A
Penile vascular study
0.00
3.05
2.59
NA
NA
0.34
3.39
2.93
NA
NA
XXX93981

A
Penile vascular study
0.44
2.88
2.87
NA
NA
0.33
3.65
3.64
NA
NA
XXX93981
26
A
Penile vascular study
0.44
0.16
0.15
0.16
0.15
0.02
0.62
0.61
0.62
0.61
XXX93981
TC
A
Penile vascular study
0.00
2.71
2.73
NA
NA
0.31
3.02
3.04
NA
NA
XXX93990

A
Doppler flow testing
0.25
5.34
4.33
NA
NA
0.26
5.85
4.84
NA
NA
XXX93990
26
A
Doppler flow testing
0.25
0.07
0.09
0.07
0.09
0.03
0.35
0.37
0.35
0.37
XXX93990
TC
A
Doppler flow testing
0.00
5.27
4.24
NA
NA
0.23
5.50
4.47
NA
NA
XXX94010

A
Breathing capacity test
0.17
0.74
0.69
NA
NA
0.03
0.94
0.89
NA
NA
XXX94010
26
A
Breathing capacity test
0.17
0.04
0.05
0.04
0.05
0.01
0.22
0.23
0.22
0.23
XXX94010
TC
A
Breathing capacity test
0.00
0.70
0.64
NA
NA
0.02
0.72
0.66
NA
NA
XXX( print page 49225)94014

A
Patient recorded spirometry
0.52
0.93
0.80
0.93
0.80
0.03
1.48
1.35
1.48
1.35
XXX94015

A
Patient recorded spirometry
0.00
0.76
0.63
NA
NA
0.01
0.77
0.64
NA
NA
XXX94016

A
Review patient spirometry
0.52
0.17
0.17
0.17
0.17
0.02
0.71
0.71
0.71
0.71
XXX94060

A
Evaluation of wheezing
0.31
1.32
1.13
1.32
1.13
0.07
1.70
1.51
1.70
1.51
XXX94060
26
A
Evaluation of wheezing
0.31
0.08
0.09
0.08
0.09
0.01
0.40
0.41
0.40
0.41
XXX94060
TC
A
Evaluation of wheezing
0.00
1.24
1.05
1.24
1.05
0.06
1.30
1.11
1.30
1.11
XXX94070

A
Evaluation of wheezing
0.60
1.01
0.87
NA
NA
0.13
1.74
1.60
NA
NA
XXX94070
26
A
Evaluation of wheezing
0.60
0.15
0.17
0.15
0.17
0.03
0.78
0.80
0.78
0.80
XXX94070
TC
A
Evaluation of wheezing
0.00
0.85
0.69
NA
NA
0.10
0.95
0.79
NA
NA
XXX94150

B
Vital capacity test
0.07
0.48
0.47
NA
NA
0.02
0.57
0.56
NA
NA
XXX94150
26
B
Vital capacity test
0.07
0.02
0.03
0.02
0.03
0.01
0.10
0.11
0.10
0.11
XXX94150
TC
B
Vital capacity test
0.00
0.47
0.45
NA
NA
0.01
0.48
0.46
NA
NA
XXX94200

A
Lung function test (MBC/MVV)
0.11
0.51
0.46
NA
NA
0.03
0.65
0.60
NA
NA
XXX94200
26
A
Lung function test (MBC/MVV)
0.11
0.03
0.03
0.03
0.03
0.01
0.15
0.15
0.15
0.15
XXX94200
TC
A
Lung function test (MBC/MVV)
0.00
0.48
0.43
NA
NA
0.02
0.50
0.45
NA
NA
XXX94240

A
Residual lung capacity
0.26
0.84
0.71
NA
NA
0.06
1.16
1.03
NA
NA
XXX94240
26
A
Residual lung capacity
0.26
0.07
0.08
0.07
0.08
0.01
0.34
0.35
0.34
0.35
XXX94240
TC
A
Residual lung capacity
0.00
0.77
0.63
NA
NA
0.05
0.82
0.68
NA
NA
XXX94250

A
Expired gas collection
0.11
0.57
0.62
NA
NA
0.02
0.70
0.75
NA
NA
XXX94250
26
A
Expired gas collection
0.11
0.04
0.03
0.04
0.03
0.01
0.16
0.15
0.16
0.15
XXX94250
TC
A
Expired gas collection
0.00
0.53
0.59
NA
NA
0.01
0.54
0.60
NA
NA
XXX94260

A
Thoracic gas volume
0.13
0.77
0.63
NA
NA
0.05
0.95
0.81
NA
NA
XXX94260
26
A
Thoracic gas volume
0.13
0.03
0.04
0.03
0.04
0.01
0.17
0.18
0.17
0.18
XXX94260
TC
A
Thoracic gas volume
0.00
0.74
0.59
NA
NA
0.04
0.78
0.63
NA
NA
XXX94350

A
Lung nitrogen washout curve
0.26
0.67
0.74
NA
NA
0.05
0.98
1.05
NA
NA
XXX94350
26
A
Lung nitrogen washout curve
0.26
0.08
0.08
0.08
0.08
0.01
0.35
0.35
0.35
0.35
XXX94350
TC
A
Lung nitrogen washout curve
0.00
0.59
0.66
NA
NA
0.04
0.63
0.70
NA
NA
XXX94360

A
Measure airflow resistance
0.26
0.99
0.77
NA
NA
0.07
1.32
1.10
NA
NA
XXX94360
26
A
Measure airflow resistance
0.26
0.07
0.08
0.07
0.08
0.01
0.34
0.35
0.34
0.35
XXX94360
TC
A
Measure airflow resistance
0.00
0.92
0.70
NA
NA
0.06
0.98
0.76
NA
NA
XXX94370

A
Breath airway closing volume
0.26
0.67
0.71
NA
NA
0.03
0.96
1.00
NA
NA
XXX94370
26
A
Breath airway closing volume
0.26
0.09
0.08
0.09
0.08
0.01
0.36
0.35
0.36
0.35
XXX94370
TC
A
Breath airway closing volume
0.00
0.58
0.63
NA
NA
0.02
0.60
0.65
NA
NA
XXX94375

A
Respiratory flow volume loop
0.31
0.75
0.64
NA
NA
0.03
1.09
0.98
NA
NA
XXX94375
26
A
Respiratory flow volume loop
0.31
0.08
0.09
0.08
0.09
0.01
0.40
0.41
0.40
0.41
XXX94375
TC
A
Respiratory flow volume loop
0.00
0.66
0.55
NA
NA
0.02
0.68
0.57
NA
NA
XXX94400

A
CO2 breathing response curve
0.40
1.03
0.89
NA
NA
0.09
1.52
1.38
NA
NA
XXX94400
26
A
CO2 breathing response curve
0.40
0.10
0.12
0.10
0.12
0.03
0.53
0.55
0.53
0.55
XXX94400
TC
A
CO2 breathing response curve
0.00
0.93
0.77
NA
NA
0.06
0.99
0.83
NA
NA
XXX94450

A
Hypoxia response curve
0.40
1.03
0.90
NA
NA
0.04
1.47
1.34
NA
NA
XXX94450
26
A
Hypoxia response curve
0.40
0.09
0.11
0.09
0.11
0.02
0.51
0.53
0.51
0.53
XXX94450
TC
A
Hypoxia response curve
0.00
0.95
0.79
NA
NA
0.02
0.97
0.81
NA
NA
XXX94452

A
Hast w/report
0.31
1.21
1.07
NA
NA
0.04
1.56
1.42
NA
NA
XXX94452
26
A
Hast w/report
0.31
0.09
0.09
0.09
0.09
0.02
0.42
0.42
0.42
0.42
XXX94452
TC
A
Hast w/report
0.00
1.12
0.98
NA
NA
0.02
1.14
1.00
NA
NA
XXX94453

A
Hast w/oxygen titrate
0.40
1.69
1.56
NA
NA
0.04
2.13
2.00
NA
NA
XXX94453
26
A
Hast w/oxygen titrate
0.40
0.11
0.12
0.11
0.12
0.02
0.53
0.54
0.53
0.54
XXX94453
TC
A
Hast w/oxygen titrate
0.00
1.58
1.44
NA
NA
0.02
1.60
1.46
NA
NA
XXX94620

A
Pulmonary stress test/simple
0.64
0.88
2.09
NA
NA
0.13
1.65
2.86
NA
NA
XXX94620
26
A
Pulmonary stress test/simple
0.64
0.20
0.20
0.20
0.20
0.03
0.87
0.87
0.87
0.87
XXX94620
TC
A
Pulmonary stress test/simple
0.00
0.68
1.89
NA
NA
0.10
0.78
1.99
NA
NA
XXX94621

A
Pulm stress test/complex
1.42
3.18
2.45
NA
NA
0.16
4.76
4.03
NA
NA
XXX94621
26
A
Pulm stress test/complex
1.42
0.45
0.44
0.45
0.44
0.06
1.93
1.92
1.93
1.92
XXX94621
TC
A
Pulm stress test/complex
0.00
2.73
2.00
NA
NA
0.10
2.83
2.10
NA
NA
XXX94640

A
Airway inhalation treatment
0.00
0.37
0.32
NA
NA
0.02
0.39
0.34
NA
NA
XXX94642

C
Aerosol inhalation treatment
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX94656

A
Initial ventilator mgmt
1.22
1.12
1.15
0.24
0.30
0.06
2.40
2.43
1.52
1.58
XXX94657

A
Continued ventilator mgmt
0.83
1.15
1.02
0.19
0.24
0.04
2.02
1.89
1.06
1.11
XXX94660

A
Pos airway pressure, CPAP
0.76
0.82
0.69
0.20
0.22
0.04
1.62
1.49
1.00
1.02
XXX94662

A
Neg press ventilation, cnp
0.76
NA
NA
0.18
0.22
0.03
NA
NA
0.97
1.01
XXX94664

A
Evaluate pt use of inhaler
0.00
0.40
0.33
NA
NA
0.04
0.44
0.37
NA
NA
XXX94667

A
Chest wall manipulation
0.00
0.55
0.53
NA
NA
0.05
0.60
0.58
NA
NA
XXX94668

A
Chest wall manipulation
0.00
0.51
0.47
NA
NA
0.02
0.53
0.49
NA
NA
XXX94680

A
Exhaled air analysis, o2
0.26
1.11
1.67
1.11
1.67
0.07
1.44
2.00
1.44
2.00
XXX94680
26
A
Exhaled air analysis, o2
0.26
0.07
0.08
0.07
0.08
0.01
0.34
0.35
0.34
0.35
XXX94680
TC
A
Exhaled air analysis, o2
0.00
1.04
1.60
1.04
1.60
0.06
1.10
1.66
1.10
1.66
XXX( print page 49226)94681

A
Exhaled air analysis, o2/co2
0.20
1.10
2.17
NA
NA
0.13
1.43
2.50
NA
NA
XXX94681
26
A
Exhaled air analysis, o2/co2
0.20
0.05
0.06
0.05
0.06
0.01
0.26
0.27
0.26
0.27
XXX94681
TC
A
Exhaled air analysis, o2/co2
0.00
1.04
2.11
NA
NA
0.12
1.16
2.23
NA
NA
XXX94690

A
Exhaled air analysis
0.07
0.89
1.72
NA
NA
0.05
1.01
1.84
NA
NA
XXX94690
26
A
Exhaled air analysis
0.07
0.02
0.02
0.02
0.02
0.01
0.10
0.10
0.10
0.10
XXX94690
TC
A
Exhaled air analysis
0.00
0.87
1.70
NA
NA
0.04
0.91
1.74
NA
NA
XXX94720

A
Monoxide diffusing capacity
0.26
1.18
1.05
NA
NA
0.07
1.51
1.38
NA
NA
XXX94720
26
A
Monoxide diffusing capacity
0.26
0.06
0.08
0.06
0.08
0.01
0.33
0.35
0.33
0.35
XXX94720
TC
A
Monoxide diffusing capacity
0.00
1.11
0.97
NA
NA
0.06
1.17
1.03
NA
NA
XXX94725

A
Membrane diffusion capacity
0.26
1.10
2.46
NA
NA
0.13
1.49
2.85
NA
NA
XXX94725
26
A
Membrane diffusion capacity
0.26
0.09
0.08
0.09
0.08
0.01
0.36
0.35
0.36
0.35
XXX94725
TC
A
Membrane diffusion capacity
0.00
1.01
2.38
NA
NA
0.12
1.13
2.50
NA
NA
XXX94750

A
Pulmonary compliance study
0.23
1.90
1.48
NA
NA
0.05
2.18
1.76
NA
NA
XXX94750
26
A
Pulmonary compliance study
0.23
0.08
0.07
0.08
0.07
0.01
0.32
0.31
0.32
0.31
XXX94750
TC
A
Pulmonary compliance study
0.00
1.82
1.41
NA
NA
0.04
1.86
1.45
NA
NA
XXX94760

T
Measure blood oxygen level
0.00
0.06
0.05
NA
NA
0.02
0.08
0.07
NA
NA
XXX94761

T
Measure blood oxygen level
0.00
0.12
0.08
NA
NA
0.06
0.18
0.14
NA
NA
XXX94762

A
Measure blood oxygen level
0.00
0.96
0.59
NA
NA
0.10
1.06
0.69
NA
NA
XXX94770

A
Exhaled carbon dioxide test
0.15
0.85
0.78
NA
NA
0.08
1.08
1.01
NA
NA
XXX94770
26
A
Exhaled carbon dioxide test
0.15
0.04
0.04
0.04
0.04
0.01
0.20
0.20
0.20
0.20
XXX94770
TC
A
Exhaled carbon dioxide test
0.00
0.81
0.74
NA
NA
0.07
0.88
0.81
NA
NA
XXX94772

C
Breath recording, infant
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX94772
26
C
Breath recording, infant
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX94772
TC
C
Breath recording, infant
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX94799

C
Pulmonary service/procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX94799
26
C
Pulmonary service/procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX94799
TC
C
Pulmonary service/procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX95004

A
Percut allergy skin tests
0.00
0.16
0.12
NA
NA
0.01
0.17
0.13
NA
NA
XXX95010

A
Percut allergy titrate test
0.15
0.30
0.32
0.04
0.06
0.01
0.46
0.48
0.20
0.22
XXX95015

A
Id allergy titrate-drug/bug
0.15
0.20
0.16
0.04
0.06
0.01
0.36
0.32
0.20
0.22
XXX95024

A
Id allergy test, drug/bug
0.00
0.21
0.17
NA
NA
0.01
0.22
0.18
NA
NA
XXX95027

A
Id allergy titrate-airborne
0.00
0.24
0.17
NA
NA
0.01
0.25
0.18
NA
NA
XXX95028

A
Id allergy test-delayed type
0.00
0.29
0.25
NA
NA
0.01
0.30
0.26
NA
NA
XXX95044

A
Allergy patch tests
0.00
0.15
0.19
NA
NA
0.01
0.16
0.20
NA
NA
XXX95052

A
Photo patch test
0.00
0.15
0.23
NA
NA
0.01
0.16
0.24
NA
NA
XXX95056

A
Photosensitivity tests
0.00
1.18
0.42
NA
NA
0.01
1.19
0.43
NA
NA
XXX95060

A
Eye allergy tests
0.00
0.75
0.45
NA
NA
0.02
0.77
0.47
NA
NA
XXX95065

A
Nose allergy test
0.00
0.67
0.32
NA
NA
0.01
0.68
0.33
NA
NA
XXX95070

A
Bronchial allergy tests
0.00
0.80
1.91
NA
NA
0.02
0.82
1.93
NA
NA
XXX95071

A
Bronchial allergy tests
0.00
0.89
2.41
NA
NA
0.02
0.91
2.43
NA
NA
XXX95075

A
Ingestion challenge test
0.95
0.67
0.78
0.25
0.35
0.03
1.65
1.76
1.23
1.33
XXX95078

A
Provocative testing
0.00
0.33
0.27
NA
NA
0.02
0.35
0.29
NA
NA
XXX95115

A
Immunotherapy, one injection
0.00
0.22
0.35
0.00
0.29
0.02
0.24
0.37
0.02
0.31
XXX95117

A
Immunotherapy injections
0.00
0.27
0.44
0.00
0.38
0.02
0.29
0.46
0.02
0.40
XXX95144

A
Antigen therapy services
0.06
0.26
0.21
0.02
0.02
0.01
0.33
0.28
0.09
0.09
XXX95145

A
Antigen therapy services
0.06
0.35
0.33
0.02
0.02
0.01
0.42
0.40
0.09
0.09
XXX95146

A
Antigen therapy services
0.06
0.66
0.50
0.02
0.03
0.01
0.73
0.57
0.09
0.10
XXX95147

A
Antigen therapy services
0.06
0.64
0.48
0.02
0.02
0.01
0.71
0.55
0.09
0.09
XXX95148

A
Antigen therapy services
0.06
0.94
0.67
0.02
0.03
0.01
1.01
0.74
0.09
0.10
XXX95149

A
Antigen therapy services
0.06
1.25
0.91
0.02
0.03
0.01
1.32
0.98
0.09
0.10
XXX95165

A
Antigen therapy services
0.06
0.25
0.21
0.02
0.02
0.01
0.32
0.28
0.09
0.09
XXX95170

A
Antigen therapy services
0.06
0.20
0.15
0.02
0.03
0.01
0.27
0.22
0.09
0.10
XXX95180

A
Rapid desensitization
2.01
1.57
1.92
0.71
0.88
0.04
3.62
3.97
2.76
2.93
XXX95199

C
Allergy immunology services
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX95250

A
Glucose monitoring, cont
0.00
3.53
3.96
NA
NA
0.01
3.54
3.97
NA
NA
XXX95251

A
Gluc monitor, cont, phys i&r
0.52
0.16
0.18
0.16
0.18
0.02
0.70
0.72
0.70
0.72
XXX( print page 49227)95805

A
Multiple sleep latency test
1.88
7.27
14.76
NA
NA
0.43
9.58
17.07
NA
NA
XXX95805
26
A
Multiple sleep latency test
1.88
0.51
0.62
0.51
0.62
0.09
2.48
2.59
2.48
2.59
XXX95805
TC
A
Multiple sleep latency test
0.00
6.76
14.14
NA
NA
0.34
7.10
14.48
NA
NA
XXX95806

A
Sleep study, unattended
1.66
4.02
3.50
NA
NA
0.39
6.07
5.55
NA
NA
XXX95806
26
A
Sleep study, unattended
1.66
0.50
0.53
0.50
0.53
0.08
2.24
2.27
2.24
2.27
XXX95806
TC
A
Sleep study, unattended
0.00
3.52
2.97
NA
NA
0.31
3.83
3.28
NA
NA
XXX95807

A
Sleep study, attended
1.66
12.81
12.09
NA
NA
0.50
14.97
14.25
NA
NA
XXX95807
26
A
Sleep study, attended
1.66
0.51
0.53
0.51
0.53
0.08
2.25
2.27
2.25
2.27
XXX95807
TC
A
Sleep study, attended
0.00
12.30
11.57
NA
NA
0.42
12.72
11.99
NA
NA
XXX95808

A
Polysomnography, 1-3
2.65
15.72
13.82
NA
NA
0.55
18.92
17.02
NA
NA
XXX95808
26
A
Polysomnography, 1-3
2.65
0.69
0.86
0.69
0.86
0.13
3.47
3.64
3.47
3.64
XXX95808
TC
A
Polysomnography, 1-3
0.00
15.03
12.96
NA
NA
0.42
15.45
13.38
NA
NA
XXX95810

A
Polysomnography, 4 or more
3.52
18.60
17.77
NA
NA
0.59
22.71
21.88
NA
NA
XXX95810
26
A
Polysomnography, 4 or more
3.52
0.98
1.13
0.98
1.13
0.17
4.67
4.82
4.67
4.82
XXX95810
TC
A
Polysomnography, 4 or more
0.00
17.62
16.64
NA
NA
0.42
18.04
17.06
NA
NA
XXX95811

A
Polysomnography w/cpap
3.79
20.70
19.56
NA
NA
0.61
25.10
23.96
NA
NA
XXX95811
26
A
Polysomnography w/cpap
3.79
1.05
1.22
1.05
1.22
0.18
5.02
5.19
5.02
5.19
XXX95811
TC
A
Polysomnography w/cpap
0.00
19.66
18.36
NA
NA
0.43
20.09
18.79
NA
NA
XXX95812

A
Eeg, 41-60 minutes
1.08
5.90
4.50
NA
NA
0.17
7.15
5.75
NA
NA
XXX95812
26
A
Eeg, 41-60 minutes
1.08
0.31
0.42
0.31
0.42
0.06
1.45
1.56
1.45
1.56
XXX95812
TC
A
Eeg, 41-60 minutes
0.00
5.59
4.08
NA
NA
0.11
5.70
4.19
NA
NA
XXX95813

A
Eeg, over 1 hour
1.73
6.64
5.43
NA
NA
0.20
8.57
7.36
NA
NA
XXX95813
26
A
Eeg, over 1 hour
1.73
0.50
0.65
0.50
0.65
0.09
2.32
2.47
2.32
2.47
XXX95813
TC
A
Eeg, over 1 hour
0.00
6.14
4.78
NA
NA
0.11
6.25
4.89
NA
NA
XXX95816

A
Eeg, awake and drowsy
1.08
5.30
4.11
NA
NA
0.16
6.54
5.35
NA
NA
XXX95816
26
A
Eeg, awake and drowsy
1.08
0.30
0.42
0.30
0.42
0.06
1.44
1.56
1.44
1.56
XXX95816
TC
A
Eeg, awake and drowsy
0.00
4.99
3.69
NA
NA
0.10
5.09
3.79
NA
NA
XXX95819

A
Eeg, awake and asleep
1.08
6.15
3.77
NA
NA
0.16
7.39
5.01
NA
NA
XXX95819
26
A
Eeg, awake and asleep
1.08
0.30
0.42
0.30
0.42
0.06
1.44
1.56
1.44
1.56
XXX95819
TC
A
Eeg, awake and asleep
0.00
5.84
3.35
NA
NA
0.10
5.94
3.45
NA
NA
XXX95822

A
Eeg, coma or sleep only
1.08
5.53
4.83
NA
NA
0.19
6.80
6.10
NA
NA
XXX95822
26
A
Eeg, coma or sleep only
1.08
0.30
0.42
0.30
0.42
0.06
1.44
1.56
1.44
1.56
XXX95822
TC
A
Eeg, coma or sleep only
0.00
5.23
4.41
NA
NA
0.13
5.36
4.54
NA
NA
XXX95824

C
Eeg, cerebral death only
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX95824
26
A
Eeg, cerebral death only
0.74
0.21
0.29
0.21
0.29
0.04
0.99
1.07
0.99
1.07
XXX95824
TC
C
Eeg, cerebral death only
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX95827

A
Eeg, all night recording
1.08
11.57
4.92
NA
NA
0.19
12.84
6.19
NA
NA
XXX95827
26
A
Eeg, all night recording
1.08
0.29
0.38
0.29
0.38
0.05
1.42
1.51
1.42
1.51
XXX95827
TC
A
Eeg, all night recording
0.00
11.28
4.54
NA
NA
0.14
11.42
4.68
NA
NA
XXX95829

A
Surgery electrocorticogram
6.20
25.44
29.61
NA
NA
0.50
32.14
36.31
NA
NA
XXX95829
26
A
Surgery electrocorticogram
6.20
1.79
2.18
1.79
2.18
0.48
8.47
8.86
8.47
8.86
XXX95829
TC
A
Surgery electrocorticogram
0.00
23.65
27.43
NA
NA
0.02
23.67
27.45
NA
NA
XXX95830

A
Insert electrodes for EEG
1.70
2.99
3.22
0.42
0.65
0.11
4.80
5.03
2.23
2.46
XXX95831

A
Limb muscle testing, manual
0.28
0.39
0.44
0.09
0.12
0.01
0.68
0.73
0.38
0.41
XXX95832

A
Hand muscle testing, manual
0.29
0.37
0.34
0.10
0.12
0.02
0.68
0.65
0.41
0.43
XXX95833

A
Body muscle testing, manual
0.47
0.47
0.55
0.13
0.21
0.02
0.96
1.04
0.62
0.70
XXX95834

A
Body muscle testing, manual
0.60
0.55
0.61
0.18
0.26
0.03
1.18
1.24
0.81
0.89
XXX95851

A
Range of motion measurements
0.16
0.26
0.34
0.04
0.07
0.01
0.43
0.51
0.21
0.24
XXX95852

A
Range of motion measurements
0.11
0.21
0.25
0.03
0.05
0.01
0.33
0.37
0.15
0.17
XXX95857

A
Tensilon test
0.53
0.59
0.60
0.16
0.21
0.02
1.14
1.15
0.71
0.76
XXX95860

A
Muscle test, one limb
0.96
1.16
1.36
NA
NA
0.07
2.19
2.39
NA
NA
XXX95860
26
A
Muscle test, one limb
0.96
0.32
0.40
0.32
0.40
0.05
1.33
1.41
1.33
1.41
XXX95860
TC
A
Muscle test, one limb
0.00
0.84
0.96
NA
NA
0.02
0.86
0.98
NA
NA
XXX95861

A
Muscle test, 2 limbs
1.54
1.67
1.48
NA
NA
0.13
3.34
3.15
NA
NA
XXX95861
26
A
Muscle test, 2 limbs
1.54
0.51
0.64
0.51
0.64
0.07
2.12
2.25
2.12
2.25
XXX95861
TC
A
Muscle test, 2 limbs
0.00
1.16
0.84
NA
NA
0.06
1.22
0.90
NA
NA
XXX95863

A
Muscle test, 3 limbs
1.87
1.94
1.78
NA
NA
0.15
3.96
3.80
NA
NA
XXX95863
26
A
Muscle test, 3 limbs
1.87
0.58
0.75
0.58
0.75
0.09
2.54
2.71
2.54
2.71
XXX95863
TC
A
Muscle test, 3 limbs
0.00
1.36
1.05
NA
NA
0.06
1.42
1.11
NA
NA
XXX95864

A
Muscle test, 4 limbs
1.99
2.20
2.54
NA
NA
0.21
4.40
4.74
NA
NA
XXX95864
26
A
Muscle test, 4 limbs
1.99
0.63
0.81
0.63
0.81
0.09
2.71
2.89
2.71
2.89
XXX95864
TC
A
Muscle test, 4 limbs
0.00
1.57
1.73
NA
NA
0.12
1.69
1.85
NA
NA
XXX95865

A
Muscle test, larynx
1.57
1.34
1.42
NA
NA
0.11
3.02
3.10
NA
NA
XXX95865
26
A
Muscle test, larynx
1.57
0.46
0.69
0.46
0.69
0.08
2.11
2.34
2.11
2.34
XXX95865
TC
A
Muscle test, larynx
0.00
0.88
0.73
NA
NA
0.03
0.91
0.76
NA
NA
XXX95866

A
Muscle test, hemidiaphragm
1.25
1.34
0.91
NA
NA
0.10
2.69
2.26
NA
NA
XXX( print page 49228)95866
26
A
Muscle test, hemidiaphragm
1.25
0.40
0.52
0.40
0.52
0.07
1.72
1.84
1.72
1.84
XXX95866
TC
A
Muscle test, hemidiaphragm
0.00
0.94
0.39
NA
NA
0.03
0.97
0.42
NA
NA
XXX95867

A
Muscle test cran nerv unilat
0.79
1.12
0.98
NA
NA
0.07
1.98
1.84
NA
NA
XXX95867
26
A
Muscle test cran nerv unilat
0.79
0.23
0.32
0.23
0.32
0.03
1.05
1.14
1.05
1.14
XXX95867
TC
A
Muscle test cran nerv unilat
0.00
0.89
0.66
NA
NA
0.04
0.93
0.70
NA
NA
XXX95868

A
Muscle test cran nerve bilat
1.18
1.43
1.27
NA
NA
0.10
2.71
2.55
NA
NA
XXX95868
26
A
Muscle test cran nerve bilat
1.18
0.35
0.47
0.35
0.47
0.05
1.58
1.70
1.58
1.70
XXX95868
TC
A
Muscle test cran nerve bilat
0.00
1.08
0.80
NA
NA
0.05
1.13
0.85
NA
NA
XXX95869

A
Muscle test, thor paraspinal
0.37
1.03
0.54
NA
NA
0.04
1.44
0.95
NA
NA
XXX95869
26
A
Muscle test, thor paraspinal
0.37
0.12
0.15
0.12
0.15
0.02
0.51
0.54
0.51
0.54
XXX95869
TC
A
Muscle test, thor paraspinal
0.00
0.91
0.39
NA
NA
0.02
0.93
0.41
NA
NA
XXX95870

A
Muscle test, nonparaspinal
0.37
1.00
0.53
NA
NA
0.04
1.41
0.94
NA
NA
XXX95870
26
A
Muscle test, nonparaspinal
0.37
0.12
0.15
0.12
0.15
0.02
0.51
0.54
0.51
0.54
XXX95870
TC
A
Muscle test, nonparaspinal
0.00
0.88
0.38
NA
NA
0.02
0.90
0.40
NA
NA
XXX95872

A
Muscle test, one fiber
2.00
1.42
1.28
NA
NA
0.13
3.55
3.41
NA
NA
XXX95872
26
A
Muscle test, one fiber
2.00
0.65
0.64
0.65
0.64
0.08
2.73
2.72
2.73
2.72
XXX95872
TC
A
Muscle test, one fiber
0.00
0.78
0.65
NA
NA
0.05
0.83
0.70
NA
NA
XXX95873

A
Guide nerv destr, elec stim
0.37
0.95
0.51
0.95
0.51
0.04
1.36
0.92
1.36
0.92
ZZZ95873
26
A
Guide nerv destr, elec stim
0.37
0.12
0.15
0.12
0.15
0.02
0.51
0.54
0.51
0.54
ZZZ95873
TC
A
Guide nerv destr, elec stim
0.00
0.83
0.36
0.83
0.36
0.02
0.85
0.38
0.85
0.38
ZZZ95874

A
Guide nerv destr, needle emg
0.37
0.96
0.52
0.96
0.52
0.04
1.37
0.93
1.37
0.93
ZZZ95874
26
A
Guide nerv destr, needle emg
0.37
0.12
0.16
0.12
0.16
0.02
0.51
0.55
0.51
0.55
ZZZ95874
TC
A
Guide nerv destr, needle emg
0.00
0.84
0.36
0.84
0.36
0.02
0.86
0.38
0.86
0.38
ZZZ95875

A
Limb exercise test
1.10
1.31
1.42
NA
NA
0.11
2.52
2.63
NA
NA
XXX95875
26
A
Limb exercise test
1.10
0.31
0.43
0.31
0.43
0.05
1.46
1.58
1.46
1.58
XXX95875
TC
A
Limb exercise test
0.00
1.00
0.99
NA
NA
0.06
1.06
1.05
NA
NA
XXX95900

A
Motor nerve conduction test
0.42
0.94
1.18
NA
NA
0.04
1.40
1.64
NA
NA
XXX95900
26
A
Motor nerve conduction test
0.42
0.14
0.17
0.14
0.17
0.02
0.58
0.61
0.58
0.61
XXX95900
TC
A
Motor nerve conduction test
0.00
0.80
1.01
NA
NA
0.02
0.82
1.03
NA
NA
XXX95903

A
Motor nerve conduction test
0.60
1.04
1.15
NA
NA
0.05
1.69
1.80
NA
NA
XXX95903
26
A
Motor nerve conduction test
0.60
0.18
0.24
0.18
0.24
0.03
0.81
0.87
0.81
0.87
XXX95903
TC
A
Motor nerve conduction test
0.00
0.86
0.91
NA
NA
0.02
0.88
0.93
NA
NA
XXX95904

A
Sense nerve conduction test
0.34
0.88
1.04
NA
NA
0.04
1.26
1.42
NA
NA
XXX95904
26
A
Sense nerve conduction test
0.34
0.11
0.14
0.11
0.14
0.02
0.47
0.50
0.47
0.50
XXX95904
TC
A
Sense nerve conduction test
0.00
0.77
0.90
NA
NA
0.02
0.79
0.92
NA
NA
XXX95920

A
Intraop nerve test add-on
2.11
1.80
2.12
1.80
2.12
0.23
4.14
4.46
4.14
4.46
ZZZ95920
26
A
Intraop nerve test add-on
2.11
0.66
0.86
0.66
0.86
0.16
2.93
3.13
2.93
3.13
ZZZ95920
TC
A
Intraop nerve test add-on
0.00
1.14
1.27
1.14
1.27
0.07
1.21
1.34
1.21
1.34
ZZZ95921

A
Autonomic nerv function test
0.90
1.14
0.82
NA
NA
0.06
2.10
1.78
NA
NA
XXX95921
26
A
Autonomic nerv function test
0.90
0.24
0.31
0.24
0.31
0.04
1.18
1.25
1.18
1.25
XXX95921
TC
A
Autonomic nerv function test
0.00
0.89
0.51
NA
NA
0.02
0.91
0.53
NA
NA
XXX95922

A
Autonomic nerv function test
0.96
1.65
1.00
NA
NA
0.07
2.68
2.03
NA
NA
XXX95922
26
A
Autonomic nerv function test
0.96
0.27
0.37
0.27
0.37
0.05
1.28
1.38
1.28
1.38
XXX95922
TC
A
Autonomic nerv function test
0.00
1.38
0.63
NA
NA
0.02
1.40
0.65
NA
NA
XXX95923

A
Autonomic nerv function test
0.90
2.12
1.98
NA
NA
0.07
3.09
2.95
NA
NA
XXX95923
26
A
Autonomic nerv function test
0.90
0.24
0.35
0.24
0.35
0.05
1.19
1.30
1.19
1.30
XXX95923
TC
A
Autonomic nerv function test
0.00
1.88
1.64
NA
NA
0.02
1.90
1.66
NA
NA
XXX95925

A
Somatosensory testing
0.54
3.19
1.65
NA
NA
0.10
3.83
2.29
NA
NA
XXX95925
26
A
Somatosensory testing
0.54
0.17
0.21
0.17
0.21
0.04
0.75
0.79
0.75
0.79
XXX95925
TC
A
Somatosensory testing
0.00
3.02
1.44
NA
NA
0.06
3.08
1.50
NA
NA
XXX95926

A
Somatosensory testing
0.54
3.06
1.62
NA
NA
0.09
3.69
2.25
NA
NA
XXX95926
26
A
Somatosensory testing
0.54
0.16
0.21
0.16
0.21
0.03
0.73
0.78
0.73
0.78
XXX95926
TC
A
Somatosensory testing
0.00
2.90
1.41
NA
NA
0.06
2.96
1.47
NA
NA
XXX95927

A
Somatosensory testing
0.54
3.08
1.64
NA
NA
0.10
3.72
2.28
NA
NA
XXX95927
26
A
Somatosensory testing
0.54
0.16
0.23
0.16
0.23
0.04
0.74
0.81
0.74
0.81
XXX95927
TC
A
Somatosensory testing
0.00
2.93
1.42
NA
NA
0.06
2.99
1.48
NA
NA
XXX( print page 49229)95928

A
C motor evoked, uppr limbs
1.50
3.98
3.26
NA
NA
0.09
5.57
4.85
NA
NA
XXX95928
26
A
C motor evoked, uppr limbs
1.50
0.46
0.60
0.46
0.60
0.06
2.02
2.16
2.02
2.16
XXX95928
TC
A
C motor evoked, uppr limbs
0.00
3.53
2.66
NA
NA
0.03
3.56
2.69
NA
NA
XXX95929

A
C motor evoked, lwr limbs
1.50
4.30
3.48
NA
NA
0.09
5.89
5.07
NA
NA
XXX95929
26
A
C motor evoked, lwr limbs
1.50
0.46
0.60
0.46
0.60
0.06
2.02
2.16
2.02
2.16
XXX95930

A
Visual evoked potential test
0.35
2.64
2.34
NA
NA
0.03
3.02
2.72
NA
NA
XXX95930
26
A
Visual evoked potential test
0.35
0.10
0.14
0.10
0.14
0.02
0.47
0.51
0.47
0.51
XXX95930
TC
A
Visual evoked potential test
0.00
2.54
2.20
NA
NA
0.01
2.55
2.21
NA
NA
XXX95933

A
Blink reflex test
0.59
1.10
1.04
NA
NA
0.10
1.79
1.73
NA
NA
XXX95933
26
A
Blink reflex test
0.59
0.17
0.22
0.17
0.22
0.04
0.80
0.85
0.80
0.85
XXX95933
TC
A
Blink reflex test
0.00
0.93
0.82
NA
NA
0.06
0.99
0.88
NA
NA
XXX95934

A
H-reflex test
0.51
0.90
0.55
NA
NA
0.04
1.45
1.10
NA
NA
XXX95934
26
A
H-reflex test
0.51
0.16
0.21
0.16
0.21
0.02
0.69
0.74
0.69
0.74
XXX95934
TC
A
H-reflex test
0.00
0.73
0.34
NA
NA
0.02
0.75
0.36
NA
NA
XXX95936

A
H-reflex test
0.55
0.62
0.49
NA
NA
0.05
1.22
1.09
NA
NA
XXX95936
26
A
H-reflex test
0.55
0.17
0.22
0.17
0.22
0.03
0.75
0.80
0.75
0.80
XXX95936
TC
A
H-reflex test
0.00
0.44
0.27
NA
NA
0.02
0.46
0.29
NA
NA
XXX95937

A
Neuromuscular junction test
0.65
0.92
0.69
NA
NA
0.10
1.67
1.44
NA
NA
XXX95937
26
A
Neuromuscular junction test
0.65
0.20
0.25
0.20
0.25
0.08
0.93
0.98
0.93
0.98
XXX95937
TC
A
Neuromuscular junction test
0.00
0.72
0.44
NA
NA
0.02
0.74
0.46
NA
NA
XXX95950

A
Ambulatory eeg monitoring
1.51
4.93
4.18
NA
NA
0.51
6.95
6.20
NA
NA
XXX95950
26
A
Ambulatory eeg monitoring
1.51
0.42
0.59
0.42
0.59
0.08
2.01
2.18
2.01
2.18
XXX95950
TC
A
Ambulatory eeg monitoring
0.00
4.52
3.60
NA
NA
0.43
4.95
4.03
NA
NA
XXX95951

C
EEG monitoring/videorecord
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX95951
26
A
EEG monitoring/videorecord
5.99
1.69
2.34
1.69
2.34
0.32
8.00
8.65
8.00
8.65
XXX95951
TC
C
EEG monitoring/videorecord
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX95953

A
EEG monitoring/computer
3.30
7.24
7.53
NA
NA
0.60
11.14
11.43
NA
NA
XXX95953
26
A
EEG monitoring/computer
3.30
0.93
1.20
0.93
1.20
0.17
4.40
4.67
4.40
4.67
XXX95953
TC
A
EEG monitoring/computer
0.00
6.31
6.33
NA
NA
0.43
6.74
6.76
NA
NA
XXX95954

A
EEG monitoring/giving drugs
2.45
4.90
4.39
NA
NA
0.19
7.54
7.03
NA
NA
XXX95954
26
A
EEG monitoring/giving drugs
2.45
0.51
0.91
0.51
0.91
0.13
3.09
3.49
3.09
3.49
XXX95954
TC
A
EEG monitoring/giving drugs
0.00
4.39
3.48
NA
NA
0.06
4.45
3.54
NA
NA
XXX95955

A
EEG during surgery
1.01
2.83
2.45
2.83
2.45
0.22
4.06
3.68
4.06
3.68
XXX95955
26
A
EEG during surgery
1.01
0.29
0.34
0.29
0.34
0.05
1.35
1.40
1.35
1.40
XXX95955
TC
A
EEG during surgery
0.00
2.54
2.11
2.54
2.11
0.17
2.71
2.28
2.71
2.28
XXX95956

A
Eeg monitoring, cable/radio
3.08
17.21
15.86
NA
NA
0.59
20.88
19.53
NA
NA
XXX95956
26
A
Eeg monitoring, cable/radio
3.08
1.03
1.23
1.03
1.23
0.16
4.27
4.47
4.27
4.47
XXX95956
TC
A
Eeg monitoring, cable/radio
0.00
16.18
14.63
NA
NA
0.43
16.61
15.06
NA
NA
XXX95957

A
EEG digital analysis
1.98
5.88
3.38
NA
NA
0.23
8.09
5.59
NA
NA
XXX95957
26
A
EEG digital analysis
1.98
0.55
0.78
0.55
0.78
0.11
2.64
2.87
2.64
2.87
XXX95957
TC
A
EEG digital analysis
0.00
5.32
2.61
NA
NA
0.12
5.44
2.73
NA
NA
XXX95958

A
EEG monitoring/function test
4.24
6.67
4.29
NA
NA
0.34
11.25
8.87
NA
NA
XXX95958
26
A
EEG monitoring/function test
4.24
1.21
1.61
1.21
1.61
0.21
5.66
6.06
5.66
6.06
XXX95958
TC
A
EEG monitoring/function test
0.00
5.46
2.67
NA
NA
0.13
5.59
2.80
NA
NA
XXX95961

A
Electrode stimulation, brain
2.97
3.12
2.75
NA
NA
0.55
6.64
6.27
NA
NA
XXX95961
26
A
Electrode stimulation, brain
2.97
0.90
1.22
0.90
1.22
0.48
4.35
4.67
4.35
4.67
XXX95961
TC
A
Electrode stimulation, brain
0.00
2.22
1.54
NA
NA
0.07
2.29
1.61
NA
NA
XXX95962

A
Electrode stim, brain add-on
3.21
2.21
2.57
2.21
2.57
0.39
5.81
6.17
5.81
6.17
ZZZ95962
26
A
Electrode stim, brain add-on
3.21
0.91
1.27
0.91
1.27
0.32
4.44
4.80
4.44
4.80
ZZZ95962
TC
A
Electrode stim, brain add-on
0.00
1.30
1.31
1.30
1.31
0.07
1.37
1.38
1.37
1.38
ZZZ95965

C
Meg, spontaneous
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX95965
26
A
Meg, spontaneous
7.99
2.29
3.14
2.29
3.14
0.46
10.74
11.59
10.74
11.59
XXX95965
TC
C
Meg, spontaneous
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX95966

C
Meg, evoked, single
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX95966
26
A
Meg, evoked, single
3.99
1.22
1.59
1.22
1.59
0.19
5.40
5.77
5.40
5.77
XXX95966
TC
C
Meg, evoked, single
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX95967

C
Meg, evoked, each addIl
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
ZZZ95967
26
A
Meg, evoked, each addIl
3.49
1.04
1.15
1.04
1.15
0.16
4.69
4.80
4.69
4.80
ZZZ95967
TC
C
Meg, evoked, each addIl
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
ZZZ95970

A
Analyze neurostim, no prog
0.45
0.89
0.86
0.13
0.14
0.03
1.37
1.34
0.61
0.62
XXX95971

A
Analyze neurostim, simple
0.78
0.62
0.67
0.20
0.22
0.07
1.47
1.52
1.05
1.07
XXX95972

A
Analyze neurostim, complex
1.50
1.20
1.21
0.46
0.48
0.14
2.84
2.85
2.10
2.12
XXX95973

A
Analyze neurostim, complex
0.92
0.56
0.61
0.24
0.32
0.07
1.55
1.60
1.23
1.31
ZZZ95974

A
Cranial neurostim, complex
3.00
1.48
1.65
0.85
1.19
0.16
4.64
4.81
4.01
4.35
XXX95975

A
Cranial neurostim, complex
1.70
0.74
0.85
0.48
0.67
0.12
2.56
2.67
2.30
2.49
ZZZ95978

A
Analyze neurostim brain/1h
3.50
1.84
1.91
1.04
1.24
0.18
5.52
5.59
4.72
4.92
XXX( print page 49230)95979

A
Analyz neurostim brain addon
1.64
0.73
0.84
0.47
0.64
0.08
2.45
2.56
2.19
2.36
ZZZ95990

A
Spin/brain pump refil & main
0.00
1.67
1.54
NA
NA
0.06
1.73
1.60
NA
NA
XXX95991

A
Spin/brain pump refil & main
0.77
1.67
1.54
NA
NA
0.06
2.50
2.37
NA
NA
XXX95999

C
Neurological procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX96000

A
Motion analysis, video/3d
1.80
NA
NA
0.58
0.54
0.11
NA
NA
2.49
2.45
XXX96001

A
Motion test w/ft press meas
2.15
NA
NA
0.53
0.63
0.10
NA
NA
2.78
2.88
XXX96002

A
Dynamic surface emg
0.41
NA
NA
0.11
0.14
0.02
NA
NA
0.54
0.57
XXX96003

A
Dynamic fine wire emg
0.37
NA
NA
0.14
0.13
0.02
NA
NA
0.53
0.52
XXX96004

A
Phys review of motion tests
2.14
0.54
0.84
0.54
0.84
0.11
2.79
3.09
2.79
3.09
XXX96101

A
Psycho testing by psych/phys
1.86
0.34
0.57
0.33
0.56
0.05
2.25
2.48
2.24
2.47
XXX96102

A
Psycho testing by technician
0.50
1.20
0.80
0.09
0.15
0.01
1.71
1.31
0.60
0.66
XXX96103

A
Psycho testing admin by comp
0.51
1.31
0.49
0.09
0.15
0.02
1.84
1.02
0.62
0.68
XXX96105

A
Assessment of aphasia
0.00
2.06
1.84
NA
NA
0.18
2.24
2.02
NA
NA
XXX96110

A
Developmental test, lim
0.00
0.18
0.18
NA
NA
0.18
0.36
0.36
NA
NA
XXX96111

A
Developmental test, extend
2.60
0.66
0.95
0.53
0.92
0.18
3.44
3.73
3.31
3.70
XXX96116

A
Neurobehavioral status exam
1.86
0.53
0.76
0.42
0.59
0.18
2.57
2.80
2.46
2.63
XXX96118

A
Neuropsych tst by psych/phys
1.86
0.81
1.25
0.32
0.55
0.18
2.85
3.29
2.36
2.59
XXX96119

A
Neuropsych testing by tech
0.55
1.53
1.15
0.09
0.17
0.18
2.26
1.88
0.82
0.90
XXX96120

A
Neuropsych tst admin w/comp
0.51
1.91
1.03
0.09
0.15
0.02
2.44
1.56
0.62
0.68
XXX96150

A
Assess hlth/behave, init
0.50
0.10
0.16
0.09
0.16
0.01
0.61
0.67
0.60
0.67
XXX96151

A
Assess hlth/behave, subseq
0.48
0.09
0.16
0.09
0.15
0.01
0.58
0.65
0.58
0.64
XXX96152

A
Intervene hlth/behave, indiv
0.46
0.09
0.15
0.08
0.14
0.01
0.56
0.62
0.55
0.61
XXX96153

A
Intervene hlth/behave, group
0.10
0.02
0.04
0.02
0.03
0.01
0.13
0.15
0.13
0.14
XXX96154

A
Interv hlth/behav, fam w/pt
0.45
0.09
0.15
0.08
0.14
0.01
0.55
0.61
0.54
0.60
XXX96155

N
Interv hlth/behav fam no pt
0.44
0.10
0.16
0.10
0.15
0.02
0.56
0.62
0.56
0.61
XXX96401

A
Chemo, anti-neopl, sq/im
0.21
1.87
1.35
NA
NA
0.01
2.09
1.57
NA
NA
XXX96402

A
Chemo hormon antineopl sq/im
0.19
0.72
0.94
NA
NA
0.01
0.92
1.14
NA
NA
XXX96405

A
Chemo intralesional, up to 7
0.52
3.49
2.70
0.22
0.24
0.03
4.04
3.25
0.77
0.79
00096406

A
Chemo intralesional over 7
0.80
3.26
3.07
0.27
0.29
0.03
4.09
3.90
1.10
1.12
00096409

A
Chemo, iv push, sngl drug
0.24
2.78
2.89
NA
NA
0.06
3.08
3.19
NA
NA
XXX96411

A
Chemo, iv push, addl drug
0.20
1.50
1.58
NA
NA
0.06
1.76
1.84
NA
NA
ZZZ96413

A
Chemo, iv infusion, 1 hr
0.28
3.63
4.05
NA
NA
0.08
3.99
4.41
NA
NA
XXX96415

A
Chemo, iv infusion, addl hr
0.19
0.66
0.74
NA
NA
0.07
0.92
1.00
NA
NA
ZZZ96416

A
Chemo prolong infuse w/pump
0.21
4.08
4.47
NA
NA
0.08
4.37
4.76
NA
NA
XXX96417

A
Chemo iv infus each addl seq
0.21
1.72
1.89
NA
NA
0.07
2.00
2.17
NA
NA
ZZZ96420

A
Chemo, ia, push tecnique
0.17
2.70
2.67
NA
NA
0.08
2.95
2.92
NA
NA
XXX96422

A
Chemo ia infusion up to 1 hr
0.17
3.70
4.55
NA
NA
0.08
3.95
4.80
NA
NA
XXX96423

A
Chemo ia infuse each addl hr
0.17
1.93
1.89
NA
NA
0.02
2.12
2.08
NA
NA
ZZZ96425

A
Chemotherapy,infusion method
0.17
4.54
4.49
NA
NA
0.08
4.79
4.74
NA
NA
XXX96440

A
Chemotherapy, intracavitary
2.37
5.56
7.49
1.00
1.17
0.17
8.10
10.03
3.54
3.71
00096445

A
Chemotherapy, intracavitary
2.20
5.45
7.39
0.94
1.12
0.14
7.79
9.73
3.28
3.46
00096450

A
Chemotherapy, into CNS
1.53
5.02
6.47
0.83
1.18
0.09
6.64
8.09
2.45
2.80
00096521

A
Refill/maint, portable pump
0.21
3.14
3.61
NA
NA
0.06
3.41
3.88
NA
NA
XXX96522

A
Refill/maint pump/resvr syst
0.21
2.74
2.67
NA
NA
0.06
3.01
2.94
NA
NA
XXX96523

T
Irrig drug delivery device
0.04
0.64
0.68
NA
NA
0.01
0.69
0.73
NA
NA
XXX96542

A
Chemotherapy injection
0.75
3.55
4.08
0.32
0.58
0.07
4.37
4.90
1.14
1.40
XXX96549

C
Chemotherapy, unspecified
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX96567

A
Photodynamic tx, skin
0.00
3.65
2.38
NA
NA
0.04
3.69
2.42
NA
NA
XXX96570

A
Photodynamic tx, 30 min
1.10
0.41
0.38
0.41
0.38
0.11
1.62
1.59
1.62
1.59
ZZZ96571

A
Photodynamic tx, addl 15 min
0.55
0.20
0.19
0.20
0.19
0.03
0.78
0.77
0.78
0.77
ZZZ96900

A
Ultraviolet light therapy
0.00
0.55
0.47
NA
NA
0.02
0.57
0.49
NA
NA
XXX96902

B
Trichogram
0.41
0.11
0.16
0.10
0.15
0.01
0.53
0.58
0.52
0.57
XXX96910

A
Photochemotherapy with UV-B
0.00
1.95
1.23
NA
NA
0.04
1.99
1.27
NA
NA
XXX96912

A
Photochemotherapy with UV-A
0.00
2.51
1.57
NA
NA
0.05
2.56
1.62
NA
NA
XXX96913

A
Photochemotherapy, UV-A or B
0.00
3.55
2.15
NA
NA
0.10
3.65
2.25
NA
NA
XXX96920

A
Laser tx, skin < 250 sq cm
1.15
3.48
2.77
0.54
0.56
0.02
4.65
3.94
1.71
1.73
000( print page 49231)96921

A
Laser tx, skin 250-500 sq cm
1.17
3.39
2.80
0.51
0.56
0.03
4.59
4.00
1.71
1.76
00096922

A
Laser tx, skin > 500 sq cm
2.10
4.46
3.73
0.98
0.71
0.04
6.60
5.87
3.12
2.85
00096999

C
Dermatological procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX97001

A
Pt evaluation
1.20
0.68
0.73
NA
NA
0.05
1.93
1.98
NA
NA
XXX97002

A
Pt re-evaluation
0.60
0.43
0.44
NA
NA
0.02
1.05
1.06
NA
NA
XXX97003

A
Ot evaluation
1.20
0.77
0.85
NA
NA
0.06
2.03
2.11
NA
NA
XXX97004

A
Ot re-evaluation
0.60
0.54
0.64
NA
NA
0.02
1.16
1.26
NA
NA
XXX97010

B
Hot or cold packs therapy
0.06
0.07
0.06
NA
NA
0.01
0.14
0.13
NA
NA
XXX97012

A
Mechanical traction therapy
0.25
0.15
0.14
NA
NA
0.01
0.41
0.40
NA
NA
XXX97014

I
Electric stimulation therapy
0.18
0.19
0.19
NA
NA
0.01
0.38
0.38
NA
NA
XXX97016

A
Vasopneumatic device therapy
0.18
0.25
0.20
NA
NA
0.01
0.44
0.39
NA
NA
XXX97018

A
Paraffin bath therapy
0.06
0.17
0.12
NA
NA
0.01
0.24
0.19
NA
NA
XXX97022

A
Whirlpool therapy
0.17
0.34
0.24
NA
NA
0.01
0.52
0.42
NA
NA
XXX97024

A
Diathermy eg, microwave
0.06
0.08
0.07
NA
NA
0.01
0.15
0.14
NA
NA
XXX97026

A
Infrared therapy
0.06
0.07
0.06
NA
NA
0.01
0.14
0.13
NA
NA
XXX97028

A
Ultraviolet therapy
0.08
0.09
0.08
NA
NA
0.01
0.18
0.17
NA
NA
XXX97032

A
Electrical stimulation
0.25
0.20
0.17
NA
NA
0.01
0.46
0.43
NA
NA
XXX97033

A
Electric current therapy
0.26
0.46
0.32
NA
NA
0.01
0.73
0.59
NA
NA
XXX97034

A
Contrast bath therapy
0.21
0.21
0.17
NA
NA
0.01
0.43
0.39
NA
NA
XXX97035

A
Ultrasound therapy
0.21
0.10
0.10
NA
NA
0.01
0.32
0.32
NA
NA
XXX97036

A
Hydrotherapy
0.28
0.45
0.35
NA
NA
0.01
0.74
0.64
NA
NA
XXX97039

C
Physical therapy treatment
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX97110

A
Therapeutic exercises
0.45
0.33
0.29
NA
NA
0.02
0.80
0.76
NA
NA
XXX97112

A
Neuromuscular reeducation
0.45
0.36
0.32
NA
NA
0.01
0.82
0.78
NA
NA
XXX97113

A
Aquatic therapy/exercises
0.44
0.55
0.43
NA
NA
0.01
1.00
0.88
NA
NA
XXX97116

A
Gait training therapy
0.40
0.29
0.25
NA
NA
0.01
0.70
0.66
NA
NA
XXX97124

A
Massage therapy
0.35
0.28
0.24
NA
NA
0.01
0.64
0.60
NA
NA
XXX97139

C
Physical medicine procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX97140

A
Manual therapy
0.43
0.30
0.26
NA
NA
0.01
0.74
0.70
NA
NA
XXX97150

A
Group therapeutic procedures
0.27
0.22
0.19
NA
NA
0.01
0.50
0.47
NA
NA
XXX97530

A
Therapeutic activities
0.44
0.39
0.34
NA
NA
0.01
0.84
0.79
NA
NA
XXX97532

A
Cognitive skills development
0.44
0.23
0.21
NA
NA
0.01
0.68
0.66
NA
NA
XXX97533

A
Sensory integration
0.44
0.28
0.25
NA
NA
0.01
0.73
0.70
NA
NA
XXX97535

A
Self care mngment training
0.45
0.39
0.35
NA
NA
0.01
0.85
0.81
NA
NA
XXX97537

A
Community/work reintegration
0.45
0.29
0.27
NA
NA
0.01
0.75
0.73
NA
NA
XXX97542

A
Wheelchair mngment training
0.45
0.30
0.29
NA
NA
0.01
0.76
0.75
NA
NA
XXX97597

A
Active wound care/20 cm or <
0.58
1.13
0.78
0.13
0.53
0.05
1.76
1.41
0.76
1.16
XXX97598

A
Active wound care > 20 cm
0.80
1.31
0.92
0.18
0.64
0.05
2.16
1.77
1.03
1.49
XXX97605

A
Neg press wound tx, < 50 cm
0.55
0.42
0.36
0.12
0.20
0.02
0.99
0.93
0.69
0.77
XXX97606

A
Neg press wound tx, > 50 cm
0.60
0.43
0.37
0.13
0.21
0.03
1.06
1.00
0.76
0.84
XXX97750

A
Physical performance test
0.45
0.34
0.33
NA
NA
0.02
0.81
0.80
NA
NA
XXX97755

A
Assistive technology assess
0.62
0.29
0.28
NA
NA
0.02
0.93
0.92
NA
NA
XXX97760

A
Orthotic mgmt and training
0.45
0.44
0.37
NA
NA
0.03
0.92
0.85
NA
NA
XXX97761

A
Prosthetic training
0.45
0.34
0.30
NA
NA
0.02
0.81
0.77
NA
NA
XXX97762

A
C/o for orthotic/prosth use
0.25
0.75
0.50
NA
NA
0.02
1.02
0.77
NA
NA
XXX97799

C
Physical medicine procedure
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX97802

A
Medical nutrition, indiv, in
0.45
0.12
0.38
0.11
0.38
0.01
0.58
0.84
0.57
0.84
XXX97803

A
Med nutrition, indiv, subseq
0.37
0.10
0.38
0.09
0.38
0.01
0.48
0.76
0.47
0.76
XXX97804

A
Medical nutrition, group
0.25
0.06
0.15
0.06
0.15
0.01
0.32
0.41
0.32
0.41
XXX97810

N
Acupunct w/o stimul 15 min
0.60
0.26
0.35
0.14
0.21
0.03
0.89
0.98
0.77
0.84
XXX97811

N
Acupunct w/o stimul addl 15m
0.50
0.16
0.23
0.12
0.17
0.03
0.69
0.76
0.65
0.70
ZZZ97813

N
Acupunct w/stimul 15 min
0.65
0.27
0.37
0.15
0.23
0.03
0.95
1.05
0.83
0.91
XXX97814

N
Acupunct w/stimul addl 15m
0.55
0.19
0.27
0.13
0.19
0.03
0.77
0.85
0.71
0.77
ZZZ98925

A
Osteopathic manipulation
0.45
0.28
0.31
0.12
0.14
0.02
0.75
0.78
0.59
0.61
00098926

A
Osteopathic manipulation
0.65
0.36
0.40
0.16
0.23
0.03
1.04
1.08
0.84
0.91
00098927

A
Osteopathic manipulation
0.87
0.45
0.49
0.22
0.27
0.03
1.35
1.39
1.12
1.17
00098928

A
Osteopathic manipulation
1.03
0.50
0.57
0.26
0.32
0.04
1.57
1.64
1.33
1.39
00098929

A
Osteopathic manipulation
1.19
0.57
0.65
0.29
0.35
0.05
1.81
1.89
1.53
1.59
00098940

A
Chiropractic manipulation
0.45
0.21
0.23
0.12
0.12
0.01
0.67
0.69
0.58
0.58
00098941

A
Chiropractic manipulation
0.65
0.27
0.29
0.17
0.17
0.01
0.93
0.95
0.83
0.83
00098942

A
Chiropractic manipulation
0.87
0.33
0.35
0.23
0.23
0.02
1.22
1.24
1.12
1.12
00098943

N
Chiropractic manipulation
0.40
0.18
0.23
0.09
0.14
0.01
0.59
0.64
0.50
0.55
XXX99082

C
Unusual physician travel
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX99143

C
Mod cs by same phys, < 5 yrs
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX99144

C
Mod cs by same phys, 5 yrs +
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX99145

C
Mod cs by same phys add-on
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
ZZZ( print page 49232)99148

C
Mod cs diff phys < 5 yrs
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX99149

C
Mod cs diff phys 5 yrs +
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX99150

C
Mod cs diff phys add-on
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
ZZZ99170

A
Anogenital exam, child
1.75
1.51
1.70
0.50
0.54
0.08
3.34
3.53
2.33
2.37
00099175

A
Induction of vomiting
0.00
0.34
1.13
NA
NA
0.10
0.44
1.23
NA
NA
XXX99183

A
Hyperbaric oxygen therapy
2.34
2.61
3.08
0.58
0.69
0.16
5.11
5.58
3.08
3.19
XXX99185

A
Regional hypothermia
0.00
1.66
0.90
NA
NA
0.04
1.70
0.94
NA
NA
XXX99186

A
Total body hypothermia
0.00
1.41
1.69
NA
NA
0.45
1.86
2.14
NA
NA
XXX99195

A
Phlebotomy
0.00
2.60
0.98
NA
NA
0.02
2.62
1.00
NA
NA
XXX99199

C
Special service/proc/report
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXX99201

A
Office/outpatient visit, new
0.45
0.54
0.50
0.15
0.15
0.03
1.02
0.98
0.63
0.63
XXX99202

A
Office/outpatient visit, new
0.88
0.83
0.80
0.29
0.31
0.05
1.76
1.73
1.22
1.24
XXX99203

A
Office/outpatient visit, new
1.34
1.10
1.12
0.42
0.47
0.09
2.53
2.55
1.85
1.90
XXX99204

A
Office/outpatient visit, new
2.30
1.49
1.50
0.71
0.71
0.12
3.91
3.92
3.13
3.13
XXX99205

A
Office/outpatient visit, new
3.00
1.79
1.78
0.91
0.94
0.15
4.94
4.93
4.06
4.09
XXX99211

A
Office/outpatient visit, est
0.17
0.33
0.38
0.06
0.06
0.01
0.51
0.56
0.24
0.24
XXX99212

A
Office/outpatient visit, est
0.45
0.55
0.54
0.15
0.16
0.03
1.03
1.02
0.63
0.64
XXX99213

A
Office/outpatient visit, est
0.92
0.76
0.71
0.28
0.25
0.03
1.71
1.66
1.23
1.20
XXX99214

A
Office/outpatient visit, est
1.42
1.10
1.05
0.44
0.42
0.05
2.57
2.52
1.91
1.89
XXX99215

A
Office/outpatient visit, est
2.00
1.39
1.34
0.61
0.64
0.08
3.47
3.42
2.69
2.72
XXX99217

A
Observation care discharge
1.28
NA
NA
0.50
0.52
0.06
NA
NA
1.84
1.86
XXX99218

A
Observation care
1.28
NA
NA
0.38
0.43
0.06
NA
NA
1.72
1.77
XXX99219

A
Observation care
2.14
NA
NA
0.60
0.69
0.10
NA
NA
2.84
2.93
XXX99220

A
Observation care
2.99
NA
NA
0.86
0.99
0.14
NA
NA
3.99
4.12
XXX99221

A
Initial hospital care
1.88
NA
NA
0.55
0.48
0.07
NA
NA
2.50
2.43
XXX99222

A
Initial hospital care
2.56
NA
NA
0.71
0.73
0.10
NA
NA
3.37
3.39
XXX99223

A
Initial hospital care
3.78
NA
NA
1.08
1.04
0.13
NA
NA
4.99
4.95
XXX99231

A
Subsequent hospital care
0.76
NA
NA
0.24
0.23
0.03
NA
NA
1.03
1.02
XXX99232

A
Subsequent hospital care
1.39
NA
NA
0.43
0.39
0.04
NA
NA
1.86
1.82
XXX99233

A
Subsequent hospital care
2.00
NA
NA
0.60
0.54
0.06
NA
NA
2.66
2.60
XXX99234

A
Observ/hosp same date
2.56
NA
NA
0.78
0.86
0.13
NA
NA
3.47
3.55
XXX99235

A
Observ/hosp same date
3.41
NA
NA
NA
NA
0.16
NA
NA
NA
NA
XXX99236

A
Observ/hosp same date
4.26
NA
NA
1.25
1.39
0.19
NA
NA
5.70
5.84
XXX99238

A
Hospital discharge day
1.28
NA
NA
0.50
0.53
0.05
NA
NA
1.83
1.86
XXX99239

A
Hospital discharge day
1.90
NA
NA
0.68
0.72
0.07
NA
NA
2.65
2.69
XXX99241

A
Office consultation
0.64
0.66
0.65
0.22
0.22
0.05
1.35
1.34
0.91
0.91
XXX99242

A
Office consultation
1.34
1.08
1.05
0.47
0.46
0.10
2.52
2.49
1.91
1.90
XXX99243

A
Office consultation
1.88
1.45
1.41
0.67
0.64
0.13
3.46
3.42
2.68
2.65
XXX99244

A
Office consultation
3.02
1.95
1.85
1.09
0.96
0.16
5.13
5.03
4.27
4.14
XXX99245

A
Office consultation
3.77
2.27
2.27
1.31
1.26
0.21
6.25
6.25
5.29
5.24
XXX99251

A
Initial inpatient consult
1.00
NA
NA
0.31
0.26
0.05
NA
NA
1.36
1.31
XXX99252

A
Initial inpatient consult
1.50
NA
NA
0.50
0.50
0.09
NA
NA
2.09
2.09
XXX99253

A
Initial inpatient consult
2.27
NA
NA
0.81
0.71
0.11
NA
NA
3.19
3.09
XXX99254

A
Initial inpatient consult
3.29
NA
NA
1.19
1.03
0.13
NA
NA
4.61
4.45
XXX99255

A
Initial inpatient consult
4.00
NA
NA
1.40
1.36
0.18
NA
NA
5.58
5.54
XXX99281

A
Emergency dept visit
0.45
NA
NA
0.09
0.09
0.02
NA
NA
0.56
0.56
XXX99282

A
Emergency dept visit
0.88
NA
NA
0.17
0.15
0.04
NA
NA
1.09
1.07
XXX99283

A
Emergency dept visit
1.34
NA
NA
0.25
0.30
0.09
NA
NA
1.68
1.73
XXX99284

A
Emergency dept visit
2.56
NA
NA
0.46
0.47
0.14
NA
NA
3.16
3.17
XXX99285

A
Emergency dept visit
3.80
NA
NA
0.67
0.71
0.23
NA
NA
4.70
4.74
XXX99289

A
Ped crit care transport
4.79
NA
NA
1.11
1.37
0.24
NA
NA
6.14
6.40
XXX99290

A
Ped crit care transport addl
2.40
NA
NA
0.60
0.76
0.12
NA
NA
3.12
3.28
ZZZ99291

A
Critical care, first hour
4.50
2.28
2.50
1.12
1.24
0.21
6.99
7.21
5.83
5.95
XXX99292

A
Critical care, addIl 30 min
2.25
0.83
0.88
0.59
0.63
0.11
3.19
3.24
2.95
2.99
ZZZ99293

A
Ped critical care, initial
15.98
NA
NA
3.59
4.46
1.12
NA
NA
20.69
21.56
XXX99294

A
Ped critical care, subseq
7.99
NA
NA
1.72
2.23
0.45
NA
NA
10.16
10.67
XXX( print page 49233)99295

A
Neonate crit care, initial
18.46
NA
NA
4.34
5.11
1.16
NA
NA
23.96
24.73
XXX99296

A
Neonate critical care subseq
7.99
NA
NA
1.76
2.35
0.32
NA
NA
10.07
10.66
XXX99298

A
Ic for lbw infant < 1500 gm
2.75
NA
NA
0.66
0.86
0.17
NA
NA
3.58
3.78
XXX99299

A
Ic, lbw infant 1500-2500 gm
2.50
NA
NA
0.75
0.83
0.16
NA
NA
3.41
3.49
XXX99300

A
Ic, infant pbw 2501-5000 gm
2.40
NA
NA
0.72
0.81
0.15
NA
NA
3.27
3.36
XXX99304

A
Nursing facility care, init
1.20
0.45
0.48
0.45
0.48
0.05
1.70
1.73
1.70
1.73
XXX99305

A
Nursing facility care, init
1.61
0.56
0.61
0.56
0.61
0.07
2.24
2.29
2.24
2.29
XXX99306

A
Nursing facility care, init
2.01
0.65
0.73
0.65
0.73
0.09
2.75
2.83
2.75
2.83
XXX99307

A
Nursing fac care, subseq
0.60
0.27
0.27
0.27
0.27
0.03
0.90
0.90
0.90
0.90
XXX99308

A
Nursing fac care, subseq
1.00
0.43
0.45
0.43
0.45
0.04
1.47
1.49
1.47
1.49
XXX99309

A
Nursing fac care, subseq
1.42
0.58
0.61
0.58
0.61
0.06
2.06
2.09
2.06
2.09
XXX99310

A
Nursing fac care, subseq
1.77
0.73
0.77
0.73
0.77
0.08
2.58
2.62
2.58
2.62
XXX99315

A
Nursing fac discharge day
1.13
0.41
0.44
0.41
0.44
0.05
1.59
1.62
1.59
1.62
XXX99316

A
Nursing fac discharge day
1.50
0.51
0.57
0.51
0.57
0.06
2.07
2.13
2.07
2.13
XXX99318

A
Annual nursing fac assessmnt
1.20
0.45
0.48
0.45
0.48
0.05
1.70
1.73
1.70
1.73
XXX99324

A
Domicil/r-home visit new pat
1.01
0.43
0.48
NA
NA
0.05
1.49
1.54
NA
NA
XXX99325

A
Domicil/r-home visit new pat
1.52
0.56
0.65
NA
NA
0.07
2.15
2.24
NA
NA
XXX99326

A
Domicil/r-home visit new pat
2.27
0.73
0.87
NA
NA
0.10
3.10
3.24
NA
NA
XXX99327

A
Domicil/r-home visit new pat
3.03
0.92
1.11
NA
NA
0.13
4.08
4.27
NA
NA
XXX99328

A
Domicil/r-home visit new pat
3.78
1.10
1.34
NA
NA
0.16
5.04
5.28
NA
NA
XXX99334

A
Domicil/r-home visit est pat
0.76
0.36
0.39
NA
NA
0.04
1.16
1.19
NA
NA
XXX99335

A
Domicil/r-home visit est pat
1.26
0.48
0.56
NA
NA
0.06
1.80
1.88
NA
NA
XXX99336

A
Domicil/r-home visit est pat
2.02
0.66
0.78
NA
NA
0.09
2.77
2.89
NA
NA
XXX99337

A
Domicil/r-home visit est pat
3.03
0.90
1.09
NA
NA
0.13
4.06
4.25
NA
NA
XXX99341

A
Home visit, new patient
1.01
0.37
0.45
NA
NA
0.05
1.43
1.51
NA
NA
XXX99342

A
Home visit, new patient
1.52
0.50
0.64
NA
NA
0.07
2.09
2.23
NA
NA
XXX99343

A
Home visit, new patient
2.27
0.69
0.88
NA
NA
0.10
3.06
3.25
NA
NA
XXX99344

A
Home visit, new patient
3.03
0.91
1.11
NA
NA
0.13
4.07
4.27
NA
NA
XXX99345

A
Home visit, new patient
3.78
1.08
1.34
NA
NA
0.16
5.02
5.28
NA
NA
XXX99347

A
Home visit, est patient
0.76
0.36
0.39
NA
NA
0.04
1.16
1.19
NA
NA
XXX99348

A
Home visit, est patient
1.26
0.49
0.56
NA
NA
0.06
1.81
1.88
NA
NA
XXX99349

A
Home visit, est patient
2.02
0.66
0.79
NA
NA
0.09
2.77
2.90
NA
NA
XXX99350

A
Home visit, est patient
3.03
0.91
1.11
NA
NA
0.13
4.07
4.27
NA
NA
XXX99354

A
Prolonged service, office
1.77
0.65
0.74
0.50
0.62
0.08
2.50
2.59
2.35
2.47
ZZZ99355

A
Prolonged service, office
1.77
0.67
0.73
0.52
0.60
0.07
2.51
2.57
2.36
2.44
ZZZ99356

A
Prolonged service, inpatient
1.71
NA
NA
0.51
0.59
0.07
NA
NA
2.29
2.37
ZZZ99357

A
Prolonged service, inpatient
1.71
NA
NA
0.50
0.60
0.08
NA
NA
2.29
2.39
ZZZ99374

B
Home health care supervision
1.10
0.55
0.66
0.26
0.38
0.05
1.70
1.81
1.41
1.53
XXX99375

I
Home health care supervision
1.73
0.76
1.35
0.40
1.26
0.07
2.56
3.15
2.20
3.06
XXX99377

B
Hospice care supervision
1.10
0.55
0.66
0.26
0.38
0.05
1.70
1.81
1.41
1.53
XXX99378

I
Hospice care supervision
1.73
0.76
1.65
0.40
1.56
0.07
2.56
3.45
2.20
3.36
XXX99379

B
Nursing fac care supervision
1.10
0.55
0.66
0.26
0.38
0.04
1.69
1.80
1.40
1.52
XXX99380

B
Nursing fac care supervision
1.73
0.76
0.93
0.40
0.60
0.06
2.55
2.72
2.19
2.39
XXX99381

N
Prev visit, new, infant
1.19
1.01
1.38
0.28
0.41
0.05
2.25
2.62
1.52
1.65
XXX99382

N
Prev visit, new, age 1-4
1.36
1.05
1.42
0.32
0.47
0.05
2.46
2.83
1.73
1.88
XXX99383

N
Prev visit, new, age 5-11
1.36
1.04
1.37
0.32
0.47
0.05
2.45
2.78
1.73
1.88
XXX99384

N
Prev visit, new, age 12-17
1.53
1.08
1.43
0.36
0.53
0.06
2.67
3.02
1.95
2.12
XXX99385

N
Prev visit, new, age 18-39
1.53
1.08
1.43
0.36
0.53
0.06
2.67
3.02
1.95
2.12
XXX99386

N
Prev visit, new, age 40-64
1.88
1.16
1.60
0.44
0.65
0.07
3.11
3.55
2.39
2.60
XXX99387

N
Prev visit, new, 65 & over
2.06
1.29
1.73
0.48
0.71
0.07
3.42
3.86
2.61
2.84
XXX99391

N
Prev visit, est, infant
1.02
0.87
0.98
0.24
0.35
0.04
1.93
2.04
1.30
1.41
XXX99392

N
Prev visit, est, age 1-4
1.19
0.91
1.05
0.28
0.41
0.05
2.15
2.29
1.52
1.65
XXX99393

N
Prev visit, est, age 5-11
1.19
0.91
1.02
0.28
0.41
0.05
2.15
2.26
1.52
1.65
XXX99394

N
Prev visit, est, age 12-17
1.36
0.95
1.09
0.32
0.47
0.05
2.36
2.50
1.73
1.88
XXX99395

N
Prev visit, est, age 18-39
1.36
0.95
1.11
0.32
0.47
0.05
2.36
2.52
1.73
1.88
XXX99396

N
Prev visit, est, age 40-64
1.53
0.99
1.19
0.36
0.53
0.06
2.58
2.78
1.95
2.12
XXX99397

N
Prev visit, est, 65 & over
1.71
1.13
1.30
0.40
0.60
0.06
2.90
3.07
2.17
2.37
XXX99401

N
Preventive counseling, indiv
0.48
0.36
0.56
0.11
0.17
0.01
0.85
1.05
0.60
0.66
XXX99402

N
Preventive counseling, indiv
0.98
0.48
0.77
0.23
0.34
0.02
1.48
1.77
1.23
1.34
XXX99403

N
Preventive counseling, indiv
1.46
0.59
0.97
0.34
0.51
0.04
2.09
2.47
1.84
2.01
XXX99404

N
Preventive counseling, indiv
1.95
0.71
1.17
0.45
0.68
0.05
2.71
3.17
2.45
2.68
XXX99411

N
Preventive counseling, group
0.15
0.22
0.19
0.03
0.05
0.01
0.38
0.35
0.19
0.21
XXX99412

N
Preventive counseling, group
0.25
0.25
0.25
0.06
0.09
0.01
0.51
0.51
0.32
0.35
XXX99431

A
Initial care, normal newborn
1.17
NA
NA
0.27
0.35
0.05
NA
NA
1.49
1.57
XXX99432

A
Newborn care, not in hosp
1.26
1.02
0.95
0.29
0.37
0.07
2.35
2.28
1.62
1.70
XXX99433

A
Normal newborn care/hospital
0.62
NA
NA
0.14
0.19
0.02
NA
NA
0.78
0.83
XXX( print page 49234)99435

A
Newborn discharge day hosp
1.50
NA
NA
0.47
0.56
0.06
NA
NA
2.03
2.12
XXX99436

A
Attendance, birth
1.50
NA
NA
0.35
0.44
0.06
NA
NA
1.91
2.00
XXX99440

A
Newborn resuscitation
2.93
NA
NA
0.68
0.87
0.12
NA
NA
3.73
3.92
XXX99499

C
Unlisted e&m service
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXXG0101

A
CA screen;pelvic/breast exam
0.45
0.49
0.51
NA
NA
0.02
0.96
0.98
NA
NA
XXXG0102

A
Prostate ca screening; dre
0.17
0.33
0.38
0.06
0.06
0.01
0.51
0.56
0.24
0.24
XXXG0104

A
CA screen;flexi sigmoidscope
0.96
2.49
2.33
0.61
0.53
0.08
3.53
3.37
1.65
1.57
000G0105

A
Colorectal scrn; hi risk ind
3.69
6.36
6.20
1.81
1.56
0.30
10.35
10.19
5.80
5.55
000G0105
53
A
Colorectal scrn; hi risk ind
0.96
2.49
2.33
0.61
0.53
0.08
3.53
3.37
1.65
1.57
000G0106

A
Colon CA screen;barium enema
0.99
4.94
3.15
NA
NA
0.17
6.10
4.31
NA
NA
XXXG0106
26
A
Colon CA screen;barium enema
0.99
0.31
0.32
0.31
0.32
0.04
1.34
1.35
1.34
1.35
XXXG0106
TC
A
Colon CA screen;barium enema
0.00
4.63
2.83
NA
NA
0.13
4.76
2.96
NA
NA
XXXG0108

A
Diab manage trn  per indiv
0.00
0.59
0.77
NA
NA
0.01
0.60
0.78
NA
NA
XXXG0109

A
Diab manage trn ind/group
0.00
0.31
0.44
NA
NA
0.01
0.32
0.45
NA
NA
XXXG0117

T
Glaucoma scrn hgh risk direc
0.45
0.80
0.74
NA
NA
0.01
1.26
1.20
NA
NA
XXXG0118

T
Glaucoma scrn hgh risk direc
0.17
0.79
0.60
NA
NA
0.01
0.97
0.78
NA
NA
XXXG0120

A
Colon ca scrn; barium enema
0.99
4.94
3.15
NA
NA
0.17
6.10
4.31
NA
NA
XXXG0120
26
A
Colon ca scrn; barium enema
0.99
0.31
0.32
0.31
0.32
0.04
1.34
1.35
1.34
1.35
XXXG0120
TC
A
Colon ca scrn; barium enema
0.00
4.63
2.83
NA
NA
0.13
4.76
2.96
NA
NA
XXXG0121

A
Colon ca scrn not hi rsk ind
3.69
6.36
6.20
1.81
1.56
0.30
10.35
10.19
5.80
5.55
000G0121
53
A
Colon ca scrn not hi rsk ind
0.96
2.49
2.33
0.61
0.53
0.08
3.53
3.37
1.65
1.57
000G0122

N
Colon ca scrn; barium enema
0.99
5.69
3.35
NA
NA
0.18
6.86
4.52
NA
NA
XXXG0122
26
N
Colon ca scrn; barium enema
0.99
0.23
0.34
0.23
0.34
0.05
1.27
1.38
1.27
1.38
XXXG0122
TC
N
Colon ca scrn; barium enema
0.00
5.46
3.01
NA
NA
0.13
5.59
3.14
NA
NA
XXXG0124

A
Screen c/v thin layer by MD
0.42
0.38
0.21
0.38
0.21
0.02
0.82
0.65
0.82
0.65
XXXG0127

R
Trim nail(s)
0.17
0.39
0.29
0.04
0.06
0.01
0.57
0.47
0.22
0.24
000G0128

R
CORF skilled nursing service
0.08
0.02
0.03
0.02
0.03
0.01
0.11
0.12
0.11
0.12
XXXG0130

A
Single energy x-ray study
0.22
0.55
0.79
NA
NA
0.06
0.83
1.07
NA
NA
XXXG0130
26
A
Single energy x-ray study
0.22
0.06
0.07
0.06
0.07
0.01
0.29
0.30
0.29
0.30
XXXG0130
TC
A
Single energy x-ray study
0.00
0.49
0.72
NA
NA
0.05
0.54
0.77
NA
NA
XXXG0141

A
Scr c/v cyto,autosys and md
0.42
0.38
0.21
0.38
0.21
0.02
0.82
0.65
0.82
0.65
XXXG0166

A
Extrnl counterpulse, per tx
0.07
4.56
3.82
NA
NA
0.01
4.64
3.90
NA
NA
XXXG0168

A
Wound closure by adhesive
0.45
1.57
1.84
0.21
0.22
0.03
2.05
2.32
0.69
0.70
000G0179

A
MD recertification HHA PT
0.45
0.48
0.89
NA
NA
0.02
0.95
1.36
NA
NA
XXXG0180

A
MD certification HHA patient
0.67
0.56
1.09
NA
NA
0.03
1.26
1.79
NA
NA
XXXG0181

A
Home health care supervision
1.73
0.81
1.31
NA
NA
0.07
2.61
3.11
NA
NA
XXXG0182

A
Hospice care supervision
1.73
0.83
1.45
NA
NA
0.07
2.63
3.25
NA
NA
XXXG0186

C
Dstry eye lesn,fdr vssl tech
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
YYYG0202

A
Screeningmammographydigital
0.70
2.82
2.78
NA
NA
0.10
3.62
3.58
NA
NA
XXXG0202
26
A
Screeningmammographydigital
0.70
0.24
0.23
0.24
0.23
0.03
0.97
0.96
0.97
0.96
XXXG0202
TC
A
Screeningmammographydigital
0.00
2.58
2.55
NA
NA
0.07
2.65
2.62
NA
NA
XXXG0204

A
Diagnosticmammographydigital
0.87
3.42
2.94
NA
NA
0.11
4.40
3.92
NA
NA
XXXG0204
26
A
Diagnosticmammographydigital
0.87
0.30
0.29
0.30
0.29
0.04
1.21
1.20
1.21
1.20
XXXG0204
TC
A
Diagnosticmammographydigital
0.00
3.12
2.66
NA
NA
0.07
3.19
2.73
NA
NA
XXXG0206

A
Diagnosticmammographydigital
0.70
2.68
2.36
NA
NA
0.09
3.47
3.15
NA
NA
XXXG0206
26
A
Diagnosticmammographydigital
0.70
0.24
0.23
0.24
0.23
0.03
0.97
0.96
0.97
0.96
XXXG0206
TC
A
Diagnosticmammographydigital
0.00
2.44
2.13
NA
NA
0.06
2.50
2.19
NA
NA
XXXG0237

A
Therapeutic procd strg endur
0.00
0.22
0.41
NA
NA
0.02
0.24
0.43
NA
NA
XXXG0238

A
Oth resp proc, indiv
0.00
0.23
0.43
NA
NA
0.02
0.25
0.45
NA
NA
XXXG0239

A
Oth resp proc, group
0.00
0.32
0.33
NA
NA
0.02
0.34
0.35
NA
NA
XXXG0245

R
Initial foot exam pt lops
0.88
0.83
0.80
0.29
0.31
0.04
1.75
1.72
1.21
1.23
XXXG0246

R
Followup eval of foot pt lop
0.45
0.55
0.54
0.15
0.16
0.02
1.02
1.01
0.62
0.63
XXXG0247

R
Routine footcare pt w lops
0.50
0.68
0.56
0.16
0.20
0.02
1.20
1.08
0.68
0.72
ZZZG0248

R
Demonstrate use home inr mon
0.00
3.30
5.78
NA
NA
0.01
3.31
5.79
NA
NA
XXXG0249

R
Provide test material,equipm
0.00
2.38
3.57
NA
NA
0.01
2.39
3.58
NA
NA
XXXG0250

R
MD review interpret of test
0.18
0.08
0.07
NA
NA
0.01
0.27
0.26
NA
NA
XXX( print page 49235)G0252
26
N
PET imaging initial dx
1.50
0.35
0.54
0.35
0.54
0.04
1.89
2.08
1.89
2.08
XXXG0268

A
Removal of impacted wax md
0.61
0.60
0.62
0.17
0.22
0.02
1.23
1.25
0.80
0.85
000G0270

A
MNT subs tx for change dx
0.37
0.10
0.38
0.09
0.38
0.01
0.48
0.76
0.47
0.76
XXXG0271

A
Group MNT 2 or more 30 mins
0.25
0.06
0.15
0.06
0.15
0.01
0.32
0.41
0.32
0.41
XXXG0275

A
Renal angio, cardiac cath
0.25
NA
NA
0.14
0.11
0.01
NA
NA
0.40
0.37
ZZZG0278

A
Iliac art angio,cardiac cath
0.25
NA
NA
0.14
0.11
0.01
NA
NA
0.40
0.37
ZZZG0281

A
Elec stim unattend for press
0.18
0.15
0.12
NA
NA
0.01
0.34
0.31
NA
NA
XXXG0283

A
Elec stim other than wound
0.18
0.15
0.12
NA
NA
0.01
0.34
0.31
NA
NA
XXXG0288

A
Recon, CTA for surg plan
0.00
0.99
8.21
NA
NA
0.18
1.17
8.39
NA
NA
XXXG0289

A
Arthro, loose body + chondro
1.48
NA
NA
0.59
0.75
0.26
NA
NA
2.33
2.49
ZZZG0308

A
ESRD related svc 4+mo < 2yrs
12.74
5.52
7.79
5.52
7.79
0.42
18.68
20.95
18.68
20.95
XXXG0309

A
ESRD related svc 2-3mo <2yrs
10.61
4.80
6.53
4.80
6.53
0.36
15.77
17.50
15.77
17.50
XXXG0310

A
ESRD related svc 1 vst <2yrs
8.49
2.87
4.98
2.87
4.98
0.28
11.64
13.75
11.64
13.75
XXXG0311

A
ESRD related svs 4+mo 2-11yr
9.73
3.59
4.44
3.59
4.44
0.34
13.66
14.51
13.66
14.51
XXXG0312

A
ESRD relate svs 2-3 mo 2-11y
8.11
2.67
3.61
2.67
3.61
0.29
11.07
12.01
11.07
12.01
XXXG0313

A
ESRD related svs 1 mon 2-11y
6.49
1.86
2.82
1.86
2.82
0.22
8.57
9.53
8.57
9.53
XXXG0314

A
ESRD related svs 4+ mo 12-19
8.28
3.43
4.17
3.43
4.17
0.27
11.98
12.72
11.98
12.72
XXXG0315

A
ESRD related svs 2-3mo/12-19
6.90
2.61
3.41
2.61
3.41
0.23
9.74
10.54
9.74
10.54
XXXG0316

A
ESRD related svs 1vis/12-19y
5.52
1.69
2.63
1.69
2.63
0.17
7.38
8.32
7.38
8.32
XXXG0317

A
ESRD related svs 4+mo 20+yrs
5.09
2.27
2.71
2.27
2.71
0.17
7.53
7.97
7.53
7.97
XXXG0318

A
ESRD related svs 2-3 mo 20+y
4.24
1.71
2.21
1.71
2.21
0.14
6.09
6.59
6.09
6.59
XXXG0319

A
ESRD related svs 1visit 20+y
3.39
1.14
1.71
1.14
1.71
0.11
4.64
5.21
4.64
5.21
XXXG0320

A
ESD related svs home undr 2
10.61
2.68
6.00
2.68
6.00
0.36
13.65
16.97
13.65
16.97
XXXG0321

A
ESRDrelatedsvs home mo 2-11y
8.11
1.99
3.44
1.99
3.44
0.29
10.39
11.84
10.39
11.84
XXXG0322

A
ESRD related svs hom mo12-19
6.90
1.73
3.19
1.73
3.19
0.23
8.86
10.32
8.86
10.32
XXXG0323

A
ESRD related svs home mo 20+
4.24
1.16
2.08
1.16
2.08
0.14
5.54
6.46
5.54
6.46
XXXG0324

A
ESRD relate svs home/dy <2yr
0.35
0.16
0.22
0.16
0.22
0.01
0.52
0.58
0.52
0.58
XXXG0325

A
ESRD relate home/day/ 2-11yr
0.23
0.09
0.11
0.09
0.11
0.01
0.33
0.35
0.33
0.35
XXXG0326

A
ESRD relate home/dy 12-19yr
0.27
0.10
0.12
0.10
0.12
0.01
0.38
0.40
0.38
0.40
XXXG0327

A
ESRD relate home/dy 20+yrs
0.14
0.06
0.08
0.06
0.08
0.01
0.21
0.23
0.21
0.23
XXXG0329

A
Electromagntic tx for ulcers
0.06
0.16
0.15
NA
NA
0.01
0.23
0.22
NA
NA
XXXG0332

D
Preadmin IV immunoglobulin
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXXG0337

X
Hospice evaluation preelecti
1.34
0.31
0.46
0.31
0.46
0.09
1.74
1.89
1.74
1.89
XXXG0339

C
Robot lin-radsurg com, first
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXXG0340

C
Robt lin-radsurg fractx 2-5
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXXG0341

A
Percutaneous islet celltrans
6.98
NA
NA
2.14
2.48
0.48
NA
NA
9.60
9.94
000G0342

A
Laparoscopy islet cell trans
11.92
NA
NA
5.13
5.25
1.46
NA
NA
18.51
18.63
090G0343

A
Laparotomy islet cell transp
19.85
NA
NA
8.69
8.74
2.06
NA
NA
30.60
30.65
090G0344

A
Initial preventive exam
1.34
1.10
1.12
0.42
0.47
0.10
2.54
2.56
1.86
1.91
XXXG0364

A
Bone marrow aspirate &biopsy
0.16
0.16
0.15
0.07
0.06
0.04
0.36
0.35
0.27
0.26
ZZZG0365

A
Vessel mapping hemo access
0.25
5.34
4.33
NA
NA
0.25
5.84
4.83
NA
NA
XXXG0365
26
A
Vessel mapping hemo access
0.25
0.07
0.09
0.07
0.09
0.02
0.34
0.36
0.34
0.36
XXXG0365
TC
A
Vessel mapping hemo access
0.00
5.27
4.24
NA
NA
0.23
5.50
4.47
NA
NA
XXXG0366

A
EKG for initial prevent exam
0.17
0.35
0.47
0.35
0.47
0.03
0.55
0.67
0.55
0.67
XXXG0367

A
EKG tracing for initial prev
0.00
0.28
0.41
NA
NA
0.02
0.30
0.43
NA
NA
XXXG0368

A
EKG interpret & report preve
0.17
0.07
0.06
0.07
0.06
0.01
0.25
0.24
0.25
0.24
XXXG0372

A
MD service required for PMD
0.17
0.04
0.30
0.04
0.06
0.01
0.22
0.48
0.22
0.24
XXXG0375

A
Smoke/tobacco counselng 3-10
0.24
0.07
0.09
0.07
0.09
0.01
0.32
0.34
0.32
0.34
XXXG0376

A
Smoke/tobacco counseling >10
0.48
0.13
0.17
0.13
0.16
0.01
0.62
0.66
0.62
0.65
XXXGxxx1

A
Ultrasound exam AAA screen
0.58
2.42
1.81
NA
NA
0.11
3.11
2.50
NA
NA
XXXGxxx1
26
A
Ultrasound exam AAA screen
0.58
0.19
0.19
0.19
0.19
0.03
0.80
0.80
0.80
0.80
XXXGxxx1
TC
A
Ultrasound exam AAA screen
0.00
2.23
1.62
NA
NA
0.08
2.31
1.70
NA
NA
XXXM0064

A
Visit for drug monitoring
0.37
0.89
0.48
0.06
0.11
0.01
1.27
0.86
0.44
0.49
XXXP3001

A
Screening pap smear by phys
0.42
0.38
0.21
0.38
0.21
0.02
0.82
0.65
0.82
0.65
XXXQ0035

A
Cardiokymography
0.17
0.30
0.41
NA
NA
0.03
0.50
0.61
NA
NA
XXXQ0035
26
A
Cardiokymography
0.17
0.05
0.06
0.05
0.06
0.01
0.23
0.24
0.23
0.24
XXXQ0035
TC
A
Cardiokymography
0.00
0.25
0.36
NA
NA
0.02
0.27
0.38
NA
NA
XXXQ0091

A
Obtaining screen pap smear
0.37
0.76
0.69
0.10
0.13
0.02
1.15
1.08
0.49
0.52
XXXQ0092

A
Set up port xray equipment
0.00
0.50
0.37
0.50
0.37
0.01
0.51
0.38
0.51
0.38
XXXQ3001

C
Brachytherapy Radioelements
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
XXXR0070

C
Transport portable x-ray
0.00
0.00
0.00
0.00
0.00
0
0.00
0.00
0.00
0.00
XXXR0075

C
Transport port x-ray multipl
0.00
0.00
0.00
0.00
0.00
0
0.00
0.00
0.00
0.00
XXX1
                                 CPT codes and descriptors only are copyright 2005 American Medical Association.  All rights reserved.  Applicable FARS/DFARS apply.2
                                 Copyright 2005 American Dental Association.  All rights reserved.
 
 
 Addendum C.—Codes for Which We Received PERC Recommendations on PE Direct Cost Inputs
CPT Codes
Short descriptor00100
Anesth, salivary gland00102
Anesth, repair of cleft lip00103
Anesth, blepharoplasty00104
Anesth, electroshock00120
Anesth, ear surgery00124
Anesth, ear exam00126
Anesth, tympanotomy00140
Anesth, procedures on eye00142
Anesth, lens surgery00144
Anesth, corneal transplant00145
Anesth, vitreoretinal surg00147
Anesth, iridectomy00148
Anesth, eye exam00160
Anesth, nose/sinus surgery00162
Anesth, nose/sinus surgery00164
Anesth, biopsy of nose00170
Anesth, procedure on mouth00172
Anesth, cleft palate repair00174
Anesth, pharyngeal surgery00176
Anesth, pharyngeal surgery00190
Anesth, face/skull bone surg00192
Anesth, facial bone surgery00210
Anesth, open head surgery00212
Anesth, skull drainage00214
Anesth, skull drainage00215
Anesth, skull repair/fract00216
Anesth, head vessel surgery00218
Anesth, special head surgery00220
Anesth, intrcrn nerve00222
Anesth, head nerve surgery00300
Anesth, head/neck/ptrunk00320
Anesth, neck organ, 1 & over00322
Anesth, biopsy of thyroid00326
Anesth, larynx/trach, < 1 yr00350
Anesth, neck vessel surgery00352
Anesth, neck vessel surgery00400
Anesth, skin, ext/per/atrunk00402
Anesth, surgery of breast00404
Anesth, surgery of breast00406
Anesth, surgery of breast00410
Anesth, correct heart rhythm00450
Anesth, surgery of shoulder00452
Anesth, surgery of shoulder00454
Anesth, collar bone biopsy00470
Anesth, removal of rib00472
Anesth, chest wall repair00474
Anesth, surgery of rib(s)00500
Anesth, esophageal surgery00520
Anesth, chest procedure00522
Anesth, chest lining biopsy00524
Anesth, chest drainage00528
Anesth, chest partition view00529
Anesth, chest partition view00530
Anesth, pacemaker insertion00532
Anesth, vascular access00534
Anesth, cardioverter/defib00537
Anesth, cardiac electrophys00539
Anesth, trach-bronch reconst00540
Anesth, chest surgery00541
Anesth, one lung ventilation00542
Anesth, release of lung00546
Anesth, lung,chest wall surg00548
Anesth, trachea,bronchi surg00550
Anesth, sternal debridement00560
Anesth, heart surg w/o pump00561
Anesth, heart surg < age 100562
Anesth, heart surg w/pump00563
Anesth, heart surg w/arrest00566
Anesth, cabg w/o pump00580
Anesth, heart/lung transplnt00600
Anesth, spine, cord surgery00604
Anesth, sitting procedure00620
Anesth, spine, cord surgery00622
Anesth, removal of nerves00630
Anesth, spine, cord surgery00632
Anesth, removal of nerves00634
Anesth for chemonucleolysis00635
Anesth, lumbar puncture00640
Anesth, spine manipulation00670
Anesth, spine, cord surgery00700
Anesth, abdominal wall surg00702
Anesth, for liver biopsy00730
Anesth, abdominal wall surg00740
Anesth, upper gi visualize00750
Anesth, repair of hernia00752
Anesth, repair of hernia00754
Anesth, repair of hernia00756
Anesth, repair of hernia00770
Anesth, blood vessel repair00790
Anesth, surg upper abdomen00792
Anesth, hemorr/excise liver00794
Anesth, pancreas removal00796
Anesth, for liver transplant00797
Anesth, surgery for obesity00800
Anesth, abdominal wall surg00802
Anesth, fat layer removal00810
Anesth, low intestine scope00820
Anesth, abdominal wall surg00830
Anesth, repair of hernia00832
Anesth, repair of hernia00834
Anesth, hernia repair < 1 yr00836
Anesth hernia repair preemie00840
Anesth, surg lower abdomen00842
Anesth, amniocentesis00844
Anesth, pelvis surgery00846
Anesth, hysterectomy00848
Anesth, pelvic organ surg00851
Anesth, tubal ligation00860
Anesth, surgery of abdomen00862
Anesth, kidney/ureter surg00864
Anesth, removal of bladder00865
Anesth, removal of prostate00866
Anesth, removal of adrenal00868
Anesth, kidney transplant00870
Anesth, bladder stone surg00872
Anesth kidney stone destruct00873
Anesth kidney stone destruct00880
Anesth, abdomen vessel surg00882
Anesth, major vein ligation00902
Anesth, anorectal surgery00904
Anesth, perineal surgery00906
Anesth, removal of vulva00908
Anesth, removal of prostate00910
Anesth, bladder surgery00912
Anesth, bladder tumor surg00914
Anesth, removal of prostate00916
Anesth, bleeding control00918
Anesth, stone removal00920
Anesth, genitalia surgery00921
Anesth, vasectomy00922
Anesth, sperm duct surgery00924
Anesth, testis exploration00926
Anesth, removal of testis00928
Anesth, removal of testis00930
Anesth, testis suspension00932
Anesth, amputation of penis00934
Anesth, penis, nodes removal00936
Anesth, penis, nodes removal00938
Anesth, insert penis device00940
Anesth, vaginal procedures00942
Anesth, surg on vag/urethral00944
Anesth, vaginal hysterectomy00948
Anesth, repair of cervix00950
Anesth, vaginal endoscopy00952
Anesth, hysteroscope/graph01112
Anesth, bone aspirate/bx01120
Anesth, pelvis surgery01130
Anesth, body cast procedure01140
Anesth, amputation at pelvis01150
Anesth, pelvic tumor surgery01160
Anesth, pelvis procedure01170
Anesth, pelvis surgery01173
Anesth, fx repair, pelvis01180
Anesth, pelvis nerve removal01190
Anesth, pelvis nerve removal01200
Anesth, hip joint procedure01202
Anesth, arthroscopy of hip01210
Anesth, hip joint surgery01212
Anesth, hip disarticulation01214
Anesth, hip arthroplasty01215
Anesth, revise hip repair01220
Anesth, procedure on femur01230
Anesth, surgery of femur01232
Anesth, amputation of femur01234
Anesth, radical femur surg01250
Anesth, upper leg surgery01260
Anesth, upper leg veins surg01270
Anesth, thigh arteries surg01272
Anesth, femoral artery surg01274
Anesth, femoral embolectomy01320
Anesth, knee area surgery01340
Anesth, knee area procedure01360
Anesth, knee area surgery01380
Anesth, knee joint procedure01382
Anesth, dx knee arthroscopy01390
Anesth, knee area procedure01392
Anesth, knee area surgery01400
Anesth, knee joint surgery01402
Anesth, knee arthroplasty01404
Anesth, amputation at knee01420
Anesth, knee joint casting01430
Anesth, knee veins surgery01432
Anesth, knee vessel surg01440
Anesth, knee arteries surg01442
Anesth, knee artery surg01444
Anesth, knee artery repair01462
Anesth, lower leg procedure01464
Anesth, ankle/ft arthroscopy01470
Anesth, lower leg surgery01472
Anesth, achilles tendon surg01474
Anesth, lower leg surgery01480
Anesth, lower leg bone surg01482
Anesth, radical leg surgery01484
Anesth, lower leg revision01486
Anesth, ankle replacement01490
Anesth, lower leg casting01500
Anesth, leg arteries surg01502
Anesth, lwr leg embolectomy01520
Anesth, lower leg vein surg01522
Anesth, lower leg vein surg01610
Anesth, surgery of shoulder( print page 49237)01620
Anesth, shoulder procedure01622
Anes dx shoulder arthroscopy01630
Anesth, surgery of shoulder01632
Anesth, surgery of shoulder01634
Anesth, shoulder joint amput01636
Anesth, forequarter amput01638
Anesth, shoulder replacement01650
Anesth, shoulder artery surg01652
Anesth, shoulder vessel surg01654
Anesth, shoulder vessel surg01656
Anesth, arm-leg vessel surg01670
Anesth, shoulder vein surg01680
Anesth, shoulder casting01682
Anesth, airplane cast01710
Anesth, elbow area surgery01712
Anesth, uppr arm tendon surg01714
Anesth, uppr arm tendon surg01716
Anesth, biceps tendon repair01730
Anesth, uppr arm procedure01732
Anesth, dx elbow arthroscopy01740
Anesth, upper arm surgery01742
Anesth, humerus surgery01744
Anesth, humerus repair01756
Anesth, radical humerus surg01758
Anesth, humeral lesion surg01760
Anesth, elbow replacement01770
Anesth, uppr arm artery surg01772
Anesth, uppr arm embolectomy01780
Anesth, upper arm vein surg01782
Anesth, uppr arm vein repair01810
Anesth, lower arm surgery01820
Anesth, lower arm procedure01829
Anesth, dx wrist arthroscopy01830
Anesth, lower arm surgery01832
Anesth, wrist replacement01840
Anesth, lwr arm artery surg01842
Anesth, lwr arm embolectomy01844
Anesth, vascular shunt surg01850
Anesth, lower arm vein surg01852
Anesth, lwr arm vein repair01860
Anesth, lower arm casting01905
Anes, spine inject, x-ray/re01916
Anesth, dx arteriography01920
Anesth, catheterize heart01922
Anesth, cat or mri scan01924
Anes, ther interven rad, art01925
Anes, ther interven rad, car01926
Anes, tx interv rad hrt/cran01930
Anes, ther interven rad, vei01931
Anes, ther interven rad, tip01932
Anes, tx interv rad, th vein01933
Anes, tx interv rad, cran v01951
Anesth, burn, less 4 percent01952
Anesth, burn, 4-9 percent01953
Anesth, burn, each 9 percent01958
Anesth, antepartum manipul01960
Anesth, vaginal delivery01961
Anesth, cs delivery01962
Anesth, emer hysterectomy01963
Anesth, cs hysterectomy01965
Anesth, inc/missed ab proc01966
Anesth, induced ab procedure01967
Anesth/analg, vag delivery01968
Anes/analg cs deliver add-on01969
Anesth/analg cs hyst add-on01990
Support for organ donor01991
Anesth, nerve block/inj01992
Anesth, n block/inj, prone01995
Regional anesthesia limb01996
Hosp manage cont drug admin01999
Unlisted anesth procedure23500
Treat clavicle fracture23680
Treat dislocation/fracture24130
Removal of head of radius24134
Removal of arm bone lesion24136
Remove radius bone lesion24138
Remove elbow bone lesion24140
Partial removal of arm bone24145
Partial removal of radius24147
Partial removal of elbow24495
Decompression of forearm24500
Treat humerus fracture24500
Treat humerus fracture24505
Treat humerus fracture24515
Treat humerus fracture24516
Treat humerus fracture24530
Treat humerus fracture24535
Treat humerus fracture24538
Treat humerus fracture24545
Treat humerus fracture24546
Treat humerus fracture24560
Treat humerus fracture24565
Treat humerus fracture24566
Treat humerus fracture24575
Treat humerus fracture24576
Treat humerus fracture24577
Treat humerus fracture24579
Treat humerus fracture24582
Treat humerus fracture24586
Treat elbow fracture24587
Treat elbow fracture24600
Treat elbow dislocation24605
Treat elbow dislocation24615
Treat elbow dislocation24620
Treat elbow fracture24635
Treat elbow fracture24640
Treat elbow dislocation24650
Treat radius fracture24655
Treat radius fracture24665
Treat radius fracture24666
Treat radius fracture24670
Treat ulnar fracture24675
Treat ulnar fracture24685
Treat ulnar fracture25000
Incision of tendon sheath25020
Decompress forearm 1 space25023
Decompress forearm 1 space25028
Drainage of forearm lesion25031
Drainage of forearm bursa25035
Treat forearm bone lesion25040
Explore/treat wrist joint25066
Biopsy forearm soft tissues25075
Removal forearm lesion subcu25076
Removal forearm lesion deep25077
Remove tumor, forearm/wrist25085
Incision of wrist capsule25100
Biopsy of wrist joint25101
Explore/treat wrist joint25105
Remove wrist joint lining25107
Remove wrist joint cartilage25110
Remove wrist tendon lesion25111
Remove wrist tendon lesion25112
Reremove wrist tendon lesion25115
Remove wrist/forearm lesion25116
Remove wrist/forearm lesion25118
Excise wrist tendon sheath25119
Partial removal of ulna25120
Removal of forearm lesion25125
Remove/graft forearm lesion25126
Remove/graft forearm lesion25130
Removal of wrist lesion25135
Remove & graft wrist lesion25136
Remove & graft wrist lesion25145
Remove forearm bone lesion25150
Partial removal of ulna25151
Partial removal of radius25170
Extensive forearm surgery25210
Removal of wrist bone25215
Removal of wrist bones25230
Partial removal of radius25240
Partial removal of ulna25248
Remove forearm foreign body25260
Repair forearm tendon/muscle25263
Repair forearm tendon/muscle25265
Repair forearm tendon/muscle25270
Repair forearm tendon/muscle25272
Repair forearm tendon/muscle25274
Repair forearm tendon/muscle25280
Revise wrist/forearm tendon25290
Incise wrist/forearm tendon25295
Release wrist/forearm tendon25300
Fusion of tendons at wrist25301
Fusion of tendons at wrist25310
Transplant forearm tendon25312
Transplant forearm tendon25315
Revise palsy hand tendon(s)25316
Revise palsy hand tendon(s)25320
Repair/revise wrist joint25335
Realignment of hand25337
Reconstruct ulna/radioulnar25350
Revision of radius25355
Revision of radius25360
Revision of ulna25365
Revise radius & ulna25370
Revise radius or ulna25375
Revise radius & ulna25390
Shorten radius or ulna25391
Lengthen radius or ulna25392
Shorten radius & ulna25393
Lengthen radius & ulna25400
Repair radius or ulna25405
Repair/graft radius or ulna25415
Repair radius & ulna25420
Repair/graft radius & ulna25425
Repair/graft radius or ulna25426
Repair/graft radius & ulna25440
Repair/graft wrist bone25450
Revision of wrist joint25455
Revision of wrist joint25490
Reinforce radius25491
Reinforce ulna25492
Reinforce radius and ulna25500
Treat fracture of radius25505
Treat fracture of radius25515
Treat fracture of radius25520
Treat fracture of radius25525
Treat fracture of radius25526
Treat fracture of radius25530
Treat fracture of ulna25535
Treat fracture of ulna25545
Treat fracture of ulna( print page 49238)25560
Treat fracture radius & ulna25565
Treat fracture radius & ulna25574
Treat fracture radius & ulna25575
Treat fracture radius/ulna25600
Treat fracture radius/ulna25605
Treat fracture radius/ulna25611
Treat fracture radius/ulna25620
Treat fracture radius/ulna25622
Treat wrist bone fracture25624
Treat wrist bone fracture25628
Treat wrist bone fracture25630
Treat wrist bone fracture25635
Treat wrist bone fracture25645
Treat wrist bone fracture25650
Treat wrist bone fracture25651
Pin ulnar styloid fracture25652
Treat fracture ulnar styloid25660
Treat wrist dislocation25670
Treat wrist dislocation25671
Pin radioulnar dislocation25675
Treat wrist dislocation25676
Treat wrist dislocation25680
Treat wrist fracture25685
Treat wrist fracture25690
Treat wrist dislocation25695
Treat wrist dislocation25800
Fusion of wrist joint25805
Fusion/graft of wrist joint25810
Fusion/graft of wrist joint25820
Fusion of hand bones25825
Fuse hand bones with graft25830
Fusion, radioulnar jnt/ulna25900
Amputation of forearm25905
Amputation of forearm25907
Amputation follow-up surgery25909
Amputation follow-up surgery25915
Amputation of forearm25920
Amputate hand at wrist25922
Amputate hand at wrist25924
Amputation follow-up surgery25927
Amputation of hand25929
Amputation follow-up surgery25931
Amputation follow-up surgery26350
Repair finger/hand tendon26352
Repair/graft hand tendon26356
Repair finger/hand tendon26357
Repair finger/hand tendon26358
Repair/graft hand tendon26370
Repair finger/hand tendon26372
Repair/graft hand tendon26373
Repair finger/hand tendon26390
Revise hand/finger tendon26392
Repair/graft hand tendon26410
Repair hand tendon26412
Repair/graft hand tendon26415
Excision, hand/finger tendon26416
Graft hand or finger tendon26418
Repair finger tendon26420
Repair/graft finger tendon26426
Repair finger/hand tendon26428
Repair/graft finger tendon26432
Repair finger tendon26433
Repair finger tendon26434
Repair/graft finger tendon26437
Realignment of tendons26440
Release palm/finger tendon26442
Release palm & finger tendon26445
Release hand/finger tendon26449
Release forearm/hand tendon26450
Incision of palm tendon26455
Incision of finger tendon26460
Incise hand/finger tendon26471
Fusion of finger tendons26474
Fusion of finger tendons26476
Tendon lengthening26477
Tendon shortening26478
Lengthening of hand tendon26479
Shortening of hand tendon26480
Transplant hand tendon26483
Transplant/graft hand tendon26485
Transplant palm tendon26489
Transplant/graft palm tendon26490
Revise thumb tendon26492
Tendon transfer with graft26494
Hand tendon/muscle transfer26496
Revise thumb tendon26497
Finger tendon transfer26498
Finger tendon transfer26499
Revision of finger26500
Hand tendon reconstruction26502
Hand tendon reconstruction26504
Hand tendon reconstruction26508
Release thumb contracture26510
Thumb tendon transfer26516
Fusion of knuckle joint26517
Fusion of knuckle joints26518
Fusion of knuckle joints26520
Release knuckle contracture26525
Release finger contracture26536
Revise/implant finger joint26540
Repair hand joint26541
Repair hand joint with graft26542
Repair hand joint with graft26545
Reconstruct finger joint26548
Reconstruct finger joint26550
Construct thumb replacement26555
Positional change of finger26560
Repair of web finger26561
Repair of web finger26562
Repair of web finger26565
Correct metacarpal flaw26567
Correct finger deformity26568
Lengthen metacarpal/finger26580
Repair hand deformity26590
Repair finger deformity26591
Repair muscles of hand26593
Release muscles of hand26596
Excision constricting tissue26600
Treat metacarpal fracture26605
Treat metacarpal fracture26607
Treat metacarpal fracture26608
Treat metacarpal fracture26615
Treat metacarpal fracture26641
Treat thumb dislocation26645
Treat thumb fracture26650
Treat thumb fracture26665
Treat thumb fracture26670
Treat hand dislocation26675
Treat hand dislocation26676
Pin hand dislocation26685
Treat hand dislocation26686
Treat hand dislocation26700
Treat knuckle dislocation26705
Treat knuckle dislocation26706
Pin knuckle dislocation26715
Treat knuckle dislocation26720
Treat finger fracture, each26725
Treat finger fracture, each26727
Treat finger fracture, each26735
Treat finger fracture, each26740
Treat finger fracture, each26742
Treat finger fracture, each26746
Treat finger fracture, each26750
Treat finger fracture, each26755
Treat finger fracture, each26756
Pin finger fracture, each26765
Treat finger fracture, each26770
Treat finger dislocation26775
Treat finger dislocation26776
Pin finger dislocation26785
Treat finger dislocation26820
Thumb fusion with graft26841
Fusion of thumb26842
Thumb fusion with graft26843
Fusion of hand joint26844
Fusion/graft of hand joint26850
Fusion of knuckle26852
Fusion of knuckle with graft26860
Fusion of finger joint26862
Fusion/graft of finger joint26910
Amputate metacarpal bone26951
Amputation of finger/thumb26952
Amputation of finger/thumb27000
Incision of hip tendon27001
Incision of hip tendon27003
Incision of hip tendon27005
Incision of hip tendon27006
Incision of hip tendons27025
Incision of hip/thigh fascia27030
Drainage of hip joint27033
Exploration of hip joint27035
Denervation of hip joint27041
Biopsy of soft tissues27048
Remove hip/pelvis lesion27049
Remove tumor, hip/pelvis27050
Biopsy of sacroiliac joint27052
Biopsy of hip joint27054
Removal of hip joint lining27060
Removal of ischial bursa27062
Remove femur lesion/bursa27065
Removal of hip bone lesion27066
Removal of hip bone lesion27067
Remove/graft hip bone lesion27075
Extensive hip surgery27076
Extensive hip surgery27077
Extensive hip surgery27078
Extensive hip surgery27079
Extensive hip surgery27080
Removal of tail bone27087
Remove hip foreign body27202
Treat tail bone fracture27310
Exploration of knee joint27315
Partial removal, thigh nerve27320
Partial removal, thigh nerve27324
Biopsy, thigh soft tissues27328
Removal of thigh lesion27329
Remove tumor, thigh/knee27330
Biopsy, knee joint lining27331
Explore/treat knee joint27332
Removal of knee cartilage27333
Removal of knee cartilage( print page 49239)27334
Remove knee joint lining27335
Remove knee joint lining27340
Removal of kneecap bursa27345
Removal of knee cyst27350
Removal of kneecap27355
Remove femur lesion27356
Remove femur lesion/graft27357
Remove femur lesion/graft27365
Extensive leg surgery27380
Repair of kneecap tendon27381
Repair/graft kneecap tendon27385
Repair of thigh muscle27386
Repair/graft of thigh muscle27455
Realignment of knee27500
Treatment of thigh fracture27501
Treatment of thigh fracture27502
Treatment of thigh fracture27506
Treatment of thigh fracture27507
Treatment of thigh fracture27508
Treatment of thigh fracture27509
Treatment of thigh fracture27510
Treatment of thigh fracture27511
Treatment of thigh fracture27513
Treatment of thigh fracture27514
Treatment of thigh fracture27516
Treat thigh fx growth plate27517
Treat thigh fx growth plate27519
Treat thigh fx growth plate27520
Treat kneecap fracture27524
Treat kneecap fracture27530
Treat knee fracture27532
Treat knee fracture27535
Treat knee fracture27536
Treat knee fracture27538
Treat knee fracture(s)27540
Treat knee fracture27550
Treat knee dislocation27552
Treat knee dislocation27556
Treat knee dislocation27557
Treat knee dislocation27558
Treat knee dislocation27560
Treat kneecap dislocation27562
Treat kneecap dislocation27566
Treat kneecap dislocation27580
Fusion of knee27590
Amputate leg at thigh27591
Amputate leg at thigh27592
Amputate leg at thigh27594
Amputation follow-up surgery27596
Amputation follow-up surgery27598
Amputate lower leg at knee27600
Decompression of lower leg27601
Decompression of lower leg27602
Decompression of lower leg27607
Treat lower leg bone lesion27610
Explore/treat ankle joint27612
Exploration of ankle joint27615
Remove tumor, lower leg27620
Explore/treat ankle joint27625
Remove ankle joint lining27626
Remove ankle joint lining27635
Remove lower leg bone lesion27637
Remove/graft leg bone lesion27638
Remove/graft leg bone lesion27640
Partial removal of tibia27641
Partial removal of fibula27645
Extensive lower leg surgery27646
Extensive lower leg surgery27647
Extensive ankle/heel surgery27650
Repair achilles tendon27652
Repair/graft achilles tendon27654
Repair of achilles tendon27675
Repair lower leg tendons27676
Repair lower leg tendons27680
Release of lower leg tendon27681
Release of lower leg tendons27687
Revision of calf tendon27690
Revise lower leg tendon27691
Revise lower leg tendon27695
Repair of ankle ligament27696
Repair of ankle ligaments27698
Repair of ankle ligament27705
Incision of tibia27707
Incision of fibula27709
Incision of tibia & fibula27712
Realignment of lower leg27715
Revision of lower leg27720
Repair of tibia27722
Repair/graft of tibia27724
Repair/graft of tibia27725
Repair of lower leg27727
Repair of lower leg27734
Repair lower leg epiphyses27745
Reinforce tibia27750
Treatment of tibia fracture27752
Treatment of tibia fracture27756
Treatment of tibia fracture27758
Treatment of tibia fracture27759
Treatment of tibia fracture27760
Treatment of ankle fracture27762
Treatment of ankle fracture27766
Treatment of ankle fracture27780
Treatment of fibula fracture27781
Treatment of fibula fracture27784
Treatment of fibula fracture27786
Treatment of ankle fracture27788
Treatment of ankle fracture27792
Treatment of ankle fracture27808
Treatment of ankle fracture27810
Treatment of ankle fracture27814
Treatment of ankle fracture27816
Treatment of ankle fracture27818
Treatment of ankle fracture27822
Treatment of ankle fracture27823
Treatment of ankle fracture27824
Treat lower leg fracture27825
Treat lower leg fracture27826
Treat lower leg fracture27827
Treat lower leg fracture27828
Treat lower leg fracture27829
Treat lower leg joint27830
Treat lower leg dislocation27831
Treat lower leg dislocation27832
Treat lower leg dislocation27840
Treat ankle dislocation27842
Treat ankle dislocation27846
Treat ankle dislocation27848
Treat ankle dislocation27870
Fusion of ankle joint, open27871
Fusion of tibiofibular joint27880
Amputation of lower leg27881
Amputation of lower leg27882
Amputation of lower leg27884
Amputation follow-up surgery27886
Amputation follow-up surgery27888
Amputation of foot at ankle27889
Amputation of foot at ankle27892
Decompression of leg27893
Decompression of leg27894
Decompression of leg28030
Removal of foot nerve28102
Remove/graft foot lesion28106
Remove/graft foot lesion28130
Removal of ankle bone28309
Incision of metatarsals28320
Repair of foot bones28400
Treatment of heel fracture28405
Treatment of heel fracture28406
Treatment of heel fracture28415
Treat heel fracture28420
Treat/graft heel fracture28430
Treatment of ankle fracture28435
Treatment of ankle fracture28436
Treatment of ankle fracture28445
Treat ankle fracture28450
Treat midfoot fracture, each28455
Treat midfoot fracture, each28456
Treat midfoot fracture28465
Treat midfoot fracture, each28470
Treat metatarsal fracture28475
Treat metatarsal fracture28476
Treat metatarsal fracture28485
Treat metatarsal fracture28490
Treat big toe fracture28495
Treat big toe fracture28496
Treat big toe fracture28505
Treat big toe fracture28510
Treatment of toe fracture28515
Treatment of toe fracture28525
Treat toe fracture28530
Treat sesamoid bone fracture28531
Treat sesamoid bone fracture28540
Treat foot dislocation28545
Treat foot dislocation28546
Treat foot dislocation28555
Repair foot dislocation28570
Treat foot dislocation28575
Treat foot dislocation28576
Treat foot dislocation28585
Repair foot dislocation28600
Treat foot dislocation28605
Treat foot dislocation28606
Treat foot dislocation28615
Repair foot dislocation28630
Treat toe dislocation28635
Treat toe dislocation28636
Treat toe dislocation28645
Repair toe dislocation28660
Treat toe dislocation28665
Treat toe dislocation28666
Treat toe dislocation28675
Repair of toe dislocation28705
Fusion of foot bones28715
Fusion of foot bones28725
Fusion of foot bones28730
Fusion of foot bones28735
Fusion of foot bones28737
Revision of foot bones29000
Application of body cast29010
Application of body cast29015
Application of body cast( print page 49240)29020
Application of body cast29025
Application of body cast29035
Application of body cast29040
Application of body cast29044
Application of body cast29046
Application of body cast29049
Application of figure eight29055
Application of shoulder cast29058
Application of shoulder cast29065
Application of long arm cast29075
Application of forearm cast29085
Apply hand/wrist cast29086
Apply finger cast29105
Apply long arm splint29125
Apply forearm splint29126
Apply forearm splint29130
Application of finger splint29131
Application of finger splint29200
Strapping of chest29220
Strapping of low back29240
Strapping of shoulder29260
Strapping of elbow or wrist29280
Strapping of hand or finger29305
Application of hip cast29325
Application of hip casts29345
Application of long leg cast29355
Application of long leg cast29358
Apply long leg cast brace29365
Application of long leg cast29405
Apply short leg cast29425
Apply short leg cast29435
Apply short leg cast29440
Addition of walker to cast29445
Apply rigid leg cast29450
Application of leg cast29505
Application, long leg splint29515
Application lower leg splint29520
Strapping of hip29530
Strapping of knee29540
Strapping of ankle and/or ft29550
Strapping of toes29580
Application of paste boot29590
Application of foot splint29700
Removal/revision of cast29705
Removal/revision of cast29710
Removal/revision of cast29715
Removal/revision of cast29720
Repair of body cast29730
Windowing of cast29740
Wedging of cast29750
Wedging of clubfoot cast29800
Jaw arthroscopy/surgery29804
Jaw arthroscopy/surgery31760
Repair of windpipe31766
Reconstruction of windpipe31770
Repair/graft of bronchus31775
Reconstruct bronchus31780
Reconstruct windpipe31781
Reconstruct windpipe31785
Remove windpipe lesion31786
Remove windpipe lesion31805
Repair of windpipe injury32035
Exploration of chest32036
Exploration of chest32095
Biopsy through chest wall32100
Exploration/biopsy of chest32110
Explore/repair chest32120
Re-exploration of chest32124
Explore chest free adhesions32140
Removal of lung lesion(s)32141
Remove/treat lung lesions32150
Removal of lung lesion(s)32151
Remove lung foreign body32160
Open chest heart massage32200
Drain, open, lung lesion33015
Incision of heart sac33414
Repair of aortic valve33415
Revision, subvalvular tissue33417
Repair of aortic valve33468
Revision of tricuspid valve33470
Revision of pulmonary valve33471
Valvotomy, pulmonary valve33503
Coronary artery graft33504
Coronary artery graft33505
Repair artery w/tunnel33506
Repair artery, translocation33600
Closure of valve33602
Closure of valve33606
Anastomosis/artery-aorta33608
Repair anomaly w/conduit33610
Repair by enlargement33611
Repair double ventricle33612
Repair double ventricle33615
Repair, modified fontan33617
Repair single ventricle33619
Repair single ventricle33645
Revision of heart veins33647
Repair heart septum defects33660
Repair of heart defects33665
Repair of heart defects33670
Repair of heart chambers33681
Repair heart septum defect33684
Repair heart septum defect33688
Repair heart septum defect33690
Reinforce pulmonary artery33692
Repair of heart defects33694
Repair of heart defects33697
Repair of heart defects33702
Repair of heart defects33710
Repair of heart defects33720
Repair of heart defect33722
Repair of heart defect33730
Repair heart-vein defect(s)33732
Repair heart-vein defect33735
Revision of heart chamber33736
Revision of heart chamber33737
Revision of heart chamber33750
Major vessel shunt33755
Major vessel shunt33762
Major vessel shunt33764
Major vessel shunt & graft33766
Major vessel shunt33767
Major vessel shunt33770
Repair great vessels defect33771
Repair great vessels defect33774
Repair great vessels defect33775
Repair great vessels defect33776
Repair great vessels defect33777
Repair great vessels defect33778
Repair great vessels defect33779
Repair great vessels defect33780
Repair great vessels defect33781
Repair great vessels defect33786
Repair arterial trunk33788
Revision of pulmonary artery33800
Aortic suspension33802
Repair vessel defect33803
Repair vessel defect33813
Repair septal defect33814
Repair septal defect33820
Revise major vessel33822
Revise major vessel33840
Remove aorta constriction33845
Remove aorta constriction33851
Remove aorta constriction33852
Repair septal defect33853
Repair septal defect33917
Repair pulmonary artery33920
Repair pulmonary atresia33922
Transect pulmonary artery34001
Removal of artery clot34051
Removal of artery clot34101
Removal of artery clot34111
Removal of arm artery clot34201
Removal of artery clot34203
Removal of leg artery clot34401
Removal of vein clot34421
Removal of vein clot34451
Removal of vein clot34471
Removal of vein clot34490
Removal of vein clot34501
Repair valve, femoral vein34502
Reconstruct vena cava34510
Transposition of vein valve34520
Cross-over vein graft34530
Leg vein fusion35001
Repair defect of artery35002
Repair artery rupture, neck35005
Repair defect of artery35011
Repair defect of artery35013
Repair artery rupture, arm35021
Repair defect of artery35022
Repair artery rupture, chest35045
Repair defect of arm artery35111
Repair defect of artery35141
Repair defect of artery35142
Repair artery rupture, thigh35151
Repair defect of artery35152
Repair artery rupture, knee35180
Repair blood vessel lesion35184
Repair blood vessel lesion35188
Repair blood vessel lesion35190
Repair blood vessel lesion35201
Repair blood vessel lesion35206
Repair blood vessel lesion35207
Repair blood vessel lesion35226
Repair blood vessel lesion35231
Repair blood vessel lesion35236
Repair blood vessel lesion35246
Repair blood vessel lesion35261
Repair blood vessel lesion35266
Repair blood vessel lesion35286
Repair blood vessel lesion35311
Rechanneling of artery35321
Rechanneling of artery35371
Rechanneling of artery35372
Rechanneling of artery35381
Rechanneling of artery35501
Artery bypass graft35506
Artery bypass graft35507
Artery bypass graft( print page 49241)35508
Artery bypass graft35509
Artery bypass graft35511
Artery bypass graft35515
Artery bypass graft35516
Artery bypass graft35518
Artery bypass graft35526
Artery bypass graft35556
Artery bypass graft35558
Artery bypass graft35571
Artery bypass graft35583
Vein bypass graft35585
Vein bypass graft35587
Vein bypass graft35601
Artery bypass graft35606
Artery bypass graft35612
Artery bypass graft35616
Artery bypass graft35626
Artery bypass graft35642
Artery bypass graft35645
Artery bypass graft35650
Artery bypass graft35656
Artery bypass graft35661
Artery bypass graft35666
Artery bypass graft35671
Artery bypass graft35691
Arterial transposition35693
Arterial transposition35694
Arterial transposition35695
Arterial transposition35701
Exploration, carotid artery35721
Exploration, femoral artery35741
Exploration popliteal artery35761
Exploration of artery/vein35800
Explore neck vessels35860
Explore limb vessels35875
Removal of clot in graft35876
Removal of clot in graft35901
Excision, graft, neck35903
Excision, graft, extremity36260
Insertion of infusion pump36261
Revision of infusion pump36262
Removal of infusion pump36475
Endovenous rf, 1st vein36476
Endovenous rf, vein add-on36478
Endovenous laser, 1st vein36479
Endovenous laser vein addon36566
Insert tunneled cv cath36835
Artery to vein shunt37565
Ligation of neck vein37600
Ligation of neck artery37605
Ligation of neck artery37606
Ligation of neck artery38740
Remove armpit lymph nodes38745
Remove armpit lymph nodes38760
Remove groin lymph nodes38765
Remove groin lymph nodes38770
Remove pelvis lymph nodes38780
Remove abdomen lymph nodes39501
Repair diaphragm laceration39502
Repair paraesophageal hernia39503
Repair of diaphragm hernia39520
Repair of diaphragm hernia39530
Repair of diaphragm hernia39531
Repair of diaphragm hernia39540
Repair of diaphragm hernia39541
Repair of diaphragm hernia39545
Revision of diaphragm43045
Incision of esophagus43100
Excision of esophagus lesion43101
Excision of esophagus lesion43108
Removal of esophagus43113
Removal of esophagus43116
Partial removal of esophagus43118
Partial removal of esophagus43123
Partial removal of esophagus43124
Removal of esophagus43130
Removal of esophagus pouch43135
Removal of esophagus pouch43300
Repair of esophagus43320
Fuse esophagus & stomach43324
Revise esophagus & stomach43325
Revise esophagus & stomach43326
Revise esophagus & stomach43330
Repair of esophagus43331
Repair of esophagus43340
Fuse esophagus & intestine43341
Fuse esophagus & intestine43350
Surgical opening, esophagus43351
Surgical opening, esophagus43352
Surgical opening, esophagus43360
Gastrointestinal repair43361
Gastrointestinal repair43400
Ligate esophagus veins43401
Esophagus surgery for veins43405
Ligate/staple esophagus43410
Repair esophagus wound43415
Repair esophagus wound43420
Repair esophagus opening43425
Repair esophagus opening43500
Surgical opening of stomach43501
Surgical repair of stomach43502
Surgical repair of stomach43520
Incision of pyloric muscle43605
Biopsy of stomach43610
Excision of stomach lesion43611
Excision of stomach lesion43620
Removal of stomach43621
Removal of stomach43622
Removal of stomach43631
Removal of stomach, partial43632
Removal of stomach, partial43633
Removal of stomach, partial43634
Removal of stomach, partial43640
Vagotomy & pylorus repair43641
Vagotomy & pylorus repair43800
Reconstruction of pylorus43810
Fusion of stomach and bowel43820
Fusion of stomach and bowel43825
Fusion of stomach and bowel43830
Place gastrostomy tube43831
Place gastrostomy tube43832
Place gastrostomy tube43840
Repair of stomach lesion43842
V-band gastroplasty43846
Gastric bypass for obesity43847
Gastric bypass incl small i43848
Revision gastroplasty43850
Revise stomach-bowel fusion43855
Revise stomach-bowel fusion43860
Revise stomach-bowel fusion43865
Revise stomach-bowel fusion43870
Repair stomach opening43880
Repair stomach-bowel fistula44005
Freeing of bowel adhesion44010
Incision of small bowel44020
Explore small intestine44021
Decompress small bowel44025
Incision of large bowel44050
Reduce bowel obstruction44055
Correct malrotation of bowel44110
Excise intestine lesion(s)44111
Excision of bowel lesion(s)45190
Destruction, rectal tumor45500
Repair of rectum45505
Repair of rectum45541
Correct rectal prolapse45550
Repair rectum/remove sigmoid45560
Repair of rectocele45562
Exploration/repair of rectum45563
Exploration/repair of rectum45800
Repair rect/bladder fistula45805
Repair fistula w/colostomy45820
Repair rectourethral fistula45825
Repair fistula w/colostomy46045
Incision of rectal abscess46060
Incision of rectal abscess46070
Incision of anal septum46257
Remove hemorrhoids & fissure46258
Remove hemorrhoids & fistula46260
Hemorrhoidectomy46261
Remove hemorrhoids & fissure46262
Remove hemorrhoids & fistula46280
Removal of anal fistula46288
Repair anal fistula46700
Repair of anal stricture46705
Repair of anal stricture46715
Rep perf anoper fistu46716
Rep perf anoper/vestib fistu46730
Construction of absent anus46735
Construction of absent anus46740
Construction of absent anus46742
Repair of imperforated anus46744
Repair of cloacal anomaly46746
Repair of cloacal anomaly46748
Repair of cloacal anomaly46750
Repair of anal sphincter46751
Repair of anal sphincter46753
Reconstruction of anus46760
Repair of anal sphincter46761
Repair of anal sphincter46762
Implant artificial sphincter47010
Open drainage, liver lesion47015
Inject/aspirate liver cyst47100
Wedge biopsy of liver47120
Partial removal of liver47122
Extensive removal of liver47125
Partial removal of liver47130
Partial removal of liver47300
Surgery for liver lesion47350
Repair liver wound47360
Repair liver wound47400
Incision of liver duct47420
Incision of bile duct47425
Incision of bile duct47460
Incise bile duct sphincter47480
Incision of gallbladder47490
Incision of gallbladder47600
Removal of gallbladder47605
Removal of gallbladder47610
Removal of gallbladder47612
Removal of gallbladder( print page 49242)47620
Removal of gallbladder47700
Exploration of bile ducts47701
Bile duct revision47711
Excision of bile duct tumor47712
Excision of bile duct tumor47715
Excision of bile duct cyst47716
Fusion of bile duct cyst47720
Fuse gallbladder & bowel47721
Fuse upper gi structures47740
Fuse gallbladder & bowel47741
Fuse gallbladder & bowel47760
Fuse bile ducts and bowel47765
Fuse liver ducts & bowel47780
Fuse bile ducts and bowel47785
Fuse bile ducts and bowel47800
Reconstruction of bile ducts47801
Placement, bile duct support47802
Fuse liver duct & intestine47900
Suture bile duct injury48000
Drainage of abdomen48001
Placement of drain, pancreas48005
Resect/debride pancreas48020
Removal of pancreatic stone48100
Biopsy of pancreas, open48120
Removal of pancreas lesion48140
Partial removal of pancreas48145
Partial removal of pancreas48146
Pancreatectomy48148
Removal of pancreatic duct48150
Partial removal of pancreas48152
Pancreatectomy48153
Pancreatectomy48154
Pancreatectomy48155
Removal of pancreas48180
Fuse pancreas and bowel48500
Surgery of pancreatic cyst48510
Drain pancreatic pseudocyst48520
Fuse pancreas cyst and bowel48540
Fuse pancreas cyst and bowel48545
Pancreatorrhaphy48547
Duodenal exclusion49215
Excise sacral spine tumor49900
Repair of abdominal wall51020
Incise & treat bladder51500
Removal of bladder cyst51530
Removal of bladder lesion51535
Repair of ureter lesion51550
Partial removal of bladder51555
Partial removal of bladder51565
Revise bladder & ureter(s)51570
Removal of bladder51575
Removal of bladder & nodes51580
Remove bladder/revise tract51585
Removal of bladder & nodes51590
Remove bladder/revise tract51595
Remove bladder/revise tract51596
Remove bladder/create pouch51597
Removal of pelvic structures51715
Endoscopic injection/implant51800
Revision of bladder/urethra51820
Revision of urinary tract51845
Repair bladder neck51860
Repair of bladder wound51865
Repair of bladder wound51880
Repair of bladder opening51900
Repair bladder/vagina lesion51920
Close bladder-uterus fistula51925
Hysterectomy/bladder repair51940
Correction of bladder defect51960
Revision of bladder & bowel51980
Construct bladder opening52000
Cystoscopy52001
Cystoscopy, removal of clots52005
Cystoscopy & ureter catheter52281
Cystoscopy and treatment52283
Cystoscopy and treatment52285
Cystoscopy and treatment52332
Cystoscopy and treatment52647
Laser surgery of prostate52648
Laser surgery of prostate53010
Incision of urethra53080
Drainage of urinary leakage53085
Drainage of urinary leakage53210
Removal of urethra53215
Removal of urethra53220
Treatment of urethra lesion53230
Removal of urethra lesion53235
Removal of urethra lesion53240
Surgery for urethra pouch53250
Removal of urethra gland53400
Revise urethra, stage 153405
Revise urethra, stage 253410
Reconstruction of urethra53415
Reconstruction of urethra53420
Reconstruct urethra, stage 153425
Reconstruct urethra, stage 253430
Reconstruction of urethra53445
Insert uro/ves nck sphincter53449
Repair uro sphincter53450
Revision of urethra53460
Revision of urethra53502
Repair of urethra injury53505
Repair of urethra injury53510
Repair of urethra injury53515
Repair of urethra injury53520
Repair of urethra defect54205
Treatment of penis lesion54300
Revision of penis54304
Revision of penis54308
Reconstruction of urethra54312
Reconstruction of urethra54316
Reconstruction of urethra54318
Reconstruction of urethra54322
Reconstruction of urethra54324
Reconstruction of urethra54326
Reconstruction of urethra54328
Revise penis/urethra54332
Revise penis/urethra54336
Revise penis/urethra54340
Secondary urethral surgery54344
Secondary urethral surgery54348
Secondary urethral surgery54352
Reconstruct urethra/penis54360
Penis plastic surgery54380
Repair penis54385
Repair penis54390
Repair penis and bladder54400
Insert semi-rigid prosthesis54401
Insert self-contd prosthesis54405
Insert multi-comp penis pros54520
Removal of testis54530
Removal of testis54535
Extensive testis surgery54550
Exploration for testis54560
Exploration for testis54600
Reduce testis torsion54640
Suspension of testis54650
Orchiopexy (fowler-stephens)54660
Revision of testis54670
Repair testis injury54680
Relocation of testis(es)54820
Exploration of epididymis54830
Remove epididymis lesion54840
Remove epididymis lesion54860
Removal of epididymis54861
Removal of epididymis54900
Fusion of spermatic ducts54901
Fusion of spermatic ducts55040
Removal of hydrocele55041
Removal of hydroceles55060
Repair of hydrocele55500
Removal of hydrocele55520
Removal of sperm cord lesion55530
Revise spermatic cord veins55535
Revise spermatic cord veins55540
Revise hernia & sperm veins55600
Incise sperm duct pouch55605
Incise sperm duct pouch55650
Remove sperm duct pouch55680
Remove sperm pouch lesion55720
Drainage of prostate abscess55725
Drainage of prostate abscess55801
Removal of prostate55810
Extensive prostate surgery55812
Extensive prostate surgery55815
Extensive prostate surgery55821
Removal of prostate55831
Removal of prostate55840
Extensive prostate surgery55842
Extensive prostate surgery55845
Extensive prostate surgery55860
Surgical exposure, prostate55862
Extensive prostate surgery55865
Extensive prostate surgery56620
Partial removal of vulva56625
Complete removal of vulva56630
Extensive vulva surgery56631
Extensive vulva surgery56632
Extensive vulva surgery56633
Extensive vulva surgery56634
Extensive vulva surgery56637
Extensive vulva surgery56640
Extensive vulva surgery56805
Repair clitoris57010
Drainage of pelvic abscess57106
Remove vagina wall, partial57107
Remove vagina tissue, part57109
Vaginectomy partial w/nodes57110
Remove vagina wall, complete57111
Remove vagina tissue, compl57112
Vaginectomy w/nodes, compl57120
Closure of vagina57210
Repair vagina/perineum57307
Fistula repair & colostomy57308
Fistula repair, transperine57310
Repair urethrovaginal lesion57311
Repair urethrovaginal lesion57320
Repair bladder-vagina lesion57330
Repair bladder-vagina lesion57335
Repair vagina57530
Removal of cervix( print page 49243)57531
Removal of cervix, radical57540
Removal of residual cervix57545
Remove cervix/repair pelvis57550
Removal of residual cervix57555
Remove cervix/repair vagina57556
Remove cervix, repair bowel57700
Revision of cervix57720
Revision of cervix58120
Dilation and curettage58140
Myomectomy abdom method58145
Myomectomy vag method58400
Suspension of uterus58410
Suspension of uterus58520
Repair of ruptured uterus58540
Revision of uterus58555
Hysteroscopy, dx, sep proc58558
Hysteroscopy, biopsy58562
Hysteroscopy, remove fb58600
Division of fallopian tube58605
Division of fallopian tube58660
Laparoscopy, lysis58662
Laparoscopy, excise lesions58670
Laparoscopy, tubal cautery58672
Laparoscopy, fimbrioplasty58673
Laparoscopy, salpingostomy58700
Removal of fallopian tube58720
Removal of ovary/tube(s)58740
Revise fallopian tube(s)58750
Repair oviduct58752
Revise ovarian tube(s)58760
Remove tubal obstruction58770
Create new tubal opening58805
Drainage of ovarian cyst(s)58820
Drain ovary abscess, open58822
Drain ovary abscess, percut58825
Transposition, ovary(s)58900
Biopsy of ovary(s)58920
Partial removal of ovary(s)58925
Removal of ovarian cyst(s)58940
Removal of ovary(s)58943
Removal of ovary(s)58950
Resect ovarian malignancy58951
Resect ovarian malignancy58952
Resect ovarian malignancy58960
Exploration of abdomen59100
Remove uterus lesion59120
Treat ectopic pregnancy59121
Treat ectopic pregnancy59130
Treat ectopic pregnancy59130
Treat ectopic pregnancy59135
Treat ectopic pregnancy59136
Treat ectopic pregnancy59150
Treat ectopic pregnancy59151
Treat ectopic pregnancy59812
Treatment of miscarriage59850
Abortion59851
Abortion59852
Abortion59855
Abortion59856
Abortion59857
Abortion59870
Evacuate mole of uterus60200
Remove thyroid lesion60210
Partial thyroid excision60212
Partial thyroid excision60220
Partial removal of thyroid60225
Partial removal of thyroid60240
Removal of thyroid60252
Removal of thyroid60254
Extensive thyroid surgery60260
Repeat thyroid surgery60270
Removal of thyroid60271
Removal of thyroid60280
Remove thyroid duct lesion60281
Remove thyroid duct lesion60500
Explore parathyroid glands60502
Re-explore parathyroids60505
Explore parathyroid glands60520
Removal of thymus gland60521
Removal of thymus gland60522
Removal of thymus gland60540
Explore adrenal gland60545
Explore adrenal gland60600
Remove carotid body lesion60605
Remove carotid body lesion61343
Incise skull (press relief)61345
Relieve cranial pressure61440
Incise skull for surgery61450
Incise skull for surgery61458
Incise skull for brain wound61460
Incise skull for surgery61470
Incise skull for surgery61480
Incise skull for surgery61490
Incise skull for surgery61500
Removal of skull lesion61501
Remove infected skull bone61510
Removal of brain lesion61512
Remove brain lining lesion61514
Removal of brain abscess61516
Removal of brain lesion61518
Removal of brain lesion61519
Remove brain lining lesion61520
Removal of brain lesion61521
Removal of brain lesion61522
Removal of brain abscess61524
Removal of brain lesion61526
Removal of brain lesion61530
Removal of brain lesion61531
Implant brain electrodes61533
Implant brain electrodes61534
Removal of brain lesion61535
Remove brain electrodes61536
Removal of brain lesion61538
Removal of brain tissue61539
Removal of brain tissue61541
Incision of brain tissue61542
Removal of brain tissue61543
Removal of brain tissue61544
Remove & treat brain lesion61545
Excision of brain tumor61546
Removal of pituitary gland61548
Removal of pituitary gland61550
Release of skull seams61552
Release of skull seams61556
Incise skull/sutures61557
Incise skull/sutures61558
Excision of skull/sutures61559
Excision of skull/sutures61563
Excision of skull tumor61564
Excision of skull tumor61570
Remove foreign body, brain61571
Incise skull for brain wound61575
Skull base/brainstem surgery61618
Repair dura61619
Repair dura61680
Intracranial vessel surgery61682
Intracranial vessel surgery61684
Intracranial vessel surgery61686
Intracranial vessel surgery61690
Intracranial vessel surgery61692
Intracranial vessel surgery61700
Brain aneurysm repr, simple61702
Inner skull vessel surgery61703
Clamp neck artery61705
Revise circulation to head61708
Revise circulation to head61710
Revise circulation to head61711
Fusion of skull arteries61720
Incise skull/brain surgery61735
Incise skull/brain surgery61750
Incise skull/brain biopsy61751
Brain biopsy w/ct/mr guide61760
Implant brain electrodes61770
Incise skull for treatment61790
Treat trigeminal nerve61791
Treat trigeminal tract61793
Focus radiation beam61850
Implant neuroelectrodes61860
Implant neuroelectrodes61870
Implant neuroelectrodes61875
Implant neuroelectrodes61880
Revise/remove neuroelectrode61885
Insrt/redo neurostim 1 array62000
Treat skull fracture62005
Treat skull fracture62010
Treatment of head injury62100
Repair brain fluid leakage62115
Reduction of skull defect62116
Reduction of skull defect62117
Reduction of skull defect62140
Repair of skull defect62141
Repair of skull defect62142
Remove skull plate/flap62143
Replace skull plate/flap62145
Repair of skull & brain62146
Repair of skull with graft62147
Repair of skull with graft62180
Establish brain cavity shunt62190
Establish brain cavity shunt62192
Establish brain cavity shunt62200
Establish brain cavity shunt62201
Brain cavity shunt w/scope62220
Establish brain cavity shunt62223
Establish brain cavity shunt62225
Replace/irrigate catheter62230
Replace/revise brain shunt62256
Remove brain cavity shunt62258
Replace brain cavity shunt62287
Percutaneous diskectomy63170
Incise spinal cord tract(s)63172
Drainage of spinal cyst63173
Drainage of spinal cyst63180
Revise spinal cord ligaments63182
Revise spinal cord ligaments63185
Incise spinal column/nerves63190
Incise spinal column/nerves63191
Incise spinal column/nerves63195
Incise spinal column & cord63196
Incise spinal column & cord63197
Incise spinal column & cord63198
Incise spinal column & cord( print page 49244)63199
Incise spinal column & cord63200
Release of spinal cord63250
Revise spinal cord vessels63251
Revise spinal cord vessels63252
Revise spinal cord vessels63265
Excise intraspinal lesion63266
Excise intraspinal lesion63267
Excise intraspinal lesion63268
Excise intraspinal lesion63270
Excise intraspinal lesion63271
Excise intraspinal lesion63272
Excise intraspinal lesion63273
Excise intraspinal lesion63275
Biopsy/excise spinal tumor63276
Biopsy/excise spinal tumor63277
Biopsy/excise spinal tumor63278
Biopsy/excise spinal tumor63280
Biopsy/excise spinal tumor63281
Biopsy/excise spinal tumor63282
Biopsy/excise spinal tumor63283
Biopsy/excise spinal tumor63285
Biopsy/excise spinal tumor63286
Biopsy/excise spinal tumor63287
Biopsy/excise spinal tumor63290
Biopsy/excise spinal tumor63300
Removal of vertebral body63301
Removal of vertebral body63302
Removal of vertebral body63303
Removal of vertebral body63304
Removal of vertebral body63305
Removal of vertebral body63306
Removal of vertebral body63307
Removal of vertebral body63650
Implant neuroelectrodes63655
Implant neuroelectrodes63660
Revise/remove neuroelectrode63685
Insrt/redo spine n generator63688
Revise/remove neuroreceiver63700
Repair of spinal herniation63702
Repair of spinal herniation63704
Repair of spinal herniation63706
Repair of spinal herniation63707
Repair spinal fluid leakage63709
Repair spinal fluid leakage63710
Graft repair of spine defect63740
Install spinal shunt63741
Install spinal shunt63744
Revision of spinal shunt63746
Removal of spinal shunt64573
Implant neuroelectrodes64575
Implant neuroelectrodes64577
Implant neuroelectrodes64580
Implant neuroelectrodes64612
Destroy nerve, face muscle64702
Revise finger/toe nerve64704
Revise hand/foot nerve64708
Revise arm/leg nerve64712
Revision of sciatic nerve64713
Revision of arm nerve(s)64714
Revise low back nerve(s)64718
Revise ulnar nerve at elbow64719
Revise ulnar nerve at wrist64721
Carpal tunnel surgery64722
Relieve pressure on nerve(s)64726
Release foot/toe nerve64732
Incision of brow nerve64734
Incision of cheek nerve64736
Incision of chin nerve64738
Incision of jaw nerve64742
Incision of facial nerve64744
Incise nerve, back of head64746
Incise diaphragm nerve64752
Incision of vagus nerve64755
Incision of stomach nerves64760
Incision of vagus nerve64761
Incision of pelvis nerve64763
Incise hip/thigh nerve64766
Incise hip/thigh nerve64771
Sever cranial nerve64772
Incision of spinal nerve64774
Remove skin nerve lesion64776
Remove digit nerve lesion64782
Remove limb nerve lesion64784
Remove nerve lesion64786
Remove sciatic nerve lesion64788
Remove skin nerve lesion64790
Removal of nerve lesion64792
Removal of nerve lesion64802
Remove sympathetic nerves64804
Remove sympathetic nerves64809
Remove sympathetic nerves64818
Remove sympathetic nerves64820
Remove sympathetic nerves64831
Repair of digit nerve64834
Repair of hand or foot nerve64835
Repair of hand or foot nerve64836
Repair of hand or foot nerve64840
Repair of leg nerve64856
Repair/transpose nerve64857
Repair arm/leg nerve64858
Repair sciatic nerve64861
Repair of arm nerves64862
Repair of low back nerves64870
Fusion of facial/other nerve64890
Nerve graft, hand or foot64891
Nerve graft, hand or foot64892
Nerve graft, arm or leg64893
Nerve graft, arm or leg64895
Nerve graft, hand or foot64896
Nerve graft, hand or foot64897
Nerve graft, arm or leg64898
Nerve graft, arm or leg64905
Nerve pedicle transfer64907
Nerve pedicle transfer65091
Revise eye65093
Revise eye with implant65101
Removal of eye65103
Remove eye/insert implant65105
Remove eye/attach implant65110
Removal of eye65112
Remove eye/revise socket65114
Remove eye/revise socket65125
Revise ocular implant65130
Insert ocular implant65135
Insert ocular implant65140
Attach ocular implant65150
Revise ocular implant65155
Reinsert ocular implant65175
Removal of ocular implant65205
Remove foreign body from eye65210
Remove foreign body from eye65220
Remove foreign body from eye65222
Remove foreign body from eye65235
Remove foreign body from eye65260
Remove foreign body from eye65265
Remove foreign body from eye65270
Repair of eye wound65272
Repair of eye wound65273
Repair of eye wound65275
Repair of eye wound65280
Repair of eye wound65285
Repair of eye wound65286
Repair of eye wound65290
Repair of eye socket wound65400
Removal of eye lesion65410
Biopsy of cornea65420
Removal of eye lesion65426
Removal of eye lesion65430
Corneal smear65435
Curette/treat cornea65436
Curette/treat cornea65450
Treatment of corneal lesion65600
Revision of cornea65710
Corneal transplant65730
Corneal transplant65750
Corneal transplant65755
Corneal transplant65760
Revision of cornea65765
Revision of cornea65767
Corneal tissue transplant65770
Revise cornea with implant65771
Radial keratotomy65772
Correction of astigmatism65775
Correction of astigmatism65780
Ocular reconst, transplant65781
Ocular reconst, transplant65782
Ocular reconst, transplant65800
Drainage of eye65805
Drainage of eye65810
Drainage of eye65815
Drainage of eye65820
Relieve inner eye pressure65850
Incision of eye65855
Laser surgery of eye65860
Incise inner eye adhesions65865
Incise inner eye adhesions65870
Incise inner eye adhesions65875
Incise inner eye adhesions65880
Incise inner eye adhesions65900
Remove eye lesion65920
Remove implant of eye65930
Remove blood clot from eye66020
Injection treatment of eye66030
Injection treatment of eye66130
Remove eye lesion66150
Glaucoma surgery66155
Glaucoma surgery66160
Glaucoma surgery66165
Glaucoma surgery66170
Glaucoma surgery66172
Incision of eye66180
Implant eye shunt66185
Revise eye shunt66220
Repair eye lesion66225
Repair/graft eye lesion66250
Follow-up surgery of eye66500
Incision of iris66505
Incision of iris66600
Remove iris and lesion66605
Removal of iris66625
Removal of iris( print page 49245)66630
Removal of iris66635
Removal of iris66680
Repair iris & ciliary body66682
Repair iris & ciliary body66700
Destruction, ciliary body66710
Ciliary transsleral therapy66711
Ciliary endoscopic ablation66720
Destruction, ciliary body66740
Destruction, ciliary body66761
Revision of iris66762
Revision of iris66770
Removal of inner eye lesion66820
Incision, secondary cataract66821
After cataract laser surgery66825
Reposition intraocular lens66830
Removal of lens lesion66840
Removal of lens material66850
Removal of lens material66852
Removal of lens material66920
Extraction of lens66930
Extraction of lens66940
Extraction of lens66982
Cataract surgery, complex66983
Cataract surg w/iol, 1 stage66984
Cataract surg w/iol, 1 stage66985
Insert lens prosthesis66986
Exchange lens prosthesis66990
Ophthalmic endoscope add-on66999
Eye surgery procedure67005
Partial removal of eye fluid67010
Partial removal of eye fluid67015
Release of eye fluid67025
Replace eye fluid67027
Implant eye drug system67028
Injection eye drug67030
Incise inner eye strands67031
Laser surgery, eye strands67036
Removal of inner eye fluid67038
Strip retinal membrane67039
Laser treatment of retina67040
Laser treatment of retina67101
Repair detached retina67105
Repair detached retina67107
Repair detached retina67108
Repair detached retina67110
Repair detached retina67112
Rerepair detached retina67115
Release encircling material67120
Remove eye implant material67121
Remove eye implant material67141
Treatment of retina67145
Treatment of retina67208
Treatment of retinal lesion67210
Treatment of retinal lesion67218
Treatment of retinal lesion67220
Treatment of choroid lesion67221
Ocular photodynamic ther67225
Eye photodynamic ther add-on67227
Treatment of retinal lesion67228
Treatment of retinal lesion67250
Reinforce eye wall67255
Reinforce/graft eye wall67299
Eye surgery procedure67311
Revise eye muscle67312
Revise two eye muscles67314
Revise eye muscle67316
Revise two eye muscles67318
Revise eye muscle(s)67320
Revise eye muscle(s) add-on67331
Eye surgery follow-up add-on67332
Rerevise eye muscles add-on67334
Revise eye muscle w/suture67335
Eye suture during surgery67340
Revise eye muscle add-on67343
Release eye tissue67345
Destroy nerve of eye muscle67350
Biopsy eye muscle67399
Eye muscle surgery procedure67400
Explore/biopsy eye socket67405
Explore/drain eye socket67412
Explore/treat eye socket67413
Explore/treat eye socket67414
Explr/decompress eye socket67415
Aspiration, orbital contents67420
Explore/treat eye socket67430
Explore/treat eye socket67440
Explore/drain eye socket67445
Explr/decompress eye socket67450
Explore/biopsy eye socket67500
Inject/treat eye socket67505
Inject/treat eye socket67515
Inject/treat eye socket67550
Insert eye socket implant67560
Revise eye socket implant67570
Decompress optic nerve67599
Orbit surgery procedure67700
Drainage of eyelid abscess67710
Incision of eyelid67715
Incision of eyelid fold67800
Remove eyelid lesion67801
Remove eyelid lesions67805
Remove eyelid lesions67808
Remove eyelid lesion(s)67810
Biopsy of eyelid67820
Revise eyelashes67825
Revise eyelashes67830
Revise eyelashes67835
Revise eyelashes67840
Remove eyelid lesion67850
Treat eyelid lesion67875
Closure of eyelid by suture67880
Revision of eyelid67882
Revision of eyelid67900
Repair brow defect67901
Repair eyelid defect67902
Repair eyelid defect67903
Repair eyelid defect67904
Repair eyelid defect67906
Repair eyelid defect67908
Repair eyelid defect67909
Revise eyelid defect67911
Revise eyelid defect67912
Correction eyelid w/implant67914
Repair eyelid defect67915
Repair eyelid defect67916
Repair eyelid defect67917
Repair eyelid defect67921
Repair eyelid defect67922
Repair eyelid defect67923
Repair eyelid defect67924
Repair eyelid defect67930
Repair eyelid wound67935
Repair eyelid wound67938
Remove eyelid foreign body67950
Revision of eyelid67961
Revision of eyelid67966
Revision of eyelid67971
Reconstruction of eyelid67973
Reconstruction of eyelid67974
Reconstruction of eyelid67975
Reconstruction of eyelid67999
Revision of eyelid68020
Incise/drain eyelid lining68040
Treatment of eyelid lesions68100
Biopsy of eyelid lining68110
Remove eyelid lining lesion68115
Remove eyelid lining lesion68130
Remove eyelid lining lesion68135
Remove eyelid lining lesion68200
Treat eyelid by injection68320
Revise/graft eyelid lining68325
Revise/graft eyelid lining68326
Revise/graft eyelid lining68328
Revise/graft eyelid lining68330
Revise eyelid lining68335
Revise/graft eyelid lining68340
Separate eyelid adhesions68360
Revise eyelid lining68362
Revise eyelid lining68371
Harvest eye tissue, alograft68399
Eyelid lining surgery68400
Incise/drain tear gland68420
Incise/drain tear sac68440
Incise tear duct opening68500
Removal of tear gland68505
Partial removal, tear gland68510
Biopsy of tear gland68520
Removal of tear sac68525
Biopsy of tear sac68530
Clearance of tear duct68540
Remove tear gland lesion68550
Remove tear gland lesion68700
Repair tear ducts68705
Revise tear duct opening68720
Create tear sac drain68745
Create tear duct drain68750
Create tear duct drain68760
Close tear duct opening68761
Close tear duct opening68770
Close tear system fistula68801
Dilate tear duct opening68810
Probe nasolacrimal duct68811
Probe nasolacrimal duct68815
Probe nasolacrimal duct68840
Explore/irrigate tear ducts68850
Injection for tear sac x-ray68899
Tear duct system surgery76075
Dxa bone density, axial76510
Ophth us, b & quant a76511
Ophth us, quant a only76512
Ophth us, b w/non-quant a76513
Echo exam of eye, water bath76514
Echo exam of eye, thickness76516
Echo exam of eye76519
Echo exam of eye76529
Echo exam of eye78350
Bone mineral, single photon78472
Gated heart, planar, single78481
Heart first pass, single78483
Heart first pass, multiple91010
Esophagus motility study( print page 49246)91034
Gastroesophageal reflux test91037
Esoph imped function test91038
Esoph imped funct test >1h92002
Eye exam, new patient92004
Eye exam, new patient92012
Eye exam established pat92014
Eye exam & treatment92015
Refraction92018
New eye exam & treatment92019
Eye exam & treatment92020
Special eye evaluation92060
Special eye evaluation92065
Orthoptic/pleoptic training92070
Fitting of contact lens92081
Visual field examination(s)92082
Visual field examination(s)92083
Visual field examination(s)92100
Serial tonometry exam(s)92120
Tonography & eye evaluation92130
Water provocation tonography92135
Opthalmic dx imaging92136
Ophthalmic biometry92140
Glaucoma provocative tests92225
Special eye exam, initial92226
Special eye exam, subsequent92230
Eye exam with photos92235
Eye exam with photos92240
Icg angiography92250
Eye exam with photos92260
Ophthalmoscopy/dynamome try92265
Eye muscle evaluation92270
Electro-oculography92275
Electroretinography92283
Color vision examination92284
Dark adaptation eye exam92285
Eye photography92286
Internal eye photography92287
Internal eye photography92310
Contact lens fitting92311
Contact lens fitting92312
Contact lens fitting92313
Contact lens fitting92314
Prescription of contact lens92315
Prescription of contact lens92316
Prescription of contact lens92317
Prescription of contact lens92325
Modification of contact lens92326
Replacement of contact lens
 Addendum D.—Proposed 2007 Geographic Practice Cost Indices by Medicare Carrier and Locality
Carrier
Locality
Locality name
Work GPCI
PE GPCI
MP GPCI00510
00
Alabama
0.982
0.847
0.74000831
01
Alaska
1.017
1.105
1.01300832
00
Arizona
0.987
0.994
1.05200520
13
Arkansas
0.961
0.832
0.43131140
03
Marin/Napa/Solano, CA
1.035
1.342
0.64031140
05
San Francisco, CA
1.060
1.546
0.64031140
06
San Mateo, CA
1.073
1.539
0.62931140
07
Oakland/Berkley, CA
1.054
1.373
0.64031140
09
Santa Clara, CA
1.083
1.543
0.59531146
17
Ventura, CA
1.028
1.181
0.73231146
18
Los Angeles, CA
1.041
1.158
0.93931146
26
Anaheim/Santa Ana, CA
1.034
1.238
0.93931140
99
Rest of California*
1.007
1.054
0.72131146
99
Rest of California*
1.007
1.054
0.72100824
01
Colorado
0.986
1.015
0.79000591
00
Connecticut
1.038
1.172
0.88600903
01
DC + MD/VA Suburbs
1.048
1.252
0.91100902
01
Delaware
1.012
1.020
0.87700590
03
Fort Lauderdale, FL
0.988
0.990
1.67500590
04
Miami, FL
1.000
1.048
2.23300590
99
Rest of Florida
0.973
0.936
1.25100511
01
Atlanta, GA
1.010
1.091
0.95000511
99
Rest of Georgia
0.979
0.874
0.95000833
01
Hawaii/Guam
1.005
1.113
0.78705130
00
Idaho
0.968
0.869
0.45200952
12
East St. Louis, IL
0.988
0.940
1.72200952
15
Suburban Chicago, IL
1.018
1.117
1.62600952
16
Chicago, IL
1.025
1.128
1.83700952
99
Rest of Illinois
0.974
0.874
1.17400630
00
Indiana
0.985
0.908
0.42900826
00
Iowa
0.967
0.869
0.57900650
00
Kansas*
0.968
0.880
0.70900740
04
Kansas*
0.968
0.880
0.70900660
00
Kentucky
0.970
0.855
0.85900528
01
New Orleans, LA
0.986
0.947
1.17800528
99
Rest of Louisiana
0.970
0.848
1.00031142
03
Southern Maine
0.980
1.014
0.62631142
99
Rest of Maine
0.962
0.887
0.62600901
01
Baltimore/Surr. Cntys, MD
1.012
1.080
0.93200901
99
Rest of Maryland
0.993
0.981
0.74831143
01
Metropolitan Boston
1.030
1.331
0.81031143
99
Rest of Massachusetts
1.007
1.015
0.81000953
01
Detroit, MI
1.037
1.056
2.70000953
99
Rest of Michigan
0.997
0.922
1.49400954
00
Minnesota
0.991
1.006
0.404( print page 49247)00512
00
Mississippi
0.960
0.841
0.71100523
01
Metropolitan St. Louis, MO
0.992
0.956
0.92600740
02
Metropolitan Kansas City, MO
0.989
0.977
0.93100523
99
Rest of Missouri*
0.950
0.803
0.87800740
99
Rest of Missouri*
0.950
0.803
0.87800751
01
Montana
0.950
0.845
0.88900655
00
Nebraska
0.959
0.876
0.44700834
00
Nevada
1.003
1.045
1.05031144
40
New Hampshire
0.981
1.029
0.92700805
01
Northern NJ
1.058
1.222
0.95800805
99
Rest of New Jersey
1.043
1.121
0.95800521
05
New Mexico
0.972
0.888
0.88000801
99
Rest of New York
0.997
0.919
0.66600803
01
Manhattan, NY
1.065
1.300
1.00000803
02
NYC Suburbs/Long I., NY
1.052
1.283
1.75600803
03
Poughkpsie/N NYC Suburbs, NY
1.014
1.076
1.14814330
04
Queens, NY
1.032
1.230
1.68205535
00
North Carolina
0.971
0.922
0.63000820
01
North Dakota
0.946
0.861
0.59300883
00
Ohio
0.992
0.934
0.96000522
00
Oklahoma
0.964
0.856
0.37600835
01
Portland, OR
1.002
1.059
0.43400835
99
Rest of Oregon
0.968
0.927
0.43400865
01
Metropolitan Philadelphia, PA
1.016
1.106
1.36400865
99
Rest of Pennsylvania
0.992
0.904
0.79300973
20
Puerto Rico
0.906
0.699
0.25700524
01
Rhode Island
1.045
0.991
0.89500880
01
South Carolina
0.975
0.894
0.38800820
02
South Dakota
0.943
0.877
0.35905440
35
Tennessee
0.977
0.881
0.62100900
09
Brazoria, TX
1.020
0.963
1.27700900
11
Dallas, TX
1.009
1.064
1.04400900
15
Galveston, TX
0.990
0.954
1.27700900
18
Houston, TX
1.016
1.016
1.27600900
20
Beaumont, TX
0.983
0.862
1.27700900
28
Fort Worth, TX
0.997
0.991
1.04400900
31
Austin, TX
0.991
1.048
0.97000900
99
Rest of Texas
0.968
0.866
1.12000910
09
Utah
0.977
0.938
0.65131145
50
Vermont
0.968
0.970
0.50500973
50
Virgin Islands
0.967
1.015
0.98700904
00
Virginia
0.981
0.942
0.56900836
02
Seattle (King Cnty), WA
1.014
1.133
0.80500836
99
Rest of Washington
0.987
0.980
0.80500884
16
West Virginia
0.973
0.820
1.52200951
00
Wisconsin
0.987
0.920
0.77700825
21
Wyoming
0.956
0.855
0.920
 Addendum E.—2007 Proposed GAFs
Carrier
Locality
Locality name
GAF31140
09
Santa Clara, CA
1.26531140
06
San Mateo, CA
1.25931140
05
San Francisco, CA
1.25600803
02
NYC Suburbs/Long I., NY
1.18031140
07
Oakland/Berkley, CA
1.17700803
01
Manhattan, NY
1.16531140
03
Marin/Napa/Solano, CA
1.15431143
01
Metropolitan Boston
1.15314330
04
Queens, NY
1.14400903
01
DC + MD/VA Suburbs
1.13200805
01
Northern NJ
1.12631146
26
Anaheim/Santa Ana, CA
1.12000953
01
Detroit, MI
1.11000952
16
Chicago, IL
1.10200591
00
Connecticut
1.09131146
18
Los Angeles, CA
1.08800952
15
Suburban Chicago, IL
1.085( print page 49248)31146
17
Ventura, CA
1.08400805
99
Rest of New Jersey
1.07400865
01
Metropolitan Philadelphia, PA
1.06900590
04
Miami, FL
1.06900836
02
Seattle (King Cnty), WA
1.05800831
01
Alaska
1.05500803
03
Poughkpsie/N NYC Suburbs, NY
1.04600833
01
Hawaii/Guam
1.04400511
01
Atlanta, GA
1.04300901
01
Baltimore/Surr. Cntys, MD
1.03900900
11
Dallas, TX
1.03500900
18
Houston, TX
1.02600834
00
Nevada
1.02331140
99
Rest of California*
1.01731146
99
Rest of California*
1.01700524
01
Rhode Island
1.01600590
03
Fort Lauderdale, FL
1.01500900
31
Austin, TX
1.01500902
01
Delaware
1.01100900
09
Brazoria, TX
1.00500835
01
Portland, OR
1.00531143
99
Rest of Massachusetts
1.00331144
40
New Hampshire
1.00000900
28
Fort Worth, TX
0.99600952
12
East St. Louis, IL
0.99500832
00
Arizona
0.99300824
01
Colorado
0.99100973
50
Virgin Islands
0.98900900
15
Galveston, TX
0.98500953
99
Rest of Michigan
0.98400740
02
Metropolitan Kansas City, MO
0.98231142
03
Southern Maine
0.98100901
99
Rest of Maryland
0.97800836
99
Rest of Washington
0.97700528
01
New Orleans, LA
0.97600954
00
Minnesota
0.97500523
01
Metropolitan St. Louis, MO
0.97400590
99
Rest of Florida
0.96800883
00
Ohio
0.96531145
50
Vermont
0.95100801
99
Rest of New York
0.95000951
00
Wisconsin
0.95000904
00
Virginia
0.94800910
09
Utah
0.94700865
99
Rest of Pennsylvania
0.94600900
20
Beaumont, TX
0.94200952
99
Rest of Illinois
0.93805535
00
North Carolina
0.93600511
99
Rest of Georgia
0.93200521
05
New Mexico
0.93200630
00
Indiana
0.93000835
99
Rest of Oregon
0.92900900
99
Rest of Texas
0.92900884
16
West Virginia
0.92705440
35
Tennessee
0.92100650
00
Kansas*
0.91900740
04
Kansas*
0.91900528
99
Rest of Louisiana
0.91800880
01
South Carolina
0.91731142
99
Rest of Maine
0.91600660
00
Kentucky
0.91500510
00
Alabama
0.91400825
21
Wyoming
0.91000826
00
Iowa
0.90905130
00
Idaho
0.90500655
00
Nebraska
0.90300751
01
Montana
0.90200512
00
Mississippi
0.89800820
01
North Dakota
0.89500522
00
Oklahoma
0.89400820
02
South Dakota
0.89100520
13
Arkansas
0.884( print page 49249)00523
99
Rest of Missouri
0.88300740
99
Rest of Missouri
0.88300973
20
Puerto Rico
0.790
 Addendum F.—Proposed CPT/HCPCS Imaging Codes Defined by Section 5102(b) of the DRA
HCPCS/
                                     CPT
Short descriptor31620
Endobronchial us add-on37250
Iv us first vessel add-on37251
Iv us each add vessel add-on51798
Us urine capacity measure70010
Contrast x-ray of brain70015
Contrast x-ray of brain70030
X-ray eye for foreign body70100
X-ray exam of jaw70110
X-ray exam of jaw70120
X-ray exam of mastoids70130
X-ray exam of mastoids70134
X-ray exam of middle ear70140
X-ray exam of facial bones70150
X-ray exam of facial bones70160
X-ray exam of nasal bones70170
X-ray exam of tear duct70190
X-ray exam of eye sockets70200
X-ray exam of eye sockets70210
X-ray exam of sinuses70220
X-ray exam of sinuses70240
X-ray exam, pituitary saddle70250
X-ray exam of skull70260
X-ray exam of skull70300
X-ray exam of teeth70310
X-ray exam of teeth70320
Full mouth x-ray of teeth70328
X-ray exam of jaw joint70330
X-ray exam of jaw joints70332
X-ray exam of jaw joint70336
Magnetic image, jaw joint70350
X-ray head for orthodontia70355
Panoramic x-ray of jaws70360
X-ray exam of neck70370
Throat x-ray & fluoroscopy70371
Speech evaluation, complex70373
Contrast x-ray of larynx70380
X-ray exam of salivary gland70390
X-ray exam of salivary duct70450
Ct head/brain w/o dye70460
Ct head/brain w/dye70470
Ct head/brain w/o & w/dye70480
Ct orbit/ear/fossa w/o dye70481
Ct orbit/ear/fossa w/dye70482
Ct orbit/ear/fossa w/o& w/dye70486
Ct maxillofacial w/o dye70487
Ct maxillofacial w/dye70488
Ct maxillofacial w/o & w/dye70490
Ct soft tissue neck w/o dye70491
Ct soft tissue neck w/dye70492
Ct sft tsue nck w/o & w/dye70496
Ct angiography, head70498
Ct angiography, neck70540
Mri orbit/face/neck w/o dye70542
Mri orbit/face/neck w/dye70543
Mri orbt/fac/nck w/o & w/dye70544
Mr angiography head w/o dye70545
Mr angiography head w/dye70546
Mr angiograph head w/o & w/dye70547
Mr angiography neck w/o dye70548
Mr angiography neck w/dye70549
Mr angiograph neck w/o & w/dye70551
Mri brain w/o dye70552
Mri brain w/dye70553
Mri brain w/o & w/dye70557
Mri brain w/o dye70558
Mri brain w/dye70559
Mri brain w/o & w/dye71010
Chest x-ray71015
Chest x-ray71020
Chest x-ray71021
Chest x-ray71022
Chest x-ray71023
Chest x-ray and fluoroscopy71030
Chest x-ray71034
Chest x-ray and fluoroscopy71035
Chest x-ray71040
Contrast x-ray of bronchi71060
Contrast x-ray of bronchi71090
X-ray & pacemaker insertion71100
X-ray exam of ribs71101
X-ray exam of ribs/chest71110
X-ray exam of ribs71111
X-ray exam of ribs/chest71120
X-ray exam of breastbone71130
X-ray exam of breastbone71250
Ct thorax w/o dye71260
Ct thorax w/dye71270
Ct thorax w/o & w/dye71275
Ct angiography, chest71550
Mri chest w/o dye71551
Mri chest w/dye71552
Mri chest w/o & w/dye71555
Mri angio chest w or w/o dye72010
X-ray exam of spine72020
X-ray exam of spine72040
X-ray exam of neck spine72050
X-ray exam of neck spine72052
X-ray exam of neck spine72069
X-ray exam of trunk spine72070
X-ray exam of thoracic spine72072
X-ray exam of thoracic spine72074
X-ray exam of thoracic spine72080
X-ray exam of trunk spine72090
X-ray exam of trunk spine72100
X-ray exam of lower spine72110
X-ray exam of lower spine72114
X-ray exam of lower spine72120
X-ray exam of lower spine72125
Ct neck spine w/o dye72126
Ct neck spine w/dye72127
Ct neck spine w/o & w/dye72128
Ct chest spine w/o dye72129
Ct chest spine w/dye72130
Ct chest spine w/o & w/dye72131
Ct lumbar spine w/o dye72132
Ct lumbar spine w/dye72133
Ct lumbar spine w/o & w/dye72141
Mri neck spine w/o dye72142
Mri neck spine w/dye72146
Mri chest spine w/o dye72147
Mri chest spine w/dye72148
Mri lumbar spine w/o dye72149
Mri lumbar spine w/dye72156
Mri neck spine w/o & w/dye72157
Mri chest spine w/o & w/dye72158
Mri lumbar spine w/o & w/dye72159
Mr angio spine w/o & w/dye72170
X-ray exam of pelvis72190
X-ray exam of pelvis72191
Ct angiograph pelv w/o & w/dye72192
Ct pelvis w/o dye72193
Ct pelvis w/dye72194
Ct pelvis w/o & w/dye72195
Mri pelvis w/o dye72196
Mri pelvis w/dye72197
Mri pelvis w/o & w/dye72198
Mr angio pelvis w/o & w/dye72200
X-ray exam sacroiliac joints72202
X-ray exam sacroiliac joints72220
X-ray exam of tailbone72240
Contrast x-ray of neck spine72255
Contrast x-ray, thorax spine72265
Contrast x-ray, lower spine72270
Contrast x-ray, spine72275
Epidurography72285
X-ray c/t spine disk72295
X-ray of lower spine disk73000
X-ray exam of collar bone73010
X-ray exam of shoulder blade73020
X-ray exam of shoulder73030
X-ray exam of shoulder73040
Contrast x-ray of shoulder73050
X-ray exam of shoulders73060
X-ray exam of humerus73070
X-ray exam of elbow73080
X-ray exam of elbow73085
Contrast x-ray of elbow73090
X-ray exam of forearm73092
X-ray exam of arm, infant73100
X-ray exam of wrist73110
X-ray exam of wrist73115
Contrast x-ray of wrist73120
X-ray exam of hand73130
X-ray exam of hand73140
X-ray exam of finger(s)73200
Ct upper extremity w/o dye73201
Ct upper extremity w/dye73202
Ct uppr extremity w/o & w/dye73206
Ct angio upr extrm w/o & w/dye73218
Mri upper extremity w/o dye73219
Mri upper extremity w/dye73220
Mri uppr extremity w/o & w/dye73221
Mri joint upr extrem w/o dye73222
Mri joint upr extrem w/dye73223
Mri joint upr extr w/o & w/dye73225
Mr angio upr extr w/o & w/dye73500
X-ray exam of hip( print page 49250)73510
X-ray exam of hip73520
X-ray exam of hips73525
Contrast x-ray of hip73530
X-ray exam of hip73540
X-ray exam of pelvis & hips73542
X-ray exam, sacroiliac joint73550
X-ray exam of thigh73560
X-ray exam of knee, 1 or 273562
X-ray exam of knee, 373564
X-ray exam, knee, 4 or more73565
X-ray exam of knees73580
Contrast x-ray of knee joint73590
X-ray exam of lower leg73592
X-ray exam of leg, infant73600
X-ray exam of ankle73610
X-ray exam of ankle73615
Contrast x-ray of ankle73620
X-ray exam of foot73630
X-ray exam of foot73650
X-ray exam of heel73660
X-ray exam of toe(s)73700
Ct lower extremity w/o dye73701
Ct lower extremity w/dye73702
Ct lwr extremity w/o & w/dye73706
Ct angio lwr extr w/o & w/dye73718
Mri lower extremity w/o dye73719
Mri lower extremity w/dye73720
Mri lwr extremity w/o & w/dye73721
Mri jnt of lwr extre w/o dye73722
Mri joint of lwr extr w/dye73723
Mri joint lwr extr w/o & w/dye73725
Mr ang lwr ext w or w/o dye74000
X-ray exam of abdomen74010
X-ray exam of abdomen74020
X-ray exam of abdomen74022
X-ray exam series, abdomen74150
Ct abdomen w/o dye74160
Ct abdomen w/dye74170
Ct abdomen w/o & w/dye74175
Ct angio abdom w/o & w/dye74181
Mri abdomen w/o dye74182
Mri abdomen w/dye74183
Mri abdomen w/o & w/dye74185
Mri angio, abdom w orw/o dye74190
X-ray exam of peritoneum74210
Contrst x-ray exam of throat74220
Contrast x-ray, esophagus74230
Cine/vid x-ray, throat/esoph74235
Remove esophagus obstruction74240
X-ray exam, upper gi tract74241
X-ray exam, upper gi tract74245
X-ray exam, upper gi tract74246
Contrst x-ray uppr gi tract74247
Contrst x-ray uppr gi tract74249
Contrst x-ray uppr gi tract74250
X-ray exam of small bowel74251
X-ray exam of small bowel74260
X-ray exam of small bowel74270
Contrast x-ray exam of colon74280
Contrast x-ray exam of colon74283
Contrast x-ray exam of colon74290
Contrast x-ray, gallbladder74291
Contrast x-rays, gallbladder74300
X-ray bile ducts/pancreas74301
X-rays at surgery add-on74305
X-ray bile ducts/pancreas74320
Contrast x-ray of bile ducts74327
X-ray bile stone removal74328
X-ray bile duct endoscopy74329
X-ray for pancreas endoscopy74330
X-ray bile/panc endoscopy74340
X-ray guide for GI tube74350
X-ray guide, stomach tube74355
X-ray guide, intestinal tube74360
X-ray guide, GI dilation74363
X-ray, bile duct dilation74400
Contrst x-ray, urinary tract74410
Contrst x-ray, urinary tract74415
Contrst x-ray, urinary tract74420
Contrst x-ray, urinary tract74425
Contrst x-ray, urinary tract74430
Contrast x-ray, bladder74440
X-ray, male genital tract74445
X-ray exam of penis74450
X-ray, urethra/bladder74455
X-ray, urethra/bladder74470
X-ray exam of kidney lesion74475
X-ray control, cath insert74480
X-ray control, cath insert74485
X-ray guide, GU dilation74710
X-ray measurement of pelvis74740
X-ray, female genital tract74742
X-ray, fallopian tube74775
X-ray exam of perineum75552
Heart mri for morph w/o dye75553
Heart mri for morph w/dye75554
Cardiac MRI/function75555
Cardiac MRI/limited study75556
Cardiac MRI/flow mapping75600
Contrast x-ray exam of aorta75605
Contrast x-ray exam of aorta75625
Contrast x-ray exam of aorta75630
X-ray aorta, leg arteries75635
Ct angio abdominal arteries75650
Artery x-rays, head & neck75658
Artery x-rays, arm75660
Artery x-rays, head & neck75662
Artery x-rays, head & neck75665
Artery x-rays, head & neck75671
Artery x-rays, head & neck75676
Artery x-rays, neck75680
Artery x-rays, neck75685
Artery x-rays, spine75705
Artery x-rays, spine75710
Artery x-rays, arm/leg75716
Artery x-rays, arms/legs75722
Artery x-rays, kidney75724
Artery x-rays, kidneys75726
Artery x-rays, abdomen75731
Artery x-rays, adrenal gland75733
Artery x-rays, adrenals75736
Artery x-rays, pelvis75741
Artery x-rays, lung75743
Artery x-rays, lungs75746
Artery x-rays, lung75756
Artery x-rays, chest75774
Artery x-ray, each vessel75790
Visualize A-V shunt75801
Lymph vessel x-ray, arm/leg75803
Lymph vessel x-ray,arms/legs75805
Lymph vessel x-ray, trunk75807
Lymph vessel x-ray, trunk75809
Nonvascular shunt, x-ray75810
Vein x-ray, spleen/liver75820
Vein x-ray, arm/leg75822
Vein x-ray, arms/legs75825
Vein x-ray, trunk75827
Vein x-ray, chest75831
Vein x-ray, kidney75833
Vein x-ray, kidneys75840
Vein x-ray, adrenal gland75842
Vein x-ray, adrenal glands75860
Vein x-ray, neck75870
Vein x-ray, skull75872
Vein x-ray, skull75880
Vein x-ray, eye socket75885
Vein x-ray, liver75887
Vein x-ray, liver75889
Vein x-ray, liver75891
Vein x-ray, liver75893
Venous sampling by catheter75894
X-rays, transcath therapy75896
X-rays, transcath therapy75898
Follow-up angiography75900
Intravascular cath exchange75901
Remove cva device obstruct75902
Remove cva lumen obstruct75940
X-ray placement, vein filter75945
Intravascular us75946
Intravascular us add-on75952
Endovasc repair abdom aorta75953
Abdom aneurysm endovas rpr75954
Iliac aneurysm endovas rpr75956
Xray, endovasc thor ao repr75957
Xray, endovasc thor ao repr75958
Xray, place prox ext thor ao75959
Xray, place dist ext thor ao75960
Transcath iv stent rs&i75961
Retrieval, broken catheter75962
Repair arterial blockage75964
Repair artery blockage, each75966
Repair arterial blockage75968
Repair artery blockage, each75970
Vascular biopsy75978
Repair venous blockage75980
Contrast xray exam bile duct75982
Contrast xray exam bile duct75984
Xray control catheter change75989
Abscess drainage under x-ray75992
Atherectomy, x-ray exam75993
Atherectomy, x-ray exam75994
Atherectomy, x-ray exam75995
Atherectomy, x-ray exam75996
Atherectomy, x-ray exam75998
Fluoroguide for vein device76000
Fluoroscope examination76001
Fluoroscope exam, extensive76003
Needle localization by x-ray76005
Fluoroguide for spine inject76006
X-ray stress view76010
X-ray, nose to rectum76012
Percut vertebroplasty fluor76013
Percut vertebroplasty, ct76020
X-rays for bone age76040
X-rays, bone evaluation76061
X-rays, bone survey76062
X-rays, bone survey76065
X-rays, bone evaluation76066
Joint survey, single view76070
Ct bone density, axial76071
Ct bone density, peripheral( print page 49251)76075
Dxa bone density, axial76076
Dxa bone density/peripheral76077
Dxa bone density/v-fracture76078
Radiographic absorptiometry76080
X-ray exam of fistula76086
X-ray of mammary duct76088
X-ray of mammary ducts76093
Magnetic image, breast76094
Magnetic image, both breasts76095
Stereotactic breast biopsy76096
X-ray of needle wire, breast76098
X-ray exam, breast specimen76100
X-ray exam of body section76101
Complex body section x-ray76102
Complex body section x-rays76120
Cine/video x-rays76125
Cine/video x-rays add-on76140
X-ray consultation76150
X-ray exam, dry process76350
Special x-ray contrast study76355
Ct scan for localization76360
Ct scan for needle biopsy76362
Ct guide for tissue ablation76370
Ct scan for therapy guide76376
3d render w/o postprocess76377
3d rendering w/postprocess76380
CAT scan follow-up study76390
Mr spectroscopy76393
Mr guidance for needle place76394
Mri for tissue ablation76400
Magnetic image, bone marrow76496
Fluoroscopic procedure76497
Ct procedure76498
Mri procedure76506
Echo exam of head76510
Ophth us, b & quant a76511
Ophth us, quant a only76512
Ophth us, b w/non-quant a76513
Echo exam of eye, water bath76514
Echo exam of eye, thickness76516
Echo exam of eye76519
Echo exam of eye76529
Echo exam of eye76536
Us exam of head and neck76604
Us exam, chest, b-scan76645
Us exam, breast(s)76700
Us exam, abdom, complete76705
Echo exam of abdomen76770
Us exam abdo back wall, comp76775
Us exam abdo back wall, lim76778
Us exam kidney transplant76800
Us exam, spinal canal76801
Ob us < 14 wks, single fetus76802
Ob us < 14 wks, add'l fetus76805
Ob us >/= 14 wks, sngl fetus76810
Ob us >/= 14 wks, addl fetus76811
Ob us, detailed, sngl fetus76812
Ob us, detailed, addl fetus76815
Ob us, limited, fetus(s)76816
Ob us, follow-up, per fetus76817
Transvaginal us, obstetric76818
Fetal biophys profile w/nst76819
Fetal biophys profil w/o nst76820
Umbilical artery echo76821
Middle cerebral artery echo76825
Echo exam of fetal heart76826
Echo exam of fetal heart76827
Echo exam of fetal heart76828
Echo exam of fetal heart76830
Transvaginal us, non-ob76831
Echo exam, uterus76856
Us exam, pelvic, complete76857
Us exam, pelvic, limited76870
Us exam, scrotum76872
Us, transrectal76873
Echograp trans r, pros study76880
Us exam, extremity76885
Us exam infant hips, dynamic76886
Us exam infant hips, static76930
Echo guide, cardiocentesis76932
Echo guide for heart biopsy76936
Echo guide for artery repair76937
Us guide, vascular access76940
Us guide, tissue ablation76941
Echo guide for transfusion76942
Echo guide for biopsy76945
Echo guide, villus sampling76946
Echo guide for amniocentesis76948
Echo guide, ova aspiration76950
Echo guidance radiotherapy76965
Echo guidance radiotherapy76970
Ultrasound exam follow-up76975
GI endoscopic ultrasound76977
Us bone density measure76986
Ultrasound guide intraoper77417
Radiology port film(s)77421
Stereoscopic x-ray guidance78006
Thyroid imaging with uptake78007
Thyroid image, mult uptakes78010
Thyroid imaging78011
Thyroid imaging with flow78015
Thyroid met imaging78016
Thyroid met imaging/studies78018
Thyroid met imaging, body78020
Thyroid met uptake78070
Parathyroid nuclear imaging78075
Adrenal nuclear imaging78102
Bone marrow imaging, ltd78103
Bone marrow imaging, mult78104
Bone marrow imaging, body78135
Red cell survival kinetics78140
Red cell sequestration78185
Spleen imaging78190
Platelet survival, kinetics78195
Lymph system imaging78201
Liver imaging78202
Liver imaging with flow78205
Liver imaging (3D)78206
Liver image (3d) with flow78215
Liver and spleen imaging78216
Liver & spleen image/flow78220
Liver function study78223
Hepatobiliary imaging78230
Salivary gland imaging78231
Serial salivary imaging78232
Salivary gland function exam78258
Esophageal motility study78261
Gastric mucosa imaging78262
Gastroesophageal reflux exam78264
Gastric emptying study78278
Acute GI blood loss imaging78282
GI protein loss exam78290
Meckel's divert exam78291
Leveen/shunt patency exam78300
Bone imaging, limited area78305
Bone imaging, multiple areas78306
Bone imaging, whole body78315
Bone imaging, 3 phase78320
Bone imaging (3D)78350
Bone mineral, single photon78351
Bone mineral, dual photon78428
Cardiac shunt imaging78445
Vascular flow imaging78456
Acute venous thrombus image78457
Venous thrombosis imaging78458
Ven thrombosis images, bilat78459
Heart muscle imaging (PET)78460
Heart muscle blood, single78461
Heart muscle blood, multiple78464
Heart image (3d), single78465
Heart image (3d), multiple78466
Heart infarct image78468
Heart infarct image (ef)78469
Heart infarct image (3D)78472
Gated heart, planar, single78473
Gated heart, multiple78478
Heart wall motion add-on78480
Heart function add-on78481
Heart first pass, single78483
Heart first pass, multiple78491
Heart image (pet), single78492
Heart image (pet), multiple78494
Heart image, spect78496
Heart first pass add-on78580
Lung perfusion imaging78584
Lung V/Q image single breath78585
Lung V/Q imaging78586
Aerosol lung image, single78587
Aerosol lung image, multiple78588
Perfusion lung image78591
Vent image, 1 breath, 1 proj78593
Vent image, 1 proj, gas78594
Vent image, mult proj, gas78596
Lung differential function78600
Brain imaging, ltd static78601
Brain imaging, ltd w/flow78605
Brain imaging, complete78606
Brain imaging, compl w/flow78607
Brain imaging (3D)78608
Brain imaging (PET)78609
Brain imaging (PET)78610
Brain flow imaging only78615
Cerebral vascular flow image78630
Cerebrospinal fluid scan78635
CSF ventriculography78645
CSF shunt evaluation78647
Cerebrospinal fluid scan78650
CSF leakage imaging78660
Nuclear exam of tear flow78700
Kidney imaging, static78701
Kidney imaging with flow78704
Imaging renogram78707
Kidney flow/function image78708
Kidney flow/function image78709
Kidney flow/function image78710
Kidney imaging (3D)78715
Renal vascular flow exam78730
Urinary bladder retention78740
Ureteral reflux study78760
Testicular imaging78761
Testicular imaging/flow( print page 49252)78800
Tumor imaging, limited area78801
Tumor imaging, mult areas78802
Tumor imaging, whole body78803
Tumor imaging (3D)78804
Tumor imaging, whole body78805
Abscess imaging, ltd area78806
Abscess imaging, whole body78807
Nuclear localization/absce ss78811
Tumor imaging (pet), limited78812
Tumor image (pet)/skul-thigh78813
Tumor image (pet) full body78814
Tumor image pet/ct, limited78815
Tumorimage pet/ct skul-thigh78816
Tumor image pet/ct full body78890
Nuclear medicine data proc78891
Nuclear med data proc93303
Echo transthoracic93304
Echo transthoracic93307
Echo exam of heart93308
Echo exam of heart93312
Echo transesophageal93313
Echo transesophageal93314
Echo transesophageal93315
Echo transesophageal93316
Echo transesophageal93317
Echo transesophageal93318
Echo transesophageal intraop93320
Doppler echo exam, heart93321
Doppler echo exam, heart93325
Doppler color flow add-on93350
Echo transthoracic93555
Imaging, cardiac cath93556
Imaging, cardiac cath93571
Heart flow reserve measure93572
Heart flow reserve measure93875
Extracranial study93880
Extracranial study93882
Extracranial study93886
Intracranial study93888
Intracranial study93890
Tcd, vasoreactivity study93892
Tcd, emboli detect w/o inj93893
Tcd, emboli detect w/inj93922
Extremity study93923
Extremity study93924
Extremity study93925
Lower extremity study93926
Lower extremity study93930
Upper extremity study93931
Upper extremity study93965
Extremity study93970
Extremity study93971
Extremity study93975
Vascular study93976
Vascular study93978
Vascular study93979
Vascular study93980
Penile vascular study93981
Penile vascular study93990
Doppler flow testing0028T
Dexa body composition study0042T
Ct perfusion w/contrast, cbf0066T
Ct colonography;scree n0067T
Ct colonography;dx0080T
Endovasc aort repr rad s&i0081T
Endovasc visc extnsn s&i0144T
CT heart wo dye; qual calc0145T
CT heart w/wo dye funct0146T
CCTA w/wo dye0147T
CCTA w/wo, quan calcium0148T
CCTA w/wo, strxr0149T
CCTA w/wo, strxr quan calc0150T
CCTA w/wo, disease strxr0151T
CT heart funct add-on0152T
Computer chest add-onG0120
Colon ca scrn; barium enemaG0122
Colon ca scrn; barium enemaG0130
Single energy x-ray studyG0219
PET img wholbod melano noncoG0235
PET not otherwise specifiedG0275
Renal angio, cardiac cathG0278
Iliac art angio,cardiac cathG0288
Recon, CTA for surg planG0365
Vessel mapping hemo access


# Footnotes

1.
    
                             RAND News Release: Rand Study Says Computerizing Medical Records Could Save $81 Billion Annually and Improve the Quality of Medical Care, September 14, 2005, available at 
                            *http://rand.org/​news/​press.05/​09.14.html.* Back to Citation
 2.
    
                             Transforming Health Care: The President's Health Information Technology Plan, available at: 
                            *http://www.whitehouse.gov/​infocus/​technology/​economic_​policy200404/​chap3.html.* Back to Citation


BILLING CODE 4120-01-P BILLING CODE 4120-01-C
                        ( print page 48993) [FR Doc. 06-6843 Filed 8-8-06; 4:15 pm] BILLING CODE 4120-03-P